{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys, os\n",
    "module_path = os.path.abspath(os.path.join('..'))\n",
    "module_path = os.path.join(module_path, 'scripts')\n",
    "if module_path not in sys.path:\n",
    "    sys.path.append(module_path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\vipsharm\\AppData\\Local\\Continuum\\anaconda3\\lib\\site-packages\\fuzzywuzzy\\fuzz.py:11: UserWarning: Using slow pure-python SequenceMatcher. Install python-Levenshtein to remove this warning\n",
      "  warnings.warn('Using slow pure-python SequenceMatcher. Install python-Levenshtein to remove this warning')\n"
     ]
    }
   ],
   "source": [
    "import pprint\n",
    "import pandas as pd\n",
    "import uuid\n",
    "import json\n",
    "import os\n",
    "import glob\n",
    "import re\n",
    "import sys\n",
    "from bs4 import NavigableString, BeautifulSoup\n",
    "from collections import defaultdict\n",
    "import random\n",
    "import string\n",
    "\n",
    "from utils.config import config\n",
    "from utils.logger.logger import loggerCreator\n",
    "\n",
    "## ePI Modules\n",
    "from parse.rulebook.rulebook import styleRuleDict, styleFeatureKeyList\n",
    "from parse.extractor.parser import parserExtractor\n",
    "from match.matchDocument.matchDocument import MatchDocument\n",
    "from documentAnnotation.documentAnnotation import DocumentAnnotation\n",
    "from htmlDocTypePartitioner.partition import DocTypePartitioner\n",
    "from  extractContentBetweenHeadings.dataBetweenHeadingsExtractor import DataBetweenHeadingsExtractor\n",
    "from fhirXmlGenerator.fhirXmlGenerator import FhirXmlGenerator\n",
    "%load_ext autoreload\n",
    "\n",
    "%autoreload 2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "def getRandomString(N):\n",
    "    str_ = ''.join(random.choice(string.ascii_uppercase + string.digits \\\n",
    "            + string.ascii_lowercase) for _ in range(N))\n",
    "    return str_\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Html Parsing Stage"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\Abasaglar-h-2835-en.html F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\outputJSON\\Abasaglar-h-2835-en.json\n",
      "F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\Abilify-h-471-e.html F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\outputJSON\\Abilify-h-471-e.json\n",
      "F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\AbilifyMaintena-h-2755-e.html F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\outputJSON\\AbilifyMaintena-h-2755-e.json\n",
      "F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\Adakveo-4874 EN PI.html F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\outputJSON\\Adakveo-4874 EN PI.json\n",
      "F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\Adcetris-ema-combined-h-2455-en-IB-SOB-C2500.html F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\outputJSON\\Adcetris-ema-combined-h-2455-en-IB-SOB-C2500.json\n",
      "F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\Advate-h-520-e.html F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\outputJSON\\Advate-h-520-e.json\n",
      "F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\ADYNOVI II-03 - EN PI clea.html F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\outputJSON\\ADYNOVI II-03 - EN PI clea.json\n",
      "F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\AERIUS-H-C-0313-N-XX2-PI-en-WRM.html F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\outputJSON\\AERIUS-H-C-0313-N-XX2-PI-en-WRM.json\n",
      "F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\Aimovig-PSUSA-10699-201911-PostPO-EN.html F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\outputJSON\\Aimovig-PSUSA-10699-201911-PostPO-EN.json\n",
      "F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\Alpivab EN PI clean.html F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\outputJSON\\Alpivab EN PI clean.json\n"
     ]
    }
   ],
   "source": [
    "module_path = os.path.abspath(os.path.join('..'))\n",
    "module_path = os.path.join(module_path, 'data')\n",
    "module_path = os.path.join(module_path, 'converted_to_html')\n",
    "\n",
    "filenames = glob.glob(os.path.join(module_path, '*.html'))\n",
    "filenames.extend(glob.glob(os.path.join(module_path, '*.htm')))\n",
    "\n",
    "logger = loggerCreator('Parser_'+ getRandomString(1))\n",
    "parserObj = parserExtractor(config, logger, styleRuleDict, styleFeatureKeyList)\n",
    "\n",
    "for input_filename in filenames:\n",
    "#     if(input_filename.find('emea-combined-h-2494-de')!=-1):\n",
    "        output_filename = input_filename.replace('converted_to_html','outputJSON')\n",
    "        output_filename = output_filename.replace('.html','.json')\n",
    "        output_filename = output_filename.replace('.htm','.json')\n",
    "        print(input_filename, output_filename)\n",
    "        parserObj.createPIJsonFromHTML(input_filepath = input_filename,output_filepath = output_filename,img_base64_dict= parserObj.convertImgToBase64(input_filename))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Partition Stage"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-04-25 17:55:04,846 : Partition_m : Partitioning Json: emea-combined-h-2494-es.json\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\outputJSON\n",
      "*************************** Texts with more than 2 characters**************************************\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Element</th>\n",
       "      <th>ID</th>\n",
       "      <th>Styles</th>\n",
       "      <th>Classes</th>\n",
       "      <th>Bold</th>\n",
       "      <th>Italics</th>\n",
       "      <th>Uppercased</th>\n",
       "      <th>Underlined</th>\n",
       "      <th>Indexed</th>\n",
       "      <th>IsListItem</th>\n",
       "      <th>HasBorder</th>\n",
       "      <th>IsPossibleHeading</th>\n",
       "      <th>IsHeadingType</th>\n",
       "      <th>Text</th>\n",
       "      <th>ParentId</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>&lt;div class=\"WordSection1\"&gt; &lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt; &lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span ...</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "      <td>None</td>\n",
       "      <td>['WordSection1']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>...</td>\n",
       "      <td>a8e75d1a-21a1-480c-a5a3-226c09194fd2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;ANEXO I&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>b8eaec4c-c8f6-4957-b2ad-c5f463a7d70f</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>None</td>\n",
       "      <td>ANEXO I</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>&lt;p class=\"TitleA\"&gt;&lt;span lang=\"ES\"&gt;FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f66371e4-593c-434d-a659-f50e59b40a46</td>\n",
       "      <td>None</td>\n",
       "      <td>['TitleA']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;1.       &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;NOMBRE DEL MEDICAMENTO&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>d1badb2a-282b-41b8-8285-e2ab478f4ae2</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>1.       NOMBRE DEL MEDICAMENTO</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Kalydeco 75 mg comprimidos recubiertos con película&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1a2936a8-0002-49b7-a9eb-3f6be7e471e4</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Kalydeco 75 mg comprimidos recubiertos con película</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                    Element  \\\n",
       "0   <div class=\"WordSection1\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span ...   \n",
       "24                                                                                                  <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\">ANEXO I</span></b></p>   \n",
       "26                                                                                                 <p class=\"TitleA\"><span lang=\"ES\">FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO</span></p>   \n",
       "34            <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">1.       </span></b><b><span lang=\"ES\">NOMBRE DEL MEDICAMENTO</span></b></p>   \n",
       "36                                                                                                      <p class=\"MsoNormal\"><span lang=\"ES\">Kalydeco 75 mg comprimidos recubiertos con película</span></p>   \n",
       "\n",
       "                                      ID  \\\n",
       "0   603f0744-ea60-46a5-a0d9-8674eac8d4dd   \n",
       "24  b8eaec4c-c8f6-4957-b2ad-c5f463a7d70f   \n",
       "26  f66371e4-593c-434d-a659-f50e59b40a46   \n",
       "34  d1badb2a-282b-41b8-8285-e2ab478f4ae2   \n",
       "36  1a2936a8-0002-49b7-a9eb-3f6be7e471e4   \n",
       "\n",
       "                                                               Styles  \\\n",
       "0                                                                None   \n",
       "24                                                  text-align:center   \n",
       "26                                                               None   \n",
       "34  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "36                                                               None   \n",
       "\n",
       "             Classes   Bold  Italics  Uppercased  Underlined  Indexed  \\\n",
       "0   ['WordSection1']  False    False       False       False    False   \n",
       "24     ['MsoNormal']   True    False        True       False    False   \n",
       "26        ['TitleA']   True    False        True       False    False   \n",
       "34     ['MsoNormal']   True    False        True       False     True   \n",
       "36     ['MsoNormal']  False    False       False       False    False   \n",
       "\n",
       "    IsListItem  HasBorder  IsPossibleHeading IsHeadingType  \\\n",
       "0        False      False              False          None   \n",
       "24       False      False               True          None   \n",
       "26       False      False              False          None   \n",
       "34       False      False               True            L1   \n",
       "36       False      False              False          None   \n",
       "\n",
       "                                                                                                                                                                                                       Text  \\\n",
       "0                                                                                                                                                                                                       ...   \n",
       "24                                                                                                                                                                                                  ANEXO I   \n",
       "26                                                                                                                                              FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO   \n",
       "34                                                                                                                                                                          1.       NOMBRE DEL MEDICAMENTO   \n",
       "36                                                                                                                                                      Kalydeco 75 mg comprimidos recubiertos con película   \n",
       "\n",
       "                                ParentId  \n",
       "0   a8e75d1a-21a1-480c-a5a3-226c09194fd2  \n",
       "24  603f0744-ea60-46a5-a0d9-8674eac8d4dd  \n",
       "26  603f0744-ea60-46a5-a0d9-8674eac8d4dd  \n",
       "34  603f0744-ea60-46a5-a0d9-8674eac8d4dd  \n",
       "36  603f0744-ea60-46a5-a0d9-8674eac8d4dd  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-04-25 17:55:05,083 : Partition_m : Writing partition to file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\partitionedJSONs\\emea-combined-h-2494-es_ANEXO I.json\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "*************************** Texts with more than 2 characters**************************************\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Element</th>\n",
       "      <th>ID</th>\n",
       "      <th>Styles</th>\n",
       "      <th>Classes</th>\n",
       "      <th>Bold</th>\n",
       "      <th>Italics</th>\n",
       "      <th>Uppercased</th>\n",
       "      <th>Underlined</th>\n",
       "      <th>Indexed</th>\n",
       "      <th>IsListItem</th>\n",
       "      <th>HasBorder</th>\n",
       "      <th>IsPossibleHeading</th>\n",
       "      <th>IsHeadingType</th>\n",
       "      <th>Text</th>\n",
       "      <th>ParentId</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1247</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;ANEXO II&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>9a1a9471-4115-4627-9954-98ead12e0c9f</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>None</td>\n",
       "      <td>ANEXO II</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1249</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.95pt;margin-bottom: 0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;A.        FABRICANTE(S) RESPONSABLE...</td>\n",
       "      <td>7982a580-0622-48d8-86c1-215356e07d3c</td>\n",
       "      <td>margin-top:0in;margin-right:-.95pt;margin-bottom:\\n0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>A.        FABRICANTE(S) RESPONSABLE(S) DE LA LIBERACIÓN DE LOS LOTES</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1251</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.95pt;margin-bottom: 0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;B.        CONDICIONES O RESTRICCION...</td>\n",
       "      <td>aee0e446-83f9-4e62-ac52-d61a88a7583c</td>\n",
       "      <td>margin-top:0in;margin-right:-.95pt;margin-bottom:\\n0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>B.        CONDICIONES O RESTRICCIONES DE SUMINISTRO Y USO</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1253</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.95pt;margin-bottom: 0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;C.        OTRAS CONDICIONES Y REQUI...</td>\n",
       "      <td>1cb313e2-175e-4732-b2d4-4e756d086993</td>\n",
       "      <td>margin-top:0in;margin-right:-.95pt;margin-bottom:\\n0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>C.        OTRAS CONDICIONES Y REQUISITOS DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1255</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.95pt;margin-bottom: 0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;D.        CONDICIONES O RESTRICCION...</td>\n",
       "      <td>afc4d444-75ec-46c7-85c5-5fda375e7566</td>\n",
       "      <td>margin-top:0in;margin-right:-.95pt;margin-bottom:\\n0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>D.        CONDICIONES O RESTRICCIONES EN RELACIÓN CON LA UTILIZACIÓN SEGURA Y EFICAZ DEL MEDICAMENTO</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                      Element  \\\n",
       "1247                                                                                                 <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\">ANEXO II</span></b></p>   \n",
       "1249  <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.95pt;margin-bottom: 0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt\"><b><span lang=\"ES\">A.        FABRICANTE(S) RESPONSABLE...   \n",
       "1251  <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.95pt;margin-bottom: 0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt\"><b><span lang=\"ES\">B.        CONDICIONES O RESTRICCION...   \n",
       "1253  <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.95pt;margin-bottom: 0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt\"><b><span lang=\"ES\">C.        OTRAS CONDICIONES Y REQUI...   \n",
       "1255  <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.95pt;margin-bottom: 0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt\"><b><span lang=\"ES\">D.        CONDICIONES O RESTRICCION...   \n",
       "\n",
       "                                        ID  \\\n",
       "1247  9a1a9471-4115-4627-9954-98ead12e0c9f   \n",
       "1249  7982a580-0622-48d8-86c1-215356e07d3c   \n",
       "1251  aee0e446-83f9-4e62-ac52-d61a88a7583c   \n",
       "1253  1cb313e2-175e-4732-b2d4-4e756d086993   \n",
       "1255  afc4d444-75ec-46c7-85c5-5fda375e7566   \n",
       "\n",
       "                                                                                                                 Styles  \\\n",
       "1247                                                                                                  text-align:center   \n",
       "1249  margin-top:0in;margin-right:-.95pt;margin-bottom:\\n0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt   \n",
       "1251  margin-top:0in;margin-right:-.95pt;margin-bottom:\\n0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt   \n",
       "1253  margin-top:0in;margin-right:-.95pt;margin-bottom:\\n0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt   \n",
       "1255  margin-top:0in;margin-right:-.95pt;margin-bottom:\\n0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-35.4pt   \n",
       "\n",
       "            Classes  Bold  Italics  Uppercased  Underlined  Indexed  \\\n",
       "1247  ['MsoNormal']  True    False        True       False    False   \n",
       "1249  ['MsoNormal']  True    False        True       False     True   \n",
       "1251  ['MsoNormal']  True    False        True       False     True   \n",
       "1253  ['MsoNormal']  True    False        True       False     True   \n",
       "1255  ['MsoNormal']  True    False        True       False     True   \n",
       "\n",
       "      IsListItem  HasBorder  IsPossibleHeading IsHeadingType  \\\n",
       "1247       False      False               True          None   \n",
       "1249       False      False               True            L1   \n",
       "1251       False      False               True            L1   \n",
       "1253       False      False               True            L1   \n",
       "1255       False      False               True            L1   \n",
       "\n",
       "                                                                                                      Text  \\\n",
       "1247                                                                                              ANEXO II   \n",
       "1249                                  A.        FABRICANTE(S) RESPONSABLE(S) DE LA LIBERACIÓN DE LOS LOTES   \n",
       "1251                                             B.        CONDICIONES O RESTRICCIONES DE SUMINISTRO Y USO   \n",
       "1253                       C.        OTRAS CONDICIONES Y REQUISITOS DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN   \n",
       "1255  D.        CONDICIONES O RESTRICCIONES EN RELACIÓN CON LA UTILIZACIÓN SEGURA Y EFICAZ DEL MEDICAMENTO   \n",
       "\n",
       "                                  ParentId  \n",
       "1247  603f0744-ea60-46a5-a0d9-8674eac8d4dd  \n",
       "1249  603f0744-ea60-46a5-a0d9-8674eac8d4dd  \n",
       "1251  603f0744-ea60-46a5-a0d9-8674eac8d4dd  \n",
       "1253  603f0744-ea60-46a5-a0d9-8674eac8d4dd  \n",
       "1255  603f0744-ea60-46a5-a0d9-8674eac8d4dd  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-04-25 17:55:05,152 : Partition_m : Writing partition to file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\partitionedJSONs\\emea-combined-h-2494-es_ANEXO II.json\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "*************************** Texts with more than 2 characters**************************************\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Element</th>\n",
       "      <th>ID</th>\n",
       "      <th>Styles</th>\n",
       "      <th>Classes</th>\n",
       "      <th>Bold</th>\n",
       "      <th>Italics</th>\n",
       "      <th>Uppercased</th>\n",
       "      <th>Underlined</th>\n",
       "      <th>Indexed</th>\n",
       "      <th>IsListItem</th>\n",
       "      <th>HasBorder</th>\n",
       "      <th>IsPossibleHeading</th>\n",
       "      <th>IsHeadingType</th>\n",
       "      <th>Text</th>\n",
       "      <th>ParentId</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1339</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;ANEXO III&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>4b18a3bf-32c1-4d32-97d8-f48b11d2192b</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>ANEXO III</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1341</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;ETIQUETADO Y PROSPECTO&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>cf602517-183b-414e-8966-0d82bae33ddb</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>ETIQUETADO Y PROSPECTO</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1368</th>\n",
       "      <td>&lt;p class=\"TitleA\"&gt;&lt;span lang=\"ES\"&gt;A. ETIQUETADO&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5c3a5600-808f-4763-b7c1-cd35106dd963</td>\n",
       "      <td>None</td>\n",
       "      <td>['TitleA']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>A. ETIQUETADO</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1373</th>\n",
       "      <td>&lt;div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"&gt; &lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;border:none; padding:0in\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;INFORM...</td>\n",
       "      <td>4ba6ec50-2860-4d48-b745-6b81539d084b</td>\n",
       "      <td>border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1374</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;border:none; padding:0in\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;INFORMACIÓN QUE DEBE FIGURAR EN EL EMBALAJE EXTERIOR&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>98c696b3-420e-447e-9dbf-259055f1feda</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;border:none;\\npadding:0in</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>INFORMACIÓN QUE DEBE FIGURAR EN EL EMBALAJE EXTERIOR</td>\n",
       "      <td>4ba6ec50-2860-4d48-b745-6b81539d084b</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                      Element  \\\n",
       "1339                                                                                                <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\">ANEXO III</span></b></p>   \n",
       "1341                                                                                   <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\">ETIQUETADO Y PROSPECTO</span></b></p>   \n",
       "1368                                                                                                                                               <p class=\"TitleA\"><span lang=\"ES\">A. ETIQUETADO</span></p>   \n",
       "1373  <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;border:none; padding:0in\"><b><span lang=\"ES\">INFORM...   \n",
       "1374                    <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;border:none; padding:0in\"><b><span lang=\"ES\">INFORMACIÓN QUE DEBE FIGURAR EN EL EMBALAJE EXTERIOR</span></b></p>   \n",
       "\n",
       "                                        ID  \\\n",
       "1339  4b18a3bf-32c1-4d32-97d8-f48b11d2192b   \n",
       "1341  cf602517-183b-414e-8966-0d82bae33ddb   \n",
       "1368  5c3a5600-808f-4763-b7c1-cd35106dd963   \n",
       "1373  4ba6ec50-2860-4d48-b745-6b81539d084b   \n",
       "1374  98c696b3-420e-447e-9dbf-259055f1feda   \n",
       "\n",
       "                                                                  Styles  \\\n",
       "1339                                                   text-align:center   \n",
       "1341                                                   text-align:center   \n",
       "1368                                                                None   \n",
       "1373       border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt   \n",
       "1374  margin-left:28.35pt;text-indent:-28.35pt;border:none;\\npadding:0in   \n",
       "\n",
       "            Classes   Bold  Italics  Uppercased  Underlined  Indexed  \\\n",
       "1339  ['MsoNormal']   True    False        True       False    False   \n",
       "1341  ['MsoNormal']   True    False        True       False    False   \n",
       "1368     ['TitleA']   True    False        True       False     True   \n",
       "1373           None  False    False       False       False    False   \n",
       "1374  ['MsoNormal']   True    False        True       False    False   \n",
       "\n",
       "      IsListItem  HasBorder  IsPossibleHeading IsHeadingType  \\\n",
       "1339       False      False               True            L1   \n",
       "1341       False      False               True            L1   \n",
       "1368       False      False               True            L2   \n",
       "1373       False       True              False          None   \n",
       "1374       False      False               True            L1   \n",
       "\n",
       "                                                      Text  \\\n",
       "1339                                             ANEXO III   \n",
       "1341                                ETIQUETADO Y PROSPECTO   \n",
       "1368                                         A. ETIQUETADO   \n",
       "1373                                                         \n",
       "1374  INFORMACIÓN QUE DEBE FIGURAR EN EL EMBALAJE EXTERIOR   \n",
       "\n",
       "                                  ParentId  \n",
       "1339  603f0744-ea60-46a5-a0d9-8674eac8d4dd  \n",
       "1341  603f0744-ea60-46a5-a0d9-8674eac8d4dd  \n",
       "1368  603f0744-ea60-46a5-a0d9-8674eac8d4dd  \n",
       "1373  603f0744-ea60-46a5-a0d9-8674eac8d4dd  \n",
       "1374  4ba6ec50-2860-4d48-b745-6b81539d084b  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-04-25 17:55:05,241 : Partition_m : Writing partition to file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\partitionedJSONs\\emea-combined-h-2494-es_ANEXO III.json\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "*************************** Texts with more than 2 characters**************************************\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Element</th>\n",
       "      <th>ID</th>\n",
       "      <th>Styles</th>\n",
       "      <th>Classes</th>\n",
       "      <th>Bold</th>\n",
       "      <th>Italics</th>\n",
       "      <th>Uppercased</th>\n",
       "      <th>Underlined</th>\n",
       "      <th>Indexed</th>\n",
       "      <th>IsListItem</th>\n",
       "      <th>HasBorder</th>\n",
       "      <th>IsPossibleHeading</th>\n",
       "      <th>IsHeadingType</th>\n",
       "      <th>Text</th>\n",
       "      <th>ParentId</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>3223</th>\n",
       "      <td>&lt;p class=\"TitleA\"&gt;&lt;span lang=\"ES\"&gt;B. PROSPECTO&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e4fc9460-4597-4d81-84fd-b0ae37bfba7c</td>\n",
       "      <td>None</td>\n",
       "      <td>['TitleA']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>None</td>\n",
       "      <td>B. PROSPECTO</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3227</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Prospecto: información para el paciente&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>7381a7b7-58a5-4a76-ba11-4fc20d6acb49</td>\n",
       "      <td>text-align:center;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>Prospecto: información para el paciente</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3229</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Kalydeco 75 mg comprimidos recubiertos con película&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>b12a6b4b-3458-45b9-aa77-428caba88d70</td>\n",
       "      <td>text-align:center;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>Kalydeco 75 mg comprimidos recubiertos con película</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3230</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Kalydeco 150 mg comprimidos recubiertos con película&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>fcdeb379-b7f4-4cb9-ab37-88a46538e719</td>\n",
       "      <td>text-align:center;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>Kalydeco 150 mg comprimidos recubiertos con película</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3231</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;ivacaftor&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d3382745-d001-4b02-986f-119ec76aa1bc</td>\n",
       "      <td>text-align:center;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>ivacaftor</td>\n",
       "      <td>603f0744-ea60-46a5-a0d9-8674eac8d4dd</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                          Element  \\\n",
       "3223                                                                                                                    <p class=\"TitleA\"><span lang=\"ES\">B. PROSPECTO</span></p>   \n",
       "3227               <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;page-break-after:avoid\"><b><span lang=\"ES\">Prospecto: información para el paciente</span></b></p>   \n",
       "3229   <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;page-break-after:avoid\"><b><span lang=\"ES\">Kalydeco 75 mg comprimidos recubiertos con película</span></b></p>   \n",
       "3230  <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;page-break-after:avoid\"><b><span lang=\"ES\">Kalydeco 150 mg comprimidos recubiertos con película</span></b></p>   \n",
       "3231                                                    <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;page-break-after:avoid\"><span lang=\"ES\">ivacaftor</span></p>   \n",
       "\n",
       "                                        ID  \\\n",
       "3223  e4fc9460-4597-4d81-84fd-b0ae37bfba7c   \n",
       "3227  7381a7b7-58a5-4a76-ba11-4fc20d6acb49   \n",
       "3229  b12a6b4b-3458-45b9-aa77-428caba88d70   \n",
       "3230  fcdeb379-b7f4-4cb9-ab37-88a46538e719   \n",
       "3231  d3382745-d001-4b02-986f-119ec76aa1bc   \n",
       "\n",
       "                                        Styles        Classes   Bold  Italics  \\\n",
       "3223                                      None     ['TitleA']   True    False   \n",
       "3227  text-align:center;page-break-after:avoid  ['MsoNormal']   True    False   \n",
       "3229  text-align:center;page-break-after:avoid  ['MsoNormal']   True    False   \n",
       "3230  text-align:center;page-break-after:avoid  ['MsoNormal']   True    False   \n",
       "3231  text-align:center;page-break-after:avoid  ['MsoNormal']  False    False   \n",
       "\n",
       "      Uppercased  Underlined  Indexed  IsListItem  HasBorder  \\\n",
       "3223        True       False     True       False      False   \n",
       "3227       False       False    False       False      False   \n",
       "3229       False       False    False       False      False   \n",
       "3230       False       False    False       False      False   \n",
       "3231       False       False    False       False      False   \n",
       "\n",
       "      IsPossibleHeading IsHeadingType  \\\n",
       "3223               True          None   \n",
       "3227               True            L1   \n",
       "3229               True            L1   \n",
       "3230               True            L1   \n",
       "3231              False          None   \n",
       "\n",
       "                                                      Text  \\\n",
       "3223                                          B. PROSPECTO   \n",
       "3227               Prospecto: información para el paciente   \n",
       "3229   Kalydeco 75 mg comprimidos recubiertos con película   \n",
       "3230  Kalydeco 150 mg comprimidos recubiertos con película   \n",
       "3231                                             ivacaftor   \n",
       "\n",
       "                                  ParentId  \n",
       "3223  603f0744-ea60-46a5-a0d9-8674eac8d4dd  \n",
       "3227  603f0744-ea60-46a5-a0d9-8674eac8d4dd  \n",
       "3229  603f0744-ea60-46a5-a0d9-8674eac8d4dd  \n",
       "3230  603f0744-ea60-46a5-a0d9-8674eac8d4dd  \n",
       "3231  603f0744-ea60-46a5-a0d9-8674eac8d4dd  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-04-25 17:55:05,282 : Partition_m : Writing partition to file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\partitionedJSONs\\emea-combined-h-2494-es_ PROSPECTO.json\n"
     ]
    }
   ],
   "source": [
    "#qrdkeys = ['SmPC', 'ANNEX II', 'ANEXO III', 'B. PACKAGE LEAFLET']\n",
    "## German\n",
    "qrdkeys = ['ANEXO I','ANEXO II','ANEXO III','B. PROSPECTO']\n",
    "path_json = os.path.join(os.path.abspath(os.path.join('..')), 'data', 'outputJSON')\n",
    "print(path_json)\n",
    "partitionlogger = loggerCreator('Partition_'+ getRandomString(1))\n",
    "partitioner = DocTypePartitioner(partitionlogger)\n",
    "partitioner.partitionHtmls(qrdkeys, path_json)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Matching Stage"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Set variables for the specific section.\n",
    "\n",
    "previousHeadingRowFound = None\n",
    "procedureType = 'CAP'\n",
    "languageCode = 'en'\n",
    "documentType = 'SmPC'\n",
    "stopWordlanguage = 'english'\n",
    "docFilter = 'SmPC.json'\n",
    "fileNameDoc = 'Kalydeco II-86-PI-clean_SmPC.json'\n",
    "fileNameQrd = 'qrd_canonical_mode_CAP_NAP.csv'\n",
    "fileNameMatchRuleBook = 'ruleDict.json'\n",
    "\n",
    "stopWordFilterLen = 6 \n",
    "topHeadingsConsidered = 4\n",
    "bottomHeadingsConsidered = 6\n",
    "isPackageLeaflet = False"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "# Set variables for the specific section.\n",
    "\n",
    "previousHeadingRowFound = None\n",
    "procedureType = 'CAP'\n",
    "languageCode = 'en'\n",
    "documentType = 'Package leaflet'\n",
    "stopWordlanguage = 'english'\n",
    "docFilter = 'LEAFLET.json'\n",
    "fileNameDoc = 'Abilify-h-471-e_ PACKAGE LEAFLET.json'\n",
    "fileNameQrd = 'qrd_canonical_mode_CAP_NAP.csv'\n",
    "fileNameMatchRuleBook = 'ruleDict.json'\n",
    "\n",
    "stopWordFilterLen = 100\n",
    "topHeadingsConsidered = 5\n",
    "bottomHeadingsConsidered = 10\n",
    "isPackageLeaflet = True"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "# Set variables for the specific section.\n",
    "\n",
    "procedureType = 'CAP'\n",
    "languageCode = 'es'\n",
    "documentNumber = 0\n",
    "stopWordlanguage = 'spanish'\n",
    "fileNameDoc = 'emea-combined-h-2494-es_ANEXO I.json'\n",
    "fileNameQrd = 'qrd_canonical_mode_CAP_NAP.csv'\n",
    "fileNameMatchRuleBook = 'ruleDict.json'\n",
    "fileNameDocumentTypeNames = 'documentTypeNames.json'\n",
    "stopWordFilterLen = 6 \n",
    "topHeadingsConsidered = 4\n",
    "bottomHeadingsConsidered = 6\n",
    "isPackageLeaflet = False\n",
    "\n",
    "\n",
    "###\n",
    "#ANGABEN AUF DER ZWISCHENVERPACKUNG\n",
    "###\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "File being processed: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\partitionedJSONs\\emea-combined-h-2494-es_ANEXO I.json\n",
      "--------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "matchDocObj = MatchDocument(procedureType,\n",
    "                 languageCode,\n",
    "                 documentNumber,\n",
    "                 fileNameDoc,\n",
    "                 fileNameQrd,\n",
    "                 fileNameMatchRuleBook,\n",
    "                 fileNameDocumentTypeNames,\n",
    "                 topHeadingsConsidered,\n",
    "                 bottomHeadingsConsidered,\n",
    "                 stopWordFilterLen,\n",
    "                 stopWordlanguage,\n",
    "                 isPackageLeaflet,'Kalydeco')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------\n",
      "RemovedByStyle  ||    ||  FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO  ||  FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO\n",
      "----------------------------------\n",
      "True  ||  <=4|4.0|(98, 96, 98)|0.99|  ||  1.       NOMBRE DEL MEDICAMENTO  ||  1 NOMBRE DEL MEDICAMENTO\n",
      "True  ||  <=7|2.44|(99, 98, 99)|1.0|  ||  2.       COMPOSICIÓN CUALITATIVA Y CUANTITATIVA  ||  2 COMPOSICIÓN CUALITATIVA Y CUANTITATIVA\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "True  ||  <=4|10.0|(95, 90, 95)|0.99|  ||  Excipiente con efecto conocido  ||  Excipiente(s) con efecto conocido\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "True  ||  <=4|10.0|(95, 90, 95)|0.99|  ||  Excipiente con efecto conocido  ||  Excipiente(s) con efecto conocido\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "True  ||  <=4|4.76|(98, 95, 97)|0.99|  ||  3.       FORMA FARMACÉUTICA  ||  3 FORMA FARMACÉUTICA\n",
      "\n",
      "OriginalCheck\n",
      "('<=4|76.47|(24, 25, 97)|0.5|', '4.       Datos clínicos', '4 DATOS CLÍNICOS')\n",
      "\n",
      "True  ||  checkLowerCase|5.88|(97, 94, 97)|0.99|  ||  4.       Datos clínicos  ||  4 DATOS CLÍNICOS\n",
      "True  ||    ||  4.1     Indicaciones terapéuticas  ||  4.1 Indicaciones terapéuticas\n",
      "True  ||    ||  4.2     Posología y forma de administración  ||  4.2 Posología y forma de administración\n",
      "True  ||    ||  Posología  ||  Posología\n",
      "True  ||    ||  Población pediátrica  ||  Población pediátrica\n",
      "True  ||    ||  Forma de administración  ||  Forma de administración \n",
      "True  ||    ||  4.3     Contraindicaciones  ||  4.3 Contraindicaciones\n",
      "True  ||    ||  4.4     Advertencias y precauciones especiales de empleo  ||  4.4 Advertencias y precauciones especiales de empleo\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "True  ||    ||  Población pediátrica  ||  Población pediátrica\n",
      "True  ||    ||  4.5     Interacción con otros medicamentos y otras formas de interacción  ||  4.5 Interacción con otros medicamentos y otras formas de interacción\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "True  ||    ||  Población pediátrica  ||  Población pediátrica\n",
      "True  ||    ||  4.6     Fertilidad, embarazo y lactancia  ||  4.6 Fertilidad, embarazo y lactancia\n",
      "True  ||    ||  Embarazo  ||  Embarazo\n",
      "True  ||    ||  Lactancia  ||  Lactancia\n",
      "True  ||    ||  Fertilidad  ||  Fertilidad\n",
      "True  ||    ||  4.7     Efectos sobre la capacidad para conducir y utilizar máquinas  ||  4.7 Efectos sobre la capacidad para conducir y utilizar máquinas\n",
      "True  ||    ||  4.8     Reacciones adversas  ||  4.8 Reacciones adversas\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "True  ||    ||  Población pediátrica  ||  Población pediátrica\n",
      "True  ||    ||  Notificación de sospechas de reacciones adversas  ||  Notificación de sospechas de reacciones adversas\n",
      "True  ||    ||  4.9     Sobredosis  ||  4.9 Sobredosis\n",
      "True  ||  <=4|3.45|(98, 96, 98)|0.99|  ||  5.       PROPIEDADES FARMACOLÓGICAS  ||  5 PROPIEDADES FARMACOLÓGICAS\n",
      "True  ||    ||  5.1     Propiedades farmacodinámicas  ||  5.1 Propiedades farmacodinámicas\n",
      "True  ||    ||  Mecanismo de acción  ||  Mecanismo de acción\n",
      "True  ||    ||  Efectos farmacodinámicos  ||  Efectos farmacodinámicos\n",
      "True  ||    ||  Eficacia clínica y seguridad  ||  Eficacia clínica y seguridad\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "True  ||    ||  Población pediátrica  ||  Población pediátrica\n",
      "True  ||  <=4|12.5|(88, 88, 90)|0.95|  ||  5.2     Propiedades farmacocinéticas  ||  5.1 Propiedades farmacodinámicas\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "True  ||    ||  Población pediátrica  ||  Población pediátrica\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "True  ||    ||  5.3     Datos preclínicos sobre seguridad  ||  5.3 Datos preclínicos sobre seguridad\n",
      "True  ||  <=4|4.55|(98, 95, 98)|0.99|  ||  6.       DATOS FARMACÉUTICOS  ||  6 DATOS FARMACÉUTICOS\n",
      "True  ||    ||  6.1     Lista de excipientes  ||  6.1 Lista de excipientes\n",
      "True  ||    ||  6.2     Incompatibilidades  ||  6.2 Incompatibilidades\n",
      "True  ||    ||  6.3     Periodo de validez  ||  6.3 Periodo de validez\n",
      "True  ||    ||  6.4     Precauciones especiales de conservación  ||  6.4 Precauciones especiales de conservación\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "True  ||  Contains<>|7.41|(96, 94, 97)|0.99|  ||  6.6     Precauciones especiales de eliminación y otras manipulaciones  ||  6.6 Precauciones especiales de eliminación <y otras manipulaciones>\n",
      "True  ||  <=4|2.5|(99, 97, 99)|1.0|  ||  7.       TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN  ||  7 TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN\n",
      "True  ||  <=7|2.08|(99, 98, 99)|1.0|  ||  8.       NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓN  ||  8 NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓN \n",
      "True  ||  <=7|1.89|(99, 98, 99)|1.0|  ||  9.       FECHA DE LA PRIMERA AUTORIZACIÓN/RENOVACIÓN DE LA AUTORIZACIÓN  ||  9 FECHA DE LA PRIMERA AUTORIZACIÓN/RENOVACIÓN DE LA AUTORIZACIÓN\n",
      "True  ||  <=4|4.17|(98, 96, 98)|0.99|  ||  10.    FECHA DE LA REVISIÓN DEL TEXTO  ||  10 FECHA DE LA REVISIÓN DEL TEXTO\n",
      "\n",
      "\n",
      "----------------Wrong Parent Heading-------------------------------\n",
      "\n",
      "\n",
      "oooooooooooooooooooooooooooooooooooooooo END OF Sub Section oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo\n",
      "True  ||  <=4|4.0|(98, 96, 98)|0.99|  ||  1.       NOMBRE DEL MEDICAMENTO  ||  1 NOMBRE DEL MEDICAMENTO\n",
      "True  ||  <=7|2.44|(99, 98, 99)|1.0|  ||  2.       COMPOSICIÓN CUALITATIVA Y CUANTITATIVA  ||  2 COMPOSICIÓN CUALITATIVA Y CUANTITATIVA\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "True  ||  <=4|10.0|(95, 90, 95)|0.99|  ||  Excipiente con efecto conocido  ||  Excipiente(s) con efecto conocido\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "True  ||  <=4|10.0|(95, 90, 95)|0.99|  ||  Excipiente con efecto conocido  ||  Excipiente(s) con efecto conocido\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "True  ||  <=4|10.0|(95, 90, 95)|0.99|  ||  Excipiente con efecto conocido  ||  Excipiente(s) con efecto conocido\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "True  ||  <=4|4.76|(98, 95, 97)|0.99|  ||  3.       FORMA FARMACÉUTICA  ||  3 FORMA FARMACÉUTICA\n",
      "\n",
      "OriginalCheck\n",
      "('<=4|76.47|(24, 25, 97)|0.5|', '4.       Datos clínicos', '4 DATOS CLÍNICOS')\n",
      "\n",
      "True  ||  checkLowerCase|5.88|(97, 94, 97)|0.99|  ||  4.       Datos clínicos  ||  4 DATOS CLÍNICOS\n",
      "True  ||    ||  4.1     Indicaciones terapéuticas  ||  4.1 Indicaciones terapéuticas\n",
      "True  ||    ||  4.2     Posología y forma de administración  ||  4.2 Posología y forma de administración\n",
      "True  ||    ||  Posología  ||  Posología\n",
      "True  ||    ||  Población pediátrica  ||  Población pediátrica\n",
      "True  ||    ||  Forma de administración  ||  Forma de administración \n",
      "True  ||    ||  4.3     Contraindicaciones  ||  4.3 Contraindicaciones\n",
      "True  ||    ||  4.4     Advertencias y precauciones especiales de empleo  ||  4.4 Advertencias y precauciones especiales de empleo\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "True  ||    ||  Población pediátrica  ||  Población pediátrica\n",
      "True  ||    ||  4.5     Interacción con otros medicamentos y otras formas de interacción  ||  4.5 Interacción con otros medicamentos y otras formas de interacción\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "True  ||    ||  Población pediátrica  ||  Población pediátrica\n",
      "True  ||    ||  4.6     Fertilidad, embarazo y lactancia  ||  4.6 Fertilidad, embarazo y lactancia\n",
      "True  ||    ||  Embarazo  ||  Embarazo\n",
      "True  ||    ||  Lactancia  ||  Lactancia\n",
      "True  ||    ||  Fertilidad  ||  Fertilidad\n",
      "True  ||    ||  4.7     Efectos sobre la capacidad para conducir y utilizar máquinas  ||  4.7 Efectos sobre la capacidad para conducir y utilizar máquinas\n",
      "True  ||    ||  4.8     Reacciones adversas  ||  4.8 Reacciones adversas\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "True  ||    ||  Población pediátrica  ||  Población pediátrica\n",
      "True  ||    ||  Notificación de sospechas de reacciones adversas  ||  Notificación de sospechas de reacciones adversas\n",
      "True  ||    ||  4.9     Sobredosis  ||  4.9 Sobredosis\n",
      "True  ||  <=4|3.45|(98, 96, 98)|0.99|  ||  5.       PROPIEDADES FARMACOLÓGICAS  ||  5 PROPIEDADES FARMACOLÓGICAS\n",
      "True  ||    ||  5.1     Propiedades farmacodinámicas  ||  5.1 Propiedades farmacodinámicas\n",
      "True  ||    ||  Mecanismo de acción  ||  Mecanismo de acción\n",
      "True  ||    ||  Efectos farmacodinámicos  ||  Efectos farmacodinámicos\n",
      "True  ||    ||  Eficacia clínica y seguridad  ||  Eficacia clínica y seguridad\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Mismatch\n",
      "\n",
      "\n",
      "True  ||    ||  Población pediátrica  ||  Población pediátrica\n",
      "True  ||  <=4|12.5|(88, 88, 90)|0.95|  ||  5.2     Propiedades farmacocinéticas  ||  5.1 Propiedades farmacodinámicas\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Heading Not Found None \n",
      "\n",
      "\n"
     ]
    },
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-82-4d55acb97d7a>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[1;32m----> 1\u001b[1;33m \u001b[0mdf\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mcoll\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mmatchDocObj\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mmatchHtmlHeaddingsWithQrd\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[1;32mF:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\code\\match\\matchDocument\\matchDocument.py\u001b[0m in \u001b[0;36mmatchHtmlHeaddingsWithQrd\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m    334\u001b[0m                             \u001b[1;31m# Call matching algorith\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    335\u001b[0m                             found, outputString = matchStringObj.matchStrings(\n\u001b[1;32m--> 336\u001b[1;33m                                 str_['Text'], qrd_str, qrd_str_row['heading_id'])\n\u001b[0m\u001b[0;32m    337\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    338\u001b[0m                             \u001b[1;32mif\u001b[0m \u001b[0mfound\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mF:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\code\\match\\matchStrings\\matchStrings.py\u001b[0m in \u001b[0;36mmatchStrings\u001b[1;34m(self, textOriginal, textToMatch, qrdRowHeadingId, avoidLowerCaseMatch)\u001b[0m\n\u001b[0;32m    135\u001b[0m         \u001b[0mnoWordstextToMatch1\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mlen\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mtextToMatch1\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msplit\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    136\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 137\u001b[1;33m         \u001b[0mstopWords\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mstopwords\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mwords\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mstopWordlanguage\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    138\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    139\u001b[0m         \u001b[1;32mif\u001b[0m \u001b[0mnoWordstextOriginal1\u001b[0m \u001b[1;33m>\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mstopWordFilterListSize\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Roaming\\Python\\Python37\\site-packages\\nltk\\corpus\\reader\\wordlist.py\u001b[0m in \u001b[0;36mwords\u001b[1;34m(self, fileids, ignore_lines_startswith)\u001b[0m\n\u001b[0;32m     21\u001b[0m         return [\n\u001b[0;32m     22\u001b[0m             \u001b[0mline\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 23\u001b[1;33m             \u001b[1;32mfor\u001b[0m \u001b[0mline\u001b[0m \u001b[1;32min\u001b[0m \u001b[0mline_tokenize\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mraw\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mfileids\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     24\u001b[0m             \u001b[1;32mif\u001b[0m \u001b[1;32mnot\u001b[0m \u001b[0mline\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mstartswith\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mignore_lines_startswith\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     25\u001b[0m         ]\n",
      "\u001b[1;32m~\\AppData\\Roaming\\Python\\Python37\\site-packages\\nltk\\corpus\\reader\\wordlist.py\u001b[0m in \u001b[0;36mraw\u001b[1;34m(self, fileids)\u001b[0m\n\u001b[0;32m     30\u001b[0m         \u001b[1;32melif\u001b[0m \u001b[0misinstance\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mfileids\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mstr\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     31\u001b[0m             \u001b[0mfileids\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;33m[\u001b[0m\u001b[0mfileids\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 32\u001b[1;33m         \u001b[1;32mreturn\u001b[0m \u001b[0mconcat\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mopen\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mf\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mread\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m \u001b[1;32mfor\u001b[0m \u001b[0mf\u001b[0m \u001b[1;32min\u001b[0m \u001b[0mfileids\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     33\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     34\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Roaming\\Python\\Python37\\site-packages\\nltk\\corpus\\reader\\wordlist.py\u001b[0m in \u001b[0;36m<listcomp>\u001b[1;34m(.0)\u001b[0m\n\u001b[0;32m     30\u001b[0m         \u001b[1;32melif\u001b[0m \u001b[0misinstance\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mfileids\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mstr\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     31\u001b[0m             \u001b[0mfileids\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;33m[\u001b[0m\u001b[0mfileids\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 32\u001b[1;33m         \u001b[1;32mreturn\u001b[0m \u001b[0mconcat\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mopen\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mf\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mread\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m \u001b[1;32mfor\u001b[0m \u001b[0mf\u001b[0m \u001b[1;32min\u001b[0m \u001b[0mfileids\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     33\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     34\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Roaming\\Python\\Python37\\site-packages\\nltk\\corpus\\reader\\api.py\u001b[0m in \u001b[0;36mopen\u001b[1;34m(self, file)\u001b[0m\n\u001b[0;32m    206\u001b[0m         \"\"\"\n\u001b[0;32m    207\u001b[0m         \u001b[0mencoding\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mencoding\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mfile\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 208\u001b[1;33m         \u001b[0mstream\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_root\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mjoin\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mfile\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mopen\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mencoding\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    209\u001b[0m         \u001b[1;32mreturn\u001b[0m \u001b[0mstream\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    210\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Roaming\\Python\\Python37\\site-packages\\nltk\\data.py\u001b[0m in \u001b[0;36mjoin\u001b[1;34m(self, fileid)\u001b[0m\n\u001b[0;32m    335\u001b[0m     \u001b[1;32mdef\u001b[0m \u001b[0mjoin\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mfileid\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    336\u001b[0m         \u001b[0m_path\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mos\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpath\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mjoin\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_path\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mfileid\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 337\u001b[1;33m         \u001b[1;32mreturn\u001b[0m \u001b[0mFileSystemPathPointer\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0m_path\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    338\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    339\u001b[0m     \u001b[1;32mdef\u001b[0m \u001b[0m__repr__\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Roaming\\Python\\Python37\\site-packages\\nltk\\compat.py\u001b[0m in \u001b[0;36m_decorator\u001b[1;34m(*args, **kwargs)\u001b[0m\n\u001b[0;32m     39\u001b[0m     \u001b[1;32mdef\u001b[0m \u001b[0m_decorator\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m*\u001b[0m\u001b[0margs\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;33m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     40\u001b[0m         \u001b[0margs\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;33m(\u001b[0m\u001b[0margs\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;36m0\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0madd_py3_data\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0margs\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m \u001b[1;33m+\u001b[0m \u001b[0margs\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;36m2\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 41\u001b[1;33m         \u001b[1;32mreturn\u001b[0m \u001b[0minit_func\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m*\u001b[0m\u001b[0margs\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;33m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     42\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     43\u001b[0m     \u001b[1;32mreturn\u001b[0m \u001b[0mwraps\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0minit_func\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0m_decorator\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Roaming\\Python\\Python37\\site-packages\\nltk\\data.py\u001b[0m in \u001b[0;36m__init__\u001b[1;34m(self, _path)\u001b[0m\n\u001b[0;32m    312\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    313\u001b[0m         \u001b[0m_path\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mos\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpath\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mabspath\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0m_path\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 314\u001b[1;33m         \u001b[1;32mif\u001b[0m \u001b[1;32mnot\u001b[0m \u001b[0mos\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpath\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mexists\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0m_path\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    315\u001b[0m             \u001b[1;32mraise\u001b[0m \u001b[0mIOError\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m\"No such file or directory: %r\"\u001b[0m \u001b[1;33m%\u001b[0m \u001b[0m_path\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    316\u001b[0m         \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_path\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0m_path\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Local\\Continuum\\anaconda3\\lib\\genericpath.py\u001b[0m in \u001b[0;36mexists\u001b[1;34m(path)\u001b[0m\n\u001b[0;32m     17\u001b[0m     \u001b[1;34m\"\"\"Test whether a path exists.  Returns False for broken symbolic links\"\"\"\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     18\u001b[0m     \u001b[1;32mtry\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 19\u001b[1;33m         \u001b[0mos\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mstat\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mpath\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     20\u001b[0m     \u001b[1;32mexcept\u001b[0m \u001b[0mOSError\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     21\u001b[0m         \u001b[1;32mreturn\u001b[0m \u001b[1;32mFalse\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;31mKeyboardInterrupt\u001b[0m: "
     ]
    }
   ],
   "source": [
    "    df, coll = matchDocObj.matchHtmlHeaddingsWithQrd()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Element</th>\n",
       "      <th>ID</th>\n",
       "      <th>Styles</th>\n",
       "      <th>Classes</th>\n",
       "      <th>Bold</th>\n",
       "      <th>Italics</th>\n",
       "      <th>Uppercased</th>\n",
       "      <th>Underlined</th>\n",
       "      <th>Indexed</th>\n",
       "      <th>IsListItem</th>\n",
       "      <th>HasBorder</th>\n",
       "      <th>IsPossibleHeading</th>\n",
       "      <th>IsHeadingType</th>\n",
       "      <th>Text</th>\n",
       "      <th>ParentId</th>\n",
       "      <th>StringLength</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>&lt;div class=\"WordSection1\"&gt; &lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt; &lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>None</td>\n",
       "      <td>['WordSection1']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>...</td>\n",
       "      <td>f8cea01e-5a38-4761-a231-51d257e0ad34</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>c147a932-fe2e-4586-ad7a-1d94722a6bbd</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>354c4ef9-6998-4604-a3de-d6c2b54ab5bd</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>84207554-4f1a-44fe-a4af-2faa4181e82f</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>666eb08a-4aa5-4ea8-a12e-2e1b48cdc1d9</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>41ca5b92-4733-4f9a-ac58-e7182fb0d166</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>9e6429ad-0e94-4062-b75f-b03eb212e2d1</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>2c762f89-12bd-4ba8-b435-7dd0ab82b1c1</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>898da31c-e821-4aa6-998f-c25d22b10de7</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>d84210a2-e953-4ced-916c-00fb0d485c9a</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>44def714-2298-4cb4-a562-8b3c09770dca</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>8e27c082-b5f0-4891-b827-446cf8aee265</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>48213e33-cdc0-487d-854f-6f06c6bb01d7</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>e6469207-b760-4eab-862c-b0e3b25cd580</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>2b4139be-943f-4b76-8f86-37e21986c540</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>81ae3027-0894-456f-9e38-42dcfd82ec07</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>9a96586a-1629-4aa8-a007-d96cc934bebe</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>44391980-f6e6-4ce1-bf8e-39157db14615</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>8b24f5eb-f709-4ebf-b0d6-1aee77e9cfe8</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>51054e10-c323-4125-8f76-d756958b37f5</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>54ae2857-4ac9-4a96-93ff-ffd5f94b08b5</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>7b01af01-2a5a-49c3-b369-b1e0d5ffecba</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>5c8252d1-b5e7-418d-b333-0db0de6aca75</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>c552eb62-af50-48fa-9876-152225c5c6df</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;ANEXO I&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>fcc67667-e0e5-470c-88f3-aab63b9ec072</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>None</td>\n",
       "      <td>ANEXO I</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>&lt;p class=\"TitleA\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>57d9dcc1-304e-4bfb-8203-8f97c5a52b11</td>\n",
       "      <td>None</td>\n",
       "      <td>['TitleA']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>&lt;p class=\"TitleA\"&gt;&lt;span lang=\"ES\"&gt;FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5798d02d-54d0-487e-abcf-8be5bfbe1458</td>\n",
       "      <td>None</td>\n",
       "      <td>['TitleA']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>59</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>e26b7b19-2fba-4af6-96bf-1df225aa2218</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4994ac1f-0ae3-4214-81ee-9d94673fb2ff</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>931caab6-9d34-4d1a-a52c-52ae389081f6</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b8622c24-b73c-4a1b-a037-b19f73a85a0c</td>\n",
       "      <td>text-align:center</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>&lt;span lang=\"ES\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif; color:green'&gt;&lt;br clear=\"all\" style=\"page-break-before:always\"/&gt; &lt;/span&gt;</td>\n",
       "      <td>7ecdb210-02c7-4ff0-b4ac-f566e0547c51</td>\n",
       "      <td>font-size:11.0pt;font-family:\"Times New Roman\",serif;\\ncolor:green</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>&lt;br clear=\"all\" style=\"page-break-before:always\"/&gt;</td>\n",
       "      <td>99f4d854-e360-4df2-b7af-4142af896a31</td>\n",
       "      <td>page-break-before:always</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>7ecdb210-02c7-4ff0-b4ac-f566e0547c51</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0bc8c6fc-7051-40ec-8064-b024d7c8e767</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;1.       &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;NOMBRE DEL MEDICAMENTO&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>d3f2e28e-6e97-4e8c-ade1-05d20e8e3285</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>1.       NOMBRE DEL MEDICAMENTO</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>25</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cadd8043-6bb4-402d-a12f-eaf3c5e313fb</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Kalydeco 75 mg comprimidos recubiertos con película&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1033c384-39af-4f77-8330-129204f5782a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Kalydeco 75 mg comprimidos recubiertos con película</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>51</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Kalydeco 150 mg comprimidos recubiertos con película&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ff34f408-bd41-4952-8cf0-b8ff1301a1e8</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Kalydeco 150 mg comprimidos recubiertos con película</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>52</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d1936675-57fc-4c3c-b93b-07cc2dc234d1</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5021f543-ad57-4893-8f00-9a3328566e4a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a0b0b3ee-4a2a-4674-a8f3-c71f5736a5f8</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;2.       &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;COMPOSICIÓN CUALITATIVA Y CUANTITATIVA&lt;/span...</td>\n",
       "      <td>4e094f8c-8299-472c-bd96-eececf118cde</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>2.       COMPOSICIÓN CUALITATIVA Y CUANTITATIVA</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>41</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>aab4c001-f5f4-4382-bd08-768bd3d5cbf0</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Kalydeco 75 mg comprimidos recubiertos con película&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>41e7c2a4-5a52-4107-a30e-2e4cc9b7d79a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Kalydeco 75 mg comprimidos recubiertos con película</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>51</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>720df005-eb3a-4b90-ac77-4a307e512e8c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Cada comprimido recubierto con película contiene 75 mg de ivacaftor.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6774333e-c925-45c7-a58d-df4769026b2f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cada comprimido recubierto con película contiene 75 mg de ivacaftor.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>68</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>216ef059-017e-4a54-9787-8aa8817c31a2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Excipiente con efecto conocido&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>b721db8d-e7d7-46b8-a7c6-6a8c7fea19df</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Excipiente con efecto conocido</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>eb3e986d-07d1-4d5c-8207-99051bf2b380</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Cada comprimido recubierto con película contiene 83,6 mg de lactosa monohidrato.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>19ecbdcd-54bd-432a-bde2-4c9a54b60c24</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cada comprimido recubierto con película contiene 83,6 mg de lactosa monohidrato.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>80</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fba6c2a3-7355-48f1-b14f-12f556934765</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Kalydeco 150 mg comprimidos recubiertos con película&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>2efd1a10-ea40-4f77-b5da-b4c09ad1c1d5</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Kalydeco 150 mg comprimidos recubiertos con película</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>52</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1a5555a6-9d7a-467d-b10d-0c0c337a194c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Cada comprimido recubierto con película contiene 150 mg de ivacaftor.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c35a4a74-0af3-4fe7-b86d-763c66d9126f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cada comprimido recubierto con película contiene 150 mg de ivacaftor.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>69</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>83a444ab-0d78-48f2-b06e-9badb4f66c90</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Excipiente con efecto conocido&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>a86d7505-835e-414c-a009-a65e6f7614a0</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Excipiente con efecto conocido</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9f7f0a8e-a2f2-4bd2-8e61-5bee16087cdf</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Cada comprimido recubierto con película contiene 167,2 mg de lactosa monohidrato.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f7fbb7a8-e407-4ce2-8f01-15775aeb0955</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cada comprimido recubierto con película contiene 167,2 mg de lactosa monohidrato.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>81</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>203388db-4ce6-4db9-ac85-352e02ea1773</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Para consultar la lista completa de excipientes, ver sección 6.1.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4f9971d3-b23f-484d-8252-618ed16fabef</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Para consultar la lista completa de excipientes, ver sección 6.1.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>65</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c0a790dc-fc9c-46ca-b1d4-12b8c7242995</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0be01718-d5f2-499e-a69d-1570de1f98da</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;3.       &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;FORMA FARMACÉUTICA&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>f87d7c46-00f7-4c9e-b2e6-957a1d19c80d</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>3.       FORMA FARMACÉUTICA</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d8b93d14-fa1d-4b8d-a87e-9d4ab4fe07b0</td>\n",
       "      <td>page-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt;Comprimido recubierto con película (comprimido)&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cc42df55-97f3-4419-b738-e1137bdcfbdb</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Comprimido recubierto con película (comprimido)</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>47</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>bfe90044-061e-4c93-a8cd-7f5b9f59db4a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Kalydeco 75 mg comprimidos recubiertos con película&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>8a9f883b-52f4-4846-83b0-37f164dbf31c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Kalydeco 75 mg comprimidos recubiertos con película</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>51</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c276b014-b87b-4374-938e-541649beb869</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Comprimidos recubiertos con película con forma de cápsula de color azul claro, con la impresión “V 75” en tinta negra en una cara y nada en la otra (12,7 mm x ...</td>\n",
       "      <td>2bfe6ca0-5119-4999-ba63-855ef24287e9</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Comprimidos recubiertos con película con forma de cápsula de color azul claro, con la impresión “V 75” en tinta negra en una cara y nada en la otra (12,7 mm x 6,8 mm en la forma de comprimido modi...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>204</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>eaa63b24-3fb6-4f16-9a7d-b6c25814080a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Kalydeco 150 mg comprimidos recubiertos con película&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>73757abe-c827-45f7-9e74-69e51ac47186</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Kalydeco 150 mg comprimidos recubiertos con película</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>52</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e7149e1b-883b-4bef-a63e-0c2caf5222f8</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Comprimidos recubiertos con película con forma de cápsula de color azul claro, con la impresión “V 150” en tinta negra en una cara y nada en la otra (16,5 mm x...</td>\n",
       "      <td>cf158710-b8d7-40bf-8aa0-f188a9a0c63f</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Comprimidos recubiertos con película con forma de cápsula de color azul claro, con la impresión “V 150” en tinta negra en una cara y nada en la otra (16,5 mm x 8,4 mm en la forma de comprimido mod...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>205</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8a858b63-de7d-45fc-a167-a712ed3c3a5f</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>01340c77-e754-458c-8d1b-d035b8986973</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\" style=\"text-transform:uppercase\"&gt;4.       &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\" style=\"text...</td>\n",
       "      <td>47d2bac2-62e4-4aae-861e-f14579501e50</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>4.       Datos clínicos</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0360892e-8b0b-4343-99ca-56158b8e446c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.1     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Indicaciones terapéuticas&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>21557003-ef67-45ee-8944-5b1fac23e3de</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.1     Indicaciones terapéuticas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>29</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a3182e32-9a3b-49ff-99d4-66b48f52c131</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Kalydeco comprimidos está indicado:&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d221b444-aadf-46fc-bb62-4a66ddf001da</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Kalydeco comprimidos está indicado:</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"margin-left:38.9pt;text-indent:-.25in\"&gt;&lt;span lang=\"ES\" style=\"font-family:Symbol\"&gt;·&lt;span style='font:7.0pt \"Times New Roman\"'&gt;         &lt;/span&gt;&lt;/span&gt;&lt;span lang=\"ES\"&gt;En ...</td>\n",
       "      <td>16cb0e18-2146-46d5-aa47-1e108e085060</td>\n",
       "      <td>margin-left:38.9pt;text-indent:-.25in</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>·         En monoterapia para el tratamiento de adultos, adolescentes y niños de 6 años o mayores con un peso de 25 kg o más con fibrosis quística (FQ) y una mutación R117H en el gen CFTR o una de...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>431</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8752a1c4-06c6-48cc-91c0-67ce1fcee266</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"margin-left:38.9pt;text-indent:-.25in\"&gt;&lt;span lang=\"ES\" style=\"font-family:Symbol\"&gt;·&lt;span style='font:7.0pt \"Times New Roman\"'&gt;         &lt;/span&gt;&lt;/span&gt;&lt;span lang=\"ES\"&gt;En ...</td>\n",
       "      <td>748a19c8-0767-4753-8866-d22efaa0bdc6</td>\n",
       "      <td>margin-left:38.9pt;text-indent:-.25in</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>·         En un esquema combinado con comprimidos de tezacaftor/vacaftor para el tratamiento de adultos, adolescentes y niños de 6 años de edad o mayores con fibrosis quística (FQ) homocigóticos p...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>495</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>&lt;p class=\"MsoListParagraph\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7e329f98-c746-4dca-a171-b0c58d629d53</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoListParagraph']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"margin-left:38.9pt;text-indent:-.25in\"&gt;&lt;span lang=\"ES\" style=\"font-family:Symbol\"&gt;·&lt;span style='font:7.0pt \"Times New Roman\"'&gt;         &lt;/span&gt;&lt;/span&gt;&lt;span lang=\"ES-TRAD...</td>\n",
       "      <td>8e03cc5b-63fc-4626-8f0f-9528e6c4ddcc</td>\n",
       "      <td>margin-left:38.9pt;text-indent:-.25in</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>·         En un esquema combinado con comprimidos ivacaftor/tezacaftor/elexacaftor para el tratamiento de adultos y adolescentes de 12 años de edad o mayores con fibrosis quística (FQ) homocigótic...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>337</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>206850db-44b0-49f6-be91-5aafb541a1dc</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.2     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Posología y forma de administración&lt;/span&gt;&lt;/b...</td>\n",
       "      <td>94c14879-3794-46f9-9a49-243f048ff152</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.2     Posología y forma de administración</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9d714a9c-8512-4713-a692-70905450b050</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Únicamente los médicos con experiencia en el tratamiento de la fibrosis quística deben prescribir Kalydeco. &lt;/span&gt;&lt;span lang=\"ES\"&gt;Si se desconoce el genotipo ...</td>\n",
       "      <td>688fa3d9-748d-46a5-8746-8ed6fc1ba656</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Únicamente los médicos con experiencia en el tratamiento de la fibrosis quística deben prescribir Kalydeco. Si se desconoce el genotipo del paciente, se debe utilizar un método de genotipificación...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>470</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;a name=\"paragraph00000061\"&gt;&lt;/a&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>989d702b-9aea-46e4-99cc-c6fbe92afdb0</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Posología&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>54f66ab0-2f8e-4009-b80a-087f092a1552</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Posología</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>41825c23-98e7-4400-b20e-df241b75528c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt;Los adultos, adolescentes y niños de 6 años de edad o mayores deben ser tratados según la Tabla 1.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>620b63a1-6e02-43bf-ac88-cec3c05e37b9</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los adultos, adolescentes y niños de 6 años de edad o mayores deben ser tratados según la Tabla 1.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>98</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7b8255d5-405a-46f5-acdd-b958883109d4</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"&gt;&lt;b&gt;Tabla 1: &lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Recomendaciones posológicas&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>a7096106-c332-4ac6-ae08-a43c654431f9</td>\n",
       "      <td>margin-bottom:6.0pt;page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 1: Recomendaciones posológicas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>36</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoTableGrid\" style=\"margin-left:-.25pt;border-collapse:collapse;border:none\" width=\"626\"&gt; &lt;thead&gt; &lt;tr style=\"page-break-inside:avoid;heigh...</td>\n",
       "      <td>51582479-86cf-49b6-99fe-f1664acd7b49</td>\n",
       "      <td>margin-left:-.25pt;border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoTableGrid']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Mañana   Noche      Ivacaftor en monoterapia     6 años o mayores,   ≥25 kg   Un   comprimido de 150 mg de ivacaftor   Un   comprimido de 150 mg de ivacaftor     Ivacaftor   en combinación...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>736</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES-TRAD\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4fe212c6-6998-4add-ba94-eadf5d5fc34b</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES-TRAD\"&gt;La dosis de la mañana y la dosis de la noche se deben tomar con un intervalo de 12 horas aproximadamente y&lt;/span&gt;&lt;span lang=\"ES\"&gt; con alimentos que conten...</td>\n",
       "      <td>4ebfb6e2-9701-4e42-b48a-00b052b4040e</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La dosis de la mañana y la dosis de la noche se deben tomar con un intervalo de 12 horas aproximadamente y con alimentos que contengan grasas (ver Forma de administración).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>172</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3ff24bee-14fb-4aa9-8796-45039168f029</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Dosis olvidadas&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>8f5652ca-f920-4309-87a4-b9060f148fd2</td>\n",
       "      <td>page-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Dosis olvidadas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>83b774e5-02cd-4a18-a6a5-a6e8b8f6f737</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt;Si han transcurrido 6 horas o menos desde la dosis olvidada de la mañana o de la noche, &lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt;se debe indicar...</td>\n",
       "      <td>c932ce65-c087-444f-a84e-5c39e2ade433</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Si han transcurrido 6 horas o menos desde la dosis olvidada de la mañana o de la noche, se debe indicar al paciente que la tome lo antes posible y luego tomar la siguiente dosis a la hora habitual...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>372</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c4769714-f48e-4eb6-a449-fc68e568d2ac</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt;Se debe indicar a los pacientes tratados con Kalydeco en un esquema combinado que no tomen más de una dosis de cualquiera de los me...</td>\n",
       "      <td>e7b2765e-f0f7-4f5e-9be7-22dafb3a571f</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se debe indicar a los pacientes tratados con Kalydeco en un esquema combinado que no tomen más de una dosis de cualquiera de los medicamentos al mismo tiempo.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>158</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c918b233-d80e-451f-ae32-53817086a63a</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Uso concomitante de inhibidores de CYP3A&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>8507ba73-11bd-4997-9605-da624982d39e</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Uso concomitante de inhibidores de CYP3A</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>40</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>7f531c58-29d1-4af0-861e-c5de460788b3</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;En administración concomitante con inhibidores moderados o potentes de CYP3A, ya sea en monoterapia o en un esquema combinado con &lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt;t...</td>\n",
       "      <td>2ed86108-84cd-4ca1-8fea-8b3fe0c6dc57</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En administración concomitante con inhibidores moderados o potentes de CYP3A, ya sea en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor, se debe r...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>390</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>20438f19-63ad-4186-a59e-fbb842481927</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"margin-top:0in;margin-right:0in;margin-bottom:6.0pt; margin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 2: Recomendaciones posoló...</td>\n",
       "      <td>cc9a6319-5801-42a4-ae28-58cb8d9bcac2</td>\n",
       "      <td>margin-top:0in;margin-right:0in;margin-bottom:6.0pt;\\nmargin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 2: Recomendaciones posológicas para el uso concomitante con inhibidores moderados o potentes de CYP3A</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>107</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>110</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoTableGrid\" style=\"border-collapse:collapse;border:none\" width=\"605\"&gt; &lt;thead&gt; &lt;tr style=\"page-break-inside:avoid\"&gt; &lt;td style=\"width:91.9p...</td>\n",
       "      <td>6ca42575-9a26-46c2-b8d2-166df22c922a</td>\n",
       "      <td>border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoTableGrid']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Inhibidores moderados de    CYP3A   Inhibidores potentes de    CYP3A      Ivacaftor en monoterapia     6 años o   mayores, ≥25 kg   Un comprimido por la mañana de 150 mg de ivacaftor una  ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>2220</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>111</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"margin-left:42.55pt;text-indent:-42.55pt;page-break-after: avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>422152c1-851b-4d6d-89dc-783f03f81822</td>\n",
       "      <td>margin-left:42.55pt;text-indent:-42.55pt;page-break-after:\\navoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>112</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Poblaciones especiales&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>0386845c-8612-474a-88c0-b7733833195f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Poblaciones especiales</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>113</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>742bd6cf-140c-478c-90d9-19989db0dcee</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>114</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Pacientes de edad avanzada&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>a3388cea-fd09-41a6-be9c-80bd0ff0ef9d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Pacientes de edad avanzada</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>85224f7b-a33e-4d54-91bc-3baeb7c6f47e</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Se dispone de datos muy limitados para pacientes de edad avanzada tratados con ivacaftor (administrado en monoterapia o en un es...</td>\n",
       "      <td>86ccff55-4abb-4afd-84ae-7d60db2449fe</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se dispone de datos muy limitados para pacientes de edad avanzada tratados con ivacaftor (administrado en monoterapia o en un esquema combinado. No es necesario realizar un ajuste de la dosis espe...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>251</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>33a5473f-295c-4766-95c1-03862aac0010</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Insuficiencia renal&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>aa06f028-3d07-4369-a323-f8cc87158da2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Insuficiencia renal</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>68d72390-aafc-498b-8aa1-058f29956b6c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;No es necesario ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Se recomienda precaución en pacientes con...</td>\n",
       "      <td>4731e837-641f-47ac-a712-849a131877f3</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No es necesario ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Se recomienda precaución en pacientes con insuficiencia renal grave (aclaramiento de la creatinina menor o ig...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>271</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9366b121-dd84-4455-88cc-d48885a5230e</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;span lang=\"ES\"&gt;Insuficiencia hepática&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4c8016ed-3c69-46ab-9845-d8aa1381976e</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Insuficiencia hepática</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>bd1a6562-4f27-4598-bc81-c24153cc3a4e</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>124</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;No es necesario ajustar la dosis &lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt;de ivacaftor en monoterapia o en un esquema combinado&lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt; &lt;/span&gt;&lt;span lan...</td>\n",
       "      <td>37982548-b65d-47f9-abaa-61fc8efd818e</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No es necesario ajustar la dosis de ivacaftor en monoterapia o en un esquema combinado en pacientes con insuficiencia hepática leve (Child-Pugh Clase A).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>153</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>125</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>917b95da-40d8-4cd3-ad33-5514bdf822c9</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Para los pacientes con insuficiencia hepática moderada (Child-Pugh Clase B), se debe reducir la dosis de ivacaftor en monoterapia a 150 mg una vez al día.&lt;/spa...</td>\n",
       "      <td>24196a95-aad5-4505-982f-1da68ebae049</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Para los pacientes con insuficiencia hepática moderada (Child-Pugh Clase B), se debe reducir la dosis de ivacaftor en monoterapia a 150 mg una vez al día.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>154</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>127</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>28f75328-87e0-45f6-94db-c5a43da0a76f</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>128</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Para los &lt;/span&gt;&lt;span lang=\"ES\"&gt;pacientes con insuficiencia hepática grave (Child-Pugh Clase &lt;/span&gt;&lt;span lang=\"ES\"&gt;C), &lt;/span&gt;&lt;span lang=\"ES\"&gt;se debe reducir ...</td>\n",
       "      <td>6c10c28c-8af2-4641-8b6f-0bcedcc212a5</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Para los pacientes con insuficiencia hepática grave (Child-Pugh Clase C), se debe reducir la dosis de ivacaftor en monoterapia a 150 mg cada dos días o a una frecuencia menor.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>175</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>129</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>efa3b8cd-283a-47e9-8d56-dd4578112787</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>130</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Para el uso como dosis de la noche en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor, v&lt;/span&gt;&lt;span lang=\"ES\"&gt;er la Tabla 3 p...</td>\n",
       "      <td>7c277987-1085-414c-aee8-aa531e6c3d90</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Para el uso como dosis de la noche en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor, ver la Tabla 3 para las recomendaciones posológicas.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>172</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>131</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>692e14aa-7674-479a-8f12-5ead09b39998</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>132</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"margin-top:0in;margin-right:0in;margin-bottom:6.0pt; margin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 3: Recomendaciones posoló...</td>\n",
       "      <td>b2e514da-ce5e-475d-a806-ab41b949c8f0</td>\n",
       "      <td>margin-top:0in;margin-right:0in;margin-bottom:6.0pt;\\nmargin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 3: Recomendaciones posológicas en pacientes con insuficiencia hepática moderada o grave</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>93</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>133</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoTableGrid\" style=\"width:474.65pt;border-collapse:collapse;border:none\" width=\"633\"&gt; &lt;thead&gt; &lt;tr style=\"page-break-inside:avoid\"&gt; &lt;td sty...</td>\n",
       "      <td>a149bce7-5bba-4788-83b9-635557348b15</td>\n",
       "      <td>width:474.65pt;border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoTableGrid']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Moderada    (Child-Pugh Clase B)   Grave    (Child-Pugh Clase C)      Ivacaftor en monoterapia     6 años o   mayores, ≥25 kg   Un comprimido por la mañana de 150 mg de ivacaftor una   vez...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>2489</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2fe27060-0d58-4b32-a51c-69ef3664589c</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>135</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Población pediátrica&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>590e551f-8740-4103-9692-c36b2c3d30eb</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Población pediátrica</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>136</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>49f9a5ad-4eae-4b6f-8d6d-0b4c1b4f12aa</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;No se ha establecido la seguridad y eficacia de ivacaftor en monoterapia en niños menores de 4 meses, ni en combinación con tezacaftor/ivacaftor en niños menor...</td>\n",
       "      <td>f53ffcc5-6b9d-43ee-ad47-8671b10d85a8</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se ha establecido la seguridad y eficacia de ivacaftor en monoterapia en niños menores de 4 meses, ni en combinación con tezacaftor/ivacaftor en niños menores de 6 años ni en combinación con te...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>279</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>138</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ab2008d1-8d69-40b9-a124-ebfdabd33b92</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>139</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Los datos disponibles en pacientes menores de 6 años con una mutación &lt;i&gt;R117H&lt;/i&gt; en el gen &lt;i&gt;CFTR&lt;/i&gt; son limitados. &lt;/span&gt;&lt;span lang=\"ES\"&gt;Los datos dispon...</td>\n",
       "      <td>2e44e44e-94d9-458d-beee-2ff0be4c9646</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los datos disponibles en pacientes menores de 6 años con una mutación R117H en el gen CFTR son limitados. Los datos disponibles en pacientes de 6 años o mayores están descritos en las secciones 4....</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>209</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>14cffc26-6b3a-4fd6-a639-546d0553030d</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>141</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Forma de administración&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>de9f881a-41fd-4793-b308-61d0730abfa8</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Forma de administración</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>23</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>142</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>bc9cd282-bb7c-4392-8779-7496665c4aab</td>\n",
       "      <td>page-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>143</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt;Vía oral.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>45fb12b9-e8f1-4218-8550-b00fccad92eb</td>\n",
       "      <td>page-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Vía oral.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>144</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c063f264-d59b-43ce-9797-f3530cc845fe</td>\n",
       "      <td>page-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>145</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt;Se debe indicar a los pacientes que ingieran los comprimidos enteros. Los comprimidos no se deben masticar, &lt;/span&gt;&lt;span lang=\"ES\"&gt;...</td>\n",
       "      <td>1abef160-be83-4c30-8b12-8b37be2ffe1c</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se debe indicar a los pacientes que ingieran los comprimidos enteros. Los comprimidos no se deben masticar, triturar ni partir antes de tomarlos ya que actualmente no hay datos clínicos que respal...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>231</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>146</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>15a413e2-d114-453d-aed1-2654539a653e</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>147</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt;Los comprimidos de ivacaftor se deben tomar con alimentos que contengan grasas.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a961baf0-9dbe-45cd-a602-e8e4bdfb309a</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los comprimidos de ivacaftor se deben tomar con alimentos que contengan grasas.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>79</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>148</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>26b918ac-5c67-44ca-93f7-e94cce571c89</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>149</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt;Se deben evitar los alimentos o bebidas que contienen pomelo durante el tratamiento (ver sección 4.5).&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4939a7c8-a97d-45bf-a315-836a92ec7d2d</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se deben evitar los alimentos o bebidas que contienen pomelo durante el tratamiento (ver sección 4.5).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>102</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>60780ad8-f39f-4a9d-90ba-79d6784faaab</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>151</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.3     Contraindicaciones&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>0f29590e-7463-420e-b34b-9e446448501d</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.3     Contraindicaciones</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>152</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>25e09e7d-c759-40ee-8a2e-a9f5829e5bb3</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>153</th>\n",
       "      <td>&lt;p class=\"MsoNormalIndent\" style=\"margin:0in\"&gt;&lt;span lang=\"ES\"&gt;Hipersensibilidad al principio activo o a alguno de los excipientes incluidos en la sección 6.1.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b2b5437c-6243-4f9a-b1f2-314ac7445054</td>\n",
       "      <td>margin:0in</td>\n",
       "      <td>['MsoNormalIndent']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Hipersensibilidad al principio activo o a alguno de los excipientes incluidos en la sección 6.1.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>96</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>154</th>\n",
       "      <td>&lt;p class=\"MsoNormalIndent\" style=\"margin:0in\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>aa6c4147-21e0-4755-913d-a769e16a6c71</td>\n",
       "      <td>margin:0in</td>\n",
       "      <td>['MsoNormalIndent']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>155</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.4     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Advertencias y precauciones especiales de emp...</td>\n",
       "      <td>9352366e-a535-43a4-be7e-44f1851649f8</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.4     Advertencias y precauciones especiales de empleo</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>52</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>156</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>b1568729-81d9-4069-8d35-0f7885788b58</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>&lt;p class=\"MsoNormalIndent\" style=\"margin:0in\"&gt;&lt;span lang=\"ES\"&gt;Únicamente los pacientes con FQ con una mutación &lt;/span&gt;&lt;span lang=\"ES\"&gt;de apertura del canal (clase III): &lt;/span&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;G...</td>\n",
       "      <td>0b3578e3-7590-4a5c-85e9-19d9976f2121</td>\n",
       "      <td>margin:0in</td>\n",
       "      <td>['MsoNormalIndent']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Únicamente los pacientes con FQ con una mutación de apertura del canal (clase III): G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N o S549R o una mutación G970R o R117H en al menos un a...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>277</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a4a26951-687e-47fd-af97-5075f3ab6d1d</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>159</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En el estudio 5 fueron incluidos cuatro pacientes con la mutación &lt;i&gt;G970R&lt;/i&gt;. En tres de los cuatro pacientes el cambio en la prueba de &lt;/span&gt;&lt;span lang=\"ES...</td>\n",
       "      <td>f5d8a9cd-47a9-4846-b648-28bdbdc7d565</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En el estudio 5 fueron incluidos cuatro pacientes con la mutación G970R. En tres de los cuatro pacientes el cambio en la prueba de cloruro en el sudor fue &lt;5 mmol/l y este grupo no demostró una me...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>384</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>160</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>be1e23d3-fdac-4364-9485-97a02e59cb66</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Los resultados de eficacia de un estudio de fase 2 en pacientes con FQ homocigóticos para la mutación &lt;i&gt;F508del &lt;/i&gt;en el gen &lt;i&gt;CFTR&lt;/i&gt; no mostraron una dif...</td>\n",
       "      <td>180349b6-6e08-427e-81fe-f34ed267a417</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los resultados de eficacia de un estudio de fase 2 en pacientes con FQ homocigóticos para la mutación F508del en el gen CFTR no mostraron una diferencia estadísticamente significativa en el VEF1 a...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>380</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>162</th>\n",
       "      <td>&lt;p class=\"labeltextheading\" style=\"page-break-after:auto\"&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5c3ad10d-4ca6-4b07-88bf-628d6bc15ba0</td>\n",
       "      <td>page-break-after:auto</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>163</th>\n",
       "      <td>&lt;p class=\"labeltextheading\" style=\"page-break-after:auto\"&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt;En el estudio 6, se ha demostrado menos evidencia de un efecto positivo de ivacaftor en paciente...</td>\n",
       "      <td>573d9b9d-0b89-499f-866d-b0fa26171291</td>\n",
       "      <td>page-break-after:auto</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>En el estudio 6, se ha demostrado menos evidencia de un efecto positivo de ivacaftor en pacientes con una mutación R117H-7T asociada a una menor gravedad de la enfermedad (ver sección 5.1).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>189</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>164</th>\n",
       "      <td>&lt;p class=\"labeltextheading\" style=\"page-break-after:auto\"&gt;&lt;u&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>2777f688-9f70-4d87-a640-0a88c4861945</td>\n",
       "      <td>page-break-after:auto</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>165</th>\n",
       "      <td>&lt;p class=\"labeltextheading\" style=\"page-break-after:auto\"&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt;No se debe prescribir ivacaftor en un esquema combinado con tezacaftor/ivacaftor a pacientes con...</td>\n",
       "      <td>bd8dc0c8-c9a9-4b98-a6b6-21accb4926bf</td>\n",
       "      <td>page-break-after:auto</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se debe prescribir ivacaftor en un esquema combinado con tezacaftor/ivacaftor a pacientes con FQ heterocigóticos para la mutación F508del con una segunda mutación en el gen CFTR que no se menci...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>218</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>166</th>\n",
       "      <td>&lt;p class=\"labeltextheading\" style=\"page-break-after:auto\"&gt;&lt;u&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>f074321e-9a30-4844-b3f6-e84950743399</td>\n",
       "      <td>page-break-after:auto</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>167</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;u&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt;Efecto en las pruebas de la función hepática&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>5d0e72ac-f963-4577-bc66-cfbef3b8818f</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Efecto en las pruebas de la función hepática</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>44</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>168</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f55ba3e1-5f62-4358-855a-207562ed321e</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>&lt;p class=\"labeltextheading\" style=\"page-break-after:auto\"&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt;Es frecuente el aumento moderado de las aminotransferasas &lt;/span&gt;&lt;span lang=\"ES\" style=\"font-sty...</td>\n",
       "      <td>f9ec7007-01fa-49a2-8627-e662c1da5a80</td>\n",
       "      <td>page-break-after:auto</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Es frecuente el aumento moderado de las aminotransferasas (alanina-aminotransferasa [ALAT] o aspartato‑aminotransferasa [ASAT]) en los sujetos con FQ. Se han observado aumentos de las aminotransfe...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>1223</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>170</th>\n",
       "      <td>&lt;p class=\"labeltextheading\" style=\"page-break-after:auto\"&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e5556fcc-ee3e-4574-ae26-18fd806a7dbe</td>\n",
       "      <td>page-break-after:auto</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Insuficiencia hepática&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>6bba032c-6e58-4c07-bc3d-72e9a2664dab</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Insuficiencia hepática</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>172</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>15e6bc81-8633-4eb0-8444-d935be34ea34</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>173</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES-TRAD\"&gt;No se recomienda utilizar ivacaftor, en monoterapia o en un esquema combinado con tezacaftor/ivacaftor, en pacientes con insuficiencia hepática grave a me...</td>\n",
       "      <td>3c98ebe3-ea99-4276-b767-033deb3a86e9</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se recomienda utilizar ivacaftor, en monoterapia o en un esquema combinado con tezacaftor/ivacaftor, en pacientes con insuficiencia hepática grave a menos que los beneficios esperados superen l...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>393</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>174</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>c334bfc2-83da-4545-a244-ed501bce00e3</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>175</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En los pacientes con insuficiencia hepática moderada, no se recomienda el uso de ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor. Únicam...</td>\n",
       "      <td>95b7a979-6084-42bc-a287-a91c9863e0a0</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En los pacientes con insuficiencia hepática moderada, no se recomienda el uso de ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor. Únicamente se debe considerar el tratamient...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>395</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>176</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f6348637-83dc-4106-82fa-6021c4a20b88</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>177</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Insuficiencia renal&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>22a1bec5-0933-4730-b26d-ec025b8b4977</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Insuficiencia renal</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>178</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>350ea231-614d-450f-aa61-8b9ce4d19f60</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Se recomienda precaución mientras se utiliza ivacaftor, en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o &lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt;ivacaft...</td>\n",
       "      <td>49655528-69ea-43f4-8440-035d99f8c8bf</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se recomienda precaución mientras se utiliza ivacaftor, en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor, en pacientes con insuficiencia renal g...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>259</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>5ae3c0bc-f5fe-495a-a293-748653fa5207</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>181</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Pacientes después de un trasplante de órganos&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>035d45fe-81d9-4420-ae2c-86eebdc5def2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Pacientes después de un trasplante de órganos</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>45</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>559a0c90-ca42-417a-bb32-1e0bec8ebb04</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>183</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Ivacaftor, en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor,&lt;/span&gt;&lt;span lang=\"ES\"&gt; no se ha estudiado en p...</td>\n",
       "      <td>83d154bb-5a1b-408d-9718-339e081a8d0a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor, en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor, no se ha estudiado en pacientes con FQ que se han sometido a un trasplante de órgan...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>337</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>58842cb8-ed6b-4f69-a4b3-d898b4c23324</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>185</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Acontecimientos de exantema&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>8bdbc96b-4551-4501-b673-98dc1782d01b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Acontecimientos de exantema</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>186</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>794b140a-7538-47c4-bef1-c9b6e2b0bbbf</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>187</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;La incidencia de los acontecimientos de exantema con ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor fue ...</td>\n",
       "      <td>a8f3b538-0167-449f-90e9-29f104eb70af</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La incidencia de los acontecimientos de exantema con ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor fue mayor en las mujeres que en los hombres, particularmente en las muje...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>892</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>188</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>1380bf15-ac06-4cfa-ad6f-3c9258bf00ba</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>189</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Interacciones con otros medicamentos&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>b2521090-ead6-43e9-bf9b-ac0adb2ca941</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Interacciones con otros medicamentos</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>36</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>190</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>8e9102f9-c8db-424c-81ad-1130885fc73f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>191</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Inductores de CYP3A&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>5d29fc4a-4db1-4a57-bb16-274656999e5d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Inductores de CYP3A</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>192</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>72679138-a933-4fb0-8e4d-96b9740cf8a4</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>193</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;La exposición a ivacaftor disminuye significativamente y se espera que las exposiciones a &lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt;elexacafto...</td>\n",
       "      <td>7bbe100a-8a5b-4c5e-b329-406d80064a56</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La exposición a ivacaftor disminuye significativamente y se espera que las exposiciones a elexacaftor y tezacaftor aumenten con el uso concomitante de inductores de CYP3A, pudiendo dar lugar a una...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>464</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>194</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>61a230a1-0285-4ee4-8655-b5619191df54</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Inhibidores de CYP3A&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>a5a5ba10-87f1-4601-b012-c45fcdf1d447</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Inhibidores de CYP3A</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>196</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2e39b475-d455-4254-8ff0-44b2c5782622</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>197</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;La exposición a ivacaftor, &lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt;tezacaftor y &lt;/span&gt;&lt;span lang=\"ES\"&gt;e&lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt;lexacaft...</td>\n",
       "      <td>7b47ae39-763a-43f1-919b-a65a679f8122</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La exposición a ivacaftor, tezacaftor y elexacaftor aumenta cuando se administra con inhibidores potentes o moderados de CYP3A. Se debe ajustar la dosis de ivacaftor (en monoterapia o en un esquem...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>398</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>198</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d09d3712-490d-4551-8e29-32c88b2d5610</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>199</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Población pediátrica&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>b185fa34-6360-43fb-8ff4-1145271af285</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Población pediátrica</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>200</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9affa245-766f-49ec-8b1e-045975ee6c5e</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>201</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Se han notificado casos de opacidad del cristalino/cataratas no congénitas sin afectar a la visión en pacientes pediátricos trat...</td>\n",
       "      <td>8d3cabd7-daf1-475d-b22e-0317b7ba5f5d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se han notificado casos de opacidad del cristalino/cataratas no congénitas sin afectar a la visión en pacientes pediátricos tratados con ivacaftor y con esquemas que contienen ivacaftor. Aunque en...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>661</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>202</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6663584a-1e63-483d-8977-a38601505e92</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>203</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Contenido de lactosa&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>bd3d3aa9-d349-4ec6-a171-994c85096e6d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Contenido de lactosa</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>204</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>58f85081-70e0-44f5-b781-3ab2d0e2afb2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>205</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Kalydeco contiene lactosa. Los pacientes con intolerancia hereditaria a galactosa, deficiencia total de lactasa o problemas de absorción de glucosa o galactosa...</td>\n",
       "      <td>afb73d38-1087-481a-83bb-f45906176e6f</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Kalydeco contiene lactosa. Los pacientes con intolerancia hereditaria a galactosa, deficiencia total de lactasa o problemas de absorción de glucosa o galactosa no deben tomar este medicamento.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>192</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>206</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>46e28d56-0ecd-447a-839c-80dc94b0895f</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>207</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Contenido de sodio&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>129c3c4c-ca35-4d48-ac53-cc86dca907b6</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Contenido de sodio</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>208</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>94fbc601-9641-4214-9020-1f4da6ed95e9</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>209</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Este medicamento contiene menos de 23 mg de sodio (1 mmol) por unidad de dosis; esto es, esencialmente “exento de sodio”.&lt;/span&gt;...</td>\n",
       "      <td>4c194a97-0b95-4037-9b77-b69996e5aed5</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Este medicamento contiene menos de 23 mg de sodio (1 mmol) por unidad de dosis; esto es, esencialmente “exento de sodio”.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>121</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>210</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>28619851-b8f2-4c33-ad72-3bd29dc1bb89</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>211</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.5     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Interacción con otros medicamentos y otras fo...</td>\n",
       "      <td>aa12f85d-f14b-4187-a87f-1e6d7026bebc</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.5     Interacción con otros medicamentos y otras formas de interacción</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>68</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>212</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4944417b-8438-4ab7-b701-7f352c5a8ff8</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>213</th>\n",
       "      <td>&lt;p class=\"MsoCommentText\"&gt;&lt;span lang=\"ES\" style=\"font-size:11.0pt\"&gt;Ivacaftor es un sustrato de CYP3A4 y CYP3A5. Es un inhibidor débil de CYP3A y P‑gp y un posible inhibidor de CYP2C9. Los estudios...</td>\n",
       "      <td>d8f34ab0-e605-43f4-a7f4-8be9e483f654</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoCommentText']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor es un sustrato de CYP3A4 y CYP3A5. Es un inhibidor débil de CYP3A y P‑gp y un posible inhibidor de CYP2C9. Los estudios in vitro demostraron que ivacaftor no es un sustrato de P‑gp.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>191</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>214</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b3d0785e-b0a9-4ebb-9948-9fc559af0aac</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>215</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Medicamentos que afectan a la farmacocinética de ivacaftor&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>d3477d85-6146-4e15-a0a8-7e5629002148</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Medicamentos que afectan a la farmacocinética de ivacaftor</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>58</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>216</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>ee34e771-d80e-463c-9af8-aa5c9940afa3</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217</th>\n",
       "      <td>&lt;p class=\"MsoCommentText\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\" style=\"font-size:11.0pt\"&gt;Inductores de CYP3A&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>95ec69d8-ad09-4762-96dc-55c91f8f73b7</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoCommentText']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Inductores de CYP3A</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a99633aa-d178-4fe6-98f2-8ef68de4237f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>219</th>\n",
       "      <td>&lt;p class=\"MsoCommentText\"&gt;&lt;span lang=\"ES\" style=\"font-size:11.0pt\"&gt;La administración conjunta de ivacaftor con rifampicina, un inductor potente de CYP3A, disminuyó la exposición a ivacaftor (AUC) ...</td>\n",
       "      <td>004eb5e2-8d4e-47f5-baa2-4dd4c17178cc</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoCommentText']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La administración conjunta de ivacaftor con rifampicina, un inductor potente de CYP3A, disminuyó la exposición a ivacaftor (AUC) en un 89 % y a hidroximetil-ivacaftor (M1), aunque en menor grado q...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>543</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>220</th>\n",
       "      <td>&lt;p class=\"MsoCommentText\"&gt;&lt;span lang=\"ES\" style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>631a9299-2946-4479-8e45-1338df0ab3d3</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoCommentText']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>221</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;No se recomienda un ajuste de la dosis cuando se utilice ivacaftor (en monoterapia o en un esquema combinado con tezacaftor/ivacaftor &lt;/span&gt;&lt;span lang=\"ES\"&gt;o ...</td>\n",
       "      <td>ccce043f-a76d-4417-aa03-96543d3d8a7d</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se recomienda un ajuste de la dosis cuando se utilice ivacaftor (en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor) junto con inductores débil...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>220</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>222</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ffb15937-5fdc-4088-a8a1-ef53642d95fe</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>223</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Inhibidores de CYP3A&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>0761372d-fda3-452f-8e88-50fc89d1c362</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Inhibidores de CYP3A</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>224</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>efc23074-2942-4df8-867e-d55ce05379c5</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>225</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Ivacaftor es un sustrato sensible de CYP3A. La administración conjunta con ketoconazol, un inhibidor potente de CYP3A, aumentó la exposición a ivacaftor (deter...</td>\n",
       "      <td>fdc0ffde-7ed8-4172-b48a-bc9f0f656f5a</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor es un sustrato sensible de CYP3A. La administración conjunta con ketoconazol, un inhibidor potente de CYP3A, aumentó la exposición a ivacaftor (determinada como área bajo la curva [AUC])...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>610</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>226</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>2147fd1f-c99c-4873-bded-69abcbdc0431</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>227</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;La administración conjunta con fluconazol, un inhibidor moderado de CYP3A, aumentó la exposición a ivacaftor en 3 veces y a su metabolito M1, aunque en menor g...</td>\n",
       "      <td>dd5b23ed-aeb9-4115-b896-44358b4f228c</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La administración conjunta con fluconazol, un inhibidor moderado de CYP3A, aumentó la exposición a ivacaftor en 3 veces y a su metabolito M1, aunque en menor grado que a ivacaftor. Se recomienda d...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>500</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>228</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7eb0edf4-2623-427e-86a5-cf11f41defa7</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>229</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;La administración conjunta de ivacaftor&lt;/span&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;span lang=\"ES\"&gt;con zumo de pomelo, que contiene uno o más componentes que inhiben de for...</td>\n",
       "      <td>27b4db21-e5bf-426c-90ac-3aa4f238ee20</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La administración conjunta de ivacaftor con zumo de pomelo, que contiene uno o más componentes que inhiben de forma moderada CYP3A, puede aumentar la exposición a ivacaftor. Se deben evitar los al...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>392</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>230</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>834006f0-7f8a-4b66-8e93-7b533eb0f3c0</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>231</th>\n",
       "      <td>&lt;p class=\"MsoCommentText\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\" style=\"font-size:11.0pt\"&gt;Capacidad de ivacaftor para interactuar con transportadores&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>ee96144e-692d-4c91-b860-34d7de8bfff1</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoCommentText']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Capacidad de ivacaftor para interactuar con transportadores</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>59</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>232</th>\n",
       "      <td>&lt;p class=\"MsoCommentText\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\" style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0809c7cf-9caa-42ce-ae9a-c50013329193</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoCommentText']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>233</th>\n",
       "      <td>&lt;p style=\"margin:0in\"&gt;&lt;span lang=\"ES\" style=\"font-size:11.0pt\"&gt;Los estudios &lt;i&gt;in vitro&lt;/i&gt; demostraron que ivacaftor no es un sustrato de OATP1B1 ni de OATP1B3. Ivacaftor y sus metabolitos son su...</td>\n",
       "      <td>ea15201d-7710-4b67-a464-eb1a3872cc9d</td>\n",
       "      <td>margin:0in</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los estudios in vitro demostraron que ivacaftor no es un sustrato de OATP1B1 ni de OATP1B3. Ivacaftor y sus metabolitos son sustratos de BCRP in vitro. Debido a su alta permeabilidad intrínseca y ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>482</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>234</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>48452677-5df9-4666-8c66-f0df2f0a39c9</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>235</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Ciprofloxacino&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>63b04285-5ea1-45d6-816a-05d1781cacfe</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Ciprofloxacino</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>236</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6c2451bc-c175-48fd-9b9c-ada405958db2</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>237</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;La administración conjunta de ciprofloxacino con ivacaftor no afectó a la exposición a ivacaftor. No es necesario ajustar la dosis cuando ivacaftor&lt;/span&gt;&lt;span...</td>\n",
       "      <td>7f9f3c55-19f3-47fe-b132-5382ff1d479a</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La administración conjunta de ciprofloxacino con ivacaftor no afectó a la exposición a ivacaftor. No es necesario ajustar la dosis cuando ivacaftor (en monoterapia o en un esquema combinado con te...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>298</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>238</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4e2c9396-8a9f-4a06-9cbb-7dd9549b6f86</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>239</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Medicamentos a los que afecta ivacaftor&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>21360eeb-0288-4335-8674-8d898d3d3616</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Medicamentos a los que afecta ivacaftor</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>49d83c44-b40a-4a8c-a58b-bd742410d80a</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>241</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;La administración de ivacaftor puede aumentar la exposición sistémica de los medicamentos que son sustratos sensibles de &lt;/span&gt;&lt;span lang=\"ES\"&gt;CYP2C9&lt;/span&gt;&lt;s...</td>\n",
       "      <td>7beb49dd-2c55-4652-bb77-a4efe392db76</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La administración de ivacaftor puede aumentar la exposición sistémica de los medicamentos que son sustratos sensibles de CYP2C9, y/o P‑gp y/o CYP3A, lo que puede aumentar o prolongar su efecto ter...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>231</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>242</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>796689b1-ab2a-446c-b719-4256b3087ace</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>243</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:13.0pt;page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Sustratos de CYP2C9&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>e0a79008-ccea-45e2-a290-370ef27870f6</td>\n",
       "      <td>line-height:13.0pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Sustratos de CYP2C9</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>244</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6cf8d64a-acd1-465a-a45e-17f125aa9f00</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>245</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Ivacaftor puede inhibir CYP2C9. Por lo tanto, se recomienda controlar la razón internacional normalizada (INR) durante la administración conjunta de warfarina ...</td>\n",
       "      <td>4a05e7fb-0743-4496-9da5-af1c3981fed0</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor puede inhibir CYP2C9. Por lo tanto, se recomienda controlar la razón internacional normalizada (INR) durante la administración conjunta de warfarina con ivacaftor (en monoterapia o en un...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>424</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>246</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7c7b56aa-f0d2-4de9-bd95-08b3ac26b545</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>247</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Digoxina y otros sustratos de P‑gp&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>236ad60c-88d9-4fef-8c35-e75636dce640</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Digoxina y otros sustratos de P‑gp</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>34</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>248</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>23e092ed-9015-4650-8b07-fd8fcb6b53c3</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>249</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;La administración conjunta con digoxina, un sustrato sensible de la P‑gp, aumentó la exposición a digoxina en 1,3 veces, lo que es coherente con la inhibición ...</td>\n",
       "      <td>e515ffab-e8f5-4f8f-89cd-1dfd4da2f596</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La administración conjunta con digoxina, un sustrato sensible de la P‑gp, aumentó la exposición a digoxina en 1,3 veces, lo que es coherente con la inhibición débil de la P‑gp por ivacaftor. La ad...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>719</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>250</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d7c63a55-192a-4d41-b1d2-7bf83aa51a14</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>251</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Sustratos de CYP3A&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>9d0a143a-a85d-4512-9f22-d2e5a3fd35e6</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Sustratos de CYP3A</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>252</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3ec10d37-3b9d-4dcc-a8ee-d1b7cd5c6f1a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>253</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;La administración conjunta con midazolam (oral), un sustrato de CYP3A sensible, aumentó la exposición a midazolam en 1,5 veces, lo que es coherente con la inhi...</td>\n",
       "      <td>74a73bbb-ed62-41e5-af29-390223abd929</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La administración conjunta con midazolam (oral), un sustrato de CYP3A sensible, aumentó la exposición a midazolam en 1,5 veces, lo que es coherente con la inhibición débil de CYP3A por ivacaftor. ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>451</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>254</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5b337208-0e3a-4cfb-85bd-5110209b9f19</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>255</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Anticonceptivos hormonales&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>e9bc4393-5a04-48f0-8758-9b0370ec2b47</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Anticonceptivos hormonales</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>256</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ee75d76c-f3ea-4996-ab64-66d22c6b2ef2</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>257</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Se ha estudiado ivacaftor (en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor) con un anticonceptivo oral de ...</td>\n",
       "      <td>f2811772-006a-4bc1-a3e4-e62a532c19aa</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se ha estudiado ivacaftor (en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor) con un anticonceptivo oral de estrógeno/progesterona y se observó q...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>347</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>258</th>\n",
       "      <td>&lt;p style=\"margin:0in\"&gt;&lt;span lang=\"ES\" style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f70ef308-6eb5-41a8-99c0-010dabf40751</td>\n",
       "      <td>margin:0in</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>259</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Población pediátrica&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>ff23edb8-7d6f-4c8e-8a06-00d06cce2260</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Población pediátrica</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>260</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ae6f0205-6d33-4b13-9892-f7276fff2440</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>261</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Los estudios de interacciones se han realizado solo en adultos.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>049286cc-82e2-4197-aede-8ad5294722ec</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los estudios de interacciones se han realizado solo en adultos.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>63</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>262</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>7e9060bb-0b00-406b-8c84-9caa70727a51</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>263</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.6     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Fertilidad, embarazo y lactancia&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>501470e6-1c87-45db-816c-e61fa1fab10c</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.6     Fertilidad, embarazo y lactancia</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>36</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>264</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0673c403-35fb-486b-b995-5e1d56cb200a</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>265</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Embarazo&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>9b681804-7340-41b8-a323-832be24d337b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Embarazo</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>266</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f69104ef-6398-4aad-918d-5ed281b1cdb3</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>267</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;No hay datos o estos son limitados (datos en menos de 300 embarazos) relativos al uso de ivacaftor en mujeres embarazadas. Los estudios en animales no sugieren...</td>\n",
       "      <td>e1654873-e378-47fb-a685-cb4cb8cee203</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No hay datos o estos son limitados (datos en menos de 300 embarazos) relativos al uso de ivacaftor en mujeres embarazadas. Los estudios en animales no sugieren efectos perjudiciales directos ni in...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>358</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>268</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f9553502-993f-413b-aa8b-ef6228a58c4b</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>269</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Lactancia&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>1af9e671-abc2-4bfd-b166-e27ca412e4c2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Lactancia</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>270</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>165c023d-76dc-4f77-87f1-a1e803498995</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>271</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;Se desconoce si &lt;/span&gt;&lt;span lang=\"ES\"&gt;ivacaftor y/o sus metabolitos se excretan en la leche materna. &lt;/span&gt;&lt;span lang=\"ES\"&gt;Los datos farm...</td>\n",
       "      <td>f3b080a1-71ac-45c0-a0c9-3b2e40cad4e2</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se desconoce si ivacaftor y/o sus metabolitos se excretan en la leche materna. Los datos farmacocinéticos disponibles en animales muestran que ivacaftor se excreta en la leche de ratas hembra en p...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>489</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>272</th>\n",
       "      <td>&lt;p class=\"MsoNormalIndent\" style=\"margin:0in\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2406ef57-1acb-49cd-9f20-f485a7f0a9ba</td>\n",
       "      <td>margin:0in</td>\n",
       "      <td>['MsoNormalIndent']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>273</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Fertilidad&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>d0b056c0-0543-4bc5-aac7-39ccc48f245f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Fertilidad</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>10</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>274</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1ffd11fc-93e9-4bc3-8c4a-f781594e0cf4</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>275</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;No se dispone de datos sobre el efecto de ivacaftor en la fertilidad en humanos. Ivacaftor tuvo un efecto en la fertilidad en ratas (ver se...</td>\n",
       "      <td>a269a172-5267-4a6d-a24d-a7e8e8c39596</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se dispone de datos sobre el efecto de ivacaftor en la fertilidad en humanos. Ivacaftor tuvo un efecto en la fertilidad en ratas (ver sección 5.3).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>150</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>276</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b2543fe0-bc59-4ca4-924b-87c0d814bed2</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>277</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.7     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Efectos sobre la capacidad para conducir y ut...</td>\n",
       "      <td>26be193e-cb11-4539-9f93-82f782dbba70</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.7     Efectos sobre la capacidad para conducir y utilizar máquinas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>64</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>278</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7b128a04-bec4-4013-a567-aaa17e07ee8a</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>279</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;La influencia de ivacaftor sobre la capacidad para conducir y utilizar máquinas es pequeña. Ivacaftor puede producir mareos (ver sección 4.8) y, por lo tanto, ...</td>\n",
       "      <td>a0b2830d-4d5b-4a87-9c39-f33a7cbee2c9</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La influencia de ivacaftor sobre la capacidad para conducir y utilizar máquinas es pequeña. Ivacaftor puede producir mareos (ver sección 4.8) y, por lo tanto, se debe aconsejar a los pacientes que...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>286</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>280</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6461878c-0fd3-4eca-b2a1-9f4e9c7c3976</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>281</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.8     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Reacciones adversas&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>845fc59a-0299-490e-ba26-c4ebc703690b</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.8     Reacciones adversas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>23</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>282</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c963a70f-236c-4dc8-a35f-66b738cd42f3</td>\n",
       "      <td>page-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>283</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Resumen del perfil de seguridad&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>d6770238-89d9-42bd-a941-eef46df81e38</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Resumen del perfil de seguridad</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>284</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>742a316c-2896-41eb-b510-e4da603e1ba1</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>285</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Las reacciones adversas más frecuentes experimentadas por los pacientes de 6 años o mayores que recibieron ivacaftor son cefalea &lt;/span&gt;&lt;span lang=\"ES\"&gt;(23,9 %...</td>\n",
       "      <td>9c9844a7-0225-475a-abdf-d386c1b51dff</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Las reacciones adversas más frecuentes experimentadas por los pacientes de 6 años o mayores que recibieron ivacaftor son cefalea (23,9 %), dolor bucofaríngeo (22,0 %), infección en las vías respir...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>537</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>286</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>952ca76a-31db-48b9-829f-e7a2d50acffa</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>287</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;En pacientes de 2 a menos de 6 años las reacciones adversas más frecuentes fueron congestión nasal (26,5 %), infección en las vías respiratorias altas (23,5 %)...</td>\n",
       "      <td>8f6c3fd9-b8b6-441c-ace9-99d2ee49dc43</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En pacientes de 2 a menos de 6 años las reacciones adversas más frecuentes fueron congestión nasal (26,5 %), infección en las vías respiratorias altas (23,5 %), aumento de las aminotransferasas (1...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>256</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>288</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>bd1ff8fe-0bde-4faf-89fd-eadfff0d7c98</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>289</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Las reacciones adversas graves observadas en los pacientes que recibieron ivacaftor incluyeron dolor abdominal y aumento de las aminotransferasas (ver sección ...</td>\n",
       "      <td>481987c2-1a97-4687-becb-c66f3e06e406</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Las reacciones adversas graves observadas en los pacientes que recibieron ivacaftor incluyeron dolor abdominal y aumento de las aminotransferasas (ver sección 4.4).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>164</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>290</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>344683cc-bb25-4d54-9973-cc7db327df8e</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>291</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"line-height:13.0pt;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Tabla de reacciones adversas&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>fd6d02d5-5cd7-47b1-8afa-9fd78e3d7cc9</td>\n",
       "      <td>line-height:13.0pt;page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Tabla de reacciones adversas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>292</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ea49dd70-eca4-45d0-80d8-fdc2195add3c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>293</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;La Tabla 4 muestra las reacciones adversas observadas&lt;/span&gt;&lt;span lang=\"ES\"&gt; con ivacaftor en monoterapia en los ensayos clínicos (estudios controlados con pla...</td>\n",
       "      <td>3f0d0850-a721-4498-9070-674d2f945c7b</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La Tabla 4 muestra las reacciones adversas observadas con ivacaftor en monoterapia en los ensayos clínicos (estudios controlados con placebo y estudios no controlados) en los que la duración de la...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>868</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>294</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6c3cd946-eebe-4ca4-afda-5ed0456f88ac</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>295</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"margin-top:0in;margin-right:0in;margin-bottom:6.0pt; margin-left:45.1pt;text-indent:-45.1pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 4: &lt;span style=\"color:black...</td>\n",
       "      <td>21ca149f-31bc-4dc9-a407-ad7975a113cd</td>\n",
       "      <td>margin-top:0in;margin-right:0in;margin-bottom:6.0pt;\\nmargin-left:45.1pt;text-indent:-45.1pt;page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 4: Reacciones adversas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>296</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:95.6%;margin-left:5.4pt;border-collapse:collapse;border:none\" width=\"95%\"&gt; &lt;thead&gt; &lt;tr style=\"page-break-insid...</td>\n",
       "      <td>a9fb7a1d-9cf4-4a04-9b99-12b9a4084328</td>\n",
       "      <td>width:95.6%;margin-left:5.4pt;border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Sistema    de clasificación de órganos   Reacciones adversas   Frecuencia      Infecciones e   infestaciones   Infección en   las vías respiratorias altas   Muy   frecuentes     Nasofaringitis...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>1680</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>297</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;* Reacción ...</td>\n",
       "      <td>bbc8e7f5-2b13-4655-b2e4-ec826dcdaec2</td>\n",
       "      <td>margin-top:6.0pt;margin-right:0in;margin-bottom:0in;\\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>* Reacción adversa y frecuencia notificadas en los estudios clínicos de ivacaftor en combinación con tezacaftor/ivacaftor.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>122</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>298</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:7.1pt;text-indent:-7.1pt\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;†&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size: 9.0pt\"&gt; Reacción adversa y frecuencia...</td>\n",
       "      <td>fa7969b0-3481-4502-bb57-ba5421714041</td>\n",
       "      <td>margin-left:7.1pt;text-indent:-7.1pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>† Reacción adversa y frecuencia notificadas en los estudios clínicos de ivacaftor en combinación con ivacaftor/tezacaftor/elexacaftor.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>134</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>299</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>a609e230-f297-4866-b435-928b643053d5</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>300</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Descripción de reacciones adversas seleccionadas&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>66961383-1392-4e3f-b3a8-4a1e774c5908</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Descripción de reacciones adversas seleccionadas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>48</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>301</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8c5f98ae-7545-4d46-a080-03974edab380</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>302</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Aumento de las aminotransferasas&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>dd8b062d-6ea7-474e-b617-876157ce11f8</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Aumento de las aminotransferasas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>32</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>303</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>227821a1-efb2-4737-bdab-6031c997eb5a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>304</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Durante los estudios clínicos 1 y 2 controlados con placebo, de 48 semanas de duración, de ivacaftor en monoterapia en pacientes de 6 años o mayores, la incide...</td>\n",
       "      <td>bb5b82d7-c871-4f4e-804b-ef116ed38d14</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Durante los estudios clínicos 1 y 2 controlados con placebo, de 48 semanas de duración, de ivacaftor en monoterapia en pacientes de 6 años o mayores, la incidencia de niveles máximos de las aminot...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>1288</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>305</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c5a2607b-813c-439f-a5c1-a1cc9506c650</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>306</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Durante los estudios de fase 3, controlados con placebo (hasta 24 semanas) de tezacaftor/ivacaftor, &lt;/span&gt;&lt;span lang=\"ES\"&gt;la incidencia de niveles máximos de ...</td>\n",
       "      <td>7a5a0c37-0e3f-405e-aca6-ba41bb006754</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Durante los estudios de fase 3, controlados con placebo (hasta 24 semanas) de tezacaftor/ivacaftor, la incidencia de niveles máximos de las aminotransferasas (ALAT o ASAT) &gt;8, &gt;5 o &gt;3 veces el LSN...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>693</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>307</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>639a472a-3144-475b-bcc3-f98500aa77a7</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>308</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Durante el estudio de fase 3, controlados con placebo de 24 semanas de duración de ivacaftor/tezacaftor/elexacaftor, estas cifras fueron del 1,5 %, 2,5 % y 7,9...</td>\n",
       "      <td>e0957090-cb84-4d92-9a62-5c440815be3a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Durante el estudio de fase 3, controlados con placebo de 24 semanas de duración de ivacaftor/tezacaftor/elexacaftor, estas cifras fueron del 1,5 %, 2,5 % y 7,9 % en los pacientes tratados con ivac...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>531</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>309</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b7bee665-bdfb-462a-8d50-432bb62cdb0b</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>310</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Acontecimientos de exantema&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>aaf0c19e-4b11-46bb-814c-030d675c0d40</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Acontecimientos de exantema</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>311</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c2cf5368-0cf7-4ee9-b1ac-e7f5f3811c4e</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>312</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Se han observado acontecimientos de exantema, por lo general de intensidad leve a moderada, con el uso de ivacaftor en un esquem...</td>\n",
       "      <td>0842b3d6-fc85-4064-a569-13699640da69</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se han observado acontecimientos de exantema, por lo general de intensidad leve a moderada, con el uso de ivacaftor en un esquema combinado, y ocurrieron con más frecuencia en las mujeres tratadas...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>285</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>313</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>698162bc-efaa-414f-ba06-4ba29b5ccd05</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>314</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Aumento de la creatina fosfoquinasa&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>78a5421c-af22-405b-955f-8681ff8e0a60</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Aumento de la creatina fosfoquinasa</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>315</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>534d716c-f298-4235-a643-2a717c8f9052</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>316</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Se observaron aumentos, por lo genral transitorios y asintomáticos, de la &lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt;creatina fosfoquinasa &lt;/span&gt;&lt;span lang=\"ES\"&gt;en los pacie...</td>\n",
       "      <td>74ce87aa-54ff-4d91-ad04-634deab19cba</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se observaron aumentos, por lo genral transitorios y asintomáticos, de la creatina fosfoquinasa en los pacientes tratados con ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>252</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>317</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1f2f9a1e-3968-4e86-a134-d91f70ae5834</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>318</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Presión arterial elevada&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>586dd4c0-a4d4-4d0c-860a-7c56e82aa2aa</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Presión arterial elevada</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>319</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>4addd79c-f424-4847-914b-f0470a347298</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>320</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Se observó un aumento &lt;/span&gt;&lt;span lang=\"ES\"&gt;de presión arterial sistólica y diastólica media desde el valor basal fue de&lt;/span&gt;&lt;span lang=\"ES\"&gt; 3,5 mmHg y 1,9...</td>\n",
       "      <td>19d99677-cee7-4c0e-be5b-3a2c9ca4841c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se observó un aumento de presión arterial sistólica y diastólica media desde el valor basal fue de 3,5 mmHg y 1,9 mmHg, respectivamente, en los pacientes tratados con ivacaftor en un esquema combi...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>238</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>321</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>06548203-ccad-40d0-96de-be803bc13c0a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>322</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Población pediátrica&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>07ecb175-32b9-41f4-9761-c80496214fe2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Población pediátrica</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>323</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6fa0f23c-6a2a-45cb-a408-d0729fd5b87c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>324</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Los datos de seguridad de ivacaftor en monoterapia se evaluaron en 6 pacientes de entre 4 meses y menos de 6 meses de edad, 11 pacientes de entre 6 meses y men...</td>\n",
       "      <td>4169db30-a0b1-4332-84b5-76a9a57e016d</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los datos de seguridad de ivacaftor en monoterapia se evaluaron en 6 pacientes de entre 4 meses y menos de 6 meses de edad, 11 pacientes de entre 6 meses y menos de 12 meses de edad, en 19 pacient...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>411</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>325</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>49ddab0e-b1e1-44db-aca1-514762492e9e</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>326</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;El perfil de seguridad de ivacaftor (en monoterapia o en un esquema combinado) es por lo general coherente entre los pacientes pediátricos y también es coheren...</td>\n",
       "      <td>dfdc6ec5-a778-4103-85a4-7f45528ab3b2</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El perfil de seguridad de ivacaftor (en monoterapia o en un esquema combinado) es por lo general coherente entre los pacientes pediátricos y también es coherente con el de los pacientes adultos.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>194</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>327</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>200b8f93-7dab-4af2-a7ef-bdef64cd51c7</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>328</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;La incidencia de &lt;/span&gt;&lt;span lang=\"ES\"&gt;aumento de las aminotransferasas&lt;/span&gt;&lt;span lang=\"ES\"&gt; (ALAT o ASAT) observada en los estudios 2, 5 y 6 (pacientes de ...</td>\n",
       "      <td>d8a7051d-22c3-49bf-87d2-5daaba112134</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La incidencia de aumento de las aminotransferasas (ALAT o ASAT) observada en los estudios 2, 5 y 6 (pacientes de 6 a menos de 12 años), el estudio 7 (pacientes de 2 a menos de 6 años) y el estudio...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>1408</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>329</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9a96183f-7698-4e40-b736-724afcc1a454</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>330</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-bottom:12.0pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 5: Aumentos de las aminotransferasas en pacientes de 4 meses a &amp;lt;12 años tratados con ivacaftor ...</td>\n",
       "      <td>9c6d5433-6be5-410e-8af5-c9ba5801812a</td>\n",
       "      <td>margin-bottom:12.0pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 5: Aumentos de las aminotransferasas en pacientes de 4 meses a &lt;12 años tratados con ivacaftor en monoterapia</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>115</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>331</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoTableGrid\" style=\"margin-left:6.85pt;border-collapse:collapse;border:none\"&gt; &lt;tr style=\"height:28.95pt\"&gt; &lt;td style=\"width:121.1pt;border:...</td>\n",
       "      <td>a86396bc-f671-4ac5-af20-94c1cdb8fdd5</td>\n",
       "      <td>margin-left:6.85pt;border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoTableGrid']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>n   % de pacientes &gt;3 veces el LSN   % de pacientes &gt;5 veces el LSN   % de pacientes &gt;8 veces el LSN     6 a   &lt;12 años   40   15,0 % (6)   2,5 % (1)   2,5 % (1)     2 a   &lt;6 años   34   14...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>332</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>bc2bfcaf-3d93-4978-add0-4996da4ef294</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>333</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Notificación de sospechas de reacciones adversas&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>74f8670e-2d23-4e3f-9683-3dba7ed827b5</td>\n",
       "      <td>page-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Notificación de sospechas de reacciones adversas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>48</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>334</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d2355432-989f-4f5f-b819-7adce09b8728</td>\n",
       "      <td>page-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>335</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt;Es importante notificar sospechas de reacciones adversas al medicamento tras su autorización. Ello permite una supervisión continua...</td>\n",
       "      <td>ee524e55-0083-4d25-aa4a-9be461d267dc</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Es importante notificar sospechas de reacciones adversas al medicamento tras su autorización. Ello permite una supervisión continuada de la relación beneficio/riesgo del medicamento. Se invita a l...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>345</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>336</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c80c2af7-c16d-4dc1-9c64-8911a3400f39</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>337</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.9     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Sobredosis&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>10eff51f-2eb4-40cf-acbf-f72f5c5feb3c</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.9     Sobredosis</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>338</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7ae31cee-0599-4c75-b0d0-6a3db992fb8c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>339</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;No existe un antídoto específico para la sobredosis de ivacaftor. El tratamiento de la sobredosis consiste en las medidas de soporte generales que incluyen con...</td>\n",
       "      <td>303978c7-cd11-46c3-ac8a-d38393eeb2c6</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No existe un antídoto específico para la sobredosis de ivacaftor. El tratamiento de la sobredosis consiste en las medidas de soporte generales que incluyen control de las constantes vitales, prueb...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>268</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>340</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b705f3d7-0ae4-48cb-a236-8285efe19e41</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>341</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2070997f-59b0-46ef-a346-c0337a1acc7d</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>342</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;5.       &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;PROPIEDADES FARMACOLÓGICAS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>9883687e-7f9c-4cfa-9fb1-79ea1f5a413c</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>5.       PROPIEDADES FARMACOLÓGICAS</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>29</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>343</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cbf9f9a5-09dc-4b59-a4b4-52ee06617158</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>344</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;5.1     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Propiedades farmacodinámicas&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>65806c6a-5fd8-4a40-8b19-9e5c9f410a06</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>5.1     Propiedades farmacodinámicas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>32</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>345</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>b681350b-09eb-40ab-92dd-e328901cf076</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>346</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Grupo farmacoterapéutico: Otros productos del sistema respiratorio, código ATC: &lt;/span&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;R07AX...</td>\n",
       "      <td>886481b7-14cf-44f1-8003-f53311b2a5a2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Grupo farmacoterapéutico: Otros productos del sistema respiratorio, código ATC: R07AX02</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>87</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>347</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>61c5019c-83ec-4338-9ce3-c0b1b96230d2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>348</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-right:-.1pt;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Mecanismo de acción&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>8f5b6b3d-559b-411a-86ea-2a0aee1112d5</td>\n",
       "      <td>margin-right:-.1pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Mecanismo de acción</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>349</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>329d7296-ac85-4d49-a5ce-206bb67e5051</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>350</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Ivacaftor es un potenciador de la proteína CFTR, es decir, ivacaftor &lt;i&gt;in vitro&lt;/i&gt; aumenta la apertura del canal de CFTR para intensificar el transporte de c...</td>\n",
       "      <td>b12ba759-ab96-4f00-a6aa-5e78d5076089</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor es un potenciador de la proteína CFTR, es decir, ivacaftor in vitro aumenta la apertura del canal de CFTR para intensificar el transporte de cloruro en las mutaciones de apertura del can...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>842</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>351</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>103988e9-f22c-4c52-8800-d3d620627d55</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>352</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Las respuestas &lt;i&gt;in vitro&lt;/i&gt; observadas en los experimentos de fijación de membranas de un solo canal utilizando membranas de células de roedores que expresa...</td>\n",
       "      <td>e939b11b-882d-48db-8872-cf77ae5e20e2</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Las respuestas in vitro observadas en los experimentos de fijación de membranas de un solo canal utilizando membranas de células de roedores que expresaban las formas de CFTR mutantes no correspon...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>501</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>353</th>\n",
       "      <td>&lt;p class=\"MsoBodyText2\" style=\"margin-bottom:0in;line-height:normal\"&gt;&lt;span lang=\"ES\" style=\"font-size:11.0pt;color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>295bae3d-d561-4d44-bb33-c7de7b131dcf</td>\n",
       "      <td>margin-bottom:0in;line-height:normal</td>\n",
       "      <td>['MsoBodyText2']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>354</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Efectos farmacodinámicos&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>204e4559-568d-4a95-a4ad-af4facdaea8c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Efectos farmacodinámicos</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>355</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a78eb7bc-9e86-4866-aafc-443dd87f3f36</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>356</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Ivacaftor en monoterapia&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>11f9a17a-8aa8-4b78-a263-8c47fff014a1</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Ivacaftor en monoterapia</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>357</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>02cedba9-6f8b-42be-b9d9-08d16a95d910</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>358</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;En los estudios 1 y 2 en pacientes con la mutación &lt;i&gt;G551D &lt;/i&gt;en un alelo del gen &lt;i&gt;CFTR&lt;/i&gt;, ivacaftor dio lugar a disminuciones rápidas (15 días), sustanc...</td>\n",
       "      <td>30e39eb9-2aa1-46e2-8c32-8ced1095b063</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En los estudios 1 y 2 en pacientes con la mutación G551D en un alelo del gen CFTR, ivacaftor dio lugar a disminuciones rápidas (15 días), sustanciales (el cambio medio del cloruro en el sudor desd...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>404</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>359</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>23bd6328-7462-4e23-abbf-710315a2c627</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>360</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En la parte 1 del estudio 5 en pacientes con una mutación de apertura del canal no &lt;i&gt;G551D&lt;/i&gt; en el gen &lt;i&gt;CFTR&lt;/i&gt;, el tratamiento con ivacaftor dio lugar a...</td>\n",
       "      <td>144165b0-fbf3-42bb-ba1f-86ea7a58e540</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En la parte 1 del estudio 5 en pacientes con una mutación de apertura del canal no G551D en el gen CFTR, el tratamiento con ivacaftor dio lugar a un cambio medio rápido (15 días) e importante desd...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>787</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>361</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d55c81b0-85f1-428e-a730-2c72f34dc129</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>362</th>\n",
       "      <td>&lt;p class=\"documenttext\" style=\"margin-bottom:0in\"&gt;&lt;span lang=\"ES\"&gt;En el estudio 6, en pacientes de 6 años o mayores con FQ con una mutación &lt;i&gt;R117H&lt;/i&gt; en el gen &lt;i&gt;CFTR&lt;/i&gt;, la diferencia entre ...</td>\n",
       "      <td>ffd466d9-5737-4344-aa2e-98c64a9885d5</td>\n",
       "      <td>margin-bottom:0in</td>\n",
       "      <td>['documenttext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En el estudio 6, en pacientes de 6 años o mayores con FQ con una mutación R117H en el gen CFTR, la diferencia entre tratamientos en el cambio medio del cloruro en el sudor desde el valor basal has...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>579</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9c141a90-32a1-4b9a-81f9-f11bd8894591</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>364</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Ivacaftor en un esquema combinado con tezacaftor/ivacaftor&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>03609267-38bc-439a-8e1e-56c0ba069f36</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Ivacaftor en un esquema combinado con tezacaftor/ivacaftor</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>58</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>365</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8b0f89d5-ef62-4f9e-9f7c-6f8ee378ad62</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>366</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En pacientes homocigóticos para la mutación &lt;i&gt;F508del&lt;/i&gt;, la diferencia del tratamiento entre ivacaftor en combinación con tezacaftor/ivacaftor y placebo en ...</td>\n",
       "      <td>0ee4b54b-470b-4bbf-9e34-164c5012fecf</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En pacientes homocigóticos para la mutación F508del, la diferencia del tratamiento entre ivacaftor en combinación con tezacaftor/ivacaftor y placebo en el cambio absoluto medio desde el valor basa...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>288</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>367</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>25926200-f836-424d-9a14-14678636f2da</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>368</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En pacientes heterocigóticos para la mutación &lt;i&gt;F508del &lt;/i&gt;y una segunda mutación asociada a la actividad residual de &lt;i&gt;CFTR&lt;/i&gt;, la diferencia del tratamie...</td>\n",
       "      <td>c4ea98d6-5e77-4c76-a8b5-15ad9cff183e</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En pacientes heterocigóticos para la mutación F508del y una segunda mutación asociada a la actividad residual de CFTR, la diferencia del tratamiento en el cambio absoluto medio desde el valor basa...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>390</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>369</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6360fa5f-ea6e-4dc7-a14f-3f568561b6c6</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>370</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;En pacientes de 6 a menos de 12&lt;/span&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;span lang=\"ES\"&gt;años homocigóticos o heterocigóticos para la mutación &lt;i&gt;F508del&lt;/i&gt; y una segund...</td>\n",
       "      <td>2e6258a8-c89d-4fe7-b8a4-506c426bf2c8</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En pacientes de 6 a menos de 12 años homocigóticos o heterocigóticos para la mutación F508del y una segunda mutación asociada a la actividad residual de CFTR, el cambio absoluto medio dentro del g...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>344</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>371</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9d347c97-404c-4d00-ae17-160b5fdd8125</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>372</th>\n",
       "      <td>&lt;p class=\"documenttext\" style=\"margin-bottom:0in;page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES-TRAD\"&gt;Ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>15fe40d2-56a9-4d51-ad0d-71833b289b81</td>\n",
       "      <td>margin-bottom:0in;page-break-after:avoid</td>\n",
       "      <td>['documenttext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>70</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>373</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>d57d0ed8-bc4d-4dd0-8ede-fe08e4fd8340</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>374</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;En&lt;/span&gt;&lt;span lang=\"ES\"&gt; pacientes con una mutación &lt;i&gt;F508del&lt;/i&gt; en un alelo y una mutación en el segundo alelo que da lugar ...</td>\n",
       "      <td>6d8f7d49-c649-4493-84d6-87f07a6ec9ba</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En pacientes con una mutación F508del en un alelo y una mutación en el segundo alelo que da lugar a una falta de producción de proteína CFTR o una proteína CFTR que no responde a ivacaftor ni a te...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>438</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>375</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ff07386b-bb81-4743-9805-4a4245e4aad3</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>376</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt;En&lt;/span&gt;&lt;span lang=\"ES\"&gt; pacientes&lt;/span&gt;&lt;span lang=\"ES\"&gt; homocigóticos para la mutación &lt;i&gt;F508del&lt;/i&gt;, la diferencia del tratami...</td>\n",
       "      <td>c6d51464-cdda-473b-9226-6f0e41543264</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En pacientes homocigóticos para la mutación F508del, la diferencia del tratamiento entre ivacaftor/tezacaftor/elexacaftor y tezacaftor/ivacaftor en el cambio absoluto medio del cloruro en el sudor...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>281</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>377</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e7ab8121-0e39-4029-9b5e-50f931e3b622</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>378</th>\n",
       "      <td>&lt;p class=\"documenttext\" style=\"margin-bottom:0in;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Eficacia clínica y seguridad&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>44af30ec-e7b0-40ee-a302-717c14940820</td>\n",
       "      <td>margin-bottom:0in;page-break-after:avoid</td>\n",
       "      <td>['documenttext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Eficacia clínica y seguridad</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>379</th>\n",
       "      <td>&lt;p class=\"documenttext\" style=\"margin-bottom:0in;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>bcb493ea-2093-4e05-9fce-52f98142e51c</td>\n",
       "      <td>margin-bottom:0in;page-break-after:avoid</td>\n",
       "      <td>['documenttext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>380</th>\n",
       "      <td>&lt;p class=\"documenttext\" style=\"margin-bottom:0in;page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Ivacaftor en monoterapia&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>2fafba15-78ec-4e61-8c6e-f2c930e44930</td>\n",
       "      <td>margin-bottom:0in;page-break-after:avoid</td>\n",
       "      <td>['documenttext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Ivacaftor en monoterapia</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>381</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>9e233aa7-b9d0-42be-a233-83542df0e5e2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>382</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Estudios 1 y 2: estudios en pacientes con FQ con mutaciones de apertura del canal G551D&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>6f55fe3c-09be-4268-9997-e2734b1f0df6</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Estudios 1 y 2: estudios en pacientes con FQ con mutaciones de apertura del canal G551D</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>87</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>383</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8a99a835-195a-4de9-8b6e-3ff4377928d4</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>384</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Se ha evaluado la eficacia de ivacaftor en dos estudios de fase 3, aleatorizados, doble ciego, controlados con placebo, multicéntricos, de pacientes clínicamen...</td>\n",
       "      <td>d3ae3d97-058b-4874-9c38-4f00d7a2e65f</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se ha evaluado la eficacia de ivacaftor en dos estudios de fase 3, aleatorizados, doble ciego, controlados con placebo, multicéntricos, de pacientes clínicamente estables con FQ que presentaban la...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>284</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>385</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>378587c9-2434-4016-912f-3ca927e71125</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>386</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Los pacientes de ambos estudios fueron aleatorizados 1:1 a recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos grasos durante 48 semanas, además ...</td>\n",
       "      <td>dfe12dc7-7523-4610-9395-af10c93fcf18</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los pacientes de ambos estudios fueron aleatorizados 1:1 a recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos grasos durante 48 semanas, además de los tratamientos prescritos para l...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>306</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>387</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ba5148dc-1c8a-44f4-b92e-13ba4496256d</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>388</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;El estudio 1 evaluó a 161 pacientes de 12 años o mayores; 122 (75,8 %) pacientes presentaban la mutación &lt;i&gt;F508del&lt;/i&gt; en el segundo alelo. Al inicio del estu...</td>\n",
       "      <td>c8d634d1-f148-4b54-9650-5c12879399f8</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El estudio 1 evaluó a 161 pacientes de 12 años o mayores; 122 (75,8 %) pacientes presentaban la mutación F508del en el segundo alelo. Al inicio del estudio, los pacientes del grupo de placebo util...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>624</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>389</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f1faef9c-ee0c-43b0-b408-588a7021a168</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>390</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;El estudio 2 evaluó a 52 pacientes de 6 a 11 años en el momento de la selección; el peso corporal medio (DE) era de 30,9 (8,63) kg; 42 (80,8 %) pacientes prese...</td>\n",
       "      <td>e3254c4a-c97d-40f2-a9f9-f2afdb5f87ed</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El estudio 2 evaluó a 52 pacientes de 6 a 11 años en el momento de la selección; el peso corporal medio (DE) era de 30,9 (8,63) kg; 42 (80,8 %) pacientes presentaban la mutación F508del en el segu...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>508</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>391</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ee8855b4-47b9-4477-ad14-1b9b7fd9dcec</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>392</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;La variable principal de eficacia en ambos estudios fue el cambio absoluto medio desde el valor basal en el porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; hasta la sem...</td>\n",
       "      <td>1f96117e-7ec9-4bb0-9972-9109570ad729</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La variable principal de eficacia en ambos estudios fue el cambio absoluto medio desde el valor basal en el porcentaje predicho de VEF1 hasta la semana 24 de tratamiento.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>170</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>393</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>56e479a7-d76f-4d9b-899a-37363fc4f56a</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>394</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; desde el valor...</td>\n",
       "      <td>85cc9dff-56e7-468e-a8b0-77bdd4e0a721</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF1 desde el valor basal hasta la semana 24 fue de 10,6 puntos por...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>905</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>395</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6e081d11-40a0-4f39-9507-7cdc12cdb5b9</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>396</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; desde el valor...</td>\n",
       "      <td>4020f423-13a3-47dc-bb44-a670eb4cd25e</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF1 desde el valor basal hasta la semana 24 en pacientes de 12 a 1...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>564</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>397</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>395098c5-445a-420b-80af-70415f81bc78</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>398</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Los resultados correspondientes a las variables de valoración secundarias clínicamente relevantes se muestran en la Tabla 6.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>54e47ab9-f9b7-40c3-9806-4623fa649486</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los resultados correspondientes a las variables de valoración secundarias clínicamente relevantes se muestran en la Tabla 6.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>124</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>399</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6de5fc30-a6c0-4718-b785-6fe42f115fa4</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>400</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 6: Efecto de ivacaftor en otras variables de eficacia en los estudios 1 y 2&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>5441d1e5-f61a-4afd-a1cc-fbed72a0bffc</td>\n",
       "      <td>margin-bottom:6.0pt;page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 6: Efecto de ivacaftor en otras variables de eficacia en los estudios 1 y 2</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>81</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>401</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"98%\"&gt; &lt;thead&gt; &lt;tr style=\"height:10.5pt\"&gt; &lt;td style=\"width:27.94%;border...</td>\n",
       "      <td>fb690df7-1693-41c9-9981-67ff130f7344</td>\n",
       "      <td>border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Estudio 1   Estudio 2     Variable   Diferencia del tratamientoa (IC del 95 %)   Valor p   Diferencia del tratamientoa (IC del 95 %)   Valor p      Cambio absoluto medio desde el   valor b...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>1127</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>402</th>\n",
       "      <td>&lt;p class=\"tablefootnote\" style=\"margin-top:6.0pt;page-break-after:avoid\"&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt;color:white\"&gt;IC: Intervalo de confianza; NA: no analizado debido a la baja incidenci...</td>\n",
       "      <td>05e81ba1-5b98-4624-8b21-1cad75bece5f</td>\n",
       "      <td>margin-top:6.0pt;page-break-after:avoid</td>\n",
       "      <td>['tablefootnote']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>IC: Intervalo de confianza; NA: no analizado debido a la baja incidencia de acontecimientos.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>92</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>403</th>\n",
       "      <td>&lt;p class=\"tablefootnote\" style=\"page-break-after:avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;a        &lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size: 9.0pt\"&gt;Diferencia del tratamiento = efe...</td>\n",
       "      <td>54a01c8d-581f-4990-a993-fa1d987bb97d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['tablefootnote']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>a        Diferencia del tratamiento = efecto de ivacaftor –efecto de placebo.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>70</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>404</th>\n",
       "      <td>&lt;p class=\"tablefootnote\" style=\"margin-left:14.2pt;text-indent:-14.2pt; page-break-after:avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;b&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt; ...</td>\n",
       "      <td>eba6837f-842c-40ec-b0dc-228a7167219c</td>\n",
       "      <td>margin-left:14.2pt;text-indent:-14.2pt;\\npage-break-after:avoid</td>\n",
       "      <td>['tablefootnote']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>b     CFQ-R: El cuestionario revisado de la calidad de vida para fibrosis quística es una determinación de la calidad de vida relacionada con la salud, específica a la enfermedad, para la FQ.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>187</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>405</th>\n",
       "      <td>&lt;p class=\"tablefootnote\" style=\"margin-left:14.2pt;text-indent:-14.2pt; page-break-after:avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;c&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt; ...</td>\n",
       "      <td>ed768de7-c817-4bae-9dd4-f613946a4e66</td>\n",
       "      <td>margin-left:14.2pt;text-indent:-14.2pt;\\npage-break-after:avoid</td>\n",
       "      <td>['tablefootnote']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>c     Los datos del estudio 1 fueron agrupados a partir del CFQ-R para adultos/adolescentes y del CFQ‑R para niños de 12 a 13 años; los datos del estudio 2 se obtuvieron a partir del CFQ-R para ni...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>211</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>406</th>\n",
       "      <td>&lt;p class=\"tablefootnotelast\" style=\"margin-bottom:0in;page-break-after:avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;d        &lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;Proporción ...</td>\n",
       "      <td>5d7ce9de-e08a-465c-bea2-fb9454487be9</td>\n",
       "      <td>margin-bottom:0in;page-break-after:avoid</td>\n",
       "      <td>['tablefootnotelast']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>d        Proporción de riesgo del tiempo hasta la primera exacerbación pulmonar.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>73</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>407</th>\n",
       "      <td>&lt;p class=\"tablefootnotelast\" style=\"margin-bottom:0in\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;e        &lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size: 9.0pt\"&gt;En sujetos menores de 20 años (gr...</td>\n",
       "      <td>48ffd17e-77ac-412a-bbed-9f24973001f8</td>\n",
       "      <td>margin-bottom:0in</td>\n",
       "      <td>['tablefootnotelast']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>e        En sujetos menores de 20 años (gráficos de crecimiento del CDC).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>66</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>408</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>54d2f24e-27b6-4d6a-a039-4efd2ba21e12</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>409</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Estudio 5: estudio en pacientes con FQ con mutaciones de apertura del canal no G551D&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>f7e7d9ea-0f28-4a99-9a65-74379ff0a0e3</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Estudio 5: estudio en pacientes con FQ con mutaciones de apertura del canal no G551D</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>84</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>410</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5b59a254-797d-4d0e-9c4c-5943bf5bc821</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>411</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;El estudio 5 fue un estudio de fase 3, de dos partes, aleatorizado, doble ciego, controlado con placebo y cruzado (parte 1) segu...</td>\n",
       "      <td>732ab0ae-48b3-4791-b09f-0053bf47d73c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El estudio 5 fue un estudio de fase 3, de dos partes, aleatorizado, doble ciego, controlado con placebo y cruzado (parte 1) seguido de un periodo de extensión abierta de 16 semanas de duración (pa...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>439</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>412</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;s&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/s&gt;&lt;/p&gt;</td>\n",
       "      <td>f6a6d6c9-bf3c-46bb-a7ff-0167673f0333</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>413</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;En la parte 1, los pacientes fueron aleatorizados 1:1 para recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos que contenían grasas durante 8 sem...</td>\n",
       "      <td>e6fca9ec-8f5f-402c-a7d4-72efc697f3aa</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En la parte 1, los pacientes fueron aleatorizados 1:1 para recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos que contenían grasas durante 8 semanas además de los tratamientos presc...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>810</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>414</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>436451cf-741d-4a3d-b7f6-314a406c795f</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>415</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Se incluyó en el estudio a 39 pacientes (edad media: 23 años) con un &lt;/span&gt;&lt;span lang=\"ES\"&gt;porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; basal ≥40 % (porcentaje pred...</td>\n",
       "      <td>f3eb8178-ed6f-49ac-ab59-298a09624839</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se incluyó en el estudio a 39 pacientes (edad media: 23 años) con un porcentaje predicho de VEF1 basal ≥40 % (porcentaje predicho medio de VEF1 del 78 % [intervalo: 43 % a 119 %]). Un 62 % (24/39)...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>367</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>416</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0eca57aa-b5f5-4fd5-ba60-1feb04e4e26d</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>417</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En la parte 1 del estudio 5, el porcentaje predicho medio de VEF&lt;sub&gt;1&lt;/sub&gt; &lt;/span&gt;&lt;span lang=\"ES\"&gt;basal en los pacientes tratados con placebo fue del 79,3 % ...</td>\n",
       "      <td>37c9242f-2545-4538-9272-17725d9d6a1e</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En la parte 1 del estudio 5, el porcentaje predicho medio de VEF1 basal en los pacientes tratados con placebo fue del 79,3 % mientras que en los pacientes tratados con ivacaftor este valor fue del...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>610</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>418</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>890cfdc5-11e6-42eb-a0b4-8175d1e672cb</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>419</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;El efecto de ivacaftor en la población global del estudio 5 (incluidas las variables secundarias del cambio absoluto en el IMC a las 8 semanas de tratamiento y...</td>\n",
       "      <td>8ae2c6fc-16a9-4f10-9474-204883369a77</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El efecto de ivacaftor en la población global del estudio 5 (incluidas las variables secundarias del cambio absoluto en el IMC a las 8 semanas de tratamiento y el cambio absoluto en la puntuación ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>641</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>420</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4284a6e5-f70b-4432-9538-9b997573c10a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>421</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:6.0pt; margin-left:40.55pt;text-indent:-40.55pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 7: Efecto de ivacaftor pa...</td>\n",
       "      <td>a6815035-3191-4461-9bc4-cd3ff41b1af6</td>\n",
       "      <td>margin-top:0in;margin-right:0in;margin-bottom:6.0pt;\\nmargin-left:40.55pt;text-indent:-40.55pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 7: Efecto de ivacaftor para las variables de eficacia en la población global y para las mutaciones específicas en el gen CFTR</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>131</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>422</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\"&gt; &lt;tr&gt; &lt;td colspan=\"2\" style=\"width:150.95pt;border:solid windowtext 1.0pt;   p...</td>\n",
       "      <td>10c0b210-0a29-49d2-a54b-60e35a6eb306</td>\n",
       "      <td>border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cambio absoluto en el porcentaje predicho de VEF1   IMC (kg/m2)   Puntuación (puntos) en el CFQ-R   dominio respiratorio       hasta la semana 8   a la semana 8   hasta la semana 8       Todos ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>1058</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>423</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:13.6pt;margin-bottom:.0001pt;text-indent:-13.6pt;page-break-after: avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"f...</td>\n",
       "      <td>38c2368b-61bf-4004-adeb-89d7958fc7a3</td>\n",
       "      <td>margin-top:6.0pt;margin-right:0in;margin-bottom:0in;\\nmargin-left:13.6pt;margin-bottom:.0001pt;text-indent:-13.6pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>*     No se realizaron análisis estadísticos debido al pequeño número de mutaciones concretas.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>90</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>424</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:13.5pt;text-indent:-13.5pt;page-break-after: avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;†&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;     ...</td>\n",
       "      <td>f3b96e42-4548-4273-bddc-fc700186d1b4</td>\n",
       "      <td>margin-left:13.5pt;text-indent:-13.5pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>†     Refleja los resultados de un paciente con la mutación G551S con datos en el punto temporal de las 8 semanas.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>110</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>425</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:13.6pt;text-indent:-13.6pt;page-break-after: avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;††&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;   n...</td>\n",
       "      <td>a6476597-b0a1-4a5f-9bce-a9f912313cfc</td>\n",
       "      <td>margin-left:13.6pt;text-indent:-13.6pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>††   n = 3 para el análisis del cambio absoluto en el cloruro en el sudor.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>72</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>426</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:2.0pt; margin-left:13.5pt;text-indent:-13.5pt\"&gt;&lt;i&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size: 9.0pt\"&gt;#&lt;/span&gt;&lt;/sup&gt;&lt;/i&gt;&lt;span la...</td>\n",
       "      <td>d7907f17-ee4c-4252-80a0-b31671ea54ed</td>\n",
       "      <td>margin-top:0in;margin-right:0in;margin-bottom:2.0pt;\\nmargin-left:13.5pt;text-indent:-13.5pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>#     Causa un defecto de empalme que da lugar a un nivel bajo o nulo de proteína CFTR en la superficie celular.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>108</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>427</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e710f07a-993c-4878-b11b-7229f96cc0cf</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>428</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En la parte 2 del estudio 5&lt;/span&gt;&lt;span lang=\"ES\"&gt;, el cambio absoluto medio (DE) en &lt;/span&gt;&lt;span lang=\"ES\"&gt;el porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; &lt;/span&gt;&lt;s...</td>\n",
       "      <td>27b9b063-4b79-48b2-a0d8-93409d49b817</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En la parte 2 del estudio 5, el cambio absoluto medio (DE) en el porcentaje predicho de VEF1 tras 16 semanas (pacientes aleatorizados a la secuencia de tratamiento ivacaftor/placebo en la parte 1)...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>936</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>429</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>8c499a00-6141-4ee3-8ddf-c2a41772ce3c</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>430</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Estudio 3: estudio en pacientes con FQ con la mutación F508del en el gen CFTR&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>44c00b3f-e4ee-43b3-8c33-96df202a0279</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Estudio 3: estudio en pacientes con FQ con la mutación F508del en el gen CFTR</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>77</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>431</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5a92107c-25da-4eb2-a74c-34973061a8b0</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>432</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;El estudio 3 (parte A) fue un estudio de fase 2, de grupos paralelos, controlado con placebo, doble ciego, aleatorizado 4:1, de 16 semanas de duración, en el q...</td>\n",
       "      <td>698357e1-a7b7-40d2-9e77-f996fcbc09c7</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El estudio 3 (parte A) fue un estudio de fase 2, de grupos paralelos, controlado con placebo, doble ciego, aleatorizado 4:1, de 16 semanas de duración, en el que se administró ivacaftor (150 mg ca...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>347</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>433</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e5809565-3b73-4754-be74-0c99da63f6fb</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>434</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;El cambio absoluto medio desde el valor basal hasta la semana 16 en el porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; (variable principal de eficacia) fue de 1,5 punto...</td>\n",
       "      <td>37fe8898-6417-4829-a20a-f736eb3b6e78</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El cambio absoluto medio desde el valor basal hasta la semana 16 en el porcentaje predicho de VEF1 (variable principal de eficacia) fue de 1,5 puntos porcentuales en el grupo de ivacaftor y de −0,...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>435</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>435</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>751d6698-8d6b-4499-ad63-53c4a5f5c7a9</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>436</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Estudio 4: estudio de extensión abierta&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>a242370e-8193-4e9f-a071-64c6d3546171</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Estudio 4: estudio de extensión abierta</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>437</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>96879f8f-fe01-41d0-bd80-dc406f988d47</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>438</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;En el estudio 4 los pacientes que completaron el tratamiento en los estudios 1 y 2 con placebo pasaron al tratamiento con ivacaftor mientra...</td>\n",
       "      <td>8c0eccab-8849-4d90-aad0-4d7d38e2e173</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En el estudio 4 los pacientes que completaron el tratamiento en los estudios 1 y 2 con placebo pasaron al tratamiento con ivacaftor mientras que los pacientes tratados con ivacaftor continuaron re...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>461</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>439</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a9ca7f58-cf85-42d9-b99b-9b325fed47ad</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>440</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;Ciento cuarenta y cuatro (144) pacientes del estudio 1 pasaron al estudio 4, 67 del grupo de placebo/ivacaftor y 77 del grupo de ivacaftor/...</td>\n",
       "      <td>039591e5-969b-470d-a068-450ba6c0f7b1</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ciento cuarenta y cuatro (144) pacientes del estudio 1 pasaron al estudio 4, 67 del grupo de placebo/ivacaftor y 77 del grupo de ivacaftor/ivacaftor. Cuarenta y ocho (48) pacientes del estudio 2 p...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>289</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>441</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f8db9ff5-5f3e-4bef-be2e-0c64a270331b</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>442</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;La Tabla 8 muestra los resultados del cambio absoluto medio (DE) en el porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; para ambos grupos de paciente...</td>\n",
       "      <td>83eb2977-67d3-4c13-897e-b23eef787ad4</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La Tabla 8 muestra los resultados del cambio absoluto medio (DE) en el porcentaje predicho de VEF1 para ambos grupos de pacientes. Para los pacientes del grupo de placebo/ivacaftor el porcentaje p...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>347</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>443</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4864550e-17d7-4de0-bf78-d8dd9099606e</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>444</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 8: Efecto de ivacaftor &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;en el porcentaje predicho ...</td>\n",
       "      <td>f81937ec-be91-4fc7-b3e3-880bf7cce40f</td>\n",
       "      <td>margin-bottom:6.0pt;page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 8: Efecto de ivacaftor en el porcentaje predicho de VEF1 en el estudio 4</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>78</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>445</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\"&gt; &lt;tr&gt; &lt;td style=\"width:99.4pt;border:solid windowtext 1.0pt;   padding:0in 5.4...</td>\n",
       "      <td>a1357ca4-573c-4660-867a-d2519f26b16f</td>\n",
       "      <td>border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Estudio   original y grupo de tratamiento   Duración del tratamiento con ivacaftor (semanas)   Cambio absoluto en el porcentaje predicho de VEF1 desde el valor basal (puntos porcentuales)      ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>396</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>446</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;page-break-after: avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"f...</td>\n",
       "      <td>2dd58385-80fa-4b41-af37-f1bfdc4437ad</td>\n",
       "      <td>margin-top:6.0pt;margin-right:0in;margin-bottom:0in;\\nmargin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>*     El tratamiento se administró durante el estudio de fase 3, doble ciego, controlado y de 48 semanas de duración.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>113</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>447</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt;position:relative;top:-3.0pt\"&gt;†&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;...</td>\n",
       "      <td>9a715951-6f92-433e-be58-a9963642566f</td>\n",
       "      <td>margin-left:14.2pt;text-indent:-14.2pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>†     Cambio desde el valor basal del estudio previo después de 48 semanas de tratamiento con placebo.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>98</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>448</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c7e057d6-61a4-43e5-822e-1c081c090c8a</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>449</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;Cuando se compara el cambio absoluto medio (DE) en el porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; desde el valor basal del estudio 4 para los pa...</td>\n",
       "      <td>bca2c677-4e80-4cf3-9f22-4d6e071fb2d1</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cuando se compara el cambio absoluto medio (DE) en el porcentaje predicho de VEF1 desde el valor basal del estudio 4 para los pacientes del grupo de ivacaftor/ivacaftor (n = 72) que pasaron del es...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>718</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>450</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f671568e-f06b-4f7f-9bfc-1e816e919e89</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>451</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;Para los pacientes del grupo de placebo/ivacaftor del estudio 1, la tasa anualizada de exacerbaciones pulmonares fue más alta en el estudio...</td>\n",
       "      <td>f2e5e44a-69c0-4d50-8bd0-712863cc5f81</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Para los pacientes del grupo de placebo/ivacaftor del estudio 1, la tasa anualizada de exacerbaciones pulmonares fue más alta en el estudio inicial cuando los pacientes recibían placebo (1,34 acon...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>858</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>452</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>84dd0f0f-51a6-4530-a065-25e36d0665d1</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>453</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;Para los pacientes que pasaron del estudio 2, el número de acontecimientos fue, en general, bajo.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>085ec989-68e1-4ccc-9174-834efb17cddf</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Para los pacientes que pasaron del estudio 2, el número de acontecimientos fue, en general, bajo.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>97</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>454</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6ab4140a-97cd-42cf-9687-7032eda3cbba</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>455</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Estudio 6: estudio en pacientes con FQ con una mutación R117H en el gen CFTR&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>f225edf7-8e84-4bf4-8dec-25b3ed501580</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Estudio 6: estudio en pacientes con FQ con una mutación R117H en el gen CFTR</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>76</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>456</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3b77bb2a-05ba-41cf-bfec-4c97dd559d4b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>457</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;En el estudio 6 se evaluaron 69 pacientes de 6 años o mayores; 53 (76,8 %) pacientes tenían la mutación &lt;i&gt;F508del&lt;/i&gt; en el seg...</td>\n",
       "      <td>b11b7723-88a8-4e23-8559-d912e5e54f7d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En el estudio 6 se evaluaron 69 pacientes de 6 años o mayores; 53 (76,8 %) pacientes tenían la mutación F508del en el segundo alelo. La variante poli-T de R117H confirmada fue 5T en 38 pacientes y...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>737</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>458</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4fba2307-0e26-445c-afa3-875d2a8c1619</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>459</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Se realizó un análisis de subgrupos previamente planificado en pacientes de 18 años o mayores (26 pacientes con placebo y 24 con ivacaftor). El tratamiento con...</td>\n",
       "      <td>5a9190e4-277d-44c1-b9e3-b8e8d7df6928</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se realizó un análisis de subgrupos previamente planificado en pacientes de 18 años o mayores (26 pacientes con placebo y 24 con ivacaftor). El tratamiento con ivacaftor produjo un cambio absoluto...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>493</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>460</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>bed6ecb7-9910-4ec9-88e3-569dc2378751</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>461</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En un análisis de subgrupos en pacientes &lt;/span&gt;&lt;span lang=\"ES\"&gt;con una variante genética &lt;i&gt;R117H-5T &lt;/i&gt;confirmada, la diferencia en el cambio absoluto medio...</td>\n",
       "      <td>f61bc5e3-c804-4fa6-87e0-a6c93738d88f</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En un análisis de subgrupos en pacientes con una variante genética R117H-5T confirmada, la diferencia en el cambio absoluto medio desde el valor basal hasta la semana 24 en el porcentaje predicho ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>452</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>462</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7817f43e-85bc-4ece-8213-8d064210ebca</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>463</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Para las variables secundarias de eficacia, no se observaron diferencias del tratamiento para ivacaftor frente a placebo en el cambio absoluto desde el valor b...</td>\n",
       "      <td>4c605b6f-8b68-4979-910f-dee543b94566</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Para las variables secundarias de eficacia, no se observaron diferencias del tratamiento para ivacaftor frente a placebo en el cambio absoluto desde el valor basal en el IMC en la semana 24 ni en ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>598</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>464</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>45815e27-3d71-4db6-ad7f-9665fabb70d2</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>465</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Ivacaftor en un esquema combinado con tezacaftor/ivacaftor o con&lt;/span&gt;&lt;span lang=\"ES\"&gt; ivacaftor/tezacaftor/elexacaftor&lt;/spa...</td>\n",
       "      <td>6a36cbe7-54eb-4900-a3a7-b83eea216699</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Ivacaftor en un esquema combinado con tezacaftor/ivacaftor o con ivacaftor/tezacaftor/elexacaftor</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>97</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>466</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e3ec2103-b7d7-4d79-a9ce-fb02a7ca755c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>467</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Se evaluaron la eficacia y la seguridad de ivacaftor en un esquema combinado con tezacaftor/ivacaftor en pacientes con FQ de 12 ...</td>\n",
       "      <td>c5b8b2cb-ddff-442c-9eab-2d1a939f9b32</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se evaluaron la eficacia y la seguridad de ivacaftor en un esquema combinado con tezacaftor/ivacaftor en pacientes con FQ de 12 años o mayores en dos estudios clínicos: un estudio aleatorizado, do...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>888</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>468</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>5d36a709-cbac-4bc7-a0dd-f0bf8136ac5d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>469</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Se demostraron la eficacia y la seguridad de ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor en pacientes de 12 años o mayores en dos es...</td>\n",
       "      <td>8afc7452-c917-4eb9-bd98-ec9b091ef3dc</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se demostraron la eficacia y la seguridad de ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor en pacientes de 12 años o mayores en dos estudios de fase 3, aleatorizados, dobl...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>1352</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>470</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1f11ef9a-1f86-4205-8646-7ce31b1c038c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>471</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Población pediátrica&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>1199b010-5705-4c22-9b59-ad9e5d61de59</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Población pediátrica</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>472</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d7420301-4219-4c8d-8450-f90741005941</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>473</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Ivacaftor en un esquema combinado con tezacaftor/ivacaftor&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>1c56596e-4a4e-48a7-b9c8-67fc5dfbae62</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Ivacaftor en un esquema combinado con tezacaftor/ivacaftor</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>58</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>474</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>86745fbf-bbdd-49f9-b9b8-166d0934b77b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>475</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Se evaluó la eficacia y la seguridad en pacientes de 6 a menos de 12 años (edad media de 8,6&lt;/span&gt;&lt;span lang=\"ES\"&gt; años&lt;/span&gt;&lt;span lang=\"ES\"&gt;) en un estudio ...</td>\n",
       "      <td>7973d72b-7623-4a2f-880f-d58a4d99d1c9</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se evaluó la eficacia y la seguridad en pacientes de 6 a menos de 12 años (edad media de 8,6 años) en un estudio de fase 3, doble ciego, de 8 semanas de duración con 67 pacientes que fueron aleato...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>612</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>476</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0d6d2e87-cc2f-47ec-815c-23cae7cf03e5</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>477</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;La Agencia Europea de Medicamentos &lt;/span&gt;&lt;span lang=\"ES\"&gt;ha concedido al titular un aplazamiento para presentar &lt;/span&gt;&lt;span lang=\"ES\"&gt;los resultados de los e...</td>\n",
       "      <td>60d92513-7669-4b52-bd61-96ea555bd75b</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La Agencia Europea de Medicamentos ha concedido al titular un aplazamiento para presentar los resultados de los ensayos realizados con Kalydeco ivacaftor en uno o más grupos de la población pediát...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>313</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>478</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0d9fec66-eab8-4af6-8a2c-32e5231ecb40</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>479</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;5.2     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Propiedades farmacocinéticas&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>32491d53-071b-4a2b-96d7-8cbedc2b0f87</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>5.2     Propiedades farmacocinéticas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>32</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>480</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ace3bc49-73c0-4534-a689-6f2bb8b01bac</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>481</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;La farmacocinética de ivacaftor es similar entre los voluntarios adultos sanos y los pacientes con FQ.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>dfae775c-5666-4eba-a908-5b72e35dd30e</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La farmacocinética de ivacaftor es similar entre los voluntarios adultos sanos y los pacientes con FQ.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>102</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>482</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>67a78308-9400-48c4-919b-b2e08dedc8e2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>483</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Después de la administración oral de una dosis única de 150 mg a voluntarios sanos con el estómago lleno, la media (± DE) para el AUC y la C&lt;sub&gt;máx&lt;/sub&gt; fue ...</td>\n",
       "      <td>c8beb47a-f667-4bf9-864a-bef67addc2e5</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Después de la administración oral de una dosis única de 150 mg a voluntarios sanos con el estómago lleno, la media (± DE) para el AUC y la Cmáx fue de 10 600 (5260) ng*h/ml y de 768 (233) ng/ml, r...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>411</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>484</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4fc9dc99-dcca-4ab5-94cf-3a09beb3e551</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>485</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;u&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt;Absorción&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>73619665-83e4-46c7-af50-b096a5ee4327</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Absorción</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>486</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>248b0af8-5184-49df-b272-c053bae696a4</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>487</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Después de la administración oral de dosis múltiples de ivacaftor, la exposición a ivacaftor aumentó por lo general con la dosis, de 25 mg cada 12 horas a 450 ...</td>\n",
       "      <td>2dd09751-4396-4769-a541-7257f0a90cc8</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Después de la administración oral de dosis múltiples de ivacaftor, la exposición a ivacaftor aumentó por lo general con la dosis, de 25 mg cada 12 horas a 450 mg cada 12 horas. Cuando se administr...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>740</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>488</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>281e1304-061a-4e8a-a36c-e7faf3fdc851</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>489</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;El granulado de ivacaftor (2 sobres de 75 mg) presentó una biodisponibilidad similar a la de los comprimidos de 150 mg cuando se administraron con alimentos qu...</td>\n",
       "      <td>5d5b6d0c-552c-4a1f-9662-0ec3c4bcaad8</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El granulado de ivacaftor (2 sobres de 75 mg) presentó una biodisponibilidad similar a la de los comprimidos de 150 mg cuando se administraron con alimentos que contenían grasas a sujetos adultos ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>530</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>490</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>0c3c75f5-13c1-46d9-84b8-b0cb3528d232</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>491</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-right:-.1pt;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Distribución&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>8dfe2c32-f7fd-45ce-8581-a3cddbce64e1</td>\n",
       "      <td>margin-right:-.1pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Distribución</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>492</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5e1e1b82-7a92-4d92-a237-9c77f47ecbc6</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>493</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Aproximadamente el 99 % de ivacaftor se fija a las proteínas plasmáticas, principalmente a la alfa-1 glicoproteína ácida y a la albúmina. Ivacaftor no se fija ...</td>\n",
       "      <td>924cb964-1d0c-45e2-8d8c-62c913fc8ee3</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Aproximadamente el 99 % de ivacaftor se fija a las proteínas plasmáticas, principalmente a la alfa-1 glicoproteína ácida y a la albúmina. Ivacaftor no se fija a los eritrocitos humanos. Después de...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>383</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>494</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8b3c1ebe-f3e0-4c2b-bf33-735f9e650542</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>495</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Biotransformación&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>38d87655-9a8b-4dd1-9db7-3d6ced8ee02d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Biotransformación</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>496</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>09308be6-9092-4e1d-a960-163c81ac6ed3</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>497</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Ivacaftor se metaboliza extensamente en humanos. Los datos &lt;i&gt;in vitro&lt;/i&gt; e &lt;i&gt;in vivo&lt;/i&gt; indican que ivacaftor se metaboliza principalmente por CYP3A. El M1...</td>\n",
       "      <td>07c6f77e-f272-4d0b-8a38-e2e2198948c6</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor se metaboliza extensamente en humanos. Los datos in vitro e in vivo indican que ivacaftor se metaboliza principalmente por CYP3A. El M1 y el M6 son los dos metabolitos principales de iva...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>437</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>498</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>0fe71f0d-aca0-4ab5-b4a9-f6b398d6f4ca</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>499</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;El efecto del genotipo heterocigótico de CYP3A4*22 en la exposición a &lt;/span&gt;&lt;span lang=\"ES\"&gt;ivacaftor, tezacaftor y elexacaftor&lt;/span&gt;&lt;span lang=\"ES\"&gt; es cohe...</td>\n",
       "      <td>92528dd1-ba17-42a1-8a72-36439a87fec0</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El efecto del genotipo heterocigótico de CYP3A4*22 en la exposición a ivacaftor, tezacaftor y elexacaftor es coherente con el efecto de la administración junto con un inhibidor débil de CYP3A4, lo...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>468</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>500</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>b8137cc2-0a32-437d-becc-8ab5696aa00f</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>501</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-right:-.1pt;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Eliminación&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>9f23cdb0-3322-40d0-ab63-cad96ca9790d</td>\n",
       "      <td>margin-right:-.1pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Eliminación</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>502</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>64e5f445-6192-4e3b-9084-690a5d5a65b3</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>503</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Tras la administración oral&lt;/span&gt;&lt;span lang=\"ES\"&gt; en voluntarios sanos&lt;/span&gt;&lt;span lang=\"ES\"&gt;, la mayor parte de ivacaftor (87,8 %) fue eliminada en las heces...</td>\n",
       "      <td>80244851-410e-4d56-9672-bc3652b0ae97</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tras la administración oral en voluntarios sanos, la mayor parte de ivacaftor (87,8 %) fue eliminada en las heces después de la conversión metabólica. Los metabolitos principales M1 y M6 represent...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>702</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>504</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>651b2c0d-9f45-4078-9ae1-6217eceb9067</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>505</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Linealidad/No linealidad&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>c8057af5-2acb-4b8a-877d-0dbd36a744cc</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Linealidad/No linealidad</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>506</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0b65f6d2-ea55-4148-b7d7-b340fcf3eaba</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>507</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;La farmacocinética de ivacaftor es en general lineal con respecto al tiempo o al intervalo de dosis de 25 mg a 250 mg.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9ede9215-822c-4e31-ac83-fb453aa76e62</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La farmacocinética de ivacaftor es en general lineal con respecto al tiempo o al intervalo de dosis de 25 mg a 250 mg.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>508</th>\n",
       "      <td>&lt;p class=\"labeltextheading\" style=\"page-break-after:auto\"&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3ff6ea96-d051-4ccb-b7b6-4491ac01be94</td>\n",
       "      <td>page-break-after:auto</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>509</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;u&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt;Poblaciones especiales&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>59debc28-ad29-4f29-9521-0d26fe0d9848</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Poblaciones especiales</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>510</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>496edf54-f4d9-4de2-98d3-825747608f55</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>511</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Insuficiencia hepática&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>a46ac954-784f-45c5-822b-2feb5d8f86ba</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Insuficiencia hepática</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>512</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>325b1bf1-621c-447e-8b46-bb95dbbdc9c9</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>513</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Tras una sola dosis de 150 mg de ivacaftor, los sujetos adultos con insuficiencia hepática moderada (Child‑Pugh Clase B, puntuación 7 a 9) presentaron una C&lt;su...</td>\n",
       "      <td>77f2c258-dee4-4393-a954-1f140bbf4945</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tras una sola dosis de 150 mg de ivacaftor, los sujetos adultos con insuficiencia hepática moderada (Child‑Pugh Clase B, puntuación 7 a 9) presentaron una Cmáx de ivacaftor similar (media [± DE] d...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>771</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>514</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>791997ef-674b-4047-b195-fa3c6b30ee4b</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>515</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;En los sujetos con insuficiencia hepática moderada (Child‑Pugh Clase B, puntuación 7 a 9), el AUC de ivacaftor aumentó aproximadamente el 50 % tras la administ...</td>\n",
       "      <td>633f9fde-9a8d-43e6-b9c8-2ad1d1344137</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En los sujetos con insuficiencia hepática moderada (Child‑Pugh Clase B, puntuación 7 a 9), el AUC de ivacaftor aumentó aproximadamente el 50 % tras la administración de múltiples dosis durante 10 ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>266</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>516</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>39e73c0c-06be-4afb-9cd8-bc7c79b87381</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>517</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;No se ha estudiado el impacto de la insuficiencia hepática grave (Child-Pugh Clase C, puntuación 10 a 15) en la farmacocinética de ivacaftor en monoterapia o e...</td>\n",
       "      <td>90ced9c6-5af2-4bcb-869d-469da57a47cd</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se ha estudiado el impacto de la insuficiencia hepática grave (Child-Pugh Clase C, puntuación 10 a 15) en la farmacocinética de ivacaftor en monoterapia o en un esquema combinado con tezacaftor...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>430</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>518</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ae05584e-a2e2-440b-ae7a-520e8cd73e3c</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>519</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES-TRAD\"&gt;Para obtener orientación sobre el uso adecuado y la modificación de la dosis, ver Tabla 3 en la sección 4.2.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c26e6277-b69a-4822-8fb2-e7b43a7c5ad8</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Para obtener orientación sobre el uso adecuado y la modificación de la dosis, ver Tabla 3 en la sección 4.2.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>108</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>520</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5c2ae285-32fd-40e0-962a-c61c430055a0</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>521</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Insuficiencia renal&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>584f25c3-6a77-4c1b-a2be-b43c70553fcd</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Insuficiencia renal</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>522</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3403e15e-1a87-4896-8470-8e526638f413</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>523</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;No se han realizado estudios farmacocinéticos con ivacaftor en pacientes con insuficiencia renal, ni en monoterapia ni en un esquema combinado con tezacaftor/i...</td>\n",
       "      <td>bcd113d9-7660-4730-9a04-f866ecef15fa</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se han realizado estudios farmacocinéticos con ivacaftor en pacientes con insuficiencia renal, ni en monoterapia ni en un esquema combinado con tezacaftor/ivacaftor o con ivacaftor/tezacaftor/e...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>602</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>524</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>45db43a4-0d75-443a-b14c-b2d967dda9ea</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>525</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;No se recomienda ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Se recomienda precaución cuando se administre ivacaftor, en monoterapia...</td>\n",
       "      <td>3537bee3-444e-47c9-8d0f-b0ccbb3b2522</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se recomienda ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Se recomienda precaución cuando se administre ivacaftor, en monoterapia o en un esquema combinado con tezaca...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>413</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>526</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>469619e9-bdfe-4749-9912-2feab5ef87ea</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>527</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Raza&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>e1ad656f-8578-426e-9302-b2a50f9ee300</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Raza</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>528</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e37f5e87-bc0e-48e1-901b-c101726ca3c4</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>529</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;En función del análisis de FC poblacional, la raza no tuvo ningún efecto clínicamente significativo en la FC de ivacaftor en pac...</td>\n",
       "      <td>8817d591-dc56-4c3b-b3f5-5e19b0c1556f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En función del análisis de FC poblacional, la raza no tuvo ningún efecto clínicamente significativo en la FC de ivacaftor en pacientes blancos (n = 379) y no blancos (n = 29).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>175</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>530</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8f821635-5074-443c-9308-985b2f16471a</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>531</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Sexo&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>05b74310-ccd3-452d-b62a-6ec83e1d370e</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Sexo</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>810af0d4-2e75-4f07-8112-831f6cfd68ac</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>533</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Los parámetros farmacocinéticos de ivacaftor, en monoterapia o en combinación con tezacaftor/&lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt;ivacaft...</td>\n",
       "      <td>7827c7fb-e24c-4fe9-911e-fc311500cfbc</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los parámetros farmacocinéticos de ivacaftor, en monoterapia o en combinación con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor, son similares en hombres y mujeres.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>174</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>534</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4d108925-6a00-4297-9dd6-998ae2d0c970</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>535</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Pacientes de edad avanzada&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>e9ff81bf-4664-4a9d-919a-ffdfd268efc9</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Pacientes de edad avanzada</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>536</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>39da9faa-6fd6-4d57-bdc4-1f41fee13498</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>537</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Los estudios clínicos con ivacaftor en monoterapia no incluyeron un número suficiente de pacientes de 65 años o mayores para det...</td>\n",
       "      <td>c895b5c9-1b5d-43c3-a093-96f208652969</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los estudios clínicos con ivacaftor en monoterapia no incluyeron un número suficiente de pacientes de 65 años o mayores para determinar si los parámetros farmacocinéticos son similares o no a los ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>223</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>538</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7cf02045-ac32-495d-8d12-27dbe5072e49</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>539</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Los parámetros farmacocinéticos de ivacaftor en combinación con tezacaftor en pacientes de edad avanzada (65‑72 años) son comparables a los de los adultos más ...</td>\n",
       "      <td>ab739d57-6205-471d-a5dd-6c1fe46d156b</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los parámetros farmacocinéticos de ivacaftor en combinación con tezacaftor en pacientes de edad avanzada (65‑72 años) son comparables a los de los adultos más jóvenes. No se incluyó a ningún pacie...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>407</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>540</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6941db31-7574-4e9b-ae69-eaaa66f2420c</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>541</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;u&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt;Población pediátrica&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>fe702e31-d670-4e50-832d-ac29eb03dddc</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Población pediátrica</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>542</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5b2ee345-a997-4384-9204-149b95eeeef4</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>543</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En la Tabla 9 se presenta por grupo de edad la exposición a ivacaftor predicha según las concentraciones de ivacaftor observadas en los estudios de fase 2 y 3,...</td>\n",
       "      <td>c2c96eef-6248-40af-9e96-9132ef8af176</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En la Tabla 9 se presenta por grupo de edad la exposición a ivacaftor predicha según las concentraciones de ivacaftor observadas en los estudios de fase 2 y 3, determinada mediante un análisis de ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>211</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>544</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ed5ef2b2-175e-44b2-b9ad-a0211eacbef6</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>545</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 9: Exposición media (DE) a ivacaftor por grupo de edad&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>55900b13-1b7c-409e-a5c1-9dbc881790ce</td>\n",
       "      <td>margin-bottom:6.0pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 9: Exposición media (DE) a ivacaftor por grupo de edad</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>60</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>546</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:98.9%;border-collapse:collapse;border:none\" width=\"98%\"&gt; &lt;thead&gt; &lt;tr style=\"page-break-inside:avoid;height:23....</td>\n",
       "      <td>8ba1ff40-e427-4572-b750-fc9952846756</td>\n",
       "      <td>width:98.9%;border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Grupo de edad   Dosis   Cmín, ee (ng/ml)   AUCτ, ee (ng*h/ml)      6 meses   a menos de 12 meses (5 kg a &lt;7 kg)*   25 mg   cada 12 h   336   5410     6 meses   a menos de 12 meses (7 kg a &lt;14 ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>750</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>547</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:14.45pt;margin-bottom:.0001pt;text-indent:-14.45pt;page-break-after: avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=...</td>\n",
       "      <td>77d8ca2d-0b37-4ed4-9028-a61000d8ced7</td>\n",
       "      <td>margin-top:6.0pt;margin-right:0in;margin-bottom:0in;\\nmargin-left:14.45pt;margin-bottom:.0001pt;text-indent:-14.45pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>*     Valores basados en los datos de un solo paciente; no se comunicó la desviación estándar.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>90</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>548</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:14.45pt;text-indent:-14.45pt\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt;position:relative;top:-3.0pt\"&gt;†&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt...</td>\n",
       "      <td>cf3edb66-6391-44f4-9ab8-c13094c6c34f</td>\n",
       "      <td>margin-left:14.45pt;text-indent:-14.45pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>†     Las exposiciones en los pacientes de 6 a 11 años son predicciones basadas en las simulaciones del modelo de FC poblacional utilizando los datos obtenidos para este grupo de edad.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>180</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>549</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6318620c-f97e-40df-adf8-e52677fe1d12</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>550</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;La exposición  &lt;/span&gt;&lt;span lang=\"ES\"&gt;de ivacaftor en combinación con tezacaftor y con &lt;/span&gt;&lt;a name=\"_Hlk46396589\"&gt;&lt;span lang=\"ES\"&gt;tezacaftor/elexacaftor &lt;/s...</td>\n",
       "      <td>e943a96b-8c0a-48a6-b7d1-4ef5d4bf44e3</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La exposición  de ivacaftor en combinación con tezacaftor y con tezacaftor/elexacaftor se presenta en la Tabla 10.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>113</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>551</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8939231b-8e9d-4bdb-ae32-60d5986df52f</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>552</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:6.0pt; margin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 10: Exposición media (DE)...</td>\n",
       "      <td>984b40b8-498d-4aaf-be5a-8ab66b811b98</td>\n",
       "      <td>margin-top:0in;margin-right:0in;margin-bottom:6.0pt;\\nmargin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 10: Exposición media (DE) a ivacaftor utilizado en combinación, por grupo de edad</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>87</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>553</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"623\"&gt; &lt;tr style=\"height:26.55pt\"&gt; &lt;td style=\"width:39.36%;border:solid ...</td>\n",
       "      <td>3d76af83-60e7-4d67-bba4-0566e7ab68b1</td>\n",
       "      <td>border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Grupo de edad   Dosis   AUC0-12h,ee (ng*h/ml) media (DE) de ivacaftor     Niños (6 a menos de 12 años; &lt;30 kg)   n = 71   50 mg de tezacaftor cada día/75 mg de   ivacaftor cada 12 h   7100 (195...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>706</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>554</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:10.0pt\"&gt;*&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:10.0pt\"&gt;Las exposiciones en el intervalo de peso de &lt;/span&gt;&lt;span lang=\"ES\" style=\"...</td>\n",
       "      <td>5d185dbe-70d4-43b5-a71d-283e9e86d8e4</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>*Las exposiciones en el intervalo de peso de ≥30 kg a &lt;40 kg son predicciones derivadas del modelo de FC poblacional.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>117</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>555</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>106f9518-f921-434c-8be4-9c93cf524278</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>556</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;5.3     Datos preclínicos sobre seguridad&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>ce887ed7-f67d-4d4a-868b-71b62691df1d</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>5.3     Datos preclínicos sobre seguridad</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>37</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>557</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c8bc9ea9-71d6-4a22-9175-4691d10cf371</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>558</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Los datos de los estudios preclínicos no muestran riesgos especiales para los seres humanos según los estudios convencionales de farmacología de seguridad, tox...</td>\n",
       "      <td>226751c7-3524-4b5b-a9d9-c656e91da74c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los datos de los estudios preclínicos no muestran riesgos especiales para los seres humanos según los estudios convencionales de farmacología de seguridad, toxicidad a dosis repetidas, genotoxicid...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>225</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>559</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>34d6e071-f409-4dde-8d05-78350835bbd8</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>560</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Embarazo y fertilidad&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>9a6f7941-1203-4248-a7db-d43d31146ec4</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Embarazo y fertilidad</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>561</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>253b308e-7d01-43b0-8f6a-14516ed5780f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>562</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Ivacaftor se asoció a una disminución ligera del peso de las vesículas seminales, a una disminución del índice de fertilidad global &lt;/span&gt;&lt;span lang=\"ES\"&gt;y de...</td>\n",
       "      <td>21e3e0b2-0c74-41c5-9d60-695bbefd10a5</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor se asoció a una disminución ligera del peso de las vesículas seminales, a una disminución del índice de fertilidad global y del número de gestaciones en las hembras apareadas con machos ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>824</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>563</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0da57e14-92ab-43b2-aef9-24799b80b8c4</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>564</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Desarrollo perinatal y posnatal&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>d9f947e0-de7e-45af-9297-a2966269fbf4</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Desarrollo perinatal y posnatal</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>565</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7c15600f-5bc8-476a-a0e3-4a0992ca9079</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>566</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Ivacaftor redujo los índices de supervivencia &lt;/span&gt;&lt;span lang=\"ES\"&gt;y lactancia y produjo una disminución en los pesos corporales de las crías. La dosis sin e...</td>\n",
       "      <td>197bf96a-e20c-464e-83b3-86eb4d325b04</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor redujo los índices de supervivencia y lactancia y produjo una disminución en los pesos corporales de las crías. La dosis sin efecto adverso observado para viabilidad y crecimiento de las...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>434</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>567</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3993f0ac-2d7d-4d8b-865a-6e49cd3f9796</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>568</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Estudios en animales jóvenes&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>aea07fb0-f4d3-4e6c-98bb-c737bf5d0404</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Estudios en animales jóvenes</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>569</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>88ad9f52-32ea-4b39-878f-a8a9373201c0</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>570</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Se observaron cataratas en las ratas jóvenes tratadas desde el día 7 después de nacer hasta el día 35 a niveles de exposición de ivacaftor de 0,22 veces la dos...</td>\n",
       "      <td>0d0d8d6b-acf4-4e3c-a9a0-4067ed0c4794</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se observaron cataratas en las ratas jóvenes tratadas desde el día 7 después de nacer hasta el día 35 a niveles de exposición de ivacaftor de 0,22 veces la dosis máxima recomendada en humanos segú...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>708</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>571</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4f2b5814-64a9-4570-a159-9c2450e2927f</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>572</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e7777365-6015-4eb1-aeb9-a14f787f27a0</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>573</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;6.       DATOS FARMACÉUTICOS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>1428b6b4-2ac9-4d26-80a5-d8e7986cb64e</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>6.       DATOS FARMACÉUTICOS</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>574</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4dd9d096-da42-482a-b2c3-2da07013e691</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>575</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;6.1     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Lista de excipientes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>ffd7840e-a716-4741-afde-45e5a4a0cba5</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.1     Lista de excipientes</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>576</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>7bb3a833-848a-44c2-9115-13d3054e9ac4</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>577</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Núcleo del comprimido&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>15427901-6351-4b03-9803-92845ae9eb81</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Núcleo del comprimido</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>578</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5fb80c30-f6e1-4c3a-a08f-6b7e568438e5</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>579</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Celulosa microcristalina&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a094aac6-e825-4154-b3c1-30ac2d4bcb21</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Celulosa microcristalina</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>580</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Lactosa monohidrato&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>20ba48cc-a3db-4995-aafb-a8a454c7f0ed</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Lactosa monohidrato</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>581</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Succinato acetato de hipromelosa&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>19210ffb-dd25-494d-95bd-1bfc91657e89</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Succinato acetato de hipromelosa</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>32</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>582</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Croscarmelosa sódica&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>311e4aa6-f86b-4004-8893-88eacde1d8bd</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Croscarmelosa sódica</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>583</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Laurilsulfato&lt;/span&gt;&lt;span lang=\"ES\"&gt; sódico (E487)&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c5a2da35-7cee-4ce6-b8a4-6745436a0421</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Laurilsulfato sódico (E487)</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>584</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Sílice coloidal anhidra&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d19825d3-d90d-41a8-bf61-20d30a321f1a</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Sílice coloidal anhidra</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>23</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>585</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Estearato de magnesio&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d92a9f13-e0dd-4ddb-9491-9e4354ae16a3</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Estearato de magnesio</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>586</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>92ba8e34-1658-44ab-96bb-ae2e2c5750c8</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>587</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Película del comprimido&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>543522bf-3cae-4607-88a8-93b3f8236fb9</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Película del comprimido</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>23</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>588</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2185f17c-8004-4709-9292-032a399df0fc</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>589</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"PT\"&gt;Alcohol de polivinilo&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>57d00876-feab-4401-9e4d-f032ce907169</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Alcohol de polivinilo</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>590</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"PT\"&gt;Dióxido de titanio (E171)&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a255945a-0f58-491c-bc27-c67cc90b0a4d</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Dióxido de titanio (E171)</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>25</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>591</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"PT\"&gt;Macrogol&lt;/span&gt;&lt;span lang=\"PT\"&gt; &lt;/span&gt;&lt;span lang=\"PT\"&gt;(PEG 3350)&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0c9443ed-b824-4103-9d23-0954ad9c3c15</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Macrogol (PEG 3350)</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>592</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"PT\"&gt;Talco&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d4f307ac-25ae-4835-9362-aefb305be296</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Talco</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>593</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"PT\"&gt;Laca de aluminio índigo carmín (E132)&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>de842d61-e1f1-4de9-9f8e-4a0c867274e3</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Laca de aluminio índigo carmín (E132)</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>37</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>594</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Cera de carnauba&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7c0b69b3-f725-4dcb-9510-ffa34e3b3578</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cera de carnauba</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>16</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>595</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>bc355e54-6c6e-4258-9931-9928c817256a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>596</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Tinta de impresión&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>80734d8c-f397-486b-8400-0705f98f2c13</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Tinta de impresión</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>597</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>14b89e60-5e21-4d1f-83fa-24819d18550f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>598</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"PT\"&gt;Shellac&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cfe48ad0-b702-4568-bb2b-87888429cb4f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Shellac</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>599</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"PT\"&gt;Óxido de hierro negro (E172)&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3303d447-6a93-4e07-b198-d9a5d0ddae34</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Óxido de hierro negro (E172)</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Propilenglicol (E1520)&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f4ff11f6-79d6-47b4-bfd1-8ff7fe8afa19</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Propilenglicol (E1520)</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>601</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Solución concentrada de amoníaco&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c074ba88-c76a-445c-922b-04782197a38b</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Solución concentrada de amoníaco</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>32</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>602</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4578dc2f-6328-4e73-8f73-d956d5e837cb</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>603</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;6.2     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Incompatibilidades&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>70c95b04-0bfa-4133-82dc-e59a14a4143c</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.2     Incompatibilidades</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>604</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0eeffb07-29d9-41f4-b109-ea185af145cf</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>605</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;No procede.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6167dd16-d0c6-4efa-b303-d17cf598531e</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No procede.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>606</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d5232e93-74f1-4890-bf52-a7b0264f53e7</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>607</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;6.3     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Periodo de validez&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>cbe86e01-6adb-4b7d-afeb-b973af3a196c</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.3     Periodo de validez</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>608</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>09ef1f5e-6678-42a6-804a-586902fe8374</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>609</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;4 años.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e734de83-a9ec-48a7-9528-e0d51874601a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>4 años.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>610</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c75e7f60-7ffc-482a-9808-fb8ceb2ee31b</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>611</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;6.4     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Precauciones especiales de conservación&lt;/span...</td>\n",
       "      <td>2c9b7b15-671f-46d7-baf6-7d64af9d2e47</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.4     Precauciones especiales de conservación</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>43</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>612</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7a1137aa-89b4-46e8-a49b-f83858b54f9f</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>613</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;No requiere condiciones especiales de conservación.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>910fa1cf-51e8-49cf-a942-9b7d5312874f</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No requiere condiciones especiales de conservación.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>51</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>614</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9df227ef-b702-4f08-b518-5f7cd719a24c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>615</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;6.5     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Naturaleza y contenido del envase&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>1c1c4465-0b6d-40c5-b466-2d87d594d1e6</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.5     Naturaleza y contenido del envase</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>37</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>616</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e7a95d6d-69e0-4477-ae4a-8e4267479776</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>617</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Los comprimidos recubiertos con película están envasados en blísteres termoformados (policlorotrifluoroetileno [PCTFE]/papel de aluminio) o en un frasco de pol...</td>\n",
       "      <td>f126b794-4ed8-4443-9712-d89aedfbfbdf</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los comprimidos recubiertos con película están envasados en blísteres termoformados (policlorotrifluoroetileno [PCTFE]/papel de aluminio) o en un frasco de polietileno de alta densidad (HDPE) con ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>618</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1e0c5cfe-8636-41e1-a1ec-44316c3a0a3a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>619</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Kalydeco 75 mg comprimidos recubiertos con película&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>0468fe6e-01c5-4372-8ff4-0759612ecb23</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Kalydeco 75 mg comprimidos recubiertos con película</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>51</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>620</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>791d04c4-f26a-433a-9396-155267f0dc3e</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>621</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Están disponibles los siguientes tamaños de envase:&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ed070782-7557-4789-9e64-04514cbb1f45</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Están disponibles los siguientes tamaños de envase:</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>51</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>622</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:13.6pt;text-indent:-13.6pt\"&gt;&lt;span lang=\"ES\" style=\"font-size:8.0pt;font-family:Symbol\"&gt;-&lt;span style='font:7.0pt \"Times New Roman\"'&gt;      &lt;/span&gt;&lt;/span&gt;&lt;span...</td>\n",
       "      <td>ccaa64eb-fd48-4142-9389-b07fdd800931</td>\n",
       "      <td>margin-left:13.6pt;text-indent:-13.6pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-      Caja con estuches de blísteres que contiene 28 comprimidos recubiertos con película</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>85</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>623</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>5777cee3-2f61-416d-86ca-622cf1cf6e1c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>624</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Kalydeco 150 mg comprimidos recubiertos con película&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>dfc85b41-7dd1-4e81-9dc2-1ead5d1cbf58</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Kalydeco 150 mg comprimidos recubiertos con película</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>52</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>625</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ddc3e3d5-bf69-417f-9601-a4dbe6f0756e</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>626</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Están disponibles los siguientes tamaños de envase:&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7c2ee847-f678-4440-b9d1-b6980fd8a160</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Están disponibles los siguientes tamaños de envase:</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>51</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>627</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:13.6pt;text-indent:-13.6pt\"&gt;&lt;span lang=\"ES\" style=\"font-size:8.0pt;font-family:Symbol\"&gt;-&lt;span style='font:7.0pt \"Times New Roman\"'&gt;      &lt;/span&gt;&lt;/span&gt;&lt;span...</td>\n",
       "      <td>ffec9008-36c7-4d7e-944d-071b995f954b</td>\n",
       "      <td>margin-left:13.6pt;text-indent:-13.6pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-      Caja con estuches de blísteres que contiene 28 comprimidos recubiertos con película</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>85</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>628</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:13.6pt;text-indent:-13.6pt\"&gt;&lt;span lang=\"ES\" style=\"font-size:8.0pt;font-family:Symbol\"&gt;-&lt;span style='font:7.0pt \"Times New Roman\"'&gt;      &lt;/span&gt;&lt;/span&gt;&lt;span...</td>\n",
       "      <td>a28e7d53-665a-4c0e-9f43-955979b340e8</td>\n",
       "      <td>margin-left:13.6pt;text-indent:-13.6pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-      Caja de blísteres que contiene 56 comprimidos recubiertos con película</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>72</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>629</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:13.6pt;text-indent:-13.6pt\"&gt;&lt;span lang=\"ES\" style=\"font-size:8.0pt;font-family:Symbol\"&gt;-&lt;span style='font:7.0pt \"Times New Roman\"'&gt;      &lt;/span&gt;&lt;/span&gt;&lt;span...</td>\n",
       "      <td>32995056-1b37-4996-9c73-d22727a79877</td>\n",
       "      <td>margin-left:13.6pt;text-indent:-13.6pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-      Frasco que contiene 56 comprimidos recubiertos con película</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>61</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>630</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ca484095-0202-422f-a168-4f3182aede5c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>631</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Puede que solamente estén comercializados algunos tamaños de envases.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>23872d64-1305-4b33-b5bd-2079084c2e23</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Puede que solamente estén comercializados algunos tamaños de envases.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>69</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>632</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7121e541-68f1-446a-97e9-9a556b09d0d4</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>633</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;a name=\"OLE_LINK1\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;6.6     Precauciones especiales de eliminación&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;b...</td>\n",
       "      <td>17291267-1fd5-4827-9f54-26567ca6c4f4</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.6     Precauciones especiales de eliminación y otras manipulaciones</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>65</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>634</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>ed914ecd-1a07-4de3-a5bb-212e7d06fdce</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>635</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;La eliminación del medicamento no utilizado y de todos los materiales que hayan estado en contacto con él se realizará de acuerdo con la normativa local.&lt;/span...</td>\n",
       "      <td>f3f8cc87-d91f-4470-bd01-10c1cdb66323</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La eliminación del medicamento no utilizado y de todos los materiales que hayan estado en contacto con él se realizará de acuerdo con la normativa local.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>153</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>636</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8bd531e8-f264-4d37-851f-a7a199656056</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>637</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7ddd3414-98cb-4f8f-a362-ae119074d43e</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>638</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;7.       TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>e87d2737-3bea-46d7-ba71-204f09625260</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>7.       TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>49</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>639</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>51954569-81c3-4412-9535-f5d15e69fe5b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>640</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;Vertex Pharmaceuticals (Ireland) Limited&lt;/p&gt;</td>\n",
       "      <td>0c34c3ab-47e8-4d0d-aa50-706a67fb48e9</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Vertex Pharmaceuticals (Ireland) Limited</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>40</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>641</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;28-32 Pembroke Street Upper&lt;/p&gt;</td>\n",
       "      <td>b62fd3ec-feb7-4abb-ac41-485e87d446b9</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>28-32 Pembroke Street Upper</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>642</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Dublin 2, D02 EK84&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1572b164-bbce-4c29-bbe6-0322d7af4815</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Dublin 2, D02 EK84</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>643</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Irlanda&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>10e10690-2a64-43fb-ba12-5d195d1b19bb</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Irlanda</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>644</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>76446bae-7d02-4d69-a04e-48b3690102ee</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>645</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>05067a88-e16d-4893-a7b0-d39d20b31a55</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>646</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;8.       &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓ...</td>\n",
       "      <td>1484a6ac-95a6-4f02-a8c5-21710c37664c</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>8.       NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓN</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>48</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>647</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>538a8bcb-a6b3-447d-8bf4-75660bd7dffe</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>648</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;EU/1/12/782/001&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e603f06a-1e1c-42cf-8c88-7121d819a70b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>EU/1/12/782/001</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>649</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;EU/1/12/782/002&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6509c5c6-1057-45b9-82d9-d5bb73c4da02</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>EU/1/12/782/002</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>650</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;EU/1/12/782/005&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9ed8089c-a71f-4691-9d81-97c35954afe0</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>EU/1/12/782/005</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>651</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;EU/1/12/782/007&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1458bc21-6906-4223-9a84-c8ca075d5bf7</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>EU/1/12/782/007</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>652</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c54179ff-a585-417c-849d-a8878a4153b0</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>653</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>308b09a0-2778-4a5c-b00e-9b4615b4a1d3</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>654</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;9.       FECHA DE LA PRIMERA AUTORIZACIÓN/RENOVACIÓN DE LA AUTORIZACIÓN&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>84f75621-8ce5-4857-9cb1-398ead495e1f</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>9.       FECHA DE LA PRIMERA AUTORIZACIÓN/RENOVACIÓN DE LA AUTORIZACIÓN</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>65</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>655</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>73a21e9f-d950-4f1b-8a7f-de0c35b64ab4</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>656</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Fecha de la primera autorización: 23/julio/2012&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>388497b5-e28a-43f0-b7b8-337d76ac961c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Fecha de la primera autorización: 23/julio/2012</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>47</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>657</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Fecha de la última renovación: 28/abril/2017&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>35181f72-3e52-4c66-97db-faec2bb75daa</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Fecha de la última renovación: 28/abril/2017</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>44</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>658</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5783a9c3-bdde-40af-8420-800260158af3</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>659</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b477cade-72ac-4920-88ca-eae86a4fab96</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>660</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.1pt;text-indent:-28.1pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;10.    &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;FECHA DE LA REVISIÓN DEL TEXTO&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>f88976c1-1b4f-4185-b181-380cc8c4377a</td>\n",
       "      <td>margin-left:28.1pt;text-indent:-28.1pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>10.    FECHA DE LA REVISIÓN DEL TEXTO</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>34</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>661</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>da8de6bf-6cb9-4db4-be03-7a172c6c0603</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>662</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;La información detallada de este medicamento está disponible en la página web de la Agencia Europea de Medicamentos &lt;/span&gt;&lt;span lang=\"ES\"&gt;&lt;a href=\"http://www....</td>\n",
       "      <td>9e7e9202-cf4d-400c-9f18-50331d1bdb70</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La información detallada de este medicamento está disponible en la página web de la Agencia Europea de Medicamentos http://www.ema.europa.eu.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>141</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>663</th>\n",
       "      <td>&lt;span lang=\"ES\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'&gt;&lt;br clear=\"all\" style=\"page-break-before:always\"/&gt; &lt;/span&gt;</td>\n",
       "      <td>3f7e1571-fc75-4ebf-bdd5-e9f623ee11d9</td>\n",
       "      <td>font-size:11.0pt;font-family:\"Times New Roman\",serif</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>664</th>\n",
       "      <td>&lt;br clear=\"all\" style=\"page-break-before:always\"/&gt;</td>\n",
       "      <td>a5de10dd-18b8-485e-a0f7-8bcf12dbe28f</td>\n",
       "      <td>page-break-before:always</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>3f7e1571-fc75-4ebf-bdd5-e9f623ee11d9</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>665</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;1.       &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;NOMBRE DEL MEDICAMENTO&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>66c04a21-a74e-4517-9440-b25767f63326</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>1.       NOMBRE DEL MEDICAMENTO</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>25</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>666</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c4c7c9ad-fedd-45ac-9b09-a9cddcc0085d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>667</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Kalydeco 25 mg granulado en sobre&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1a8dbeee-7179-4ad6-a11c-f0ac3c926d4e</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Kalydeco 25 mg granulado en sobre</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>33</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>668</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Kalydeco 50 mg granulado en sobre&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b0b006f6-0880-4844-9ea5-23f30d4052f8</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Kalydeco 50 mg granulado en sobre</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>33</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>669</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Kalydeco 75 mg granulado en sobre&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2ea77c67-6e00-4e32-b258-280fd551e325</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Kalydeco 75 mg granulado en sobre</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>33</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>670</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f7634e68-abd2-4e0f-bb6b-6685b3b165a5</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>671</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3e9f5439-69bc-44ab-8c92-5033ea88fa4b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>672</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;2.       &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;COMPOSICIÓN CUALITATIVA Y CUANTITATIVA&lt;/span...</td>\n",
       "      <td>48260c4e-d124-401e-916c-473b4c220fe7</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>2.       COMPOSICIÓN CUALITATIVA Y CUANTITATIVA</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>41</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>673</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>99e363b3-686f-41cb-aef1-3258ef1fcad4</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>674</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Kalydeco 25 mg granulado en sobre&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>b1707e33-2e72-4aa4-9741-bd90cd3c22e7</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Kalydeco 25 mg granulado en sobre</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>33</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>675</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>191fe717-5e11-413b-bfd6-80f719f24c78</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>676</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Cada sobre contiene 25 mg de ivacaftor.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cc086aff-ed5f-4010-94ae-9c38fc18f759</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cada sobre contiene 25 mg de ivacaftor.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>677</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0dd1b678-0190-4e82-b6af-596974736f8d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>678</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Excipiente con efecto conocido&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>af51d8df-527c-42b1-8671-0617a71e972e</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Excipiente con efecto conocido</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>679</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0cd9541d-6bc9-46fc-aa03-23fbe92b17c3</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>680</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Cada sobre contiene 36,6 mg de lactosa monohidrato.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>42290fe0-513d-406a-b5cb-dc7da67b9910</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cada sobre contiene 36,6 mg de lactosa monohidrato.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>51</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>681</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>72ff6375-b3f4-4f0d-be12-546507cfb15d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>682</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Kalydeco 50 mg granulado en sobre&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>21c8af27-32f6-49ee-8d83-881a7d850b2f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Kalydeco 50 mg granulado en sobre</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>33</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>683</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>494fe594-aded-433a-a91b-207565c07773</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>684</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Cada sobre contiene 50 mg de ivacaftor.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c0453a06-9a44-4084-b555-50430572b90c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cada sobre contiene 50 mg de ivacaftor.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>685</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>6682bf15-98f7-4e0d-a346-1f7d8d712680</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>686</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Excipiente con efecto conocido&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>87d6fee7-f9bb-462f-8eec-901c12e9e4fa</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Excipiente con efecto conocido</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>687</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d3c12c65-5533-4c76-aaba-aa99bac4bd9c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>688</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Cada sobre contiene 73,2 mg de lactosa monohidrato.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c552973b-511a-4a2a-8aa1-0f8fdcadbbf4</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cada sobre contiene 73,2 mg de lactosa monohidrato.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>51</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>689</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e2b94145-284b-41ee-ac1e-2b6a3563ae7f</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>690</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Kalydeco 75 mg granulado en sobre&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>fbd49f4c-6849-47c7-bec4-9bf2cefc0cc1</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Kalydeco 75 mg granulado en sobre</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>33</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>691</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>991326a2-4ab9-497c-8d8a-833f0bf9f1fc</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>692</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Cada sobre contiene 75 mg de ivacaftor.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cdfa4018-715f-4483-ad68-5d547b7b702d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cada sobre contiene 75 mg de ivacaftor.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>693</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4e9f1abf-db79-4c5c-8b73-cb24a3f46172</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>694</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Excipiente con efecto conocido&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>5166e7ec-5c39-442a-a2c4-b1290faf563e</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Excipiente con efecto conocido</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>695</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c1ad8521-5864-4185-8801-c1470b82da10</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>696</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Cada sobre contiene 109,8 mg de lactosa monohidrato.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a441e44a-0789-4e8d-8973-831e341617ea</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cada sobre contiene 109,8 mg de lactosa monohidrato.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>52</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>697</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1a46f767-cb4e-4179-b905-126b2e990eda</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>698</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Para consultar la lista completa de excipientes, ver sección 6.1.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3326bc5e-ae3f-4b2c-9186-42af804930d9</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Para consultar la lista completa de excipientes, ver sección 6.1.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>65</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>699</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>10f0d57e-0b5a-4b00-af9a-3213ffb68c79</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>700</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>11cc3fcc-04cc-4c75-a827-a8d885661657</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>701</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;3.       &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;FORMA FARMACÉUTICA&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>426b4d6b-9f33-4683-965c-303364c7fd97</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>3.       FORMA FARMACÉUTICA</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>702</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph; page-break-after:avoid;text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>35903167-cc2a-4536-8de2-b8a33612cb2f</td>\n",
       "      <td>text-align:justify;text-justify:inter-ideograph;\\npage-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>703</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Granulado en sobre.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c35ec9f8-e1e3-416b-8ea9-738e2d856440</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Granulado en sobre.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>704</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ab34eccd-91cb-4cc9-93e8-4e30e114b75d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>705</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Granulado de color blanco a blanquecino de 2 mm aproximadamente de diámetro.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f940a79a-d6cd-450a-92b5-32080cd30d1b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Granulado de color blanco a blanquecino de 2 mm aproximadamente de diámetro.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>76</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>706</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f85d8c67-f5f6-4879-ba64-e22b8ea8507a</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>707</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>93a9f665-fa91-4409-a974-e5bacbf35835</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>708</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\" style=\"text-transform:uppercase\"&gt;4.       &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\" style=\"text...</td>\n",
       "      <td>f2e8c0b7-5b61-420b-bd54-6d7fbf897a16</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>4.       Datos clínicos</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>709</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>894f33b4-3034-43a8-8352-d1adf94d2401</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>710</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.1     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Indicaciones terapéuticas&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>13c17474-f283-42f2-8650-5661f0a59bdc</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.1     Indicaciones terapéuticas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>29</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>711</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>158427b6-6044-475f-9881-b751fb327a89</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>712</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Kalydeco granulado está indicado para el tratamiento de lactantes de al menos 4 meses y niños con un peso de 5 kg a menos de 25 ...</td>\n",
       "      <td>e721b9f7-2734-4698-884a-6c5e784b965b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Kalydeco granulado está indicado para el tratamiento de lactantes de al menos 4 meses y niños con un peso de 5 kg a menos de 25 kg con fibrosis quística (FQ) y una mutación R117H en el gen CFTR o ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>376</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>713</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ab1a4fa9-0906-45a3-acb5-5b90ad905710</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>714</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.2     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Posología y forma de administración&lt;/span&gt;&lt;/b...</td>\n",
       "      <td>54b8ac25-676c-47e8-b3d2-f1e86b6e332f</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.2     Posología y forma de administración</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>715</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>01719aa6-c184-407d-a09b-1fb0e3aec52c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>716</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Únicamente los médicos con experiencia en el tratamiento de la fibrosis quística deben prescribir Kalydeco. &lt;/span&gt;&lt;span lang=\"E...</td>\n",
       "      <td>180ac772-58ae-4c26-9c09-a580cba920be</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Únicamente los médicos con experiencia en el tratamiento de la fibrosis quística deben prescribir Kalydeco. Si se desconoce el genotipo del paciente, se debe utilizar un método de genotipificación...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>489</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>717</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>69bd7494-c66e-439d-ab96-c0d506c6cc86</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>718</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Posología&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>0b696526-d4cb-41c0-806e-e2bc11cce97f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Posología</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>719</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>4130ea55-21c2-4d88-9c15-a2b2fde7a2ea</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>720</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;La dosis&lt;/span&gt;&lt;span lang=\"ES\"&gt; en lactantes de al menos 4 meses, niños, adolescentes y adultos &lt;/span&gt;&lt;span lang=\"ES\"&gt;debe ser ...</td>\n",
       "      <td>c622a6b9-3002-4fce-b84f-ee2091dedb0c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La dosis en lactantes de al menos 4 meses, niños, adolescentes y adultos debe ser conforme a la Tabla 1.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>104</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>721</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5817070a-a536-437a-a5b1-8e8b4d8d4973</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>722</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 1: Recomendaciones posológicas para los pacientes de 4 meses o mayores&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>6b0630ff-2b2e-4592-9681-977997dea276</td>\n",
       "      <td>margin-bottom:6.0pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 1: Recomendaciones posológicas para los pacientes de 4 meses o mayores</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>76</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>723</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\"&gt; &lt;thead&gt; &lt;tr style=\"height:10.85pt\"&gt; &lt;td style=\"width:78.7pt;border:solid wind...</td>\n",
       "      <td>392204d5-827d-4555-87c5-f7ea29defb39</td>\n",
       "      <td>border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Edad   Peso   Dosis   Dosis    total diaria     4 meses    a menos de 6 meses   ≥5 kg   25 mg de granulado por vía oral cada 12 horas con alimentos que    contengan grasas   50 mg     6 meses ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>600</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>724</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ee87fe85-20ae-481d-b7df-af93a39e5110</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>725</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Dosis olvidadas&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>710a89e9-da6e-4433-9784-44f24fe35161</td>\n",
       "      <td>page-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Dosis olvidadas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>726</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f5dfc52b-5bd4-4b16-b26a-b8de800d68b3</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>727</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt;Si han transcurrido 6 horas o menos desde la dosis olvidada de la mañana o de la noche, &lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt;se debe indicar...</td>\n",
       "      <td>5198d430-979e-4126-a307-5ee8d7d20c33</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Si han transcurrido 6 horas o menos desde la dosis olvidada de la mañana o de la noche, se debe indicar al paciente que la tome lo antes posible y luego tomar la siguiente dosis a la hora habitual...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>372</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>728</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e9dc38ce-7f70-438e-93f2-a582fe1854de</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>729</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Uso concomitante de inhibidores de CYP3A&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>c3e39c0c-390b-4440-9115-0c54bc11e645</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Uso concomitante de inhibidores de CYP3A</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>40</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>730</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>06e99cee-c780-489e-841e-26a07306157c</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>731</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;En administración concomitante con inhibidores potentes de CYP3A en pacientes de 6 meses o mayores, la dosis de ivacaftor se debe reducir a un sobre (25 mg de ...</td>\n",
       "      <td>b4f0d4a4-387f-4275-bacb-e55a4e3f8dc6</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En administración concomitante con inhibidores potentes de CYP3A en pacientes de 6 meses o mayores, la dosis de ivacaftor se debe reducir a un sobre (25 mg de ivacaftor en pacientes con un peso de...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>388</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>732</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>42905801-f4c7-4548-9cb6-93e060fd16a9</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>733</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;En administración concomitante con inhibidores moderados de CYP3A en pacientes de 6 meses o mayores, la dosis de ivacaftor es la recomendada anteriormente, per...</td>\n",
       "      <td>993fd176-6ece-4361-a2d3-3f7f091ad6b8</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En administración concomitante con inhibidores moderados de CYP3A en pacientes de 6 meses o mayores, la dosis de ivacaftor es la recomendada anteriormente, pero administrada una vez al día (ver la...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>219</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>734</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1a419e2c-7ce8-4f45-9da3-cc82aa3cd5ab</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>735</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Debido a la variabilidad en la maduración de las enzimas del citocromo (CYP) que intervienen en el metabolismo de ivacaftor, no se recomienda el tratamiento co...</td>\n",
       "      <td>815eb89c-fb14-4a04-8cdb-30edd4280905</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Debido a la variabilidad en la maduración de las enzimas del citocromo (CYP) que intervienen en el metabolismo de ivacaftor, no se recomienda el tratamiento con ivacaftor en administración concomi...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>630</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>736</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8c87d6b5-f6cb-4bbc-a56c-2bd3075fc241</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>737</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Poblaciones especiales&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>d7e03f75-00b1-42b8-80ff-3101181ab82f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Poblaciones especiales</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>738</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f57a935c-c053-4c9f-9779-ec073e41947d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>739</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Insuficiencia renal&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>c20b24d5-9e3b-4b84-994b-87434dd2ca8f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Insuficiencia renal</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>740</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0886524c-5770-4f27-861c-779221ec6cb7</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>741</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;No es necesario ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Se recomienda precaución en pacientes con insuficiencia renal grave (acl...</td>\n",
       "      <td>bf0b4d01-cbaf-4182-91a2-5c7edd9b77b1</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No es necesario ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Se recomienda precaución en pacientes con insuficiencia renal grave (aclaramiento de la creatinina menor o ig...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>271</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>742</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c850fb6a-93ca-4d1b-ab93-7266515c1e35</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>743</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;span lang=\"ES\"&gt;Insuficiencia hepática&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1de54931-baa2-4acf-8f18-ffd0c1d33955</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Insuficiencia hepática</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>744</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d9f4af01-aa9a-40ba-a906-bca8141699b2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>745</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;No es necesario ajustar la dosis en pacientes de 6 meses o mayores con insuficiencia hepática leve (Child-Pugh Clase A). Para los pacientes de 6 meses o mayore...</td>\n",
       "      <td>f9268644-0e17-4ebf-bb6e-401653f3d672</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No es necesario ajustar la dosis en pacientes de 6 meses o mayores con insuficiencia hepática leve (Child-Pugh Clase A). Para los pacientes de 6 meses o mayores con insuficiencia hepática moderada...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>920</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>746</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>93c52d2b-04a1-4a63-895b-215393418638</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>747</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Debido a la variabilidad en la maduración de las enzimas del citocromo (CYP) que intervienen en el metabolismo de ivacaftor, no se recomienda el tratamiento co...</td>\n",
       "      <td>14906e17-40c1-4cea-9225-749afc95f0ef</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Debido a la variabilidad en la maduración de las enzimas del citocromo (CYP) que intervienen en el metabolismo de ivacaftor, no se recomienda el tratamiento con ivacaftor en pacientes de 4 meses a...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>540</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>748</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>21c3383b-5b28-4ae5-88b3-d3ad33b0fc1c</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>749</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Población pediátrica&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>ce59da86-e9fa-43f7-8438-aa42a9638391</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Población pediátrica</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>750</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>95f63047-0001-4c38-a302-f65e9adae371</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>751</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;No se ha establecido la seguridad y eficacia de ivacaftor en niños menores de 4 meses. No se dispone de datos.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>158f7b71-d1b4-4e7d-9e90-8e848b2f7b56</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se ha establecido la seguridad y eficacia de ivacaftor en niños menores de 4 meses. No se dispone de datos.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>110</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>752</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>799855f4-5040-4f82-b34b-57b0b4fce7b9</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>753</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Los datos disponibles en pacientes menores de 6 años con una mutación &lt;i&gt;R117H&lt;/i&gt; en el gen &lt;i&gt;CFTR&lt;/i&gt; son limitados. &lt;/span&gt;&lt;span lang=\"ES\"&gt;Los datos dispon...</td>\n",
       "      <td>fd059f2d-3ab6-493a-84bd-7bcc050e9fa0</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los datos disponibles en pacientes menores de 6 años con una mutación R117H en el gen CFTR son limitados. Los datos disponibles en pacientes de 6 años o mayores están descritos en las secciones 4....</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>209</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>754</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>86eb85b6-f717-4345-bbbd-e8bed108eca9</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>755</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Forma de administración&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>f943bbda-1966-44bb-a8cf-049b3a8c5057</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Forma de administración</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>23</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>756</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f628ede4-d86f-4dd6-beb4-0095e3324f29</td>\n",
       "      <td>page-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>757</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt;Vía oral.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>73c3de24-b7ae-4fb2-96e4-a2e1c9f5d0ac</td>\n",
       "      <td>page-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Vía oral.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>758</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>aefeb7d3-1a63-4add-a336-d584699afe42</td>\n",
       "      <td>page-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>759</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt;Cada sobre es únicamente de un solo uso.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a6d36348-3065-422d-8cda-993ffa2210a1</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cada sobre es únicamente de un solo uso.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>40</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>760</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9f9c16ff-5163-45bb-a6b6-0801cf0d5223</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>761</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Cada sobre de granulado se debe mezclar con 5 ml de un alimento blando o líquido adecuado para la edad y consumir todo inmediatamente. El alimento o el líquido...</td>\n",
       "      <td>2e2dc74c-1eef-474e-ace6-8d8f31c4123f</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cada sobre de granulado se debe mezclar con 5 ml de un alimento blando o líquido adecuado para la edad y consumir todo inmediatamente. El alimento o el líquido deben estar a temperatura ambiente o...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>469</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>762</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4d801b59-a185-431d-ae3a-b508168440c3</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>763</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt;Se deben evitar los alimentos o bebidas que contienen pomelo durante el tratamiento (ver sección 4.5).&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7e598f26-346b-440e-b86d-ea66b5979e72</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se deben evitar los alimentos o bebidas que contienen pomelo durante el tratamiento (ver sección 4.5).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>102</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>764</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d26c79b6-d537-4d90-be94-f0d443a2e69d</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>765</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.3     Contraindicaciones&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>2fdfc0cb-9a32-4734-8685-6c9e7a229b48</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.3     Contraindicaciones</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>766</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c1dd6ee4-7aa1-421c-b702-58d3d376348a</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>767</th>\n",
       "      <td>&lt;p class=\"MsoNormalIndent\" style=\"margin:0in\"&gt;&lt;span lang=\"ES\"&gt;Hipersensibilidad al principio activo o a alguno de los excipientes incluidos en la sección 6.1.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a22ef426-9115-44ba-bbaa-1dc7401dc200</td>\n",
       "      <td>margin:0in</td>\n",
       "      <td>['MsoNormalIndent']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Hipersensibilidad al principio activo o a alguno de los excipientes incluidos en la sección 6.1.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>96</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>768</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7e591be8-1dfa-4bf5-9e6d-03819422f6b3</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>769</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.4     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Advertencias y precauciones especiales de emp...</td>\n",
       "      <td>0953da74-be6f-4309-8ca2-2e8144d577da</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.4     Advertencias y precauciones especiales de empleo</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>52</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>770</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>c10369ea-b680-4b70-9012-92478ba98338</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>771</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Únicamente los pacientes con FQ con una mutación &lt;/span&gt;&lt;span lang=\"ES\"&gt;de apertura del canal (clase III): &lt;/span&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;G551D, &lt;/span&gt;&lt;span lang=\"...</td>\n",
       "      <td>5cb7c7a5-fade-4b75-b726-267dd8b13743</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Únicamente los pacientes con FQ con una mutación de apertura del canal (clase III): G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N o S549R o una mutación G970R en al menos un alelo del...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>269</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>772</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3a6fa4a3-c442-4b93-b1e1-b4e32f6e617c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>773</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En el estudio 6, se ha demostrado menos evidencia de un efecto positivo de ivacaftor en pacientes con una mutación &lt;i&gt;R117H-7T&lt;/i&gt; asociada a una menor graveda...</td>\n",
       "      <td>c01f507c-2109-46ad-bff7-8df1c66358e6</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En el estudio 6, se ha demostrado menos evidencia de un efecto positivo de ivacaftor en pacientes con una mutación R117H-7T asociada a una menor gravedad de la enfermedad (ver sección 5.1).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>189</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>774</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ca5d083a-cbd0-4be6-883e-aad672c78406</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>775</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En el estudio 5 fueron incluidos cuatro pacientes con la mutación &lt;i&gt;G970R&lt;/i&gt;. En tres de los cuatro pacientes el cambio en la prueba de &lt;/span&gt;&lt;span lang=\"ES...</td>\n",
       "      <td>1e602bda-9675-44a2-9693-b0a79c773eac</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En el estudio 5 fueron incluidos cuatro pacientes con la mutación G970R. En tres de los cuatro pacientes el cambio en la prueba de cloruro en el sudor fue &lt;5 mmol/l y este grupo no demostró una me...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>384</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>776</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6854f2aa-6ee9-462b-ba47-936916d1e9ec</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>777</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Los resultados de eficacia de un estudio de fase 2 en pacientes con FQ homocigóticos para la mutación &lt;i&gt;F508del &lt;/i&gt;en el gen &lt;i&gt;CFTR&lt;/i&gt; no mostraron una dif...</td>\n",
       "      <td>22f101eb-b76c-469a-8bdc-147b59d87aae</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los resultados de eficacia de un estudio de fase 2 en pacientes con FQ homocigóticos para la mutación F508del en el gen CFTR no mostraron una diferencia estadísticamente significativa en el VEF1 a...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>380</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>778</th>\n",
       "      <td>&lt;p class=\"labeltextheading\" style=\"page-break-after:auto\"&gt;&lt;u&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>a29a72b5-768c-4e4a-8998-3fcc04ec4b82</td>\n",
       "      <td>page-break-after:auto</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>779</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;u&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt;Efecto en las pruebas de la función hepática&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>db1eb4cf-4436-444c-b5fa-0f9a3014f69b</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Efecto en las pruebas de la función hepática</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>44</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>780</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>92444636-9fdd-4956-b14a-5b63f64b2d1e</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>781</th>\n",
       "      <td>&lt;p class=\"labeltextheading\" style=\"page-break-after:auto\"&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt;Es frecuente el aumento moderado de las aminotransferasas &lt;/span&gt;&lt;span lang=\"ES\" style=\"font-sty...</td>\n",
       "      <td>9af3aa9c-59b4-44fc-9846-bee61b7e14d0</td>\n",
       "      <td>page-break-after:auto</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Es frecuente el aumento moderado de las aminotransferasas (alanina-aminotransferasa [ALAT] o aspartato‑aminotransferasa [ASAT]) en los sujetos con FQ. Se han observado aumentos de las aminotransfe...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>1138</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>782</th>\n",
       "      <td>&lt;p class=\"labeltextheading\" style=\"page-break-after:auto\"&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>676fe39d-4f31-4f42-81cf-2f8862d44096</td>\n",
       "      <td>page-break-after:auto</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>783</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Insuficiencia hepática&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>c7f1fec8-891f-4bfb-a721-9076cb54f282</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Insuficiencia hepática</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>784</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d75c7481-1dd0-49e5-9771-5a7272ad18fb</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>785</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;No se recomienda utilizar ivacaftor en pacientes con insuficiencia hepática grave a menos que los beneficios esperados superen los riesgos (ver las secciones 4...</td>\n",
       "      <td>ee0015fa-a6cf-4c61-831b-635086f6ce09</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se recomienda utilizar ivacaftor en pacientes con insuficiencia hepática grave a menos que los beneficios esperados superen los riesgos (ver las secciones 4.2 y 5.2). No se dispone de datos de ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>325</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>786</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b747a55f-433a-4d88-8f8b-7f8aa223f239</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>787</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Insuficiencia renal&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>47371c69-cec3-470c-94a6-b70a41f9cade</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Insuficiencia renal</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>788</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>15bd63eb-2456-43bc-bf91-8d6d53bbcd36</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>789</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Se recomienda precaución mientras se utiliza ivacaftor en pacientes con insuficiencia renal grave o enfermedad renal terminal (ver las secciones 4.2 y 5.2).&lt;/s...</td>\n",
       "      <td>6dffb3c8-b57d-47ef-aee3-567e594eccf0</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se recomienda precaución mientras se utiliza ivacaftor en pacientes con insuficiencia renal grave o enfermedad renal terminal (ver las secciones 4.2 y 5.2).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>156</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>790</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>78e60b73-c25c-49e8-bd32-90e63f20f8e2</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>791</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Pacientes después de un trasplante de órganos&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>5a71be2e-74d4-4f2a-af91-3e5915bf75e3</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Pacientes después de un trasplante de órganos</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>45</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>792</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9291ec93-2939-440d-9f30-45aa7f9bf1ff</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>793</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Ivacaftor&lt;/span&gt;&lt;span lang=\"ES\"&gt; no se ha estudiado en pacientes con FQ que se han sometido a un trasplante de órganos. Por lo tanto, no se recomienda utilizar...</td>\n",
       "      <td>7a6b70de-775e-425d-8600-b1e1031232bc</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor no se ha estudiado en pacientes con FQ que se han sometido a un trasplante de órganos. Por lo tanto, no se recomienda utilizar en pacientes trasplantados. Ver sección 4.5 para las intera...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>234</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>794</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>3b680c49-7481-4966-a763-8c5b54a36081</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>795</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Interacciones con otros medicamentos&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>1c53f5d1-2af0-43b5-87ea-11db6f301951</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Interacciones con otros medicamentos</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>36</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>796</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>16884384-47db-4d86-87c6-c91185bf701f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>797</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Inductores de CYP3A&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>d0bbf95d-2f83-43d8-a0df-8b525caa3e85</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Inductores de CYP3A</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>798</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>71ef6bd4-430f-47e7-9505-77c620cf31cd</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>799</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;La exposición a ivacaftor disminuye significativamente con el uso concomitante de inductores de CYP3A, pudiendo dar lugar a una posible pérdida de la eficacia ...</td>\n",
       "      <td>b18bef28-f7c3-48d0-953f-a81de3f0c953</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La exposición a ivacaftor disminuye significativamente con el uso concomitante de inductores de CYP3A, pudiendo dar lugar a una posible pérdida de la eficacia de ivacaftor; por lo tanto, no se rec...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>292</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>800</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a39cfa13-00b0-483d-9717-c040b338d0d9</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>801</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Inhibidores de CYP3A&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>2f44a121-a5db-49f8-965e-47143e6e9b66</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Inhibidores de CYP3A</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>802</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6c08e1d5-a15d-49a6-a2aa-a9102c795793</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>803</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;La exposición a ivacaftor&lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt; aumenta cuando se administra con inhibidores potentes o moderados de CYP3A...</td>\n",
       "      <td>bce2e699-5986-4d72-8c0d-04cc69c98af7</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La exposición a ivacaftor aumenta cuando se administra con inhibidores potentes o moderados de CYP3A. Se debe ajustar la dosis de ivacaftor cuando se utilice de forma concomitante con inhibidores ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>457</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>804</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4863b602-9bde-4a6b-a7d0-8e014db9e59f</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Población pediátrica&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>da2a0565-9706-4d38-b635-3331fcdda3e0</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Población pediátrica</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>806</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>656d0921-ddce-427b-8f3b-46dd1d6feb86</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>807</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Se han notificado casos de opacidad del cristalino/cataratas no congénitas sin afectar a la visión en pacientes pediátricos tratados con ivacaftor. Aunque en a...</td>\n",
       "      <td>72a92666-a5f8-4776-a27e-009fcb9d8b4e</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se han notificado casos de opacidad del cristalino/cataratas no congénitas sin afectar a la visión en pacientes pediátricos tratados con ivacaftor. Aunque en algunos casos había otros factores de ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>502</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>808</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d2b6a21d-bfca-4dfe-8446-d4f8d425756b</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>809</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Contenido de lactosa&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>ecce3a8e-82b7-46c7-8b99-627744b43cc2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Contenido de lactosa</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>810</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>13da4448-d51c-40fe-b779-ed72929bd20e</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>811</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Kalydeco contiene lactosa. Los pacientes con intolerancia hereditaria a galactosa, deficiencia total de lactasa o problemas de absorción de glucosa o galactosa...</td>\n",
       "      <td>28842a74-e255-44c4-afae-3364c6e13899</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Kalydeco contiene lactosa. Los pacientes con intolerancia hereditaria a galactosa, deficiencia total de lactasa o problemas de absorción de glucosa o galactosa no deben tomar este medicamento.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>192</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>812</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>da571d88-fae8-4575-9c3b-e97d45a93f4b</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>813</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Contenido de sodio&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>2da12ee4-9668-4fac-b987-0f7cf771ba61</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Contenido de sodio</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>814</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e96fbb07-fae8-4150-a331-3fa0be7a8ac1</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>815</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Este medicamento contiene menos de 23 mg de sodio (1 mmol) por unidad de dosis; esto es, esencialmente “exento de sodio”.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>122e8c2f-29c6-460a-8fea-5aa559aff719</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Este medicamento contiene menos de 23 mg de sodio (1 mmol) por unidad de dosis; esto es, esencialmente “exento de sodio”.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>121</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>816</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>384c6ae7-15a8-4176-a7b5-1d0a075be770</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>817</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.5     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Interacción con otros medicamentos y otras fo...</td>\n",
       "      <td>755764fd-55cf-4d8b-b437-c79aa83945a9</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.5     Interacción con otros medicamentos y otras formas de interacción</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>68</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>818</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>85629b22-bb20-41a3-b852-9728a945defe</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>819</th>\n",
       "      <td>&lt;p class=\"MsoCommentText\"&gt;&lt;span lang=\"ES\" style=\"font-size:11.0pt\"&gt;Ivacaftor es un sustrato de CYP3A4 y CYP3A5. Es un inhibidor débil de CYP3A y P&lt;/span&gt;&lt;span lang=\"ES\"&gt;‑&lt;/span&gt;&lt;span lang=\"ES\" sty...</td>\n",
       "      <td>9fe635f9-7aec-4a86-975c-941e5225d796</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoCommentText']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor es un sustrato de CYP3A4 y CYP3A5. Es un inhibidor débil de CYP3A y P‑gp y un posible inhibidor de CYP2C9. Los estudios in vitro demostraron que ivacaftor no es un sustrato de P‑gp.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>191</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>820</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f9d7584c-5e8f-422c-8dff-949094af0305</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>821</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Medicamentos que afectan a la farmacocinética de ivacaftor&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>ddeb4a41-89bf-4924-9874-32f0f306e2dd</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Medicamentos que afectan a la farmacocinética de ivacaftor</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>58</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>822</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>5e7b01f7-b23c-420b-b526-e9711f6b7200</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>823</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Inductores de CYP3A&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>5c5646cc-91fa-4f2f-a612-fdecfd76a1a0</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Inductores de CYP3A</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>824</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d44795b3-6a8c-47fb-83f4-2ff3593c3ffa</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>825</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;La administración conjunta de ivacaftor con rifampicina, un inductor potente de CYP3A, disminuyó la exposición a ivacaftor (AUC)...</td>\n",
       "      <td>147173d5-9db0-44ee-a1d2-bc159521b390</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La administración conjunta de ivacaftor con rifampicina, un inductor potente de CYP3A, disminuyó la exposición a ivacaftor (AUC) en un 89 % y a hidroximetil-ivacaftor (M1), aunque en menor grado q...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>440</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>826</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>33027756-dc07-4809-a933-9b0fab0bf479</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>827</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;No se recomienda un ajuste de la dosis c&lt;/span&gt;&lt;span lang=\"ES\"&gt;uando se utilice ivacaftor junto con inductores débiles o moderados de CYP3A.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a77133ca-f8d3-4226-9e3b-0c8348ff34a4</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se recomienda un ajuste de la dosis cuando se utilice ivacaftor junto con inductores débiles o moderados de CYP3A.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>117</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>828</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>7cf6ea66-a942-4607-8830-9139ed3b0bbf</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>829</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Inhibidores de CYP3A&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>2df12e1e-43e4-4bea-9782-5ccc5879b7e4</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Inhibidores de CYP3A</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>830</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e364ca29-cdf7-43b2-814f-21a271ece95f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>831</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Ivacaftor es un sustrato sensible de CYP3A. La administración conjunta con ketoconazol, un inhibidor potente de CYP3A, aumentó l...</td>\n",
       "      <td>d579318d-bee5-4d68-877d-b1e9b12f7ef1</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor es un sustrato sensible de CYP3A. La administración conjunta con ketoconazol, un inhibidor potente de CYP3A, aumentó la exposición a ivacaftor (determinada como área bajo la curva [AUC])...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>495</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>832</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>1a8b8221-2aaa-4482-a20d-a4a7d85a362e</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>833</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;La administración conjunta con fluconazol, un inhibidor moderado de CYP3A, aumentó la exposición a ivacaftor en 3 veces y a su metabolito M1, aunque en menor g...</td>\n",
       "      <td>35e1f7e8-061f-4771-97ba-19a325f5f947</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La administración conjunta con fluconazol, un inhibidor moderado de CYP3A, aumentó la exposición a ivacaftor en 3 veces y a su metabolito M1, aunque en menor grado que a ivacaftor. Se recomienda d...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>387</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>834</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>62b6978a-4c3d-4b92-af52-97d73f120e54</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>835</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;La administración conjunta de ivacaftor&lt;/span&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;span lang=\"ES\"&gt;con zumo de pomelo, que contiene uno o más componentes que inhiben de for...</td>\n",
       "      <td>a772ab90-d41d-4248-b216-c8b5fba6f5c9</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La administración conjunta de ivacaftor con zumo de pomelo, que contiene uno o más componentes que inhiben de forma moderada CYP3A, puede aumentar la exposición a ivacaftor. Se deben evitar los al...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>290</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>836</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f00e15c6-0857-42eb-999f-64e8e4131375</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>837</th>\n",
       "      <td>&lt;p class=\"MsoCommentText\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\" style=\"font-size:11.0pt\"&gt;Capacidad de ivacaftor para interactuar con transportadores&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>e851f92e-95f3-4ab3-b0cf-6b2284395c3b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoCommentText']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Capacidad de ivacaftor para interactuar con transportadores</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>59</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>838</th>\n",
       "      <td>&lt;p class=\"MsoCommentText\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\" style=\"font-size:11.0pt\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>2f45a708-69af-4703-80dd-8eb31fbbbe1c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoCommentText']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>839</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Los estudios &lt;i&gt;in vitro&lt;/i&gt; demostraron que ivacaftor no es un sustrato de OATP1B1 ni de OATP1B3. Ivacaftor y sus metabolitos s...</td>\n",
       "      <td>92fa0ad7-e99f-49ce-b687-1198ef801466</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los estudios in vitro demostraron que ivacaftor no es un sustrato de OATP1B1 ni de OATP1B3. Ivacaftor y sus metabolitos son sustratos de BCRP in vitro. Debido a su alta permeabilidad intrínseca y ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>482</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>840</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>221ea1a6-352a-434c-86f0-14491c1f2f0b</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>841</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Ciprofloxacino&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>5970b640-69e4-4205-a9bd-0775f4a82887</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Ciprofloxacino</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>842</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fc73c54f-28c0-4507-abc6-c025105fc1bd</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>843</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;La administración conjunta de ciprofloxacino con ivacaftor no afectó a la exposición a ivacaftor. No es necesario ajustar la dos...</td>\n",
       "      <td>0da394e7-0003-41f0-b832-75ba23a5ded8</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La administración conjunta de ciprofloxacino con ivacaftor no afectó a la exposición a ivacaftor. No es necesario ajustar la dosis cuando ivacaftor se administra conjuntamente con ciprofloxacino.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>195</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>844</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>84555af4-c486-4fa7-b19a-d08cdd6a44bc</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>845</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Medicamentos a los que afecta ivacaftor&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>ec6cfce3-805b-4862-9c07-00dd063e5222</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Medicamentos a los que afecta ivacaftor</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>846</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9199fb81-21f8-4e51-ad2e-80a710638111</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>847</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;La administración de ivacaftor puede aumentar la exposición sistémica de los medicamentos que son sustratos sensibles de &lt;/span&gt;...</td>\n",
       "      <td>055fff5f-f7a8-4e4a-8202-1db0de32a577</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La administración de ivacaftor puede aumentar la exposición sistémica de los medicamentos que son sustratos sensibles de CYP2C9, y/o P‑gp y/o CYP3A, lo que puede aumentar o prolongar su efecto ter...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>231</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>848</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>75f7972e-23d0-470b-ad4d-63bc71b7c8eb</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>849</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Sustratos de CYP2C9&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>70b79d03-e888-433f-856b-e48e34262edd</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Sustratos de CYP2C9</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>850</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>03c3704b-83d2-4020-8ac0-0f3cb803822f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>851</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;Ivacaftor puede inhibir CYP2C9. Por lo tanto, se recomienda controlar la razón internacional normalizada (INR) durante la a...</td>\n",
       "      <td>8c5473d5-ab9e-4180-ae74-89cbd5bb51c9</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor puede inhibir CYP2C9. Por lo tanto, se recomienda controlar la razón internacional normalizada (INR) durante la administración conjunta de warfarina con ivacaftor. Los otros medicamentos...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>321</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>852</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f0c9ea0a-bd82-48a6-a036-b0bccc81c235</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>853</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Digoxina y otros sustratos de P‑gp&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>446fa670-9c97-47d1-8c05-d69607c38c54</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Digoxina y otros sustratos de P‑gp</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>34</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>854</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5b3e8733-b6a5-4a28-88ce-3549ab7580fb</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>855</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;La administración conjunta con digoxina, un sustrato sensible de la P&lt;u&gt;‑&lt;/u&gt;gp, aumentó la exposición a digoxina en 1,3 ve...</td>\n",
       "      <td>9d862247-d0f4-495c-8d69-c56a26363d46</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La administración conjunta con digoxina, un sustrato sensible de la P‑gp, aumentó la exposición a digoxina en 1,3 veces, lo que es coherente con la inhibición débil de la P‑gp por ivacaftor. La ad...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>616</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>856</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2f3ce197-bb9e-4146-a7a0-9d39a4f03297</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>857</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Sustratos de CYP3A&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>74c83933-b2ec-4035-bc53-ac72893d8ac7</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Sustratos de CYP3A</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>858</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d65d4700-b322-4ab6-8716-4426681f1d55</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>859</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;La administración conjunta con midazolam (oral), un sustrato de CYP3A sensible, aumentó la exposición a midazolam en 1,5 ve...</td>\n",
       "      <td>7ba4250e-a51a-4a9e-abbc-0d09c953d7be</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La administración conjunta con midazolam (oral), un sustrato de CYP3A sensible, aumentó la exposición a midazolam en 1,5 veces, lo que es coherente con la inhibición débil de CYP3A por ivacaftor. ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>348</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>860</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fb2d1b72-43f9-4423-a0bb-05c85bb776f0</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>861</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Anticonceptivos hormonales&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>1d0291a2-5162-4fb8-99a2-d13d368cf942</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Anticonceptivos hormonales</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>862</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0aa0d92b-9c15-406f-b682-e3c65bd81343</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>863</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;Se ha estudiado ivacaftor con un anticonceptivo oral de estrógeno/progesterona y se observó que no afectaba significativame...</td>\n",
       "      <td>c6fd0923-67ce-42fd-b564-d44a2efa3d65</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se ha estudiado ivacaftor con un anticonceptivo oral de estrógeno/progesterona y se observó que no afectaba significativamente a la exposición al anticonceptivo oral. Por lo tanto, no es necesario...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>244</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>864</th>\n",
       "      <td>&lt;p style=\"margin:0in\"&gt;&lt;span lang=\"ES\" style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0cee1856-3d85-45db-8f6e-02fe48436bde</td>\n",
       "      <td>margin:0in</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>865</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Población pediátrica&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>39acdbb3-4da7-4eac-bac9-dfea031f4dc5</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Población pediátrica</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>866</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>789a0c1f-d5b7-446f-85e2-1ce5458fce5e</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>867</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Los estudios de interacciones se han realizado solo en adultos.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>73e12586-56a0-4fa2-b1bf-f2acf4a576b6</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los estudios de interacciones se han realizado solo en adultos.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>63</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>868</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>70163af9-c2bd-4517-8d8d-7ca48e264afd</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>869</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.6     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Fertilidad, embarazo y lactancia&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>3a238aa8-0e03-4a18-ba74-688440fda9c9</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.6     Fertilidad, embarazo y lactancia</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>36</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>870</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>76d3b309-7d23-4385-bf36-6f263586e3e5</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>871</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Embarazo&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>98f58bbc-a54c-4848-942f-4ad8e420205d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Embarazo</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>872</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3b465e2a-99e9-4a6a-a8d7-bd7dd0fd337c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>873</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;No hay datos o estos son limitados (datos en menos de 300 embarazos) relativos al uso de ivacaftor en mujeres embarazadas. Los e...</td>\n",
       "      <td>88949b11-3ece-4d6d-8576-488adc1e74b0</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No hay datos o estos son limitados (datos en menos de 300 embarazos) relativos al uso de ivacaftor en mujeres embarazadas. Los estudios en animales no sugieren efectos perjudiciales directos ni in...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>358</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>874</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e9759447-1327-49aa-baee-ff3f413fad94</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>875</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Lactancia&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>1487baa6-278f-4dec-b95c-f118e861926e</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Lactancia</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>876</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8ea1fa31-dcaf-46fc-b6c8-a4d15f21ff2d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>877</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;Se desconoce si &lt;/span&gt;&lt;span lang=\"ES\"&gt;ivacaftor y/o sus metabolitos se excretan en la leche materna. &lt;/span...</td>\n",
       "      <td>de9629f2-5199-46bd-a695-03c9f5693e7f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se desconoce si ivacaftor y/o sus metabolitos se excretan en la leche materna. Los datos farmacocinéticos disponibles en animales muestran que ivacaftor se excreta en la leche de ratas hembra en p...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>489</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>878</th>\n",
       "      <td>&lt;p class=\"MsoNormalIndent\" style=\"margin:0in\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2adef6b9-d9b0-448e-925d-cf86e10aa533</td>\n",
       "      <td>margin:0in</td>\n",
       "      <td>['MsoNormalIndent']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>879</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Fertilidad&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>b612376a-87ff-4893-9abc-27deb94a7874</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Fertilidad</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>10</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>880</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5630b8ff-8a07-4382-adb5-7224ef096460</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>881</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\" style=\"color:black\"&gt;No se dispone de datos sobre el efecto de ivacaftor en la fertilidad en humanos. Ivacaftor tuvo un efec...</td>\n",
       "      <td>3c9bec28-7028-4e42-8311-3ffd64eccab9</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se dispone de datos sobre el efecto de ivacaftor en la fertilidad en humanos. Ivacaftor tuvo un efecto en la fertilidad en ratas (ver sección 5.3).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>150</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>882</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>df8d7a11-f8da-49b0-96e9-721c5bb9d630</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>883</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.7     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Efectos sobre la capacidad para conducir y ut...</td>\n",
       "      <td>e1bb0ae1-8bb4-4374-a062-a57061f9b014</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.7     Efectos sobre la capacidad para conducir y utilizar máquinas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>64</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>884</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b91dc91f-a1e8-4c56-89cf-d39925acb2ce</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>885</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;La influencia de ivacaftor sobre la capacidad para conducir y utilizar máquinas es pequeña. Ivacaftor puede producir mareos (ver sección 4.8) y, por lo tanto, ...</td>\n",
       "      <td>ceefb56f-fbf3-4bba-9169-4f65b1977e4c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La influencia de ivacaftor sobre la capacidad para conducir y utilizar máquinas es pequeña. Ivacaftor puede producir mareos (ver sección 4.8) y, por lo tanto, se debe aconsejar a los pacientes que...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>286</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>886</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8556165a-5481-4647-b4be-b78ca8319081</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>887</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.8     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Reacciones adversas&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>1fdaa717-d084-4b17-829e-d6b5a23f0074</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.8     Reacciones adversas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>23</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>888</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph; page-break-after:avoid;text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e4215e59-61d4-45de-9121-80c0c52e14b4</td>\n",
       "      <td>text-align:justify;text-justify:inter-ideograph;\\npage-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>889</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Resumen del perfil de seguridad&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>f539ef02-9791-4358-be88-45ee80e293b8</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Resumen del perfil de seguridad</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>890</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f3635820-b638-4d9b-ac29-19598572c980</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>891</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Las reacciones adversas más frecuentes experimentadas por los pacientes de 6 años o mayores son cefalea &lt;/span&gt;&lt;span lang=\"ES\"&gt;(...</td>\n",
       "      <td>3a902801-ef00-4384-ad74-44ec70b52150</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Las reacciones adversas más frecuentes experimentadas por los pacientes de 6 años o mayores son cefalea (23,9 %), dolor bucofaríngeo (22,0 %), infección en las vías respiratorias altas (22,0 %), c...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>512</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>892</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>dae5eb4e-88f8-4473-a6b4-9fc91d9fc29f</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>893</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;En pacientes de 2 a menos de 6 años las reacciones adversas más frecuentes fueron congestión nasal (26,5 %), infección en las vías respiratorias altas (23,5 %)...</td>\n",
       "      <td>b0a508fe-0ef4-4165-8ff8-53e3cf5a4c93</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En pacientes de 2 a menos de 6 años las reacciones adversas más frecuentes fueron congestión nasal (26,5 %), infección en las vías respiratorias altas (23,5 %), aumento de las aminotransferasas (1...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>256</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>894</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>971f5fcb-4653-40d3-8aae-35960b80c7e6</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>895</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Las reacciones adversas graves observadas en los pacientes que recibieron ivacaftor incluyeron dolor abdominal y aumento de las aminotransferasas (ver sección ...</td>\n",
       "      <td>8ee2b21d-8909-48c4-b966-581eccc8890c</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Las reacciones adversas graves observadas en los pacientes que recibieron ivacaftor incluyeron dolor abdominal y aumento de las aminotransferasas (ver sección 4.4).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>164</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>896</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3b434b38-404a-47ab-a27e-1707d1547dcf</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>897</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"line-height:13.0pt;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Tabla de reacciones adversas&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>006cee7a-7acc-4bd8-a630-61ffc69f1f1c</td>\n",
       "      <td>line-height:13.0pt;page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Tabla de reacciones adversas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>898</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1f6711b4-247d-4149-acf6-0662b2ef7fc2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>899</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;La Tabla 2 muestra las reacciones adversas observadas&lt;/span&gt;&lt;span lang=\"ES\"&gt; con ivacaftor en los ensayos clínicos (estudios con...</td>\n",
       "      <td>f596d942-ca1f-4f2f-a906-826da1b1ff0b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La Tabla 2 muestra las reacciones adversas observadas con ivacaftor en los ensayos clínicos (estudios controlados con placebo y estudios no controlados) en los que la duración de la exposición a i...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>639</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>900</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>84fa50be-d11e-4ba5-9e64-4e143e2e1020</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>901</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 2: &lt;span style=\"color:black\"&gt;Reacciones adversas&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>67f7c9f6-5d68-4d18-9dd2-50ba56acbebd</td>\n",
       "      <td>margin-bottom:6.0pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 2: Reacciones adversas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>902</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:95.3%;border-collapse:collapse;border:none\" width=\"95%\"&gt; &lt;thead&gt; &lt;tr style=\"page-break-inside:avoid;height:27....</td>\n",
       "      <td>c599867e-6bfb-472c-913e-d3751cfb582b</td>\n",
       "      <td>width:95.3%;border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Sistema    de clasificación de órganos    Reacciones adversas   Frecuencia      Infecciones e   infestaciones   Infección en   las vías respiratorias altas   Muy   frecuentes     Nasofaringiti...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>1206</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>903</th>\n",
       "      <td>&lt;p class=\"labeltextheading\" style=\"page-break-after:auto\"&gt;&lt;span lang=\"ES\" style=\"color:black;font-style:normal\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>12b2dd97-71f1-4c5d-b51d-88825cfc44c8</td>\n",
       "      <td>page-break-after:auto</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>904</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Descripción de reacciones adversas seleccionadas&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>f072cd09-0ff9-41b0-a138-ee1931d425e7</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Descripción de reacciones adversas seleccionadas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>48</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>905</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>961211e3-71af-4208-a795-a8f88413e076</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>906</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Aumento de las aminotransferasas&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>532f003d-a451-440d-9ac3-f4bb08f2c8ff</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Aumento de las aminotransferasas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>32</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>907</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>789f2ef0-e677-46cd-9724-44227bcde824</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>908</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Durante los estudios clínicos 1 y 2 controlados con placebo, de 48 semanas de duración en pacientes de 6 años o mayores, la incidencia de niveles máximos de la...</td>\n",
       "      <td>b758be93-21f8-4393-92e2-7474c630f818</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Durante los estudios clínicos 1 y 2 controlados con placebo, de 48 semanas de duración en pacientes de 6 años o mayores, la incidencia de niveles máximos de las aminotransferasas (ALAT o ASAT) &gt;8,...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>1260</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>909</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d4dccd08-d74b-4ea1-966c-c511dcac092b</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>910</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Durante los estudios de fase 3, controlados con placebo (hasta 24 semanas) de tezacaftor/ivacaftor, &lt;/span&gt;&lt;span lang=\"ES\"&gt;la incidencia de niveles máximos de ...</td>\n",
       "      <td>cad6ff55-11ef-4674-9273-a84720c43977</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Durante los estudios de fase 3, controlados con placebo (hasta 24 semanas) de tezacaftor/ivacaftor, la incidencia de niveles máximos de las aminotransferasas (ALAT o ASAT) &gt;8, &gt;5 o &gt;3 veces el LSN...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>693</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>911</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e9b8b240-6e66-405d-8bab-6ecd53dd9ff0</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>912</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Durante el estudio de fase 3, controlados con placebo de 24 semanas de duración de ivacaftor/tezacaftor/elexacaftor, estas cifras fueron del 1,5 %, 2,5 % y 7,9...</td>\n",
       "      <td>7802902b-ff9a-4ce9-8220-39876e2ccfc4</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Durante el estudio de fase 3, controlados con placebo de 24 semanas de duración de ivacaftor/tezacaftor/elexacaftor, estas cifras fueron del 1,5 %, 2,5 % y 7,9 % en los pacientes tratados con ivac...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>531</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>913</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9d9db260-22ed-462e-949d-a7411e5584ec</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>914</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Población pediátrica&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>eb4e93d1-701f-4f56-b062-b7de2610bb1d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Población pediátrica</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>915</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>dacc3cca-2130-4042-beb8-d4fe5e4d11f5</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>916</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Los datos de seguridad de ivacaftor se evaluaron en 6 pacientes de entre 4 meses y menos de 6 meses de edad, 11 pacientes de entre 6 meses y menos de 12 meses ...</td>\n",
       "      <td>a7da497d-1e55-4c51-ac5d-7d1f597ec524</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los datos de seguridad de ivacaftor se evaluaron en 6 pacientes de entre 4 meses y menos de 6 meses de edad, 11 pacientes de entre 6 meses y menos de 12 meses de edad, en 19 pacientes de entre 12 ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>396</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>917</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>06af87bd-b585-4af4-b274-7cedb58df30a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>918</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;El perfil de seguridad es por lo general coherente entre los pacientes pediátricos de 4 meses o mayores y también es coherente con el de los pacientes adultos....</td>\n",
       "      <td>d16d4116-d076-4d26-8a67-7fe5c326122c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El perfil de seguridad es por lo general coherente entre los pacientes pediátricos de 4 meses o mayores y también es coherente con el de los pacientes adultos.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>159</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>919</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>12d48435-132b-44ba-bd29-3f0f741cc6e6</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>920</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;La incidencia de &lt;/span&gt;&lt;span lang=\"ES\"&gt;aumento de las aminotransferasas&lt;/span&gt;&lt;span lang=\"ES\"&gt; (ALAT o ASAT) observada en los estudios 2, 5 y 6 (pacientes de ...</td>\n",
       "      <td>596583e6-2511-48b3-870d-b9dfe3ae2c57</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La incidencia de aumento de las aminotransferasas (ALAT o ASAT) observada en los estudios 2, 5 y 6 (pacientes de 6 a menos de 12 años), el estudio 7 (pacientes de 2 a menos de 6 años) y el estudio...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>1408</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>921</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0a8f392d-c134-4286-af83-cbac64b3257c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>922</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-bottom:12.0pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 3: Aumentos de las aminotransferasas en pacientes de 4 meses a &amp;lt;12 años tratados con ivacaftor ...</td>\n",
       "      <td>05f5bf19-a00a-4d29-957c-596f7f1afd39</td>\n",
       "      <td>margin-bottom:12.0pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 3: Aumentos de las aminotransferasas en pacientes de 4 meses a &lt;12 años tratados con ivacaftor en monoterapia</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>115</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>923</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoTableGrid\" style=\"margin-left:6.85pt;border-collapse:collapse;border:none\"&gt; &lt;tr style=\"height:28.95pt\"&gt; &lt;td style=\"width:121.1pt;border:...</td>\n",
       "      <td>a054570d-c763-4e07-947a-99a6052278f3</td>\n",
       "      <td>margin-left:6.85pt;border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoTableGrid']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>n   % de pacientes &gt;3 veces el LSN   % de pacientes &gt;5 veces el LSN   % de pacientes &gt;8 veces el LSN     6 a   &lt;12 años   40   15,0 % (6)   2,5 % (1)   2,5 % (1)     2 a   &lt;6 años   34   14...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>924</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5054b6e5-5e1d-4002-a4de-3e91ef0dddbd</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>925</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Notificación de sospechas de reacciones adversas&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>1036511f-3930-4295-b418-0d372cb5b42b</td>\n",
       "      <td>page-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Notificación de sospechas de reacciones adversas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>48</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>926</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0ab2a5bd-bef3-44f5-8427-8869d69bb918</td>\n",
       "      <td>page-break-after:avoid;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>927</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;Es importante notificar sospechas de reacciones adversas al medicamento tras su autorización. Ello permite una supervisión ...</td>\n",
       "      <td>642658e9-e148-4bda-a559-b44ab61a3d9f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Es importante notificar sospechas de reacciones adversas al medicamento tras su autorización. Ello permite una supervisión continuada de la relación beneficio/riesgo del medicamento. Se invita a l...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>345</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>928</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c23850ae-6a8d-4bad-96be-ee46a44a2602</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>929</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;4.9     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Sobredosis&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>d7016c77-f503-4815-bd2d-7d16e9d8d94c</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.9     Sobredosis</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>930</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>560c2fb4-0cec-4613-a728-b300cbc43820</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>931</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;No existe un antídoto específico para la sobredosis de ivacaftor. El tratamiento de la sobredosis consiste en las medidas de sop...</td>\n",
       "      <td>f8ff4b34-2c18-400f-87bb-ceea573d357a</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No existe un antídoto específico para la sobredosis de ivacaftor. El tratamiento de la sobredosis consiste en las medidas de soporte generales que incluyen control de las constantes vitales, prueb...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>268</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>932</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5fd0d3dd-e1c7-4243-b8fe-b4ce8f067dee</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>933</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5290b3cb-7d69-4d9b-a2c7-7be5d924e61e</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>934</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;5.       &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;PROPIEDADES FARMACOLÓGICAS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>c3059255-ef36-4c16-826c-42ba1b081757</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>5.       PROPIEDADES FARMACOLÓGICAS</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>29</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>935</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ad1d7eca-c847-4d1b-91d3-2b0e67f8ef42</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>936</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;5.1     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Propiedades farmacodinámicas&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>4349b42b-0f9b-4a63-8882-b5d2ad4c24b6</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>5.1     Propiedades farmacodinámicas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>32</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>937</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>fbf06eba-b97a-40fa-849b-3683d5a33348</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>938</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Grupo farmacoterapéutico: Otros productos del sistema respiratorio, código ATC: &lt;/span&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;R07AX...</td>\n",
       "      <td>9373508c-9878-4723-984f-3c769eda2623</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Grupo farmacoterapéutico: Otros productos del sistema respiratorio, código ATC: R07AX02</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>87</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>939</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>58df89cd-2168-4447-8659-9bb2e68beaed</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>940</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-right:-.1pt;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Mecanismo de acción&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>decfb79e-44b8-406a-8f3c-8c9abf6d589e</td>\n",
       "      <td>margin-right:-.1pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Mecanismo de acción</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>941</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>774c2fea-2f4a-4c1f-8e30-0b6e67a23447</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>942</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;Ivacaftor es un potenciador de la proteína CFTR, es decir, ivacaftor &lt;i&gt;in vitro&lt;/i&gt; aumenta la apertura del canal de CFTR ...</td>\n",
       "      <td>9f49c900-7ab7-4276-b0f0-5ec1b18bb4c3</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor es un potenciador de la proteína CFTR, es decir, ivacaftor in vitro aumenta la apertura del canal de CFTR para intensificar el transporte de cloruro en las mutaciones de apertura del can...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>842</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>943</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4a011bfc-e8ab-48e4-b842-49c31df5e65e</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>944</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Las respuestas &lt;i&gt;in vitro&lt;/i&gt; observadas en los experimentos de fijación de membranas de un solo canal utilizando membranas de células de roedores que expresa...</td>\n",
       "      <td>569422d9-f0b2-468e-b854-baf7759f2b40</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Las respuestas in vitro observadas en los experimentos de fijación de membranas de un solo canal utilizando membranas de células de roedores que expresaban las formas de CFTR mutantes no correspon...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>501</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>945</th>\n",
       "      <td>&lt;p class=\"MsoBodyText2\" style=\"margin-bottom:0in;line-height:normal\"&gt;&lt;span lang=\"ES\" style=\"font-size:11.0pt;color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>dd536eb3-194a-4461-a2ca-58561ea14015</td>\n",
       "      <td>margin-bottom:0in;line-height:normal</td>\n",
       "      <td>['MsoBodyText2']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>946</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Efectos farmacodinámicos&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>609b872f-7b8f-4f5b-bcd0-87bb1e10cf9b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Efectos farmacodinámicos</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>947</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a3b42306-9cc2-4726-a373-289590cbaa8b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>948</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;En los estudios 1 y 2 en pacientes con la mutación &lt;i&gt;G551D &lt;/i&gt;en un alelo del gen &lt;i&gt;CFTR&lt;/i&gt;, ivacaftor dio lugar a disminuci...</td>\n",
       "      <td>fb51bd98-c22d-4a79-a952-15ed13b3b66e</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En los estudios 1 y 2 en pacientes con la mutación G551D en un alelo del gen CFTR, ivacaftor dio lugar a disminuciones rápidas (15 días), sustanciales (el cambio medio del cloruro en el sudor desd...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>404</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>949</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>14eb61c3-60cc-44aa-938b-c3a7f1c29d1f</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>950</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En la parte 1 del estudio 5 en pacientes con una mutación de apertura del canal no &lt;i&gt;G551D&lt;/i&gt; en el gen &lt;i&gt;CFTR&lt;/i&gt;, el tratamiento con ivacaftor dio lugar a...</td>\n",
       "      <td>0c6ccc17-92a5-479b-9eab-7a0407daab2d</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En la parte 1 del estudio 5 en pacientes con una mutación de apertura del canal no G551D en el gen CFTR, el tratamiento con ivacaftor dio lugar a un cambio medio rápido (15 días) e importante desd...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>787</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>951</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>88545a76-b7f8-4b94-9056-ce93a86b2007</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>952</th>\n",
       "      <td>&lt;p class=\"documenttext\" style=\"margin-bottom:0in\"&gt;&lt;span lang=\"ES\"&gt;En el estudio 6, en pacientes de 6 años o mayores con FQ con una mutación &lt;i&gt;R117H&lt;/i&gt; en el gen &lt;i&gt;CFTR&lt;/i&gt;, la diferencia entre ...</td>\n",
       "      <td>ba16fe8b-6d35-4b32-a052-792f7484c035</td>\n",
       "      <td>margin-bottom:0in</td>\n",
       "      <td>['documenttext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En el estudio 6, en pacientes de 6 años o mayores con FQ con una mutación R117H en el gen CFTR, la diferencia entre tratamientos en el cambio medio del cloruro en el sudor desde el valor basal has...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>579</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>953</th>\n",
       "      <td>&lt;p class=\"documenttext\" style=\"margin-bottom:0in\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>76a598a6-f889-421f-ad46-9e32a264a094</td>\n",
       "      <td>margin-bottom:0in</td>\n",
       "      <td>['documenttext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>954</th>\n",
       "      <td>&lt;p class=\"documenttext\" style=\"margin-bottom:0in\"&gt;&lt;span lang=\"ES\"&gt;En el estudio 7 en pacientes de 2 a menos de 6 años con una mutación de apertura del canal en al menos un alelo del gen &lt;i&gt;CFTR&lt;/i...</td>\n",
       "      <td>4b1599cb-4ead-4f82-a204-9f11885c0c3b</td>\n",
       "      <td>margin-bottom:0in</td>\n",
       "      <td>['documenttext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En el estudio 7 en pacientes de 2 a menos de 6 años con una mutación de apertura del canal en al menos un alelo del gen CFTR que recibieron 50 mg o 75 mg de ivacaftor dos veces al día, el cambio a...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>313</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>955</th>\n",
       "      <td>&lt;p class=\"documenttext\" style=\"margin-bottom:0in\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>35d0443a-e95f-4709-8fbe-3df4babca865</td>\n",
       "      <td>margin-bottom:0in</td>\n",
       "      <td>['documenttext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>956</th>\n",
       "      <td>&lt;p class=\"documenttext\" style=\"margin-bottom:0in\"&gt;&lt;span lang=\"ES\"&gt;En el estudio 8 en pacientes con FQ menores de 24 meses, el cambio absoluto medio del cloruro en el sudor desde el valor basal fue...</td>\n",
       "      <td>2fb69da0-65a7-4a87-be6c-8b3cb522d273</td>\n",
       "      <td>margin-bottom:0in</td>\n",
       "      <td>['documenttext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En el estudio 8 en pacientes con FQ menores de 24 meses, el cambio absoluto medio del cloruro en el sudor desde el valor basal fue de –65,1 mmol/l (IC del 95 %: –74,1; –56,0) en la semana 24. Los ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>337</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>957</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>02b33290-1ded-4fc6-ac1c-14c259809b2d</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>958</th>\n",
       "      <td>&lt;p class=\"documenttext\" style=\"margin-bottom:0in;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Eficacia clínica y seguridad&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>af7a78bc-029b-4bb1-80df-cd8716e1861d</td>\n",
       "      <td>margin-bottom:0in;page-break-after:avoid</td>\n",
       "      <td>['documenttext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Eficacia clínica y seguridad</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>959</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>e1deb970-7d7c-405d-bd83-68471fa1fee9</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>960</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Estudios 1 y 2: estudios en pacientes con FQ con mutaciones de apertura del canal G551D&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>71e279f5-20b3-431d-a45c-993c44ebb974</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Estudios 1 y 2: estudios en pacientes con FQ con mutaciones de apertura del canal G551D</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>87</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>961</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>dc0215e0-8533-440b-ade1-7fb4491bc114</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>962</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Se ha evaluado la eficacia de ivacaftor en dos estudios de fase 3, aleatorizados, doble ciego, controlados con placebo, multicén...</td>\n",
       "      <td>597e04cd-b40f-4acd-8f95-af210fc76e3d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se ha evaluado la eficacia de ivacaftor en dos estudios de fase 3, aleatorizados, doble ciego, controlados con placebo, multicéntricos, de pacientes clínicamente estables con FQ que presentaban la...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>284</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>963</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cc31d358-ed4b-4997-ad1d-b0e0bfd1b444</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>964</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Los pacientes de ambos estudios fueron aleatorizados 1:1 a recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos grasos durante 48 semanas, además ...</td>\n",
       "      <td>cbcad490-6236-4ee8-b529-1cb7825aa6f4</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los pacientes de ambos estudios fueron aleatorizados 1:1 a recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos grasos durante 48 semanas, además de los tratamientos prescritos para l...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>306</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>965</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>649bdc07-a654-4f02-8965-7dcb82e75639</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>966</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;El estudio 1 evaluó a 161 pacientes de 12 años o mayores; 122 (75,8 %) pacientes presentaban la mutación &lt;i&gt;F508del&lt;/i&gt; en el segundo alelo. Al inicio del estu...</td>\n",
       "      <td>5838ffc3-727e-4be7-8510-9e97c5cf5997</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El estudio 1 evaluó a 161 pacientes de 12 años o mayores; 122 (75,8 %) pacientes presentaban la mutación F508del en el segundo alelo. Al inicio del estudio, los pacientes del grupo de placebo util...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>624</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>967</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2ef351b0-7bb2-47da-912f-c68d04f3df80</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>968</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;El estudio 2 evaluó a 52 pacientes de 6 a 11 años en el momento de la selección; el peso corporal medio (DE) era de 30,9 (8,63) kg; 42 (80,8 %) pacientes prese...</td>\n",
       "      <td>560f66a6-a49b-408c-aeeb-0e55a3e08eaf</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El estudio 2 evaluó a 52 pacientes de 6 a 11 años en el momento de la selección; el peso corporal medio (DE) era de 30,9 (8,63) kg; 42 (80,8 %) pacientes presentaban la mutación F508del en el segu...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>508</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>969</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3a4f47f3-3f42-4cb8-b3a3-5b5dd3a160ce</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>970</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;La variable principal de eficacia en ambos estudios fue el cambio absoluto medio desde el valor basal en el porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; hasta la sem...</td>\n",
       "      <td>1bc9c654-d233-4b91-af77-3f0288680715</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La variable principal de eficacia en ambos estudios fue el cambio absoluto medio desde el valor basal en el porcentaje predicho de VEF1 hasta la semana 24 de tratamiento.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>170</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>971</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9b8c1cfc-51e3-4f64-85dc-b7bcccdc4ea6</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>972</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; desde el valor...</td>\n",
       "      <td>d823c618-b14c-4900-92ae-452fb4102752</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF1 desde el valor basal hasta la semana 24 fue de 10,6 puntos por...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>905</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>973</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3ad75909-8901-4fa8-b0a8-05450d9a9c06</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>974</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; desde el valor...</td>\n",
       "      <td>774347b4-2c56-4eb9-a057-e400b11497d9</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF1 desde el valor basal hasta la semana 24 en pacientes de 12 a 1...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>564</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>975</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>aa40da48-d2e8-4769-b19e-d026fa987dbd</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>976</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Los resultados correspondientes a las variables secundarias clínicamente relevantes se muestran en la Tabla 4&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>57ec925c-92d1-49a5-b81c-0d7164945fdc</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los resultados correspondientes a las variables secundarias clínicamente relevantes se muestran en la Tabla 4</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>109</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>977</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>046f3fe3-b506-41de-b413-4b2998f7acbb</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>978</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 4: Efecto de ivacaftor en otras variables de eficacia en los estudios 1 y 2&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>e2feac31-7447-4bfd-81be-bcd382d11466</td>\n",
       "      <td>margin-bottom:6.0pt;page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 4: Efecto de ivacaftor en otras variables de eficacia en los estudios 1 y 2</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>81</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>979</th>\n",
       "      <td>&lt;table align=\"left\" border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none;margin-left:6.75pt;  margin-right:6.75pt\" width=\"98%\"&gt; &lt;thead&gt; &lt;tr...</td>\n",
       "      <td>cc77b262-528d-4480-b5fc-f06e661cf8f1</td>\n",
       "      <td>border-collapse:collapse;border:none;margin-left:6.75pt;\\n margin-right:6.75pt</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Estudio 1   Estudio 2     Variable   Diferencia del tratamientoa (IC del 95 %)   Valor p   Diferencia del tratamientoa (IC del 95 %)   Valor p      Cambio absoluto medio desde el   valor b...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>1127</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>980</th>\n",
       "      <td>&lt;p class=\"tablefootnote\" style=\"margin-top:6.0pt;page-break-after:avoid\"&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt;color:white\"&gt;IC: Intervalo de confianza; NA: no analizado debido a la baja incidenci...</td>\n",
       "      <td>3e7e5126-7f30-4eba-9a18-e97f47a8698c</td>\n",
       "      <td>margin-top:6.0pt;page-break-after:avoid</td>\n",
       "      <td>['tablefootnote']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>IC: Intervalo de confianza; NA: no analizado debido a la baja incidencia de acontecimientos.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>92</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>981</th>\n",
       "      <td>&lt;p class=\"tablefootnote\" style=\"page-break-after:avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;a&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;     Diferencia del tratamiento = efecto ...</td>\n",
       "      <td>8e78e887-05c3-4fc9-ac6b-d19f244140f4</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['tablefootnote']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>a     Diferencia del tratamiento = efecto de ivacaftor–efecto de placebo.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>69</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>982</th>\n",
       "      <td>&lt;p class=\"tablefootnote\" style=\"margin-left:14.2pt;text-indent:-14.2pt; page-break-after:avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;b&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt; ...</td>\n",
       "      <td>0cab584f-c711-4eb7-ac62-ce0742ae4913</td>\n",
       "      <td>margin-left:14.2pt;text-indent:-14.2pt;\\npage-break-after:avoid</td>\n",
       "      <td>['tablefootnote']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>b     CFQ-R: El cuestionario revisado de la calidad de vida para fibrosis quística es una determinación de la calidad de vida relacionada con la salud, específica a la enfermedad, para la FQ.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>187</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>983</th>\n",
       "      <td>&lt;p class=\"tablefootnote\" style=\"margin-left:14.2pt;text-indent:-14.2pt; page-break-after:avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;c&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt; ...</td>\n",
       "      <td>172a2b9f-a2ce-49bf-af53-7642a58c8b17</td>\n",
       "      <td>margin-left:14.2pt;text-indent:-14.2pt;\\npage-break-after:avoid</td>\n",
       "      <td>['tablefootnote']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>c     Los datos del estudio 1 fueron agrupados a partir del CFQ-R para adultos/adolescentes y del CFQ‑R para niños de 12 a 13 años; los datos del estudio 2 se obtuvieron a partir del CFQ-R para ni...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>211</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>984</th>\n",
       "      <td>&lt;p class=\"tablefootnotelast\" style=\"margin-bottom:0in;page-break-after:avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;d        &lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;Proporción ...</td>\n",
       "      <td>6ff04d1d-0ca8-48bf-9861-564e173cf4bf</td>\n",
       "      <td>margin-bottom:0in;page-break-after:avoid</td>\n",
       "      <td>['tablefootnotelast']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>d        Proporción de riesgo del tiempo hasta la primera exacerbación pulmonar.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>73</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>985</th>\n",
       "      <td>&lt;p class=\"tablefootnotelast\" style=\"margin-bottom:0in\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;e&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;     En sujetos menores de 20 años (gráfic...</td>\n",
       "      <td>63aee60b-a3dd-4436-ba1c-de84a46b1fca</td>\n",
       "      <td>margin-bottom:0in</td>\n",
       "      <td>['tablefootnotelast']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>e     En sujetos menores de 20 años (gráficos de crecimiento del CDC).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>66</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>986</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;s&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/s&gt;&lt;/p&gt;</td>\n",
       "      <td>ec8bf870-ef73-41bb-b14b-a514ae8ab83a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>987</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Estudio 5: estudio en pacientes con FQ con mutaciones de apertura del canal no G551D&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>ef9ff58c-6174-42f1-8642-e3d227c112dc</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Estudio 5: estudio en pacientes con FQ con mutaciones de apertura del canal no G551D</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>84</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>988</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>73b707c8-4f9a-4270-a0a1-c416db883b22</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>989</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;El estudio 5 fue un estudio de fase 3, de dos partes, aleatorizado, doble ciego, controlado con placebo y cruzado (parte 1)...</td>\n",
       "      <td>d7f04229-ba0c-42ee-b285-e84deac26d59</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El estudio 5 fue un estudio de fase 3, de dos partes, aleatorizado, doble ciego, controlado con placebo y cruzado (parte 1) seguido de un periodo de extensión abierta de 16 semanas de duración (pa...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>439</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>990</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;s&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/s&gt;&lt;/p&gt;</td>\n",
       "      <td>2223d5a5-ca79-4c2a-bf34-0b3f8f26a8e2</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>991</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;En la parte 1, los pacientes fueron aleatorizados 1:1 para recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos que contenían grasas durante 8 sem...</td>\n",
       "      <td>9c66f6fc-d806-409d-b8b0-6b1ab9fc7745</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En la parte 1, los pacientes fueron aleatorizados 1:1 para recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos que contenían grasas durante 8 semanas además de los tratamientos presc...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>810</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>992</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7e118ee8-4eb9-441f-bedd-32aaddb259e9</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>993</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;Se incluyó en el estudio a 39 pacientes (edad media: 23 años) con un &lt;/span&gt;&lt;span lang=\"ES\"&gt;porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; basal ≥40 % (porcentaje pred...</td>\n",
       "      <td>42e8c55a-2b0a-4ef8-a975-f4076b72f607</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se incluyó en el estudio a 39 pacientes (edad media: 23 años) con un porcentaje predicho de VEF1 basal ≥40 % (porcentaje predicho medio de VEF1 del 78 % [intervalo: 43 % a 119 %]). Un 62 % (24/39)...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>367</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>994</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0f0b8094-336d-4e61-91b3-992aceeef909</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>995</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En la parte 1 del estudio 5, el porcentaje predicho medio de VEF&lt;sub&gt;1&lt;/sub&gt; &lt;/span&gt;&lt;span lang=\"ES\"&gt;basal en los pacientes tratados con placebo fue del 79,3 % ...</td>\n",
       "      <td>84a48635-25b5-4a35-8c43-9acb3642b7a5</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En la parte 1 del estudio 5, el porcentaje predicho medio de VEF1 basal en los pacientes tratados con placebo fue del 79,3 % mientras que en los pacientes tratados con ivacaftor este valor fue del...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>610</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>996</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c7724ffd-bee6-4402-a94a-e33b528d807c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>997</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;El efecto de ivacaftor en la población global del estudio 5 (incluidas las variables secundarias del cambio absoluto en el IMC a las 8 semanas de tratamiento y...</td>\n",
       "      <td>d40570e8-6f60-4a0b-ac14-78d2a6694772</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El efecto de ivacaftor en la población global del estudio 5 (incluidas las variables secundarias del cambio absoluto en el IMC a las 8 semanas de tratamiento y el cambio absoluto en la puntuación ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>641</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>998</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>42842aae-510a-4ecb-b124-b38bf2c847b5</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>999</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:6.0pt; margin-left:45.0pt;text-indent:-45.0pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 5: Efecto de ivacaftor para...</td>\n",
       "      <td>dcffc844-cc53-4a2d-8bc5-0d5fb6dbb417</td>\n",
       "      <td>margin-top:0in;margin-right:0in;margin-bottom:6.0pt;\\nmargin-left:45.0pt;text-indent:-45.0pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 5: Efecto de ivacaftor para las variables de eficacia en la población global y para las mutaciones específicas en el gen CFTR</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>131</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1000</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:479.1pt;border-collapse:collapse;border:none\" width=\"639\"&gt; &lt;tr&gt; &lt;td colspan=\"2\" style=\"width:159.7pt;border:so...</td>\n",
       "      <td>3490535e-9d48-42c1-95e8-a22e1568da99</td>\n",
       "      <td>width:479.1pt;border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cambio absoluto en el porcentaje predicho de VEF1   IMC (kg/m2)   Puntuación (puntos) en el CFQ-R   dominio respiratorio     hasta la semana 8   a la semana 8   hasta la semana 8     Todos los ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>1058</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1001</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:13.6pt;margin-bottom:.0001pt;text-indent:-13.6pt;page-break-after: avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"f...</td>\n",
       "      <td>3bc716a0-3290-4a1f-a326-9fbc17d57e0e</td>\n",
       "      <td>margin-top:6.0pt;margin-right:0in;margin-bottom:0in;\\nmargin-left:13.6pt;margin-bottom:.0001pt;text-indent:-13.6pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>*     No se realizaron análisis estadísticos debido al pequeño número de mutaciones concretas.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>90</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1002</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:13.5pt;text-indent:-13.5pt;page-break-after: avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;†&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;     ...</td>\n",
       "      <td>154190ae-7eca-4653-939e-b69efe9e222e</td>\n",
       "      <td>margin-left:13.5pt;text-indent:-13.5pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>†     Refleja los resultados de un paciente con la mutación G551S con datos en el punto temporal de las 8 semanas.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>110</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1003</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:13.6pt;text-indent:-13.6pt;page-break-after: avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;††&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;   n...</td>\n",
       "      <td>44f666b9-8f2e-44a9-a519-b4d00fe2f516</td>\n",
       "      <td>margin-left:13.6pt;text-indent:-13.6pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>††   n = 3 para el análisis del cambio absoluto en el cloruro en el sudor.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>72</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1004</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:13.6pt;text-indent:-13.6pt\"&gt;&lt;i&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;#&lt;/span&gt;&lt;/sup&gt;&lt;/i&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;     &lt;/span&gt;&lt;span lang...</td>\n",
       "      <td>0cf94c1f-b277-4421-8c5c-69bf8d3d251e</td>\n",
       "      <td>margin-left:13.6pt;text-indent:-13.6pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>#     Causa un defecto de empalme que da lugar a un nivel bajo o nulo de proteína CFTR en la superficie celular.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>108</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1005</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4b0e6191-4216-47a2-9380-336a74d5c940</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1006</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En la parte 2 del estudio 5&lt;/span&gt;&lt;span lang=\"ES\"&gt;, el cambio absoluto medio (DE) en &lt;/span&gt;&lt;span lang=\"ES\"&gt;el porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; &lt;/span&gt;&lt;s...</td>\n",
       "      <td>43147c40-fdc8-40af-b776-b15b26271e7f</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En la parte 2 del estudio 5, el cambio absoluto medio (DE) en el porcentaje predicho de VEF1 tras 16 semanas (pacientes aleatorizados a la secuencia de tratamiento ivacaftor/placebo en la parte 1)...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>936</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1007</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>cf6c3a38-dca0-4b5c-b3eb-a9ce8042e36b</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1008</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Estudio 3: estudio en pacientes con FQ con la mutación F508del en el gen CFTR&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>36a56359-6f93-4f73-945e-f9a7d19b0243</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Estudio 3: estudio en pacientes con FQ con la mutación F508del en el gen CFTR</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>77</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1009</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>840c1ae0-3b25-445b-b195-99e69c28d18e</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1010</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;El estudio 3 (parte A) fue un estudio de fase 2, de grupos paralelos, controlado con placebo, doble ciego, aleatorizado 4:1...</td>\n",
       "      <td>23b374a2-ad30-4c9b-bb83-fbaf56b7a41d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El estudio 3 (parte A) fue un estudio de fase 2, de grupos paralelos, controlado con placebo, doble ciego, aleatorizado 4:1, de 16 semanas de duración, en el que se administró ivacaftor (150 mg ca...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>347</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1011</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>669848d0-65a4-49a0-9049-296f87a63ee3</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1012</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;El cambio absoluto medio desde el valor basal hasta la semana 16 en el porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; (variable principal de eficacia) fue de 1,5 punto...</td>\n",
       "      <td>b13741f2-57bc-4067-bf05-ffc03d479b0f</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El cambio absoluto medio desde el valor basal hasta la semana 16 en el porcentaje predicho de VEF1 (variable principal de eficacia) fue de 1,5 puntos porcentuales en el grupo de ivacaftor y de −0,...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>435</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1013</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fc33af57-6936-4302-b5c2-926407909d54</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1014</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Estudio 4: estudio de extensión abierta&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>e0f0a840-a74b-4545-8215-a6e8044d752e</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Estudio 4: estudio de extensión abierta</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1015</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2d7e2e73-d1ed-42dc-9cdf-13b4a747d959</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1016</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\" style=\"color:black\"&gt;En el estudio 4, los pacientes que completaron el tratamiento en los estudios 1 y 2 con placebo pasaron...</td>\n",
       "      <td>85509d0a-59b5-43d9-a23b-4542fa8699fd</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En el estudio 4, los pacientes que completaron el tratamiento en los estudios 1 y 2 con placebo pasaron al tratamiento con ivacaftor mientras que los pacientes tratados con ivacaftor continuaron r...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>462</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1017</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5810b860-2d2c-43ed-8d49-8e9d5bff35ff</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1018</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;Ciento cuarenta y cuatro (144) pacientes del estudio 1 pasaron al estudio 4, 67 del grupo de placebo/ivacaftor y 77 del grupo de ivacaftor/...</td>\n",
       "      <td>69d8221c-3103-45ef-bb75-0393c793aef3</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ciento cuarenta y cuatro (144) pacientes del estudio 1 pasaron al estudio 4, 67 del grupo de placebo/ivacaftor y 77 del grupo de ivacaftor/ivacaftor. Cuarenta y ocho (48) pacientes del estudio 2 p...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>289</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1019</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>36c72528-d953-4a27-aa01-997ee14893f3</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1020</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;La Tabla 6 muestra los resultados del cambio absoluto medio (DE) en el porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; para ambos grupos de paciente...</td>\n",
       "      <td>0becfcc8-d480-4025-8015-37530fdf9c38</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La Tabla 6 muestra los resultados del cambio absoluto medio (DE) en el porcentaje predicho de VEF1 para ambos grupos de pacientes. Para los pacientes del grupo de placebo/ivacaftor el porcentaje p...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>347</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1021</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>66975fc9-a643-4cfd-839d-fc02ebaf4718</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1022</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 6: Efecto de ivacaftor &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;en el porcentaje predicho ...</td>\n",
       "      <td>b34fe2fb-2355-4519-bdb4-219f15b407e8</td>\n",
       "      <td>margin-bottom:6.0pt;page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 6: Efecto de ivacaftor en el porcentaje predicho de VEF1 en el estudio 4</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>78</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1023</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\"&gt; &lt;tr&gt; &lt;td rowspan=\"2\" style=\"width:99.3pt;border:solid windowtext 1.0pt;   pad...</td>\n",
       "      <td>a12b9a35-fcf0-411e-b7d8-0a87178064bf</td>\n",
       "      <td>border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Estudio   original y grupo de tratamiento   Duración   del tratamiento con ivacaftor (semanas)   Cambio absoluto en el porcentaje predicho de VEF1 desde el valor basal (puntos porcentuales)    ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>396</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1024</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after: avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\"&gt;*&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\"&gt;    &lt;/span&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;El...</td>\n",
       "      <td>76adab62-1c5c-4868-a2c8-9b0460f731d7</td>\n",
       "      <td>margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>*    El tratamiento se administró durante el estudio de fase 3, doble ciego, controlado y de 48 semanas de duración.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>113</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1025</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:8.0pt;position:relative; top:-3.0pt\"&gt;†&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\"&gt;    &lt;/span&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt\"&gt;Cambio desde el val...</td>\n",
       "      <td>c6b59fe1-2db2-4da4-b11e-552aa3d4dc0b</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>†    Cambio desde el valor basal del estudio previo después de 48 semanas de tratamiento con placebo.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>98</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1026</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5e86ef36-275f-46de-86cc-328a6f5a7f05</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1027</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;Cuando se compara el cambio absoluto medio (DE) en el porcentaje predicho de VEF&lt;sub&gt;1&lt;/sub&gt; desde el valor basal del estudio 4 para los pa...</td>\n",
       "      <td>05012b83-46cd-422d-a439-0ec325c08a75</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Cuando se compara el cambio absoluto medio (DE) en el porcentaje predicho de VEF1 desde el valor basal del estudio 4 para los pacientes del grupo de ivacaftor/ivacaftor (n = 72) que pasaron del es...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>718</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1028</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9b685be9-2739-47e5-8be1-4952350918f0</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1029</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;Para los pacientes del grupo de placebo/ivacaftor del estudio 1, la tasa anualizada de exacerbaciones pulmonares fue más alta en el estudio...</td>\n",
       "      <td>0375f746-e768-4aa7-a28e-806c0e8ce412</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Para los pacientes del grupo de placebo/ivacaftor del estudio 1, la tasa anualizada de exacerbaciones pulmonares fue más alta en el estudio inicial cuando los pacientes recibían placebo (1,34 acon...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>858</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1030</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>159643d5-1564-4382-86f1-d43fdfd79e58</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1031</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;Para los pacientes que pasaron del estudio 2, el número de acontecimientos fue, en general, bajo.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>87d1f661-c88b-453d-90a5-8654ce87ee7c</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Para los pacientes que pasaron del estudio 2, el número de acontecimientos fue, en general, bajo.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>97</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1032</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>281e7d61-90a2-46d8-aae6-709db096b0e7</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1033</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Estudio 6: estudio en pacientes con FQ con una mutación R117H en el gen CFTR&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>edf5e5eb-5c73-4a7d-8030-6156180514e6</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Estudio 6: estudio en pacientes con FQ con una mutación R117H en el gen CFTR</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>76</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1034</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>45bc7dff-799f-475b-8a6d-060048c90835</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1035</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;En el estudio 6 se evaluaron 69 pacientes de 6 años o mayores; 53 (76,8 %) pacientes tenían la mutación &lt;i&gt;F508del&lt;/i&gt; en el seg...</td>\n",
       "      <td>6b0e39ea-3fb1-40d0-8032-4272d51742d3</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En el estudio 6 se evaluaron 69 pacientes de 6 años o mayores; 53 (76,8 %) pacientes tenían la mutación F508del en el segundo alelo. La variante poli-T de R117H confirmada fue 5T en 38 pacientes y...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>737</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1036</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>95fa3d5c-b602-4fd9-a656-d32ed4e7280d</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1037</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Se realizó un análisis de subgrupos previamente planificado en pacientes de 18 años o mayores (26 pacientes con placebo y 24 con ivacaftor). El tratamiento con...</td>\n",
       "      <td>86886682-436c-4ce6-9312-970cfb3b2607</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se realizó un análisis de subgrupos previamente planificado en pacientes de 18 años o mayores (26 pacientes con placebo y 24 con ivacaftor). El tratamiento con ivacaftor produjo un cambio absoluto...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>493</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1038</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3247b6ef-d52a-4003-89c2-63952127ef49</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1039</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En un análisis de subgrupos en pacientes &lt;/span&gt;&lt;span lang=\"ES\"&gt;con una variante genética &lt;i&gt;R117H-5T &lt;/i&gt;confirmada, la diferencia en el cambio absoluto medio...</td>\n",
       "      <td>e27f2788-0bcd-4777-8d2f-a22860731954</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En un análisis de subgrupos en pacientes con una variante genética R117H-5T confirmada, la diferencia en el cambio absoluto medio desde el valor basal hasta la semana 24 en el porcentaje predicho ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>452</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1040</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cf34192c-6552-4601-9441-0b2db9f0ae80</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1041</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Para las variables secundarias de eficacia, no se observaron diferencias del tratamiento para ivacaftor frente a placebo en el cambio absoluto desde el valor b...</td>\n",
       "      <td>d1aff4d0-a9d6-424a-8745-228363c7d51b</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Para las variables secundarias de eficacia, no se observaron diferencias del tratamiento para ivacaftor frente a placebo en el cambio absoluto desde el valor basal en el IMC en la semana 24 ni en ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>598</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1042</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5122f4fd-7b18-4bc4-bd81-5301c0f6d460</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1043</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Estudio 7: estudio en pacientes pediátricos con FQ de 2 a menos de 6 años con la mutación G551D u otra mutación de apertura d...</td>\n",
       "      <td>2c133f56-0ac5-4cda-af1d-8e322413ee1c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Estudio 7: estudio en pacientes pediátricos con FQ de 2 a menos de 6 años con la mutación G551D u otra mutación de apertura del canal</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>133</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1044</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>77c035cd-4cb2-472c-92b4-86a7ed0aef8a</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1045</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;En un estudio no controlado de 24 semanas de duración con ivacaftor (los pacientes con un peso inferior a 14 kg recibieron ...</td>\n",
       "      <td>f42cfa8e-3337-40e0-87fa-a8b76594f031</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En un estudio no controlado de 24 semanas de duración con ivacaftor (los pacientes con un peso inferior a 14 kg recibieron 50 mg de ivacaftor y los pacientes con un peso de 14 kg o más recibieron ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>578</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1046</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fde4859d-aceb-4baf-a238-e8feb3b939ed</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1047</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Los pacientes del estudio 7 tenían de 2 a menos de 6 años (edad media: 3 años). De los 34 pacientes incluidos, 26 pacientes (76,5 %) tenían un genotipo &lt;i&gt;G551...</td>\n",
       "      <td>9196ec6c-f826-4f4c-be54-f703bdec721e</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los pacientes del estudio 7 tenían de 2 a menos de 6 años (edad media: 3 años). De los 34 pacientes incluidos, 26 pacientes (76,5 %) tenían un genotipo G551D/F508del del gen CFTR y solo 2 paciente...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>402</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1048</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c78450bf-12c2-407b-93ed-9837238b1285</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1049</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Se evaluó &lt;/span&gt;&lt;span lang=\"ES\"&gt;la variable &lt;/span&gt;&lt;span lang=\"ES\"&gt;principal de seguridad hasta la semana&lt;/span&gt;&lt;span lang=\"ES\"&gt; 24 (ver sección 4.8). Las var...</td>\n",
       "      <td>e567276a-967b-40f9-8853-f10a9c962607</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se evaluó la variable principal de seguridad hasta la semana 24 (ver sección 4.8). Las variables secundarias y exploratorias de eficacia evaluadas fueron el cambio absoluto desde el valor basal en...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>677</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1050</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>06400f1b-8f35-4f13-9f3d-f5c41080f53c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1051</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;El cambio absoluto &lt;/span&gt;&lt;span lang=\"ES\"&gt;medio (DE) &lt;/span&gt;&lt;span lang=\"ES\"&gt;global (los dos grupos de ivacaftor combinados) desde el valor basal en el IMC en l...</td>\n",
       "      <td>b6bb7395-e3ea-4ea3-a4c3-22b7d207d436</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El cambio absoluto medio (DE) global (los dos grupos de ivacaftor combinados) desde el valor basal en el IMC en la semana 24 fue de 0,32 kg/m2 (0,54) y el cambio medio (DE) global en la puntuación...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>688</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1052</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cbd28795-9584-4035-83df-b2f6f3fb3b4c</td>\n",
       "      <td>text-align:justify;text-justify:inter-ideograph</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1053</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES-TRAD\"&gt;Estudio 8: estudio en pacientes pediátricos con FQ menores de 24 meses&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>68515851-e285-4f8f-acd0-eb0026a4471c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Estudio 8: estudio en pacientes pediátricos con FQ menores de 24 meses</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>70</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1054</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5e78f462-14da-4fb1-a043-a05b247d5517</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1055</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Se evaluaron e&lt;/span&gt;&lt;span lang=\"ES\"&gt;l perfil farmacocinético, la seguridad y la eficacia de ivacaftor en pacientes con FQ de 6 ...</td>\n",
       "      <td>5b480373-a185-4412-8885-55415cbcdd36</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se evaluaron el perfil farmacocinético, la seguridad y la eficacia de ivacaftor en pacientes con FQ de 6 meses a menos de 24 meses en una cohorte completa de pacientes en un estudio clínico de fas...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>292</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1056</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>791b71c9-5faa-42e0-8960-9697e997926a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1057</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En la parte B del estudio 8 fueron incluidos 19 pacientes de 12 meses a menos de 24 meses (edad media de 15,2 meses al inicio), de los cuales 18 pacientes comp...</td>\n",
       "      <td>57914a1b-818e-4ab0-becd-2288acfeebea</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En la parte B del estudio 8 fueron incluidos 19 pacientes de 12 meses a menos de 24 meses (edad media de 15,2 meses al inicio), de los cuales 18 pacientes completaron el periodo de tratamiento de ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>833</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1058</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3199cb29-2f4e-44d1-9634-fa387b201009</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1059</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;En la parte B del estudio 8 se evaluó la variable principal de seguridad durante las 24 semanas (ver sección 4.8). Las variables secundarias fueron la evaluaci...</td>\n",
       "      <td>e5c9f8ff-4140-4c9b-9034-a85497b16a01</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En la parte B del estudio 8 se evaluó la variable principal de seguridad durante las 24 semanas (ver sección 4.8). Las variables secundarias fueron la evaluación de la farmacocinética y el cambio ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>435</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1060</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>15902a9d-9bd9-4bad-b1e8-94a672c57e48</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1061</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;Para los pacientes de 4 meses a menos de 24 meses, con valores iniciales y de la semana 24 disponibles, se proporcionan en ...</td>\n",
       "      <td>a98f5cd9-20c4-4c0c-beca-eef39286422d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Para los pacientes de 4 meses a menos de 24 meses, con valores iniciales y de la semana 24 disponibles, se proporcionan en la Tabla 7 las puntuaciones z medias (DE) del peso ajustado a la edad, de...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>262</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1062</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>bbcf9d02-e4a5-45f4-ab3c-bd5a00530793</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1063</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:6.0pt; margin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 7: Efecto de ivacaftor en...</td>\n",
       "      <td>8617ecb7-1dc9-49e0-b269-4c46eaebb4b1</td>\n",
       "      <td>margin-top:0in;margin-right:0in;margin-bottom:6.0pt;\\nmargin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 7: Efecto de ivacaftor en los parámetros de crecimiento en pacientes de 4 meses a menos de 24 meses con valores iniciales y de la semana 24</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>145</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1064</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"TableGrid1\" style=\"border-collapse:collapse;border:none\" width=\"601\"&gt; &lt;tr&gt; &lt;td rowspan=\"2\" style=\"width:126.9pt;border:solid windowtext 1.0...</td>\n",
       "      <td>c950d40a-2330-421c-9a64-d2edb1843ffa</td>\n",
       "      <td>border-collapse:collapse;border:none</td>\n",
       "      <td>['TableGrid1']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Parámetro   Número de pacientes   Inicio     Cambio absoluto   en la semana 24     Media (DE)   Mediana (mín, máx)   Media (DE)   Mediana (mín, máx)</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>129</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1065</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"601\"&gt; &lt;tr&gt; &lt;td style=\"width:126.9pt;border:solid windowtext 1.0pt;   pa...</td>\n",
       "      <td>61f09fa4-dd25-4bab-94a6-d06b69767890</td>\n",
       "      <td>border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Puntuación z   del peso ajustado a la edad   35   0,17 (0,85)   0,20 [−1,92; 1,79]   0,33 (0,53)   0,26 [−0,54; 1,63]</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>106</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1066</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"TableGrid1\" style=\"border-collapse:collapse;border:none\" width=\"601\"&gt; &lt;tr&gt; &lt;td style=\"width:126.9pt;border:solid windowtext 1.0pt;   paddin...</td>\n",
       "      <td>25b57ae9-8c89-45a7-9da8-75a84f2b5895</td>\n",
       "      <td>border-collapse:collapse;border:none</td>\n",
       "      <td>['TableGrid1']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Puntuación z de la estatura ajustada a la   edad   34   0,06 (1,03)    0,12 [−1,99; 2,79]   0,32 (0,92)   0,47 [−1,81; 3,38]     Puntuación   z del peso ajustado a la estatura   34   0,24 (1,01...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>222</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1067</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>20be1b10-30ba-40d6-a024-d421d6c37610</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1068</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:13.0pt\"&gt;&lt;span lang=\"ES\"&gt;En los pacientes de 4 meses a menos de 24 meses, con valores iniciales y de la semana 24 disponibles, había 18 pacientes con insufic...</td>\n",
       "      <td>e7adf9a8-f848-4df7-8d43-75f9743e3647</td>\n",
       "      <td>line-height:13.0pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En los pacientes de 4 meses a menos de 24 meses, con valores iniciales y de la semana 24 disponibles, había 18 pacientes con insuficiencia pancreática al inicio (definida como valores de elastasa‑...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>543</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1069</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5bca2c67-4c0b-4c3e-b51d-81f995aa14aa</td>\n",
       "      <td>text-align:justify;text-justify:inter-ideograph</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1070</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Población pediátrica&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>32400e93-ead8-4599-8c74-e00f5061ae63</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Población pediátrica</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1071</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7c35c2af-b562-4626-bcb9-7122e3735b87</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1072</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;La Agencia Europea de Medicamentos ha concedido al titular un aplazamiento para presentar los resultados de los ensayos realizados con Kalydeco en uno o más gr...</td>\n",
       "      <td>6223d11b-e3b9-400f-a8ff-ea43e08fba2d</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La Agencia Europea de Medicamentos ha concedido al titular un aplazamiento para presentar los resultados de los ensayos realizados con Kalydeco en uno o más grupos de la población pediátrica en la...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>303</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1073</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-right:-.1pt\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ec6f09e7-827a-483b-a466-213a380264dd</td>\n",
       "      <td>margin-right:-.1pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1074</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;5.2     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Propiedades farmacocinéticas&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>2935ba0d-7080-43f5-8569-165af78c24e0</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>5.2     Propiedades farmacocinéticas</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>32</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1075</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>92d627d8-9c75-489f-8e96-b460aae802b8</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1076</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;La farmacocinética de ivacaftor es similar entre los voluntarios adultos sanos y los pacientes con FQ.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2fdf117f-29d2-4979-baa0-00961a896142</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La farmacocinética de ivacaftor es similar entre los voluntarios adultos sanos y los pacientes con FQ.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>102</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1077</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>36739d36-88d2-4de7-b470-9294b9f0948d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1078</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-right:-.1pt\"&gt;&lt;span lang=\"ES\"&gt;Después de la administración oral de una dosis única de 150 mg a voluntarios sanos con el estómago lleno, la media (± DE) para el AU...</td>\n",
       "      <td>5f547522-175d-498a-a093-9436d105c3f7</td>\n",
       "      <td>margin-right:-.1pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Después de la administración oral de una dosis única de 150 mg a voluntarios sanos con el estómago lleno, la media (± DE) para el AUC y la Cmáx fue de 10 600 (5260) ng*h/ml y de 768 (233) ng/ml, r...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>411</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1079</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-right:-.1pt\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5c541bfc-bff1-4ffc-b522-82e35a15eda9</td>\n",
       "      <td>margin-right:-.1pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1080</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;u&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt;Absorción&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>aed283a5-6550-47f6-862b-582b96895c57</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Absorción</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1081</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cce1d3d7-3450-4437-a5e0-5d142ece4bd0</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1082</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Después de la administración oral de dosis múltiples de ivacaftor, la exposición a ivacaftor aumentó por lo general con la dosis...</td>\n",
       "      <td>1d83389a-818f-4a82-acee-698f77431910</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Después de la administración oral de dosis múltiples de ivacaftor, la exposición a ivacaftor aumentó por lo general con la dosis, de 25 mg cada 12 horas a 450 mg cada 12 horas. Cuando se administr...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>474</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1083</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>422ab9ec-fabc-4d16-b706-fbd4e0e9cf39</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1084</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;El granulado de ivacaftor (2 sobres de 75 mg) presentó una biodisponibilidad similar a la de los comprimidos de 150 mg cuando se administraron con alimentos qu...</td>\n",
       "      <td>919204c3-d88d-4595-8562-5feab23acb60</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El granulado de ivacaftor (2 sobres de 75 mg) presentó una biodisponibilidad similar a la de los comprimidos de 150 mg cuando se administraron con alimentos que contenían grasas a sujetos adultos ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>530</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1085</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-right:-.1pt\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>5db1294b-cef6-4d09-a408-0db0e14dad8a</td>\n",
       "      <td>margin-right:-.1pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1086</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-right:-.1pt;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Distribución&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>36b89e3d-e880-4bf3-ae7d-3bcdb74e9c29</td>\n",
       "      <td>margin-right:-.1pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Distribución</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1087</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c14e98a3-ddd4-42ed-b7da-3d4423e6d164</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1088</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Aproximadamente el 99 % de ivacaftor se fija a las proteínas plasmáticas, principalmente a la alfa-1 glicoproteína ácida y a la ...</td>\n",
       "      <td>195db189-fc7a-490d-9dae-e7887974fac1</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Aproximadamente el 99 % de ivacaftor se fija a las proteínas plasmáticas, principalmente a la alfa-1 glicoproteína ácida y a la albúmina. Ivacaftor no se fija a los eritrocitos humanos. Después de...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>383</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1089</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f9baf936-2923-4a3f-b8f6-1d6fe057c7f0</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1090</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Biotransformación&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>2e4e2aed-8faa-4eba-9edd-7a9a6cf82155</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Biotransformación</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1091</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>98484464-b6d0-479a-8d8f-3c9f709fa660</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1092</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Ivacaftor se metaboliza extensamente en humanos. Los datos &lt;i&gt;in vitro&lt;/i&gt; e &lt;i&gt;in vivo&lt;/i&gt; indican que ivacaftor se metaboliza ...</td>\n",
       "      <td>9b3620c9-44aa-4ae5-bb86-4c67e1526ecb</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor se metaboliza extensamente en humanos. Los datos in vitro e in vivo indican que ivacaftor se metaboliza principalmente por CYP3A. El M1 y el M6 son los dos metabolitos principales de iva...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>437</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1093</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>00cd6044-f798-4ac9-8eed-9fb59295256c</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1094</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES-TRAD\"&gt;El efecto del genotipo heterocigótico de CYP3A4*22 en la exposición a &lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt;ivacaftor &lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt;es coherente con e...</td>\n",
       "      <td>e3cfb0c5-4876-4cd2-aacc-ecbd9c0a2735</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El efecto del genotipo heterocigótico de CYP3A4*22 en la exposición a ivacaftor es coherente con el efecto de la administración junto con un inhibidor débil de CYP3A4, lo que no tiene relevancia c...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>416</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1095</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-right:-.1pt\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>6ce263e3-be3c-466c-bdb2-f8c29c16b1ee</td>\n",
       "      <td>margin-right:-.1pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1096</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-right:-.1pt;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Eliminación&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>83768da5-637e-45e1-9fff-2d960521b588</td>\n",
       "      <td>margin-right:-.1pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Eliminación</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1097</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>67c68874-25cc-47da-82fa-02c24c468df7</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1098</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Tras la administración oral en voluntarios sanos, la mayor parte de ivacaftor (87,8 %) fue eliminada en las heces después de la ...</td>\n",
       "      <td>505b8c60-826c-4585-bf98-c17873a2885c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tras la administración oral en voluntarios sanos, la mayor parte de ivacaftor (87,8 %) fue eliminada en las heces después de la conversión metabólica. Los metabolitos principales M1 y M6 represent...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>702</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1099</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>523e40f6-aec5-4464-9474-582a2d8e52ba</td>\n",
       "      <td>text-align:justify;text-justify:inter-ideograph</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1100</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Linealidad/No linealidad&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>7feb3184-5e8d-4688-ac95-8e01ee263c79</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Linealidad/No linealidad</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1101</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>de6cde47-1ba1-4ce5-ad37-821e9870a59a</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1102</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;La farmacocinética de ivacaftor es en general lineal con respecto al tiempo o al intervalo de dosis de 25 mg a 250 mg.&lt;/spa...</td>\n",
       "      <td>90e42c00-050d-429a-a678-df28b59d4018</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La farmacocinética de ivacaftor es en general lineal con respecto al tiempo o al intervalo de dosis de 25 mg a 250 mg.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1103</th>\n",
       "      <td>&lt;p class=\"labeltextheading\" style=\"page-break-after:auto\"&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>318bcf35-431e-4558-80d8-7deaac88812b</td>\n",
       "      <td>page-break-after:auto</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1104</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;u&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt;Poblaciones especiales&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>91a8584c-e824-4cdb-a40b-0783035ce81e</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Poblaciones especiales</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1105</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;span lang=\"ES\" style=\"font-style:normal\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ce257cc6-4cd0-48fa-9544-0ff559bdb07d</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1106</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Insuficiencia hepática&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>3aabb0c4-9744-47fa-b8c8-eb36f0f1b401</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Insuficiencia hepática</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1107</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>aae2a25f-ff0f-4ed6-94a9-65a0e2021b73</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1108</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Tras una sola dosis de 150 mg de ivacaftor, los sujetos adultos con insuficiencia hepática moderada (Child‑Pugh Clase B, puntuac...</td>\n",
       "      <td>0e176fb3-e97f-457a-ac7d-52406ba2cc62</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tras una sola dosis de 150 mg de ivacaftor, los sujetos adultos con insuficiencia hepática moderada (Child‑Pugh Clase B, puntuación 7 a 9) presentaron una Cmáx de ivacaftor similar (media [± DE] d...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>934</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1109</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3769aeb8-88f0-4cb8-95fe-7871f8b6a9e3</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1110</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;No se ha estudiado el impacto de la insuficiencia hepática grave (Child-Pugh Clase C, puntuación 10 a 15) en la farmacocinética de ivacaftor. Se desconoce la m...</td>\n",
       "      <td>66426472-c957-4dbf-8bec-13dafdf3c150</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se ha estudiado el impacto de la insuficiencia hepática grave (Child-Pugh Clase C, puntuación 10 a 15) en la farmacocinética de ivacaftor. Se desconoce la magnitud del aumento de la exposición ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>502</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1111</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>daac92cf-1f53-4375-adda-93653a0f4204</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1112</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;No se considera necesario ajustar la dosis en pacientes con insuficiencia hepática leve.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0543687b-d522-432d-99eb-e21cac7e6385</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se considera necesario ajustar la dosis en pacientes con insuficiencia hepática leve.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>88</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1113</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1b066af7-33dc-4e36-ab5a-9e3e248ef0a9</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1114</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Insuficiencia renal&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>b426e585-1400-4569-b7d5-8e38e3420667</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Insuficiencia renal</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1115</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>24eb3532-9514-465d-abe6-98144188a36b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1116</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;No se han realizado estudios farmacocinéticos con ivacaftor en pacientes con insuficiencia renal. En un estudio farmacocinético ...</td>\n",
       "      <td>903cc152-65fc-4699-9f58-c4162bf567a1</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se han realizado estudios farmacocinéticos con ivacaftor en pacientes con insuficiencia renal. En un estudio farmacocinético realizado en humanos, se observó una eliminación mínima de ivacaftor...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>463</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1117</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8bdb43b5-fad1-4b7d-b903-2d80c9a1f9b8</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1118</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt;No se recomienda ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Sin embargo, se recomienda precaución cuando se administre ivacaftor a ...</td>\n",
       "      <td>f41a82be-12b6-4769-9d83-5c590461a392</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No se recomienda ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Sin embargo, se recomienda precaución cuando se administre ivacaftor a pacientes con insuficiencia renal gra...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>319</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1119</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>57b6ec9c-f710-4374-9cc9-6c4eab711f18</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1120</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Raza&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>01da852c-60d3-4487-999e-f6248000c6c6</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Raza</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1121</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d946f857-b475-4bc9-975c-aac2ab4d72de</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1122</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;En función del análisis de FC poblacional, la raza no tuvo ningún efecto clínicamente significativo en la FC de ivacaftor en pac...</td>\n",
       "      <td>bfbbdfb3-6f01-47db-a936-0de042ae3533</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En función del análisis de FC poblacional, la raza no tuvo ningún efecto clínicamente significativo en la FC de ivacaftor en pacientes blancos (n = 379) y no blancos (n = 29).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>175</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1123</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>389e94db-92d9-4018-b6e5-9228b44fe707</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1124</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Sexo&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>0ad29d15-50a2-4297-839e-593f32d68a99</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Sexo</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1125</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0e38d909-6650-4a15-96ba-26bdf274b168</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1126</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Los parámetros farmacocinéticos de ivacaftor son similares en hombres y mujeres.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>eb27183d-4c45-4b01-90ba-d8d5f5249d0b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los parámetros farmacocinéticos de ivacaftor son similares en hombres y mujeres.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>80</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1127</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b77f9e61-0c3a-4d98-8215-06f0da6b80c9</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1128</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt;Pacientes de edad avanzada&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>413d6c63-c6d1-4d96-b12b-322b48f969bb</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Pacientes de edad avanzada</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1129</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cceb8cc3-4e77-473c-8bfd-702891459325</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1130</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Los estudios clínicos con ivacaftor en monoterapia no incluyeron un número suficiente de pacientes de 65 años o mayores para det...</td>\n",
       "      <td>44ac7f0a-8239-4c00-a3e2-8419c9e1efad</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los estudios clínicos con ivacaftor en monoterapia no incluyeron un número suficiente de pacientes de 65 años o mayores para determinar si los parámetros farmacocinéticos son similares o no a los ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>223</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1131</th>\n",
       "      <td>&lt;p class=\"labeltext\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b882773f-7b30-4774-b663-7d6459716381</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1132</th>\n",
       "      <td>&lt;p class=\"labeltextheading\"&gt;&lt;span lang=\"ES\"&gt;Población pediátrica&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5b41b887-dcae-4881-89cd-79aa4351579f</td>\n",
       "      <td>None</td>\n",
       "      <td>['labeltextheading']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Población pediátrica</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1133</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>49c59f24-0ec1-4859-ba03-1416b3915e13</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1134</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;En la Tabla 8 se presenta por grupo de edad la exposición a ivacaftor predicha según las concentraciones de ivacaftor obser...</td>\n",
       "      <td>394d06cd-92cb-4bc3-b201-ad80917f3f12</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>En la Tabla 8 se presenta por grupo de edad la exposición a ivacaftor predicha según las concentraciones de ivacaftor observadas en los estudios de fase 2 y 3, determinada mediante un análisis de ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>211</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1135</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>78bfaa7c-641f-486b-956d-f844f4a607c8</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1136</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Tabla 8 Exposición media (DE) a ivacaftor por grupo de edad&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>7fb800be-515a-44d7-b5cc-50c525f52442</td>\n",
       "      <td>margin-bottom:6.0pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tabla 8 Exposición media (DE) a ivacaftor por grupo de edad</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>59</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1137</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\"&gt; &lt;thead&gt; &lt;tr style=\"page-break-inside:avoid;height:23.9pt\"&gt; &lt;td style=\"width:2...</td>\n",
       "      <td>4873de8d-bb9f-4dad-844a-173fd65c01fe</td>\n",
       "      <td>border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Grupo de edad   Dosis   Cmín, ee (ng/ml)   AUCτ,ee (ng*h/ml)      4 meses   a menos de 6 meses (≥5 kg)   25 mg   cada 12 h   371 (183)   6480 (2520)     6 meses   a menos de 12 meses (5 kg a &lt;...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>823</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1138</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:14.45pt;margin-bottom:.0001pt;text-indent:-14.45pt;page-break-after: avoid\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=...</td>\n",
       "      <td>74df90ef-79c2-4e13-9e4b-aecc95e79d56</td>\n",
       "      <td>margin-top:6.0pt;margin-right:0in;margin-bottom:0in;\\nmargin-left:14.45pt;margin-bottom:.0001pt;text-indent:-14.45pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>*     Valores basados en los datos de un solo paciente; no se comunicó la desviación estándar.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>90</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1139</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:14.45pt;text-indent:-14.45pt\"&gt;&lt;sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt;position:relative;top:-3.0pt\"&gt;†&lt;/span&gt;&lt;/sup&gt;&lt;span lang=\"ES\" style=\"font-size:9.0pt...</td>\n",
       "      <td>becd3346-9412-433a-b899-1a6f4d674565</td>\n",
       "      <td>margin-left:14.45pt;text-indent:-14.45pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>†     Las exposiciones en los pacientes de 6 a 11 años son predicciones basadas en las simulaciones del modelo de FC poblacional utilizando los datos obtenidos para este grupo de edad.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>180</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1140</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>27821a59-9bf9-49ea-a835-e927dad511a1</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1141</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;5.3     Datos preclínicos sobre seguridad&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>9c349410-4db0-46a1-95e4-ef7cd3fad3fe</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>5.3     Datos preclínicos sobre seguridad</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>37</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1142</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>beee6207-bae3-44e5-932f-434b2ce0789c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1143</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;Los datos de los estudios preclínicos no muestran riesgos especiales para los seres humanos según los estudios convencional...</td>\n",
       "      <td>286efd28-43bb-4358-b743-0009a6f5fd43</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Los datos de los estudios preclínicos no muestran riesgos especiales para los seres humanos según los estudios convencionales de farmacología de seguridad, toxicidad a dosis repetidas, genotoxicid...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>225</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1144</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5bcda218-3b99-49b5-a1fa-4d21200daddf</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1145</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Embarazo y fertilidad&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>43fb788b-626c-4983-bdfc-4de71a106c8b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Embarazo y fertilidad</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1146</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>730c73f7-1d20-4307-92d5-5b457ce36ab8</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1147</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;Ivacaftor se asoció a &lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt;una disminución ligera del peso de las vesículas seminales&lt;/span&gt;&lt;span la...</td>\n",
       "      <td>02a0c084-1bed-45d1-8203-1f8d988bf970</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor se asoció a una disminución ligera del peso de las vesículas seminales, a una disminución del índice de fertilidad global y del número de gestaciones en las hembras apareadas con machos ...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>824</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1148</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>55e21e9d-1501-45f0-b6ee-fc8332db8538</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1149</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Desarrollo perinatal y posnatal&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>ec8e0976-4f16-42fd-b543-94f84809b1b2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Desarrollo perinatal y posnatal</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1150</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0bb275c9-704a-4fbc-a45a-e44995d1c5b0</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1151</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;Ivacaftor redujo los índices de supervivencia y lactancia y produjo una disminución en los pesos corporales de las crías. L...</td>\n",
       "      <td>f0c77f95-5679-4af7-aeb9-d4fa893e75e5</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ivacaftor redujo los índices de supervivencia y lactancia y produjo una disminución en los pesos corporales de las crías. La dosis sin efecto adverso observado para viabilidad y crecimiento de las...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>434</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1152</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7bb967d7-0df0-4486-b0a6-1ead239ada89</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1153</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"ES\"&gt;Estudios en animales jóvenes&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>c900fa7b-1bbf-4da3-9123-ed5a59827b35</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Estudios en animales jóvenes</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1154</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8bff0836-af98-482c-be95-fd5c7da0545b</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1155</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;Se observaron cataratas en las ratas jóvenes tratadas desde el día 7 después de nacer hasta el día 35 a niveles de exposici...</td>\n",
       "      <td>0e43bb0a-b9f2-44aa-9aa0-42ed79289205</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Se observaron cataratas en las ratas jóvenes tratadas desde el día 7 después de nacer hasta el día 35 a niveles de exposición de ivacaftor de 0,22 veces la dosis máxima recomendada en humanos segú...</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>708</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1156</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>c8f96fd7-5f63-4033-972a-3d75274cf24b</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1157</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>33e35ace-7a00-4ed5-a0d2-c90168217a8a</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1158</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;6.       DATOS FARMACÉUTICOS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>32438407-a778-40ce-bfdb-fe62990a1056</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>6.       DATOS FARMACÉUTICOS</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1159</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>41c13e40-decf-4dd7-9972-c5f43fdf6af7</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1160</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;6.1     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Lista de excipientes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>c15032e7-88ae-446d-b660-f36263c54ac3</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.1     Lista de excipientes</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1161</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>d5d5e3a4-8616-4bb9-83df-c94dfa64a1d8</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1162</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Sílice coloidal anhidra&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>429bc572-2c0e-46b8-890e-030dff3abb72</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Sílice coloidal anhidra</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>23</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1163</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Croscarmelosa sódica&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d4e91b46-e7ed-4c99-a4c6-5c378a597348</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Croscarmelosa sódica</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1164</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Succinato acetato de hipromelosa&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ee7a3610-5c33-4433-bc65-62a883b9eb80</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Succinato acetato de hipromelosa</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>32</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1165</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Lactosa monohidrato&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ce9b3b32-d318-4292-8cb3-78216ce0b1f5</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Lactosa monohidrato</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1166</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"IT\"&gt;Estearato de magnesio&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f62dc282-2106-432d-a72e-46c9a1f4a055</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Estearato de magnesio</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1167</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"IT\"&gt;Manitol&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>dbc092cf-7bb7-4d3d-90b9-fad801510e4d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Manitol</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1168</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"IT\"&gt;Sucralosa&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>29e92832-505b-486d-9ce3-c3d89ac3c97f</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Sucralosa</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1169</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"IT\"&gt;Laurilsulfato sódico (E487)&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d5261708-6ab9-4088-821a-58c96cf5ccdb</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Laurilsulfato sódico (E487)</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1170</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"IT\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>dd9078cc-f39a-47bd-bce3-0850601e0350</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1171</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;6.2     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Incompatibilidades&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>fb24cccd-e41e-4405-bd34-8364f5890ab1</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.2     Incompatibilidades</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1172</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fdaea94f-02de-4e64-b8ca-b5be89207244</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1173</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;No procede.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>98f651fd-67ae-499c-9b82-fdb663c60a09</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No procede.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1174</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3012167d-b82d-44b3-b8b4-b6f4ece240cf</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1175</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;6.3     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Periodo de validez&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>daa2e37e-5bc7-4a85-8fc8-b522738e691a</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.3     Periodo de validez</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1176</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>60299a20-4ec5-47bb-ac2c-9695686c668c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1177</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;3 años.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>111c668b-2b67-4289-b201-4e57295b3ee2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>3 años.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1178</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>edb57bd3-2ea0-469a-b5d6-f3095979c71d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1179</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;Una vez mezclado, la mezcla ha demostrado ser estable durante una hora.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>be44e3bc-d67b-4843-ba2e-5f146c169ad2</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Una vez mezclado, la mezcla ha demostrado ser estable durante una hora.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>71</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1180</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5a92dfe7-c811-4ae6-a265-808356828893</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1181</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;6.4     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Precauciones especiales de conservación&lt;/span...</td>\n",
       "      <td>3169aede-babf-4718-94ea-b819364926ee</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.4     Precauciones especiales de conservación</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>43</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1182</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>926f75e9-f6cd-4f8b-9992-f8b33f66e453</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1183</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;No requiere condiciones especiales de conservación.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0a43f770-254b-4f3f-9e4f-bdb42eefd352</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No requiere condiciones especiales de conservación.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>51</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1184</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>81aea285-d701-4984-b399-576095da202f</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1185</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;6.5     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;Naturaleza y contenido del envase&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>c1c7d49c-764d-4923-843f-4e79a6628995</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.5     Naturaleza y contenido del envase</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>37</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1186</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f6aa0358-6523-436e-aa31-06825c759241</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1187</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;El granulado está envasado en un sobre de tereftalato de polietileno de orientación biaxial/polietileno/&lt;/span&gt;&lt;span lang=\"...</td>\n",
       "      <td>08ed5c42-40d6-450a-a5f5-5a73183e0572</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>El granulado está envasado en un sobre de tereftalato de polietileno de orientación biaxial/polietileno/papel de aluminio/polietileno (BOPET/PE/papel de aluminio/PE).</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>166</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1188</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"text-autospace:none\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ddbc7bcc-5954-44f0-b2f8-b5c025020813</td>\n",
       "      <td>text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1189</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;Tamaño de envase de 56 sobres (contiene 4 estuches individuales con 14 sobres cada uno)&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>361a1237-2ebb-4362-bf8f-57422fefa1ee</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Tamaño de envase de 56 sobres (contiene 4 estuches individuales con 14 sobres cada uno)</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>87</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1190</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4ff6e3fa-0089-4510-a954-665bfbf4299e</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1191</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;6.6     Precauciones especiales de eliminación&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt; y otra...</td>\n",
       "      <td>c9e5e6a6-9301-479c-8c1e-028679d9d007</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.6     Precauciones especiales de eliminación y otras manipulaciones</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>65</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1192</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>ed1c55f0-1ebb-424b-a17d-525c1d7cc628</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1193</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;La eliminación del medicamento no utilizado y de todos los &lt;/span&gt;&lt;span lang=\"ES\"&gt;materiales&lt;/span&gt;&lt;span lang=\"ES-TRAD\"&gt; qu...</td>\n",
       "      <td>6dfe27fa-ae57-4d7b-9604-a597562d13aa</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La eliminación del medicamento no utilizado y de todos los materiales que hayan estado en contacto con él se realizará de acuerdo con la normativa local.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>153</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1194</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b976ee46-2728-40ff-bc71-00d41c29257e</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1195</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ae108dc6-3da0-46e8-8acf-fe7fe0a9302c</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1196</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;7.       TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>7a2b7723-882d-4438-80a9-5ddeb9516e69</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>7.       TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>49</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1197</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>eb58cd42-7e5a-4363-bc3a-004231f1399c</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1198</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;Vertex Pharmaceuticals (Ireland) Limited&lt;/p&gt;</td>\n",
       "      <td>ccf406a5-d594-43aa-8f99-6935cf210ce5</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Vertex Pharmaceuticals (Ireland) Limited</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>40</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1199</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;28-32 Pembroke Street Upper&lt;/p&gt;</td>\n",
       "      <td>10ac1386-3687-447a-9bff-f482c2218cea</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>28-32 Pembroke Street Upper</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1200</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Dublin 2, D02 EK84&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ccba8523-560c-41b9-bef5-d6010fdc7ba0</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Dublin 2, D02 EK84</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1201</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;Irlanda&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b7d2b43a-559b-45db-9890-1b38a24e618d</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Irlanda</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1202</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>aa606d6f-0bbc-4356-9c3e-32f677f4edd5</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1203</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b98ea5b8-b48f-4641-a8be-988dcd1cbae8</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1204</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;8.       &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓ...</td>\n",
       "      <td>be004057-4f79-4fc2-a92d-f91381e62f4d</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>8.       NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓN</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>48</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1205</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>35d8534b-6127-46cc-8ba8-d0d148d12135</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1206</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:13.0pt;page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;EU&lt;/span&gt;&lt;span lang=\"ES\" style=\"color:black\"&gt;/1/12/782/003&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8d4bf407-8aaa-4990-9de9-d7fef261910d</td>\n",
       "      <td>line-height:13.0pt;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>EU/1/12/782/003</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1207</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;EU/1/12/782/004&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2c908221-4b52-40b1-81e2-8966b8ce0814</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>EU/1/12/782/004</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1208</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt;EU/1/12/782/006&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>bf7b80ad-9d58-4ef0-9132-a6e94e24cb23</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>EU/1/12/782/006</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1209</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>87b43bf6-c2d7-4e6c-a3d7-30904c063eb3</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1210</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8e7bc614-70a8-47bd-8c30-b1f187865d72</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1211</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;9.       FECHA DE LA PRIMERA AUTORIZACIÓN/RENOVACIÓN DE LA AUTORIZACIÓN&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>6562a125-9524-44b2-ac26-896abaadc776</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>9.       FECHA DE LA PRIMERA AUTORIZACIÓN/RENOVACIÓN DE LA AUTORIZACIÓN</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>65</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1212</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>29639930-2895-483f-b0e7-bec97d4447a5</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1213</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt;Fecha de la primera autorización: 23/julio/2012&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>346e0cb5-caca-4e4d-8f85-e9dd3ce9e3f0</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Fecha de la primera autorización: 23/julio/2012</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>47</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1214</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;Fecha de la última renovación: 28/abril/2017&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c7ac5b3e-0d96-42ba-b22d-5faf2e837761</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Fecha de la última renovación: 28/abril/2017</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>44</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1215</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>afd5d605-f093-49e7-9563-71b10b864b97</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1216</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b573fb82-4502-4c0a-a62a-e113191b8931</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1217</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.1pt;text-indent:-28.1pt;page-break-after: avoid\"&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;10.    &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"ES\"&gt;FECHA DE LA REVISIÓN DEL TEXTO&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>7d866d74-882e-4292-bae4-efe3fa2e7713</td>\n",
       "      <td>margin-left:28.1pt;text-indent:-28.1pt;page-break-after:\\navoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>10.    FECHA DE LA REVISIÓN DEL TEXTO</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>34</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1218</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>db6b9877-d0d1-4196-9079-e10a8e0a4ec4</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1219</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c0d236d6-5a3e-4601-8264-54e917191486</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1220</th>\n",
       "      <td>&lt;p class=\"labeltext\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"ES-TRAD\"&gt;La información detallada de este medicamento está disponible en la página web de la Agencia Europea de Medicamentos &lt;/span&gt;...</td>\n",
       "      <td>01fe15c9-4c31-4abe-9f14-586c906860db</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['labeltext']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>La información detallada de este medicamento está disponible en la página web de la Agencia Europea de Medicamentos http://www.ema.europa.eu.</td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>141</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1221</th>\n",
       "      <td>&lt;span lang=\"ES\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'&gt;&lt;br clear=\"all\" style=\"page-break-before:always\"/&gt; &lt;/span&gt;</td>\n",
       "      <td>98bc41c5-7a64-484d-b4d2-0c37657c9f3b</td>\n",
       "      <td>font-size:11.0pt;font-family:\"Times New Roman\",serif</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>af72c67e-e145-4951-a2ae-9d6e209e11df</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                      Element  \\\n",
       "0     <div class=\"WordSection1\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span ...   \n",
       "1                                                                                                           <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "2                                                                                                           <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "3                                                                                                           <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "4                                                                                                           <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "5                                                                                                           <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "6                                                                                                           <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "7                                                                                                           <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "8                                                                                                           <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "9                                                                                                           <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "10                                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "11                                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "12                                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "13                                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "14                                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "15                                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "16                                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "17                                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "18                                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "19                                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "20                                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "21                                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "22                                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "23                                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "24                                                                                                    <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\">ANEXO I</span></b></p>   \n",
       "25                                                                                                                                                             <p class=\"TitleA\"><span lang=\"ES\"> </span></p>   \n",
       "26                                                                                                   <p class=\"TitleA\"><span lang=\"ES\">FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO</span></p>   \n",
       "27                                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"ES\"> </span></b></p>   \n",
       "28                                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "29                                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "30                                                                                                                 <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"ES\"> </span></p>   \n",
       "31                                                       <span lang=\"ES\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif; color:green'><br clear=\"all\" style=\"page-break-before:always\"/> </span>   \n",
       "32                                                                                                                                                         <br clear=\"all\" style=\"page-break-before:always\"/>   \n",
       "33                                                                                 <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><span lang=\"ES\"> </span></p>   \n",
       "34              <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">1.       </span></b><b><span lang=\"ES\">NOMBRE DEL MEDICAMENTO</span></b></p>   \n",
       "35                                                                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "36                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\">Kalydeco 75 mg comprimidos recubiertos con película</span></p>   \n",
       "37                                                                                                       <p class=\"MsoNormal\"><span lang=\"ES\">Kalydeco 150 mg comprimidos recubiertos con película</span></p>   \n",
       "38                                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "39                                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "40                                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "41    <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">2.       </span></b><b><span lang=\"ES\">COMPOSICIÓN CUALITATIVA Y CUANTITATIVA</span...   \n",
       "42                                                                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "43                                                                                                 <p class=\"MsoNormal\"><u><span lang=\"ES\">Kalydeco 75 mg comprimidos recubiertos con película</span></u></p>   \n",
       "44                                                                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "45                                                        <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Cada comprimido recubierto con película contiene 75 mg de ivacaftor.</span></p>   \n",
       "46                                                                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "47                                                                                       <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Excipiente con efecto conocido</span></i></p>   \n",
       "48                                                                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "49                                            <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Cada comprimido recubierto con película contiene 83,6 mg de lactosa monohidrato.</span></p>   \n",
       "50                                                                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "51                                                                                                <p class=\"MsoNormal\"><u><span lang=\"ES\">Kalydeco 150 mg comprimidos recubiertos con película</span></u></p>   \n",
       "52                                                                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "53                                                       <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Cada comprimido recubierto con película contiene 150 mg de ivacaftor.</span></p>   \n",
       "54                                                                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "55                                                                                       <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Excipiente con efecto conocido</span></i></p>   \n",
       "56                                                                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "57                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Cada comprimido recubierto con película contiene 167,2 mg de lactosa monohidrato.</span></p>   \n",
       "58                                                                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "59                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Para consultar la lista completa de excipientes, ver sección 6.1.</span></p>   \n",
       "60                                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "61                                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "62                  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">3.       </span></b><b><span lang=\"ES\">FORMA FARMACÉUTICA</span></b></p>   \n",
       "63                                                                                                       <p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "64                                                                                <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\">Comprimido recubierto con película (comprimido)</span></p>   \n",
       "65                                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "66                                                                                                 <p class=\"MsoNormal\"><u><span lang=\"ES\">Kalydeco 75 mg comprimidos recubiertos con película</span></u></p>   \n",
       "67                                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "68    <p class=\"MsoNormal\"><span lang=\"ES\">Comprimidos recubiertos con película con forma de cápsula de color azul claro, con la impresión “V 75” en tinta negra en una cara y nada en la otra (12,7 mm x ...   \n",
       "69                                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "70                                                                                                <p class=\"MsoNormal\"><u><span lang=\"ES\">Kalydeco 150 mg comprimidos recubiertos con película</span></u></p>   \n",
       "71                                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "72    <p class=\"MsoNormal\"><span lang=\"ES\">Comprimidos recubiertos con película con forma de cápsula de color azul claro, con la impresión “V 150” en tinta negra en una cara y nada en la otra (16,5 mm x...   \n",
       "73                                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "74                                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "75    <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\" style=\"text-transform:uppercase\">4.       </span></b><b><span lang=\"ES\" style=\"text...   \n",
       "76                                                                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "77            <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.1     </span></b><b><span lang=\"ES\">Indicaciones terapéuticas</span></b></p>   \n",
       "78                                                                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "79                                                                                                                        <p class=\"labeltext\"><span lang=\"ES\">Kalydeco comprimidos está indicado:</span></p>   \n",
       "80    <p class=\"labeltext\" style=\"margin-left:38.9pt;text-indent:-.25in\"><span lang=\"ES\" style=\"font-family:Symbol\">·<span style='font:7.0pt \"Times New Roman\"'>         </span></span><span lang=\"ES\">En ...   \n",
       "81                                                                                                                                                          <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "82    <p class=\"labeltext\" style=\"margin-left:38.9pt;text-indent:-.25in\"><span lang=\"ES\" style=\"font-family:Symbol\">·<span style='font:7.0pt \"Times New Roman\"'>         </span></span><span lang=\"ES\">En ...   \n",
       "83                                                                                                                                                   <p class=\"MsoListParagraph\"><span lang=\"ES\"> </span></p>   \n",
       "84    <p class=\"labeltext\" style=\"margin-left:38.9pt;text-indent:-.25in\"><span lang=\"ES\" style=\"font-family:Symbol\">·<span style='font:7.0pt \"Times New Roman\"'>         </span></span><span lang=\"ES-TRAD...   \n",
       "85                                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "86    <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.2     </span></b><b><span lang=\"ES\">Posología y forma de administración</span></b...   \n",
       "87                                                                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "88    <p class=\"MsoNormal\"><span lang=\"ES\">Únicamente los médicos con experiencia en el tratamiento de la fibrosis quística deben prescribir Kalydeco. </span><span lang=\"ES\">Si se desconoce el genotipo ...   \n",
       "89                                                                         <p class=\"MsoNormal\"><a name=\"paragraph00000061\"></a><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "90                                                                                                            <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Posología</span></u></p>   \n",
       "91                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "92                             <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\">Los adultos, adolescentes y niños de 6 años de edad o mayores deben ser tratados según la Tabla 1.</span></p>   \n",
       "93                                                                                                                              <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "94                                                      <p class=\"labeltext\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"><b>Tabla 1: </b><b><span lang=\"ES\">Recomendaciones posológicas</span></b></p>   \n",
       "95    <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoTableGrid\" style=\"margin-left:-.25pt;border-collapse:collapse;border:none\" width=\"626\"> <thead> <tr style=\"page-break-inside:avoid;heigh...   \n",
       "96                                                                                                                                                     <p class=\"labeltext\"><span lang=\"ES-TRAD\"> </span></p>   \n",
       "97    <p class=\"labeltext\"><span lang=\"ES-TRAD\">La dosis de la mañana y la dosis de la noche se deben tomar con un intervalo de 12 horas aproximadamente y</span><span lang=\"ES\"> con alimentos que conten...   \n",
       "98                                                                                                                              <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "99                                                                                  <p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"><i><span lang=\"ES\">Dosis olvidadas</span></i></p>   \n",
       "100                                                                                                                             <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "101   <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\">Si han transcurrido 6 horas o menos desde la dosis olvidada de la mañana o de la noche, </span><span lang=\"ES-TRAD\">se debe indicar...   \n",
       "102                                                                                                                             <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "103   <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\">Se debe indicar a los pacientes tratados con Kalydeco en un esquema combinado que no tomen más de una dosis de cualquiera de los me...   \n",
       "104                                                                                                                             <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "105                                                                            <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Uso concomitante de inhibidores de CYP3A</span></i></p>   \n",
       "106                                                                  <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></i></p>   \n",
       "107   <p class=\"labeltext\"><span lang=\"ES\">En administración concomitante con inhibidores moderados o potentes de CYP3A, ya sea en monoterapia o en un esquema combinado con </span><span lang=\"ES-TRAD\">t...   \n",
       "108                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "109   <p class=\"labeltext\" style=\"margin-top:0in;margin-right:0in;margin-bottom:6.0pt; margin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 2: Recomendaciones posoló...   \n",
       "110   <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoTableGrid\" style=\"border-collapse:collapse;border:none\" width=\"605\"> <thead> <tr style=\"page-break-inside:avoid\"> <td style=\"width:91.9p...   \n",
       "111                                                                                <p class=\"labeltext\" style=\"margin-left:42.55pt;text-indent:-42.55pt;page-break-after: avoid\"><span lang=\"ES\"> </span></p>   \n",
       "112                                                                                              <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Poblaciones especiales</span></u></p>   \n",
       "113                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "114                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Pacientes de edad avanzada</span></i></p>   \n",
       "115                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "116   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Se dispone de datos muy limitados para pacientes de edad avanzada tratados con ivacaftor (administrado en monoterapia o en un es...   \n",
       "117                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "118                                                                                                 <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Insuficiencia renal</span></i></p>   \n",
       "119                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "120   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">No es necesario ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Se recomienda precaución en pacientes con...   \n",
       "121                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "122                                                                                                                             <p class=\"labeltextheading\"><span lang=\"ES\">Insuficiencia hepática</span></p>   \n",
       "123                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "124   <p class=\"labeltext\"><span lang=\"ES\">No es necesario ajustar la dosis </span><span lang=\"ES-TRAD\">de ivacaftor en monoterapia o en un esquema combinado</span><span lang=\"ES-TRAD\"> </span><span lan...   \n",
       "125                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "126   <p class=\"MsoNormal\"><span lang=\"ES\">Para los pacientes con insuficiencia hepática moderada (Child-Pugh Clase B), se debe reducir la dosis de ivacaftor en monoterapia a 150 mg una vez al día.</spa...   \n",
       "127                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "128   <p class=\"MsoNormal\"><span lang=\"ES\">Para los </span><span lang=\"ES\">pacientes con insuficiencia hepática grave (Child-Pugh Clase </span><span lang=\"ES\">C), </span><span lang=\"ES\">se debe reducir ...   \n",
       "129                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "130   <p class=\"labeltext\"><span lang=\"ES\">Para el uso como dosis de la noche en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor, v</span><span lang=\"ES\">er la Tabla 3 p...   \n",
       "131                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "132   <p class=\"labeltext\" style=\"margin-top:0in;margin-right:0in;margin-bottom:6.0pt; margin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 3: Recomendaciones posoló...   \n",
       "133   <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoTableGrid\" style=\"width:474.65pt;border-collapse:collapse;border:none\" width=\"633\"> <thead> <tr style=\"page-break-inside:avoid\"> <td sty...   \n",
       "134                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "135                                                                                                <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Población pediátrica</span></u></p>   \n",
       "136                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "137   <p class=\"labeltext\"><span lang=\"ES\">No se ha establecido la seguridad y eficacia de ivacaftor en monoterapia en niños menores de 4 meses, ni en combinación con tezacaftor/ivacaftor en niños menor...   \n",
       "138                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "139   <p class=\"labeltext\"><span lang=\"ES\">Los datos disponibles en pacientes menores de 6 años con una mutación <i>R117H</i> en el gen <i>CFTR</i> son limitados. </span><span lang=\"ES\">Los datos dispon...   \n",
       "140                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "141                                                                                             <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Forma de administración</span></u></p>   \n",
       "142                                                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "143                                                                                              <p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"><span lang=\"ES\">Vía oral.</span></p>   \n",
       "144                                                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "145   <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\">Se debe indicar a los pacientes que ingieran los comprimidos enteros. Los comprimidos no se deben masticar, </span><span lang=\"ES\">...   \n",
       "146                                                                                                                             <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "147                                               <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\">Los comprimidos de ivacaftor se deben tomar con alimentos que contengan grasas.</span></p>   \n",
       "148                                                                                                                             <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "149                        <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\">Se deben evitar los alimentos o bebidas que contienen pomelo durante el tratamiento (ver sección 4.5).</span></p>   \n",
       "150                                                                                                                             <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "151                                                <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.3     Contraindicaciones</span></b></p>   \n",
       "152                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "153                                 <p class=\"MsoNormalIndent\" style=\"margin:0in\"><span lang=\"ES\">Hipersensibilidad al principio activo o a alguno de los excipientes incluidos en la sección 6.1.</span></p>   \n",
       "154                                                                                                                                <p class=\"MsoNormalIndent\" style=\"margin:0in\"><span lang=\"ES\"> </span></p>   \n",
       "155   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.4     </span></b><b><span lang=\"ES\">Advertencias y precauciones especiales de emp...   \n",
       "156                                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "157   <p class=\"MsoNormalIndent\" style=\"margin:0in\"><span lang=\"ES\">Únicamente los pacientes con FQ con una mutación </span><span lang=\"ES\">de apertura del canal (clase III): </span><i><span lang=\"ES\">G...   \n",
       "158                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "159   <p class=\"MsoNormal\"><span lang=\"ES\">En el estudio 5 fueron incluidos cuatro pacientes con la mutación <i>G970R</i>. En tres de los cuatro pacientes el cambio en la prueba de </span><span lang=\"ES...   \n",
       "160                                                                                                        <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"ES\"> </span></p>   \n",
       "161   <p class=\"MsoNormal\"><span lang=\"ES\">Los resultados de eficacia de un estudio de fase 2 en pacientes con FQ homocigóticos para la mutación <i>F508del </i>en el gen <i>CFTR</i> no mostraron una dif...   \n",
       "162                                                                                          <p class=\"labeltextheading\" style=\"page-break-after:auto\"><span lang=\"ES\" style=\"font-style:normal\"> </span></p>   \n",
       "163   <p class=\"labeltextheading\" style=\"page-break-after:auto\"><span lang=\"ES\" style=\"font-style:normal\">En el estudio 6, se ha demostrado menos evidencia de un efecto positivo de ivacaftor en paciente...   \n",
       "164                                         <p class=\"labeltextheading\" style=\"page-break-after:auto\"><u><span lang=\"ES\" style=\"font-style:normal\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "165   <p class=\"labeltextheading\" style=\"page-break-after:auto\"><span lang=\"ES\" style=\"font-style:normal\">No se debe prescribir ivacaftor en un esquema combinado con tezacaftor/ivacaftor a pacientes con...   \n",
       "166                                         <p class=\"labeltextheading\" style=\"page-break-after:auto\"><u><span lang=\"ES\" style=\"font-style:normal\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "167                                                                      <p class=\"labeltextheading\"><u><span lang=\"ES\" style=\"font-style:normal\">Efecto en las pruebas de la función hepática</span></u></p>   \n",
       "168                                                                                                                        <p class=\"labeltextheading\"><span lang=\"ES\" style=\"font-style:normal\"> </span></p>   \n",
       "169   <p class=\"labeltextheading\" style=\"page-break-after:auto\"><span lang=\"ES\" style=\"font-style:normal\">Es frecuente el aumento moderado de las aminotransferasas </span><span lang=\"ES\" style=\"font-sty...   \n",
       "170                                                                                          <p class=\"labeltextheading\" style=\"page-break-after:auto\"><span lang=\"ES\" style=\"font-style:normal\"> </span></p>   \n",
       "171                                                                                              <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Insuficiencia hepática</span></u></p>   \n",
       "172                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "173   <p class=\"labeltext\"><span lang=\"ES-TRAD\">No se recomienda utilizar ivacaftor, en monoterapia o en un esquema combinado con tezacaftor/ivacaftor, en pacientes con insuficiencia hepática grave a me...   \n",
       "174                                                                                                        <p class=\"MsoNormal\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "175   <p class=\"MsoNormal\"><span lang=\"ES\">En los pacientes con insuficiencia hepática moderada, no se recomienda el uso de ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor. Únicam...   \n",
       "176                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "177                                                                                                 <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Insuficiencia renal</span></u></p>   \n",
       "178                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "179   <p class=\"labeltext\"><span lang=\"ES\">Se recomienda precaución mientras se utiliza ivacaftor, en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o </span><span lang=\"ES-TRAD\">ivacaft...   \n",
       "180                                                                                                        <p class=\"MsoNormal\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "181                                                                       <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Pacientes después de un trasplante de órganos</span></u></p>   \n",
       "182                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "183   <p class=\"MsoNormal\"><span lang=\"ES\">Ivacaftor, en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor,</span><span lang=\"ES\"> no se ha estudiado en p...   \n",
       "184                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "185                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Acontecimientos de exantema</span></u></p>   \n",
       "186                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "187   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">La incidencia de los acontecimientos de exantema con ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor fue ...   \n",
       "188                                                                                                        <p class=\"MsoNormal\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "189                                                                                <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Interacciones con otros medicamentos</span></u></p>   \n",
       "190                                                                                                                   <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "191                                                                                                 <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Inductores de CYP3A</span></i></p>   \n",
       "192                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "193   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">La exposición a ivacaftor disminuye significativamente y se espera que las exposiciones a </span><span lang=\"ES-TRAD\">elexacafto...   \n",
       "194                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "195                                                                                                <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Inhibidores de CYP3A</span></i></p>   \n",
       "196                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "197   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">La exposición a ivacaftor, </span><span lang=\"ES-TRAD\">tezacaftor y </span><span lang=\"ES\">e</span><span lang=\"ES-TRAD\">lexacaft...   \n",
       "198                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "199                                                                                                <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Población pediátrica</span></u></p>   \n",
       "200                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "201   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Se han notificado casos de opacidad del cristalino/cataratas no congénitas sin afectar a la visión en pacientes pediátricos trat...   \n",
       "202                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "203                                                                                                <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Contenido de lactosa</span></u></p>   \n",
       "204                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "205   <p class=\"MsoNormal\"><span lang=\"ES\">Kalydeco contiene lactosa. Los pacientes con intolerancia hereditaria a galactosa, deficiencia total de lactasa o problemas de absorción de glucosa o galactosa...   \n",
       "206                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "207                                                                                                  <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Contenido de sodio</span></u></p>   \n",
       "208                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "209   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Este medicamento contiene menos de 23 mg de sodio (1 mmol) por unidad de dosis; esto es, esencialmente “exento de sodio”.</span>...   \n",
       "210                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "211   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.5     </span></b><b><span lang=\"ES\">Interacción con otros medicamentos y otras fo...   \n",
       "212                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "213   <p class=\"MsoCommentText\"><span lang=\"ES\" style=\"font-size:11.0pt\">Ivacaftor es un sustrato de CYP3A4 y CYP3A5. Es un inhibidor débil de CYP3A y P‑gp y un posible inhibidor de CYP2C9. Los estudios...   \n",
       "214                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "215                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Medicamentos que afectan a la farmacocinética de ivacaftor</span></u></p>   \n",
       "216                                                                         <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "217                                                                   <p class=\"MsoCommentText\" style=\"page-break-after:avoid\"><i><span lang=\"ES\" style=\"font-size:11.0pt\">Inductores de CYP3A</span></i></p>   \n",
       "218                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "219   <p class=\"MsoCommentText\"><span lang=\"ES\" style=\"font-size:11.0pt\">La administración conjunta de ivacaftor con rifampicina, un inductor potente de CYP3A, disminuyó la exposición a ivacaftor (AUC) ...   \n",
       "220                                                                                                                           <p class=\"MsoCommentText\"><span lang=\"ES\" style=\"font-size:11.0pt\"> </span></p>   \n",
       "221   <p class=\"labeltext\"><span lang=\"ES\">No se recomienda un ajuste de la dosis cuando se utilice ivacaftor (en monoterapia o en un esquema combinado con tezacaftor/ivacaftor </span><span lang=\"ES\">o ...   \n",
       "222                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "223                                                                                                <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Inhibidores de CYP3A</span></i></p>   \n",
       "224                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "225   <p class=\"labeltext\"><span lang=\"ES\">Ivacaftor es un sustrato sensible de CYP3A. La administración conjunta con ketoconazol, un inhibidor potente de CYP3A, aumentó la exposición a ivacaftor (deter...   \n",
       "226                                                                                                        <p class=\"labeltext\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "227   <p class=\"labeltext\"><span lang=\"ES\">La administración conjunta con fluconazol, un inhibidor moderado de CYP3A, aumentó la exposición a ivacaftor en 3 veces y a su metabolito M1, aunque en menor g...   \n",
       "228                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "229   <p class=\"labeltext\"><span lang=\"ES\">La administración conjunta de ivacaftor</span><span lang=\"ES\"> </span><span lang=\"ES\">con zumo de pomelo, que contiene uno o más componentes que inhiben de for...   \n",
       "230                                                                                                        <p class=\"labeltext\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "231                           <p class=\"MsoCommentText\" style=\"page-break-after:avoid\"><i><span lang=\"ES\" style=\"font-size:11.0pt\">Capacidad de ivacaftor para interactuar con transportadores</span></i></p>   \n",
       "232                                                                                            <p class=\"MsoCommentText\" style=\"page-break-after:avoid\"><span lang=\"ES\" style=\"font-size:11.0pt\"> </span></p>   \n",
       "233   <p style=\"margin:0in\"><span lang=\"ES\" style=\"font-size:11.0pt\">Los estudios <i>in vitro</i> demostraron que ivacaftor no es un sustrato de OATP1B1 ni de OATP1B3. Ivacaftor y sus metabolitos son su...   \n",
       "234                                                                                                        <p class=\"labeltext\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "235                                                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Ciprofloxacino</span></i></p>   \n",
       "236                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "237   <p class=\"labeltext\"><span lang=\"ES\">La administración conjunta de ciprofloxacino con ivacaftor no afectó a la exposición a ivacaftor. No es necesario ajustar la dosis cuando ivacaftor</span><span...   \n",
       "238                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "239                                                                             <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Medicamentos a los que afecta ivacaftor</span></u></p>   \n",
       "240                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "241   <p class=\"labeltext\"><span lang=\"ES\">La administración de ivacaftor puede aumentar la exposición sistémica de los medicamentos que son sustratos sensibles de </span><span lang=\"ES\">CYP2C9</span><s...   \n",
       "242                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "243                                                                              <p class=\"MsoNormal\" style=\"line-height:13.0pt;page-break-after:avoid\"><i><span lang=\"ES\">Sustratos de CYP2C9</span></i></p>   \n",
       "244                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "245   <p class=\"MsoNormal\"><span lang=\"ES\">Ivacaftor puede inhibir CYP2C9. Por lo tanto, se recomienda controlar la razón internacional normalizada (INR) durante la administración conjunta de warfarina ...   \n",
       "246                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "247                                                                                  <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Digoxina y otros sustratos de P‑gp</span></i></p>   \n",
       "248                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "249   <p class=\"MsoNormal\"><span lang=\"ES\">La administración conjunta con digoxina, un sustrato sensible de la P‑gp, aumentó la exposición a digoxina en 1,3 veces, lo que es coherente con la inhibición ...   \n",
       "250                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "251                                                                                                  <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Sustratos de CYP3A</span></i></p>   \n",
       "252                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "253   <p class=\"MsoNormal\"><span lang=\"ES\">La administración conjunta con midazolam (oral), un sustrato de CYP3A sensible, aumentó la exposición a midazolam en 1,5 veces, lo que es coherente con la inhi...   \n",
       "254                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "255                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Anticonceptivos hormonales</span></i></p>   \n",
       "256                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "257   <p class=\"MsoNormal\"><span lang=\"ES\">Se ha estudiado ivacaftor (en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor) con un anticonceptivo oral de ...   \n",
       "258                                                                                                                               <p style=\"margin:0in\"><span lang=\"ES\" style=\"font-size:11.0pt\"> </span></p>   \n",
       "259                                                                                                <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Población pediátrica</span></u></p>   \n",
       "260                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "261                                                                                           <p class=\"labeltext\"><span lang=\"ES\">Los estudios de interacciones se han realizado solo en adultos.</span></p>   \n",
       "262                                                                                                        <p class=\"labeltext\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "263    <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.6     </span></b><b><span lang=\"ES\">Fertilidad, embarazo y lactancia</span></b></p>   \n",
       "264                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "265                                                                                                            <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Embarazo</span></u></p>   \n",
       "266                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "267   <p class=\"labeltext\"><span lang=\"ES\">No hay datos o estos son limitados (datos en menos de 300 embarazos) relativos al uso de ivacaftor en mujeres embarazadas. Los estudios en animales no sugieren...   \n",
       "268                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "269                                                                                                           <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Lactancia</span></u></p>   \n",
       "270                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "271   <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\">Se desconoce si </span><span lang=\"ES\">ivacaftor y/o sus metabolitos se excretan en la leche materna. </span><span lang=\"ES\">Los datos farm...   \n",
       "272                                                                                                                                <p class=\"MsoNormalIndent\" style=\"margin:0in\"><span lang=\"ES\"> </span></p>   \n",
       "273                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Fertilidad</span></u></p>   \n",
       "274                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "275   <p class=\"MsoNormal\"><span lang=\"ES\" style=\"color:black\">No se dispone de datos sobre el efecto de ivacaftor en la fertilidad en humanos. Ivacaftor tuvo un efecto en la fertilidad en ratas (ver se...   \n",
       "276                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "277   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.7     </span></b><b><span lang=\"ES\">Efectos sobre la capacidad para conducir y ut...   \n",
       "278                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "279   <p class=\"MsoNormal\"><span lang=\"ES\">La influencia de ivacaftor sobre la capacidad para conducir y utilizar máquinas es pequeña. Ivacaftor puede producir mareos (ver sección 4.8) y, por lo tanto, ...   \n",
       "280                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "281                 <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.8     </span></b><b><span lang=\"ES\">Reacciones adversas</span></b></p>   \n",
       "282                                                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "283                                                                                     <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Resumen del perfil de seguridad</span></u></p>   \n",
       "284                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "285   <p class=\"labeltext\"><span lang=\"ES\">Las reacciones adversas más frecuentes experimentadas por los pacientes de 6 años o mayores que recibieron ivacaftor son cefalea </span><span lang=\"ES\">(23,9 %...   \n",
       "286                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "287   <p class=\"labeltext\"><span lang=\"ES\">En pacientes de 2 a menos de 6 años las reacciones adversas más frecuentes fueron congestión nasal (26,5 %), infección en las vías respiratorias altas (23,5 %)...   \n",
       "288                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "289   <p class=\"labeltext\"><span lang=\"ES\">Las reacciones adversas graves observadas en los pacientes que recibieron ivacaftor incluyeron dolor abdominal y aumento de las aminotransferasas (ver sección ...   \n",
       "290                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "291                                                                     <p class=\"labeltext\" style=\"line-height:13.0pt;page-break-after:avoid\"><u><span lang=\"ES\">Tabla de reacciones adversas</span></u></p>   \n",
       "292                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "293   <p class=\"labeltext\"><span lang=\"ES\">La Tabla 4 muestra las reacciones adversas observadas</span><span lang=\"ES\"> con ivacaftor en monoterapia en los ensayos clínicos (estudios controlados con pla...   \n",
       "294                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "295   <p class=\"labeltext\" style=\"margin-top:0in;margin-right:0in;margin-bottom:6.0pt; margin-left:45.1pt;text-indent:-45.1pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 4: <span style=\"color:black...   \n",
       "296   <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:95.6%;margin-left:5.4pt;border-collapse:collapse;border:none\" width=\"95%\"> <thead> <tr style=\"page-break-insid...   \n",
       "297   <p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"ES\" style=\"font-size:9.0pt\">* Reacción ...   \n",
       "298   <p class=\"MsoNormal\" style=\"margin-left:7.1pt;text-indent:-7.1pt\"><sup><span lang=\"ES\" style=\"font-size:9.0pt\">†</span></sup><span lang=\"ES\" style=\"font-size: 9.0pt\"> Reacción adversa y frecuencia...   \n",
       "299                                                                                                        <p class=\"MsoNormal\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "300                                                                    <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Descripción de reacciones adversas seleccionadas</span></u></p>   \n",
       "301                                                                                                                        <p class=\"labeltextheading\"><span lang=\"ES\" style=\"font-style:normal\"> </span></p>   \n",
       "302                                                                                    <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Aumento de las aminotransferasas</span></i></p>   \n",
       "303                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "304   <p class=\"MsoNormal\"><span lang=\"ES\">Durante los estudios clínicos 1 y 2 controlados con placebo, de 48 semanas de duración, de ivacaftor en monoterapia en pacientes de 6 años o mayores, la incide...   \n",
       "305                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "306   <p class=\"MsoNormal\"><span lang=\"ES\">Durante los estudios de fase 3, controlados con placebo (hasta 24 semanas) de tezacaftor/ivacaftor, </span><span lang=\"ES\">la incidencia de niveles máximos de ...   \n",
       "307                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "308   <p class=\"MsoNormal\"><span lang=\"ES\">Durante el estudio de fase 3, controlados con placebo de 24 semanas de duración de ivacaftor/tezacaftor/elexacaftor, estas cifras fueron del 1,5 %, 2,5 % y 7,9...   \n",
       "309                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "310                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Acontecimientos de exantema</span></i></p>   \n",
       "311                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "312   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Se han observado acontecimientos de exantema, por lo general de intensidad leve a moderada, con el uso de ivacaftor en un esquem...   \n",
       "313                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "314                                                                                 <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Aumento de la creatina fosfoquinasa</span></i></p>   \n",
       "315                                                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "316   <p class=\"MsoNormal\"><span lang=\"ES\">Se observaron aumentos, por lo genral transitorios y asintomáticos, de la </span><span lang=\"ES-TRAD\">creatina fosfoquinasa </span><span lang=\"ES\">en los pacie...   \n",
       "317                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "318                                                                                            <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Presión arterial elevada</span></i></p>   \n",
       "319                                                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "320   <p class=\"MsoNormal\"><span lang=\"ES\">Se observó un aumento </span><span lang=\"ES\">de presión arterial sistólica y diastólica media desde el valor basal fue de</span><span lang=\"ES\"> 3,5 mmHg y 1,9...   \n",
       "321                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "322                                                                                                <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Población pediátrica</span></u></p>   \n",
       "323                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "324   <p class=\"MsoNormal\"><span lang=\"ES\">Los datos de seguridad de ivacaftor en monoterapia se evaluaron en 6 pacientes de entre 4 meses y menos de 6 meses de edad, 11 pacientes de entre 6 meses y men...   \n",
       "325                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "326   <p class=\"MsoNormal\"><span lang=\"ES\">El perfil de seguridad de ivacaftor (en monoterapia o en un esquema combinado) es por lo general coherente entre los pacientes pediátricos y también es coheren...   \n",
       "327                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "328   <p class=\"MsoNormal\"><span lang=\"ES\">La incidencia de </span><span lang=\"ES\">aumento de las aminotransferasas</span><span lang=\"ES\"> (ALAT o ASAT) observada en los estudios 2, 5 y 6 (pacientes de ...   \n",
       "329                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "330   <p class=\"MsoNormal\" style=\"margin-bottom:12.0pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 5: Aumentos de las aminotransferasas en pacientes de 4 meses a &lt;12 años tratados con ivacaftor ...   \n",
       "331   <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoTableGrid\" style=\"margin-left:6.85pt;border-collapse:collapse;border:none\"> <tr style=\"height:28.95pt\"> <td style=\"width:121.1pt;border:...   \n",
       "332                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "333                                                <p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"><u><span lang=\"ES\">Notificación de sospechas de reacciones adversas</span></u></p>   \n",
       "334                                                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "335   <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\">Es importante notificar sospechas de reacciones adversas al medicamento tras su autorización. Ello permite una supervisión continua...   \n",
       "336                                                                                                        <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"ES\"> </span></p>   \n",
       "337                          <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.9     </span></b><b><span lang=\"ES\">Sobredosis</span></b></p>   \n",
       "338                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "339   <p class=\"labeltext\"><span lang=\"ES\">No existe un antídoto específico para la sobredosis de ivacaftor. El tratamiento de la sobredosis consiste en las medidas de soporte generales que incluyen con...   \n",
       "340                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "341                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "342         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">5.       </span></b><b><span lang=\"ES\">PROPIEDADES FARMACOLÓGICAS</span></b></p>   \n",
       "343                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "344        <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">5.1     </span></b><b><span lang=\"ES\">Propiedades farmacodinámicas</span></b></p>   \n",
       "345                                                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "346   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Grupo farmacoterapéutico: Otros productos del sistema respiratorio, código ATC: </span><span lang=\"ES\" style=\"color:black\">R07AX...   \n",
       "347                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "348                                                                              <p class=\"MsoNormal\" style=\"margin-right:-.1pt;page-break-after:avoid\"><u><span lang=\"ES\">Mecanismo de acción</span></u></p>   \n",
       "349                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "350   <p class=\"MsoNormal\"><span lang=\"ES\">Ivacaftor es un potenciador de la proteína CFTR, es decir, ivacaftor <i>in vitro</i> aumenta la apertura del canal de CFTR para intensificar el transporte de c...   \n",
       "351                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "352   <p class=\"MsoNormal\"><span lang=\"ES\">Las respuestas <i>in vitro</i> observadas en los experimentos de fijación de membranas de un solo canal utilizando membranas de células de roedores que expresa...   \n",
       "353                                                                    <p class=\"MsoBodyText2\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"ES\" style=\"font-size:11.0pt;color:black\"> </span></p>   \n",
       "354                                                                                            <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Efectos farmacodinámicos</span></u></p>   \n",
       "355                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "356                                                                                            <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Ivacaftor en monoterapia</span></i></p>   \n",
       "357                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "358   <p class=\"labeltext\"><span lang=\"ES\">En los estudios 1 y 2 en pacientes con la mutación <i>G551D </i>en un alelo del gen <i>CFTR</i>, ivacaftor dio lugar a disminuciones rápidas (15 días), sustanc...   \n",
       "359                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "360   <p class=\"MsoNormal\"><span lang=\"ES\">En la parte 1 del estudio 5 en pacientes con una mutación de apertura del canal no <i>G551D</i> en el gen <i>CFTR</i>, el tratamiento con ivacaftor dio lugar a...   \n",
       "361                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "362   <p class=\"documenttext\" style=\"margin-bottom:0in\"><span lang=\"ES\">En el estudio 6, en pacientes de 6 años o mayores con FQ con una mutación <i>R117H</i> en el gen <i>CFTR</i>, la diferencia entre ...   \n",
       "363                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "364                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Ivacaftor en un esquema combinado con tezacaftor/ivacaftor</span></i></p>   \n",
       "365                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "366   <p class=\"MsoNormal\"><span lang=\"ES\">En pacientes homocigóticos para la mutación <i>F508del</i>, la diferencia del tratamiento entre ivacaftor en combinación con tezacaftor/ivacaftor y placebo en ...   \n",
       "367                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "368   <p class=\"MsoNormal\"><span lang=\"ES\">En pacientes heterocigóticos para la mutación <i>F508del </i>y una segunda mutación asociada a la actividad residual de <i>CFTR</i>, la diferencia del tratamie...   \n",
       "369                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "370   <p class=\"labeltext\"><span lang=\"ES\">En pacientes de 6 a menos de 12</span><span lang=\"ES\"> </span><span lang=\"ES\">años homocigóticos o heterocigóticos para la mutación <i>F508del</i> y una segund...   \n",
       "371                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "372                    <p class=\"documenttext\" style=\"margin-bottom:0in;page-break-after:avoid\"><i><span lang=\"ES-TRAD\">Ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor</span></i></p>   \n",
       "373                                                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "374   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">En</span><span lang=\"ES\"> pacientes con una mutación <i>F508del</i> en un alelo y una mutación en el segundo alelo que da lugar ...   \n",
       "375                                                                                                                             <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "376   <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\">En</span><span lang=\"ES\"> pacientes</span><span lang=\"ES\"> homocigóticos para la mutación <i>F508del</i>, la diferencia del tratami...   \n",
       "377                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "378                                                                   <p class=\"documenttext\" style=\"margin-bottom:0in;page-break-after:avoid\"><u><span lang=\"ES\">Eficacia clínica y seguridad</span></u></p>   \n",
       "379                                                    <p class=\"documenttext\" style=\"margin-bottom:0in;page-break-after:avoid\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "380                                                                       <p class=\"documenttext\" style=\"margin-bottom:0in;page-break-after:avoid\"><i><span lang=\"ES\">Ivacaftor en monoterapia</span></i></p>   \n",
       "381                                                                                                                   <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "382                      <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><u><span lang=\"ES\">Estudios 1 y 2: estudios en pacientes con FQ con mutaciones de apertura del canal G551D</span></u></i></p>   \n",
       "383                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "384   <p class=\"labeltext\"><span lang=\"ES\">Se ha evaluado la eficacia de ivacaftor en dos estudios de fase 3, aleatorizados, doble ciego, controlados con placebo, multicéntricos, de pacientes clínicamen...   \n",
       "385                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "386   <p class=\"labeltext\"><span lang=\"ES\">Los pacientes de ambos estudios fueron aleatorizados 1:1 a recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos grasos durante 48 semanas, además ...   \n",
       "387                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "388   <p class=\"labeltext\"><span lang=\"ES\">El estudio 1 evaluó a 161 pacientes de 12 años o mayores; 122 (75,8 %) pacientes presentaban la mutación <i>F508del</i> en el segundo alelo. Al inicio del estu...   \n",
       "389                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "390   <p class=\"labeltext\"><span lang=\"ES\">El estudio 2 evaluó a 52 pacientes de 6 a 11 años en el momento de la selección; el peso corporal medio (DE) era de 30,9 (8,63) kg; 42 (80,8 %) pacientes prese...   \n",
       "391                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "392   <p class=\"labeltext\"><span lang=\"ES\">La variable principal de eficacia en ambos estudios fue el cambio absoluto medio desde el valor basal en el porcentaje predicho de VEF<sub>1</sub> hasta la sem...   \n",
       "393                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "394   <p class=\"labeltext\"><span lang=\"ES\">La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF<sub>1</sub> desde el valor...   \n",
       "395                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "396   <p class=\"MsoNormal\"><span lang=\"ES\">La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF<sub>1</sub> desde el valor...   \n",
       "397                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "398                              <p class=\"labeltext\"><span lang=\"ES\">Los resultados correspondientes a las variables de valoración secundarias clínicamente relevantes se muestran en la Tabla 6.</span></p>   \n",
       "399                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "400               <p class=\"labeltext\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 6: Efecto de ivacaftor en otras variables de eficacia en los estudios 1 y 2</span></b></p>   \n",
       "401   <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"98%\"> <thead> <tr style=\"height:10.5pt\"> <td style=\"width:27.94%;border...   \n",
       "402   <p class=\"tablefootnote\" style=\"margin-top:6.0pt;page-break-after:avoid\"><span lang=\"ES\" style=\"font-size:9.0pt;color:white\">IC: Intervalo de confianza; NA: no analizado debido a la baja incidenci...   \n",
       "403   <p class=\"tablefootnote\" style=\"page-break-after:avoid\"><sup><span lang=\"ES\" style=\"font-size:9.0pt\">a        </span></sup><span lang=\"ES\" style=\"font-size: 9.0pt\">Diferencia del tratamiento = efe...   \n",
       "404   <p class=\"tablefootnote\" style=\"margin-left:14.2pt;text-indent:-14.2pt; page-break-after:avoid\"><sup><span lang=\"ES\" style=\"font-size:9.0pt\">b</span></sup><span lang=\"ES\" style=\"font-size:9.0pt\"> ...   \n",
       "405   <p class=\"tablefootnote\" style=\"margin-left:14.2pt;text-indent:-14.2pt; page-break-after:avoid\"><sup><span lang=\"ES\" style=\"font-size:9.0pt\">c</span></sup><span lang=\"ES\" style=\"font-size:9.0pt\"> ...   \n",
       "406   <p class=\"tablefootnotelast\" style=\"margin-bottom:0in;page-break-after:avoid\"><sup><span lang=\"ES\" style=\"font-size:9.0pt\">d        </span></sup><span lang=\"ES\" style=\"font-size:9.0pt\">Proporción ...   \n",
       "407   <p class=\"tablefootnotelast\" style=\"margin-bottom:0in\"><sup><span lang=\"ES\" style=\"font-size:9.0pt\">e        </span></sup><span lang=\"ES\" style=\"font-size: 9.0pt\">En sujetos menores de 20 años (gr...   \n",
       "408                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "409                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><u><span lang=\"ES\">Estudio 5: estudio en pacientes con FQ con mutaciones de apertura del canal no G551D</span></u></i></p>   \n",
       "410                                                                                                                     <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\"> </span></p>   \n",
       "411   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">El estudio 5 fue un estudio de fase 3, de dos partes, aleatorizado, doble ciego, controlado con placebo y cruzado (parte 1) segu...   \n",
       "412                                                                                                        <p class=\"MsoNormal\"><s><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></s></p>   \n",
       "413   <p class=\"labeltext\"><span lang=\"ES\">En la parte 1, los pacientes fueron aleatorizados 1:1 para recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos que contenían grasas durante 8 sem...   \n",
       "414                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "415   <p class=\"labeltext\"><span lang=\"ES\">Se incluyó en el estudio a 39 pacientes (edad media: 23 años) con un </span><span lang=\"ES\">porcentaje predicho de VEF<sub>1</sub> basal ≥40 % (porcentaje pred...   \n",
       "416                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "417   <p class=\"MsoNormal\"><span lang=\"ES\">En la parte 1 del estudio 5, el porcentaje predicho medio de VEF<sub>1</sub> </span><span lang=\"ES\">basal en los pacientes tratados con placebo fue del 79,3 % ...   \n",
       "418                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "419   <p class=\"MsoNormal\"><span lang=\"ES\">El efecto de ivacaftor en la población global del estudio 5 (incluidas las variables secundarias del cambio absoluto en el IMC a las 8 semanas de tratamiento y...   \n",
       "420                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "421   <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:6.0pt; margin-left:40.55pt;text-indent:-40.55pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 7: Efecto de ivacaftor pa...   \n",
       "422   <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\"> <tr> <td colspan=\"2\" style=\"width:150.95pt;border:solid windowtext 1.0pt;   p...   \n",
       "423   <p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:13.6pt;margin-bottom:.0001pt;text-indent:-13.6pt;page-break-after: avoid\"><sup><span lang=\"ES\" style=\"f...   \n",
       "424   <p class=\"MsoNormal\" style=\"margin-left:13.5pt;text-indent:-13.5pt;page-break-after: avoid\"><sup><span lang=\"ES\" style=\"font-size:9.0pt\">†</span></sup><span lang=\"ES\" style=\"font-size:9.0pt\">     ...   \n",
       "425   <p class=\"MsoNormal\" style=\"margin-left:13.6pt;text-indent:-13.6pt;page-break-after: avoid\"><sup><span lang=\"ES\" style=\"font-size:9.0pt\">††</span></sup><span lang=\"ES\" style=\"font-size:9.0pt\">   n...   \n",
       "426   <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:2.0pt; margin-left:13.5pt;text-indent:-13.5pt\"><i><sup><span lang=\"ES\" style=\"font-size: 9.0pt\">#</span></sup></i><span la...   \n",
       "427                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "428   <p class=\"MsoNormal\"><span lang=\"ES\">En la parte 2 del estudio 5</span><span lang=\"ES\">, el cambio absoluto medio (DE) en </span><span lang=\"ES\">el porcentaje predicho de VEF<sub>1</sub> </span><s...   \n",
       "429                                                                                                        <p class=\"labeltext\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "430                                <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><u><span lang=\"ES\">Estudio 3: estudio en pacientes con FQ con la mutación F508del en el gen CFTR</span></u></i></p>   \n",
       "431                                                                                                                     <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\"> </span></p>   \n",
       "432   <p class=\"MsoNormal\"><span lang=\"ES\">El estudio 3 (parte A) fue un estudio de fase 2, de grupos paralelos, controlado con placebo, doble ciego, aleatorizado 4:1, de 16 semanas de duración, en el q...   \n",
       "433                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "434   <p class=\"MsoNormal\"><span lang=\"ES\">El cambio absoluto medio desde el valor basal hasta la semana 16 en el porcentaje predicho de VEF<sub>1</sub> (variable principal de eficacia) fue de 1,5 punto...   \n",
       "435                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "436                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><u><span lang=\"ES\">Estudio 4: estudio de extensión abierta</span></u></i></p>   \n",
       "437                                                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "438   <p class=\"MsoNormal\"><span lang=\"ES\" style=\"color:black\">En el estudio 4 los pacientes que completaron el tratamiento en los estudios 1 y 2 con placebo pasaron al tratamiento con ivacaftor mientra...   \n",
       "439                                                                                                                                     <p class=\"MsoNormal\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "440   <p class=\"MsoNormal\"><span lang=\"ES\" style=\"color:black\">Ciento cuarenta y cuatro (144) pacientes del estudio 1 pasaron al estudio 4, 67 del grupo de placebo/ivacaftor y 77 del grupo de ivacaftor/...   \n",
       "441                                                                                                                                     <p class=\"MsoNormal\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "442   <p class=\"MsoNormal\"><span lang=\"ES\" style=\"color:black\">La Tabla 8 muestra los resultados del cambio absoluto medio (DE) en el porcentaje predicho de VEF<sub>1</sub> para ambos grupos de paciente...   \n",
       "443                                                                                                                                     <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "444   <p class=\"labeltext\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 8: Efecto de ivacaftor </span></b><b><span lang=\"ES\" style=\"color:black\">en el porcentaje predicho ...   \n",
       "445   <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\"> <tr> <td style=\"width:99.4pt;border:solid windowtext 1.0pt;   padding:0in 5.4...   \n",
       "446   <p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;page-break-after: avoid\"><sup><span lang=\"ES\" style=\"f...   \n",
       "447   <p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt\"><sup><span lang=\"ES\" style=\"font-size:9.0pt;position:relative;top:-3.0pt\">†</span></sup><span lang=\"ES\" style=\"font-size:9.0pt\">...   \n",
       "448                                                                                                                                     <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "449   <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\">Cuando se compara el cambio absoluto medio (DE) en el porcentaje predicho de VEF<sub>1</sub> desde el valor basal del estudio 4 para los pa...   \n",
       "450                                                                                                                                     <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "451   <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\">Para los pacientes del grupo de placebo/ivacaftor del estudio 1, la tasa anualizada de exacerbaciones pulmonares fue más alta en el estudio...   \n",
       "452                                                                                                                                     <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "453                                     <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\">Para los pacientes que pasaron del estudio 2, el número de acontecimientos fue, en general, bajo.</span></p>   \n",
       "454                                                                                                                                     <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "455                                 <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><u><span lang=\"ES\">Estudio 6: estudio en pacientes con FQ con una mutación R117H en el gen CFTR</span></u></i></p>   \n",
       "456                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "457   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">En el estudio 6 se evaluaron 69 pacientes de 6 años o mayores; 53 (76,8 %) pacientes tenían la mutación <i>F508del</i> en el seg...   \n",
       "458                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "459   <p class=\"MsoNormal\"><span lang=\"ES\">Se realizó un análisis de subgrupos previamente planificado en pacientes de 18 años o mayores (26 pacientes con placebo y 24 con ivacaftor). El tratamiento con...   \n",
       "460                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "461   <p class=\"MsoNormal\"><span lang=\"ES\">En un análisis de subgrupos en pacientes </span><span lang=\"ES\">con una variante genética <i>R117H-5T </i>confirmada, la diferencia en el cambio absoluto medio...   \n",
       "462                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "463   <p class=\"MsoNormal\"><span lang=\"ES\">Para las variables secundarias de eficacia, no se observaron diferencias del tratamiento para ivacaftor frente a placebo en el cambio absoluto desde el valor b...   \n",
       "464                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "465   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Ivacaftor en un esquema combinado con tezacaftor/ivacaftor o con</span><span lang=\"ES\"> ivacaftor/tezacaftor/elexacaftor</spa...   \n",
       "466                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "467   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Se evaluaron la eficacia y la seguridad de ivacaftor en un esquema combinado con tezacaftor/ivacaftor en pacientes con FQ de 12 ...   \n",
       "468                                                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "469   <p class=\"MsoNormal\"><span lang=\"ES\">Se demostraron la eficacia y la seguridad de ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor en pacientes de 12 años o mayores en dos es...   \n",
       "470                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "471                                                                                                <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Población pediátrica</span></u></p>   \n",
       "472                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "473                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Ivacaftor en un esquema combinado con tezacaftor/ivacaftor</span></i></p>   \n",
       "474                                                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "475   <p class=\"MsoNormal\"><span lang=\"ES\">Se evaluó la eficacia y la seguridad en pacientes de 6 a menos de 12 años (edad media de 8,6</span><span lang=\"ES\"> años</span><span lang=\"ES\">) en un estudio ...   \n",
       "476                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "477   <p class=\"MsoNormal\"><span lang=\"ES\">La Agencia Europea de Medicamentos </span><span lang=\"ES\">ha concedido al titular un aplazamiento para presentar </span><span lang=\"ES\">los resultados de los e...   \n",
       "478                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "479        <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">5.2     </span></b><b><span lang=\"ES\">Propiedades farmacocinéticas</span></b></p>   \n",
       "480                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "481                     <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">La farmacocinética de ivacaftor es similar entre los voluntarios adultos sanos y los pacientes con FQ.</span></p>   \n",
       "482                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "483   <p class=\"MsoNormal\"><span lang=\"ES\">Después de la administración oral de una dosis única de 150 mg a voluntarios sanos con el estómago lleno, la media (± DE) para el AUC y la C<sub>máx</sub> fue ...   \n",
       "484                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "485                                                                                                         <p class=\"labeltextheading\"><u><span lang=\"ES\" style=\"font-style:normal\">Absorción</span></u></p>   \n",
       "486                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "487   <p class=\"labeltext\"><span lang=\"ES\">Después de la administración oral de dosis múltiples de ivacaftor, la exposición a ivacaftor aumentó por lo general con la dosis, de 25 mg cada 12 horas a 450 ...   \n",
       "488                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "489   <p class=\"MsoNormal\"><span lang=\"ES\">El granulado de ivacaftor (2 sobres de 75 mg) presentó una biodisponibilidad similar a la de los comprimidos de 150 mg cuando se administraron con alimentos qu...   \n",
       "490                                                                                                        <p class=\"MsoNormal\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "491                                                                                     <p class=\"MsoNormal\" style=\"margin-right:-.1pt;page-break-after:avoid\"><u><span lang=\"ES\">Distribución</span></u></p>   \n",
       "492                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "493   <p class=\"labeltext\"><span lang=\"ES\">Aproximadamente el 99 % de ivacaftor se fija a las proteínas plasmáticas, principalmente a la alfa-1 glicoproteína ácida y a la albúmina. Ivacaftor no se fija ...   \n",
       "494                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "495                                                                                                   <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Biotransformación</span></u></p>   \n",
       "496                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "497   <p class=\"labeltext\"><span lang=\"ES\">Ivacaftor se metaboliza extensamente en humanos. Los datos <i>in vitro</i> e <i>in vivo</i> indican que ivacaftor se metaboliza principalmente por CYP3A. El M1...   \n",
       "498                                                                                                        <p class=\"MsoNormal\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "499   <p class=\"MsoNormal\"><span lang=\"ES\">El efecto del genotipo heterocigótico de CYP3A4*22 en la exposición a </span><span lang=\"ES\">ivacaftor, tezacaftor y elexacaftor</span><span lang=\"ES\"> es cohe...   \n",
       "500                                                                                                        <p class=\"MsoNormal\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "501                                                                                      <p class=\"MsoNormal\" style=\"margin-right:-.1pt;page-break-after:avoid\"><u><span lang=\"ES\">Eliminación</span></u></p>   \n",
       "502                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "503   <p class=\"labeltext\"><span lang=\"ES\">Tras la administración oral</span><span lang=\"ES\"> en voluntarios sanos</span><span lang=\"ES\">, la mayor parte de ivacaftor (87,8 %) fue eliminada en las heces...   \n",
       "504                                                                                                        <p class=\"MsoNormal\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "505                                                                                            <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Linealidad/No linealidad</span></u></p>   \n",
       "506                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "507                                    <p class=\"MsoNormal\"><span lang=\"ES\">La farmacocinética de ivacaftor es en general lineal con respecto al tiempo o al intervalo de dosis de 25 mg a 250 mg.</span></p>   \n",
       "508                                                                                          <p class=\"labeltextheading\" style=\"page-break-after:auto\"><span lang=\"ES\" style=\"font-style:normal\"> </span></p>   \n",
       "509                                                                                            <p class=\"labeltextheading\"><u><span lang=\"ES\" style=\"font-style:normal\">Poblaciones especiales</span></u></p>   \n",
       "510                                                                                                                        <p class=\"labeltextheading\"><span lang=\"ES\" style=\"font-style:normal\"> </span></p>   \n",
       "511                                                                                              <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Insuficiencia hepática</span></i></p>   \n",
       "512                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "513   <p class=\"labeltext\"><span lang=\"ES\">Tras una sola dosis de 150 mg de ivacaftor, los sujetos adultos con insuficiencia hepática moderada (Child‑Pugh Clase B, puntuación 7 a 9) presentaron una C<su...   \n",
       "514                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "515   <p class=\"labeltext\"><span lang=\"ES\">En los sujetos con insuficiencia hepática moderada (Child‑Pugh Clase B, puntuación 7 a 9), el AUC de ivacaftor aumentó aproximadamente el 50 % tras la administ...   \n",
       "516                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "517   <p class=\"labeltext\"><span lang=\"ES\">No se ha estudiado el impacto de la insuficiencia hepática grave (Child-Pugh Clase C, puntuación 10 a 15) en la farmacocinética de ivacaftor en monoterapia o e...   \n",
       "518                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "519                                         <p class=\"labeltext\"><span lang=\"ES-TRAD\">Para obtener orientación sobre el uso adecuado y la modificación de la dosis, ver Tabla 3 en la sección 4.2.</span></p>   \n",
       "520                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "521                                                                                                 <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Insuficiencia renal</span></i></p>   \n",
       "522                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "523   <p class=\"labeltext\"><span lang=\"ES\">No se han realizado estudios farmacocinéticos con ivacaftor en pacientes con insuficiencia renal, ni en monoterapia ni en un esquema combinado con tezacaftor/i...   \n",
       "524                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "525   <p class=\"labeltext\"><span lang=\"ES\">No se recomienda ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Se recomienda precaución cuando se administre ivacaftor, en monoterapia...   \n",
       "526                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "527                                                                                                                <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Raza</span></i></p>   \n",
       "528                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "529   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">En función del análisis de FC poblacional, la raza no tuvo ningún efecto clínicamente significativo en la FC de ivacaftor en pac...   \n",
       "530                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "531                                                                                                                <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Sexo</span></i></p>   \n",
       "532                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "533   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Los parámetros farmacocinéticos de ivacaftor, en monoterapia o en combinación con tezacaftor/</span><span lang=\"ES-TRAD\">ivacaft...   \n",
       "534                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "535                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Pacientes de edad avanzada</span></i></p>   \n",
       "536                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "537   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Los estudios clínicos con ivacaftor en monoterapia no incluyeron un número suficiente de pacientes de 65 años o mayores para det...   \n",
       "538                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "539   <p class=\"labeltext\"><span lang=\"ES\">Los parámetros farmacocinéticos de ivacaftor en combinación con tezacaftor en pacientes de edad avanzada (65‑72 años) son comparables a los de los adultos más ...   \n",
       "540                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "541                                                                                              <p class=\"labeltextheading\"><u><span lang=\"ES\" style=\"font-style:normal\">Población pediátrica</span></u></p>   \n",
       "542                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "543   <p class=\"MsoNormal\"><span lang=\"ES\">En la Tabla 9 se presenta por grupo de edad la exposición a ivacaftor predicha según las concentraciones de ivacaftor observadas en los estudios de fase 2 y 3,...   \n",
       "544                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "545                                    <p class=\"MsoNormal\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 9: Exposición media (DE) a ivacaftor por grupo de edad</span></b></p>   \n",
       "546   <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:98.9%;border-collapse:collapse;border:none\" width=\"98%\"> <thead> <tr style=\"page-break-inside:avoid;height:23....   \n",
       "547   <p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:14.45pt;margin-bottom:.0001pt;text-indent:-14.45pt;page-break-after: avoid\"><sup><span lang=\"ES\" style=...   \n",
       "548   <p class=\"MsoNormal\" style=\"margin-left:14.45pt;text-indent:-14.45pt\"><sup><span lang=\"ES\" style=\"font-size:9.0pt;position:relative;top:-3.0pt\">†</span></sup><span lang=\"ES\" style=\"font-size:9.0pt...   \n",
       "549                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "550   <p class=\"MsoNormal\"><span lang=\"ES\">La exposición  </span><span lang=\"ES\">de ivacaftor en combinación con tezacaftor y con </span><a name=\"_Hlk46396589\"><span lang=\"ES\">tezacaftor/elexacaftor </s...   \n",
       "551                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "552   <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:6.0pt; margin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 10: Exposición media (DE)...   \n",
       "553   <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"623\"> <tr style=\"height:26.55pt\"> <td style=\"width:39.36%;border:solid ...   \n",
       "554   <p class=\"MsoNormal\"><sup><span lang=\"ES\" style=\"font-size:10.0pt\">*</span></sup><span lang=\"ES\" style=\"font-size:10.0pt\">Las exposiciones en el intervalo de peso de </span><span lang=\"ES\" style=\"...   \n",
       "555                                                                                                        <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"ES\"> </span></p>   \n",
       "556                                 <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">5.3     Datos preclínicos sobre seguridad</span></b></p>   \n",
       "557                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "558   <p class=\"MsoNormal\"><span lang=\"ES\">Los datos de los estudios preclínicos no muestran riesgos especiales para los seres humanos según los estudios convencionales de farmacología de seguridad, tox...   \n",
       "559                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "560                                                                                               <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Embarazo y fertilidad</span></u></p>   \n",
       "561                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "562   <p class=\"MsoNormal\"><span lang=\"ES\">Ivacaftor se asoció a una disminución ligera del peso de las vesículas seminales, a una disminución del índice de fertilidad global </span><span lang=\"ES\">y de...   \n",
       "563                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "564                                                                                     <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Desarrollo perinatal y posnatal</span></u></p>   \n",
       "565                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "566   <p class=\"MsoNormal\"><span lang=\"ES\">Ivacaftor redujo los índices de supervivencia </span><span lang=\"ES\">y lactancia y produjo una disminución en los pesos corporales de las crías. La dosis sin e...   \n",
       "567                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "568                                                                                        <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Estudios en animales jóvenes</span></u></p>   \n",
       "569                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "570   <p class=\"MsoNormal\"><span lang=\"ES\">Se observaron cataratas en las ratas jóvenes tratadas desde el día 7 después de nacer hasta el día 35 a niveles de exposición de ivacaftor de 0,22 veces la dos...   \n",
       "571                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "572                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "573                                              <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">6.       DATOS FARMACÉUTICOS</span></b></p>   \n",
       "574                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "575                <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">6.1     </span></b><b><span lang=\"ES\">Lista de excipientes</span></b></p>   \n",
       "576                                                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "577                                                                                               <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Núcleo del comprimido</span></u></p>   \n",
       "578                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "579                                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Celulosa microcristalina</span></p>   \n",
       "580                                                                                                        <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Lactosa monohidrato</span></p>   \n",
       "581                                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Succinato acetato de hipromelosa</span></p>   \n",
       "582                                                                                                       <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Croscarmelosa sódica</span></p>   \n",
       "583                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Laurilsulfato</span><span lang=\"ES\"> sódico (E487)</span></p>   \n",
       "584                                                                                                    <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Sílice coloidal anhidra</span></p>   \n",
       "585                                                                                                                                     <p class=\"MsoNormal\"><span lang=\"ES\">Estearato de magnesio</span></p>   \n",
       "586                                                                                                                                                  <p class=\"MsoNormal\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "587                                                                                             <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Película del comprimido</span></u></p>   \n",
       "588                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "589                                                                                                                                     <p class=\"MsoNormal\"><span lang=\"PT\">Alcohol de polivinilo</span></p>   \n",
       "590                                                                                                                                 <p class=\"MsoNormal\"><span lang=\"PT\">Dióxido de titanio (E171)</span></p>   \n",
       "591                                                                                         <p class=\"MsoNormal\"><span lang=\"PT\">Macrogol</span><span lang=\"PT\"> </span><span lang=\"PT\">(PEG 3350)</span></p>   \n",
       "592                                                                                                                                                     <p class=\"MsoNormal\"><span lang=\"PT\">Talco</span></p>   \n",
       "593                                                                                                                     <p class=\"MsoNormal\"><span lang=\"PT\">Laca de aluminio índigo carmín (E132)</span></p>   \n",
       "594                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\">Cera de carnauba</span></p>   \n",
       "595                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "596                                                                                                  <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Tinta de impresión</span></u></p>   \n",
       "597                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "598                                                                                                                    <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"PT\">Shellac</span></p>   \n",
       "599                                                                                               <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"PT\">Óxido de hierro negro (E172)</span></p>   \n",
       "600                                                                                                     <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Propilenglicol (E1520)</span></p>   \n",
       "601                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\">Solución concentrada de amoníaco</span></p>   \n",
       "602                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "603                  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">6.2     </span></b><b><span lang=\"ES\">Incompatibilidades</span></b></p>   \n",
       "604                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "605                                                                                                                                               <p class=\"MsoNormal\"><span lang=\"ES\">No procede.</span></p>   \n",
       "606                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "607                  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">6.3     </span></b><b><span lang=\"ES\">Periodo de validez</span></b></p>   \n",
       "608                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "609                                                                                                                                                   <p class=\"MsoNormal\"><span lang=\"ES\">4 años.</span></p>   \n",
       "610                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "611   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">6.4     </span></b><b><span lang=\"ES\">Precauciones especiales de conservación</span...   \n",
       "612                                                                                <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><span lang=\"ES\"> </span></p>   \n",
       "613                                                                                                       <p class=\"MsoNormal\"><span lang=\"ES\">No requiere condiciones especiales de conservación.</span></p>   \n",
       "614                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "615   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">6.5     </span></b><b><span lang=\"ES\">Naturaleza y contenido del envase</span></b></p>   \n",
       "616                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "617   <p class=\"MsoNormal\"><span lang=\"ES\">Los comprimidos recubiertos con película están envasados en blísteres termoformados (policlorotrifluoroetileno [PCTFE]/papel de aluminio) o en un frasco de pol...   \n",
       "618                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "619                                                                 <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Kalydeco 75 mg comprimidos recubiertos con película</span></u></p>   \n",
       "620                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "621                                                                        <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Están disponibles los siguientes tamaños de envase:</span></p>   \n",
       "622   <p class=\"MsoNormal\" style=\"margin-left:13.6pt;text-indent:-13.6pt\"><span lang=\"ES\" style=\"font-size:8.0pt;font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>      </span></span><span...   \n",
       "623                                                                                                        <p class=\"MsoNormal\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "624                                                                <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Kalydeco 150 mg comprimidos recubiertos con película</span></u></p>   \n",
       "625                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "626                                                                        <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Están disponibles los siguientes tamaños de envase:</span></p>   \n",
       "627   <p class=\"MsoNormal\" style=\"margin-left:13.6pt;text-indent:-13.6pt\"><span lang=\"ES\" style=\"font-size:8.0pt;font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>      </span></span><span...   \n",
       "628   <p class=\"MsoNormal\" style=\"margin-left:13.6pt;text-indent:-13.6pt\"><span lang=\"ES\" style=\"font-size:8.0pt;font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>      </span></span><span...   \n",
       "629   <p class=\"MsoNormal\" style=\"margin-left:13.6pt;text-indent:-13.6pt\"><span lang=\"ES\" style=\"font-size:8.0pt;font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>      </span></span><span...   \n",
       "630                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "631                                                                                     <p class=\"MsoNormal\"><span lang=\"ES\">Puede que solamente estén comercializados algunos tamaños de envases.</span></p>   \n",
       "632                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "633   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><a name=\"OLE_LINK1\"><b><span lang=\"ES\">6.6     Precauciones especiales de eliminación</span></b></a><b...   \n",
       "634                                                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "635   <p class=\"MsoNormal\"><span lang=\"ES\">La eliminación del medicamento no utilizado y de todos los materiales que hayan estado en contacto con él se realizará de acuerdo con la normativa local.</span...   \n",
       "636                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "637                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "638                   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">7.       TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN</span></b></p>   \n",
       "639                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "640                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\">Vertex Pharmaceuticals (Ireland) Limited</p>   \n",
       "641                                                                                                                       <p class=\"MsoNormal\" style=\"page-break-after:avoid\">28-32 Pembroke Street Upper</p>   \n",
       "642                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Dublin 2, D02 EK84</span></p>   \n",
       "643                                                                                                                                                   <p class=\"MsoNormal\"><span lang=\"ES\">Irlanda</span></p>   \n",
       "644                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "645                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "646   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">8.       </span></b><b><span lang=\"ES\">NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓ...   \n",
       "647                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "648                                                                                                            <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">EU/1/12/782/001</span></p>   \n",
       "649                                                                                                            <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">EU/1/12/782/002</span></p>   \n",
       "650                                                                                                                                           <p class=\"MsoNormal\"><span lang=\"ES\">EU/1/12/782/005</span></p>   \n",
       "651                                                                                                                                           <p class=\"MsoNormal\"><span lang=\"ES\">EU/1/12/782/007</span></p>   \n",
       "652                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "653                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "654   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">9.       FECHA DE LA PRIMERA AUTORIZACIÓN/RENOVACIÓN DE LA AUTORIZACIÓN</span></b></p>   \n",
       "655                                                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "656                                                                            <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Fecha de la primera autorización: 23/julio/2012</span></p>   \n",
       "657                                                                                                              <p class=\"MsoNormal\"><span lang=\"ES\">Fecha de la última renovación: 28/abril/2017</span></p>   \n",
       "658                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "659                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "660         <p class=\"MsoNormal\" style=\"margin-left:28.1pt;text-indent:-28.1pt;page-break-after: avoid\"><b><span lang=\"ES\">10.    </span></b><b><span lang=\"ES\">FECHA DE LA REVISIÓN DEL TEXTO</span></b></p>   \n",
       "661                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "662   <p class=\"MsoNormal\"><span lang=\"ES\">La información detallada de este medicamento está disponible en la página web de la Agencia Europea de Medicamentos </span><span lang=\"ES\"><a href=\"http://www....   \n",
       "663                                                                   <span lang=\"ES\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/> </span>   \n",
       "664                                                                                                                                                        <br clear=\"all\" style=\"page-break-before:always\"/>   \n",
       "665             <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">1.       </span></b><b><span lang=\"ES\">NOMBRE DEL MEDICAMENTO</span></b></p>   \n",
       "666                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "667                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\">Kalydeco 25 mg granulado en sobre</span></p>   \n",
       "668                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\">Kalydeco 50 mg granulado en sobre</span></p>   \n",
       "669                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\">Kalydeco 75 mg granulado en sobre</span></p>   \n",
       "670                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "671                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "672   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">2.       </span></b><b><span lang=\"ES\">COMPOSICIÓN CUALITATIVA Y CUANTITATIVA</span...   \n",
       "673                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "674                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Kalydeco 25 mg granulado en sobre</span></u></p>   \n",
       "675                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "676                                                                                    <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Cada sobre contiene 25 mg de ivacaftor.</span></p>   \n",
       "677                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "678                                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Excipiente con efecto conocido</span></i></p>   \n",
       "679                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "680                                                                        <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Cada sobre contiene 36,6 mg de lactosa monohidrato.</span></p>   \n",
       "681                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "682                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Kalydeco 50 mg granulado en sobre</span></u></p>   \n",
       "683                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "684                                                                                                                   <p class=\"MsoNormal\"><span lang=\"ES\">Cada sobre contiene 50 mg de ivacaftor.</span></p>   \n",
       "685                                                                                                        <p class=\"MsoNormal\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "686                                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Excipiente con efecto conocido</span></i></p>   \n",
       "687                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "688                                                                                                       <p class=\"MsoNormal\"><span lang=\"ES\">Cada sobre contiene 73,2 mg de lactosa monohidrato.</span></p>   \n",
       "689                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "690                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Kalydeco 75 mg granulado en sobre</span></u></p>   \n",
       "691                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "692                                                                                    <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Cada sobre contiene 75 mg de ivacaftor.</span></p>   \n",
       "693                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "694                                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Excipiente con efecto conocido</span></i></p>   \n",
       "695                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "696                                                                       <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Cada sobre contiene 109,8 mg de lactosa monohidrato.</span></p>   \n",
       "697                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "698                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Para consultar la lista completa de excipientes, ver sección 6.1.</span></p>   \n",
       "699                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "700                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "701                 <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">3.       </span></b><b><span lang=\"ES\">FORMA FARMACÉUTICA</span></b></p>   \n",
       "702                                                     <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph; page-break-after:avoid;text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "703                                                                                                        <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Granulado en sobre.</span></p>   \n",
       "704                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "705                                               <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Granulado de color blanco a blanquecino de 2 mm aproximadamente de diámetro.</span></p>   \n",
       "706                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "707                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "708   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\" style=\"text-transform:uppercase\">4.       </span></b><b><span lang=\"ES\" style=\"text...   \n",
       "709                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "710           <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.1     </span></b><b><span lang=\"ES\">Indicaciones terapéuticas</span></b></p>   \n",
       "711                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "712   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Kalydeco granulado está indicado para el tratamiento de lactantes de al menos 4 meses y niños con un peso de 5 kg a menos de 25 ...   \n",
       "713                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "714   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.2     </span></b><b><span lang=\"ES\">Posología y forma de administración</span></b...   \n",
       "715                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "716   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Únicamente los médicos con experiencia en el tratamiento de la fibrosis quística deben prescribir Kalydeco. </span><span lang=\"E...   \n",
       "717                                                                                                        <p class=\"MsoNormal\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "718                                                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Posología</span></u></p>   \n",
       "719                                                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "720   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">La dosis</span><span lang=\"ES\"> en lactantes de al menos 4 meses, niños, adolescentes y adultos </span><span lang=\"ES\">debe ser ...   \n",
       "721                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "722                    <p class=\"MsoNormal\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 1: Recomendaciones posológicas para los pacientes de 4 meses o mayores</span></b></p>   \n",
       "723   <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\"> <thead> <tr style=\"height:10.85pt\"> <td style=\"width:78.7pt;border:solid wind...   \n",
       "724                                                                                                                             <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "725                                                                                 <p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"><i><span lang=\"ES\">Dosis olvidadas</span></i></p>   \n",
       "726                                                                                                                             <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "727   <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\">Si han transcurrido 6 horas o menos desde la dosis olvidada de la mañana o de la noche, </span><span lang=\"ES-TRAD\">se debe indicar...   \n",
       "728                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "729                                                                            <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Uso concomitante de inhibidores de CYP3A</span></i></p>   \n",
       "730                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "731   <p class=\"labeltext\"><span lang=\"ES\">En administración concomitante con inhibidores potentes de CYP3A en pacientes de 6 meses o mayores, la dosis de ivacaftor se debe reducir a un sobre (25 mg de ...   \n",
       "732                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "733   <p class=\"labeltext\"><span lang=\"ES\">En administración concomitante con inhibidores moderados de CYP3A en pacientes de 6 meses o mayores, la dosis de ivacaftor es la recomendada anteriormente, per...   \n",
       "734                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "735   <p class=\"MsoNormal\"><span lang=\"ES\">Debido a la variabilidad en la maduración de las enzimas del citocromo (CYP) que intervienen en el metabolismo de ivacaftor, no se recomienda el tratamiento co...   \n",
       "736                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "737                                                                                              <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Poblaciones especiales</span></u></p>   \n",
       "738                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "739                                                                                                 <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Insuficiencia renal</span></i></p>   \n",
       "740                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "741   <p class=\"labeltext\"><span lang=\"ES\">No es necesario ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Se recomienda precaución en pacientes con insuficiencia renal grave (acl...   \n",
       "742                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "743                                                                                                                             <p class=\"labeltextheading\"><span lang=\"ES\">Insuficiencia hepática</span></p>   \n",
       "744                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "745   <p class=\"labeltext\"><span lang=\"ES\">No es necesario ajustar la dosis en pacientes de 6 meses o mayores con insuficiencia hepática leve (Child-Pugh Clase A). Para los pacientes de 6 meses o mayore...   \n",
       "746                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "747   <p class=\"labeltext\"><span lang=\"ES\">Debido a la variabilidad en la maduración de las enzimas del citocromo (CYP) que intervienen en el metabolismo de ivacaftor, no se recomienda el tratamiento co...   \n",
       "748                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "749                                                                                                <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Población pediátrica</span></u></p>   \n",
       "750                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "751             <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">No se ha establecido la seguridad y eficacia de ivacaftor en niños menores de 4 meses. No se dispone de datos.</span></p>   \n",
       "752                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "753   <p class=\"labeltext\"><span lang=\"ES\">Los datos disponibles en pacientes menores de 6 años con una mutación <i>R117H</i> en el gen <i>CFTR</i> son limitados. </span><span lang=\"ES\">Los datos dispon...   \n",
       "754                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "755                                                                                             <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Forma de administración</span></u></p>   \n",
       "756                                                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "757                                                                                              <p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"><span lang=\"ES\">Vía oral.</span></p>   \n",
       "758                                                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "759                                                                                      <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\">Cada sobre es únicamente de un solo uso.</span></p>   \n",
       "760                                                                                                                             <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "761   <p class=\"MsoNormal\"><span lang=\"ES\">Cada sobre de granulado se debe mezclar con 5 ml de un alimento blando o líquido adecuado para la edad y consumir todo inmediatamente. El alimento o el líquido...   \n",
       "762                                                                                                                             <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "763                        <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\">Se deben evitar los alimentos o bebidas que contienen pomelo durante el tratamiento (ver sección 4.5).</span></p>   \n",
       "764                                                                                                                             <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "765                                                <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.3     Contraindicaciones</span></b></p>   \n",
       "766                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "767                                 <p class=\"MsoNormalIndent\" style=\"margin:0in\"><span lang=\"ES\">Hipersensibilidad al principio activo o a alguno de los excipientes incluidos en la sección 6.1.</span></p>   \n",
       "768                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "769   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.4     </span></b><b><span lang=\"ES\">Advertencias y precauciones especiales de emp...   \n",
       "770                                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "771   <p class=\"MsoNormal\"><span lang=\"ES\">Únicamente los pacientes con FQ con una mutación </span><span lang=\"ES\">de apertura del canal (clase III): </span><i><span lang=\"ES\">G551D, </span><span lang=\"...   \n",
       "772                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "773   <p class=\"MsoNormal\"><span lang=\"ES\">En el estudio 6, se ha demostrado menos evidencia de un efecto positivo de ivacaftor en pacientes con una mutación <i>R117H-7T</i> asociada a una menor graveda...   \n",
       "774                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "775   <p class=\"MsoNormal\"><span lang=\"ES\">En el estudio 5 fueron incluidos cuatro pacientes con la mutación <i>G970R</i>. En tres de los cuatro pacientes el cambio en la prueba de </span><span lang=\"ES...   \n",
       "776                                                                                                        <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"ES\"> </span></p>   \n",
       "777   <p class=\"MsoNormal\"><span lang=\"ES\">Los resultados de eficacia de un estudio de fase 2 en pacientes con FQ homocigóticos para la mutación <i>F508del </i>en el gen <i>CFTR</i> no mostraron una dif...   \n",
       "778                                         <p class=\"labeltextheading\" style=\"page-break-after:auto\"><u><span lang=\"ES\" style=\"font-style:normal\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "779                                                                      <p class=\"labeltextheading\"><u><span lang=\"ES\" style=\"font-style:normal\">Efecto en las pruebas de la función hepática</span></u></p>   \n",
       "780                                                                                                                        <p class=\"labeltextheading\"><span lang=\"ES\" style=\"font-style:normal\"> </span></p>   \n",
       "781   <p class=\"labeltextheading\" style=\"page-break-after:auto\"><span lang=\"ES\" style=\"font-style:normal\">Es frecuente el aumento moderado de las aminotransferasas </span><span lang=\"ES\" style=\"font-sty...   \n",
       "782                                                                                          <p class=\"labeltextheading\" style=\"page-break-after:auto\"><span lang=\"ES\" style=\"font-style:normal\"> </span></p>   \n",
       "783                                                                                              <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Insuficiencia hepática</span></u></p>   \n",
       "784                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "785   <p class=\"MsoNormal\"><span lang=\"ES\">No se recomienda utilizar ivacaftor en pacientes con insuficiencia hepática grave a menos que los beneficios esperados superen los riesgos (ver las secciones 4...   \n",
       "786                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "787                                                                                                 <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Insuficiencia renal</span></u></p>   \n",
       "788                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "789   <p class=\"labeltext\"><span lang=\"ES\">Se recomienda precaución mientras se utiliza ivacaftor en pacientes con insuficiencia renal grave o enfermedad renal terminal (ver las secciones 4.2 y 5.2).</s...   \n",
       "790                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "791                                                                       <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Pacientes después de un trasplante de órganos</span></u></p>   \n",
       "792                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "793   <p class=\"MsoNormal\"><span lang=\"ES\">Ivacaftor</span><span lang=\"ES\"> no se ha estudiado en pacientes con FQ que se han sometido a un trasplante de órganos. Por lo tanto, no se recomienda utilizar...   \n",
       "794                                                                                                        <p class=\"MsoNormal\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "795                                                                                <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Interacciones con otros medicamentos</span></u></p>   \n",
       "796                                                                                                                   <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "797                                                                                                 <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Inductores de CYP3A</span></i></p>   \n",
       "798                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "799   <p class=\"labeltext\"><span lang=\"ES\">La exposición a ivacaftor disminuye significativamente con el uso concomitante de inductores de CYP3A, pudiendo dar lugar a una posible pérdida de la eficacia ...   \n",
       "800                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "801                                                                                                <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Inhibidores de CYP3A</span></i></p>   \n",
       "802                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "803   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">La exposición a ivacaftor</span><span lang=\"ES-TRAD\"> aumenta cuando se administra con inhibidores potentes o moderados de CYP3A...   \n",
       "804                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "805                                                                                                <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Población pediátrica</span></u></p>   \n",
       "806                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "807   <p class=\"labeltext\"><span lang=\"ES\">Se han notificado casos de opacidad del cristalino/cataratas no congénitas sin afectar a la visión en pacientes pediátricos tratados con ivacaftor. Aunque en a...   \n",
       "808                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "809                                                                                                <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Contenido de lactosa</span></u></p>   \n",
       "810                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "811   <p class=\"MsoNormal\"><span lang=\"ES\">Kalydeco contiene lactosa. Los pacientes con intolerancia hereditaria a galactosa, deficiencia total de lactasa o problemas de absorción de glucosa o galactosa...   \n",
       "812                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "813                                                                                                  <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Contenido de sodio</span></u></p>   \n",
       "814                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "815                                 <p class=\"MsoNormal\"><span lang=\"ES\">Este medicamento contiene menos de 23 mg de sodio (1 mmol) por unidad de dosis; esto es, esencialmente “exento de sodio”.</span></p>   \n",
       "816                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "817   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.5     </span></b><b><span lang=\"ES\">Interacción con otros medicamentos y otras fo...   \n",
       "818                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "819   <p class=\"MsoCommentText\"><span lang=\"ES\" style=\"font-size:11.0pt\">Ivacaftor es un sustrato de CYP3A4 y CYP3A5. Es un inhibidor débil de CYP3A y P</span><span lang=\"ES\">‑</span><span lang=\"ES\" sty...   \n",
       "820                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "821                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Medicamentos que afectan a la farmacocinética de ivacaftor</span></u></p>   \n",
       "822                                                                         <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "823                                                                                                                                <p class=\"labeltext\"><i><span lang=\"ES\">Inductores de CYP3A</span></i></p>   \n",
       "824                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "825   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">La administración conjunta de ivacaftor con rifampicina, un inductor potente de CYP3A, disminuyó la exposición a ivacaftor (AUC)...   \n",
       "826                                                                                                        <p class=\"labeltext\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "827              <p class=\"labeltext\"><span lang=\"ES\">No se recomienda un ajuste de la dosis c</span><span lang=\"ES\">uando se utilice ivacaftor junto con inductores débiles o moderados de CYP3A.</span></p>   \n",
       "828                                                                                                        <p class=\"labeltext\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "829                                                                                                <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Inhibidores de CYP3A</span></i></p>   \n",
       "830                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "831   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Ivacaftor es un sustrato sensible de CYP3A. La administración conjunta con ketoconazol, un inhibidor potente de CYP3A, aumentó l...   \n",
       "832                                                                                                        <p class=\"labeltext\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "833   <p class=\"labeltext\"><span lang=\"ES\">La administración conjunta con fluconazol, un inhibidor moderado de CYP3A, aumentó la exposición a ivacaftor en 3 veces y a su metabolito M1, aunque en menor g...   \n",
       "834                                                                                                        <p class=\"labeltext\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "835   <p class=\"labeltext\"><span lang=\"ES\">La administración conjunta de ivacaftor</span><span lang=\"ES\"> </span><span lang=\"ES\">con zumo de pomelo, que contiene uno o más componentes que inhiben de for...   \n",
       "836                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "837                           <p class=\"MsoCommentText\" style=\"page-break-after:avoid\"><i><span lang=\"ES\" style=\"font-size:11.0pt\">Capacidad de ivacaftor para interactuar con transportadores</span></i></p>   \n",
       "838                                           <p class=\"MsoCommentText\" style=\"page-break-after:avoid\"><u><span lang=\"ES\" style=\"font-size:11.0pt\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "839   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Los estudios <i>in vitro</i> demostraron que ivacaftor no es un sustrato de OATP1B1 ni de OATP1B3. Ivacaftor y sus metabolitos s...   \n",
       "840                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "841                                                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Ciprofloxacino</span></i></p>   \n",
       "842                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "843   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">La administración conjunta de ciprofloxacino con ivacaftor no afectó a la exposición a ivacaftor. No es necesario ajustar la dos...   \n",
       "844                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "845                                                                             <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Medicamentos a los que afecta ivacaftor</span></u></p>   \n",
       "846                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "847   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">La administración de ivacaftor puede aumentar la exposición sistémica de los medicamentos que son sustratos sensibles de </span>...   \n",
       "848                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "849                                                                                                 <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Sustratos de CYP2C9</span></i></p>   \n",
       "850                                                                                                                     <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\"> </span></p>   \n",
       "851   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">Ivacaftor puede inhibir CYP2C9. Por lo tanto, se recomienda controlar la razón internacional normalizada (INR) durante la a...   \n",
       "852                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "853                                                                                  <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Digoxina y otros sustratos de P‑gp</span></i></p>   \n",
       "854                                                                                                                     <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\"> </span></p>   \n",
       "855   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">La administración conjunta con digoxina, un sustrato sensible de la P<u>‑</u>gp, aumentó la exposición a digoxina en 1,3 ve...   \n",
       "856                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "857                                                                                                  <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Sustratos de CYP3A</span></i></p>   \n",
       "858                                                                                                                     <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\"> </span></p>   \n",
       "859   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">La administración conjunta con midazolam (oral), un sustrato de CYP3A sensible, aumentó la exposición a midazolam en 1,5 ve...   \n",
       "860                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "861                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Anticonceptivos hormonales</span></i></p>   \n",
       "862                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "863   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">Se ha estudiado ivacaftor con un anticonceptivo oral de estrógeno/progesterona y se observó que no afectaba significativame...   \n",
       "864                                                                                                                               <p style=\"margin:0in\"><span lang=\"ES\" style=\"font-size:11.0pt\"> </span></p>   \n",
       "865                                                                                                <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Población pediátrica</span></u></p>   \n",
       "866                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "867                                                            <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Los estudios de interacciones se han realizado solo en adultos.</span></p>   \n",
       "868                                                                                                        <p class=\"labeltext\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "869    <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.6     </span></b><b><span lang=\"ES\">Fertilidad, embarazo y lactancia</span></b></p>   \n",
       "870                                                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "871                                                                                                            <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Embarazo</span></u></p>   \n",
       "872                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "873   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">No hay datos o estos son limitados (datos en menos de 300 embarazos) relativos al uso de ivacaftor en mujeres embarazadas. Los e...   \n",
       "874                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "875                                                                                                           <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Lactancia</span></u></p>   \n",
       "876                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "877   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\" style=\"color:black\">Se desconoce si </span><span lang=\"ES\">ivacaftor y/o sus metabolitos se excretan en la leche materna. </span...   \n",
       "878                                                                                                                                <p class=\"MsoNormalIndent\" style=\"margin:0in\"><span lang=\"ES\"> </span></p>   \n",
       "879                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Fertilidad</span></u></p>   \n",
       "880                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "881   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\" style=\"color:black\">No se dispone de datos sobre el efecto de ivacaftor en la fertilidad en humanos. Ivacaftor tuvo un efec...   \n",
       "882                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "883   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.7     </span></b><b><span lang=\"ES\">Efectos sobre la capacidad para conducir y ut...   \n",
       "884                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "885   <p class=\"MsoNormal\"><span lang=\"ES\">La influencia de ivacaftor sobre la capacidad para conducir y utilizar máquinas es pequeña. Ivacaftor puede producir mareos (ver sección 4.8) y, por lo tanto, ...   \n",
       "886                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "887                 <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.8     </span></b><b><span lang=\"ES\">Reacciones adversas</span></b></p>   \n",
       "888                                                     <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph; page-break-after:avoid;text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "889                                                                                     <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Resumen del perfil de seguridad</span></u></p>   \n",
       "890                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "891   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Las reacciones adversas más frecuentes experimentadas por los pacientes de 6 años o mayores son cefalea </span><span lang=\"ES\">(...   \n",
       "892                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "893   <p class=\"labeltext\"><span lang=\"ES\">En pacientes de 2 a menos de 6 años las reacciones adversas más frecuentes fueron congestión nasal (26,5 %), infección en las vías respiratorias altas (23,5 %)...   \n",
       "894                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "895   <p class=\"labeltext\"><span lang=\"ES\">Las reacciones adversas graves observadas en los pacientes que recibieron ivacaftor incluyeron dolor abdominal y aumento de las aminotransferasas (ver sección ...   \n",
       "896                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "897                                                                     <p class=\"labeltext\" style=\"line-height:13.0pt;page-break-after:avoid\"><u><span lang=\"ES\">Tabla de reacciones adversas</span></u></p>   \n",
       "898                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "899   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">La Tabla 2 muestra las reacciones adversas observadas</span><span lang=\"ES\"> con ivacaftor en los ensayos clínicos (estudios con...   \n",
       "900                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "901                                   <p class=\"MsoNormal\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 2: <span style=\"color:black\">Reacciones adversas</span></span></b></p>   \n",
       "902   <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:95.3%;border-collapse:collapse;border:none\" width=\"95%\"> <thead> <tr style=\"page-break-inside:avoid;height:27....   \n",
       "903                                                                              <p class=\"labeltextheading\" style=\"page-break-after:auto\"><span lang=\"ES\" style=\"color:black;font-style:normal\"> </span></p>   \n",
       "904                                                                    <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Descripción de reacciones adversas seleccionadas</span></u></p>   \n",
       "905                                                                                                                                                  <p class=\"labeltextheading\"><span lang=\"ES\"> </span></p>   \n",
       "906                                                                                    <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Aumento de las aminotransferasas</span></i></p>   \n",
       "907                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "908   <p class=\"MsoNormal\"><span lang=\"ES\">Durante los estudios clínicos 1 y 2 controlados con placebo, de 48 semanas de duración en pacientes de 6 años o mayores, la incidencia de niveles máximos de la...   \n",
       "909                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "910   <p class=\"MsoNormal\"><span lang=\"ES\">Durante los estudios de fase 3, controlados con placebo (hasta 24 semanas) de tezacaftor/ivacaftor, </span><span lang=\"ES\">la incidencia de niveles máximos de ...   \n",
       "911                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "912   <p class=\"MsoNormal\"><span lang=\"ES\">Durante el estudio de fase 3, controlados con placebo de 24 semanas de duración de ivacaftor/tezacaftor/elexacaftor, estas cifras fueron del 1,5 %, 2,5 % y 7,9...   \n",
       "913                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "914                                                                                                <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Población pediátrica</span></u></p>   \n",
       "915                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "916   <p class=\"MsoNormal\"><span lang=\"ES\">Los datos de seguridad de ivacaftor se evaluaron en 6 pacientes de entre 4 meses y menos de 6 meses de edad, 11 pacientes de entre 6 meses y menos de 12 meses ...   \n",
       "917                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "918   <p class=\"MsoNormal\"><span lang=\"ES\">El perfil de seguridad es por lo general coherente entre los pacientes pediátricos de 4 meses o mayores y también es coherente con el de los pacientes adultos....   \n",
       "919                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "920   <p class=\"MsoNormal\"><span lang=\"ES\">La incidencia de </span><span lang=\"ES\">aumento de las aminotransferasas</span><span lang=\"ES\"> (ALAT o ASAT) observada en los estudios 2, 5 y 6 (pacientes de ...   \n",
       "921                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "922   <p class=\"MsoNormal\" style=\"margin-bottom:12.0pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 3: Aumentos de las aminotransferasas en pacientes de 4 meses a &lt;12 años tratados con ivacaftor ...   \n",
       "923   <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoTableGrid\" style=\"margin-left:6.85pt;border-collapse:collapse;border:none\"> <tr style=\"height:28.95pt\"> <td style=\"width:121.1pt;border:...   \n",
       "924                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "925                                                <p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"><u><span lang=\"ES\">Notificación de sospechas de reacciones adversas</span></u></p>   \n",
       "926                                                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid;text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "927   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">Es importante notificar sospechas de reacciones adversas al medicamento tras su autorización. Ello permite una supervisión ...   \n",
       "928                                                                                                        <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"ES\"> </span></p>   \n",
       "929                          <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">4.9     </span></b><b><span lang=\"ES\">Sobredosis</span></b></p>   \n",
       "930                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "931   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">No existe un antídoto específico para la sobredosis de ivacaftor. El tratamiento de la sobredosis consiste en las medidas de sop...   \n",
       "932                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "933                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "934         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">5.       </span></b><b><span lang=\"ES\">PROPIEDADES FARMACOLÓGICAS</span></b></p>   \n",
       "935                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "936        <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">5.1     </span></b><b><span lang=\"ES\">Propiedades farmacodinámicas</span></b></p>   \n",
       "937                                                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "938   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Grupo farmacoterapéutico: Otros productos del sistema respiratorio, código ATC: </span><span lang=\"ES\" style=\"color:black\">R07AX...   \n",
       "939                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "940                                                                              <p class=\"MsoNormal\" style=\"margin-right:-.1pt;page-break-after:avoid\"><u><span lang=\"ES\">Mecanismo de acción</span></u></p>   \n",
       "941                                                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "942   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">Ivacaftor es un potenciador de la proteína CFTR, es decir, ivacaftor <i>in vitro</i> aumenta la apertura del canal de CFTR ...   \n",
       "943                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "944   <p class=\"MsoNormal\"><span lang=\"ES\">Las respuestas <i>in vitro</i> observadas en los experimentos de fijación de membranas de un solo canal utilizando membranas de células de roedores que expresa...   \n",
       "945                                                                    <p class=\"MsoBodyText2\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"ES\" style=\"font-size:11.0pt;color:black\"> </span></p>   \n",
       "946                                                                                            <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Efectos farmacodinámicos</span></u></p>   \n",
       "947                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "948   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">En los estudios 1 y 2 en pacientes con la mutación <i>G551D </i>en un alelo del gen <i>CFTR</i>, ivacaftor dio lugar a disminuci...   \n",
       "949                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "950   <p class=\"MsoNormal\"><span lang=\"ES\">En la parte 1 del estudio 5 en pacientes con una mutación de apertura del canal no <i>G551D</i> en el gen <i>CFTR</i>, el tratamiento con ivacaftor dio lugar a...   \n",
       "951                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "952   <p class=\"documenttext\" style=\"margin-bottom:0in\"><span lang=\"ES\">En el estudio 6, en pacientes de 6 años o mayores con FQ con una mutación <i>R117H</i> en el gen <i>CFTR</i>, la diferencia entre ...   \n",
       "953                                                                                                                            <p class=\"documenttext\" style=\"margin-bottom:0in\"><span lang=\"ES\"> </span></p>   \n",
       "954   <p class=\"documenttext\" style=\"margin-bottom:0in\"><span lang=\"ES\">En el estudio 7 en pacientes de 2 a menos de 6 años con una mutación de apertura del canal en al menos un alelo del gen <i>CFTR</i...   \n",
       "955                                                                                                                            <p class=\"documenttext\" style=\"margin-bottom:0in\"><span lang=\"ES\"> </span></p>   \n",
       "956   <p class=\"documenttext\" style=\"margin-bottom:0in\"><span lang=\"ES\">En el estudio 8 en pacientes con FQ menores de 24 meses, el cambio absoluto medio del cloruro en el sudor desde el valor basal fue...   \n",
       "957                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "958                                                                   <p class=\"documenttext\" style=\"margin-bottom:0in;page-break-after:avoid\"><u><span lang=\"ES\">Eficacia clínica y seguridad</span></u></p>   \n",
       "959                                                                                                                   <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "960                             <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Estudios 1 y 2: estudios en pacientes con FQ con mutaciones de apertura del canal G551D</span></i></p>   \n",
       "961                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "962   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Se ha evaluado la eficacia de ivacaftor en dos estudios de fase 3, aleatorizados, doble ciego, controlados con placebo, multicén...   \n",
       "963                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "964   <p class=\"labeltext\"><span lang=\"ES\">Los pacientes de ambos estudios fueron aleatorizados 1:1 a recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos grasos durante 48 semanas, además ...   \n",
       "965                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "966   <p class=\"labeltext\"><span lang=\"ES\">El estudio 1 evaluó a 161 pacientes de 12 años o mayores; 122 (75,8 %) pacientes presentaban la mutación <i>F508del</i> en el segundo alelo. Al inicio del estu...   \n",
       "967                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "968   <p class=\"labeltext\"><span lang=\"ES\">El estudio 2 evaluó a 52 pacientes de 6 a 11 años en el momento de la selección; el peso corporal medio (DE) era de 30,9 (8,63) kg; 42 (80,8 %) pacientes prese...   \n",
       "969                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "970   <p class=\"labeltext\"><span lang=\"ES\">La variable principal de eficacia en ambos estudios fue el cambio absoluto medio desde el valor basal en el porcentaje predicho de VEF<sub>1</sub> hasta la sem...   \n",
       "971                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "972   <p class=\"labeltext\"><span lang=\"ES\">La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF<sub>1</sub> desde el valor...   \n",
       "973                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "974   <p class=\"MsoNormal\"><span lang=\"ES\">La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF<sub>1</sub> desde el valor...   \n",
       "975                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "976                                             <p class=\"labeltext\"><span lang=\"ES\">Los resultados correspondientes a las variables secundarias clínicamente relevantes se muestran en la Tabla 4</span></p>   \n",
       "977                                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "978               <p class=\"labeltext\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 4: Efecto de ivacaftor en otras variables de eficacia en los estudios 1 y 2</span></b></p>   \n",
       "979   <table align=\"left\" border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none;margin-left:6.75pt;  margin-right:6.75pt\" width=\"98%\"> <thead> <tr...   \n",
       "980   <p class=\"tablefootnote\" style=\"margin-top:6.0pt;page-break-after:avoid\"><span lang=\"ES\" style=\"font-size:9.0pt;color:white\">IC: Intervalo de confianza; NA: no analizado debido a la baja incidenci...   \n",
       "981   <p class=\"tablefootnote\" style=\"page-break-after:avoid\"><sup><span lang=\"ES\" style=\"font-size:9.0pt\">a</span></sup><span lang=\"ES\" style=\"font-size:9.0pt\">     Diferencia del tratamiento = efecto ...   \n",
       "982   <p class=\"tablefootnote\" style=\"margin-left:14.2pt;text-indent:-14.2pt; page-break-after:avoid\"><sup><span lang=\"ES\" style=\"font-size:9.0pt\">b</span></sup><span lang=\"ES\" style=\"font-size:9.0pt\"> ...   \n",
       "983   <p class=\"tablefootnote\" style=\"margin-left:14.2pt;text-indent:-14.2pt; page-break-after:avoid\"><sup><span lang=\"ES\" style=\"font-size:9.0pt\">c</span></sup><span lang=\"ES\" style=\"font-size:9.0pt\"> ...   \n",
       "984   <p class=\"tablefootnotelast\" style=\"margin-bottom:0in;page-break-after:avoid\"><sup><span lang=\"ES\" style=\"font-size:9.0pt\">d        </span></sup><span lang=\"ES\" style=\"font-size:9.0pt\">Proporción ...   \n",
       "985   <p class=\"tablefootnotelast\" style=\"margin-bottom:0in\"><sup><span lang=\"ES\" style=\"font-size:9.0pt\">e</span></sup><span lang=\"ES\" style=\"font-size:9.0pt\">     En sujetos menores de 20 años (gráfic...   \n",
       "986                                                                                                        <p class=\"MsoNormal\"><s><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></s></p>   \n",
       "987                                <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Estudio 5: estudio en pacientes con FQ con mutaciones de apertura del canal no G551D</span></i></p>   \n",
       "988                                                                                                                     <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\"> </span></p>   \n",
       "989   <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">El estudio 5 fue un estudio de fase 3, de dos partes, aleatorizado, doble ciego, controlado con placebo y cruzado (parte 1)...   \n",
       "990                                                                                                        <p class=\"MsoNormal\"><s><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></s></p>   \n",
       "991   <p class=\"labeltext\"><span lang=\"ES\">En la parte 1, los pacientes fueron aleatorizados 1:1 para recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos que contenían grasas durante 8 sem...   \n",
       "992                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "993   <p class=\"labeltext\"><span lang=\"ES\">Se incluyó en el estudio a 39 pacientes (edad media: 23 años) con un </span><span lang=\"ES\">porcentaje predicho de VEF<sub>1</sub> basal ≥40 % (porcentaje pred...   \n",
       "994                                                                                                                                                         <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "995   <p class=\"MsoNormal\"><span lang=\"ES\">En la parte 1 del estudio 5, el porcentaje predicho medio de VEF<sub>1</sub> </span><span lang=\"ES\">basal en los pacientes tratados con placebo fue del 79,3 % ...   \n",
       "996                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "997   <p class=\"MsoNormal\"><span lang=\"ES\">El efecto de ivacaftor en la población global del estudio 5 (incluidas las variables secundarias del cambio absoluto en el IMC a las 8 semanas de tratamiento y...   \n",
       "998                                                                                                                                                         <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "999   <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:6.0pt; margin-left:45.0pt;text-indent:-45.0pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 5: Efecto de ivacaftor para...   \n",
       "1000  <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:479.1pt;border-collapse:collapse;border:none\" width=\"639\"> <tr> <td colspan=\"2\" style=\"width:159.7pt;border:so...   \n",
       "1001  <p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:13.6pt;margin-bottom:.0001pt;text-indent:-13.6pt;page-break-after: avoid\"><sup><span lang=\"ES\" style=\"f...   \n",
       "1002  <p class=\"MsoNormal\" style=\"margin-left:13.5pt;text-indent:-13.5pt;page-break-after: avoid\"><sup><span lang=\"ES\" style=\"font-size:9.0pt\">†</span></sup><span lang=\"ES\" style=\"font-size:9.0pt\">     ...   \n",
       "1003  <p class=\"MsoNormal\" style=\"margin-left:13.6pt;text-indent:-13.6pt;page-break-after: avoid\"><sup><span lang=\"ES\" style=\"font-size:9.0pt\">††</span></sup><span lang=\"ES\" style=\"font-size:9.0pt\">   n...   \n",
       "1004  <p class=\"MsoNormal\" style=\"margin-left:13.6pt;text-indent:-13.6pt\"><i><sup><span lang=\"ES\" style=\"font-size:9.0pt\">#</span></sup></i><span lang=\"ES\" style=\"font-size:9.0pt\">     </span><span lang...   \n",
       "1005                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1006  <p class=\"MsoNormal\"><span lang=\"ES\">En la parte 2 del estudio 5</span><span lang=\"ES\">, el cambio absoluto medio (DE) en </span><span lang=\"ES\">el porcentaje predicho de VEF<sub>1</sub> </span><s...   \n",
       "1007                                                                                                       <p class=\"labeltext\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "1008                                      <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Estudio 3: estudio en pacientes con FQ con la mutación F508del en el gen CFTR</span></i></p>   \n",
       "1009                                                                                                                    <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\"> </span></p>   \n",
       "1010  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">El estudio 3 (parte A) fue un estudio de fase 2, de grupos paralelos, controlado con placebo, doble ciego, aleatorizado 4:1...   \n",
       "1011                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1012  <p class=\"MsoNormal\"><span lang=\"ES\">El cambio absoluto medio desde el valor basal hasta la semana 16 en el porcentaje predicho de VEF<sub>1</sub> (variable principal de eficacia) fue de 1,5 punto...   \n",
       "1013                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1014                                                                            <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Estudio 4: estudio de extensión abierta</span></i></p>   \n",
       "1015                                                                                                <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\" style=\"color:black\"> </span></p>   \n",
       "1016  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\" style=\"color:black\">En el estudio 4, los pacientes que completaron el tratamiento en los estudios 1 y 2 con placebo pasaron...   \n",
       "1017                                                                                                                                    <p class=\"MsoNormal\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "1018  <p class=\"MsoNormal\"><span lang=\"ES\" style=\"color:black\">Ciento cuarenta y cuatro (144) pacientes del estudio 1 pasaron al estudio 4, 67 del grupo de placebo/ivacaftor y 77 del grupo de ivacaftor/...   \n",
       "1019                                                                                                                                    <p class=\"MsoNormal\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "1020  <p class=\"MsoNormal\"><span lang=\"ES\" style=\"color:black\">La Tabla 6 muestra los resultados del cambio absoluto medio (DE) en el porcentaje predicho de VEF<sub>1</sub> para ambos grupos de paciente...   \n",
       "1021                                                                                                                                    <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "1022  <p class=\"labeltext\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 6: Efecto de ivacaftor </span></b><b><span lang=\"ES\" style=\"color:black\">en el porcentaje predicho ...   \n",
       "1023  <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\"> <tr> <td rowspan=\"2\" style=\"width:99.3pt;border:solid windowtext 1.0pt;   pad...   \n",
       "1024  <p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after: avoid\"><sup><span lang=\"ES\">*</span></sup><span lang=\"ES\">    </span><span lang=\"ES\" style=\"font-size:9.0pt\">El...   \n",
       "1025  <p class=\"labeltext\"><sup><span lang=\"ES\" style=\"font-size:8.0pt;position:relative; top:-3.0pt\">†</span></sup><span lang=\"ES\">    </span><span lang=\"ES\" style=\"font-size:9.0pt\">Cambio desde el val...   \n",
       "1026                                                                                                                                    <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "1027  <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\">Cuando se compara el cambio absoluto medio (DE) en el porcentaje predicho de VEF<sub>1</sub> desde el valor basal del estudio 4 para los pa...   \n",
       "1028                                                                                                                                    <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "1029  <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\">Para los pacientes del grupo de placebo/ivacaftor del estudio 1, la tasa anualizada de exacerbaciones pulmonares fue más alta en el estudio...   \n",
       "1030                                                                                                                                    <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "1031                                    <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\">Para los pacientes que pasaron del estudio 2, el número de acontecimientos fue, en general, bajo.</span></p>   \n",
       "1032                                                                                                                                    <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "1033                                       <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Estudio 6: estudio en pacientes con FQ con una mutación R117H en el gen CFTR</span></i></p>   \n",
       "1034                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1035  <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">En el estudio 6 se evaluaron 69 pacientes de 6 años o mayores; 53 (76,8 %) pacientes tenían la mutación <i>F508del</i> en el seg...   \n",
       "1036                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1037  <p class=\"MsoNormal\"><span lang=\"ES\">Se realizó un análisis de subgrupos previamente planificado en pacientes de 18 años o mayores (26 pacientes con placebo y 24 con ivacaftor). El tratamiento con...   \n",
       "1038                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1039  <p class=\"MsoNormal\"><span lang=\"ES\">En un análisis de subgrupos en pacientes </span><span lang=\"ES\">con una variante genética <i>R117H-5T </i>confirmada, la diferencia en el cambio absoluto medio...   \n",
       "1040                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1041  <p class=\"MsoNormal\"><span lang=\"ES\">Para las variables secundarias de eficacia, no se observaron diferencias del tratamiento para ivacaftor frente a placebo en el cambio absoluto desde el valor b...   \n",
       "1042                                                                                                                                    <p class=\"labeltext\"><span lang=\"ES\" style=\"color:black\"> </span></p>   \n",
       "1043  <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Estudio 7: estudio en pacientes pediátricos con FQ de 2 a menos de 6 años con la mutación G551D u otra mutación de apertura d...   \n",
       "1044                                                                                                                    <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\"> </span></p>   \n",
       "1045  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">En un estudio no controlado de 24 semanas de duración con ivacaftor (los pacientes con un peso inferior a 14 kg recibieron ...   \n",
       "1046                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1047  <p class=\"MsoNormal\"><span lang=\"ES\">Los pacientes del estudio 7 tenían de 2 a menos de 6 años (edad media: 3 años). De los 34 pacientes incluidos, 26 pacientes (76,5 %) tenían un genotipo <i>G551...   \n",
       "1048                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1049  <p class=\"MsoNormal\"><span lang=\"ES\">Se evaluó </span><span lang=\"ES\">la variable </span><span lang=\"ES\">principal de seguridad hasta la semana</span><span lang=\"ES\"> 24 (ver sección 4.8). Las var...   \n",
       "1050                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1051  <p class=\"MsoNormal\"><span lang=\"ES\">El cambio absoluto </span><span lang=\"ES\">medio (DE) </span><span lang=\"ES\">global (los dos grupos de ivacaftor combinados) desde el valor basal en el IMC en l...   \n",
       "1052                                                                                                <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"><span lang=\"ES\"> </span></p>   \n",
       "1053                                        <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES-TRAD\">Estudio 8: estudio en pacientes pediátricos con FQ menores de 24 meses</span></i></p>   \n",
       "1054                                                                                                                         <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1055  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Se evaluaron e</span><span lang=\"ES\">l perfil farmacocinético, la seguridad y la eficacia de ivacaftor en pacientes con FQ de 6 ...   \n",
       "1056                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1057  <p class=\"MsoNormal\"><span lang=\"ES\">En la parte B del estudio 8 fueron incluidos 19 pacientes de 12 meses a menos de 24 meses (edad media de 15,2 meses al inicio), de los cuales 18 pacientes comp...   \n",
       "1058                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1059  <p class=\"MsoNormal\"><span lang=\"ES\">En la parte B del estudio 8 se evaluó la variable principal de seguridad durante las 24 semanas (ver sección 4.8). Las variables secundarias fueron la evaluaci...   \n",
       "1060                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1061  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">Para los pacientes de 4 meses a menos de 24 meses, con valores iniciales y de la semana 24 disponibles, se proporcionan en ...   \n",
       "1062                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1063  <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:6.0pt; margin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 7: Efecto de ivacaftor en...   \n",
       "1064  <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"TableGrid1\" style=\"border-collapse:collapse;border:none\" width=\"601\"> <tr> <td rowspan=\"2\" style=\"width:126.9pt;border:solid windowtext 1.0...   \n",
       "1065  <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"601\"> <tr> <td style=\"width:126.9pt;border:solid windowtext 1.0pt;   pa...   \n",
       "1066  <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"TableGrid1\" style=\"border-collapse:collapse;border:none\" width=\"601\"> <tr> <td style=\"width:126.9pt;border:solid windowtext 1.0pt;   paddin...   \n",
       "1067                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1068  <p class=\"MsoNormal\" style=\"line-height:13.0pt\"><span lang=\"ES\">En los pacientes de 4 meses a menos de 24 meses, con valores iniciales y de la semana 24 disponibles, había 18 pacientes con insufic...   \n",
       "1069                                                                                                <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"><span lang=\"ES\"> </span></p>   \n",
       "1070                                                                                               <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Población pediátrica</span></u></p>   \n",
       "1071                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1072  <p class=\"MsoNormal\"><span lang=\"ES\">La Agencia Europea de Medicamentos ha concedido al titular un aplazamiento para presentar los resultados de los ensayos realizados con Kalydeco en uno o más gr...   \n",
       "1073                                                                                                                             <p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><span lang=\"ES\"> </span></p>   \n",
       "1074       <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">5.2     </span></b><b><span lang=\"ES\">Propiedades farmacocinéticas</span></b></p>   \n",
       "1075                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1076                    <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">La farmacocinética de ivacaftor es similar entre los voluntarios adultos sanos y los pacientes con FQ.</span></p>   \n",
       "1077                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1078  <p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><span lang=\"ES\">Después de la administración oral de una dosis única de 150 mg a voluntarios sanos con el estómago lleno, la media (± DE) para el AU...   \n",
       "1079                                                                                                                             <p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><span lang=\"ES\"> </span></p>   \n",
       "1080                                                                                                        <p class=\"labeltextheading\"><u><span lang=\"ES\" style=\"font-style:normal\">Absorción</span></u></p>   \n",
       "1081                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1082  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Después de la administración oral de dosis múltiples de ivacaftor, la exposición a ivacaftor aumentó por lo general con la dosis...   \n",
       "1083                                                                                                                                                        <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "1084  <p class=\"MsoNormal\"><span lang=\"ES\">El granulado de ivacaftor (2 sobres de 75 mg) presentó una biodisponibilidad similar a la de los comprimidos de 150 mg cuando se administraron con alimentos qu...   \n",
       "1085                                                                            <p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "1086                                                                                    <p class=\"MsoNormal\" style=\"margin-right:-.1pt;page-break-after:avoid\"><u><span lang=\"ES\">Distribución</span></u></p>   \n",
       "1087                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1088  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Aproximadamente el 99 % de ivacaftor se fija a las proteínas plasmáticas, principalmente a la alfa-1 glicoproteína ácida y a la ...   \n",
       "1089                                                                                                                                                        <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "1090                                                                                                  <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Biotransformación</span></u></p>   \n",
       "1091                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1092  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Ivacaftor se metaboliza extensamente en humanos. Los datos <i>in vitro</i> e <i>in vivo</i> indican que ivacaftor se metaboliza ...   \n",
       "1093                                                                                                                                                        <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "1094  <p class=\"labeltext\"><span lang=\"ES-TRAD\">El efecto del genotipo heterocigótico de CYP3A4*22 en la exposición a </span><span lang=\"ES-TRAD\">ivacaftor </span><span lang=\"ES-TRAD\">es coherente con e...   \n",
       "1095                                                                            <p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "1096                                                                                     <p class=\"MsoNormal\" style=\"margin-right:-.1pt;page-break-after:avoid\"><u><span lang=\"ES\">Eliminación</span></u></p>   \n",
       "1097                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1098  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Tras la administración oral en voluntarios sanos, la mayor parte de ivacaftor (87,8 %) fue eliminada en las heces después de la ...   \n",
       "1099                                               <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "1100                                                                                           <p class=\"labeltext\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Linealidad/No linealidad</span></u></p>   \n",
       "1101                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1102  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">La farmacocinética de ivacaftor es en general lineal con respecto al tiempo o al intervalo de dosis de 25 mg a 250 mg.</spa...   \n",
       "1103                                                                                         <p class=\"labeltextheading\" style=\"page-break-after:auto\"><span lang=\"ES\" style=\"font-style:normal\"> </span></p>   \n",
       "1104                                                                                           <p class=\"labeltextheading\"><u><span lang=\"ES\" style=\"font-style:normal\">Poblaciones especiales</span></u></p>   \n",
       "1105                                                                                                                       <p class=\"labeltextheading\"><span lang=\"ES\" style=\"font-style:normal\"> </span></p>   \n",
       "1106                                                                                             <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Insuficiencia hepática</span></i></p>   \n",
       "1107                                                                                                                         <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1108  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Tras una sola dosis de 150 mg de ivacaftor, los sujetos adultos con insuficiencia hepática moderada (Child‑Pugh Clase B, puntuac...   \n",
       "1109                                                                                                                                                        <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "1110  <p class=\"labeltext\"><span lang=\"ES\">No se ha estudiado el impacto de la insuficiencia hepática grave (Child-Pugh Clase C, puntuación 10 a 15) en la farmacocinética de ivacaftor. Se desconoce la m...   \n",
       "1111                                                                                                                                                        <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "1112                                                                 <p class=\"labeltext\"><span lang=\"ES\">No se considera necesario ajustar la dosis en pacientes con insuficiencia hepática leve.</span></p>   \n",
       "1113                                                                                                                                                        <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "1114                                                                                                <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Insuficiencia renal</span></i></p>   \n",
       "1115                                                                                                                         <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1116  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">No se han realizado estudios farmacocinéticos con ivacaftor en pacientes con insuficiencia renal. En un estudio farmacocinético ...   \n",
       "1117                                                                                                                                                        <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "1118  <p class=\"labeltext\"><span lang=\"ES\">No se recomienda ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Sin embargo, se recomienda precaución cuando se administre ivacaftor a ...   \n",
       "1119                                                                                                                                                        <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "1120                                                                                                               <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Raza</span></i></p>   \n",
       "1121                                                                                                                         <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1122  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">En función del análisis de FC poblacional, la raza no tuvo ningún efecto clínicamente significativo en la FC de ivacaftor en pac...   \n",
       "1123                                                                                                                                                        <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "1124                                                                                                               <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Sexo</span></i></p>   \n",
       "1125                                                                                                                         <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1126                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Los parámetros farmacocinéticos de ivacaftor son similares en hombres y mujeres.</span></p>   \n",
       "1127                                                                                                                                                        <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "1128                                                                                         <p class=\"labeltext\" style=\"page-break-after:avoid\"><i><span lang=\"ES\">Pacientes de edad avanzada</span></i></p>   \n",
       "1129                                                                                                                         <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1130  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES\">Los estudios clínicos con ivacaftor en monoterapia no incluyeron un número suficiente de pacientes de 65 años o mayores para det...   \n",
       "1131                                                                                                                                                        <p class=\"labeltext\"><span lang=\"ES\"> </span></p>   \n",
       "1132                                                                                                                              <p class=\"labeltextheading\"><span lang=\"ES\">Población pediátrica</span></p>   \n",
       "1133                                                                                                                    <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\"> </span></p>   \n",
       "1134  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">En la Tabla 8 se presenta por grupo de edad la exposición a ivacaftor predicha según las concentraciones de ivacaftor obser...   \n",
       "1135                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1136                                    <p class=\"MsoNormal\" style=\"margin-bottom:6.0pt;page-break-after:avoid\"><b><span lang=\"ES\">Tabla 8 Exposición media (DE) a ivacaftor por grupo de edad</span></b></p>   \n",
       "1137  <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\"> <thead> <tr style=\"page-break-inside:avoid;height:23.9pt\"> <td style=\"width:2...   \n",
       "1138  <p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:14.45pt;margin-bottom:.0001pt;text-indent:-14.45pt;page-break-after: avoid\"><sup><span lang=\"ES\" style=...   \n",
       "1139  <p class=\"MsoNormal\" style=\"margin-left:14.45pt;text-indent:-14.45pt\"><sup><span lang=\"ES\" style=\"font-size:9.0pt;position:relative;top:-3.0pt\">†</span></sup><span lang=\"ES\" style=\"font-size:9.0pt...   \n",
       "1140                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1141                                <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">5.3     Datos preclínicos sobre seguridad</span></b></p>   \n",
       "1142                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1143  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">Los datos de los estudios preclínicos no muestran riesgos especiales para los seres humanos según los estudios convencional...   \n",
       "1144                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1145                                                                                              <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Embarazo y fertilidad</span></u></p>   \n",
       "1146                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1147  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">Ivacaftor se asoció a </span><span lang=\"ES-TRAD\">una disminución ligera del peso de las vesículas seminales</span><span la...   \n",
       "1148                                                                                                       <p class=\"MsoNormal\"><u><span lang=\"ES\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "1149                                                                                    <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Desarrollo perinatal y posnatal</span></u></p>   \n",
       "1150                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1151  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">Ivacaftor redujo los índices de supervivencia y lactancia y produjo una disminución en los pesos corporales de las crías. L...   \n",
       "1152                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1153                                                                                       <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><u><span lang=\"ES\">Estudios en animales jóvenes</span></u></p>   \n",
       "1154                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1155  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">Se observaron cataratas en las ratas jóvenes tratadas desde el día 7 después de nacer hasta el día 35 a niveles de exposici...   \n",
       "1156                                                                                                                                                 <p class=\"MsoNormal\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "1157                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1158                                             <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">6.       DATOS FARMACÉUTICOS</span></b></p>   \n",
       "1159                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1160               <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">6.1     </span></b><b><span lang=\"ES\">Lista de excipientes</span></b></p>   \n",
       "1161                                                                                                                  <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "1162                                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Sílice coloidal anhidra</span></p>   \n",
       "1163                                                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Croscarmelosa sódica</span></p>   \n",
       "1164                                                                                          <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Succinato acetato de hipromelosa</span></p>   \n",
       "1165                                                                                                       <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Lactosa monohidrato</span></p>   \n",
       "1166                                                                                                     <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"IT\">Estearato de magnesio</span></p>   \n",
       "1167                                                                                                                   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"IT\">Manitol</span></p>   \n",
       "1168                                                                                                                 <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"IT\">Sucralosa</span></p>   \n",
       "1169                                                                                                                              <p class=\"MsoNormal\"><span lang=\"IT\">Laurilsulfato sódico (E487)</span></p>   \n",
       "1170                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"IT\"> </span></p>   \n",
       "1171                 <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">6.2     </span></b><b><span lang=\"ES\">Incompatibilidades</span></b></p>   \n",
       "1172                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1173                                                                                                          <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">No procede.</span></p>   \n",
       "1174                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1175                 <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">6.3     </span></b><b><span lang=\"ES\">Periodo de validez</span></b></p>   \n",
       "1176                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1177                                                                                                              <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">3 años.</span></p>   \n",
       "1178                                                                                                                    <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\"> </span></p>   \n",
       "1179                                              <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">Una vez mezclado, la mezcla ha demostrado ser estable durante una hora.</span></p>   \n",
       "1180                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1181  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">6.4     </span></b><b><span lang=\"ES\">Precauciones especiales de conservación</span...   \n",
       "1182                                                                               <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1183                                                                  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">No requiere condiciones especiales de conservación.</span></p>   \n",
       "1184                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1185  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">6.5     </span></b><b><span lang=\"ES\">Naturaleza y contenido del envase</span></b></p>   \n",
       "1186                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1187  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">El granulado está envasado en un sobre de tereftalato de polietileno de orientación biaxial/polietileno/</span><span lang=\"...   \n",
       "1188                                                                                                                            <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"ES\"> </span></p>   \n",
       "1189                                                                  <p class=\"MsoNormal\"><span lang=\"ES\">Tamaño de envase de 56 sobres (contiene 4 estuches individuales con 14 sobres cada uno)</span></p>   \n",
       "1190                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1191  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">6.6     Precauciones especiales de eliminación</span></b><b><span lang=\"ES\"> y otra...   \n",
       "1192                                                                                                                  <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "1193  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">La eliminación del medicamento no utilizado y de todos los </span><span lang=\"ES\">materiales</span><span lang=\"ES-TRAD\"> qu...   \n",
       "1194                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1195                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1196                  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">7.       TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN</span></b></p>   \n",
       "1197                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1198                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\">Vertex Pharmaceuticals (Ireland) Limited</p>   \n",
       "1199                                                                                                                      <p class=\"MsoNormal\" style=\"page-break-after:avoid\">28-32 Pembroke Street Upper</p>   \n",
       "1200                                                                                                        <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Dublin 2, D02 EK84</span></p>   \n",
       "1201                                                                                                              <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">Irlanda</span></p>   \n",
       "1202                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1203                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1204  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">8.       </span></b><b><span lang=\"ES\">NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓ...   \n",
       "1205                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1206                                             <p class=\"MsoNormal\" style=\"line-height:13.0pt;page-break-after:avoid\"><span lang=\"ES\">EU</span><span lang=\"ES\" style=\"color:black\">/1/12/782/003</span></p>   \n",
       "1207                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\">EU/1/12/782/004</span></p>   \n",
       "1208                                                                                                                                          <p class=\"MsoNormal\"><span lang=\"ES\">EU/1/12/782/006</span></p>   \n",
       "1209                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1210                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1211  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after: avoid\"><b><span lang=\"ES\">9.       FECHA DE LA PRIMERA AUTORIZACIÓN/RENOVACIÓN DE LA AUTORIZACIÓN</span></b></p>   \n",
       "1212                                                                                                                  <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><i><span lang=\"ES\"> </span></i></p>   \n",
       "1213                                                                           <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\">Fecha de la primera autorización: 23/julio/2012</span></p>   \n",
       "1214                                                                         <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">Fecha de la última renovación: 28/abril/2017</span></p>   \n",
       "1215                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1216                                                                                                                                                        <p class=\"MsoNormal\"><span lang=\"ES\"> </span></p>   \n",
       "1217        <p class=\"MsoNormal\" style=\"margin-left:28.1pt;text-indent:-28.1pt;page-break-after: avoid\"><b><span lang=\"ES\">10.    </span></b><b><span lang=\"ES\">FECHA DE LA REVISIÓN DEL TEXTO</span></b></p>   \n",
       "1218                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1219                                                                                                                         <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"ES\"> </span></p>   \n",
       "1220  <p class=\"labeltext\" style=\"page-break-after:avoid\"><span lang=\"ES-TRAD\">La información detallada de este medicamento está disponible en la página web de la Agencia Europea de Medicamentos </span>...   \n",
       "1221                                                                  <span lang=\"ES\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/> </span>   \n",
       "\n",
       "                                        ID  \\\n",
       "0     af72c67e-e145-4951-a2ae-9d6e209e11df   \n",
       "1     c147a932-fe2e-4586-ad7a-1d94722a6bbd   \n",
       "2     354c4ef9-6998-4604-a3de-d6c2b54ab5bd   \n",
       "3     84207554-4f1a-44fe-a4af-2faa4181e82f   \n",
       "4     666eb08a-4aa5-4ea8-a12e-2e1b48cdc1d9   \n",
       "5     41ca5b92-4733-4f9a-ac58-e7182fb0d166   \n",
       "6     9e6429ad-0e94-4062-b75f-b03eb212e2d1   \n",
       "7     2c762f89-12bd-4ba8-b435-7dd0ab82b1c1   \n",
       "8     898da31c-e821-4aa6-998f-c25d22b10de7   \n",
       "9     d84210a2-e953-4ced-916c-00fb0d485c9a   \n",
       "10    44def714-2298-4cb4-a562-8b3c09770dca   \n",
       "11    8e27c082-b5f0-4891-b827-446cf8aee265   \n",
       "12    48213e33-cdc0-487d-854f-6f06c6bb01d7   \n",
       "13    e6469207-b760-4eab-862c-b0e3b25cd580   \n",
       "14    2b4139be-943f-4b76-8f86-37e21986c540   \n",
       "15    81ae3027-0894-456f-9e38-42dcfd82ec07   \n",
       "16    9a96586a-1629-4aa8-a007-d96cc934bebe   \n",
       "17    44391980-f6e6-4ce1-bf8e-39157db14615   \n",
       "18    8b24f5eb-f709-4ebf-b0d6-1aee77e9cfe8   \n",
       "19    51054e10-c323-4125-8f76-d756958b37f5   \n",
       "20    54ae2857-4ac9-4a96-93ff-ffd5f94b08b5   \n",
       "21    7b01af01-2a5a-49c3-b369-b1e0d5ffecba   \n",
       "22    5c8252d1-b5e7-418d-b333-0db0de6aca75   \n",
       "23    c552eb62-af50-48fa-9876-152225c5c6df   \n",
       "24    fcc67667-e0e5-470c-88f3-aab63b9ec072   \n",
       "25    57d9dcc1-304e-4bfb-8203-8f97c5a52b11   \n",
       "26    5798d02d-54d0-487e-abcf-8be5bfbe1458   \n",
       "27    e26b7b19-2fba-4af6-96bf-1df225aa2218   \n",
       "28    4994ac1f-0ae3-4214-81ee-9d94673fb2ff   \n",
       "29    931caab6-9d34-4d1a-a52c-52ae389081f6   \n",
       "30    b8622c24-b73c-4a1b-a037-b19f73a85a0c   \n",
       "31    7ecdb210-02c7-4ff0-b4ac-f566e0547c51   \n",
       "32    99f4d854-e360-4df2-b7af-4142af896a31   \n",
       "33    0bc8c6fc-7051-40ec-8064-b024d7c8e767   \n",
       "34    d3f2e28e-6e97-4e8c-ade1-05d20e8e3285   \n",
       "35    cadd8043-6bb4-402d-a12f-eaf3c5e313fb   \n",
       "36    1033c384-39af-4f77-8330-129204f5782a   \n",
       "37    ff34f408-bd41-4952-8cf0-b8ff1301a1e8   \n",
       "38    d1936675-57fc-4c3c-b93b-07cc2dc234d1   \n",
       "39    5021f543-ad57-4893-8f00-9a3328566e4a   \n",
       "40    a0b0b3ee-4a2a-4674-a8f3-c71f5736a5f8   \n",
       "41    4e094f8c-8299-472c-bd96-eececf118cde   \n",
       "42    aab4c001-f5f4-4382-bd08-768bd3d5cbf0   \n",
       "43    41e7c2a4-5a52-4107-a30e-2e4cc9b7d79a   \n",
       "44    720df005-eb3a-4b90-ac77-4a307e512e8c   \n",
       "45    6774333e-c925-45c7-a58d-df4769026b2f   \n",
       "46    216ef059-017e-4a54-9787-8aa8817c31a2   \n",
       "47    b721db8d-e7d7-46b8-a7c6-6a8c7fea19df   \n",
       "48    eb3e986d-07d1-4d5c-8207-99051bf2b380   \n",
       "49    19ecbdcd-54bd-432a-bde2-4c9a54b60c24   \n",
       "50    fba6c2a3-7355-48f1-b14f-12f556934765   \n",
       "51    2efd1a10-ea40-4f77-b5da-b4c09ad1c1d5   \n",
       "52    1a5555a6-9d7a-467d-b10d-0c0c337a194c   \n",
       "53    c35a4a74-0af3-4fe7-b86d-763c66d9126f   \n",
       "54    83a444ab-0d78-48f2-b06e-9badb4f66c90   \n",
       "55    a86d7505-835e-414c-a009-a65e6f7614a0   \n",
       "56    9f7f0a8e-a2f2-4bd2-8e61-5bee16087cdf   \n",
       "57    f7fbb7a8-e407-4ce2-8f01-15775aeb0955   \n",
       "58    203388db-4ce6-4db9-ac85-352e02ea1773   \n",
       "59    4f9971d3-b23f-484d-8252-618ed16fabef   \n",
       "60    c0a790dc-fc9c-46ca-b1d4-12b8c7242995   \n",
       "61    0be01718-d5f2-499e-a69d-1570de1f98da   \n",
       "62    f87d7c46-00f7-4c9e-b2e6-957a1d19c80d   \n",
       "63    d8b93d14-fa1d-4b8d-a87e-9d4ab4fe07b0   \n",
       "64    cc42df55-97f3-4419-b738-e1137bdcfbdb   \n",
       "65    bfe90044-061e-4c93-a8cd-7f5b9f59db4a   \n",
       "66    8a9f883b-52f4-4846-83b0-37f164dbf31c   \n",
       "67    c276b014-b87b-4374-938e-541649beb869   \n",
       "68    2bfe6ca0-5119-4999-ba63-855ef24287e9   \n",
       "69    eaa63b24-3fb6-4f16-9a7d-b6c25814080a   \n",
       "70    73757abe-c827-45f7-9e74-69e51ac47186   \n",
       "71    e7149e1b-883b-4bef-a63e-0c2caf5222f8   \n",
       "72    cf158710-b8d7-40bf-8aa0-f188a9a0c63f   \n",
       "73    8a858b63-de7d-45fc-a167-a712ed3c3a5f   \n",
       "74    01340c77-e754-458c-8d1b-d035b8986973   \n",
       "75    47d2bac2-62e4-4aae-861e-f14579501e50   \n",
       "76    0360892e-8b0b-4343-99ca-56158b8e446c   \n",
       "77    21557003-ef67-45ee-8944-5b1fac23e3de   \n",
       "78    a3182e32-9a3b-49ff-99d4-66b48f52c131   \n",
       "79    d221b444-aadf-46fc-bb62-4a66ddf001da   \n",
       "80    16cb0e18-2146-46d5-aa47-1e108e085060   \n",
       "81    8752a1c4-06c6-48cc-91c0-67ce1fcee266   \n",
       "82    748a19c8-0767-4753-8866-d22efaa0bdc6   \n",
       "83    7e329f98-c746-4dca-a171-b0c58d629d53   \n",
       "84    8e03cc5b-63fc-4626-8f0f-9528e6c4ddcc   \n",
       "85    206850db-44b0-49f6-be91-5aafb541a1dc   \n",
       "86    94c14879-3794-46f9-9a49-243f048ff152   \n",
       "87    9d714a9c-8512-4713-a692-70905450b050   \n",
       "88    688fa3d9-748d-46a5-8746-8ed6fc1ba656   \n",
       "89    989d702b-9aea-46e4-99cc-c6fbe92afdb0   \n",
       "90    54f66ab0-2f8e-4009-b80a-087f092a1552   \n",
       "91    41825c23-98e7-4400-b20e-df241b75528c   \n",
       "92    620b63a1-6e02-43bf-ac88-cec3c05e37b9   \n",
       "93    7b8255d5-405a-46f5-acdd-b958883109d4   \n",
       "94    a7096106-c332-4ac6-ae08-a43c654431f9   \n",
       "95    51582479-86cf-49b6-99fe-f1664acd7b49   \n",
       "96    4fe212c6-6998-4add-ba94-eadf5d5fc34b   \n",
       "97    4ebfb6e2-9701-4e42-b48a-00b052b4040e   \n",
       "98    3ff24bee-14fb-4aa9-8796-45039168f029   \n",
       "99    8f5652ca-f920-4309-87a4-b9060f148fd2   \n",
       "100   83b774e5-02cd-4a18-a6a5-a6e8b8f6f737   \n",
       "101   c932ce65-c087-444f-a84e-5c39e2ade433   \n",
       "102   c4769714-f48e-4eb6-a449-fc68e568d2ac   \n",
       "103   e7b2765e-f0f7-4f5e-9be7-22dafb3a571f   \n",
       "104   c918b233-d80e-451f-ae32-53817086a63a   \n",
       "105   8507ba73-11bd-4997-9605-da624982d39e   \n",
       "106   7f531c58-29d1-4af0-861e-c5de460788b3   \n",
       "107   2ed86108-84cd-4ca1-8fea-8b3fe0c6dc57   \n",
       "108   20438f19-63ad-4186-a59e-fbb842481927   \n",
       "109   cc9a6319-5801-42a4-ae28-58cb8d9bcac2   \n",
       "110   6ca42575-9a26-46c2-b8d2-166df22c922a   \n",
       "111   422152c1-851b-4d6d-89dc-783f03f81822   \n",
       "112   0386845c-8612-474a-88c0-b7733833195f   \n",
       "113   742bd6cf-140c-478c-90d9-19989db0dcee   \n",
       "114   a3388cea-fd09-41a6-be9c-80bd0ff0ef9d   \n",
       "115   85224f7b-a33e-4d54-91bc-3baeb7c6f47e   \n",
       "116   86ccff55-4abb-4afd-84ae-7d60db2449fe   \n",
       "117   33a5473f-295c-4766-95c1-03862aac0010   \n",
       "118   aa06f028-3d07-4369-a323-f8cc87158da2   \n",
       "119   68d72390-aafc-498b-8aa1-058f29956b6c   \n",
       "120   4731e837-641f-47ac-a712-849a131877f3   \n",
       "121   9366b121-dd84-4455-88cc-d48885a5230e   \n",
       "122   4c8016ed-3c69-46ab-9845-d8aa1381976e   \n",
       "123   bd1a6562-4f27-4598-bc81-c24153cc3a4e   \n",
       "124   37982548-b65d-47f9-abaa-61fc8efd818e   \n",
       "125   917b95da-40d8-4cd3-ad33-5514bdf822c9   \n",
       "126   24196a95-aad5-4505-982f-1da68ebae049   \n",
       "127   28f75328-87e0-45f6-94db-c5a43da0a76f   \n",
       "128   6c10c28c-8af2-4641-8b6f-0bcedcc212a5   \n",
       "129   efa3b8cd-283a-47e9-8d56-dd4578112787   \n",
       "130   7c277987-1085-414c-aee8-aa531e6c3d90   \n",
       "131   692e14aa-7674-479a-8f12-5ead09b39998   \n",
       "132   b2e514da-ce5e-475d-a806-ab41b949c8f0   \n",
       "133   a149bce7-5bba-4788-83b9-635557348b15   \n",
       "134   2fe27060-0d58-4b32-a51c-69ef3664589c   \n",
       "135   590e551f-8740-4103-9692-c36b2c3d30eb   \n",
       "136   49f9a5ad-4eae-4b6f-8d6d-0b4c1b4f12aa   \n",
       "137   f53ffcc5-6b9d-43ee-ad47-8671b10d85a8   \n",
       "138   ab2008d1-8d69-40b9-a124-ebfdabd33b92   \n",
       "139   2e44e44e-94d9-458d-beee-2ff0be4c9646   \n",
       "140   14cffc26-6b3a-4fd6-a639-546d0553030d   \n",
       "141   de9f881a-41fd-4793-b308-61d0730abfa8   \n",
       "142   bc9cd282-bb7c-4392-8779-7496665c4aab   \n",
       "143   45fb12b9-e8f1-4218-8550-b00fccad92eb   \n",
       "144   c063f264-d59b-43ce-9797-f3530cc845fe   \n",
       "145   1abef160-be83-4c30-8b12-8b37be2ffe1c   \n",
       "146   15a413e2-d114-453d-aed1-2654539a653e   \n",
       "147   a961baf0-9dbe-45cd-a602-e8e4bdfb309a   \n",
       "148   26b918ac-5c67-44ca-93f7-e94cce571c89   \n",
       "149   4939a7c8-a97d-45bf-a315-836a92ec7d2d   \n",
       "150   60780ad8-f39f-4a9d-90ba-79d6784faaab   \n",
       "151   0f29590e-7463-420e-b34b-9e446448501d   \n",
       "152   25e09e7d-c759-40ee-8a2e-a9f5829e5bb3   \n",
       "153   b2b5437c-6243-4f9a-b1f2-314ac7445054   \n",
       "154   aa6c4147-21e0-4755-913d-a769e16a6c71   \n",
       "155   9352366e-a535-43a4-be7e-44f1851649f8   \n",
       "156   b1568729-81d9-4069-8d35-0f7885788b58   \n",
       "157   0b3578e3-7590-4a5c-85e9-19d9976f2121   \n",
       "158   a4a26951-687e-47fd-af97-5075f3ab6d1d   \n",
       "159   f5d8a9cd-47a9-4846-b648-28bdbdc7d565   \n",
       "160   be1e23d3-fdac-4364-9485-97a02e59cb66   \n",
       "161   180349b6-6e08-427e-81fe-f34ed267a417   \n",
       "162   5c3ad10d-4ca6-4b07-88bf-628d6bc15ba0   \n",
       "163   573d9b9d-0b89-499f-866d-b0fa26171291   \n",
       "164   2777f688-9f70-4d87-a640-0a88c4861945   \n",
       "165   bd8dc0c8-c9a9-4b98-a6b6-21accb4926bf   \n",
       "166   f074321e-9a30-4844-b3f6-e84950743399   \n",
       "167   5d0e72ac-f963-4577-bc66-cfbef3b8818f   \n",
       "168   f55ba3e1-5f62-4358-855a-207562ed321e   \n",
       "169   f9ec7007-01fa-49a2-8627-e662c1da5a80   \n",
       "170   e5556fcc-ee3e-4574-ae26-18fd806a7dbe   \n",
       "171   6bba032c-6e58-4c07-bc3d-72e9a2664dab   \n",
       "172   15e6bc81-8633-4eb0-8444-d935be34ea34   \n",
       "173   3c98ebe3-ea99-4276-b767-033deb3a86e9   \n",
       "174   c334bfc2-83da-4545-a244-ed501bce00e3   \n",
       "175   95b7a979-6084-42bc-a287-a91c9863e0a0   \n",
       "176   f6348637-83dc-4106-82fa-6021c4a20b88   \n",
       "177   22a1bec5-0933-4730-b26d-ec025b8b4977   \n",
       "178   350ea231-614d-450f-aa61-8b9ce4d19f60   \n",
       "179   49655528-69ea-43f4-8440-035d99f8c8bf   \n",
       "180   5ae3c0bc-f5fe-495a-a293-748653fa5207   \n",
       "181   035d45fe-81d9-4420-ae2c-86eebdc5def2   \n",
       "182   559a0c90-ca42-417a-bb32-1e0bec8ebb04   \n",
       "183   83d154bb-5a1b-408d-9718-339e081a8d0a   \n",
       "184   58842cb8-ed6b-4f69-a4b3-d898b4c23324   \n",
       "185   8bdbc96b-4551-4501-b673-98dc1782d01b   \n",
       "186   794b140a-7538-47c4-bef1-c9b6e2b0bbbf   \n",
       "187   a8f3b538-0167-449f-90e9-29f104eb70af   \n",
       "188   1380bf15-ac06-4cfa-ad6f-3c9258bf00ba   \n",
       "189   b2521090-ead6-43e9-bf9b-ac0adb2ca941   \n",
       "190   8e9102f9-c8db-424c-81ad-1130885fc73f   \n",
       "191   5d29fc4a-4db1-4a57-bb16-274656999e5d   \n",
       "192   72679138-a933-4fb0-8e4d-96b9740cf8a4   \n",
       "193   7bbe100a-8a5b-4c5e-b329-406d80064a56   \n",
       "194   61a230a1-0285-4ee4-8655-b5619191df54   \n",
       "195   a5a5ba10-87f1-4601-b012-c45fcdf1d447   \n",
       "196   2e39b475-d455-4254-8ff0-44b2c5782622   \n",
       "197   7b47ae39-763a-43f1-919b-a65a679f8122   \n",
       "198   d09d3712-490d-4551-8e29-32c88b2d5610   \n",
       "199   b185fa34-6360-43fb-8ff4-1145271af285   \n",
       "200   9affa245-766f-49ec-8b1e-045975ee6c5e   \n",
       "201   8d3cabd7-daf1-475d-b22e-0317b7ba5f5d   \n",
       "202   6663584a-1e63-483d-8977-a38601505e92   \n",
       "203   bd3d3aa9-d349-4ec6-a171-994c85096e6d   \n",
       "204   58f85081-70e0-44f5-b781-3ab2d0e2afb2   \n",
       "205   afb73d38-1087-481a-83bb-f45906176e6f   \n",
       "206   46e28d56-0ecd-447a-839c-80dc94b0895f   \n",
       "207   129c3c4c-ca35-4d48-ac53-cc86dca907b6   \n",
       "208   94fbc601-9641-4214-9020-1f4da6ed95e9   \n",
       "209   4c194a97-0b95-4037-9b77-b69996e5aed5   \n",
       "210   28619851-b8f2-4c33-ad72-3bd29dc1bb89   \n",
       "211   aa12f85d-f14b-4187-a87f-1e6d7026bebc   \n",
       "212   4944417b-8438-4ab7-b701-7f352c5a8ff8   \n",
       "213   d8f34ab0-e605-43f4-a7f4-8be9e483f654   \n",
       "214   b3d0785e-b0a9-4ebb-9948-9fc559af0aac   \n",
       "215   d3477d85-6146-4e15-a0a8-7e5629002148   \n",
       "216   ee34e771-d80e-463c-9af8-aa5c9940afa3   \n",
       "217   95ec69d8-ad09-4762-96dc-55c91f8f73b7   \n",
       "218   a99633aa-d178-4fe6-98f2-8ef68de4237f   \n",
       "219   004eb5e2-8d4e-47f5-baa2-4dd4c17178cc   \n",
       "220   631a9299-2946-4479-8e45-1338df0ab3d3   \n",
       "221   ccce043f-a76d-4417-aa03-96543d3d8a7d   \n",
       "222   ffb15937-5fdc-4088-a8a1-ef53642d95fe   \n",
       "223   0761372d-fda3-452f-8e88-50fc89d1c362   \n",
       "224   efc23074-2942-4df8-867e-d55ce05379c5   \n",
       "225   fdc0ffde-7ed8-4172-b48a-bc9f0f656f5a   \n",
       "226   2147fd1f-c99c-4873-bded-69abcbdc0431   \n",
       "227   dd5b23ed-aeb9-4115-b896-44358b4f228c   \n",
       "228   7eb0edf4-2623-427e-86a5-cf11f41defa7   \n",
       "229   27b4db21-e5bf-426c-90ac-3aa4f238ee20   \n",
       "230   834006f0-7f8a-4b66-8e93-7b533eb0f3c0   \n",
       "231   ee96144e-692d-4c91-b860-34d7de8bfff1   \n",
       "232   0809c7cf-9caa-42ce-ae9a-c50013329193   \n",
       "233   ea15201d-7710-4b67-a464-eb1a3872cc9d   \n",
       "234   48452677-5df9-4666-8c66-f0df2f0a39c9   \n",
       "235   63b04285-5ea1-45d6-816a-05d1781cacfe   \n",
       "236   6c2451bc-c175-48fd-9b9c-ada405958db2   \n",
       "237   7f9f3c55-19f3-47fe-b132-5382ff1d479a   \n",
       "238   4e2c9396-8a9f-4a06-9cbb-7dd9549b6f86   \n",
       "239   21360eeb-0288-4335-8674-8d898d3d3616   \n",
       "240   49d83c44-b40a-4a8c-a58b-bd742410d80a   \n",
       "241   7beb49dd-2c55-4652-bb77-a4efe392db76   \n",
       "242   796689b1-ab2a-446c-b719-4256b3087ace   \n",
       "243   e0a79008-ccea-45e2-a290-370ef27870f6   \n",
       "244   6cf8d64a-acd1-465a-a45e-17f125aa9f00   \n",
       "245   4a05e7fb-0743-4496-9da5-af1c3981fed0   \n",
       "246   7c7b56aa-f0d2-4de9-bd95-08b3ac26b545   \n",
       "247   236ad60c-88d9-4fef-8c35-e75636dce640   \n",
       "248   23e092ed-9015-4650-8b07-fd8fcb6b53c3   \n",
       "249   e515ffab-e8f5-4f8f-89cd-1dfd4da2f596   \n",
       "250   d7c63a55-192a-4d41-b1d2-7bf83aa51a14   \n",
       "251   9d0a143a-a85d-4512-9f22-d2e5a3fd35e6   \n",
       "252   3ec10d37-3b9d-4dcc-a8ee-d1b7cd5c6f1a   \n",
       "253   74a73bbb-ed62-41e5-af29-390223abd929   \n",
       "254   5b337208-0e3a-4cfb-85bd-5110209b9f19   \n",
       "255   e9bc4393-5a04-48f0-8758-9b0370ec2b47   \n",
       "256   ee75d76c-f3ea-4996-ab64-66d22c6b2ef2   \n",
       "257   f2811772-006a-4bc1-a3e4-e62a532c19aa   \n",
       "258   f70ef308-6eb5-41a8-99c0-010dabf40751   \n",
       "259   ff23edb8-7d6f-4c8e-8a06-00d06cce2260   \n",
       "260   ae6f0205-6d33-4b13-9892-f7276fff2440   \n",
       "261   049286cc-82e2-4197-aede-8ad5294722ec   \n",
       "262   7e9060bb-0b00-406b-8c84-9caa70727a51   \n",
       "263   501470e6-1c87-45db-816c-e61fa1fab10c   \n",
       "264   0673c403-35fb-486b-b995-5e1d56cb200a   \n",
       "265   9b681804-7340-41b8-a323-832be24d337b   \n",
       "266   f69104ef-6398-4aad-918d-5ed281b1cdb3   \n",
       "267   e1654873-e378-47fb-a685-cb4cb8cee203   \n",
       "268   f9553502-993f-413b-aa8b-ef6228a58c4b   \n",
       "269   1af9e671-abc2-4bfd-b166-e27ca412e4c2   \n",
       "270   165c023d-76dc-4f77-87f1-a1e803498995   \n",
       "271   f3b080a1-71ac-45c0-a0c9-3b2e40cad4e2   \n",
       "272   2406ef57-1acb-49cd-9f20-f485a7f0a9ba   \n",
       "273   d0b056c0-0543-4bc5-aac7-39ccc48f245f   \n",
       "274   1ffd11fc-93e9-4bc3-8c4a-f781594e0cf4   \n",
       "275   a269a172-5267-4a6d-a24d-a7e8e8c39596   \n",
       "276   b2543fe0-bc59-4ca4-924b-87c0d814bed2   \n",
       "277   26be193e-cb11-4539-9f93-82f782dbba70   \n",
       "278   7b128a04-bec4-4013-a567-aaa17e07ee8a   \n",
       "279   a0b2830d-4d5b-4a87-9c39-f33a7cbee2c9   \n",
       "280   6461878c-0fd3-4eca-b2a1-9f4e9c7c3976   \n",
       "281   845fc59a-0299-490e-ba26-c4ebc703690b   \n",
       "282   c963a70f-236c-4dc8-a35f-66b738cd42f3   \n",
       "283   d6770238-89d9-42bd-a941-eef46df81e38   \n",
       "284   742a316c-2896-41eb-b510-e4da603e1ba1   \n",
       "285   9c9844a7-0225-475a-abdf-d386c1b51dff   \n",
       "286   952ca76a-31db-48b9-829f-e7a2d50acffa   \n",
       "287   8f6c3fd9-b8b6-441c-ace9-99d2ee49dc43   \n",
       "288   bd1ff8fe-0bde-4faf-89fd-eadfff0d7c98   \n",
       "289   481987c2-1a97-4687-becb-c66f3e06e406   \n",
       "290   344683cc-bb25-4d54-9973-cc7db327df8e   \n",
       "291   fd6d02d5-5cd7-47b1-8afa-9fd78e3d7cc9   \n",
       "292   ea49dd70-eca4-45d0-80d8-fdc2195add3c   \n",
       "293   3f0d0850-a721-4498-9070-674d2f945c7b   \n",
       "294   6c3cd946-eebe-4ca4-afda-5ed0456f88ac   \n",
       "295   21ca149f-31bc-4dc9-a407-ad7975a113cd   \n",
       "296   a9fb7a1d-9cf4-4a04-9b99-12b9a4084328   \n",
       "297   bbc8e7f5-2b13-4655-b2e4-ec826dcdaec2   \n",
       "298   fa7969b0-3481-4502-bb57-ba5421714041   \n",
       "299   a609e230-f297-4866-b435-928b643053d5   \n",
       "300   66961383-1392-4e3f-b3a8-4a1e774c5908   \n",
       "301   8c5f98ae-7545-4d46-a080-03974edab380   \n",
       "302   dd8b062d-6ea7-474e-b617-876157ce11f8   \n",
       "303   227821a1-efb2-4737-bdab-6031c997eb5a   \n",
       "304   bb5b82d7-c871-4f4e-804b-ef116ed38d14   \n",
       "305   c5a2607b-813c-439f-a5c1-a1cc9506c650   \n",
       "306   7a5a0c37-0e3f-405e-aca6-ba41bb006754   \n",
       "307   639a472a-3144-475b-bcc3-f98500aa77a7   \n",
       "308   e0957090-cb84-4d92-9a62-5c440815be3a   \n",
       "309   b7bee665-bdfb-462a-8d50-432bb62cdb0b   \n",
       "310   aaf0c19e-4b11-46bb-814c-030d675c0d40   \n",
       "311   c2cf5368-0cf7-4ee9-b1ac-e7f5f3811c4e   \n",
       "312   0842b3d6-fc85-4064-a569-13699640da69   \n",
       "313   698162bc-efaa-414f-ba06-4ba29b5ccd05   \n",
       "314   78a5421c-af22-405b-955f-8681ff8e0a60   \n",
       "315   534d716c-f298-4235-a643-2a717c8f9052   \n",
       "316   74ce87aa-54ff-4d91-ad04-634deab19cba   \n",
       "317   1f2f9a1e-3968-4e86-a134-d91f70ae5834   \n",
       "318   586dd4c0-a4d4-4d0c-860a-7c56e82aa2aa   \n",
       "319   4addd79c-f424-4847-914b-f0470a347298   \n",
       "320   19d99677-cee7-4c0e-be5b-3a2c9ca4841c   \n",
       "321   06548203-ccad-40d0-96de-be803bc13c0a   \n",
       "322   07ecb175-32b9-41f4-9761-c80496214fe2   \n",
       "323   6fa0f23c-6a2a-45cb-a408-d0729fd5b87c   \n",
       "324   4169db30-a0b1-4332-84b5-76a9a57e016d   \n",
       "325   49ddab0e-b1e1-44db-aca1-514762492e9e   \n",
       "326   dfdc6ec5-a778-4103-85a4-7f45528ab3b2   \n",
       "327   200b8f93-7dab-4af2-a7ef-bdef64cd51c7   \n",
       "328   d8a7051d-22c3-49bf-87d2-5daaba112134   \n",
       "329   9a96183f-7698-4e40-b736-724afcc1a454   \n",
       "330   9c6d5433-6be5-410e-8af5-c9ba5801812a   \n",
       "331   a86396bc-f671-4ac5-af20-94c1cdb8fdd5   \n",
       "332   bc2bfcaf-3d93-4978-add0-4996da4ef294   \n",
       "333   74f8670e-2d23-4e3f-9683-3dba7ed827b5   \n",
       "334   d2355432-989f-4f5f-b819-7adce09b8728   \n",
       "335   ee524e55-0083-4d25-aa4a-9be461d267dc   \n",
       "336   c80c2af7-c16d-4dc1-9c64-8911a3400f39   \n",
       "337   10eff51f-2eb4-40cf-acbf-f72f5c5feb3c   \n",
       "338   7ae31cee-0599-4c75-b0d0-6a3db992fb8c   \n",
       "339   303978c7-cd11-46c3-ac8a-d38393eeb2c6   \n",
       "340   b705f3d7-0ae4-48cb-a236-8285efe19e41   \n",
       "341   2070997f-59b0-46ef-a346-c0337a1acc7d   \n",
       "342   9883687e-7f9c-4cfa-9fb1-79ea1f5a413c   \n",
       "343   cbf9f9a5-09dc-4b59-a4b4-52ee06617158   \n",
       "344   65806c6a-5fd8-4a40-8b19-9e5c9f410a06   \n",
       "345   b681350b-09eb-40ab-92dd-e328901cf076   \n",
       "346   886481b7-14cf-44f1-8003-f53311b2a5a2   \n",
       "347   61c5019c-83ec-4338-9ce3-c0b1b96230d2   \n",
       "348   8f5b6b3d-559b-411a-86ea-2a0aee1112d5   \n",
       "349   329d7296-ac85-4d49-a5ce-206bb67e5051   \n",
       "350   b12ba759-ab96-4f00-a6aa-5e78d5076089   \n",
       "351   103988e9-f22c-4c52-8800-d3d620627d55   \n",
       "352   e939b11b-882d-48db-8872-cf77ae5e20e2   \n",
       "353   295bae3d-d561-4d44-bb33-c7de7b131dcf   \n",
       "354   204e4559-568d-4a95-a4ad-af4facdaea8c   \n",
       "355   a78eb7bc-9e86-4866-aafc-443dd87f3f36   \n",
       "356   11f9a17a-8aa8-4b78-a263-8c47fff014a1   \n",
       "357   02cedba9-6f8b-42be-b9d9-08d16a95d910   \n",
       "358   30e39eb9-2aa1-46e2-8c32-8ced1095b063   \n",
       "359   23bd6328-7462-4e23-abbf-710315a2c627   \n",
       "360   144165b0-fbf3-42bb-ba1f-86ea7a58e540   \n",
       "361   d55c81b0-85f1-428e-a730-2c72f34dc129   \n",
       "362   ffd466d9-5737-4344-aa2e-98c64a9885d5   \n",
       "363   9c141a90-32a1-4b9a-81f9-f11bd8894591   \n",
       "364   03609267-38bc-439a-8e1e-56c0ba069f36   \n",
       "365   8b0f89d5-ef62-4f9e-9f7c-6f8ee378ad62   \n",
       "366   0ee4b54b-470b-4bbf-9e34-164c5012fecf   \n",
       "367   25926200-f836-424d-9a14-14678636f2da   \n",
       "368   c4ea98d6-5e77-4c76-a8b5-15ad9cff183e   \n",
       "369   6360fa5f-ea6e-4dc7-a14f-3f568561b6c6   \n",
       "370   2e6258a8-c89d-4fe7-b8a4-506c426bf2c8   \n",
       "371   9d347c97-404c-4d00-ae17-160b5fdd8125   \n",
       "372   15fe40d2-56a9-4d51-ad0d-71833b289b81   \n",
       "373   d57d0ed8-bc4d-4dd0-8ede-fe08e4fd8340   \n",
       "374   6d8f7d49-c649-4493-84d6-87f07a6ec9ba   \n",
       "375   ff07386b-bb81-4743-9805-4a4245e4aad3   \n",
       "376   c6d51464-cdda-473b-9226-6f0e41543264   \n",
       "377   e7ab8121-0e39-4029-9b5e-50f931e3b622   \n",
       "378   44af30ec-e7b0-40ee-a302-717c14940820   \n",
       "379   bcb493ea-2093-4e05-9fce-52f98142e51c   \n",
       "380   2fafba15-78ec-4e61-8c6e-f2c930e44930   \n",
       "381   9e233aa7-b9d0-42be-a233-83542df0e5e2   \n",
       "382   6f55fe3c-09be-4268-9997-e2734b1f0df6   \n",
       "383   8a99a835-195a-4de9-8b6e-3ff4377928d4   \n",
       "384   d3ae3d97-058b-4874-9c38-4f00d7a2e65f   \n",
       "385   378587c9-2434-4016-912f-3ca927e71125   \n",
       "386   dfe12dc7-7523-4610-9395-af10c93fcf18   \n",
       "387   ba5148dc-1c8a-44f4-b92e-13ba4496256d   \n",
       "388   c8d634d1-f148-4b54-9650-5c12879399f8   \n",
       "389   f1faef9c-ee0c-43b0-b408-588a7021a168   \n",
       "390   e3254c4a-c97d-40f2-a9f9-f2afdb5f87ed   \n",
       "391   ee8855b4-47b9-4477-ad14-1b9b7fd9dcec   \n",
       "392   1f96117e-7ec9-4bb0-9972-9109570ad729   \n",
       "393   56e479a7-d76f-4d9b-899a-37363fc4f56a   \n",
       "394   85cc9dff-56e7-468e-a8b0-77bdd4e0a721   \n",
       "395   6e081d11-40a0-4f39-9507-7cdc12cdb5b9   \n",
       "396   4020f423-13a3-47dc-bb44-a670eb4cd25e   \n",
       "397   395098c5-445a-420b-80af-70415f81bc78   \n",
       "398   54e47ab9-f9b7-40c3-9806-4623fa649486   \n",
       "399   6de5fc30-a6c0-4718-b785-6fe42f115fa4   \n",
       "400   5441d1e5-f61a-4afd-a1cc-fbed72a0bffc   \n",
       "401   fb690df7-1693-41c9-9981-67ff130f7344   \n",
       "402   05e81ba1-5b98-4624-8b21-1cad75bece5f   \n",
       "403   54a01c8d-581f-4990-a993-fa1d987bb97d   \n",
       "404   eba6837f-842c-40ec-b0dc-228a7167219c   \n",
       "405   ed768de7-c817-4bae-9dd4-f613946a4e66   \n",
       "406   5d7ce9de-e08a-465c-bea2-fb9454487be9   \n",
       "407   48ffd17e-77ac-412a-bbed-9f24973001f8   \n",
       "408   54d2f24e-27b6-4d6a-a039-4efd2ba21e12   \n",
       "409   f7e7d9ea-0f28-4a99-9a65-74379ff0a0e3   \n",
       "410   5b59a254-797d-4d0e-9c4c-5943bf5bc821   \n",
       "411   732ab0ae-48b3-4791-b09f-0053bf47d73c   \n",
       "412   f6a6d6c9-bf3c-46bb-a7ff-0167673f0333   \n",
       "413   e6fca9ec-8f5f-402c-a7d4-72efc697f3aa   \n",
       "414   436451cf-741d-4a3d-b7f6-314a406c795f   \n",
       "415   f3eb8178-ed6f-49ac-ab59-298a09624839   \n",
       "416   0eca57aa-b5f5-4fd5-ba60-1feb04e4e26d   \n",
       "417   37c9242f-2545-4538-9272-17725d9d6a1e   \n",
       "418   890cfdc5-11e6-42eb-a0b4-8175d1e672cb   \n",
       "419   8ae2c6fc-16a9-4f10-9474-204883369a77   \n",
       "420   4284a6e5-f70b-4432-9538-9b997573c10a   \n",
       "421   a6815035-3191-4461-9bc4-cd3ff41b1af6   \n",
       "422   10c0b210-0a29-49d2-a54b-60e35a6eb306   \n",
       "423   38c2368b-61bf-4004-adeb-89d7958fc7a3   \n",
       "424   f3b96e42-4548-4273-bddc-fc700186d1b4   \n",
       "425   a6476597-b0a1-4a5f-9bce-a9f912313cfc   \n",
       "426   d7907f17-ee4c-4252-80a0-b31671ea54ed   \n",
       "427   e710f07a-993c-4878-b11b-7229f96cc0cf   \n",
       "428   27b9b063-4b79-48b2-a0d8-93409d49b817   \n",
       "429   8c499a00-6141-4ee3-8ddf-c2a41772ce3c   \n",
       "430   44c00b3f-e4ee-43b3-8c33-96df202a0279   \n",
       "431   5a92107c-25da-4eb2-a74c-34973061a8b0   \n",
       "432   698357e1-a7b7-40d2-9e77-f996fcbc09c7   \n",
       "433   e5809565-3b73-4754-be74-0c99da63f6fb   \n",
       "434   37fe8898-6417-4829-a20a-f736eb3b6e78   \n",
       "435   751d6698-8d6b-4499-ad63-53c4a5f5c7a9   \n",
       "436   a242370e-8193-4e9f-a071-64c6d3546171   \n",
       "437   96879f8f-fe01-41d0-bd80-dc406f988d47   \n",
       "438   8c0eccab-8849-4d90-aad0-4d7d38e2e173   \n",
       "439   a9ca7f58-cf85-42d9-b99b-9b325fed47ad   \n",
       "440   039591e5-969b-470d-a068-450ba6c0f7b1   \n",
       "441   f8db9ff5-5f3e-4bef-be2e-0c64a270331b   \n",
       "442   83eb2977-67d3-4c13-897e-b23eef787ad4   \n",
       "443   4864550e-17d7-4de0-bf78-d8dd9099606e   \n",
       "444   f81937ec-be91-4fc7-b3e3-880bf7cce40f   \n",
       "445   a1357ca4-573c-4660-867a-d2519f26b16f   \n",
       "446   2dd58385-80fa-4b41-af37-f1bfdc4437ad   \n",
       "447   9a715951-6f92-433e-be58-a9963642566f   \n",
       "448   c7e057d6-61a4-43e5-822e-1c081c090c8a   \n",
       "449   bca2c677-4e80-4cf3-9f22-4d6e071fb2d1   \n",
       "450   f671568e-f06b-4f7f-9bfc-1e816e919e89   \n",
       "451   f2e5e44a-69c0-4d50-8bd0-712863cc5f81   \n",
       "452   84dd0f0f-51a6-4530-a065-25e36d0665d1   \n",
       "453   085ec989-68e1-4ccc-9174-834efb17cddf   \n",
       "454   6ab4140a-97cd-42cf-9687-7032eda3cbba   \n",
       "455   f225edf7-8e84-4bf4-8dec-25b3ed501580   \n",
       "456   3b77bb2a-05ba-41cf-bfec-4c97dd559d4b   \n",
       "457   b11b7723-88a8-4e23-8559-d912e5e54f7d   \n",
       "458   4fba2307-0e26-445c-afa3-875d2a8c1619   \n",
       "459   5a9190e4-277d-44c1-b9e3-b8e8d7df6928   \n",
       "460   bed6ecb7-9910-4ec9-88e3-569dc2378751   \n",
       "461   f61bc5e3-c804-4fa6-87e0-a6c93738d88f   \n",
       "462   7817f43e-85bc-4ece-8213-8d064210ebca   \n",
       "463   4c605b6f-8b68-4979-910f-dee543b94566   \n",
       "464   45815e27-3d71-4db6-ad7f-9665fabb70d2   \n",
       "465   6a36cbe7-54eb-4900-a3a7-b83eea216699   \n",
       "466   e3ec2103-b7d7-4d79-a9ce-fb02a7ca755c   \n",
       "467   c5b8b2cb-ddff-442c-9eab-2d1a939f9b32   \n",
       "468   5d36a709-cbac-4bc7-a0dd-f0bf8136ac5d   \n",
       "469   8afc7452-c917-4eb9-bd98-ec9b091ef3dc   \n",
       "470   1f11ef9a-1f86-4205-8646-7ce31b1c038c   \n",
       "471   1199b010-5705-4c22-9b59-ad9e5d61de59   \n",
       "472   d7420301-4219-4c8d-8450-f90741005941   \n",
       "473   1c56596e-4a4e-48a7-b9c8-67fc5dfbae62   \n",
       "474   86745fbf-bbdd-49f9-b9b8-166d0934b77b   \n",
       "475   7973d72b-7623-4a2f-880f-d58a4d99d1c9   \n",
       "476   0d6d2e87-cc2f-47ec-815c-23cae7cf03e5   \n",
       "477   60d92513-7669-4b52-bd61-96ea555bd75b   \n",
       "478   0d9fec66-eab8-4af6-8a2c-32e5231ecb40   \n",
       "479   32491d53-071b-4a2b-96d7-8cbedc2b0f87   \n",
       "480   ace3bc49-73c0-4534-a689-6f2bb8b01bac   \n",
       "481   dfae775c-5666-4eba-a908-5b72e35dd30e   \n",
       "482   67a78308-9400-48c4-919b-b2e08dedc8e2   \n",
       "483   c8beb47a-f667-4bf9-864a-bef67addc2e5   \n",
       "484   4fc9dc99-dcca-4ab5-94cf-3a09beb3e551   \n",
       "485   73619665-83e4-46c7-af50-b096a5ee4327   \n",
       "486   248b0af8-5184-49df-b272-c053bae696a4   \n",
       "487   2dd09751-4396-4769-a541-7257f0a90cc8   \n",
       "488   281e1304-061a-4e8a-a36c-e7faf3fdc851   \n",
       "489   5d5b6d0c-552c-4a1f-9662-0ec3c4bcaad8   \n",
       "490   0c3c75f5-13c1-46d9-84b8-b0cb3528d232   \n",
       "491   8dfe2c32-f7fd-45ce-8581-a3cddbce64e1   \n",
       "492   5e1e1b82-7a92-4d92-a237-9c77f47ecbc6   \n",
       "493   924cb964-1d0c-45e2-8d8c-62c913fc8ee3   \n",
       "494   8b3c1ebe-f3e0-4c2b-bf33-735f9e650542   \n",
       "495   38d87655-9a8b-4dd1-9db7-3d6ced8ee02d   \n",
       "496   09308be6-9092-4e1d-a960-163c81ac6ed3   \n",
       "497   07c6f77e-f272-4d0b-8a38-e2e2198948c6   \n",
       "498   0fe71f0d-aca0-4ab5-b4a9-f6b398d6f4ca   \n",
       "499   92528dd1-ba17-42a1-8a72-36439a87fec0   \n",
       "500   b8137cc2-0a32-437d-becc-8ab5696aa00f   \n",
       "501   9f23cdb0-3322-40d0-ab63-cad96ca9790d   \n",
       "502   64e5f445-6192-4e3b-9084-690a5d5a65b3   \n",
       "503   80244851-410e-4d56-9672-bc3652b0ae97   \n",
       "504   651b2c0d-9f45-4078-9ae1-6217eceb9067   \n",
       "505   c8057af5-2acb-4b8a-877d-0dbd36a744cc   \n",
       "506   0b65f6d2-ea55-4148-b7d7-b340fcf3eaba   \n",
       "507   9ede9215-822c-4e31-ac83-fb453aa76e62   \n",
       "508   3ff6ea96-d051-4ccb-b7b6-4491ac01be94   \n",
       "509   59debc28-ad29-4f29-9521-0d26fe0d9848   \n",
       "510   496edf54-f4d9-4de2-98d3-825747608f55   \n",
       "511   a46ac954-784f-45c5-822b-2feb5d8f86ba   \n",
       "512   325b1bf1-621c-447e-8b46-bb95dbbdc9c9   \n",
       "513   77f2c258-dee4-4393-a954-1f140bbf4945   \n",
       "514   791997ef-674b-4047-b195-fa3c6b30ee4b   \n",
       "515   633f9fde-9a8d-43e6-b9c8-2ad1d1344137   \n",
       "516   39e73c0c-06be-4afb-9cd8-bc7c79b87381   \n",
       "517   90ced9c6-5af2-4bcb-869d-469da57a47cd   \n",
       "518   ae05584e-a2e2-440b-ae7a-520e8cd73e3c   \n",
       "519   c26e6277-b69a-4822-8fb2-e7b43a7c5ad8   \n",
       "520   5c2ae285-32fd-40e0-962a-c61c430055a0   \n",
       "521   584f25c3-6a77-4c1b-a2be-b43c70553fcd   \n",
       "522   3403e15e-1a87-4896-8470-8e526638f413   \n",
       "523   bcd113d9-7660-4730-9a04-f866ecef15fa   \n",
       "524   45db43a4-0d75-443a-b14c-b2d967dda9ea   \n",
       "525   3537bee3-444e-47c9-8d0f-b0ccbb3b2522   \n",
       "526   469619e9-bdfe-4749-9912-2feab5ef87ea   \n",
       "527   e1ad656f-8578-426e-9302-b2a50f9ee300   \n",
       "528   e37f5e87-bc0e-48e1-901b-c101726ca3c4   \n",
       "529   8817d591-dc56-4c3b-b3f5-5e19b0c1556f   \n",
       "530   8f821635-5074-443c-9308-985b2f16471a   \n",
       "531   05b74310-ccd3-452d-b62a-6ec83e1d370e   \n",
       "532   810af0d4-2e75-4f07-8112-831f6cfd68ac   \n",
       "533   7827c7fb-e24c-4fe9-911e-fc311500cfbc   \n",
       "534   4d108925-6a00-4297-9dd6-998ae2d0c970   \n",
       "535   e9ff81bf-4664-4a9d-919a-ffdfd268efc9   \n",
       "536   39da9faa-6fd6-4d57-bdc4-1f41fee13498   \n",
       "537   c895b5c9-1b5d-43c3-a093-96f208652969   \n",
       "538   7cf02045-ac32-495d-8d12-27dbe5072e49   \n",
       "539   ab739d57-6205-471d-a5dd-6c1fe46d156b   \n",
       "540   6941db31-7574-4e9b-ae69-eaaa66f2420c   \n",
       "541   fe702e31-d670-4e50-832d-ac29eb03dddc   \n",
       "542   5b2ee345-a997-4384-9204-149b95eeeef4   \n",
       "543   c2c96eef-6248-40af-9e96-9132ef8af176   \n",
       "544   ed5ef2b2-175e-44b2-b9ad-a0211eacbef6   \n",
       "545   55900b13-1b7c-409e-a5c1-9dbc881790ce   \n",
       "546   8ba1ff40-e427-4572-b750-fc9952846756   \n",
       "547   77d8ca2d-0b37-4ed4-9028-a61000d8ced7   \n",
       "548   cf3edb66-6391-44f4-9ab8-c13094c6c34f   \n",
       "549   6318620c-f97e-40df-adf8-e52677fe1d12   \n",
       "550   e943a96b-8c0a-48a6-b7d1-4ef5d4bf44e3   \n",
       "551   8939231b-8e9d-4bdb-ae32-60d5986df52f   \n",
       "552   984b40b8-498d-4aaf-be5a-8ab66b811b98   \n",
       "553   3d76af83-60e7-4d67-bba4-0566e7ab68b1   \n",
       "554   5d185dbe-70d4-43b5-a71d-283e9e86d8e4   \n",
       "555   106f9518-f921-434c-8be4-9c93cf524278   \n",
       "556   ce887ed7-f67d-4d4a-868b-71b62691df1d   \n",
       "557   c8bc9ea9-71d6-4a22-9175-4691d10cf371   \n",
       "558   226751c7-3524-4b5b-a9d9-c656e91da74c   \n",
       "559   34d6e071-f409-4dde-8d05-78350835bbd8   \n",
       "560   9a6f7941-1203-4248-a7db-d43d31146ec4   \n",
       "561   253b308e-7d01-43b0-8f6a-14516ed5780f   \n",
       "562   21e3e0b2-0c74-41c5-9d60-695bbefd10a5   \n",
       "563   0da57e14-92ab-43b2-aef9-24799b80b8c4   \n",
       "564   d9f947e0-de7e-45af-9297-a2966269fbf4   \n",
       "565   7c15600f-5bc8-476a-a0e3-4a0992ca9079   \n",
       "566   197bf96a-e20c-464e-83b3-86eb4d325b04   \n",
       "567   3993f0ac-2d7d-4d8b-865a-6e49cd3f9796   \n",
       "568   aea07fb0-f4d3-4e6c-98bb-c737bf5d0404   \n",
       "569   88ad9f52-32ea-4b39-878f-a8a9373201c0   \n",
       "570   0d0d8d6b-acf4-4e3c-a9a0-4067ed0c4794   \n",
       "571   4f2b5814-64a9-4570-a159-9c2450e2927f   \n",
       "572   e7777365-6015-4eb1-aeb9-a14f787f27a0   \n",
       "573   1428b6b4-2ac9-4d26-80a5-d8e7986cb64e   \n",
       "574   4dd9d096-da42-482a-b2c3-2da07013e691   \n",
       "575   ffd7840e-a716-4741-afde-45e5a4a0cba5   \n",
       "576   7bb3a833-848a-44c2-9115-13d3054e9ac4   \n",
       "577   15427901-6351-4b03-9803-92845ae9eb81   \n",
       "578   5fb80c30-f6e1-4c3a-a08f-6b7e568438e5   \n",
       "579   a094aac6-e825-4154-b3c1-30ac2d4bcb21   \n",
       "580   20ba48cc-a3db-4995-aafb-a8a454c7f0ed   \n",
       "581   19210ffb-dd25-494d-95bd-1bfc91657e89   \n",
       "582   311e4aa6-f86b-4004-8893-88eacde1d8bd   \n",
       "583   c5a2da35-7cee-4ce6-b8a4-6745436a0421   \n",
       "584   d19825d3-d90d-41a8-bf61-20d30a321f1a   \n",
       "585   d92a9f13-e0dd-4ddb-9491-9e4354ae16a3   \n",
       "586   92ba8e34-1658-44ab-96bb-ae2e2c5750c8   \n",
       "587   543522bf-3cae-4607-88a8-93b3f8236fb9   \n",
       "588   2185f17c-8004-4709-9292-032a399df0fc   \n",
       "589   57d00876-feab-4401-9e4d-f032ce907169   \n",
       "590   a255945a-0f58-491c-bc27-c67cc90b0a4d   \n",
       "591   0c9443ed-b824-4103-9d23-0954ad9c3c15   \n",
       "592   d4f307ac-25ae-4835-9362-aefb305be296   \n",
       "593   de842d61-e1f1-4de9-9f8e-4a0c867274e3   \n",
       "594   7c0b69b3-f725-4dcb-9510-ffa34e3b3578   \n",
       "595   bc355e54-6c6e-4258-9931-9928c817256a   \n",
       "596   80734d8c-f397-486b-8400-0705f98f2c13   \n",
       "597   14b89e60-5e21-4d1f-83fa-24819d18550f   \n",
       "598   cfe48ad0-b702-4568-bb2b-87888429cb4f   \n",
       "599   3303d447-6a93-4e07-b198-d9a5d0ddae34   \n",
       "600   f4ff11f6-79d6-47b4-bfd1-8ff7fe8afa19   \n",
       "601   c074ba88-c76a-445c-922b-04782197a38b   \n",
       "602   4578dc2f-6328-4e73-8f73-d956d5e837cb   \n",
       "603   70c95b04-0bfa-4133-82dc-e59a14a4143c   \n",
       "604   0eeffb07-29d9-41f4-b109-ea185af145cf   \n",
       "605   6167dd16-d0c6-4efa-b303-d17cf598531e   \n",
       "606   d5232e93-74f1-4890-bf52-a7b0264f53e7   \n",
       "607   cbe86e01-6adb-4b7d-afeb-b973af3a196c   \n",
       "608   09ef1f5e-6678-42a6-804a-586902fe8374   \n",
       "609   e734de83-a9ec-48a7-9528-e0d51874601a   \n",
       "610   c75e7f60-7ffc-482a-9808-fb8ceb2ee31b   \n",
       "611   2c9b7b15-671f-46d7-baf6-7d64af9d2e47   \n",
       "612   7a1137aa-89b4-46e8-a49b-f83858b54f9f   \n",
       "613   910fa1cf-51e8-49cf-a942-9b7d5312874f   \n",
       "614   9df227ef-b702-4f08-b518-5f7cd719a24c   \n",
       "615   1c1c4465-0b6d-40c5-b466-2d87d594d1e6   \n",
       "616   e7a95d6d-69e0-4477-ae4a-8e4267479776   \n",
       "617   f126b794-4ed8-4443-9712-d89aedfbfbdf   \n",
       "618   1e0c5cfe-8636-41e1-a1ec-44316c3a0a3a   \n",
       "619   0468fe6e-01c5-4372-8ff4-0759612ecb23   \n",
       "620   791d04c4-f26a-433a-9396-155267f0dc3e   \n",
       "621   ed070782-7557-4789-9e64-04514cbb1f45   \n",
       "622   ccaa64eb-fd48-4142-9389-b07fdd800931   \n",
       "623   5777cee3-2f61-416d-86ca-622cf1cf6e1c   \n",
       "624   dfc85b41-7dd1-4e81-9dc2-1ead5d1cbf58   \n",
       "625   ddc3e3d5-bf69-417f-9601-a4dbe6f0756e   \n",
       "626   7c2ee847-f678-4440-b9d1-b6980fd8a160   \n",
       "627   ffec9008-36c7-4d7e-944d-071b995f954b   \n",
       "628   a28e7d53-665a-4c0e-9f43-955979b340e8   \n",
       "629   32995056-1b37-4996-9c73-d22727a79877   \n",
       "630   ca484095-0202-422f-a168-4f3182aede5c   \n",
       "631   23872d64-1305-4b33-b5bd-2079084c2e23   \n",
       "632   7121e541-68f1-446a-97e9-9a556b09d0d4   \n",
       "633   17291267-1fd5-4827-9f54-26567ca6c4f4   \n",
       "634   ed914ecd-1a07-4de3-a5bb-212e7d06fdce   \n",
       "635   f3f8cc87-d91f-4470-bd01-10c1cdb66323   \n",
       "636   8bd531e8-f264-4d37-851f-a7a199656056   \n",
       "637   7ddd3414-98cb-4f8f-a362-ae119074d43e   \n",
       "638   e87d2737-3bea-46d7-ba71-204f09625260   \n",
       "639   51954569-81c3-4412-9535-f5d15e69fe5b   \n",
       "640   0c34c3ab-47e8-4d0d-aa50-706a67fb48e9   \n",
       "641   b62fd3ec-feb7-4abb-ac41-485e87d446b9   \n",
       "642   1572b164-bbce-4c29-bbe6-0322d7af4815   \n",
       "643   10e10690-2a64-43fb-ba12-5d195d1b19bb   \n",
       "644   76446bae-7d02-4d69-a04e-48b3690102ee   \n",
       "645   05067a88-e16d-4893-a7b0-d39d20b31a55   \n",
       "646   1484a6ac-95a6-4f02-a8c5-21710c37664c   \n",
       "647   538a8bcb-a6b3-447d-8bf4-75660bd7dffe   \n",
       "648   e603f06a-1e1c-42cf-8c88-7121d819a70b   \n",
       "649   6509c5c6-1057-45b9-82d9-d5bb73c4da02   \n",
       "650   9ed8089c-a71f-4691-9d81-97c35954afe0   \n",
       "651   1458bc21-6906-4223-9a84-c8ca075d5bf7   \n",
       "652   c54179ff-a585-417c-849d-a8878a4153b0   \n",
       "653   308b09a0-2778-4a5c-b00e-9b4615b4a1d3   \n",
       "654   84f75621-8ce5-4857-9cb1-398ead495e1f   \n",
       "655   73a21e9f-d950-4f1b-8a7f-de0c35b64ab4   \n",
       "656   388497b5-e28a-43f0-b7b8-337d76ac961c   \n",
       "657   35181f72-3e52-4c66-97db-faec2bb75daa   \n",
       "658   5783a9c3-bdde-40af-8420-800260158af3   \n",
       "659   b477cade-72ac-4920-88ca-eae86a4fab96   \n",
       "660   f88976c1-1b4f-4185-b181-380cc8c4377a   \n",
       "661   da8de6bf-6cb9-4db4-be03-7a172c6c0603   \n",
       "662   9e7e9202-cf4d-400c-9f18-50331d1bdb70   \n",
       "663   3f7e1571-fc75-4ebf-bdd5-e9f623ee11d9   \n",
       "664   a5de10dd-18b8-485e-a0f7-8bcf12dbe28f   \n",
       "665   66c04a21-a74e-4517-9440-b25767f63326   \n",
       "666   c4c7c9ad-fedd-45ac-9b09-a9cddcc0085d   \n",
       "667   1a8dbeee-7179-4ad6-a11c-f0ac3c926d4e   \n",
       "668   b0b006f6-0880-4844-9ea5-23f30d4052f8   \n",
       "669   2ea77c67-6e00-4e32-b258-280fd551e325   \n",
       "670   f7634e68-abd2-4e0f-bb6b-6685b3b165a5   \n",
       "671   3e9f5439-69bc-44ab-8c92-5033ea88fa4b   \n",
       "672   48260c4e-d124-401e-916c-473b4c220fe7   \n",
       "673   99e363b3-686f-41cb-aef1-3258ef1fcad4   \n",
       "674   b1707e33-2e72-4aa4-9741-bd90cd3c22e7   \n",
       "675   191fe717-5e11-413b-bfd6-80f719f24c78   \n",
       "676   cc086aff-ed5f-4010-94ae-9c38fc18f759   \n",
       "677   0dd1b678-0190-4e82-b6af-596974736f8d   \n",
       "678   af51d8df-527c-42b1-8671-0617a71e972e   \n",
       "679   0cd9541d-6bc9-46fc-aa03-23fbe92b17c3   \n",
       "680   42290fe0-513d-406a-b5cb-dc7da67b9910   \n",
       "681   72ff6375-b3f4-4f0d-be12-546507cfb15d   \n",
       "682   21c8af27-32f6-49ee-8d83-881a7d850b2f   \n",
       "683   494fe594-aded-433a-a91b-207565c07773   \n",
       "684   c0453a06-9a44-4084-b555-50430572b90c   \n",
       "685   6682bf15-98f7-4e0d-a346-1f7d8d712680   \n",
       "686   87d6fee7-f9bb-462f-8eec-901c12e9e4fa   \n",
       "687   d3c12c65-5533-4c76-aaba-aa99bac4bd9c   \n",
       "688   c552973b-511a-4a2a-8aa1-0f8fdcadbbf4   \n",
       "689   e2b94145-284b-41ee-ac1e-2b6a3563ae7f   \n",
       "690   fbd49f4c-6849-47c7-bec4-9bf2cefc0cc1   \n",
       "691   991326a2-4ab9-497c-8d8a-833f0bf9f1fc   \n",
       "692   cdfa4018-715f-4483-ad68-5d547b7b702d   \n",
       "693   4e9f1abf-db79-4c5c-8b73-cb24a3f46172   \n",
       "694   5166e7ec-5c39-442a-a2c4-b1290faf563e   \n",
       "695   c1ad8521-5864-4185-8801-c1470b82da10   \n",
       "696   a441e44a-0789-4e8d-8973-831e341617ea   \n",
       "697   1a46f767-cb4e-4179-b905-126b2e990eda   \n",
       "698   3326bc5e-ae3f-4b2c-9186-42af804930d9   \n",
       "699   10f0d57e-0b5a-4b00-af9a-3213ffb68c79   \n",
       "700   11cc3fcc-04cc-4c75-a827-a8d885661657   \n",
       "701   426b4d6b-9f33-4683-965c-303364c7fd97   \n",
       "702   35903167-cc2a-4536-8de2-b8a33612cb2f   \n",
       "703   c35ec9f8-e1e3-416b-8ea9-738e2d856440   \n",
       "704   ab34eccd-91cb-4cc9-93e8-4e30e114b75d   \n",
       "705   f940a79a-d6cd-450a-92b5-32080cd30d1b   \n",
       "706   f85d8c67-f5f6-4879-ba64-e22b8ea8507a   \n",
       "707   93a9f665-fa91-4409-a974-e5bacbf35835   \n",
       "708   f2e8c0b7-5b61-420b-bd54-6d7fbf897a16   \n",
       "709   894f33b4-3034-43a8-8352-d1adf94d2401   \n",
       "710   13c17474-f283-42f2-8650-5661f0a59bdc   \n",
       "711   158427b6-6044-475f-9881-b751fb327a89   \n",
       "712   e721b9f7-2734-4698-884a-6c5e784b965b   \n",
       "713   ab1a4fa9-0906-45a3-acb5-5b90ad905710   \n",
       "714   54b8ac25-676c-47e8-b3d2-f1e86b6e332f   \n",
       "715   01719aa6-c184-407d-a09b-1fb0e3aec52c   \n",
       "716   180ac772-58ae-4c26-9c09-a580cba920be   \n",
       "717   69bd7494-c66e-439d-ab96-c0d506c6cc86   \n",
       "718   0b696526-d4cb-41c0-806e-e2bc11cce97f   \n",
       "719   4130ea55-21c2-4d88-9c15-a2b2fde7a2ea   \n",
       "720   c622a6b9-3002-4fce-b84f-ee2091dedb0c   \n",
       "721   5817070a-a536-437a-a5b1-8e8b4d8d4973   \n",
       "722   6b0630ff-2b2e-4592-9681-977997dea276   \n",
       "723   392204d5-827d-4555-87c5-f7ea29defb39   \n",
       "724   ee87fe85-20ae-481d-b7df-af93a39e5110   \n",
       "725   710a89e9-da6e-4433-9784-44f24fe35161   \n",
       "726   f5dfc52b-5bd4-4b16-b26a-b8de800d68b3   \n",
       "727   5198d430-979e-4126-a307-5ee8d7d20c33   \n",
       "728   e9dc38ce-7f70-438e-93f2-a582fe1854de   \n",
       "729   c3e39c0c-390b-4440-9115-0c54bc11e645   \n",
       "730   06e99cee-c780-489e-841e-26a07306157c   \n",
       "731   b4f0d4a4-387f-4275-bacb-e55a4e3f8dc6   \n",
       "732   42905801-f4c7-4548-9cb6-93e060fd16a9   \n",
       "733   993fd176-6ece-4361-a2d3-3f7f091ad6b8   \n",
       "734   1a419e2c-7ce8-4f45-9da3-cc82aa3cd5ab   \n",
       "735   815eb89c-fb14-4a04-8cdb-30edd4280905   \n",
       "736   8c87d6b5-f6cb-4bbc-a56c-2bd3075fc241   \n",
       "737   d7e03f75-00b1-42b8-80ff-3101181ab82f   \n",
       "738   f57a935c-c053-4c9f-9779-ec073e41947d   \n",
       "739   c20b24d5-9e3b-4b84-994b-87434dd2ca8f   \n",
       "740   0886524c-5770-4f27-861c-779221ec6cb7   \n",
       "741   bf0b4d01-cbaf-4182-91a2-5c7edd9b77b1   \n",
       "742   c850fb6a-93ca-4d1b-ab93-7266515c1e35   \n",
       "743   1de54931-baa2-4acf-8f18-ffd0c1d33955   \n",
       "744   d9f4af01-aa9a-40ba-a906-bca8141699b2   \n",
       "745   f9268644-0e17-4ebf-bb6e-401653f3d672   \n",
       "746   93c52d2b-04a1-4a63-895b-215393418638   \n",
       "747   14906e17-40c1-4cea-9225-749afc95f0ef   \n",
       "748   21c3383b-5b28-4ae5-88b3-d3ad33b0fc1c   \n",
       "749   ce59da86-e9fa-43f7-8438-aa42a9638391   \n",
       "750   95f63047-0001-4c38-a302-f65e9adae371   \n",
       "751   158f7b71-d1b4-4e7d-9e90-8e848b2f7b56   \n",
       "752   799855f4-5040-4f82-b34b-57b0b4fce7b9   \n",
       "753   fd059f2d-3ab6-493a-84bd-7bcc050e9fa0   \n",
       "754   86eb85b6-f717-4345-bbbd-e8bed108eca9   \n",
       "755   f943bbda-1966-44bb-a8cf-049b3a8c5057   \n",
       "756   f628ede4-d86f-4dd6-beb4-0095e3324f29   \n",
       "757   73c3de24-b7ae-4fb2-96e4-a2e1c9f5d0ac   \n",
       "758   aefeb7d3-1a63-4add-a336-d584699afe42   \n",
       "759   a6d36348-3065-422d-8cda-993ffa2210a1   \n",
       "760   9f9c16ff-5163-45bb-a6b6-0801cf0d5223   \n",
       "761   2e2dc74c-1eef-474e-ace6-8d8f31c4123f   \n",
       "762   4d801b59-a185-431d-ae3a-b508168440c3   \n",
       "763   7e598f26-346b-440e-b86d-ea66b5979e72   \n",
       "764   d26c79b6-d537-4d90-be94-f0d443a2e69d   \n",
       "765   2fdfc0cb-9a32-4734-8685-6c9e7a229b48   \n",
       "766   c1dd6ee4-7aa1-421c-b702-58d3d376348a   \n",
       "767   a22ef426-9115-44ba-bbaa-1dc7401dc200   \n",
       "768   7e591be8-1dfa-4bf5-9e6d-03819422f6b3   \n",
       "769   0953da74-be6f-4309-8ca2-2e8144d577da   \n",
       "770   c10369ea-b680-4b70-9012-92478ba98338   \n",
       "771   5cb7c7a5-fade-4b75-b726-267dd8b13743   \n",
       "772   3a6fa4a3-c442-4b93-b1e1-b4e32f6e617c   \n",
       "773   c01f507c-2109-46ad-bff7-8df1c66358e6   \n",
       "774   ca5d083a-cbd0-4be6-883e-aad672c78406   \n",
       "775   1e602bda-9675-44a2-9693-b0a79c773eac   \n",
       "776   6854f2aa-6ee9-462b-ba47-936916d1e9ec   \n",
       "777   22f101eb-b76c-469a-8bdc-147b59d87aae   \n",
       "778   a29a72b5-768c-4e4a-8998-3fcc04ec4b82   \n",
       "779   db1eb4cf-4436-444c-b5fa-0f9a3014f69b   \n",
       "780   92444636-9fdd-4956-b14a-5b63f64b2d1e   \n",
       "781   9af3aa9c-59b4-44fc-9846-bee61b7e14d0   \n",
       "782   676fe39d-4f31-4f42-81cf-2f8862d44096   \n",
       "783   c7f1fec8-891f-4bfb-a721-9076cb54f282   \n",
       "784   d75c7481-1dd0-49e5-9771-5a7272ad18fb   \n",
       "785   ee0015fa-a6cf-4c61-831b-635086f6ce09   \n",
       "786   b747a55f-433a-4d88-8f8b-7f8aa223f239   \n",
       "787   47371c69-cec3-470c-94a6-b70a41f9cade   \n",
       "788   15bd63eb-2456-43bc-bf91-8d6d53bbcd36   \n",
       "789   6dffb3c8-b57d-47ef-aee3-567e594eccf0   \n",
       "790   78e60b73-c25c-49e8-bd32-90e63f20f8e2   \n",
       "791   5a71be2e-74d4-4f2a-af91-3e5915bf75e3   \n",
       "792   9291ec93-2939-440d-9f30-45aa7f9bf1ff   \n",
       "793   7a6b70de-775e-425d-8600-b1e1031232bc   \n",
       "794   3b680c49-7481-4966-a763-8c5b54a36081   \n",
       "795   1c53f5d1-2af0-43b5-87ea-11db6f301951   \n",
       "796   16884384-47db-4d86-87c6-c91185bf701f   \n",
       "797   d0bbf95d-2f83-43d8-a0df-8b525caa3e85   \n",
       "798   71ef6bd4-430f-47e7-9505-77c620cf31cd   \n",
       "799   b18bef28-f7c3-48d0-953f-a81de3f0c953   \n",
       "800   a39cfa13-00b0-483d-9717-c040b338d0d9   \n",
       "801   2f44a121-a5db-49f8-965e-47143e6e9b66   \n",
       "802   6c08e1d5-a15d-49a6-a2aa-a9102c795793   \n",
       "803   bce2e699-5986-4d72-8c0d-04cc69c98af7   \n",
       "804   4863b602-9bde-4a6b-a7d0-8e014db9e59f   \n",
       "805   da2a0565-9706-4d38-b635-3331fcdda3e0   \n",
       "806   656d0921-ddce-427b-8f3b-46dd1d6feb86   \n",
       "807   72a92666-a5f8-4776-a27e-009fcb9d8b4e   \n",
       "808   d2b6a21d-bfca-4dfe-8446-d4f8d425756b   \n",
       "809   ecce3a8e-82b7-46c7-8b99-627744b43cc2   \n",
       "810   13da4448-d51c-40fe-b779-ed72929bd20e   \n",
       "811   28842a74-e255-44c4-afae-3364c6e13899   \n",
       "812   da571d88-fae8-4575-9c3b-e97d45a93f4b   \n",
       "813   2da12ee4-9668-4fac-b987-0f7cf771ba61   \n",
       "814   e96fbb07-fae8-4150-a331-3fa0be7a8ac1   \n",
       "815   122e8c2f-29c6-460a-8fea-5aa559aff719   \n",
       "816   384c6ae7-15a8-4176-a7b5-1d0a075be770   \n",
       "817   755764fd-55cf-4d8b-b437-c79aa83945a9   \n",
       "818   85629b22-bb20-41a3-b852-9728a945defe   \n",
       "819   9fe635f9-7aec-4a86-975c-941e5225d796   \n",
       "820   f9d7584c-5e8f-422c-8dff-949094af0305   \n",
       "821   ddeb4a41-89bf-4924-9874-32f0f306e2dd   \n",
       "822   5e7b01f7-b23c-420b-b526-e9711f6b7200   \n",
       "823   5c5646cc-91fa-4f2f-a612-fdecfd76a1a0   \n",
       "824   d44795b3-6a8c-47fb-83f4-2ff3593c3ffa   \n",
       "825   147173d5-9db0-44ee-a1d2-bc159521b390   \n",
       "826   33027756-dc07-4809-a933-9b0fab0bf479   \n",
       "827   a77133ca-f8d3-4226-9e3b-0c8348ff34a4   \n",
       "828   7cf6ea66-a942-4607-8830-9139ed3b0bbf   \n",
       "829   2df12e1e-43e4-4bea-9782-5ccc5879b7e4   \n",
       "830   e364ca29-cdf7-43b2-814f-21a271ece95f   \n",
       "831   d579318d-bee5-4d68-877d-b1e9b12f7ef1   \n",
       "832   1a8b8221-2aaa-4482-a20d-a4a7d85a362e   \n",
       "833   35e1f7e8-061f-4771-97ba-19a325f5f947   \n",
       "834   62b6978a-4c3d-4b92-af52-97d73f120e54   \n",
       "835   a772ab90-d41d-4248-b216-c8b5fba6f5c9   \n",
       "836   f00e15c6-0857-42eb-999f-64e8e4131375   \n",
       "837   e851f92e-95f3-4ab3-b0cf-6b2284395c3b   \n",
       "838   2f45a708-69af-4703-80dd-8eb31fbbbe1c   \n",
       "839   92fa0ad7-e99f-49ce-b687-1198ef801466   \n",
       "840   221ea1a6-352a-434c-86f0-14491c1f2f0b   \n",
       "841   5970b640-69e4-4205-a9bd-0775f4a82887   \n",
       "842   fc73c54f-28c0-4507-abc6-c025105fc1bd   \n",
       "843   0da394e7-0003-41f0-b832-75ba23a5ded8   \n",
       "844   84555af4-c486-4fa7-b19a-d08cdd6a44bc   \n",
       "845   ec6cfce3-805b-4862-9c07-00dd063e5222   \n",
       "846   9199fb81-21f8-4e51-ad2e-80a710638111   \n",
       "847   055fff5f-f7a8-4e4a-8202-1db0de32a577   \n",
       "848   75f7972e-23d0-470b-ad4d-63bc71b7c8eb   \n",
       "849   70b79d03-e888-433f-856b-e48e34262edd   \n",
       "850   03c3704b-83d2-4020-8ac0-0f3cb803822f   \n",
       "851   8c5473d5-ab9e-4180-ae74-89cbd5bb51c9   \n",
       "852   f0c9ea0a-bd82-48a6-a036-b0bccc81c235   \n",
       "853   446fa670-9c97-47d1-8c05-d69607c38c54   \n",
       "854   5b3e8733-b6a5-4a28-88ce-3549ab7580fb   \n",
       "855   9d862247-d0f4-495c-8d69-c56a26363d46   \n",
       "856   2f3ce197-bb9e-4146-a7a0-9d39a4f03297   \n",
       "857   74c83933-b2ec-4035-bc53-ac72893d8ac7   \n",
       "858   d65d4700-b322-4ab6-8716-4426681f1d55   \n",
       "859   7ba4250e-a51a-4a9e-abbc-0d09c953d7be   \n",
       "860   fb2d1b72-43f9-4423-a0bb-05c85bb776f0   \n",
       "861   1d0291a2-5162-4fb8-99a2-d13d368cf942   \n",
       "862   0aa0d92b-9c15-406f-b682-e3c65bd81343   \n",
       "863   c6fd0923-67ce-42fd-b564-d44a2efa3d65   \n",
       "864   0cee1856-3d85-45db-8f6e-02fe48436bde   \n",
       "865   39acdbb3-4da7-4eac-bac9-dfea031f4dc5   \n",
       "866   789a0c1f-d5b7-446f-85e2-1ce5458fce5e   \n",
       "867   73e12586-56a0-4fa2-b1bf-f2acf4a576b6   \n",
       "868   70163af9-c2bd-4517-8d8d-7ca48e264afd   \n",
       "869   3a238aa8-0e03-4a18-ba74-688440fda9c9   \n",
       "870   76d3b309-7d23-4385-bf36-6f263586e3e5   \n",
       "871   98f58bbc-a54c-4848-942f-4ad8e420205d   \n",
       "872   3b465e2a-99e9-4a6a-a8d7-bd7dd0fd337c   \n",
       "873   88949b11-3ece-4d6d-8576-488adc1e74b0   \n",
       "874   e9759447-1327-49aa-baee-ff3f413fad94   \n",
       "875   1487baa6-278f-4dec-b95c-f118e861926e   \n",
       "876   8ea1fa31-dcaf-46fc-b6c8-a4d15f21ff2d   \n",
       "877   de9629f2-5199-46bd-a695-03c9f5693e7f   \n",
       "878   2adef6b9-d9b0-448e-925d-cf86e10aa533   \n",
       "879   b612376a-87ff-4893-9abc-27deb94a7874   \n",
       "880   5630b8ff-8a07-4382-adb5-7224ef096460   \n",
       "881   3c9bec28-7028-4e42-8311-3ffd64eccab9   \n",
       "882   df8d7a11-f8da-49b0-96e9-721c5bb9d630   \n",
       "883   e1bb0ae1-8bb4-4374-a062-a57061f9b014   \n",
       "884   b91dc91f-a1e8-4c56-89cf-d39925acb2ce   \n",
       "885   ceefb56f-fbf3-4bba-9169-4f65b1977e4c   \n",
       "886   8556165a-5481-4647-b4be-b78ca8319081   \n",
       "887   1fdaa717-d084-4b17-829e-d6b5a23f0074   \n",
       "888   e4215e59-61d4-45de-9121-80c0c52e14b4   \n",
       "889   f539ef02-9791-4358-be88-45ee80e293b8   \n",
       "890   f3635820-b638-4d9b-ac29-19598572c980   \n",
       "891   3a902801-ef00-4384-ad74-44ec70b52150   \n",
       "892   dae5eb4e-88f8-4473-a6b4-9fc91d9fc29f   \n",
       "893   b0a508fe-0ef4-4165-8ff8-53e3cf5a4c93   \n",
       "894   971f5fcb-4653-40d3-8aae-35960b80c7e6   \n",
       "895   8ee2b21d-8909-48c4-b966-581eccc8890c   \n",
       "896   3b434b38-404a-47ab-a27e-1707d1547dcf   \n",
       "897   006cee7a-7acc-4bd8-a630-61ffc69f1f1c   \n",
       "898   1f6711b4-247d-4149-acf6-0662b2ef7fc2   \n",
       "899   f596d942-ca1f-4f2f-a906-826da1b1ff0b   \n",
       "900   84fa50be-d11e-4ba5-9e64-4e143e2e1020   \n",
       "901   67f7c9f6-5d68-4d18-9dd2-50ba56acbebd   \n",
       "902   c599867e-6bfb-472c-913e-d3751cfb582b   \n",
       "903   12b2dd97-71f1-4c5d-b51d-88825cfc44c8   \n",
       "904   f072cd09-0ff9-41b0-a138-ee1931d425e7   \n",
       "905   961211e3-71af-4208-a795-a8f88413e076   \n",
       "906   532f003d-a451-440d-9ac3-f4bb08f2c8ff   \n",
       "907   789f2ef0-e677-46cd-9724-44227bcde824   \n",
       "908   b758be93-21f8-4393-92e2-7474c630f818   \n",
       "909   d4dccd08-d74b-4ea1-966c-c511dcac092b   \n",
       "910   cad6ff55-11ef-4674-9273-a84720c43977   \n",
       "911   e9b8b240-6e66-405d-8bab-6ecd53dd9ff0   \n",
       "912   7802902b-ff9a-4ce9-8220-39876e2ccfc4   \n",
       "913   9d9db260-22ed-462e-949d-a7411e5584ec   \n",
       "914   eb4e93d1-701f-4f56-b062-b7de2610bb1d   \n",
       "915   dacc3cca-2130-4042-beb8-d4fe5e4d11f5   \n",
       "916   a7da497d-1e55-4c51-ac5d-7d1f597ec524   \n",
       "917   06af87bd-b585-4af4-b274-7cedb58df30a   \n",
       "918   d16d4116-d076-4d26-8a67-7fe5c326122c   \n",
       "919   12d48435-132b-44ba-bd29-3f0f741cc6e6   \n",
       "920   596583e6-2511-48b3-870d-b9dfe3ae2c57   \n",
       "921   0a8f392d-c134-4286-af83-cbac64b3257c   \n",
       "922   05f5bf19-a00a-4d29-957c-596f7f1afd39   \n",
       "923   a054570d-c763-4e07-947a-99a6052278f3   \n",
       "924   5054b6e5-5e1d-4002-a4de-3e91ef0dddbd   \n",
       "925   1036511f-3930-4295-b418-0d372cb5b42b   \n",
       "926   0ab2a5bd-bef3-44f5-8427-8869d69bb918   \n",
       "927   642658e9-e148-4bda-a559-b44ab61a3d9f   \n",
       "928   c23850ae-6a8d-4bad-96be-ee46a44a2602   \n",
       "929   d7016c77-f503-4815-bd2d-7d16e9d8d94c   \n",
       "930   560c2fb4-0cec-4613-a728-b300cbc43820   \n",
       "931   f8ff4b34-2c18-400f-87bb-ceea573d357a   \n",
       "932   5fd0d3dd-e1c7-4243-b8fe-b4ce8f067dee   \n",
       "933   5290b3cb-7d69-4d9b-a2c7-7be5d924e61e   \n",
       "934   c3059255-ef36-4c16-826c-42ba1b081757   \n",
       "935   ad1d7eca-c847-4d1b-91d3-2b0e67f8ef42   \n",
       "936   4349b42b-0f9b-4a63-8882-b5d2ad4c24b6   \n",
       "937   fbf06eba-b97a-40fa-849b-3683d5a33348   \n",
       "938   9373508c-9878-4723-984f-3c769eda2623   \n",
       "939   58df89cd-2168-4447-8659-9bb2e68beaed   \n",
       "940   decfb79e-44b8-406a-8f3c-8c9abf6d589e   \n",
       "941   774c2fea-2f4a-4c1f-8e30-0b6e67a23447   \n",
       "942   9f49c900-7ab7-4276-b0f0-5ec1b18bb4c3   \n",
       "943   4a011bfc-e8ab-48e4-b842-49c31df5e65e   \n",
       "944   569422d9-f0b2-468e-b854-baf7759f2b40   \n",
       "945   dd536eb3-194a-4461-a2ca-58561ea14015   \n",
       "946   609b872f-7b8f-4f5b-bcd0-87bb1e10cf9b   \n",
       "947   a3b42306-9cc2-4726-a373-289590cbaa8b   \n",
       "948   fb51bd98-c22d-4a79-a952-15ed13b3b66e   \n",
       "949   14eb61c3-60cc-44aa-938b-c3a7f1c29d1f   \n",
       "950   0c6ccc17-92a5-479b-9eab-7a0407daab2d   \n",
       "951   88545a76-b7f8-4b94-9056-ce93a86b2007   \n",
       "952   ba16fe8b-6d35-4b32-a052-792f7484c035   \n",
       "953   76a598a6-f889-421f-ad46-9e32a264a094   \n",
       "954   4b1599cb-4ead-4f82-a204-9f11885c0c3b   \n",
       "955   35d0443a-e95f-4709-8fbe-3df4babca865   \n",
       "956   2fb69da0-65a7-4a87-be6c-8b3cb522d273   \n",
       "957   02b33290-1ded-4fc6-ac1c-14c259809b2d   \n",
       "958   af7a78bc-029b-4bb1-80df-cd8716e1861d   \n",
       "959   e1deb970-7d7c-405d-bd83-68471fa1fee9   \n",
       "960   71e279f5-20b3-431d-a45c-993c44ebb974   \n",
       "961   dc0215e0-8533-440b-ade1-7fb4491bc114   \n",
       "962   597e04cd-b40f-4acd-8f95-af210fc76e3d   \n",
       "963   cc31d358-ed4b-4997-ad1d-b0e0bfd1b444   \n",
       "964   cbcad490-6236-4ee8-b529-1cb7825aa6f4   \n",
       "965   649bdc07-a654-4f02-8965-7dcb82e75639   \n",
       "966   5838ffc3-727e-4be7-8510-9e97c5cf5997   \n",
       "967   2ef351b0-7bb2-47da-912f-c68d04f3df80   \n",
       "968   560f66a6-a49b-408c-aeeb-0e55a3e08eaf   \n",
       "969   3a4f47f3-3f42-4cb8-b3a3-5b5dd3a160ce   \n",
       "970   1bc9c654-d233-4b91-af77-3f0288680715   \n",
       "971   9b8c1cfc-51e3-4f64-85dc-b7bcccdc4ea6   \n",
       "972   d823c618-b14c-4900-92ae-452fb4102752   \n",
       "973   3ad75909-8901-4fa8-b0a8-05450d9a9c06   \n",
       "974   774347b4-2c56-4eb9-a057-e400b11497d9   \n",
       "975   aa40da48-d2e8-4769-b19e-d026fa987dbd   \n",
       "976   57ec925c-92d1-49a5-b81c-0d7164945fdc   \n",
       "977   046f3fe3-b506-41de-b413-4b2998f7acbb   \n",
       "978   e2feac31-7447-4bfd-81be-bcd382d11466   \n",
       "979   cc77b262-528d-4480-b5fc-f06e661cf8f1   \n",
       "980   3e7e5126-7f30-4eba-9a18-e97f47a8698c   \n",
       "981   8e78e887-05c3-4fc9-ac6b-d19f244140f4   \n",
       "982   0cab584f-c711-4eb7-ac62-ce0742ae4913   \n",
       "983   172a2b9f-a2ce-49bf-af53-7642a58c8b17   \n",
       "984   6ff04d1d-0ca8-48bf-9861-564e173cf4bf   \n",
       "985   63aee60b-a3dd-4436-ba1c-de84a46b1fca   \n",
       "986   ec8bf870-ef73-41bb-b14b-a514ae8ab83a   \n",
       "987   ef9ff58c-6174-42f1-8642-e3d227c112dc   \n",
       "988   73b707c8-4f9a-4270-a0a1-c416db883b22   \n",
       "989   d7f04229-ba0c-42ee-b285-e84deac26d59   \n",
       "990   2223d5a5-ca79-4c2a-bf34-0b3f8f26a8e2   \n",
       "991   9c66f6fc-d806-409d-b8b0-6b1ab9fc7745   \n",
       "992   7e118ee8-4eb9-441f-bedd-32aaddb259e9   \n",
       "993   42e8c55a-2b0a-4ef8-a975-f4076b72f607   \n",
       "994   0f0b8094-336d-4e61-91b3-992aceeef909   \n",
       "995   84a48635-25b5-4a35-8c43-9acb3642b7a5   \n",
       "996   c7724ffd-bee6-4402-a94a-e33b528d807c   \n",
       "997   d40570e8-6f60-4a0b-ac14-78d2a6694772   \n",
       "998   42842aae-510a-4ecb-b124-b38bf2c847b5   \n",
       "999   dcffc844-cc53-4a2d-8bc5-0d5fb6dbb417   \n",
       "1000  3490535e-9d48-42c1-95e8-a22e1568da99   \n",
       "1001  3bc716a0-3290-4a1f-a326-9fbc17d57e0e   \n",
       "1002  154190ae-7eca-4653-939e-b69efe9e222e   \n",
       "1003  44f666b9-8f2e-44a9-a519-b4d00fe2f516   \n",
       "1004  0cf94c1f-b277-4421-8c5c-69bf8d3d251e   \n",
       "1005  4b0e6191-4216-47a2-9380-336a74d5c940   \n",
       "1006  43147c40-fdc8-40af-b776-b15b26271e7f   \n",
       "1007  cf6c3a38-dca0-4b5c-b3eb-a9ce8042e36b   \n",
       "1008  36a56359-6f93-4f73-945e-f9a7d19b0243   \n",
       "1009  840c1ae0-3b25-445b-b195-99e69c28d18e   \n",
       "1010  23b374a2-ad30-4c9b-bb83-fbaf56b7a41d   \n",
       "1011  669848d0-65a4-49a0-9049-296f87a63ee3   \n",
       "1012  b13741f2-57bc-4067-bf05-ffc03d479b0f   \n",
       "1013  fc33af57-6936-4302-b5c2-926407909d54   \n",
       "1014  e0f0a840-a74b-4545-8215-a6e8044d752e   \n",
       "1015  2d7e2e73-d1ed-42dc-9cdf-13b4a747d959   \n",
       "1016  85509d0a-59b5-43d9-a23b-4542fa8699fd   \n",
       "1017  5810b860-2d2c-43ed-8d49-8e9d5bff35ff   \n",
       "1018  69d8221c-3103-45ef-bb75-0393c793aef3   \n",
       "1019  36c72528-d953-4a27-aa01-997ee14893f3   \n",
       "1020  0becfcc8-d480-4025-8015-37530fdf9c38   \n",
       "1021  66975fc9-a643-4cfd-839d-fc02ebaf4718   \n",
       "1022  b34fe2fb-2355-4519-bdb4-219f15b407e8   \n",
       "1023  a12b9a35-fcf0-411e-b7d8-0a87178064bf   \n",
       "1024  76adab62-1c5c-4868-a2c8-9b0460f731d7   \n",
       "1025  c6b59fe1-2db2-4da4-b11e-552aa3d4dc0b   \n",
       "1026  5e86ef36-275f-46de-86cc-328a6f5a7f05   \n",
       "1027  05012b83-46cd-422d-a439-0ec325c08a75   \n",
       "1028  9b685be9-2739-47e5-8be1-4952350918f0   \n",
       "1029  0375f746-e768-4aa7-a28e-806c0e8ce412   \n",
       "1030  159643d5-1564-4382-86f1-d43fdfd79e58   \n",
       "1031  87d1f661-c88b-453d-90a5-8654ce87ee7c   \n",
       "1032  281e7d61-90a2-46d8-aae6-709db096b0e7   \n",
       "1033  edf5e5eb-5c73-4a7d-8030-6156180514e6   \n",
       "1034  45bc7dff-799f-475b-8a6d-060048c90835   \n",
       "1035  6b0e39ea-3fb1-40d0-8032-4272d51742d3   \n",
       "1036  95fa3d5c-b602-4fd9-a656-d32ed4e7280d   \n",
       "1037  86886682-436c-4ce6-9312-970cfb3b2607   \n",
       "1038  3247b6ef-d52a-4003-89c2-63952127ef49   \n",
       "1039  e27f2788-0bcd-4777-8d2f-a22860731954   \n",
       "1040  cf34192c-6552-4601-9441-0b2db9f0ae80   \n",
       "1041  d1aff4d0-a9d6-424a-8745-228363c7d51b   \n",
       "1042  5122f4fd-7b18-4bc4-bd81-5301c0f6d460   \n",
       "1043  2c133f56-0ac5-4cda-af1d-8e322413ee1c   \n",
       "1044  77c035cd-4cb2-472c-92b4-86a7ed0aef8a   \n",
       "1045  f42cfa8e-3337-40e0-87fa-a8b76594f031   \n",
       "1046  fde4859d-aceb-4baf-a238-e8feb3b939ed   \n",
       "1047  9196ec6c-f826-4f4c-be54-f703bdec721e   \n",
       "1048  c78450bf-12c2-407b-93ed-9837238b1285   \n",
       "1049  e567276a-967b-40f9-8853-f10a9c962607   \n",
       "1050  06400f1b-8f35-4f13-9f3d-f5c41080f53c   \n",
       "1051  b6bb7395-e3ea-4ea3-a4c3-22b7d207d436   \n",
       "1052  cbd28795-9584-4035-83df-b2f6f3fb3b4c   \n",
       "1053  68515851-e285-4f8f-acd0-eb0026a4471c   \n",
       "1054  5e78f462-14da-4fb1-a043-a05b247d5517   \n",
       "1055  5b480373-a185-4412-8885-55415cbcdd36   \n",
       "1056  791b71c9-5faa-42e0-8960-9697e997926a   \n",
       "1057  57914a1b-818e-4ab0-becd-2288acfeebea   \n",
       "1058  3199cb29-2f4e-44d1-9634-fa387b201009   \n",
       "1059  e5c9f8ff-4140-4c9b-9034-a85497b16a01   \n",
       "1060  15902a9d-9bd9-4bad-b1e8-94a672c57e48   \n",
       "1061  a98f5cd9-20c4-4c0c-beca-eef39286422d   \n",
       "1062  bbcf9d02-e4a5-45f4-ab3c-bd5a00530793   \n",
       "1063  8617ecb7-1dc9-49e0-b269-4c46eaebb4b1   \n",
       "1064  c950d40a-2330-421c-9a64-d2edb1843ffa   \n",
       "1065  61f09fa4-dd25-4bab-94a6-d06b69767890   \n",
       "1066  25b57ae9-8c89-45a7-9da8-75a84f2b5895   \n",
       "1067  20be1b10-30ba-40d6-a024-d421d6c37610   \n",
       "1068  e7adf9a8-f848-4df7-8d43-75f9743e3647   \n",
       "1069  5bca2c67-4c0b-4c3e-b51d-81f995aa14aa   \n",
       "1070  32400e93-ead8-4599-8c74-e00f5061ae63   \n",
       "1071  7c35c2af-b562-4626-bcb9-7122e3735b87   \n",
       "1072  6223d11b-e3b9-400f-a8ff-ea43e08fba2d   \n",
       "1073  ec6f09e7-827a-483b-a466-213a380264dd   \n",
       "1074  2935ba0d-7080-43f5-8569-165af78c24e0   \n",
       "1075  92d627d8-9c75-489f-8e96-b460aae802b8   \n",
       "1076  2fdf117f-29d2-4979-baa0-00961a896142   \n",
       "1077  36739d36-88d2-4de7-b470-9294b9f0948d   \n",
       "1078  5f547522-175d-498a-a093-9436d105c3f7   \n",
       "1079  5c541bfc-bff1-4ffc-b522-82e35a15eda9   \n",
       "1080  aed283a5-6550-47f6-862b-582b96895c57   \n",
       "1081  cce1d3d7-3450-4437-a5e0-5d142ece4bd0   \n",
       "1082  1d83389a-818f-4a82-acee-698f77431910   \n",
       "1083  422ab9ec-fabc-4d16-b706-fbd4e0e9cf39   \n",
       "1084  919204c3-d88d-4595-8562-5feab23acb60   \n",
       "1085  5db1294b-cef6-4d09-a408-0db0e14dad8a   \n",
       "1086  36b89e3d-e880-4bf3-ae7d-3bcdb74e9c29   \n",
       "1087  c14e98a3-ddd4-42ed-b7da-3d4423e6d164   \n",
       "1088  195db189-fc7a-490d-9dae-e7887974fac1   \n",
       "1089  f9baf936-2923-4a3f-b8f6-1d6fe057c7f0   \n",
       "1090  2e4e2aed-8faa-4eba-9edd-7a9a6cf82155   \n",
       "1091  98484464-b6d0-479a-8d8f-3c9f709fa660   \n",
       "1092  9b3620c9-44aa-4ae5-bb86-4c67e1526ecb   \n",
       "1093  00cd6044-f798-4ac9-8eed-9fb59295256c   \n",
       "1094  e3cfb0c5-4876-4cd2-aacc-ecbd9c0a2735   \n",
       "1095  6ce263e3-be3c-466c-bdb2-f8c29c16b1ee   \n",
       "1096  83768da5-637e-45e1-9fff-2d960521b588   \n",
       "1097  67c68874-25cc-47da-82fa-02c24c468df7   \n",
       "1098  505b8c60-826c-4585-bf98-c17873a2885c   \n",
       "1099  523e40f6-aec5-4464-9474-582a2d8e52ba   \n",
       "1100  7feb3184-5e8d-4688-ac95-8e01ee263c79   \n",
       "1101  de6cde47-1ba1-4ce5-ad37-821e9870a59a   \n",
       "1102  90e42c00-050d-429a-a678-df28b59d4018   \n",
       "1103  318bcf35-431e-4558-80d8-7deaac88812b   \n",
       "1104  91a8584c-e824-4cdb-a40b-0783035ce81e   \n",
       "1105  ce257cc6-4cd0-48fa-9544-0ff559bdb07d   \n",
       "1106  3aabb0c4-9744-47fa-b8c8-eb36f0f1b401   \n",
       "1107  aae2a25f-ff0f-4ed6-94a9-65a0e2021b73   \n",
       "1108  0e176fb3-e97f-457a-ac7d-52406ba2cc62   \n",
       "1109  3769aeb8-88f0-4cb8-95fe-7871f8b6a9e3   \n",
       "1110  66426472-c957-4dbf-8bec-13dafdf3c150   \n",
       "1111  daac92cf-1f53-4375-adda-93653a0f4204   \n",
       "1112  0543687b-d522-432d-99eb-e21cac7e6385   \n",
       "1113  1b066af7-33dc-4e36-ab5a-9e3e248ef0a9   \n",
       "1114  b426e585-1400-4569-b7d5-8e38e3420667   \n",
       "1115  24eb3532-9514-465d-abe6-98144188a36b   \n",
       "1116  903cc152-65fc-4699-9f58-c4162bf567a1   \n",
       "1117  8bdb43b5-fad1-4b7d-b903-2d80c9a1f9b8   \n",
       "1118  f41a82be-12b6-4769-9d83-5c590461a392   \n",
       "1119  57b6ec9c-f710-4374-9cc9-6c4eab711f18   \n",
       "1120  01da852c-60d3-4487-999e-f6248000c6c6   \n",
       "1121  d946f857-b475-4bc9-975c-aac2ab4d72de   \n",
       "1122  bfbbdfb3-6f01-47db-a936-0de042ae3533   \n",
       "1123  389e94db-92d9-4018-b6e5-9228b44fe707   \n",
       "1124  0ad29d15-50a2-4297-839e-593f32d68a99   \n",
       "1125  0e38d909-6650-4a15-96ba-26bdf274b168   \n",
       "1126  eb27183d-4c45-4b01-90ba-d8d5f5249d0b   \n",
       "1127  b77f9e61-0c3a-4d98-8215-06f0da6b80c9   \n",
       "1128  413d6c63-c6d1-4d96-b12b-322b48f969bb   \n",
       "1129  cceb8cc3-4e77-473c-8bfd-702891459325   \n",
       "1130  44ac7f0a-8239-4c00-a3e2-8419c9e1efad   \n",
       "1131  b882773f-7b30-4774-b663-7d6459716381   \n",
       "1132  5b41b887-dcae-4881-89cd-79aa4351579f   \n",
       "1133  49c59f24-0ec1-4859-ba03-1416b3915e13   \n",
       "1134  394d06cd-92cb-4bc3-b201-ad80917f3f12   \n",
       "1135  78bfaa7c-641f-486b-956d-f844f4a607c8   \n",
       "1136  7fb800be-515a-44d7-b5cc-50c525f52442   \n",
       "1137  4873de8d-bb9f-4dad-844a-173fd65c01fe   \n",
       "1138  74df90ef-79c2-4e13-9e4b-aecc95e79d56   \n",
       "1139  becd3346-9412-433a-b899-1a6f4d674565   \n",
       "1140  27821a59-9bf9-49ea-a835-e927dad511a1   \n",
       "1141  9c349410-4db0-46a1-95e4-ef7cd3fad3fe   \n",
       "1142  beee6207-bae3-44e5-932f-434b2ce0789c   \n",
       "1143  286efd28-43bb-4358-b743-0009a6f5fd43   \n",
       "1144  5bcda218-3b99-49b5-a1fa-4d21200daddf   \n",
       "1145  43fb788b-626c-4983-bdfc-4de71a106c8b   \n",
       "1146  730c73f7-1d20-4307-92d5-5b457ce36ab8   \n",
       "1147  02a0c084-1bed-45d1-8203-1f8d988bf970   \n",
       "1148  55e21e9d-1501-45f0-b6ee-fc8332db8538   \n",
       "1149  ec8e0976-4f16-42fd-b543-94f84809b1b2   \n",
       "1150  0bb275c9-704a-4fbc-a45a-e44995d1c5b0   \n",
       "1151  f0c77f95-5679-4af7-aeb9-d4fa893e75e5   \n",
       "1152  7bb967d7-0df0-4486-b0a6-1ead239ada89   \n",
       "1153  c900fa7b-1bbf-4da3-9123-ed5a59827b35   \n",
       "1154  8bff0836-af98-482c-be95-fd5c7da0545b   \n",
       "1155  0e43bb0a-b9f2-44aa-9aa0-42ed79289205   \n",
       "1156  c8f96fd7-5f63-4033-972a-3d75274cf24b   \n",
       "1157  33e35ace-7a00-4ed5-a0d2-c90168217a8a   \n",
       "1158  32438407-a778-40ce-bfdb-fe62990a1056   \n",
       "1159  41c13e40-decf-4dd7-9972-c5f43fdf6af7   \n",
       "1160  c15032e7-88ae-446d-b660-f36263c54ac3   \n",
       "1161  d5d5e3a4-8616-4bb9-83df-c94dfa64a1d8   \n",
       "1162  429bc572-2c0e-46b8-890e-030dff3abb72   \n",
       "1163  d4e91b46-e7ed-4c99-a4c6-5c378a597348   \n",
       "1164  ee7a3610-5c33-4433-bc65-62a883b9eb80   \n",
       "1165  ce9b3b32-d318-4292-8cb3-78216ce0b1f5   \n",
       "1166  f62dc282-2106-432d-a72e-46c9a1f4a055   \n",
       "1167  dbc092cf-7bb7-4d3d-90b9-fad801510e4d   \n",
       "1168  29e92832-505b-486d-9ce3-c3d89ac3c97f   \n",
       "1169  d5261708-6ab9-4088-821a-58c96cf5ccdb   \n",
       "1170  dd9078cc-f39a-47bd-bce3-0850601e0350   \n",
       "1171  fb24cccd-e41e-4405-bd34-8364f5890ab1   \n",
       "1172  fdaea94f-02de-4e64-b8ca-b5be89207244   \n",
       "1173  98f651fd-67ae-499c-9b82-fdb663c60a09   \n",
       "1174  3012167d-b82d-44b3-b8b4-b6f4ece240cf   \n",
       "1175  daa2e37e-5bc7-4a85-8fc8-b522738e691a   \n",
       "1176  60299a20-4ec5-47bb-ac2c-9695686c668c   \n",
       "1177  111c668b-2b67-4289-b201-4e57295b3ee2   \n",
       "1178  edb57bd3-2ea0-469a-b5d6-f3095979c71d   \n",
       "1179  be44e3bc-d67b-4843-ba2e-5f146c169ad2   \n",
       "1180  5a92dfe7-c811-4ae6-a265-808356828893   \n",
       "1181  3169aede-babf-4718-94ea-b819364926ee   \n",
       "1182  926f75e9-f6cd-4f8b-9992-f8b33f66e453   \n",
       "1183  0a43f770-254b-4f3f-9e4f-bdb42eefd352   \n",
       "1184  81aea285-d701-4984-b399-576095da202f   \n",
       "1185  c1c7d49c-764d-4923-843f-4e79a6628995   \n",
       "1186  f6aa0358-6523-436e-aa31-06825c759241   \n",
       "1187  08ed5c42-40d6-450a-a5f5-5a73183e0572   \n",
       "1188  ddbc7bcc-5954-44f0-b2f8-b5c025020813   \n",
       "1189  361a1237-2ebb-4362-bf8f-57422fefa1ee   \n",
       "1190  4ff6e3fa-0089-4510-a954-665bfbf4299e   \n",
       "1191  c9e5e6a6-9301-479c-8c1e-028679d9d007   \n",
       "1192  ed1c55f0-1ebb-424b-a17d-525c1d7cc628   \n",
       "1193  6dfe27fa-ae57-4d7b-9604-a597562d13aa   \n",
       "1194  b976ee46-2728-40ff-bc71-00d41c29257e   \n",
       "1195  ae108dc6-3da0-46e8-8acf-fe7fe0a9302c   \n",
       "1196  7a2b7723-882d-4438-80a9-5ddeb9516e69   \n",
       "1197  eb58cd42-7e5a-4363-bc3a-004231f1399c   \n",
       "1198  ccf406a5-d594-43aa-8f99-6935cf210ce5   \n",
       "1199  10ac1386-3687-447a-9bff-f482c2218cea   \n",
       "1200  ccba8523-560c-41b9-bef5-d6010fdc7ba0   \n",
       "1201  b7d2b43a-559b-45db-9890-1b38a24e618d   \n",
       "1202  aa606d6f-0bbc-4356-9c3e-32f677f4edd5   \n",
       "1203  b98ea5b8-b48f-4641-a8be-988dcd1cbae8   \n",
       "1204  be004057-4f79-4fc2-a92d-f91381e62f4d   \n",
       "1205  35d8534b-6127-46cc-8ba8-d0d148d12135   \n",
       "1206  8d4bf407-8aaa-4990-9de9-d7fef261910d   \n",
       "1207  2c908221-4b52-40b1-81e2-8966b8ce0814   \n",
       "1208  bf7b80ad-9d58-4ef0-9132-a6e94e24cb23   \n",
       "1209  87b43bf6-c2d7-4e6c-a3d7-30904c063eb3   \n",
       "1210  8e7bc614-70a8-47bd-8c30-b1f187865d72   \n",
       "1211  6562a125-9524-44b2-ac26-896abaadc776   \n",
       "1212  29639930-2895-483f-b0e7-bec97d4447a5   \n",
       "1213  346e0cb5-caca-4e4d-8f85-e9dd3ce9e3f0   \n",
       "1214  c7ac5b3e-0d96-42ba-b22d-5faf2e837761   \n",
       "1215  afd5d605-f093-49e7-9563-71b10b864b97   \n",
       "1216  b573fb82-4502-4c0a-a62a-e113191b8931   \n",
       "1217  7d866d74-882e-4292-bae4-efe3fa2e7713   \n",
       "1218  db6b9877-d0d1-4196-9079-e10a8e0a4ec4   \n",
       "1219  c0d236d6-5a3e-4601-8264-54e917191486   \n",
       "1220  01fe15c9-4c31-4abe-9f14-586c906860db   \n",
       "1221  98bc41c5-7a64-484d-b4d2-0c37657c9f3b   \n",
       "\n",
       "                                                                                                                                             Styles  \\\n",
       "0                                                                                                                                              None   \n",
       "1                                                                                                                                 text-align:center   \n",
       "2                                                                                                                                 text-align:center   \n",
       "3                                                                                                                                 text-align:center   \n",
       "4                                                                                                                                 text-align:center   \n",
       "5                                                                                                                                 text-align:center   \n",
       "6                                                                                                                                 text-align:center   \n",
       "7                                                                                                                                 text-align:center   \n",
       "8                                                                                                                                 text-align:center   \n",
       "9                                                                                                                                 text-align:center   \n",
       "10                                                                                                                                text-align:center   \n",
       "11                                                                                                                                text-align:center   \n",
       "12                                                                                                                                text-align:center   \n",
       "13                                                                                                                                text-align:center   \n",
       "14                                                                                                                                text-align:center   \n",
       "15                                                                                                                                text-align:center   \n",
       "16                                                                                                                                text-align:center   \n",
       "17                                                                                                                                text-align:center   \n",
       "18                                                                                                                                text-align:center   \n",
       "19                                                                                                                                text-align:center   \n",
       "20                                                                                                                                text-align:center   \n",
       "21                                                                                                                                text-align:center   \n",
       "22                                                                                                                                text-align:center   \n",
       "23                                                                                                                                text-align:center   \n",
       "24                                                                                                                                text-align:center   \n",
       "25                                                                                                                                             None   \n",
       "26                                                                                                                                             None   \n",
       "27                                                                                                                                text-align:center   \n",
       "28                                                                                                                                             None   \n",
       "29                                                                                                                                             None   \n",
       "30                                                                                                                                text-align:center   \n",
       "31                                                                               font-size:11.0pt;font-family:\"Times New Roman\",serif;\\ncolor:green   \n",
       "32                                                                                                                         page-break-before:always   \n",
       "33                                                                                margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "34                                                                                margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "35                                                                                                                           page-break-after:avoid   \n",
       "36                                                                                                                                             None   \n",
       "37                                                                                                                                             None   \n",
       "38                                                                                                                                             None   \n",
       "39                                                                                                                                             None   \n",
       "40                                                                                                                                             None   \n",
       "41                                                                                margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "42                                                                                                                           page-break-after:avoid   \n",
       "43                                                                                                                                             None   \n",
       "44                                                                                                                           page-break-after:avoid   \n",
       "45                                                                                                                           page-break-after:avoid   \n",
       "46                                                                                                                           page-break-after:avoid   \n",
       "47                                                                                                                           page-break-after:avoid   \n",
       "48                                                                                                                           page-break-after:avoid   \n",
       "49                                                                                                                           page-break-after:avoid   \n",
       "50                                                                                                                           page-break-after:avoid   \n",
       "51                                                                                                                                             None   \n",
       "52                                                                                                                           page-break-after:avoid   \n",
       "53                                                                                                                           page-break-after:avoid   \n",
       "54                                                                                                                           page-break-after:avoid   \n",
       "55                                                                                                                           page-break-after:avoid   \n",
       "56                                                                                                                           page-break-after:avoid   \n",
       "57                                                                                                                           page-break-after:avoid   \n",
       "58                                                                                                                           page-break-after:avoid   \n",
       "59                                                                                                                           page-break-after:avoid   \n",
       "60                                                                                                                                             None   \n",
       "61                                                                                                                                             None   \n",
       "62                                                                                margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "63                                                                                                       page-break-after:avoid;text-autospace:none   \n",
       "64                                                                                                                              text-autospace:none   \n",
       "65                                                                                                                                             None   \n",
       "66                                                                                                                                             None   \n",
       "67                                                                                                                                             None   \n",
       "68                                                                                                                                             None   \n",
       "69                                                                                                                                             None   \n",
       "70                                                                                                                                             None   \n",
       "71                                                                                                                                             None   \n",
       "72                                                                                                                                             None   \n",
       "73                                                                                                                                             None   \n",
       "74                                                                                                                                             None   \n",
       "75                                                                                margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "76                                                                                                                           page-break-after:avoid   \n",
       "77                                                                                margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "78                                                                                                                           page-break-after:avoid   \n",
       "79                                                                                                                                             None   \n",
       "80                                                                                                            margin-left:38.9pt;text-indent:-.25in   \n",
       "81                                                                                                                                             None   \n",
       "82                                                                                                            margin-left:38.9pt;text-indent:-.25in   \n",
       "83                                                                                                                                             None   \n",
       "84                                                                                                            margin-left:38.9pt;text-indent:-.25in   \n",
       "85                                                                                                                                             None   \n",
       "86                                                                                margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "87                                                                                                                           page-break-after:avoid   \n",
       "88                                                                                                                                             None   \n",
       "89                                                                                                                                             None   \n",
       "90                                                                                                                           page-break-after:avoid   \n",
       "91                                                                                                                           page-break-after:avoid   \n",
       "92                                                                                                                              text-autospace:none   \n",
       "93                                                                                                                              text-autospace:none   \n",
       "94                                                                                                       margin-bottom:6.0pt;page-break-after:avoid   \n",
       "95                                                                                          margin-left:-.25pt;border-collapse:collapse;border:none   \n",
       "96                                                                                                                                             None   \n",
       "97                                                                                                                                             None   \n",
       "98                                                                                                                              text-autospace:none   \n",
       "99                                                                                                       page-break-after:avoid;text-autospace:none   \n",
       "100                                                                                                                             text-autospace:none   \n",
       "101                                                                                                                             text-autospace:none   \n",
       "102                                                                                                                             text-autospace:none   \n",
       "103                                                                                                                             text-autospace:none   \n",
       "104                                                                                                                             text-autospace:none   \n",
       "105                                                                                                                          page-break-after:avoid   \n",
       "106                                                                                                                          page-break-after:avoid   \n",
       "107                                                                                                                                            None   \n",
       "108                                                                                                                                            None   \n",
       "109                           margin-top:0in;margin-right:0in;margin-bottom:6.0pt;\\nmargin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid   \n",
       "110                                                                                                            border-collapse:collapse;border:none   \n",
       "111                                                                               margin-left:42.55pt;text-indent:-42.55pt;page-break-after:\\navoid   \n",
       "112                                                                                                                          page-break-after:avoid   \n",
       "113                                                                                                                          page-break-after:avoid   \n",
       "114                                                                                                                          page-break-after:avoid   \n",
       "115                                                                                                                          page-break-after:avoid   \n",
       "116                                                                                                                          page-break-after:avoid   \n",
       "117                                                                                                                                            None   \n",
       "118                                                                                                                          page-break-after:avoid   \n",
       "119                                                                                                                          page-break-after:avoid   \n",
       "120                                                                                                                          page-break-after:avoid   \n",
       "121                                                                                                                                            None   \n",
       "122                                                                                                                                            None   \n",
       "123                                                                                                                                            None   \n",
       "124                                                                                                                                            None   \n",
       "125                                                                                                                                            None   \n",
       "126                                                                                                                                            None   \n",
       "127                                                                                                                                            None   \n",
       "128                                                                                                                                            None   \n",
       "129                                                                                                                                            None   \n",
       "130                                                                                                                                            None   \n",
       "131                                                                                                                                            None   \n",
       "132                           margin-top:0in;margin-right:0in;margin-bottom:6.0pt;\\nmargin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid   \n",
       "133                                                                                             width:474.65pt;border-collapse:collapse;border:none   \n",
       "134                                                                                                                                            None   \n",
       "135                                                                                                                          page-break-after:avoid   \n",
       "136                                                                                                                          page-break-after:avoid   \n",
       "137                                                                                                                                            None   \n",
       "138                                                                                                                                            None   \n",
       "139                                                                                                                                            None   \n",
       "140                                                                                                                                            None   \n",
       "141                                                                                                                          page-break-after:avoid   \n",
       "142                                                                                                      page-break-after:avoid;text-autospace:none   \n",
       "143                                                                                                      page-break-after:avoid;text-autospace:none   \n",
       "144                                                                                                      page-break-after:avoid;text-autospace:none   \n",
       "145                                                                                                                             text-autospace:none   \n",
       "146                                                                                                                             text-autospace:none   \n",
       "147                                                                                                                             text-autospace:none   \n",
       "148                                                                                                                             text-autospace:none   \n",
       "149                                                                                                                             text-autospace:none   \n",
       "150                                                                                                                             text-autospace:none   \n",
       "151                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "152                                                                                                                          page-break-after:avoid   \n",
       "153                                                                                                                                      margin:0in   \n",
       "154                                                                                                                                      margin:0in   \n",
       "155                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "156                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "157                                                                                                                                      margin:0in   \n",
       "158                                                                                                                                            None   \n",
       "159                                                                                                                                            None   \n",
       "160                                                                                                        margin-left:28.35pt;text-indent:-28.35pt   \n",
       "161                                                                                                                                            None   \n",
       "162                                                                                                                           page-break-after:auto   \n",
       "163                                                                                                                           page-break-after:auto   \n",
       "164                                                                                                                           page-break-after:auto   \n",
       "165                                                                                                                           page-break-after:auto   \n",
       "166                                                                                                                           page-break-after:auto   \n",
       "167                                                                                                                                            None   \n",
       "168                                                                                                                                            None   \n",
       "169                                                                                                                           page-break-after:auto   \n",
       "170                                                                                                                           page-break-after:auto   \n",
       "171                                                                                                                          page-break-after:avoid   \n",
       "172                                                                                                                          page-break-after:avoid   \n",
       "173                                                                                                                                            None   \n",
       "174                                                                                                                                            None   \n",
       "175                                                                                                                                            None   \n",
       "176                                                                                                                                            None   \n",
       "177                                                                                                                          page-break-after:avoid   \n",
       "178                                                                                                                          page-break-after:avoid   \n",
       "179                                                                                                                                            None   \n",
       "180                                                                                                                                            None   \n",
       "181                                                                                                                          page-break-after:avoid   \n",
       "182                                                                                                                          page-break-after:avoid   \n",
       "183                                                                                                                                            None   \n",
       "184                                                                                                                                            None   \n",
       "185                                                                                                                          page-break-after:avoid   \n",
       "186                                                                                                                          page-break-after:avoid   \n",
       "187                                                                                                                          page-break-after:avoid   \n",
       "188                                                                                                                                            None   \n",
       "189                                                                                                                          page-break-after:avoid   \n",
       "190                                                                                                                          page-break-after:avoid   \n",
       "191                                                                                                                          page-break-after:avoid   \n",
       "192                                                                                                                          page-break-after:avoid   \n",
       "193                                                                                                                          page-break-after:avoid   \n",
       "194                                                                                                                                            None   \n",
       "195                                                                                                                          page-break-after:avoid   \n",
       "196                                                                                                                          page-break-after:avoid   \n",
       "197                                                                                                                          page-break-after:avoid   \n",
       "198                                                                                                                                            None   \n",
       "199                                                                                                                          page-break-after:avoid   \n",
       "200                                                                                                                          page-break-after:avoid   \n",
       "201                                                                                                                          page-break-after:avoid   \n",
       "202                                                                                                                                            None   \n",
       "203                                                                                                                          page-break-after:avoid   \n",
       "204                                                                                                                          page-break-after:avoid   \n",
       "205                                                                                                                                            None   \n",
       "206                                                                                                                                            None   \n",
       "207                                                                                                                          page-break-after:avoid   \n",
       "208                                                                                                                          page-break-after:avoid   \n",
       "209                                                                                                                          page-break-after:avoid   \n",
       "210                                                                                                                                            None   \n",
       "211                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "212                                                                                                                          page-break-after:avoid   \n",
       "213                                                                                                                                            None   \n",
       "214                                                                                                                                            None   \n",
       "215                                                                                                                          page-break-after:avoid   \n",
       "216                                                                                                                          page-break-after:avoid   \n",
       "217                                                                                                                          page-break-after:avoid   \n",
       "218                                                                                                                          page-break-after:avoid   \n",
       "219                                                                                                                                            None   \n",
       "220                                                                                                                                            None   \n",
       "221                                                                                                                                            None   \n",
       "222                                                                                                                                            None   \n",
       "223                                                                                                                          page-break-after:avoid   \n",
       "224                                                                                                                          page-break-after:avoid   \n",
       "225                                                                                                                                            None   \n",
       "226                                                                                                                                            None   \n",
       "227                                                                                                                                            None   \n",
       "228                                                                                                                                            None   \n",
       "229                                                                                                                                            None   \n",
       "230                                                                                                                                            None   \n",
       "231                                                                                                                          page-break-after:avoid   \n",
       "232                                                                                                                          page-break-after:avoid   \n",
       "233                                                                                                                                      margin:0in   \n",
       "234                                                                                                                                            None   \n",
       "235                                                                                                                          page-break-after:avoid   \n",
       "236                                                                                                                                            None   \n",
       "237                                                                                                                                            None   \n",
       "238                                                                                                                                            None   \n",
       "239                                                                                                                          page-break-after:avoid   \n",
       "240                                                                                                                          page-break-after:avoid   \n",
       "241                                                                                                                                            None   \n",
       "242                                                                                                                                            None   \n",
       "243                                                                                                       line-height:13.0pt;page-break-after:avoid   \n",
       "244                                                                                                                                            None   \n",
       "245                                                                                                                                            None   \n",
       "246                                                                                                                                            None   \n",
       "247                                                                                                                          page-break-after:avoid   \n",
       "248                                                                                                                                            None   \n",
       "249                                                                                                                                            None   \n",
       "250                                                                                                                                            None   \n",
       "251                                                                                                                          page-break-after:avoid   \n",
       "252                                                                                                                                            None   \n",
       "253                                                                                                                                            None   \n",
       "254                                                                                                                                            None   \n",
       "255                                                                                                                          page-break-after:avoid   \n",
       "256                                                                                                                                            None   \n",
       "257                                                                                                                                            None   \n",
       "258                                                                                                                                      margin:0in   \n",
       "259                                                                                                                          page-break-after:avoid   \n",
       "260                                                                                                                          page-break-after:avoid   \n",
       "261                                                                                                                                            None   \n",
       "262                                                                                                                                            None   \n",
       "263                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "264                                                                                                                          page-break-after:avoid   \n",
       "265                                                                                                                          page-break-after:avoid   \n",
       "266                                                                                                                          page-break-after:avoid   \n",
       "267                                                                                                                                            None   \n",
       "268                                                                                                                                            None   \n",
       "269                                                                                                                          page-break-after:avoid   \n",
       "270                                                                                                                          page-break-after:avoid   \n",
       "271                                                                                                                                            None   \n",
       "272                                                                                                                                      margin:0in   \n",
       "273                                                                                                                          page-break-after:avoid   \n",
       "274                                                                                                                          page-break-after:avoid   \n",
       "275                                                                                                                                            None   \n",
       "276                                                                                                                                            None   \n",
       "277                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "278                                                                                                                          page-break-after:avoid   \n",
       "279                                                                                                                                            None   \n",
       "280                                                                                                                                            None   \n",
       "281                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "282                                                                                                      page-break-after:avoid;text-autospace:none   \n",
       "283                                                                                                                          page-break-after:avoid   \n",
       "284                                                                                                                          page-break-after:avoid   \n",
       "285                                                                                                                                            None   \n",
       "286                                                                                                                                            None   \n",
       "287                                                                                                                                            None   \n",
       "288                                                                                                                                            None   \n",
       "289                                                                                                                                            None   \n",
       "290                                                                                                                                            None   \n",
       "291                                                                                                       line-height:13.0pt;page-break-after:avoid   \n",
       "292                                                                                                                          page-break-after:avoid   \n",
       "293                                                                                                                                            None   \n",
       "294                                                                                                                                            None   \n",
       "295                             margin-top:0in;margin-right:0in;margin-bottom:6.0pt;\\nmargin-left:45.1pt;text-indent:-45.1pt;page-break-after:avoid   \n",
       "296                                                                              width:95.6%;margin-left:5.4pt;border-collapse:collapse;border:none   \n",
       "297                            margin-top:6.0pt;margin-right:0in;margin-bottom:0in;\\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt   \n",
       "298                                                                                                            margin-left:7.1pt;text-indent:-7.1pt   \n",
       "299                                                                                                                                            None   \n",
       "300                                                                                                                          page-break-after:avoid   \n",
       "301                                                                                                                                            None   \n",
       "302                                                                                                                          page-break-after:avoid   \n",
       "303                                                                                                                                            None   \n",
       "304                                                                                                                                            None   \n",
       "305                                                                                                                                            None   \n",
       "306                                                                                                                                            None   \n",
       "307                                                                                                                                            None   \n",
       "308                                                                                                                                            None   \n",
       "309                                                                                                                                            None   \n",
       "310                                                                                                                          page-break-after:avoid   \n",
       "311                                                                                                                          page-break-after:avoid   \n",
       "312                                                                                                                          page-break-after:avoid   \n",
       "313                                                                                                                                            None   \n",
       "314                                                                                                                          page-break-after:avoid   \n",
       "315                                                                                                                          page-break-after:avoid   \n",
       "316                                                                                                                                            None   \n",
       "317                                                                                                                                            None   \n",
       "318                                                                                                                          page-break-after:avoid   \n",
       "319                                                                                                                          page-break-after:avoid   \n",
       "320                                                                                                                                            None   \n",
       "321                                                                                                                                            None   \n",
       "322                                                                                                                          page-break-after:avoid   \n",
       "323                                                                                                                          page-break-after:avoid   \n",
       "324                                                                                                                                            None   \n",
       "325                                                                                                                                            None   \n",
       "326                                                                                                                                            None   \n",
       "327                                                                                                                                            None   \n",
       "328                                                                                                                                            None   \n",
       "329                                                                                                                                            None   \n",
       "330                                                                                                     margin-bottom:12.0pt;page-break-after:avoid   \n",
       "331                                                                                         margin-left:6.85pt;border-collapse:collapse;border:none   \n",
       "332                                                                                                                                            None   \n",
       "333                                                                                                      page-break-after:avoid;text-autospace:none   \n",
       "334                                                                                                      page-break-after:avoid;text-autospace:none   \n",
       "335                                                                                                                             text-autospace:none   \n",
       "336                                                                                                        margin-left:28.35pt;text-indent:-28.35pt   \n",
       "337                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "338                                                                                                                          page-break-after:avoid   \n",
       "339                                                                                                                                            None   \n",
       "340                                                                                                                                            None   \n",
       "341                                                                                                                                            None   \n",
       "342                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "343                                                                                                                          page-break-after:avoid   \n",
       "344                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "345                                                                                                                          page-break-after:avoid   \n",
       "346                                                                                                                          page-break-after:avoid   \n",
       "347                                                                                                                          page-break-after:avoid   \n",
       "348                                                                                                       margin-right:-.1pt;page-break-after:avoid   \n",
       "349                                                                                                                          page-break-after:avoid   \n",
       "350                                                                                                                                            None   \n",
       "351                                                                                                                                            None   \n",
       "352                                                                                                                                            None   \n",
       "353                                                                                                            margin-bottom:0in;line-height:normal   \n",
       "354                                                                                                                          page-break-after:avoid   \n",
       "355                                                                                                                          page-break-after:avoid   \n",
       "356                                                                                                                          page-break-after:avoid   \n",
       "357                                                                                                                          page-break-after:avoid   \n",
       "358                                                                                                                                            None   \n",
       "359                                                                                                                                            None   \n",
       "360                                                                                                                                            None   \n",
       "361                                                                                                                                            None   \n",
       "362                                                                                                                               margin-bottom:0in   \n",
       "363                                                                                                                                            None   \n",
       "364                                                                                                                          page-break-after:avoid   \n",
       "365                                                                                                                                            None   \n",
       "366                                                                                                                                            None   \n",
       "367                                                                                                                                            None   \n",
       "368                                                                                                                                            None   \n",
       "369                                                                                                                                            None   \n",
       "370                                                                                                                                            None   \n",
       "371                                                                                                                                            None   \n",
       "372                                                                                                        margin-bottom:0in;page-break-after:avoid   \n",
       "373                                                                                                                          page-break-after:avoid   \n",
       "374                                                                                                                          page-break-after:avoid   \n",
       "375                                                                                                                             text-autospace:none   \n",
       "376                                                                                                                             text-autospace:none   \n",
       "377                                                                                                                                            None   \n",
       "378                                                                                                        margin-bottom:0in;page-break-after:avoid   \n",
       "379                                                                                                        margin-bottom:0in;page-break-after:avoid   \n",
       "380                                                                                                        margin-bottom:0in;page-break-after:avoid   \n",
       "381                                                                                                                          page-break-after:avoid   \n",
       "382                                                                                                                          page-break-after:avoid   \n",
       "383                                                                                                                                            None   \n",
       "384                                                                                                                                            None   \n",
       "385                                                                                                                                            None   \n",
       "386                                                                                                                                            None   \n",
       "387                                                                                                                                            None   \n",
       "388                                                                                                                                            None   \n",
       "389                                                                                                                                            None   \n",
       "390                                                                                                                                            None   \n",
       "391                                                                                                                                            None   \n",
       "392                                                                                                                                            None   \n",
       "393                                                                                                                                            None   \n",
       "394                                                                                                                                            None   \n",
       "395                                                                                                                                            None   \n",
       "396                                                                                                                                            None   \n",
       "397                                                                                                                                            None   \n",
       "398                                                                                                                                            None   \n",
       "399                                                                                                                                            None   \n",
       "400                                                                                                      margin-bottom:6.0pt;page-break-after:avoid   \n",
       "401                                                                                                            border-collapse:collapse;border:none   \n",
       "402                                                                                                         margin-top:6.0pt;page-break-after:avoid   \n",
       "403                                                                                                                          page-break-after:avoid   \n",
       "404                                                                                 margin-left:14.2pt;text-indent:-14.2pt;\\npage-break-after:avoid   \n",
       "405                                                                                 margin-left:14.2pt;text-indent:-14.2pt;\\npage-break-after:avoid   \n",
       "406                                                                                                        margin-bottom:0in;page-break-after:avoid   \n",
       "407                                                                                                                               margin-bottom:0in   \n",
       "408                                                                                                                                            None   \n",
       "409                                                                                                                          page-break-after:avoid   \n",
       "410                                                                                                                          page-break-after:avoid   \n",
       "411                                                                                                                          page-break-after:avoid   \n",
       "412                                                                                                                                            None   \n",
       "413                                                                                                                                            None   \n",
       "414                                                                                                                                            None   \n",
       "415                                                                                                                                            None   \n",
       "416                                                                                                                                            None   \n",
       "417                                                                                                                                            None   \n",
       "418                                                                                                                                            None   \n",
       "419                                                                                                                                            None   \n",
       "420                                                                                                                                            None   \n",
       "421                           margin-top:0in;margin-right:0in;margin-bottom:6.0pt;\\nmargin-left:40.55pt;text-indent:-40.55pt;page-break-after:avoid   \n",
       "422                                                                                                            border-collapse:collapse;border:none   \n",
       "423     margin-top:6.0pt;margin-right:0in;margin-bottom:0in;\\nmargin-left:13.6pt;margin-bottom:.0001pt;text-indent:-13.6pt;page-break-after:\\navoid   \n",
       "424                                                                                 margin-left:13.5pt;text-indent:-13.5pt;page-break-after:\\navoid   \n",
       "425                                                                                 margin-left:13.6pt;text-indent:-13.6pt;page-break-after:\\navoid   \n",
       "426                                                    margin-top:0in;margin-right:0in;margin-bottom:2.0pt;\\nmargin-left:13.5pt;text-indent:-13.5pt   \n",
       "427                                                                                                                                            None   \n",
       "428                                                                                                                                            None   \n",
       "429                                                                                                                                            None   \n",
       "430                                                                                                                          page-break-after:avoid   \n",
       "431                                                                                                                          page-break-after:avoid   \n",
       "432                                                                                                                                            None   \n",
       "433                                                                                                                                            None   \n",
       "434                                                                                                                                            None   \n",
       "435                                                                                                                                            None   \n",
       "436                                                                                                                          page-break-after:avoid   \n",
       "437                                                                                                                          page-break-after:avoid   \n",
       "438                                                                                                                                            None   \n",
       "439                                                                                                                                            None   \n",
       "440                                                                                                                                            None   \n",
       "441                                                                                                                                            None   \n",
       "442                                                                                                                                            None   \n",
       "443                                                                                                                                            None   \n",
       "444                                                                                                      margin-bottom:6.0pt;page-break-after:avoid   \n",
       "445                                                                                                            border-collapse:collapse;border:none   \n",
       "446     margin-top:6.0pt;margin-right:0in;margin-bottom:0in;\\nmargin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;page-break-after:\\navoid   \n",
       "447                                                                                                          margin-left:14.2pt;text-indent:-14.2pt   \n",
       "448                                                                                                                                            None   \n",
       "449                                                                                                                                            None   \n",
       "450                                                                                                                                            None   \n",
       "451                                                                                                                                            None   \n",
       "452                                                                                                                                            None   \n",
       "453                                                                                                                                            None   \n",
       "454                                                                                                                                            None   \n",
       "455                                                                                                                          page-break-after:avoid   \n",
       "456                                                                                                                          page-break-after:avoid   \n",
       "457                                                                                                                          page-break-after:avoid   \n",
       "458                                                                                                                                            None   \n",
       "459                                                                                                                                            None   \n",
       "460                                                                                                                                            None   \n",
       "461                                                                                                                                            None   \n",
       "462                                                                                                                                            None   \n",
       "463                                                                                                                                            None   \n",
       "464                                                                                                                                            None   \n",
       "465                                                                                                                          page-break-after:avoid   \n",
       "466                                                                                                                          page-break-after:avoid   \n",
       "467                                                                                                                          page-break-after:avoid   \n",
       "468                                                                                                                          page-break-after:avoid   \n",
       "469                                                                                                                                            None   \n",
       "470                                                                                                                                            None   \n",
       "471                                                                                                                          page-break-after:avoid   \n",
       "472                                                                                                                          page-break-after:avoid   \n",
       "473                                                                                                                          page-break-after:avoid   \n",
       "474                                                                                                                          page-break-after:avoid   \n",
       "475                                                                                                                                            None   \n",
       "476                                                                                                                          page-break-after:avoid   \n",
       "477                                                                                                                                            None   \n",
       "478                                                                                                                                            None   \n",
       "479                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "480                                                                                                                          page-break-after:avoid   \n",
       "481                                                                                                                          page-break-after:avoid   \n",
       "482                                                                                                                          page-break-after:avoid   \n",
       "483                                                                                                                                            None   \n",
       "484                                                                                                                                            None   \n",
       "485                                                                                                                                            None   \n",
       "486                                                                                                                          page-break-after:avoid   \n",
       "487                                                                                                                                            None   \n",
       "488                                                                                                                                            None   \n",
       "489                                                                                                                                            None   \n",
       "490                                                                                                                                            None   \n",
       "491                                                                                                       margin-right:-.1pt;page-break-after:avoid   \n",
       "492                                                                                                                          page-break-after:avoid   \n",
       "493                                                                                                                                            None   \n",
       "494                                                                                                                                            None   \n",
       "495                                                                                                                          page-break-after:avoid   \n",
       "496                                                                                                                          page-break-after:avoid   \n",
       "497                                                                                                                                            None   \n",
       "498                                                                                                                                            None   \n",
       "499                                                                                                                                            None   \n",
       "500                                                                                                                                            None   \n",
       "501                                                                                                       margin-right:-.1pt;page-break-after:avoid   \n",
       "502                                                                                                                          page-break-after:avoid   \n",
       "503                                                                                                                                            None   \n",
       "504                                                                                                                                            None   \n",
       "505                                                                                                                          page-break-after:avoid   \n",
       "506                                                                                                                          page-break-after:avoid   \n",
       "507                                                                                                                                            None   \n",
       "508                                                                                                                           page-break-after:auto   \n",
       "509                                                                                                                                            None   \n",
       "510                                                                                                                                            None   \n",
       "511                                                                                                                          page-break-after:avoid   \n",
       "512                                                                                                                                            None   \n",
       "513                                                                                                                                            None   \n",
       "514                                                                                                                                            None   \n",
       "515                                                                                                                                            None   \n",
       "516                                                                                                                                            None   \n",
       "517                                                                                                                                            None   \n",
       "518                                                                                                                                            None   \n",
       "519                                                                                                                                            None   \n",
       "520                                                                                                                                            None   \n",
       "521                                                                                                                          page-break-after:avoid   \n",
       "522                                                                                                                          page-break-after:avoid   \n",
       "523                                                                                                                                            None   \n",
       "524                                                                                                                                            None   \n",
       "525                                                                                                                                            None   \n",
       "526                                                                                                                                            None   \n",
       "527                                                                                                                          page-break-after:avoid   \n",
       "528                                                                                                                          page-break-after:avoid   \n",
       "529                                                                                                                          page-break-after:avoid   \n",
       "530                                                                                                                                            None   \n",
       "531                                                                                                                          page-break-after:avoid   \n",
       "532                                                                                                                          page-break-after:avoid   \n",
       "533                                                                                                                          page-break-after:avoid   \n",
       "534                                                                                                                                            None   \n",
       "535                                                                                                                          page-break-after:avoid   \n",
       "536                                                                                                                          page-break-after:avoid   \n",
       "537                                                                                                                          page-break-after:avoid   \n",
       "538                                                                                                                                            None   \n",
       "539                                                                                                                                            None   \n",
       "540                                                                                                                                            None   \n",
       "541                                                                                                                                            None   \n",
       "542                                                                                                                          page-break-after:avoid   \n",
       "543                                                                                                                                            None   \n",
       "544                                                                                                                                            None   \n",
       "545                                                                                                      margin-bottom:6.0pt;page-break-after:avoid   \n",
       "546                                                                                                width:98.9%;border-collapse:collapse;border:none   \n",
       "547   margin-top:6.0pt;margin-right:0in;margin-bottom:0in;\\nmargin-left:14.45pt;margin-bottom:.0001pt;text-indent:-14.45pt;page-break-after:\\navoid   \n",
       "548                                                                                                        margin-left:14.45pt;text-indent:-14.45pt   \n",
       "549                                                                                                                                            None   \n",
       "550                                                                                                                                            None   \n",
       "551                                                                                                                                            None   \n",
       "552                           margin-top:0in;margin-right:0in;margin-bottom:6.0pt;\\nmargin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid   \n",
       "553                                                                                                            border-collapse:collapse;border:none   \n",
       "554                                                                                                                                            None   \n",
       "555                                                                                                        margin-left:28.35pt;text-indent:-28.35pt   \n",
       "556                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "557                                                                                                                          page-break-after:avoid   \n",
       "558                                                                                                                                            None   \n",
       "559                                                                                                                                            None   \n",
       "560                                                                                                                          page-break-after:avoid   \n",
       "561                                                                                                                          page-break-after:avoid   \n",
       "562                                                                                                                                            None   \n",
       "563                                                                                                                                            None   \n",
       "564                                                                                                                          page-break-after:avoid   \n",
       "565                                                                                                                          page-break-after:avoid   \n",
       "566                                                                                                                                            None   \n",
       "567                                                                                                                                            None   \n",
       "568                                                                                                                          page-break-after:avoid   \n",
       "569                                                                                                                          page-break-after:avoid   \n",
       "570                                                                                                                                            None   \n",
       "571                                                                                                                                            None   \n",
       "572                                                                                                                                            None   \n",
       "573                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "574                                                                                                                          page-break-after:avoid   \n",
       "575                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "576                                                                                                                          page-break-after:avoid   \n",
       "577                                                                                                                          page-break-after:avoid   \n",
       "578                                                                                                                          page-break-after:avoid   \n",
       "579                                                                                                                          page-break-after:avoid   \n",
       "580                                                                                                                          page-break-after:avoid   \n",
       "581                                                                                                                          page-break-after:avoid   \n",
       "582                                                                                                                          page-break-after:avoid   \n",
       "583                                                                                                                          page-break-after:avoid   \n",
       "584                                                                                                                          page-break-after:avoid   \n",
       "585                                                                                                                                            None   \n",
       "586                                                                                                                                            None   \n",
       "587                                                                                                                          page-break-after:avoid   \n",
       "588                                                                                                                          page-break-after:avoid   \n",
       "589                                                                                                                                            None   \n",
       "590                                                                                                                                            None   \n",
       "591                                                                                                                                            None   \n",
       "592                                                                                                                                            None   \n",
       "593                                                                                                                                            None   \n",
       "594                                                                                                                                            None   \n",
       "595                                                                                                                                            None   \n",
       "596                                                                                                                          page-break-after:avoid   \n",
       "597                                                                                                                          page-break-after:avoid   \n",
       "598                                                                                                                          page-break-after:avoid   \n",
       "599                                                                                                                          page-break-after:avoid   \n",
       "600                                                                                                                          page-break-after:avoid   \n",
       "601                                                                                                                                            None   \n",
       "602                                                                                                                                            None   \n",
       "603                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "604                                                                                                                          page-break-after:avoid   \n",
       "605                                                                                                                                            None   \n",
       "606                                                                                                                                            None   \n",
       "607                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "608                                                                                                                          page-break-after:avoid   \n",
       "609                                                                                                                                            None   \n",
       "610                                                                                                                                            None   \n",
       "611                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "612                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "613                                                                                                                                            None   \n",
       "614                                                                                                                                            None   \n",
       "615                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "616                                                                                                                          page-break-after:avoid   \n",
       "617                                                                                                                                            None   \n",
       "618                                                                                                                                            None   \n",
       "619                                                                                                                          page-break-after:avoid   \n",
       "620                                                                                                                          page-break-after:avoid   \n",
       "621                                                                                                                          page-break-after:avoid   \n",
       "622                                                                                                          margin-left:13.6pt;text-indent:-13.6pt   \n",
       "623                                                                                                                                            None   \n",
       "624                                                                                                                          page-break-after:avoid   \n",
       "625                                                                                                                                            None   \n",
       "626                                                                                                                          page-break-after:avoid   \n",
       "627                                                                                                          margin-left:13.6pt;text-indent:-13.6pt   \n",
       "628                                                                                                          margin-left:13.6pt;text-indent:-13.6pt   \n",
       "629                                                                                                          margin-left:13.6pt;text-indent:-13.6pt   \n",
       "630                                                                                                                                            None   \n",
       "631                                                                                                                                            None   \n",
       "632                                                                                                                                            None   \n",
       "633                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "634                                                                                                                          page-break-after:avoid   \n",
       "635                                                                                                                                            None   \n",
       "636                                                                                                                                            None   \n",
       "637                                                                                                                                            None   \n",
       "638                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "639                                                                                                                          page-break-after:avoid   \n",
       "640                                                                                                                          page-break-after:avoid   \n",
       "641                                                                                                                          page-break-after:avoid   \n",
       "642                                                                                                                          page-break-after:avoid   \n",
       "643                                                                                                                                            None   \n",
       "644                                                                                                                                            None   \n",
       "645                                                                                                                                            None   \n",
       "646                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "647                                                                                                                          page-break-after:avoid   \n",
       "648                                                                                                                          page-break-after:avoid   \n",
       "649                                                                                                                          page-break-after:avoid   \n",
       "650                                                                                                                                            None   \n",
       "651                                                                                                                                            None   \n",
       "652                                                                                                                                            None   \n",
       "653                                                                                                                                            None   \n",
       "654                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "655                                                                                                                          page-break-after:avoid   \n",
       "656                                                                                                                          page-break-after:avoid   \n",
       "657                                                                                                                                            None   \n",
       "658                                                                                                                                            None   \n",
       "659                                                                                                                                            None   \n",
       "660                                                                                 margin-left:28.1pt;text-indent:-28.1pt;page-break-after:\\navoid   \n",
       "661                                                                                                                          page-break-after:avoid   \n",
       "662                                                                                                                                            None   \n",
       "663                                                                                            font-size:11.0pt;font-family:\"Times New Roman\",serif   \n",
       "664                                                                                                                        page-break-before:always   \n",
       "665                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "666                                                                                                                          page-break-after:avoid   \n",
       "667                                                                                                                                            None   \n",
       "668                                                                                                                                            None   \n",
       "669                                                                                                                                            None   \n",
       "670                                                                                                                          page-break-after:avoid   \n",
       "671                                                                                                                          page-break-after:avoid   \n",
       "672                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "673                                                                                                                          page-break-after:avoid   \n",
       "674                                                                                                                          page-break-after:avoid   \n",
       "675                                                                                                                          page-break-after:avoid   \n",
       "676                                                                                                                          page-break-after:avoid   \n",
       "677                                                                                                                          page-break-after:avoid   \n",
       "678                                                                                                                          page-break-after:avoid   \n",
       "679                                                                                                                          page-break-after:avoid   \n",
       "680                                                                                                                          page-break-after:avoid   \n",
       "681                                                                                                                          page-break-after:avoid   \n",
       "682                                                                                                                          page-break-after:avoid   \n",
       "683                                                                                                                          page-break-after:avoid   \n",
       "684                                                                                                                                            None   \n",
       "685                                                                                                                                            None   \n",
       "686                                                                                                                          page-break-after:avoid   \n",
       "687                                                                                                                                            None   \n",
       "688                                                                                                                                            None   \n",
       "689                                                                                                                                            None   \n",
       "690                                                                                                                          page-break-after:avoid   \n",
       "691                                                                                                                          page-break-after:avoid   \n",
       "692                                                                                                                          page-break-after:avoid   \n",
       "693                                                                                                                          page-break-after:avoid   \n",
       "694                                                                                                                          page-break-after:avoid   \n",
       "695                                                                                                                          page-break-after:avoid   \n",
       "696                                                                                                                          page-break-after:avoid   \n",
       "697                                                                                                                          page-break-after:avoid   \n",
       "698                                                                                                                          page-break-after:avoid   \n",
       "699                                                                                                                          page-break-after:avoid   \n",
       "700                                                                                                                                            None   \n",
       "701                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "702                                                    text-align:justify;text-justify:inter-ideograph;\\npage-break-after:avoid;text-autospace:none   \n",
       "703                                                                                                                          page-break-after:avoid   \n",
       "704                                                                                                                          page-break-after:avoid   \n",
       "705                                                                                                                          page-break-after:avoid   \n",
       "706                                                                                                                          page-break-after:avoid   \n",
       "707                                                                                                                          page-break-after:avoid   \n",
       "708                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "709                                                                                                                          page-break-after:avoid   \n",
       "710                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "711                                                                                                                          page-break-after:avoid   \n",
       "712                                                                                                                          page-break-after:avoid   \n",
       "713                                                                                                                                            None   \n",
       "714                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "715                                                                                                                          page-break-after:avoid   \n",
       "716                                                                                                                          page-break-after:avoid   \n",
       "717                                                                                                                                            None   \n",
       "718                                                                                                                          page-break-after:avoid   \n",
       "719                                                                                                                          page-break-after:avoid   \n",
       "720                                                                                                                          page-break-after:avoid   \n",
       "721                                                                                                                          page-break-after:avoid   \n",
       "722                                                                                                      margin-bottom:6.0pt;page-break-after:avoid   \n",
       "723                                                                                                            border-collapse:collapse;border:none   \n",
       "724                                                                                                                             text-autospace:none   \n",
       "725                                                                                                      page-break-after:avoid;text-autospace:none   \n",
       "726                                                                                                                             text-autospace:none   \n",
       "727                                                                                                                             text-autospace:none   \n",
       "728                                                                                                                                            None   \n",
       "729                                                                                                                          page-break-after:avoid   \n",
       "730                                                                                                                                            None   \n",
       "731                                                                                                                                            None   \n",
       "732                                                                                                                                            None   \n",
       "733                                                                                                                                            None   \n",
       "734                                                                                                                                            None   \n",
       "735                                                                                                                                            None   \n",
       "736                                                                                                                                            None   \n",
       "737                                                                                                                          page-break-after:avoid   \n",
       "738                                                                                                                          page-break-after:avoid   \n",
       "739                                                                                                                          page-break-after:avoid   \n",
       "740                                                                                                                          page-break-after:avoid   \n",
       "741                                                                                                                                            None   \n",
       "742                                                                                                                                            None   \n",
       "743                                                                                                                                            None   \n",
       "744                                                                                                                          page-break-after:avoid   \n",
       "745                                                                                                                                            None   \n",
       "746                                                                                                                                            None   \n",
       "747                                                                                                                                            None   \n",
       "748                                                                                                                                            None   \n",
       "749                                                                                                                          page-break-after:avoid   \n",
       "750                                                                                                                          page-break-after:avoid   \n",
       "751                                                                                                                          page-break-after:avoid   \n",
       "752                                                                                                                                            None   \n",
       "753                                                                                                                                            None   \n",
       "754                                                                                                                                            None   \n",
       "755                                                                                                                          page-break-after:avoid   \n",
       "756                                                                                                      page-break-after:avoid;text-autospace:none   \n",
       "757                                                                                                      page-break-after:avoid;text-autospace:none   \n",
       "758                                                                                                      page-break-after:avoid;text-autospace:none   \n",
       "759                                                                                                                             text-autospace:none   \n",
       "760                                                                                                                             text-autospace:none   \n",
       "761                                                                                                                                            None   \n",
       "762                                                                                                                             text-autospace:none   \n",
       "763                                                                                                                             text-autospace:none   \n",
       "764                                                                                                                             text-autospace:none   \n",
       "765                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "766                                                                                                                          page-break-after:avoid   \n",
       "767                                                                                                                                      margin:0in   \n",
       "768                                                                                                                                            None   \n",
       "769                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "770                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "771                                                                                                                                            None   \n",
       "772                                                                                                                                            None   \n",
       "773                                                                                                                                            None   \n",
       "774                                                                                                                                            None   \n",
       "775                                                                                                                                            None   \n",
       "776                                                                                                        margin-left:28.35pt;text-indent:-28.35pt   \n",
       "777                                                                                                                                            None   \n",
       "778                                                                                                                           page-break-after:auto   \n",
       "779                                                                                                                                            None   \n",
       "780                                                                                                                                            None   \n",
       "781                                                                                                                           page-break-after:auto   \n",
       "782                                                                                                                           page-break-after:auto   \n",
       "783                                                                                                                          page-break-after:avoid   \n",
       "784                                                                                                                          page-break-after:avoid   \n",
       "785                                                                                                                                            None   \n",
       "786                                                                                                                                            None   \n",
       "787                                                                                                                          page-break-after:avoid   \n",
       "788                                                                                                                          page-break-after:avoid   \n",
       "789                                                                                                                                            None   \n",
       "790                                                                                                                                            None   \n",
       "791                                                                                                                          page-break-after:avoid   \n",
       "792                                                                                                                          page-break-after:avoid   \n",
       "793                                                                                                                                            None   \n",
       "794                                                                                                                                            None   \n",
       "795                                                                                                                          page-break-after:avoid   \n",
       "796                                                                                                                          page-break-after:avoid   \n",
       "797                                                                                                                          page-break-after:avoid   \n",
       "798                                                                                                                          page-break-after:avoid   \n",
       "799                                                                                                                                            None   \n",
       "800                                                                                                                                            None   \n",
       "801                                                                                                                          page-break-after:avoid   \n",
       "802                                                                                                                          page-break-after:avoid   \n",
       "803                                                                                                                          page-break-after:avoid   \n",
       "804                                                                                                                                            None   \n",
       "805                                                                                                                          page-break-after:avoid   \n",
       "806                                                                                                                          page-break-after:avoid   \n",
       "807                                                                                                                                            None   \n",
       "808                                                                                                                                            None   \n",
       "809                                                                                                                          page-break-after:avoid   \n",
       "810                                                                                                                          page-break-after:avoid   \n",
       "811                                                                                                                                            None   \n",
       "812                                                                                                                                            None   \n",
       "813                                                                                                                          page-break-after:avoid   \n",
       "814                                                                                                                          page-break-after:avoid   \n",
       "815                                                                                                                                            None   \n",
       "816                                                                                                                                            None   \n",
       "817                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "818                                                                                                                          page-break-after:avoid   \n",
       "819                                                                                                                                            None   \n",
       "820                                                                                                                                            None   \n",
       "821                                                                                                                          page-break-after:avoid   \n",
       "822                                                                                                                          page-break-after:avoid   \n",
       "823                                                                                                                                            None   \n",
       "824                                                                                                                          page-break-after:avoid   \n",
       "825                                                                                                                          page-break-after:avoid   \n",
       "826                                                                                                                                            None   \n",
       "827                                                                                                                                            None   \n",
       "828                                                                                                                                            None   \n",
       "829                                                                                                                          page-break-after:avoid   \n",
       "830                                                                                                                          page-break-after:avoid   \n",
       "831                                                                                                                          page-break-after:avoid   \n",
       "832                                                                                                                                            None   \n",
       "833                                                                                                                                            None   \n",
       "834                                                                                                                                            None   \n",
       "835                                                                                                                                            None   \n",
       "836                                                                                                                                            None   \n",
       "837                                                                                                                          page-break-after:avoid   \n",
       "838                                                                                                                          page-break-after:avoid   \n",
       "839                                                                                                                          page-break-after:avoid   \n",
       "840                                                                                                                                            None   \n",
       "841                                                                                                                          page-break-after:avoid   \n",
       "842                                                                                                                          page-break-after:avoid   \n",
       "843                                                                                                                          page-break-after:avoid   \n",
       "844                                                                                                                                            None   \n",
       "845                                                                                                                          page-break-after:avoid   \n",
       "846                                                                                                                          page-break-after:avoid   \n",
       "847                                                                                                                          page-break-after:avoid   \n",
       "848                                                                                                                                            None   \n",
       "849                                                                                                                          page-break-after:avoid   \n",
       "850                                                                                                                          page-break-after:avoid   \n",
       "851                                                                                                                          page-break-after:avoid   \n",
       "852                                                                                                                                            None   \n",
       "853                                                                                                                          page-break-after:avoid   \n",
       "854                                                                                                                          page-break-after:avoid   \n",
       "855                                                                                                                          page-break-after:avoid   \n",
       "856                                                                                                                                            None   \n",
       "857                                                                                                                          page-break-after:avoid   \n",
       "858                                                                                                                          page-break-after:avoid   \n",
       "859                                                                                                                          page-break-after:avoid   \n",
       "860                                                                                                                                            None   \n",
       "861                                                                                                                          page-break-after:avoid   \n",
       "862                                                                                                                          page-break-after:avoid   \n",
       "863                                                                                                                          page-break-after:avoid   \n",
       "864                                                                                                                                      margin:0in   \n",
       "865                                                                                                                          page-break-after:avoid   \n",
       "866                                                                                                                          page-break-after:avoid   \n",
       "867                                                                                                                          page-break-after:avoid   \n",
       "868                                                                                                                                            None   \n",
       "869                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "870                                                                                                                          page-break-after:avoid   \n",
       "871                                                                                                                          page-break-after:avoid   \n",
       "872                                                                                                                          page-break-after:avoid   \n",
       "873                                                                                                                          page-break-after:avoid   \n",
       "874                                                                                                                                            None   \n",
       "875                                                                                                                          page-break-after:avoid   \n",
       "876                                                                                                                          page-break-after:avoid   \n",
       "877                                                                                                                          page-break-after:avoid   \n",
       "878                                                                                                                                      margin:0in   \n",
       "879                                                                                                                          page-break-after:avoid   \n",
       "880                                                                                                                          page-break-after:avoid   \n",
       "881                                                                                                                          page-break-after:avoid   \n",
       "882                                                                                                                                            None   \n",
       "883                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "884                                                                                                                          page-break-after:avoid   \n",
       "885                                                                                                                                            None   \n",
       "886                                                                                                                                            None   \n",
       "887                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "888                                                    text-align:justify;text-justify:inter-ideograph;\\npage-break-after:avoid;text-autospace:none   \n",
       "889                                                                                                                          page-break-after:avoid   \n",
       "890                                                                                                                          page-break-after:avoid   \n",
       "891                                                                                                                          page-break-after:avoid   \n",
       "892                                                                                                                                            None   \n",
       "893                                                                                                                                            None   \n",
       "894                                                                                                                                            None   \n",
       "895                                                                                                                                            None   \n",
       "896                                                                                                                                            None   \n",
       "897                                                                                                       line-height:13.0pt;page-break-after:avoid   \n",
       "898                                                                                                                          page-break-after:avoid   \n",
       "899                                                                                                                          page-break-after:avoid   \n",
       "900                                                                                                                                            None   \n",
       "901                                                                                                      margin-bottom:6.0pt;page-break-after:avoid   \n",
       "902                                                                                                width:95.3%;border-collapse:collapse;border:none   \n",
       "903                                                                                                                           page-break-after:auto   \n",
       "904                                                                                                                          page-break-after:avoid   \n",
       "905                                                                                                                                            None   \n",
       "906                                                                                                                          page-break-after:avoid   \n",
       "907                                                                                                                          page-break-after:avoid   \n",
       "908                                                                                                                                            None   \n",
       "909                                                                                                                                            None   \n",
       "910                                                                                                                                            None   \n",
       "911                                                                                                                                            None   \n",
       "912                                                                                                                                            None   \n",
       "913                                                                                                                                            None   \n",
       "914                                                                                                                          page-break-after:avoid   \n",
       "915                                                                                                                          page-break-after:avoid   \n",
       "916                                                                                                                                            None   \n",
       "917                                                                                                                                            None   \n",
       "918                                                                                                                                            None   \n",
       "919                                                                                                                                            None   \n",
       "920                                                                                                                                            None   \n",
       "921                                                                                                                                            None   \n",
       "922                                                                                                     margin-bottom:12.0pt;page-break-after:avoid   \n",
       "923                                                                                         margin-left:6.85pt;border-collapse:collapse;border:none   \n",
       "924                                                                                                                                            None   \n",
       "925                                                                                                      page-break-after:avoid;text-autospace:none   \n",
       "926                                                                                                      page-break-after:avoid;text-autospace:none   \n",
       "927                                                                                                                          page-break-after:avoid   \n",
       "928                                                                                                        margin-left:28.35pt;text-indent:-28.35pt   \n",
       "929                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "930                                                                                                                          page-break-after:avoid   \n",
       "931                                                                                                                          page-break-after:avoid   \n",
       "932                                                                                                                                            None   \n",
       "933                                                                                                                                            None   \n",
       "934                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "935                                                                                                                          page-break-after:avoid   \n",
       "936                                                                               margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "937                                                                                                                          page-break-after:avoid   \n",
       "938                                                                                                                          page-break-after:avoid   \n",
       "939                                                                                                                          page-break-after:avoid   \n",
       "940                                                                                                       margin-right:-.1pt;page-break-after:avoid   \n",
       "941                                                                                                                          page-break-after:avoid   \n",
       "942                                                                                                                          page-break-after:avoid   \n",
       "943                                                                                                                                            None   \n",
       "944                                                                                                                                            None   \n",
       "945                                                                                                            margin-bottom:0in;line-height:normal   \n",
       "946                                                                                                                          page-break-after:avoid   \n",
       "947                                                                                                                          page-break-after:avoid   \n",
       "948                                                                                                                          page-break-after:avoid   \n",
       "949                                                                                                                                            None   \n",
       "950                                                                                                                                            None   \n",
       "951                                                                                                                                            None   \n",
       "952                                                                                                                               margin-bottom:0in   \n",
       "953                                                                                                                               margin-bottom:0in   \n",
       "954                                                                                                                               margin-bottom:0in   \n",
       "955                                                                                                                               margin-bottom:0in   \n",
       "956                                                                                                                               margin-bottom:0in   \n",
       "957                                                                                                                                            None   \n",
       "958                                                                                                        margin-bottom:0in;page-break-after:avoid   \n",
       "959                                                                                                                          page-break-after:avoid   \n",
       "960                                                                                                                          page-break-after:avoid   \n",
       "961                                                                                                                          page-break-after:avoid   \n",
       "962                                                                                                                          page-break-after:avoid   \n",
       "963                                                                                                                                            None   \n",
       "964                                                                                                                                            None   \n",
       "965                                                                                                                                            None   \n",
       "966                                                                                                                                            None   \n",
       "967                                                                                                                                            None   \n",
       "968                                                                                                                                            None   \n",
       "969                                                                                                                                            None   \n",
       "970                                                                                                                                            None   \n",
       "971                                                                                                                                            None   \n",
       "972                                                                                                                                            None   \n",
       "973                                                                                                                                            None   \n",
       "974                                                                                                                                            None   \n",
       "975                                                                                                                                            None   \n",
       "976                                                                                                                                            None   \n",
       "977                                                                                                                          page-break-after:avoid   \n",
       "978                                                                                                      margin-bottom:6.0pt;page-break-after:avoid   \n",
       "979                                                                  border-collapse:collapse;border:none;margin-left:6.75pt;\\n margin-right:6.75pt   \n",
       "980                                                                                                         margin-top:6.0pt;page-break-after:avoid   \n",
       "981                                                                                                                          page-break-after:avoid   \n",
       "982                                                                                 margin-left:14.2pt;text-indent:-14.2pt;\\npage-break-after:avoid   \n",
       "983                                                                                 margin-left:14.2pt;text-indent:-14.2pt;\\npage-break-after:avoid   \n",
       "984                                                                                                        margin-bottom:0in;page-break-after:avoid   \n",
       "985                                                                                                                               margin-bottom:0in   \n",
       "986                                                                                                                                            None   \n",
       "987                                                                                                                          page-break-after:avoid   \n",
       "988                                                                                                                          page-break-after:avoid   \n",
       "989                                                                                                                          page-break-after:avoid   \n",
       "990                                                                                                                                            None   \n",
       "991                                                                                                                                            None   \n",
       "992                                                                                                                                            None   \n",
       "993                                                                                                                                            None   \n",
       "994                                                                                                                                            None   \n",
       "995                                                                                                                                            None   \n",
       "996                                                                                                                                            None   \n",
       "997                                                                                                                                            None   \n",
       "998                                                                                                                                            None   \n",
       "999                             margin-top:0in;margin-right:0in;margin-bottom:6.0pt;\\nmargin-left:45.0pt;text-indent:-45.0pt;page-break-after:avoid   \n",
       "1000                                                                                             width:479.1pt;border-collapse:collapse;border:none   \n",
       "1001    margin-top:6.0pt;margin-right:0in;margin-bottom:0in;\\nmargin-left:13.6pt;margin-bottom:.0001pt;text-indent:-13.6pt;page-break-after:\\navoid   \n",
       "1002                                                                                margin-left:13.5pt;text-indent:-13.5pt;page-break-after:\\navoid   \n",
       "1003                                                                                margin-left:13.6pt;text-indent:-13.6pt;page-break-after:\\navoid   \n",
       "1004                                                                                                         margin-left:13.6pt;text-indent:-13.6pt   \n",
       "1005                                                                                                                                           None   \n",
       "1006                                                                                                                                           None   \n",
       "1007                                                                                                                                           None   \n",
       "1008                                                                                                                         page-break-after:avoid   \n",
       "1009                                                                                                                         page-break-after:avoid   \n",
       "1010                                                                                                                         page-break-after:avoid   \n",
       "1011                                                                                                                                           None   \n",
       "1012                                                                                                                                           None   \n",
       "1013                                                                                                                                           None   \n",
       "1014                                                                                                                         page-break-after:avoid   \n",
       "1015                                                                                                                         page-break-after:avoid   \n",
       "1016                                                                                                                         page-break-after:avoid   \n",
       "1017                                                                                                                                           None   \n",
       "1018                                                                                                                                           None   \n",
       "1019                                                                                                                                           None   \n",
       "1020                                                                                                                                           None   \n",
       "1021                                                                                                                                           None   \n",
       "1022                                                                                                     margin-bottom:6.0pt;page-break-after:avoid   \n",
       "1023                                                                                                           border-collapse:collapse;border:none   \n",
       "1024                                                                                margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\\navoid   \n",
       "1025                                                                                                                                           None   \n",
       "1026                                                                                                                                           None   \n",
       "1027                                                                                                                                           None   \n",
       "1028                                                                                                                                           None   \n",
       "1029                                                                                                                                           None   \n",
       "1030                                                                                                                                           None   \n",
       "1031                                                                                                                                           None   \n",
       "1032                                                                                                                                           None   \n",
       "1033                                                                                                                         page-break-after:avoid   \n",
       "1034                                                                                                                         page-break-after:avoid   \n",
       "1035                                                                                                                         page-break-after:avoid   \n",
       "1036                                                                                                                                           None   \n",
       "1037                                                                                                                                           None   \n",
       "1038                                                                                                                                           None   \n",
       "1039                                                                                                                                           None   \n",
       "1040                                                                                                                                           None   \n",
       "1041                                                                                                                                           None   \n",
       "1042                                                                                                                                           None   \n",
       "1043                                                                                                                         page-break-after:avoid   \n",
       "1044                                                                                                                         page-break-after:avoid   \n",
       "1045                                                                                                                         page-break-after:avoid   \n",
       "1046                                                                                                                                           None   \n",
       "1047                                                                                                                                           None   \n",
       "1048                                                                                                                                           None   \n",
       "1049                                                                                                                                           None   \n",
       "1050                                                                                                                                           None   \n",
       "1051                                                                                                                                           None   \n",
       "1052                                                                                                text-align:justify;text-justify:inter-ideograph   \n",
       "1053                                                                                                                         page-break-after:avoid   \n",
       "1054                                                                                                                         page-break-after:avoid   \n",
       "1055                                                                                                                         page-break-after:avoid   \n",
       "1056                                                                                                                                           None   \n",
       "1057                                                                                                                                           None   \n",
       "1058                                                                                                                                           None   \n",
       "1059                                                                                                                                           None   \n",
       "1060                                                                                                                                           None   \n",
       "1061                                                                                                                         page-break-after:avoid   \n",
       "1062                                                                                                                                           None   \n",
       "1063                          margin-top:0in;margin-right:0in;margin-bottom:6.0pt;\\nmargin-left:42.55pt;text-indent:-42.55pt;page-break-after:avoid   \n",
       "1064                                                                                                           border-collapse:collapse;border:none   \n",
       "1065                                                                                                           border-collapse:collapse;border:none   \n",
       "1066                                                                                                           border-collapse:collapse;border:none   \n",
       "1067                                                                                                                                           None   \n",
       "1068                                                                                                                             line-height:13.0pt   \n",
       "1069                                                                                                text-align:justify;text-justify:inter-ideograph   \n",
       "1070                                                                                                                         page-break-after:avoid   \n",
       "1071                                                                                                                         page-break-after:avoid   \n",
       "1072                                                                                                                                           None   \n",
       "1073                                                                                                                             margin-right:-.1pt   \n",
       "1074                                                                              margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "1075                                                                                                                         page-break-after:avoid   \n",
       "1076                                                                                                                         page-break-after:avoid   \n",
       "1077                                                                                                                         page-break-after:avoid   \n",
       "1078                                                                                                                             margin-right:-.1pt   \n",
       "1079                                                                                                                             margin-right:-.1pt   \n",
       "1080                                                                                                                                           None   \n",
       "1081                                                                                                                         page-break-after:avoid   \n",
       "1082                                                                                                                         page-break-after:avoid   \n",
       "1083                                                                                                                                           None   \n",
       "1084                                                                                                                                           None   \n",
       "1085                                                                                                                             margin-right:-.1pt   \n",
       "1086                                                                                                      margin-right:-.1pt;page-break-after:avoid   \n",
       "1087                                                                                                                         page-break-after:avoid   \n",
       "1088                                                                                                                         page-break-after:avoid   \n",
       "1089                                                                                                                                           None   \n",
       "1090                                                                                                                         page-break-after:avoid   \n",
       "1091                                                                                                                         page-break-after:avoid   \n",
       "1092                                                                                                                         page-break-after:avoid   \n",
       "1093                                                                                                                                           None   \n",
       "1094                                                                                                                                           None   \n",
       "1095                                                                                                                             margin-right:-.1pt   \n",
       "1096                                                                                                      margin-right:-.1pt;page-break-after:avoid   \n",
       "1097                                                                                                                         page-break-after:avoid   \n",
       "1098                                                                                                                         page-break-after:avoid   \n",
       "1099                                                                                                text-align:justify;text-justify:inter-ideograph   \n",
       "1100                                                                                                                         page-break-after:avoid   \n",
       "1101                                                                                                                         page-break-after:avoid   \n",
       "1102                                                                                                                         page-break-after:avoid   \n",
       "1103                                                                                                                          page-break-after:auto   \n",
       "1104                                                                                                                                           None   \n",
       "1105                                                                                                                                           None   \n",
       "1106                                                                                                                         page-break-after:avoid   \n",
       "1107                                                                                                                         page-break-after:avoid   \n",
       "1108                                                                                                                         page-break-after:avoid   \n",
       "1109                                                                                                                                           None   \n",
       "1110                                                                                                                                           None   \n",
       "1111                                                                                                                                           None   \n",
       "1112                                                                                                                                           None   \n",
       "1113                                                                                                                                           None   \n",
       "1114                                                                                                                         page-break-after:avoid   \n",
       "1115                                                                                                                         page-break-after:avoid   \n",
       "1116                                                                                                                         page-break-after:avoid   \n",
       "1117                                                                                                                                           None   \n",
       "1118                                                                                                                                           None   \n",
       "1119                                                                                                                                           None   \n",
       "1120                                                                                                                         page-break-after:avoid   \n",
       "1121                                                                                                                         page-break-after:avoid   \n",
       "1122                                                                                                                         page-break-after:avoid   \n",
       "1123                                                                                                                                           None   \n",
       "1124                                                                                                                         page-break-after:avoid   \n",
       "1125                                                                                                                         page-break-after:avoid   \n",
       "1126                                                                                                                         page-break-after:avoid   \n",
       "1127                                                                                                                                           None   \n",
       "1128                                                                                                                         page-break-after:avoid   \n",
       "1129                                                                                                                         page-break-after:avoid   \n",
       "1130                                                                                                                         page-break-after:avoid   \n",
       "1131                                                                                                                                           None   \n",
       "1132                                                                                                                                           None   \n",
       "1133                                                                                                                         page-break-after:avoid   \n",
       "1134                                                                                                                         page-break-after:avoid   \n",
       "1135                                                                                                                                           None   \n",
       "1136                                                                                                     margin-bottom:6.0pt;page-break-after:avoid   \n",
       "1137                                                                                                           border-collapse:collapse;border:none   \n",
       "1138  margin-top:6.0pt;margin-right:0in;margin-bottom:0in;\\nmargin-left:14.45pt;margin-bottom:.0001pt;text-indent:-14.45pt;page-break-after:\\navoid   \n",
       "1139                                                                                                       margin-left:14.45pt;text-indent:-14.45pt   \n",
       "1140                                                                                                                                           None   \n",
       "1141                                                                              margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "1142                                                                                                                         page-break-after:avoid   \n",
       "1143                                                                                                                         page-break-after:avoid   \n",
       "1144                                                                                                                                           None   \n",
       "1145                                                                                                                         page-break-after:avoid   \n",
       "1146                                                                                                                         page-break-after:avoid   \n",
       "1147                                                                                                                         page-break-after:avoid   \n",
       "1148                                                                                                                                           None   \n",
       "1149                                                                                                                         page-break-after:avoid   \n",
       "1150                                                                                                                         page-break-after:avoid   \n",
       "1151                                                                                                                         page-break-after:avoid   \n",
       "1152                                                                                                                                           None   \n",
       "1153                                                                                                                         page-break-after:avoid   \n",
       "1154                                                                                                                         page-break-after:avoid   \n",
       "1155                                                                                                                         page-break-after:avoid   \n",
       "1156                                                                                                                                           None   \n",
       "1157                                                                                                                                           None   \n",
       "1158                                                                              margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "1159                                                                                                                         page-break-after:avoid   \n",
       "1160                                                                              margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "1161                                                                                                                         page-break-after:avoid   \n",
       "1162                                                                                                                         page-break-after:avoid   \n",
       "1163                                                                                                                         page-break-after:avoid   \n",
       "1164                                                                                                                         page-break-after:avoid   \n",
       "1165                                                                                                                         page-break-after:avoid   \n",
       "1166                                                                                                                         page-break-after:avoid   \n",
       "1167                                                                                                                         page-break-after:avoid   \n",
       "1168                                                                                                                         page-break-after:avoid   \n",
       "1169                                                                                                                                           None   \n",
       "1170                                                                                                                                           None   \n",
       "1171                                                                              margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "1172                                                                                                                         page-break-after:avoid   \n",
       "1173                                                                                                                         page-break-after:avoid   \n",
       "1174                                                                                                                                           None   \n",
       "1175                                                                              margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "1176                                                                                                                         page-break-after:avoid   \n",
       "1177                                                                                                                         page-break-after:avoid   \n",
       "1178                                                                                                                         page-break-after:avoid   \n",
       "1179                                                                                                                         page-break-after:avoid   \n",
       "1180                                                                                                                                           None   \n",
       "1181                                                                              margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "1182                                                                              margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "1183                                                                                                                         page-break-after:avoid   \n",
       "1184                                                                                                                                           None   \n",
       "1185                                                                              margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "1186                                                                                                                         page-break-after:avoid   \n",
       "1187                                                                                                                         page-break-after:avoid   \n",
       "1188                                                                                                                            text-autospace:none   \n",
       "1189                                                                                                                                           None   \n",
       "1190                                                                                                                                           None   \n",
       "1191                                                                              margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "1192                                                                                                                         page-break-after:avoid   \n",
       "1193                                                                                                                         page-break-after:avoid   \n",
       "1194                                                                                                                                           None   \n",
       "1195                                                                                                                                           None   \n",
       "1196                                                                              margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "1197                                                                                                                         page-break-after:avoid   \n",
       "1198                                                                                                                         page-break-after:avoid   \n",
       "1199                                                                                                                         page-break-after:avoid   \n",
       "1200                                                                                                                         page-break-after:avoid   \n",
       "1201                                                                                                                         page-break-after:avoid   \n",
       "1202                                                                                                                                           None   \n",
       "1203                                                                                                                                           None   \n",
       "1204                                                                              margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "1205                                                                                                                         page-break-after:avoid   \n",
       "1206                                                                                                      line-height:13.0pt;page-break-after:avoid   \n",
       "1207                                                                                                                                           None   \n",
       "1208                                                                                                                                           None   \n",
       "1209                                                                                                                                           None   \n",
       "1210                                                                                                                                           None   \n",
       "1211                                                                              margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\\navoid   \n",
       "1212                                                                                                                         page-break-after:avoid   \n",
       "1213                                                                                                                         page-break-after:avoid   \n",
       "1214                                                                                                                         page-break-after:avoid   \n",
       "1215                                                                                                                                           None   \n",
       "1216                                                                                                                                           None   \n",
       "1217                                                                                margin-left:28.1pt;text-indent:-28.1pt;page-break-after:\\navoid   \n",
       "1218                                                                                                                         page-break-after:avoid   \n",
       "1219                                                                                                                         page-break-after:avoid   \n",
       "1220                                                                                                                         page-break-after:avoid   \n",
       "1221                                                                                           font-size:11.0pt;font-family:\"Times New Roman\",serif   \n",
       "\n",
       "                    Classes   Bold  Italics  Uppercased  Underlined  Indexed  \\\n",
       "0          ['WordSection1']  False    False       False       False    False   \n",
       "1             ['MsoNormal']  False    False       False       False    False   \n",
       "2             ['MsoNormal']  False    False       False       False    False   \n",
       "3             ['MsoNormal']  False    False       False       False    False   \n",
       "4             ['MsoNormal']  False    False       False       False    False   \n",
       "5             ['MsoNormal']  False    False       False       False    False   \n",
       "6             ['MsoNormal']  False    False       False       False    False   \n",
       "7             ['MsoNormal']  False    False       False       False    False   \n",
       "8             ['MsoNormal']  False    False       False       False    False   \n",
       "9             ['MsoNormal']  False    False       False       False    False   \n",
       "10            ['MsoNormal']  False    False       False       False    False   \n",
       "11            ['MsoNormal']  False    False       False       False    False   \n",
       "12            ['MsoNormal']  False    False       False       False    False   \n",
       "13            ['MsoNormal']  False    False       False       False    False   \n",
       "14            ['MsoNormal']  False    False       False       False    False   \n",
       "15            ['MsoNormal']  False    False       False       False    False   \n",
       "16            ['MsoNormal']  False    False       False       False    False   \n",
       "17            ['MsoNormal']  False    False       False       False    False   \n",
       "18            ['MsoNormal']  False    False       False       False    False   \n",
       "19            ['MsoNormal']  False    False       False       False    False   \n",
       "20            ['MsoNormal']  False    False       False       False    False   \n",
       "21            ['MsoNormal']  False    False       False       False    False   \n",
       "22            ['MsoNormal']  False    False       False       False    False   \n",
       "23            ['MsoNormal']  False    False       False       False    False   \n",
       "24            ['MsoNormal']   True    False        True       False    False   \n",
       "25               ['TitleA']  False    False       False       False    False   \n",
       "26               ['TitleA']   True    False        True       False    False   \n",
       "27            ['MsoNormal']  False    False       False       False    False   \n",
       "28            ['MsoNormal']  False    False       False       False    False   \n",
       "29            ['MsoNormal']  False    False       False       False    False   \n",
       "30            ['MsoNormal']  False    False       False       False    False   \n",
       "31                     None  False    False       False       False    False   \n",
       "32                     None  False    False       False       False    False   \n",
       "33            ['MsoNormal']  False    False       False       False    False   \n",
       "34            ['MsoNormal']   True    False        True       False     True   \n",
       "35            ['MsoNormal']  False    False       False       False    False   \n",
       "36            ['MsoNormal']  False    False       False       False    False   \n",
       "37            ['MsoNormal']  False    False       False       False    False   \n",
       "38            ['MsoNormal']  False    False       False       False    False   \n",
       "39            ['MsoNormal']  False    False       False       False    False   \n",
       "40            ['MsoNormal']  False    False       False       False    False   \n",
       "41            ['MsoNormal']   True    False        True       False     True   \n",
       "42            ['MsoNormal']  False    False       False       False    False   \n",
       "43            ['MsoNormal']  False    False       False        True    False   \n",
       "44            ['MsoNormal']  False    False       False       False    False   \n",
       "45            ['MsoNormal']  False    False       False       False    False   \n",
       "46            ['MsoNormal']  False    False       False       False    False   \n",
       "47            ['MsoNormal']  False     True       False       False    False   \n",
       "48            ['MsoNormal']  False    False       False       False    False   \n",
       "49            ['MsoNormal']  False    False       False       False    False   \n",
       "50            ['MsoNormal']  False    False       False       False    False   \n",
       "51            ['MsoNormal']  False    False       False        True    False   \n",
       "52            ['MsoNormal']  False    False       False       False    False   \n",
       "53            ['MsoNormal']  False    False       False       False    False   \n",
       "54            ['MsoNormal']  False    False       False       False    False   \n",
       "55            ['MsoNormal']  False     True       False       False    False   \n",
       "56            ['MsoNormal']  False    False       False       False    False   \n",
       "57            ['MsoNormal']  False    False       False       False    False   \n",
       "58            ['MsoNormal']  False    False       False       False    False   \n",
       "59            ['MsoNormal']  False    False       False       False    False   \n",
       "60            ['MsoNormal']  False    False       False       False    False   \n",
       "61            ['MsoNormal']  False    False       False       False    False   \n",
       "62            ['MsoNormal']   True    False        True       False     True   \n",
       "63            ['MsoNormal']  False    False       False       False    False   \n",
       "64            ['MsoNormal']  False    False       False       False    False   \n",
       "65            ['MsoNormal']  False    False       False       False    False   \n",
       "66            ['MsoNormal']  False    False       False        True    False   \n",
       "67            ['MsoNormal']  False    False       False       False    False   \n",
       "68            ['MsoNormal']  False    False       False       False    False   \n",
       "69            ['MsoNormal']  False    False       False       False    False   \n",
       "70            ['MsoNormal']  False    False       False        True    False   \n",
       "71            ['MsoNormal']  False    False       False       False    False   \n",
       "72            ['MsoNormal']  False    False       False       False    False   \n",
       "73            ['MsoNormal']  False    False       False       False    False   \n",
       "74            ['MsoNormal']  False    False       False       False    False   \n",
       "75            ['MsoNormal']   True    False        True       False     True   \n",
       "76            ['MsoNormal']  False    False       False       False    False   \n",
       "77            ['MsoNormal']   True    False       False       False     True   \n",
       "78            ['MsoNormal']  False    False       False       False    False   \n",
       "79            ['labeltext']  False    False       False       False    False   \n",
       "80            ['labeltext']  False    False       False       False    False   \n",
       "81            ['labeltext']  False    False       False       False    False   \n",
       "82            ['labeltext']  False    False       False       False    False   \n",
       "83     ['MsoListParagraph']  False    False       False       False    False   \n",
       "84            ['labeltext']  False    False       False       False    False   \n",
       "85            ['MsoNormal']  False    False       False       False    False   \n",
       "86            ['MsoNormal']   True    False       False       False     True   \n",
       "87            ['MsoNormal']  False    False       False       False    False   \n",
       "88            ['MsoNormal']  False    False       False       False    False   \n",
       "89            ['MsoNormal']  False    False       False       False    False   \n",
       "90            ['MsoNormal']  False    False       False        True    False   \n",
       "91            ['MsoNormal']  False    False       False       False    False   \n",
       "92            ['MsoNormal']  False    False       False       False    False   \n",
       "93            ['MsoNormal']  False    False       False       False    False   \n",
       "94            ['labeltext']   True    False       False       False    False   \n",
       "95         ['MsoTableGrid']  False    False       False       False    False   \n",
       "96            ['labeltext']  False    False       False       False    False   \n",
       "97            ['labeltext']  False    False       False       False    False   \n",
       "98            ['MsoNormal']  False    False       False       False    False   \n",
       "99            ['MsoNormal']  False     True       False       False    False   \n",
       "100           ['MsoNormal']  False    False       False       False    False   \n",
       "101           ['MsoNormal']  False    False       False       False    False   \n",
       "102           ['MsoNormal']  False    False       False       False    False   \n",
       "103           ['MsoNormal']  False    False       False       False    False   \n",
       "104           ['MsoNormal']  False    False       False       False    False   \n",
       "105           ['labeltext']  False     True       False       False    False   \n",
       "106           ['labeltext']  False    False       False       False    False   \n",
       "107           ['labeltext']  False    False       False       False    False   \n",
       "108           ['labeltext']  False    False       False       False    False   \n",
       "109           ['labeltext']   True    False       False       False    False   \n",
       "110        ['MsoTableGrid']  False    False       False       False    False   \n",
       "111           ['labeltext']  False    False       False       False    False   \n",
       "112           ['MsoNormal']  False    False       False        True    False   \n",
       "113           ['labeltext']  False    False       False       False    False   \n",
       "114           ['MsoNormal']  False     True       False       False    False   \n",
       "115           ['MsoNormal']  False    False       False       False    False   \n",
       "116           ['MsoNormal']  False    False       False       False    False   \n",
       "117           ['MsoNormal']  False    False       False       False    False   \n",
       "118           ['MsoNormal']  False     True       False       False    False   \n",
       "119           ['MsoNormal']  False    False       False       False    False   \n",
       "120           ['MsoNormal']  False    False       False       False    False   \n",
       "121           ['labeltext']  False    False       False       False    False   \n",
       "122    ['labeltextheading']  False     True       False       False    False   \n",
       "123           ['labeltext']  False    False       False       False    False   \n",
       "124           ['labeltext']  False    False       False       False    False   \n",
       "125           ['labeltext']  False    False       False       False    False   \n",
       "126           ['MsoNormal']  False    False       False       False    False   \n",
       "127           ['MsoNormal']  False    False       False       False    False   \n",
       "128           ['MsoNormal']  False    False       False       False    False   \n",
       "129           ['MsoNormal']  False    False       False       False    False   \n",
       "130           ['labeltext']  False    False       False       False    False   \n",
       "131           ['labeltext']  False    False       False       False    False   \n",
       "132           ['labeltext']   True    False       False       False    False   \n",
       "133        ['MsoTableGrid']  False    False       False       False    False   \n",
       "134           ['labeltext']  False    False       False       False    False   \n",
       "135           ['MsoNormal']  False    False       False        True    False   \n",
       "136           ['labeltext']  False    False       False       False    False   \n",
       "137           ['labeltext']  False    False       False       False    False   \n",
       "138           ['labeltext']  False    False       False       False    False   \n",
       "139           ['labeltext']  False    False       False       False    False   \n",
       "140           ['labeltext']  False    False       False       False    False   \n",
       "141           ['MsoNormal']  False    False       False        True    False   \n",
       "142           ['MsoNormal']  False    False       False       False    False   \n",
       "143           ['MsoNormal']  False    False       False       False    False   \n",
       "144           ['MsoNormal']  False    False       False       False    False   \n",
       "145           ['MsoNormal']  False    False       False       False    False   \n",
       "146           ['MsoNormal']  False    False       False       False    False   \n",
       "147           ['MsoNormal']  False    False       False       False    False   \n",
       "148           ['MsoNormal']  False    False       False       False    False   \n",
       "149           ['MsoNormal']  False    False       False       False    False   \n",
       "150           ['MsoNormal']  False    False       False       False    False   \n",
       "151           ['MsoNormal']   True    False       False       False     True   \n",
       "152           ['MsoNormal']  False    False       False       False    False   \n",
       "153     ['MsoNormalIndent']  False    False       False       False    False   \n",
       "154     ['MsoNormalIndent']  False    False       False       False    False   \n",
       "155           ['MsoNormal']   True    False       False       False     True   \n",
       "156           ['MsoNormal']  False    False       False       False    False   \n",
       "157     ['MsoNormalIndent']  False    False       False       False    False   \n",
       "158           ['MsoNormal']  False    False       False       False    False   \n",
       "159           ['MsoNormal']  False    False       False       False    False   \n",
       "160           ['MsoNormal']  False    False       False       False    False   \n",
       "161           ['MsoNormal']  False    False       False       False    False   \n",
       "162    ['labeltextheading']  False    False       False       False    False   \n",
       "163    ['labeltextheading']  False     True       False       False    False   \n",
       "164    ['labeltextheading']  False    False       False       False    False   \n",
       "165    ['labeltextheading']  False    False       False       False    False   \n",
       "166    ['labeltextheading']  False    False       False       False    False   \n",
       "167    ['labeltextheading']  False     True       False        True    False   \n",
       "168    ['labeltextheading']  False    False       False       False    False   \n",
       "169    ['labeltextheading']  False    False       False       False    False   \n",
       "170    ['labeltextheading']  False    False       False       False    False   \n",
       "171           ['MsoNormal']  False    False       False        True    False   \n",
       "172           ['MsoNormal']  False    False       False       False    False   \n",
       "173           ['labeltext']  False    False       False       False    False   \n",
       "174           ['MsoNormal']  False    False       False       False    False   \n",
       "175           ['MsoNormal']  False    False       False       False    False   \n",
       "176           ['MsoNormal']  False    False       False       False    False   \n",
       "177           ['MsoNormal']  False    False       False        True    False   \n",
       "178           ['labeltext']  False    False       False       False    False   \n",
       "179           ['labeltext']  False    False       False       False    False   \n",
       "180           ['MsoNormal']  False    False       False       False    False   \n",
       "181           ['MsoNormal']  False    False       False        True    False   \n",
       "182           ['MsoNormal']  False    False       False       False    False   \n",
       "183           ['MsoNormal']  False    False       False       False    False   \n",
       "184           ['MsoNormal']  False    False       False       False    False   \n",
       "185           ['MsoNormal']  False    False       False        True    False   \n",
       "186           ['MsoNormal']  False    False       False       False    False   \n",
       "187           ['MsoNormal']  False    False       False       False    False   \n",
       "188           ['MsoNormal']  False    False       False       False    False   \n",
       "189           ['MsoNormal']  False    False       False        True    False   \n",
       "190           ['labeltext']  False    False       False       False    False   \n",
       "191           ['labeltext']  False     True       False       False    False   \n",
       "192           ['labeltext']  False    False       False       False    False   \n",
       "193           ['labeltext']  False    False       False       False    False   \n",
       "194           ['labeltext']  False    False       False       False    False   \n",
       "195           ['labeltext']  False     True       False       False    False   \n",
       "196           ['labeltext']  False    False       False       False    False   \n",
       "197           ['labeltext']  False    False       False       False    False   \n",
       "198           ['labeltext']  False    False       False       False    False   \n",
       "199           ['labeltext']  False    False       False        True    False   \n",
       "200           ['labeltext']  False    False       False       False    False   \n",
       "201           ['labeltext']  False    False       False       False    False   \n",
       "202           ['labeltext']  False    False       False       False    False   \n",
       "203           ['MsoNormal']  False    False       False        True    False   \n",
       "204           ['MsoNormal']  False    False       False       False    False   \n",
       "205           ['MsoNormal']  False    False       False       False    False   \n",
       "206           ['MsoNormal']  False    False       False       False    False   \n",
       "207           ['MsoNormal']  False    False       False        True    False   \n",
       "208           ['MsoNormal']  False    False       False       False    False   \n",
       "209           ['labeltext']  False    False       False       False    False   \n",
       "210           ['MsoNormal']  False    False       False       False    False   \n",
       "211           ['MsoNormal']   True    False       False       False     True   \n",
       "212           ['MsoNormal']  False    False       False       False    False   \n",
       "213      ['MsoCommentText']  False    False       False       False    False   \n",
       "214           ['labeltext']  False    False       False       False    False   \n",
       "215           ['labeltext']  False    False       False        True    False   \n",
       "216           ['labeltext']  False    False       False       False    False   \n",
       "217      ['MsoCommentText']  False     True       False       False    False   \n",
       "218           ['labeltext']  False    False       False       False    False   \n",
       "219      ['MsoCommentText']  False    False       False       False    False   \n",
       "220      ['MsoCommentText']  False    False       False       False    False   \n",
       "221           ['labeltext']  False    False       False       False    False   \n",
       "222           ['labeltext']  False    False       False       False    False   \n",
       "223           ['labeltext']  False     True       False       False    False   \n",
       "224           ['labeltext']  False    False       False       False    False   \n",
       "225           ['labeltext']  False    False       False       False    False   \n",
       "226           ['labeltext']  False    False       False       False    False   \n",
       "227           ['labeltext']  False    False       False       False    False   \n",
       "228           ['labeltext']  False    False       False       False    False   \n",
       "229           ['labeltext']  False    False       False       False    False   \n",
       "230           ['labeltext']  False    False       False       False    False   \n",
       "231      ['MsoCommentText']  False     True       False       False    False   \n",
       "232      ['MsoCommentText']  False    False       False       False    False   \n",
       "233                    None  False    False       False       False    False   \n",
       "234           ['labeltext']  False    False       False       False    False   \n",
       "235           ['MsoNormal']  False     True       False       False    False   \n",
       "236           ['labeltext']  False    False       False       False    False   \n",
       "237           ['labeltext']  False    False       False       False    False   \n",
       "238           ['labeltext']  False    False       False       False    False   \n",
       "239           ['labeltext']  False    False       False        True    False   \n",
       "240           ['labeltext']  False    False       False       False    False   \n",
       "241           ['labeltext']  False    False       False       False    False   \n",
       "242           ['labeltext']  False    False       False       False    False   \n",
       "243           ['MsoNormal']  False     True       False       False    False   \n",
       "244           ['MsoNormal']  False    False       False       False    False   \n",
       "245           ['MsoNormal']  False    False       False       False    False   \n",
       "246           ['MsoNormal']  False    False       False       False    False   \n",
       "247           ['MsoNormal']  False     True       False       False    False   \n",
       "248           ['MsoNormal']  False    False       False       False    False   \n",
       "249           ['MsoNormal']  False    False       False       False    False   \n",
       "250           ['MsoNormal']  False    False       False       False    False   \n",
       "251           ['MsoNormal']  False     True       False       False    False   \n",
       "252           ['MsoNormal']  False    False       False       False    False   \n",
       "253           ['MsoNormal']  False    False       False       False    False   \n",
       "254           ['MsoNormal']  False    False       False       False    False   \n",
       "255           ['MsoNormal']  False     True       False       False    False   \n",
       "256           ['MsoNormal']  False    False       False       False    False   \n",
       "257           ['MsoNormal']  False    False       False       False    False   \n",
       "258                    None  False    False       False       False    False   \n",
       "259           ['labeltext']  False    False       False        True    False   \n",
       "260           ['labeltext']  False    False       False       False    False   \n",
       "261           ['labeltext']  False    False       False       False    False   \n",
       "262           ['labeltext']  False    False       False       False    False   \n",
       "263           ['MsoNormal']   True    False       False       False     True   \n",
       "264           ['MsoNormal']  False    False       False       False    False   \n",
       "265           ['labeltext']  False    False       False        True    False   \n",
       "266           ['MsoNormal']  False    False       False       False    False   \n",
       "267           ['labeltext']  False    False       False       False    False   \n",
       "268           ['MsoNormal']  False    False       False       False    False   \n",
       "269           ['labeltext']  False    False       False        True    False   \n",
       "270           ['MsoNormal']  False    False       False       False    False   \n",
       "271           ['labeltext']  False    False       False       False    False   \n",
       "272     ['MsoNormalIndent']  False    False       False       False    False   \n",
       "273           ['labeltext']  False    False       False        True    False   \n",
       "274           ['MsoNormal']  False    False       False       False    False   \n",
       "275           ['MsoNormal']  False    False       False       False    False   \n",
       "276           ['MsoNormal']  False    False       False       False    False   \n",
       "277           ['MsoNormal']   True    False       False       False     True   \n",
       "278           ['MsoNormal']  False    False       False       False    False   \n",
       "279           ['MsoNormal']  False    False       False       False    False   \n",
       "280           ['MsoNormal']  False    False       False       False    False   \n",
       "281           ['MsoNormal']   True    False       False       False     True   \n",
       "282           ['MsoNormal']  False    False       False       False    False   \n",
       "283           ['labeltext']  False    False       False        True    False   \n",
       "284           ['labeltext']  False    False       False       False    False   \n",
       "285           ['labeltext']  False    False       False       False    False   \n",
       "286           ['labeltext']  False    False       False       False    False   \n",
       "287           ['labeltext']  False    False       False       False    False   \n",
       "288           ['labeltext']  False    False       False       False    False   \n",
       "289           ['labeltext']  False    False       False       False    False   \n",
       "290           ['labeltext']  False    False       False       False    False   \n",
       "291           ['labeltext']  False    False       False        True    False   \n",
       "292           ['labeltext']  False    False       False       False    False   \n",
       "293           ['labeltext']  False    False       False       False    False   \n",
       "294           ['MsoNormal']  False    False       False       False    False   \n",
       "295           ['labeltext']   True    False       False       False    False   \n",
       "296      ['MsoNormalTable']  False    False       False       False    False   \n",
       "297           ['MsoNormal']  False    False       False       False    False   \n",
       "298           ['MsoNormal']  False    False       False       False    False   \n",
       "299           ['MsoNormal']  False    False       False       False    False   \n",
       "300           ['MsoNormal']  False    False       False        True    False   \n",
       "301    ['labeltextheading']  False    False       False       False    False   \n",
       "302           ['MsoNormal']  False     True       False       False    False   \n",
       "303           ['MsoNormal']  False    False       False       False    False   \n",
       "304           ['MsoNormal']  False    False       False       False    False   \n",
       "305           ['MsoNormal']  False    False       False       False    False   \n",
       "306           ['MsoNormal']  False    False       False       False    False   \n",
       "307           ['MsoNormal']  False    False       False       False    False   \n",
       "308           ['MsoNormal']  False    False       False       False    False   \n",
       "309           ['MsoNormal']  False    False       False       False    False   \n",
       "310           ['MsoNormal']  False     True       False       False    False   \n",
       "311           ['MsoNormal']  False    False       False       False    False   \n",
       "312           ['MsoNormal']  False    False       False       False    False   \n",
       "313           ['MsoNormal']  False    False       False       False    False   \n",
       "314           ['MsoNormal']  False     True       False       False    False   \n",
       "315           ['MsoNormal']  False    False       False       False    False   \n",
       "316           ['MsoNormal']  False    False       False       False    False   \n",
       "317           ['MsoNormal']  False    False       False       False    False   \n",
       "318           ['MsoNormal']  False     True       False       False    False   \n",
       "319           ['MsoNormal']  False    False       False       False    False   \n",
       "320           ['MsoNormal']  False    False       False       False    False   \n",
       "321           ['MsoNormal']  False    False       False       False    False   \n",
       "322           ['MsoNormal']  False    False       False        True    False   \n",
       "323           ['MsoNormal']  False    False       False       False    False   \n",
       "324           ['MsoNormal']  False    False       False       False    False   \n",
       "325           ['MsoNormal']  False    False       False       False    False   \n",
       "326           ['MsoNormal']  False    False       False       False    False   \n",
       "327           ['MsoNormal']  False    False       False       False    False   \n",
       "328           ['MsoNormal']  False    False       False       False    False   \n",
       "329           ['MsoNormal']  False    False       False       False    False   \n",
       "330           ['MsoNormal']   True    False       False       False    False   \n",
       "331        ['MsoTableGrid']  False    False       False       False    False   \n",
       "332           ['MsoNormal']  False    False       False       False    False   \n",
       "333           ['MsoNormal']  False    False       False        True    False   \n",
       "334           ['MsoNormal']  False    False       False       False    False   \n",
       "335           ['MsoNormal']  False    False       False       False    False   \n",
       "336           ['MsoNormal']  False    False       False       False    False   \n",
       "337           ['MsoNormal']   True    False       False       False     True   \n",
       "338           ['labeltext']  False    False       False       False    False   \n",
       "339           ['labeltext']  False    False       False       False    False   \n",
       "340           ['MsoNormal']  False    False       False       False    False   \n",
       "341           ['MsoNormal']  False    False       False       False    False   \n",
       "342           ['MsoNormal']   True    False        True       False     True   \n",
       "343           ['MsoNormal']  False    False       False       False    False   \n",
       "344           ['MsoNormal']   True    False       False       False     True   \n",
       "345           ['MsoNormal']  False    False       False       False    False   \n",
       "346           ['MsoNormal']  False    False       False       False    False   \n",
       "347           ['MsoNormal']  False    False       False       False    False   \n",
       "348           ['MsoNormal']  False    False       False        True    False   \n",
       "349           ['MsoNormal']  False    False       False       False    False   \n",
       "350           ['MsoNormal']  False    False       False       False    False   \n",
       "351           ['MsoNormal']  False    False       False       False    False   \n",
       "352           ['MsoNormal']  False    False       False       False    False   \n",
       "353        ['MsoBodyText2']  False    False       False       False    False   \n",
       "354           ['MsoNormal']  False    False       False        True    False   \n",
       "355           ['MsoNormal']  False    False       False       False    False   \n",
       "356           ['labeltext']  False     True       False       False    False   \n",
       "357           ['labeltext']  False    False       False       False    False   \n",
       "358           ['labeltext']  False    False       False       False    False   \n",
       "359           ['labeltext']  False    False       False       False    False   \n",
       "360           ['MsoNormal']  False    False       False       False    False   \n",
       "361           ['labeltext']  False    False       False       False    False   \n",
       "362        ['documenttext']  False    False       False       False    False   \n",
       "363           ['labeltext']  False    False       False       False    False   \n",
       "364           ['MsoNormal']  False     True       False       False    False   \n",
       "365           ['MsoNormal']  False    False       False       False    False   \n",
       "366           ['MsoNormal']  False    False       False       False    False   \n",
       "367           ['MsoNormal']  False    False       False       False    False   \n",
       "368           ['MsoNormal']  False    False       False       False    False   \n",
       "369           ['labeltext']  False    False       False       False    False   \n",
       "370           ['labeltext']  False    False       False       False    False   \n",
       "371           ['labeltext']  False    False       False       False    False   \n",
       "372        ['documenttext']  False     True       False       False    False   \n",
       "373           ['MsoNormal']  False    False       False       False    False   \n",
       "374           ['MsoNormal']  False    False       False       False    False   \n",
       "375           ['MsoNormal']  False    False       False       False    False   \n",
       "376           ['MsoNormal']  False    False       False       False    False   \n",
       "377           ['labeltext']  False    False       False       False    False   \n",
       "378        ['documenttext']  False    False       False        True    False   \n",
       "379        ['documenttext']  False    False       False       False    False   \n",
       "380        ['documenttext']  False     True       False       False    False   \n",
       "381           ['labeltext']  False    False       False       False    False   \n",
       "382           ['labeltext']  False     True       False        True    False   \n",
       "383           ['labeltext']  False    False       False       False    False   \n",
       "384           ['labeltext']  False    False       False       False    False   \n",
       "385           ['labeltext']  False    False       False       False    False   \n",
       "386           ['labeltext']  False    False       False       False    False   \n",
       "387           ['labeltext']  False    False       False       False    False   \n",
       "388           ['labeltext']  False    False       False       False    False   \n",
       "389           ['labeltext']  False    False       False       False    False   \n",
       "390           ['labeltext']  False    False       False       False    False   \n",
       "391           ['labeltext']  False    False       False       False    False   \n",
       "392           ['labeltext']  False    False       False       False    False   \n",
       "393           ['labeltext']  False    False       False       False    False   \n",
       "394           ['labeltext']  False    False       False       False    False   \n",
       "395           ['labeltext']  False    False       False       False    False   \n",
       "396           ['MsoNormal']  False    False       False       False    False   \n",
       "397           ['MsoNormal']  False    False       False       False    False   \n",
       "398           ['labeltext']  False    False       False       False    False   \n",
       "399           ['labeltext']  False    False       False       False    False   \n",
       "400           ['labeltext']   True    False       False       False    False   \n",
       "401      ['MsoNormalTable']  False    False       False       False    False   \n",
       "402       ['tablefootnote']  False    False       False       False    False   \n",
       "403       ['tablefootnote']  False    False       False       False    False   \n",
       "404       ['tablefootnote']  False    False       False       False    False   \n",
       "405       ['tablefootnote']  False    False       False       False    False   \n",
       "406   ['tablefootnotelast']  False    False       False       False    False   \n",
       "407   ['tablefootnotelast']  False    False       False       False    False   \n",
       "408           ['MsoNormal']  False    False       False       False    False   \n",
       "409           ['MsoNormal']  False     True       False        True    False   \n",
       "410           ['labeltext']  False    False       False       False    False   \n",
       "411           ['MsoNormal']  False    False       False       False    False   \n",
       "412           ['MsoNormal']  False    False       False       False    False   \n",
       "413           ['labeltext']  False    False       False       False    False   \n",
       "414           ['labeltext']  False    False       False       False    False   \n",
       "415           ['labeltext']  False    False       False       False    False   \n",
       "416           ['labeltext']  False    False       False       False    False   \n",
       "417           ['MsoNormal']  False    False       False       False    False   \n",
       "418           ['MsoNormal']  False    False       False       False    False   \n",
       "419           ['MsoNormal']  False    False       False       False    False   \n",
       "420           ['MsoNormal']  False    False       False       False    False   \n",
       "421           ['MsoNormal']   True     True       False       False    False   \n",
       "422      ['MsoNormalTable']  False    False       False       False    False   \n",
       "423           ['MsoNormal']  False    False       False       False    False   \n",
       "424           ['MsoNormal']  False    False       False       False    False   \n",
       "425           ['MsoNormal']  False    False       False       False    False   \n",
       "426           ['MsoNormal']  False    False       False       False    False   \n",
       "427           ['MsoNormal']  False    False       False       False    False   \n",
       "428           ['MsoNormal']  False    False       False       False    False   \n",
       "429           ['labeltext']  False    False       False       False    False   \n",
       "430           ['labeltext']  False     True       False        True    False   \n",
       "431           ['labeltext']  False    False       False       False    False   \n",
       "432           ['MsoNormal']  False    False       False       False    False   \n",
       "433           ['MsoNormal']  False    False       False       False    False   \n",
       "434           ['MsoNormal']  False    False       False       False    False   \n",
       "435           ['MsoNormal']  False    False       False       False    False   \n",
       "436           ['MsoNormal']  False     True       False        True    False   \n",
       "437           ['MsoNormal']  False    False       False       False    False   \n",
       "438           ['MsoNormal']  False    False       False       False    False   \n",
       "439           ['MsoNormal']  False    False       False       False    False   \n",
       "440           ['MsoNormal']  False    False       False       False    False   \n",
       "441           ['MsoNormal']  False    False       False       False    False   \n",
       "442           ['MsoNormal']  False    False       False       False    False   \n",
       "443           ['labeltext']  False    False       False       False    False   \n",
       "444           ['labeltext']   True    False       False       False    False   \n",
       "445      ['MsoNormalTable']  False    False       False       False    False   \n",
       "446           ['MsoNormal']  False    False       False       False    False   \n",
       "447           ['MsoNormal']  False    False       False       False    False   \n",
       "448           ['labeltext']  False    False       False       False    False   \n",
       "449           ['labeltext']  False    False       False       False    False   \n",
       "450           ['labeltext']  False    False       False       False    False   \n",
       "451           ['labeltext']  False    False       False       False    False   \n",
       "452           ['labeltext']  False    False       False       False    False   \n",
       "453           ['labeltext']  False    False       False       False    False   \n",
       "454           ['labeltext']  False    False       False       False    False   \n",
       "455           ['MsoNormal']  False     True       False        True    False   \n",
       "456           ['MsoNormal']  False    False       False       False    False   \n",
       "457           ['MsoNormal']  False    False       False       False    False   \n",
       "458           ['MsoNormal']  False    False       False       False    False   \n",
       "459           ['MsoNormal']  False    False       False       False    False   \n",
       "460           ['MsoNormal']  False    False       False       False    False   \n",
       "461           ['MsoNormal']  False    False       False       False    False   \n",
       "462           ['MsoNormal']  False    False       False       False    False   \n",
       "463           ['MsoNormal']  False    False       False       False    False   \n",
       "464           ['MsoNormal']  False    False       False       False    False   \n",
       "465           ['MsoNormal']  False     True       False       False    False   \n",
       "466           ['MsoNormal']  False    False       False       False    False   \n",
       "467           ['MsoNormal']  False    False       False       False    False   \n",
       "468           ['MsoNormal']  False    False       False       False    False   \n",
       "469           ['MsoNormal']  False    False       False       False    False   \n",
       "470           ['MsoNormal']  False    False       False       False    False   \n",
       "471           ['MsoNormal']  False    False       False        True    False   \n",
       "472           ['MsoNormal']  False    False       False       False    False   \n",
       "473           ['MsoNormal']  False     True       False       False    False   \n",
       "474           ['MsoNormal']  False    False       False       False    False   \n",
       "475           ['MsoNormal']  False    False       False       False    False   \n",
       "476           ['MsoNormal']  False    False       False       False    False   \n",
       "477           ['MsoNormal']  False    False       False       False    False   \n",
       "478           ['MsoNormal']  False    False       False       False    False   \n",
       "479           ['MsoNormal']   True    False       False       False     True   \n",
       "480           ['MsoNormal']  False    False       False       False    False   \n",
       "481           ['MsoNormal']  False    False       False       False    False   \n",
       "482           ['MsoNormal']  False    False       False       False    False   \n",
       "483           ['MsoNormal']  False    False       False       False    False   \n",
       "484           ['MsoNormal']  False    False       False       False    False   \n",
       "485    ['labeltextheading']  False     True       False        True    False   \n",
       "486           ['labeltext']  False    False       False       False    False   \n",
       "487           ['labeltext']  False    False       False       False    False   \n",
       "488           ['labeltext']  False    False       False       False    False   \n",
       "489           ['MsoNormal']  False    False       False       False    False   \n",
       "490           ['MsoNormal']  False    False       False       False    False   \n",
       "491           ['MsoNormal']  False    False       False        True    False   \n",
       "492           ['labeltext']  False    False       False       False    False   \n",
       "493           ['labeltext']  False    False       False       False    False   \n",
       "494           ['labeltext']  False    False       False       False    False   \n",
       "495           ['labeltext']  False    False       False        True    False   \n",
       "496           ['labeltext']  False    False       False       False    False   \n",
       "497           ['labeltext']  False    False       False       False    False   \n",
       "498           ['MsoNormal']  False    False       False       False    False   \n",
       "499           ['MsoNormal']  False    False       False       False    False   \n",
       "500           ['MsoNormal']  False    False       False       False    False   \n",
       "501           ['MsoNormal']  False    False       False        True    False   \n",
       "502           ['labeltext']  False    False       False       False    False   \n",
       "503           ['labeltext']  False    False       False       False    False   \n",
       "504           ['MsoNormal']  False    False       False       False    False   \n",
       "505           ['labeltext']  False    False       False        True    False   \n",
       "506           ['labeltext']  False    False       False       False    False   \n",
       "507           ['MsoNormal']  False    False       False       False    False   \n",
       "508    ['labeltextheading']  False    False       False       False    False   \n",
       "509    ['labeltextheading']  False     True       False        True    False   \n",
       "510    ['labeltextheading']  False    False       False       False    False   \n",
       "511           ['labeltext']  False     True       False       False    False   \n",
       "512           ['labeltext']  False    False       False       False    False   \n",
       "513           ['labeltext']  False    False       False       False    False   \n",
       "514           ['labeltext']  False    False       False       False    False   \n",
       "515           ['labeltext']  False    False       False       False    False   \n",
       "516           ['labeltext']  False    False       False       False    False   \n",
       "517           ['labeltext']  False    False       False       False    False   \n",
       "518           ['labeltext']  False    False       False       False    False   \n",
       "519           ['labeltext']  False    False       False       False    False   \n",
       "520           ['labeltext']  False    False       False       False    False   \n",
       "521           ['labeltext']  False     True       False       False    False   \n",
       "522           ['labeltext']  False    False       False       False    False   \n",
       "523           ['labeltext']  False    False       False       False    False   \n",
       "524           ['labeltext']  False    False       False       False    False   \n",
       "525           ['labeltext']  False    False       False       False    False   \n",
       "526           ['labeltext']  False    False       False       False    False   \n",
       "527           ['labeltext']  False     True       False       False    False   \n",
       "528           ['labeltext']  False    False       False       False    False   \n",
       "529           ['labeltext']  False    False       False       False    False   \n",
       "530           ['labeltext']  False    False       False       False    False   \n",
       "531           ['labeltext']  False     True       False       False    False   \n",
       "532           ['labeltext']  False    False       False       False    False   \n",
       "533           ['labeltext']  False    False       False       False    False   \n",
       "534           ['labeltext']  False    False       False       False    False   \n",
       "535           ['labeltext']  False     True       False       False    False   \n",
       "536           ['labeltext']  False    False       False       False    False   \n",
       "537           ['labeltext']  False    False       False       False    False   \n",
       "538           ['labeltext']  False    False       False       False    False   \n",
       "539           ['labeltext']  False    False       False       False    False   \n",
       "540           ['labeltext']  False    False       False       False    False   \n",
       "541    ['labeltextheading']  False     True       False        True    False   \n",
       "542           ['labeltext']  False    False       False       False    False   \n",
       "543           ['MsoNormal']  False    False       False       False    False   \n",
       "544           ['MsoNormal']  False    False       False       False    False   \n",
       "545           ['MsoNormal']   True    False       False       False    False   \n",
       "546      ['MsoNormalTable']  False    False       False       False    False   \n",
       "547           ['MsoNormal']  False    False       False       False    False   \n",
       "548           ['MsoNormal']  False    False       False       False    False   \n",
       "549           ['MsoNormal']  False    False       False       False    False   \n",
       "550           ['MsoNormal']  False    False       False       False    False   \n",
       "551           ['MsoNormal']  False    False       False       False    False   \n",
       "552           ['MsoNormal']   True    False       False       False    False   \n",
       "553      ['MsoNormalTable']  False    False       False       False    False   \n",
       "554           ['MsoNormal']  False    False       False       False    False   \n",
       "555           ['MsoNormal']  False    False       False       False    False   \n",
       "556           ['MsoNormal']   True    False       False       False     True   \n",
       "557           ['MsoNormal']  False    False       False       False    False   \n",
       "558           ['MsoNormal']  False    False       False       False    False   \n",
       "559           ['MsoNormal']  False    False       False       False    False   \n",
       "560           ['MsoNormal']  False    False       False        True    False   \n",
       "561           ['MsoNormal']  False    False       False       False    False   \n",
       "562           ['MsoNormal']  False    False       False       False    False   \n",
       "563           ['MsoNormal']  False    False       False       False    False   \n",
       "564           ['MsoNormal']  False    False       False        True    False   \n",
       "565           ['MsoNormal']  False    False       False       False    False   \n",
       "566           ['MsoNormal']  False    False       False       False    False   \n",
       "567           ['MsoNormal']  False    False       False       False    False   \n",
       "568           ['MsoNormal']  False    False       False        True    False   \n",
       "569           ['MsoNormal']  False    False       False       False    False   \n",
       "570           ['MsoNormal']  False    False       False       False    False   \n",
       "571           ['MsoNormal']  False    False       False       False    False   \n",
       "572           ['MsoNormal']  False    False       False       False    False   \n",
       "573           ['MsoNormal']   True    False        True       False     True   \n",
       "574           ['MsoNormal']  False    False       False       False    False   \n",
       "575           ['MsoNormal']   True    False       False       False     True   \n",
       "576           ['MsoNormal']  False    False       False       False    False   \n",
       "577           ['MsoNormal']  False    False       False        True    False   \n",
       "578           ['MsoNormal']  False    False       False       False    False   \n",
       "579           ['MsoNormal']  False    False       False       False    False   \n",
       "580           ['MsoNormal']  False    False       False       False    False   \n",
       "581           ['MsoNormal']  False    False       False       False    False   \n",
       "582           ['MsoNormal']  False    False       False       False    False   \n",
       "583           ['MsoNormal']  False    False       False       False    False   \n",
       "584           ['MsoNormal']  False    False       False       False    False   \n",
       "585           ['MsoNormal']  False    False       False       False    False   \n",
       "586           ['MsoNormal']  False    False       False       False    False   \n",
       "587           ['MsoNormal']  False    False       False        True    False   \n",
       "588           ['MsoNormal']  False    False       False       False    False   \n",
       "589           ['MsoNormal']  False    False       False       False    False   \n",
       "590           ['MsoNormal']  False    False       False       False    False   \n",
       "591           ['MsoNormal']  False    False       False       False    False   \n",
       "592           ['MsoNormal']  False    False       False       False    False   \n",
       "593           ['MsoNormal']  False    False       False       False    False   \n",
       "594           ['MsoNormal']  False    False       False       False    False   \n",
       "595           ['MsoNormal']  False    False       False       False    False   \n",
       "596           ['MsoNormal']  False    False       False        True    False   \n",
       "597           ['MsoNormal']  False    False       False       False    False   \n",
       "598           ['MsoNormal']  False    False       False       False    False   \n",
       "599           ['MsoNormal']  False    False       False       False    False   \n",
       "600           ['MsoNormal']  False    False       False       False    False   \n",
       "601           ['MsoNormal']  False    False       False       False    False   \n",
       "602           ['MsoNormal']  False    False       False       False    False   \n",
       "603           ['MsoNormal']   True    False       False       False     True   \n",
       "604           ['MsoNormal']  False    False       False       False    False   \n",
       "605           ['MsoNormal']  False    False       False       False    False   \n",
       "606           ['MsoNormal']  False    False       False       False    False   \n",
       "607           ['MsoNormal']   True    False       False       False     True   \n",
       "608           ['MsoNormal']  False    False       False       False    False   \n",
       "609           ['MsoNormal']  False    False       False       False    False   \n",
       "610           ['MsoNormal']  False    False       False       False    False   \n",
       "611           ['MsoNormal']   True    False       False       False     True   \n",
       "612           ['MsoNormal']  False    False       False       False    False   \n",
       "613           ['MsoNormal']  False    False       False       False    False   \n",
       "614           ['MsoNormal']  False    False       False       False    False   \n",
       "615           ['MsoNormal']   True    False       False       False     True   \n",
       "616           ['MsoNormal']  False    False       False       False    False   \n",
       "617           ['MsoNormal']  False    False       False       False    False   \n",
       "618           ['MsoNormal']  False    False       False       False    False   \n",
       "619           ['MsoNormal']  False    False       False        True    False   \n",
       "620           ['MsoNormal']  False    False       False       False    False   \n",
       "621           ['MsoNormal']  False    False       False       False    False   \n",
       "622           ['MsoNormal']  False    False       False       False    False   \n",
       "623           ['MsoNormal']  False    False       False       False    False   \n",
       "624           ['MsoNormal']  False    False       False        True    False   \n",
       "625           ['MsoNormal']  False    False       False       False    False   \n",
       "626           ['MsoNormal']  False    False       False       False    False   \n",
       "627           ['MsoNormal']  False    False       False       False    False   \n",
       "628           ['MsoNormal']  False    False       False       False    False   \n",
       "629           ['MsoNormal']  False    False       False       False    False   \n",
       "630           ['MsoNormal']  False    False       False       False    False   \n",
       "631           ['MsoNormal']  False    False       False       False    False   \n",
       "632           ['MsoNormal']  False    False       False       False    False   \n",
       "633           ['MsoNormal']   True    False       False       False     True   \n",
       "634           ['MsoNormal']  False    False       False       False    False   \n",
       "635           ['MsoNormal']  False    False       False       False    False   \n",
       "636           ['MsoNormal']  False    False       False       False    False   \n",
       "637           ['MsoNormal']  False    False       False       False    False   \n",
       "638           ['MsoNormal']   True    False        True       False     True   \n",
       "639           ['MsoNormal']  False    False       False       False    False   \n",
       "640           ['MsoNormal']  False    False       False       False    False   \n",
       "641           ['MsoNormal']  False    False       False       False    False   \n",
       "642           ['MsoNormal']  False    False       False       False    False   \n",
       "643           ['MsoNormal']  False    False       False       False    False   \n",
       "644           ['MsoNormal']  False    False       False       False    False   \n",
       "645           ['MsoNormal']  False    False       False       False    False   \n",
       "646           ['MsoNormal']   True    False        True       False     True   \n",
       "647           ['MsoNormal']  False    False       False       False    False   \n",
       "648           ['MsoNormal']  False    False        True       False    False   \n",
       "649           ['MsoNormal']  False    False        True       False    False   \n",
       "650           ['MsoNormal']  False    False        True       False    False   \n",
       "651           ['MsoNormal']  False    False        True       False    False   \n",
       "652           ['MsoNormal']  False    False       False       False    False   \n",
       "653           ['MsoNormal']  False    False       False       False    False   \n",
       "654           ['MsoNormal']   True    False        True       False     True   \n",
       "655           ['MsoNormal']  False    False       False       False    False   \n",
       "656           ['MsoNormal']  False    False       False       False    False   \n",
       "657           ['MsoNormal']  False    False       False       False    False   \n",
       "658           ['MsoNormal']  False    False       False       False    False   \n",
       "659           ['MsoNormal']  False    False       False       False    False   \n",
       "660           ['MsoNormal']   True    False        True       False     True   \n",
       "661           ['MsoNormal']  False    False       False       False    False   \n",
       "662           ['MsoNormal']  False    False       False       False    False   \n",
       "663                    None  False    False       False       False    False   \n",
       "664                    None  False    False       False       False    False   \n",
       "665           ['MsoNormal']   True    False        True       False     True   \n",
       "666           ['MsoNormal']  False    False       False       False    False   \n",
       "667           ['MsoNormal']  False    False       False       False    False   \n",
       "668           ['MsoNormal']  False    False       False       False    False   \n",
       "669           ['MsoNormal']  False    False       False       False    False   \n",
       "670           ['MsoNormal']  False    False       False       False    False   \n",
       "671           ['MsoNormal']  False    False       False       False    False   \n",
       "672           ['MsoNormal']   True    False        True       False     True   \n",
       "673           ['MsoNormal']  False    False       False       False    False   \n",
       "674           ['MsoNormal']  False    False       False        True    False   \n",
       "675           ['MsoNormal']  False    False       False       False    False   \n",
       "676           ['MsoNormal']  False    False       False       False    False   \n",
       "677           ['MsoNormal']  False    False       False       False    False   \n",
       "678           ['MsoNormal']  False     True       False       False    False   \n",
       "679           ['MsoNormal']  False    False       False       False    False   \n",
       "680           ['MsoNormal']  False    False       False       False    False   \n",
       "681           ['MsoNormal']  False    False       False       False    False   \n",
       "682           ['MsoNormal']  False    False       False        True    False   \n",
       "683           ['MsoNormal']  False    False       False       False    False   \n",
       "684           ['MsoNormal']  False    False       False       False    False   \n",
       "685           ['MsoNormal']  False    False       False       False    False   \n",
       "686           ['MsoNormal']  False     True       False       False    False   \n",
       "687           ['MsoNormal']  False    False       False       False    False   \n",
       "688           ['MsoNormal']  False    False       False       False    False   \n",
       "689           ['MsoNormal']  False    False       False       False    False   \n",
       "690           ['MsoNormal']  False    False       False        True    False   \n",
       "691           ['MsoNormal']  False    False       False       False    False   \n",
       "692           ['MsoNormal']  False    False       False       False    False   \n",
       "693           ['MsoNormal']  False    False       False       False    False   \n",
       "694           ['MsoNormal']  False     True       False       False    False   \n",
       "695           ['MsoNormal']  False    False       False       False    False   \n",
       "696           ['MsoNormal']  False    False       False       False    False   \n",
       "697           ['MsoNormal']  False    False       False       False    False   \n",
       "698           ['MsoNormal']  False    False       False       False    False   \n",
       "699           ['MsoNormal']  False    False       False       False    False   \n",
       "700           ['MsoNormal']  False    False       False       False    False   \n",
       "701           ['MsoNormal']   True    False        True       False     True   \n",
       "702           ['MsoNormal']  False    False       False       False    False   \n",
       "703           ['MsoNormal']  False    False       False       False    False   \n",
       "704           ['MsoNormal']  False    False       False       False    False   \n",
       "705           ['MsoNormal']  False    False       False       False    False   \n",
       "706           ['MsoNormal']  False    False       False       False    False   \n",
       "707           ['MsoNormal']  False    False       False       False    False   \n",
       "708           ['MsoNormal']   True    False        True       False     True   \n",
       "709           ['MsoNormal']  False    False       False       False    False   \n",
       "710           ['MsoNormal']   True    False       False       False     True   \n",
       "711           ['MsoNormal']  False    False       False       False    False   \n",
       "712           ['MsoNormal']  False    False       False       False    False   \n",
       "713           ['MsoNormal']  False    False       False       False    False   \n",
       "714           ['MsoNormal']   True    False       False       False     True   \n",
       "715           ['MsoNormal']  False    False       False       False    False   \n",
       "716           ['MsoNormal']  False    False       False       False    False   \n",
       "717           ['MsoNormal']  False    False       False       False    False   \n",
       "718           ['MsoNormal']  False    False       False        True    False   \n",
       "719           ['MsoNormal']  False    False       False       False    False   \n",
       "720           ['MsoNormal']  False    False       False       False    False   \n",
       "721           ['MsoNormal']  False    False       False       False    False   \n",
       "722           ['MsoNormal']   True    False       False       False    False   \n",
       "723      ['MsoNormalTable']  False    False       False       False    False   \n",
       "724           ['MsoNormal']  False    False       False       False    False   \n",
       "725           ['MsoNormal']  False     True       False       False    False   \n",
       "726           ['MsoNormal']  False    False       False       False    False   \n",
       "727           ['MsoNormal']  False    False       False       False    False   \n",
       "728           ['labeltext']  False    False       False       False    False   \n",
       "729           ['labeltext']  False     True       False       False    False   \n",
       "730           ['labeltext']  False    False       False       False    False   \n",
       "731           ['labeltext']  False    False       False       False    False   \n",
       "732           ['labeltext']  False    False       False       False    False   \n",
       "733           ['labeltext']  False    False       False       False    False   \n",
       "734           ['MsoNormal']  False    False       False       False    False   \n",
       "735           ['MsoNormal']  False    False       False       False    False   \n",
       "736           ['labeltext']  False    False       False       False    False   \n",
       "737           ['MsoNormal']  False    False       False        True    False   \n",
       "738           ['labeltext']  False    False       False       False    False   \n",
       "739           ['MsoNormal']  False     True       False       False    False   \n",
       "740           ['labeltext']  False    False       False       False    False   \n",
       "741           ['labeltext']  False    False       False       False    False   \n",
       "742           ['labeltext']  False    False       False       False    False   \n",
       "743    ['labeltextheading']  False     True       False       False    False   \n",
       "744           ['labeltext']  False    False       False       False    False   \n",
       "745           ['labeltext']  False    False       False       False    False   \n",
       "746           ['labeltext']  False    False       False       False    False   \n",
       "747           ['labeltext']  False    False       False       False    False   \n",
       "748           ['labeltext']  False    False       False       False    False   \n",
       "749           ['MsoNormal']  False    False       False        True    False   \n",
       "750           ['labeltext']  False    False       False       False    False   \n",
       "751           ['labeltext']  False    False       False       False    False   \n",
       "752           ['labeltext']  False    False       False       False    False   \n",
       "753           ['labeltext']  False    False       False       False    False   \n",
       "754           ['labeltext']  False    False       False       False    False   \n",
       "755           ['MsoNormal']  False    False       False        True    False   \n",
       "756           ['MsoNormal']  False    False       False       False    False   \n",
       "757           ['MsoNormal']  False    False       False       False    False   \n",
       "758           ['MsoNormal']  False    False       False       False    False   \n",
       "759           ['MsoNormal']  False    False       False       False    False   \n",
       "760           ['MsoNormal']  False    False       False       False    False   \n",
       "761           ['MsoNormal']  False    False       False       False    False   \n",
       "762           ['MsoNormal']  False    False       False       False    False   \n",
       "763           ['MsoNormal']  False    False       False       False    False   \n",
       "764           ['MsoNormal']  False    False       False       False    False   \n",
       "765           ['MsoNormal']   True    False       False       False     True   \n",
       "766           ['MsoNormal']  False    False       False       False    False   \n",
       "767     ['MsoNormalIndent']  False    False       False       False    False   \n",
       "768           ['MsoNormal']  False    False       False       False    False   \n",
       "769           ['MsoNormal']   True    False       False       False     True   \n",
       "770           ['MsoNormal']  False    False       False       False    False   \n",
       "771           ['MsoNormal']  False    False       False       False    False   \n",
       "772           ['MsoNormal']  False    False       False       False    False   \n",
       "773           ['MsoNormal']  False    False       False       False    False   \n",
       "774           ['MsoNormal']  False    False       False       False    False   \n",
       "775           ['MsoNormal']  False    False       False       False    False   \n",
       "776           ['MsoNormal']  False    False       False       False    False   \n",
       "777           ['MsoNormal']  False    False       False       False    False   \n",
       "778    ['labeltextheading']  False    False       False       False    False   \n",
       "779    ['labeltextheading']  False     True       False        True    False   \n",
       "780    ['labeltextheading']  False    False       False       False    False   \n",
       "781    ['labeltextheading']  False    False       False       False    False   \n",
       "782    ['labeltextheading']  False    False       False       False    False   \n",
       "783           ['MsoNormal']  False    False       False        True    False   \n",
       "784           ['MsoNormal']  False    False       False       False    False   \n",
       "785           ['MsoNormal']  False    False       False       False    False   \n",
       "786           ['MsoNormal']  False    False       False       False    False   \n",
       "787           ['MsoNormal']  False    False       False        True    False   \n",
       "788           ['MsoNormal']  False    False       False       False    False   \n",
       "789           ['labeltext']  False    False       False       False    False   \n",
       "790           ['MsoNormal']  False    False       False       False    False   \n",
       "791           ['MsoNormal']  False    False       False        True    False   \n",
       "792           ['MsoNormal']  False    False       False       False    False   \n",
       "793           ['MsoNormal']  False    False       False       False    False   \n",
       "794           ['MsoNormal']  False    False       False       False    False   \n",
       "795           ['MsoNormal']  False    False       False        True    False   \n",
       "796           ['labeltext']  False    False       False       False    False   \n",
       "797           ['labeltext']  False     True       False       False    False   \n",
       "798           ['labeltext']  False    False       False       False    False   \n",
       "799           ['labeltext']  False    False       False       False    False   \n",
       "800           ['labeltext']  False    False       False       False    False   \n",
       "801           ['labeltext']  False     True       False       False    False   \n",
       "802           ['labeltext']  False    False       False       False    False   \n",
       "803           ['labeltext']  False    False       False       False    False   \n",
       "804           ['labeltext']  False    False       False       False    False   \n",
       "805           ['labeltext']  False    False       False        True    False   \n",
       "806           ['MsoNormal']  False    False       False       False    False   \n",
       "807           ['labeltext']  False    False       False       False    False   \n",
       "808           ['labeltext']  False    False       False       False    False   \n",
       "809           ['MsoNormal']  False    False       False        True    False   \n",
       "810           ['MsoNormal']  False    False       False       False    False   \n",
       "811           ['MsoNormal']  False    False       False       False    False   \n",
       "812           ['MsoNormal']  False    False       False       False    False   \n",
       "813           ['MsoNormal']  False    False       False        True    False   \n",
       "814           ['MsoNormal']  False    False       False       False    False   \n",
       "815           ['MsoNormal']  False    False       False       False    False   \n",
       "816           ['MsoNormal']  False    False       False       False    False   \n",
       "817           ['MsoNormal']   True    False       False       False     True   \n",
       "818           ['MsoNormal']  False    False       False       False    False   \n",
       "819      ['MsoCommentText']  False    False       False       False    False   \n",
       "820           ['labeltext']  False    False       False       False    False   \n",
       "821           ['labeltext']  False    False       False        True    False   \n",
       "822           ['labeltext']  False    False       False       False    False   \n",
       "823           ['labeltext']  False     True       False       False    False   \n",
       "824           ['labeltext']  False    False       False       False    False   \n",
       "825           ['labeltext']  False    False       False       False    False   \n",
       "826           ['labeltext']  False    False       False       False    False   \n",
       "827           ['labeltext']  False    False       False       False    False   \n",
       "828           ['labeltext']  False    False       False       False    False   \n",
       "829           ['labeltext']  False     True       False       False    False   \n",
       "830           ['labeltext']  False    False       False       False    False   \n",
       "831           ['labeltext']  False    False       False       False    False   \n",
       "832           ['labeltext']  False    False       False       False    False   \n",
       "833           ['labeltext']  False    False       False       False    False   \n",
       "834           ['labeltext']  False    False       False       False    False   \n",
       "835           ['labeltext']  False    False       False       False    False   \n",
       "836           ['labeltext']  False    False       False       False    False   \n",
       "837      ['MsoCommentText']  False     True       False       False    False   \n",
       "838      ['MsoCommentText']  False    False       False       False    False   \n",
       "839           ['labeltext']  False    False       False       False    False   \n",
       "840           ['labeltext']  False    False       False       False    False   \n",
       "841           ['MsoNormal']  False     True       False       False    False   \n",
       "842           ['labeltext']  False    False       False       False    False   \n",
       "843           ['labeltext']  False    False       False       False    False   \n",
       "844           ['labeltext']  False    False       False       False    False   \n",
       "845           ['labeltext']  False    False       False        True    False   \n",
       "846           ['MsoNormal']  False    False       False       False    False   \n",
       "847           ['labeltext']  False    False       False       False    False   \n",
       "848           ['MsoNormal']  False    False       False       False    False   \n",
       "849           ['MsoNormal']  False     True       False       False    False   \n",
       "850           ['labeltext']  False    False       False       False    False   \n",
       "851           ['labeltext']  False    False       False       False    False   \n",
       "852           ['MsoNormal']  False    False       False       False    False   \n",
       "853           ['MsoNormal']  False     True       False       False    False   \n",
       "854           ['labeltext']  False    False       False       False    False   \n",
       "855           ['labeltext']  False    False       False       False    False   \n",
       "856           ['MsoNormal']  False    False       False       False    False   \n",
       "857           ['MsoNormal']  False     True       False       False    False   \n",
       "858           ['labeltext']  False    False       False       False    False   \n",
       "859           ['labeltext']  False    False       False       False    False   \n",
       "860           ['MsoNormal']  False    False       False       False    False   \n",
       "861           ['MsoNormal']  False     True       False       False    False   \n",
       "862           ['MsoNormal']  False    False       False       False    False   \n",
       "863           ['labeltext']  False    False       False       False    False   \n",
       "864                    None  False    False       False       False    False   \n",
       "865           ['labeltext']  False    False       False        True    False   \n",
       "866           ['labeltext']  False    False       False       False    False   \n",
       "867           ['labeltext']  False    False       False       False    False   \n",
       "868           ['labeltext']  False    False       False       False    False   \n",
       "869           ['MsoNormal']   True    False       False       False     True   \n",
       "870           ['MsoNormal']  False    False       False       False    False   \n",
       "871           ['labeltext']  False    False       False        True    False   \n",
       "872           ['MsoNormal']  False    False       False       False    False   \n",
       "873           ['labeltext']  False    False       False       False    False   \n",
       "874           ['MsoNormal']  False    False       False       False    False   \n",
       "875           ['labeltext']  False    False       False        True    False   \n",
       "876           ['MsoNormal']  False    False       False       False    False   \n",
       "877           ['labeltext']  False    False       False       False    False   \n",
       "878     ['MsoNormalIndent']  False    False       False       False    False   \n",
       "879           ['labeltext']  False    False       False        True    False   \n",
       "880           ['MsoNormal']  False    False       False       False    False   \n",
       "881           ['labeltext']  False    False       False       False    False   \n",
       "882           ['MsoNormal']  False    False       False       False    False   \n",
       "883           ['MsoNormal']   True    False       False       False     True   \n",
       "884           ['MsoNormal']  False    False       False       False    False   \n",
       "885           ['MsoNormal']  False    False       False       False    False   \n",
       "886           ['MsoNormal']  False    False       False       False    False   \n",
       "887           ['MsoNormal']   True    False       False       False     True   \n",
       "888           ['MsoNormal']  False    False       False       False    False   \n",
       "889           ['labeltext']  False    False       False        True    False   \n",
       "890           ['MsoNormal']  False    False       False       False    False   \n",
       "891           ['labeltext']  False    False       False       False    False   \n",
       "892           ['labeltext']  False    False       False       False    False   \n",
       "893           ['labeltext']  False    False       False       False    False   \n",
       "894           ['labeltext']  False    False       False       False    False   \n",
       "895           ['labeltext']  False    False       False       False    False   \n",
       "896           ['labeltext']  False    False       False       False    False   \n",
       "897           ['labeltext']  False    False       False        True    False   \n",
       "898           ['MsoNormal']  False    False       False       False    False   \n",
       "899           ['labeltext']  False    False       False       False    False   \n",
       "900           ['MsoNormal']  False    False       False       False    False   \n",
       "901           ['MsoNormal']   True    False       False       False    False   \n",
       "902      ['MsoNormalTable']  False    False       False       False    False   \n",
       "903    ['labeltextheading']  False    False       False       False    False   \n",
       "904           ['MsoNormal']  False    False       False        True    False   \n",
       "905    ['labeltextheading']  False    False       False       False    False   \n",
       "906           ['MsoNormal']  False     True       False       False    False   \n",
       "907           ['MsoNormal']  False    False       False       False    False   \n",
       "908           ['MsoNormal']  False    False       False       False    False   \n",
       "909           ['MsoNormal']  False    False       False       False    False   \n",
       "910           ['MsoNormal']  False    False       False       False    False   \n",
       "911           ['MsoNormal']  False    False       False       False    False   \n",
       "912           ['MsoNormal']  False    False       False       False    False   \n",
       "913           ['MsoNormal']  False    False       False       False    False   \n",
       "914           ['MsoNormal']  False    False       False        True    False   \n",
       "915           ['MsoNormal']  False    False       False       False    False   \n",
       "916           ['MsoNormal']  False    False       False       False    False   \n",
       "917           ['MsoNormal']  False    False       False       False    False   \n",
       "918           ['MsoNormal']  False    False       False       False    False   \n",
       "919           ['MsoNormal']  False    False       False       False    False   \n",
       "920           ['MsoNormal']  False    False       False       False    False   \n",
       "921           ['MsoNormal']  False    False       False       False    False   \n",
       "922           ['MsoNormal']   True    False       False       False    False   \n",
       "923        ['MsoTableGrid']  False    False       False       False    False   \n",
       "924           ['MsoNormal']  False    False       False       False    False   \n",
       "925           ['MsoNormal']  False    False       False        True    False   \n",
       "926           ['MsoNormal']  False    False       False       False    False   \n",
       "927           ['labeltext']  False    False       False       False    False   \n",
       "928           ['MsoNormal']  False    False       False       False    False   \n",
       "929           ['MsoNormal']   True    False       False       False     True   \n",
       "930           ['labeltext']  False    False       False       False    False   \n",
       "931           ['labeltext']  False    False       False       False    False   \n",
       "932           ['MsoNormal']  False    False       False       False    False   \n",
       "933           ['MsoNormal']  False    False       False       False    False   \n",
       "934           ['MsoNormal']   True    False        True       False     True   \n",
       "935           ['MsoNormal']  False    False       False       False    False   \n",
       "936           ['MsoNormal']   True    False       False       False     True   \n",
       "937           ['MsoNormal']  False    False       False       False    False   \n",
       "938           ['MsoNormal']  False    False       False       False    False   \n",
       "939           ['MsoNormal']  False    False       False       False    False   \n",
       "940           ['MsoNormal']  False    False       False        True    False   \n",
       "941           ['MsoNormal']  False    False       False       False    False   \n",
       "942           ['labeltext']  False    False       False       False    False   \n",
       "943           ['MsoNormal']  False    False       False       False    False   \n",
       "944           ['MsoNormal']  False    False       False       False    False   \n",
       "945        ['MsoBodyText2']  False    False       False       False    False   \n",
       "946           ['MsoNormal']  False    False       False        True    False   \n",
       "947           ['labeltext']  False    False       False       False    False   \n",
       "948           ['labeltext']  False    False       False       False    False   \n",
       "949           ['labeltext']  False    False       False       False    False   \n",
       "950           ['MsoNormal']  False    False       False       False    False   \n",
       "951           ['labeltext']  False    False       False       False    False   \n",
       "952        ['documenttext']  False    False       False       False    False   \n",
       "953        ['documenttext']  False    False       False       False    False   \n",
       "954        ['documenttext']  False    False       False       False    False   \n",
       "955        ['documenttext']  False    False       False       False    False   \n",
       "956        ['documenttext']  False    False       False       False    False   \n",
       "957           ['labeltext']  False    False       False       False    False   \n",
       "958        ['documenttext']  False    False       False        True    False   \n",
       "959           ['labeltext']  False    False       False       False    False   \n",
       "960           ['labeltext']  False     True       False       False    False   \n",
       "961           ['labeltext']  False    False       False       False    False   \n",
       "962           ['labeltext']  False    False       False       False    False   \n",
       "963           ['labeltext']  False    False       False       False    False   \n",
       "964           ['labeltext']  False    False       False       False    False   \n",
       "965           ['labeltext']  False    False       False       False    False   \n",
       "966           ['labeltext']  False    False       False       False    False   \n",
       "967           ['labeltext']  False    False       False       False    False   \n",
       "968           ['labeltext']  False    False       False       False    False   \n",
       "969           ['labeltext']  False    False       False       False    False   \n",
       "970           ['labeltext']  False    False       False       False    False   \n",
       "971           ['labeltext']  False    False       False       False    False   \n",
       "972           ['labeltext']  False    False       False       False    False   \n",
       "973           ['labeltext']  False    False       False       False    False   \n",
       "974           ['MsoNormal']  False    False       False       False    False   \n",
       "975           ['MsoNormal']  False    False       False       False    False   \n",
       "976           ['labeltext']  False    False       False       False    False   \n",
       "977           ['labeltext']  False    False       False       False    False   \n",
       "978           ['labeltext']   True    False       False       False    False   \n",
       "979      ['MsoNormalTable']  False    False       False       False    False   \n",
       "980       ['tablefootnote']  False    False       False       False    False   \n",
       "981       ['tablefootnote']  False    False       False       False    False   \n",
       "982       ['tablefootnote']  False    False       False       False    False   \n",
       "983       ['tablefootnote']  False    False       False       False    False   \n",
       "984   ['tablefootnotelast']  False    False       False       False    False   \n",
       "985   ['tablefootnotelast']  False    False       False       False    False   \n",
       "986           ['MsoNormal']  False    False       False       False    False   \n",
       "987           ['MsoNormal']  False     True       False       False    False   \n",
       "988           ['labeltext']  False    False       False       False    False   \n",
       "989           ['labeltext']  False    False       False       False    False   \n",
       "990           ['MsoNormal']  False    False       False       False    False   \n",
       "991           ['labeltext']  False    False       False       False    False   \n",
       "992           ['labeltext']  False    False       False       False    False   \n",
       "993           ['labeltext']  False    False       False       False    False   \n",
       "994           ['labeltext']  False    False       False       False    False   \n",
       "995           ['MsoNormal']  False    False       False       False    False   \n",
       "996           ['MsoNormal']  False    False       False       False    False   \n",
       "997           ['MsoNormal']  False    False       False       False    False   \n",
       "998           ['MsoNormal']  False    False       False       False    False   \n",
       "999           ['MsoNormal']   True     True       False       False    False   \n",
       "1000     ['MsoNormalTable']  False    False       False       False    False   \n",
       "1001          ['MsoNormal']  False    False       False       False    False   \n",
       "1002          ['MsoNormal']  False    False       False       False    False   \n",
       "1003          ['MsoNormal']  False    False       False       False    False   \n",
       "1004          ['MsoNormal']  False    False       False       False    False   \n",
       "1005          ['MsoNormal']  False    False       False       False    False   \n",
       "1006          ['MsoNormal']  False    False       False       False    False   \n",
       "1007          ['labeltext']  False    False       False       False    False   \n",
       "1008          ['labeltext']  False     True       False       False    False   \n",
       "1009          ['labeltext']  False    False       False       False    False   \n",
       "1010          ['labeltext']  False    False       False       False    False   \n",
       "1011          ['MsoNormal']  False    False       False       False    False   \n",
       "1012          ['MsoNormal']  False    False       False       False    False   \n",
       "1013          ['MsoNormal']  False    False       False       False    False   \n",
       "1014          ['MsoNormal']  False     True       False       False    False   \n",
       "1015          ['labeltext']  False    False       False       False    False   \n",
       "1016          ['labeltext']  False    False       False       False    False   \n",
       "1017          ['MsoNormal']  False    False       False       False    False   \n",
       "1018          ['MsoNormal']  False    False       False       False    False   \n",
       "1019          ['MsoNormal']  False    False       False       False    False   \n",
       "1020          ['MsoNormal']  False    False       False       False    False   \n",
       "1021          ['labeltext']  False    False       False       False    False   \n",
       "1022          ['labeltext']   True    False       False       False    False   \n",
       "1023     ['MsoNormalTable']  False    False       False       False    False   \n",
       "1024          ['MsoNormal']  False    False       False       False    False   \n",
       "1025          ['labeltext']  False    False       False       False    False   \n",
       "1026          ['labeltext']  False    False       False       False    False   \n",
       "1027          ['labeltext']  False    False       False       False    False   \n",
       "1028          ['labeltext']  False    False       False       False    False   \n",
       "1029          ['labeltext']  False    False       False       False    False   \n",
       "1030          ['labeltext']  False    False       False       False    False   \n",
       "1031          ['labeltext']  False    False       False       False    False   \n",
       "1032          ['labeltext']  False    False       False       False    False   \n",
       "1033          ['MsoNormal']  False     True       False       False    False   \n",
       "1034          ['MsoNormal']  False    False       False       False    False   \n",
       "1035          ['MsoNormal']  False    False       False       False    False   \n",
       "1036          ['MsoNormal']  False    False       False       False    False   \n",
       "1037          ['MsoNormal']  False    False       False       False    False   \n",
       "1038          ['MsoNormal']  False    False       False       False    False   \n",
       "1039          ['MsoNormal']  False    False       False       False    False   \n",
       "1040          ['MsoNormal']  False    False       False       False    False   \n",
       "1041          ['MsoNormal']  False    False       False       False    False   \n",
       "1042          ['labeltext']  False    False       False       False    False   \n",
       "1043          ['MsoNormal']  False     True       False       False    False   \n",
       "1044          ['labeltext']  False    False       False       False    False   \n",
       "1045          ['labeltext']  False    False       False       False    False   \n",
       "1046          ['MsoNormal']  False    False       False       False    False   \n",
       "1047          ['MsoNormal']  False    False       False       False    False   \n",
       "1048          ['MsoNormal']  False    False       False       False    False   \n",
       "1049          ['MsoNormal']  False    False       False       False    False   \n",
       "1050          ['MsoNormal']  False    False       False       False    False   \n",
       "1051          ['MsoNormal']  False    False       False       False    False   \n",
       "1052          ['MsoNormal']  False    False       False       False    False   \n",
       "1053          ['labeltext']  False     True       False       False    False   \n",
       "1054          ['labeltext']  False    False       False       False    False   \n",
       "1055          ['labeltext']  False    False       False       False    False   \n",
       "1056          ['MsoNormal']  False    False       False       False    False   \n",
       "1057          ['MsoNormal']  False    False       False       False    False   \n",
       "1058          ['MsoNormal']  False    False       False       False    False   \n",
       "1059          ['MsoNormal']  False    False       False       False    False   \n",
       "1060          ['MsoNormal']  False    False       False       False    False   \n",
       "1061          ['labeltext']  False    False       False       False    False   \n",
       "1062          ['MsoNormal']  False    False       False       False    False   \n",
       "1063          ['MsoNormal']   True    False       False       False    False   \n",
       "1064         ['TableGrid1']  False    False       False       False    False   \n",
       "1065     ['MsoNormalTable']  False    False       False       False    False   \n",
       "1066         ['TableGrid1']  False    False       False       False    False   \n",
       "1067          ['MsoNormal']  False    False       False       False    False   \n",
       "1068          ['MsoNormal']  False    False       False       False    False   \n",
       "1069          ['MsoNormal']  False    False       False       False    False   \n",
       "1070          ['MsoNormal']  False    False       False        True    False   \n",
       "1071          ['MsoNormal']  False    False       False       False    False   \n",
       "1072          ['MsoNormal']  False    False       False       False    False   \n",
       "1073          ['MsoNormal']  False    False       False       False    False   \n",
       "1074          ['MsoNormal']   True    False       False       False     True   \n",
       "1075          ['MsoNormal']  False    False       False       False    False   \n",
       "1076          ['MsoNormal']  False    False       False       False    False   \n",
       "1077          ['MsoNormal']  False    False       False       False    False   \n",
       "1078          ['MsoNormal']  False    False       False       False    False   \n",
       "1079          ['MsoNormal']  False    False       False       False    False   \n",
       "1080   ['labeltextheading']  False     True       False        True    False   \n",
       "1081          ['MsoNormal']  False    False       False       False    False   \n",
       "1082          ['labeltext']  False    False       False       False    False   \n",
       "1083          ['labeltext']  False    False       False       False    False   \n",
       "1084          ['MsoNormal']  False    False       False       False    False   \n",
       "1085          ['MsoNormal']  False    False       False       False    False   \n",
       "1086          ['MsoNormal']  False    False       False        True    False   \n",
       "1087          ['MsoNormal']  False    False       False       False    False   \n",
       "1088          ['labeltext']  False    False       False       False    False   \n",
       "1089          ['labeltext']  False    False       False       False    False   \n",
       "1090          ['labeltext']  False    False       False        True    False   \n",
       "1091          ['MsoNormal']  False    False       False       False    False   \n",
       "1092          ['labeltext']  False    False       False       False    False   \n",
       "1093          ['labeltext']  False    False       False       False    False   \n",
       "1094          ['labeltext']  False    False       False       False    False   \n",
       "1095          ['MsoNormal']  False    False       False       False    False   \n",
       "1096          ['MsoNormal']  False    False       False        True    False   \n",
       "1097          ['MsoNormal']  False    False       False       False    False   \n",
       "1098          ['labeltext']  False    False       False       False    False   \n",
       "1099          ['MsoNormal']  False    False       False       False    False   \n",
       "1100          ['labeltext']  False    False       False        True    False   \n",
       "1101          ['MsoNormal']  False    False       False       False    False   \n",
       "1102          ['labeltext']  False    False       False       False    False   \n",
       "1103   ['labeltextheading']  False    False       False       False    False   \n",
       "1104   ['labeltextheading']  False     True       False        True    False   \n",
       "1105   ['labeltextheading']  False    False       False       False    False   \n",
       "1106          ['labeltext']  False     True       False       False    False   \n",
       "1107          ['labeltext']  False    False       False       False    False   \n",
       "1108          ['labeltext']  False    False       False       False    False   \n",
       "1109          ['labeltext']  False    False       False       False    False   \n",
       "1110          ['labeltext']  False    False       False       False    False   \n",
       "1111          ['labeltext']  False    False       False       False    False   \n",
       "1112          ['labeltext']  False    False       False       False    False   \n",
       "1113          ['labeltext']  False    False       False       False    False   \n",
       "1114          ['labeltext']  False     True       False       False    False   \n",
       "1115          ['labeltext']  False    False       False       False    False   \n",
       "1116          ['labeltext']  False    False       False       False    False   \n",
       "1117          ['labeltext']  False    False       False       False    False   \n",
       "1118          ['labeltext']  False    False       False       False    False   \n",
       "1119          ['labeltext']  False    False       False       False    False   \n",
       "1120          ['labeltext']  False     True       False       False    False   \n",
       "1121          ['labeltext']  False    False       False       False    False   \n",
       "1122          ['labeltext']  False    False       False       False    False   \n",
       "1123          ['labeltext']  False    False       False       False    False   \n",
       "1124          ['labeltext']  False     True       False       False    False   \n",
       "1125          ['labeltext']  False    False       False       False    False   \n",
       "1126          ['labeltext']  False    False       False       False    False   \n",
       "1127          ['labeltext']  False    False       False       False    False   \n",
       "1128          ['labeltext']  False     True       False       False    False   \n",
       "1129          ['labeltext']  False    False       False       False    False   \n",
       "1130          ['labeltext']  False    False       False       False    False   \n",
       "1131          ['labeltext']  False    False       False       False    False   \n",
       "1132   ['labeltextheading']  False     True       False       False    False   \n",
       "1133          ['labeltext']  False    False       False       False    False   \n",
       "1134          ['labeltext']  False    False       False       False    False   \n",
       "1135          ['MsoNormal']  False    False       False       False    False   \n",
       "1136          ['MsoNormal']   True    False       False       False    False   \n",
       "1137     ['MsoNormalTable']  False    False       False       False    False   \n",
       "1138          ['MsoNormal']  False    False       False       False    False   \n",
       "1139          ['MsoNormal']  False    False       False       False    False   \n",
       "1140          ['MsoNormal']  False    False       False       False    False   \n",
       "1141          ['MsoNormal']   True    False       False       False     True   \n",
       "1142          ['MsoNormal']  False    False       False       False    False   \n",
       "1143          ['labeltext']  False    False       False       False    False   \n",
       "1144          ['MsoNormal']  False    False       False       False    False   \n",
       "1145          ['MsoNormal']  False    False       False        True    False   \n",
       "1146          ['MsoNormal']  False    False       False       False    False   \n",
       "1147          ['labeltext']  False    False       False       False    False   \n",
       "1148          ['MsoNormal']  False    False       False       False    False   \n",
       "1149          ['MsoNormal']  False    False       False        True    False   \n",
       "1150          ['MsoNormal']  False    False       False       False    False   \n",
       "1151          ['labeltext']  False    False       False       False    False   \n",
       "1152          ['MsoNormal']  False    False       False       False    False   \n",
       "1153          ['MsoNormal']  False    False       False        True    False   \n",
       "1154          ['MsoNormal']  False    False       False       False    False   \n",
       "1155          ['labeltext']  False    False       False       False    False   \n",
       "1156          ['MsoNormal']  False    False       False       False    False   \n",
       "1157          ['MsoNormal']  False    False       False       False    False   \n",
       "1158          ['MsoNormal']   True    False        True       False     True   \n",
       "1159          ['MsoNormal']  False    False       False       False    False   \n",
       "1160          ['MsoNormal']   True    False       False       False     True   \n",
       "1161          ['MsoNormal']  False    False       False       False    False   \n",
       "1162          ['MsoNormal']  False    False       False       False    False   \n",
       "1163          ['MsoNormal']  False    False       False       False    False   \n",
       "1164          ['MsoNormal']  False    False       False       False    False   \n",
       "1165          ['MsoNormal']  False    False       False       False    False   \n",
       "1166          ['MsoNormal']  False    False       False       False    False   \n",
       "1167          ['MsoNormal']  False    False       False       False    False   \n",
       "1168          ['MsoNormal']  False    False       False       False    False   \n",
       "1169          ['MsoNormal']  False    False       False       False    False   \n",
       "1170          ['MsoNormal']  False    False       False       False    False   \n",
       "1171          ['MsoNormal']   True    False       False       False     True   \n",
       "1172          ['MsoNormal']  False    False       False       False    False   \n",
       "1173          ['labeltext']  False    False       False       False    False   \n",
       "1174          ['MsoNormal']  False    False       False       False    False   \n",
       "1175          ['MsoNormal']   True    False       False       False     True   \n",
       "1176          ['MsoNormal']  False    False       False       False    False   \n",
       "1177          ['labeltext']  False    False       False       False    False   \n",
       "1178          ['labeltext']  False    False       False       False    False   \n",
       "1179          ['labeltext']  False    False       False       False    False   \n",
       "1180          ['MsoNormal']  False    False       False       False    False   \n",
       "1181          ['MsoNormal']   True    False       False       False     True   \n",
       "1182          ['MsoNormal']  False    False       False       False    False   \n",
       "1183          ['labeltext']  False    False       False       False    False   \n",
       "1184          ['MsoNormal']  False    False       False       False    False   \n",
       "1185          ['MsoNormal']   True    False       False       False     True   \n",
       "1186          ['MsoNormal']  False    False       False       False    False   \n",
       "1187          ['labeltext']  False    False       False       False    False   \n",
       "1188          ['MsoNormal']  False    False       False       False    False   \n",
       "1189          ['MsoNormal']  False    False       False       False    False   \n",
       "1190          ['MsoNormal']  False    False       False       False    False   \n",
       "1191          ['MsoNormal']   True    False       False       False     True   \n",
       "1192          ['MsoNormal']  False    False       False       False    False   \n",
       "1193          ['labeltext']  False    False       False       False    False   \n",
       "1194          ['MsoNormal']  False    False       False       False    False   \n",
       "1195          ['MsoNormal']  False    False       False       False    False   \n",
       "1196          ['MsoNormal']   True    False        True       False     True   \n",
       "1197          ['MsoNormal']  False    False       False       False    False   \n",
       "1198          ['MsoNormal']  False    False       False       False    False   \n",
       "1199          ['MsoNormal']  False    False       False       False    False   \n",
       "1200          ['MsoNormal']  False    False       False       False    False   \n",
       "1201          ['labeltext']  False    False       False       False    False   \n",
       "1202          ['MsoNormal']  False    False       False       False    False   \n",
       "1203          ['MsoNormal']  False    False       False       False    False   \n",
       "1204          ['MsoNormal']   True    False        True       False     True   \n",
       "1205          ['MsoNormal']  False    False       False       False    False   \n",
       "1206          ['MsoNormal']  False    False        True       False    False   \n",
       "1207          ['MsoNormal']  False    False        True       False    False   \n",
       "1208          ['MsoNormal']  False    False        True       False    False   \n",
       "1209          ['MsoNormal']  False    False       False       False    False   \n",
       "1210          ['MsoNormal']  False    False       False       False    False   \n",
       "1211          ['MsoNormal']   True    False        True       False     True   \n",
       "1212          ['MsoNormal']  False    False       False       False    False   \n",
       "1213          ['MsoNormal']  False    False       False       False    False   \n",
       "1214          ['labeltext']  False    False       False       False    False   \n",
       "1215          ['MsoNormal']  False    False       False       False    False   \n",
       "1216          ['MsoNormal']  False    False       False       False    False   \n",
       "1217          ['MsoNormal']   True    False        True       False     True   \n",
       "1218          ['MsoNormal']  False    False       False       False    False   \n",
       "1219          ['MsoNormal']  False    False       False       False    False   \n",
       "1220          ['labeltext']  False    False       False       False    False   \n",
       "1221                   None  False    False       False       False    False   \n",
       "\n",
       "      IsListItem  HasBorder  IsPossibleHeading IsHeadingType  \\\n",
       "0          False      False              False          None   \n",
       "1          False      False              False          None   \n",
       "2          False      False              False          None   \n",
       "3          False      False              False          None   \n",
       "4          False      False              False          None   \n",
       "5          False      False              False          None   \n",
       "6          False      False              False          None   \n",
       "7          False      False              False          None   \n",
       "8          False      False              False          None   \n",
       "9          False      False              False          None   \n",
       "10         False      False              False          None   \n",
       "11         False      False              False          None   \n",
       "12         False      False              False          None   \n",
       "13         False      False              False          None   \n",
       "14         False      False              False          None   \n",
       "15         False      False              False          None   \n",
       "16         False      False              False          None   \n",
       "17         False      False              False          None   \n",
       "18         False      False              False          None   \n",
       "19         False      False              False          None   \n",
       "20         False      False              False          None   \n",
       "21         False      False              False          None   \n",
       "22         False      False              False          None   \n",
       "23         False      False              False          None   \n",
       "24         False      False               True          None   \n",
       "25         False      False              False          None   \n",
       "26         False      False              False          None   \n",
       "27         False      False              False          None   \n",
       "28         False      False              False          None   \n",
       "29         False      False              False          None   \n",
       "30         False      False              False          None   \n",
       "31         False      False              False          None   \n",
       "32         False      False              False          None   \n",
       "33         False      False              False          None   \n",
       "34         False      False               True            L1   \n",
       "35         False      False              False          None   \n",
       "36         False      False              False          None   \n",
       "37         False      False              False          None   \n",
       "38         False      False              False          None   \n",
       "39         False      False              False          None   \n",
       "40         False      False              False          None   \n",
       "41         False      False               True            L1   \n",
       "42         False      False              False          None   \n",
       "43         False      False               True            L3   \n",
       "44         False      False              False          None   \n",
       "45         False      False              False          None   \n",
       "46         False      False              False          None   \n",
       "47         False      False               True            L4   \n",
       "48         False      False              False          None   \n",
       "49         False      False              False          None   \n",
       "50         False      False              False          None   \n",
       "51         False      False               True            L3   \n",
       "52         False      False              False          None   \n",
       "53         False      False              False          None   \n",
       "54         False      False              False          None   \n",
       "55         False      False               True            L4   \n",
       "56         False      False              False          None   \n",
       "57         False      False              False          None   \n",
       "58         False      False              False          None   \n",
       "59         False      False              False          None   \n",
       "60         False      False              False          None   \n",
       "61         False      False              False          None   \n",
       "62         False      False               True            L1   \n",
       "63         False      False              False          None   \n",
       "64         False      False              False          None   \n",
       "65         False      False              False          None   \n",
       "66         False      False               True            L3   \n",
       "67         False      False              False          None   \n",
       "68         False      False              False          None   \n",
       "69         False      False              False          None   \n",
       "70         False      False               True            L3   \n",
       "71         False      False              False          None   \n",
       "72         False      False              False          None   \n",
       "73         False      False              False          None   \n",
       "74         False      False              False          None   \n",
       "75         False      False               True            L1   \n",
       "76         False      False              False          None   \n",
       "77         False      False               True            L2   \n",
       "78         False      False              False          None   \n",
       "79         False      False              False          None   \n",
       "80         False      False              False          None   \n",
       "81         False      False              False          None   \n",
       "82         False      False              False          None   \n",
       "83         False      False              False          None   \n",
       "84         False      False              False          None   \n",
       "85         False      False              False          None   \n",
       "86         False      False               True            L2   \n",
       "87         False      False              False          None   \n",
       "88         False      False              False          None   \n",
       "89         False      False              False          None   \n",
       "90         False      False               True            L3   \n",
       "91         False      False              False          None   \n",
       "92         False      False              False          None   \n",
       "93         False      False              False          None   \n",
       "94         False      False              False          None   \n",
       "95         False      False              False          None   \n",
       "96         False      False              False          None   \n",
       "97         False      False              False          None   \n",
       "98         False      False              False          None   \n",
       "99         False      False               True            L4   \n",
       "100        False      False              False          None   \n",
       "101        False      False              False          None   \n",
       "102        False      False              False          None   \n",
       "103        False      False              False          None   \n",
       "104        False      False              False          None   \n",
       "105        False      False               True            L4   \n",
       "106        False      False              False          None   \n",
       "107        False      False              False          None   \n",
       "108        False      False              False          None   \n",
       "109        False      False              False          None   \n",
       "110        False      False              False          None   \n",
       "111        False      False              False          None   \n",
       "112        False      False               True            L3   \n",
       "113        False      False              False          None   \n",
       "114        False      False               True            L4   \n",
       "115        False      False              False          None   \n",
       "116        False      False              False          None   \n",
       "117        False      False              False          None   \n",
       "118        False      False               True            L4   \n",
       "119        False      False              False          None   \n",
       "120        False      False              False          None   \n",
       "121        False      False              False          None   \n",
       "122        False      False               True            L4   \n",
       "123        False      False              False          None   \n",
       "124        False      False              False          None   \n",
       "125        False      False              False          None   \n",
       "126        False      False              False          None   \n",
       "127        False      False              False          None   \n",
       "128        False      False              False          None   \n",
       "129        False      False              False          None   \n",
       "130        False      False              False          None   \n",
       "131        False      False              False          None   \n",
       "132        False      False              False          None   \n",
       "133        False      False              False          None   \n",
       "134        False      False              False          None   \n",
       "135        False      False               True            L3   \n",
       "136        False      False              False          None   \n",
       "137        False      False              False          None   \n",
       "138        False      False              False          None   \n",
       "139        False      False              False          None   \n",
       "140        False      False              False          None   \n",
       "141        False      False               True            L3   \n",
       "142        False      False              False          None   \n",
       "143        False      False              False          None   \n",
       "144        False      False              False          None   \n",
       "145        False      False              False          None   \n",
       "146        False      False              False          None   \n",
       "147        False      False              False          None   \n",
       "148        False      False              False          None   \n",
       "149        False      False              False          None   \n",
       "150        False      False              False          None   \n",
       "151        False      False               True            L2   \n",
       "152        False      False              False          None   \n",
       "153        False      False              False          None   \n",
       "154        False      False              False          None   \n",
       "155        False      False               True            L2   \n",
       "156        False      False              False          None   \n",
       "157        False      False              False          None   \n",
       "158        False      False              False          None   \n",
       "159        False      False              False          None   \n",
       "160        False      False              False          None   \n",
       "161        False      False              False          None   \n",
       "162        False      False              False          None   \n",
       "163        False      False               True            L4   \n",
       "164        False      False              False          None   \n",
       "165        False      False              False          None   \n",
       "166        False      False              False          None   \n",
       "167        False      False               True            L4   \n",
       "168        False      False              False          None   \n",
       "169        False      False              False          None   \n",
       "170        False      False              False          None   \n",
       "171        False      False               True            L3   \n",
       "172        False      False              False          None   \n",
       "173        False      False              False          None   \n",
       "174        False      False              False          None   \n",
       "175        False      False              False          None   \n",
       "176        False      False              False          None   \n",
       "177        False      False               True            L3   \n",
       "178        False      False              False          None   \n",
       "179        False      False              False          None   \n",
       "180        False      False              False          None   \n",
       "181        False      False               True            L3   \n",
       "182        False      False              False          None   \n",
       "183        False      False              False          None   \n",
       "184        False      False              False          None   \n",
       "185        False      False               True            L3   \n",
       "186        False      False              False          None   \n",
       "187        False      False              False          None   \n",
       "188        False      False              False          None   \n",
       "189        False      False               True            L3   \n",
       "190        False      False              False          None   \n",
       "191        False      False               True            L4   \n",
       "192        False      False              False          None   \n",
       "193        False      False              False          None   \n",
       "194        False      False              False          None   \n",
       "195        False      False               True            L4   \n",
       "196        False      False              False          None   \n",
       "197        False      False              False          None   \n",
       "198        False      False              False          None   \n",
       "199        False      False               True            L3   \n",
       "200        False      False              False          None   \n",
       "201        False      False              False          None   \n",
       "202        False      False              False          None   \n",
       "203        False      False               True            L3   \n",
       "204        False      False              False          None   \n",
       "205        False      False              False          None   \n",
       "206        False      False              False          None   \n",
       "207        False      False               True            L3   \n",
       "208        False      False              False          None   \n",
       "209        False      False              False          None   \n",
       "210        False      False              False          None   \n",
       "211        False      False               True            L2   \n",
       "212        False      False              False          None   \n",
       "213        False      False              False          None   \n",
       "214        False      False              False          None   \n",
       "215        False      False               True            L3   \n",
       "216        False      False              False          None   \n",
       "217        False      False               True            L4   \n",
       "218        False      False              False          None   \n",
       "219        False      False              False          None   \n",
       "220        False      False              False          None   \n",
       "221        False      False              False          None   \n",
       "222        False      False              False          None   \n",
       "223        False      False               True            L4   \n",
       "224        False      False              False          None   \n",
       "225        False      False              False          None   \n",
       "226        False      False              False          None   \n",
       "227        False      False              False          None   \n",
       "228        False      False              False          None   \n",
       "229        False      False              False          None   \n",
       "230        False      False              False          None   \n",
       "231        False      False               True            L4   \n",
       "232        False      False              False          None   \n",
       "233        False      False              False          None   \n",
       "234        False      False              False          None   \n",
       "235        False      False               True            L4   \n",
       "236        False      False              False          None   \n",
       "237        False      False              False          None   \n",
       "238        False      False              False          None   \n",
       "239        False      False               True            L3   \n",
       "240        False      False              False          None   \n",
       "241        False      False              False          None   \n",
       "242        False      False              False          None   \n",
       "243        False      False               True            L4   \n",
       "244        False      False              False          None   \n",
       "245        False      False              False          None   \n",
       "246        False      False              False          None   \n",
       "247        False      False               True            L4   \n",
       "248        False      False              False          None   \n",
       "249        False      False              False          None   \n",
       "250        False      False              False          None   \n",
       "251        False      False               True            L4   \n",
       "252        False      False              False          None   \n",
       "253        False      False              False          None   \n",
       "254        False      False              False          None   \n",
       "255        False      False               True            L4   \n",
       "256        False      False              False          None   \n",
       "257        False      False              False          None   \n",
       "258        False      False              False          None   \n",
       "259        False      False               True            L3   \n",
       "260        False      False              False          None   \n",
       "261        False      False              False          None   \n",
       "262        False      False              False          None   \n",
       "263        False      False               True            L2   \n",
       "264        False      False              False          None   \n",
       "265        False      False               True            L3   \n",
       "266        False      False              False          None   \n",
       "267        False      False              False          None   \n",
       "268        False      False              False          None   \n",
       "269        False      False               True            L3   \n",
       "270        False      False              False          None   \n",
       "271        False      False              False          None   \n",
       "272        False      False              False          None   \n",
       "273        False      False               True            L3   \n",
       "274        False      False              False          None   \n",
       "275        False      False              False          None   \n",
       "276        False      False              False          None   \n",
       "277        False      False               True            L2   \n",
       "278        False      False              False          None   \n",
       "279        False      False              False          None   \n",
       "280        False      False              False          None   \n",
       "281        False      False               True            L2   \n",
       "282        False      False              False          None   \n",
       "283        False      False               True            L3   \n",
       "284        False      False              False          None   \n",
       "285        False      False              False          None   \n",
       "286        False      False              False          None   \n",
       "287        False      False              False          None   \n",
       "288        False      False              False          None   \n",
       "289        False      False              False          None   \n",
       "290        False      False              False          None   \n",
       "291        False      False               True            L3   \n",
       "292        False      False              False          None   \n",
       "293        False      False              False          None   \n",
       "294        False      False              False          None   \n",
       "295        False      False              False          None   \n",
       "296        False      False              False          None   \n",
       "297         True      False              False          None   \n",
       "298         True      False              False          None   \n",
       "299        False      False              False          None   \n",
       "300        False      False               True            L3   \n",
       "301        False      False              False          None   \n",
       "302        False      False               True            L4   \n",
       "303        False      False              False          None   \n",
       "304        False      False              False          None   \n",
       "305        False      False              False          None   \n",
       "306        False      False              False          None   \n",
       "307        False      False              False          None   \n",
       "308        False      False              False          None   \n",
       "309        False      False              False          None   \n",
       "310        False      False               True            L4   \n",
       "311        False      False              False          None   \n",
       "312        False      False              False          None   \n",
       "313        False      False              False          None   \n",
       "314        False      False               True            L4   \n",
       "315        False      False              False          None   \n",
       "316        False      False              False          None   \n",
       "317        False      False              False          None   \n",
       "318        False      False               True            L4   \n",
       "319        False      False              False          None   \n",
       "320        False      False              False          None   \n",
       "321        False      False              False          None   \n",
       "322        False      False               True            L3   \n",
       "323        False      False              False          None   \n",
       "324        False      False              False          None   \n",
       "325        False      False              False          None   \n",
       "326        False      False              False          None   \n",
       "327        False      False              False          None   \n",
       "328        False      False              False          None   \n",
       "329        False      False              False          None   \n",
       "330        False      False              False          None   \n",
       "331        False      False              False          None   \n",
       "332        False      False              False          None   \n",
       "333        False      False               True            L3   \n",
       "334        False      False              False          None   \n",
       "335        False      False              False          None   \n",
       "336        False      False              False          None   \n",
       "337        False      False               True            L2   \n",
       "338        False      False              False          None   \n",
       "339        False      False              False          None   \n",
       "340        False      False              False          None   \n",
       "341        False      False              False          None   \n",
       "342        False      False               True            L1   \n",
       "343        False      False              False          None   \n",
       "344        False      False               True            L2   \n",
       "345        False      False              False          None   \n",
       "346        False      False              False          None   \n",
       "347        False      False              False          None   \n",
       "348        False      False               True            L3   \n",
       "349        False      False              False          None   \n",
       "350        False      False              False          None   \n",
       "351        False      False              False          None   \n",
       "352        False      False              False          None   \n",
       "353        False      False              False          None   \n",
       "354        False      False               True            L3   \n",
       "355        False      False              False          None   \n",
       "356        False      False               True            L4   \n",
       "357        False      False              False          None   \n",
       "358        False      False              False          None   \n",
       "359        False      False              False          None   \n",
       "360        False      False              False          None   \n",
       "361        False      False              False          None   \n",
       "362        False      False              False          None   \n",
       "363        False      False              False          None   \n",
       "364        False      False               True            L4   \n",
       "365        False      False              False          None   \n",
       "366        False      False              False          None   \n",
       "367        False      False              False          None   \n",
       "368        False      False              False          None   \n",
       "369        False      False              False          None   \n",
       "370        False      False              False          None   \n",
       "371        False      False              False          None   \n",
       "372        False      False               True            L4   \n",
       "373        False      False              False          None   \n",
       "374        False      False              False          None   \n",
       "375        False      False              False          None   \n",
       "376        False      False              False          None   \n",
       "377        False      False              False          None   \n",
       "378        False      False               True            L3   \n",
       "379        False      False              False          None   \n",
       "380        False      False               True            L4   \n",
       "381        False      False              False          None   \n",
       "382        False      False               True            L4   \n",
       "383        False      False              False          None   \n",
       "384        False      False              False          None   \n",
       "385        False      False              False          None   \n",
       "386        False      False              False          None   \n",
       "387        False      False              False          None   \n",
       "388        False      False              False          None   \n",
       "389        False      False              False          None   \n",
       "390        False      False              False          None   \n",
       "391        False      False              False          None   \n",
       "392        False      False              False          None   \n",
       "393        False      False              False          None   \n",
       "394        False      False              False          None   \n",
       "395        False      False              False          None   \n",
       "396        False      False              False          None   \n",
       "397        False      False              False          None   \n",
       "398        False      False              False          None   \n",
       "399        False      False              False          None   \n",
       "400        False      False              False          None   \n",
       "401        False      False              False          None   \n",
       "402        False      False              False          None   \n",
       "403         True      False              False          None   \n",
       "404         True      False              False          None   \n",
       "405        False      False              False          None   \n",
       "406         True      False              False          None   \n",
       "407         True      False              False          None   \n",
       "408        False      False              False          None   \n",
       "409        False      False               True            L4   \n",
       "410        False      False              False          None   \n",
       "411        False      False              False          None   \n",
       "412        False      False              False          None   \n",
       "413        False      False              False          None   \n",
       "414        False      False              False          None   \n",
       "415        False      False              False          None   \n",
       "416        False      False              False          None   \n",
       "417        False      False              False          None   \n",
       "418        False      False              False          None   \n",
       "419        False      False              False          None   \n",
       "420        False      False              False          None   \n",
       "421        False      False              False          None   \n",
       "422        False      False              False          None   \n",
       "423         True      False              False          None   \n",
       "424         True      False              False          None   \n",
       "425        False      False              False          None   \n",
       "426         True      False              False          None   \n",
       "427        False      False              False          None   \n",
       "428        False      False              False          None   \n",
       "429        False      False              False          None   \n",
       "430        False      False               True            L4   \n",
       "431        False      False              False          None   \n",
       "432        False      False              False          None   \n",
       "433        False      False              False          None   \n",
       "434        False      False              False          None   \n",
       "435        False      False              False          None   \n",
       "436        False      False               True            L4   \n",
       "437        False      False              False          None   \n",
       "438        False      False              False          None   \n",
       "439        False      False              False          None   \n",
       "440        False      False              False          None   \n",
       "441        False      False              False          None   \n",
       "442        False      False              False          None   \n",
       "443        False      False              False          None   \n",
       "444        False      False              False          None   \n",
       "445        False      False              False          None   \n",
       "446         True      False              False          None   \n",
       "447         True      False              False          None   \n",
       "448        False      False              False          None   \n",
       "449        False      False              False          None   \n",
       "450        False      False              False          None   \n",
       "451        False      False              False          None   \n",
       "452        False      False              False          None   \n",
       "453        False      False              False          None   \n",
       "454        False      False              False          None   \n",
       "455        False      False               True            L4   \n",
       "456        False      False              False          None   \n",
       "457        False      False              False          None   \n",
       "458        False      False              False          None   \n",
       "459        False      False              False          None   \n",
       "460        False      False              False          None   \n",
       "461        False      False              False          None   \n",
       "462        False      False              False          None   \n",
       "463        False      False              False          None   \n",
       "464        False      False              False          None   \n",
       "465        False      False               True            L4   \n",
       "466        False      False              False          None   \n",
       "467        False      False              False          None   \n",
       "468        False      False              False          None   \n",
       "469        False      False              False          None   \n",
       "470        False      False              False          None   \n",
       "471        False      False               True            L3   \n",
       "472        False      False              False          None   \n",
       "473        False      False               True            L4   \n",
       "474        False      False              False          None   \n",
       "475        False      False              False          None   \n",
       "476        False      False              False          None   \n",
       "477        False      False              False          None   \n",
       "478        False      False              False          None   \n",
       "479        False      False               True            L2   \n",
       "480        False      False              False          None   \n",
       "481        False      False              False          None   \n",
       "482        False      False              False          None   \n",
       "483        False      False              False          None   \n",
       "484        False      False              False          None   \n",
       "485        False      False               True            L4   \n",
       "486        False      False              False          None   \n",
       "487        False      False              False          None   \n",
       "488        False      False              False          None   \n",
       "489        False      False              False          None   \n",
       "490        False      False              False          None   \n",
       "491        False      False               True            L3   \n",
       "492        False      False              False          None   \n",
       "493        False      False              False          None   \n",
       "494        False      False              False          None   \n",
       "495        False      False               True            L3   \n",
       "496        False      False              False          None   \n",
       "497        False      False              False          None   \n",
       "498        False      False              False          None   \n",
       "499        False      False              False          None   \n",
       "500        False      False              False          None   \n",
       "501        False      False               True            L3   \n",
       "502        False      False              False          None   \n",
       "503        False      False              False          None   \n",
       "504        False      False              False          None   \n",
       "505        False      False               True            L3   \n",
       "506        False      False              False          None   \n",
       "507        False      False              False          None   \n",
       "508        False      False              False          None   \n",
       "509        False      False               True            L4   \n",
       "510        False      False              False          None   \n",
       "511        False      False               True            L4   \n",
       "512        False      False              False          None   \n",
       "513        False      False              False          None   \n",
       "514        False      False              False          None   \n",
       "515        False      False              False          None   \n",
       "516        False      False              False          None   \n",
       "517        False      False              False          None   \n",
       "518        False      False              False          None   \n",
       "519        False      False              False          None   \n",
       "520        False      False              False          None   \n",
       "521        False      False               True            L4   \n",
       "522        False      False              False          None   \n",
       "523        False      False              False          None   \n",
       "524        False      False              False          None   \n",
       "525        False      False              False          None   \n",
       "526        False      False              False          None   \n",
       "527        False      False               True            L4   \n",
       "528        False      False              False          None   \n",
       "529        False      False              False          None   \n",
       "530        False      False              False          None   \n",
       "531        False      False               True            L4   \n",
       "532        False      False              False          None   \n",
       "533        False      False              False          None   \n",
       "534        False      False              False          None   \n",
       "535        False      False               True            L4   \n",
       "536        False      False              False          None   \n",
       "537        False      False              False          None   \n",
       "538        False      False              False          None   \n",
       "539        False      False              False          None   \n",
       "540        False      False              False          None   \n",
       "541        False      False               True            L4   \n",
       "542        False      False              False          None   \n",
       "543        False      False              False          None   \n",
       "544        False      False              False          None   \n",
       "545        False      False              False          None   \n",
       "546        False      False              False          None   \n",
       "547         True      False              False          None   \n",
       "548         True      False              False          None   \n",
       "549        False      False              False          None   \n",
       "550        False      False              False          None   \n",
       "551        False      False              False          None   \n",
       "552        False      False              False          None   \n",
       "553        False      False              False          None   \n",
       "554        False      False              False          None   \n",
       "555        False      False              False          None   \n",
       "556        False      False               True            L2   \n",
       "557        False      False              False          None   \n",
       "558        False      False              False          None   \n",
       "559        False      False              False          None   \n",
       "560        False      False               True            L3   \n",
       "561        False      False              False          None   \n",
       "562        False      False              False          None   \n",
       "563        False      False              False          None   \n",
       "564        False      False               True            L3   \n",
       "565        False      False              False          None   \n",
       "566        False      False              False          None   \n",
       "567        False      False              False          None   \n",
       "568        False      False               True            L3   \n",
       "569        False      False              False          None   \n",
       "570        False      False              False          None   \n",
       "571        False      False              False          None   \n",
       "572        False      False              False          None   \n",
       "573        False      False               True            L1   \n",
       "574        False      False              False          None   \n",
       "575        False      False               True            L2   \n",
       "576        False      False              False          None   \n",
       "577        False      False               True            L3   \n",
       "578        False      False              False          None   \n",
       "579        False      False              False          None   \n",
       "580        False      False              False          None   \n",
       "581        False      False              False          None   \n",
       "582        False      False              False          None   \n",
       "583        False      False              False          None   \n",
       "584        False      False              False          None   \n",
       "585        False      False              False          None   \n",
       "586        False      False              False          None   \n",
       "587        False      False               True            L3   \n",
       "588        False      False              False          None   \n",
       "589        False      False              False          None   \n",
       "590        False      False              False          None   \n",
       "591        False      False              False          None   \n",
       "592        False      False              False          None   \n",
       "593        False      False              False          None   \n",
       "594        False      False              False          None   \n",
       "595        False      False              False          None   \n",
       "596        False      False               True            L3   \n",
       "597        False      False              False          None   \n",
       "598        False      False              False          None   \n",
       "599        False      False              False          None   \n",
       "600        False      False              False          None   \n",
       "601        False      False              False          None   \n",
       "602        False      False              False          None   \n",
       "603        False      False               True            L2   \n",
       "604        False      False              False          None   \n",
       "605        False      False              False          None   \n",
       "606        False      False              False          None   \n",
       "607        False      False               True            L2   \n",
       "608        False      False              False          None   \n",
       "609         True      False              False          None   \n",
       "610        False      False              False          None   \n",
       "611        False      False               True            L2   \n",
       "612        False      False              False          None   \n",
       "613        False      False              False          None   \n",
       "614        False      False              False          None   \n",
       "615        False      False               True            L2   \n",
       "616        False      False              False          None   \n",
       "617        False      False              False          None   \n",
       "618        False      False              False          None   \n",
       "619        False      False               True            L3   \n",
       "620        False      False              False          None   \n",
       "621        False      False              False          None   \n",
       "622         True      False              False          None   \n",
       "623        False      False              False          None   \n",
       "624        False      False               True            L3   \n",
       "625        False      False              False          None   \n",
       "626        False      False              False          None   \n",
       "627         True      False              False          None   \n",
       "628         True      False              False          None   \n",
       "629         True      False              False          None   \n",
       "630        False      False              False          None   \n",
       "631        False      False              False          None   \n",
       "632        False      False              False          None   \n",
       "633        False      False               True            L2   \n",
       "634        False      False              False          None   \n",
       "635        False      False              False          None   \n",
       "636        False      False              False          None   \n",
       "637        False      False              False          None   \n",
       "638        False      False               True            L1   \n",
       "639        False      False              False          None   \n",
       "640        False      False              False          None   \n",
       "641        False      False              False          None   \n",
       "642        False      False              False          None   \n",
       "643        False      False              False          None   \n",
       "644        False      False              False          None   \n",
       "645        False      False              False          None   \n",
       "646        False      False               True            L1   \n",
       "647        False      False              False          None   \n",
       "648        False      False              False          None   \n",
       "649        False      False              False          None   \n",
       "650        False      False              False          None   \n",
       "651        False      False              False          None   \n",
       "652        False      False              False          None   \n",
       "653        False      False              False          None   \n",
       "654        False      False               True            L1   \n",
       "655        False      False              False          None   \n",
       "656        False      False              False          None   \n",
       "657        False      False              False          None   \n",
       "658        False      False              False          None   \n",
       "659        False      False              False          None   \n",
       "660        False      False               True            L1   \n",
       "661        False      False              False          None   \n",
       "662        False      False              False          None   \n",
       "663        False      False              False          None   \n",
       "664        False      False              False          None   \n",
       "665        False      False               True            L1   \n",
       "666        False      False              False          None   \n",
       "667        False      False              False          None   \n",
       "668        False      False              False          None   \n",
       "669        False      False              False          None   \n",
       "670        False      False              False          None   \n",
       "671        False      False              False          None   \n",
       "672        False      False               True            L1   \n",
       "673        False      False              False          None   \n",
       "674        False      False               True            L3   \n",
       "675        False      False              False          None   \n",
       "676        False      False              False          None   \n",
       "677        False      False              False          None   \n",
       "678        False      False               True            L4   \n",
       "679        False      False              False          None   \n",
       "680        False      False              False          None   \n",
       "681        False      False              False          None   \n",
       "682        False      False               True            L3   \n",
       "683        False      False              False          None   \n",
       "684        False      False              False          None   \n",
       "685        False      False              False          None   \n",
       "686        False      False               True            L4   \n",
       "687        False      False              False          None   \n",
       "688        False      False              False          None   \n",
       "689        False      False              False          None   \n",
       "690        False      False               True            L3   \n",
       "691        False      False              False          None   \n",
       "692        False      False              False          None   \n",
       "693        False      False              False          None   \n",
       "694        False      False               True            L4   \n",
       "695        False      False              False          None   \n",
       "696        False      False              False          None   \n",
       "697        False      False              False          None   \n",
       "698        False      False              False          None   \n",
       "699        False      False              False          None   \n",
       "700        False      False              False          None   \n",
       "701        False      False               True            L1   \n",
       "702        False      False              False          None   \n",
       "703        False      False              False          None   \n",
       "704        False      False              False          None   \n",
       "705        False      False              False          None   \n",
       "706        False      False              False          None   \n",
       "707        False      False              False          None   \n",
       "708        False      False               True            L1   \n",
       "709        False      False              False          None   \n",
       "710        False      False               True            L2   \n",
       "711        False      False              False          None   \n",
       "712        False      False              False          None   \n",
       "713        False      False              False          None   \n",
       "714        False      False               True            L2   \n",
       "715        False      False              False          None   \n",
       "716        False      False              False          None   \n",
       "717        False      False              False          None   \n",
       "718        False      False               True            L3   \n",
       "719        False      False              False          None   \n",
       "720        False      False              False          None   \n",
       "721        False      False              False          None   \n",
       "722        False      False              False          None   \n",
       "723        False      False              False          None   \n",
       "724        False      False              False          None   \n",
       "725        False      False               True            L4   \n",
       "726        False      False              False          None   \n",
       "727        False      False              False          None   \n",
       "728        False      False              False          None   \n",
       "729        False      False               True            L4   \n",
       "730        False      False              False          None   \n",
       "731        False      False              False          None   \n",
       "732        False      False              False          None   \n",
       "733        False      False              False          None   \n",
       "734        False      False              False          None   \n",
       "735        False      False              False          None   \n",
       "736        False      False              False          None   \n",
       "737        False      False               True            L3   \n",
       "738        False      False              False          None   \n",
       "739        False      False               True            L4   \n",
       "740        False      False              False          None   \n",
       "741        False      False              False          None   \n",
       "742        False      False              False          None   \n",
       "743        False      False               True            L4   \n",
       "744        False      False              False          None   \n",
       "745        False      False              False          None   \n",
       "746        False      False              False          None   \n",
       "747        False      False              False          None   \n",
       "748        False      False              False          None   \n",
       "749        False      False               True            L3   \n",
       "750        False      False              False          None   \n",
       "751        False      False              False          None   \n",
       "752        False      False              False          None   \n",
       "753        False      False              False          None   \n",
       "754        False      False              False          None   \n",
       "755        False      False               True            L3   \n",
       "756        False      False              False          None   \n",
       "757        False      False              False          None   \n",
       "758        False      False              False          None   \n",
       "759        False      False              False          None   \n",
       "760        False      False              False          None   \n",
       "761        False      False              False          None   \n",
       "762        False      False              False          None   \n",
       "763        False      False              False          None   \n",
       "764        False      False              False          None   \n",
       "765        False      False               True            L2   \n",
       "766        False      False              False          None   \n",
       "767        False      False              False          None   \n",
       "768        False      False              False          None   \n",
       "769        False      False               True            L2   \n",
       "770        False      False              False          None   \n",
       "771        False      False              False          None   \n",
       "772        False      False              False          None   \n",
       "773        False      False              False          None   \n",
       "774        False      False              False          None   \n",
       "775        False      False              False          None   \n",
       "776        False      False              False          None   \n",
       "777        False      False              False          None   \n",
       "778        False      False              False          None   \n",
       "779        False      False               True            L4   \n",
       "780        False      False              False          None   \n",
       "781        False      False              False          None   \n",
       "782        False      False              False          None   \n",
       "783        False      False               True            L3   \n",
       "784        False      False              False          None   \n",
       "785        False      False              False          None   \n",
       "786        False      False              False          None   \n",
       "787        False      False               True            L3   \n",
       "788        False      False              False          None   \n",
       "789        False      False              False          None   \n",
       "790        False      False              False          None   \n",
       "791        False      False               True            L3   \n",
       "792        False      False              False          None   \n",
       "793        False      False              False          None   \n",
       "794        False      False              False          None   \n",
       "795        False      False               True            L3   \n",
       "796        False      False              False          None   \n",
       "797        False      False               True            L4   \n",
       "798        False      False              False          None   \n",
       "799        False      False              False          None   \n",
       "800        False      False              False          None   \n",
       "801        False      False               True            L4   \n",
       "802        False      False              False          None   \n",
       "803        False      False              False          None   \n",
       "804        False      False              False          None   \n",
       "805        False      False               True            L3   \n",
       "806        False      False              False          None   \n",
       "807        False      False              False          None   \n",
       "808        False      False              False          None   \n",
       "809        False      False               True            L3   \n",
       "810        False      False              False          None   \n",
       "811        False      False              False          None   \n",
       "812        False      False              False          None   \n",
       "813        False      False               True            L3   \n",
       "814        False      False              False          None   \n",
       "815        False      False              False          None   \n",
       "816        False      False              False          None   \n",
       "817        False      False               True            L2   \n",
       "818        False      False              False          None   \n",
       "819        False      False              False          None   \n",
       "820        False      False              False          None   \n",
       "821        False      False               True            L3   \n",
       "822        False      False              False          None   \n",
       "823        False      False               True            L4   \n",
       "824        False      False              False          None   \n",
       "825        False      False              False          None   \n",
       "826        False      False              False          None   \n",
       "827        False      False              False          None   \n",
       "828        False      False              False          None   \n",
       "829        False      False               True            L4   \n",
       "830        False      False              False          None   \n",
       "831        False      False              False          None   \n",
       "832        False      False              False          None   \n",
       "833        False      False              False          None   \n",
       "834        False      False              False          None   \n",
       "835        False      False              False          None   \n",
       "836        False      False              False          None   \n",
       "837        False      False               True            L4   \n",
       "838        False      False              False          None   \n",
       "839        False      False              False          None   \n",
       "840        False      False              False          None   \n",
       "841        False      False               True            L4   \n",
       "842        False      False              False          None   \n",
       "843        False      False              False          None   \n",
       "844        False      False              False          None   \n",
       "845        False      False               True            L3   \n",
       "846        False      False              False          None   \n",
       "847        False      False              False          None   \n",
       "848        False      False              False          None   \n",
       "849        False      False               True            L4   \n",
       "850        False      False              False          None   \n",
       "851        False      False              False          None   \n",
       "852        False      False              False          None   \n",
       "853        False      False               True            L4   \n",
       "854        False      False              False          None   \n",
       "855        False      False              False          None   \n",
       "856        False      False              False          None   \n",
       "857        False      False               True            L4   \n",
       "858        False      False              False          None   \n",
       "859        False      False              False          None   \n",
       "860        False      False              False          None   \n",
       "861        False      False               True            L4   \n",
       "862        False      False              False          None   \n",
       "863        False      False              False          None   \n",
       "864        False      False              False          None   \n",
       "865        False      False               True            L3   \n",
       "866        False      False              False          None   \n",
       "867        False      False              False          None   \n",
       "868        False      False              False          None   \n",
       "869        False      False               True            L2   \n",
       "870        False      False              False          None   \n",
       "871        False      False               True            L3   \n",
       "872        False      False              False          None   \n",
       "873        False      False              False          None   \n",
       "874        False      False              False          None   \n",
       "875        False      False               True            L3   \n",
       "876        False      False              False          None   \n",
       "877        False      False              False          None   \n",
       "878        False      False              False          None   \n",
       "879        False      False               True            L3   \n",
       "880        False      False              False          None   \n",
       "881        False      False              False          None   \n",
       "882        False      False              False          None   \n",
       "883        False      False               True            L2   \n",
       "884        False      False              False          None   \n",
       "885        False      False              False          None   \n",
       "886        False      False              False          None   \n",
       "887        False      False               True            L2   \n",
       "888        False      False              False          None   \n",
       "889        False      False               True            L3   \n",
       "890        False      False              False          None   \n",
       "891        False      False              False          None   \n",
       "892        False      False              False          None   \n",
       "893        False      False              False          None   \n",
       "894        False      False              False          None   \n",
       "895        False      False              False          None   \n",
       "896        False      False              False          None   \n",
       "897        False      False               True            L3   \n",
       "898        False      False              False          None   \n",
       "899        False      False              False          None   \n",
       "900        False      False              False          None   \n",
       "901        False      False              False          None   \n",
       "902        False      False              False          None   \n",
       "903        False      False              False          None   \n",
       "904        False      False               True            L3   \n",
       "905        False      False              False          None   \n",
       "906        False      False               True            L4   \n",
       "907        False      False              False          None   \n",
       "908        False      False              False          None   \n",
       "909        False      False              False          None   \n",
       "910        False      False              False          None   \n",
       "911        False      False              False          None   \n",
       "912        False      False              False          None   \n",
       "913        False      False              False          None   \n",
       "914        False      False               True            L3   \n",
       "915        False      False              False          None   \n",
       "916        False      False              False          None   \n",
       "917        False      False              False          None   \n",
       "918        False      False              False          None   \n",
       "919        False      False              False          None   \n",
       "920        False      False              False          None   \n",
       "921        False      False              False          None   \n",
       "922        False      False              False          None   \n",
       "923        False      False              False          None   \n",
       "924        False      False              False          None   \n",
       "925        False      False               True            L3   \n",
       "926        False      False              False          None   \n",
       "927        False      False              False          None   \n",
       "928        False      False              False          None   \n",
       "929        False      False               True            L2   \n",
       "930        False      False              False          None   \n",
       "931        False      False              False          None   \n",
       "932        False      False              False          None   \n",
       "933        False      False              False          None   \n",
       "934        False      False               True            L1   \n",
       "935        False      False              False          None   \n",
       "936        False      False               True            L2   \n",
       "937        False      False              False          None   \n",
       "938        False      False              False          None   \n",
       "939        False      False              False          None   \n",
       "940        False      False               True            L3   \n",
       "941        False      False              False          None   \n",
       "942        False      False              False          None   \n",
       "943        False      False              False          None   \n",
       "944        False      False              False          None   \n",
       "945        False      False              False          None   \n",
       "946        False      False               True            L3   \n",
       "947        False      False              False          None   \n",
       "948        False      False              False          None   \n",
       "949        False      False              False          None   \n",
       "950        False      False              False          None   \n",
       "951        False      False              False          None   \n",
       "952        False      False              False          None   \n",
       "953        False      False              False          None   \n",
       "954        False      False              False          None   \n",
       "955        False      False              False          None   \n",
       "956        False      False              False          None   \n",
       "957        False      False              False          None   \n",
       "958        False      False               True            L3   \n",
       "959        False      False              False          None   \n",
       "960        False      False               True            L4   \n",
       "961        False      False              False          None   \n",
       "962        False      False              False          None   \n",
       "963        False      False              False          None   \n",
       "964        False      False              False          None   \n",
       "965        False      False              False          None   \n",
       "966        False      False              False          None   \n",
       "967        False      False              False          None   \n",
       "968        False      False              False          None   \n",
       "969        False      False              False          None   \n",
       "970        False      False              False          None   \n",
       "971        False      False              False          None   \n",
       "972        False      False              False          None   \n",
       "973        False      False              False          None   \n",
       "974        False      False              False          None   \n",
       "975        False      False              False          None   \n",
       "976        False      False              False          None   \n",
       "977        False      False              False          None   \n",
       "978        False      False              False          None   \n",
       "979        False      False              False          None   \n",
       "980        False      False              False          None   \n",
       "981         True      False              False          None   \n",
       "982         True      False              False          None   \n",
       "983        False      False              False          None   \n",
       "984         True      False              False          None   \n",
       "985         True      False              False          None   \n",
       "986        False      False              False          None   \n",
       "987        False      False               True            L4   \n",
       "988        False      False              False          None   \n",
       "989        False      False              False          None   \n",
       "990        False      False              False          None   \n",
       "991        False      False              False          None   \n",
       "992        False      False              False          None   \n",
       "993        False      False              False          None   \n",
       "994        False      False              False          None   \n",
       "995        False      False              False          None   \n",
       "996        False      False              False          None   \n",
       "997        False      False              False          None   \n",
       "998        False      False              False          None   \n",
       "999        False      False              False          None   \n",
       "1000       False      False              False          None   \n",
       "1001        True      False              False          None   \n",
       "1002        True      False              False          None   \n",
       "1003       False      False              False          None   \n",
       "1004        True      False              False          None   \n",
       "1005       False      False              False          None   \n",
       "1006       False      False              False          None   \n",
       "1007       False      False              False          None   \n",
       "1008       False      False               True            L4   \n",
       "1009       False      False              False          None   \n",
       "1010       False      False              False          None   \n",
       "1011       False      False              False          None   \n",
       "1012       False      False              False          None   \n",
       "1013       False      False              False          None   \n",
       "1014       False      False               True            L4   \n",
       "1015       False      False              False          None   \n",
       "1016       False      False              False          None   \n",
       "1017       False      False              False          None   \n",
       "1018       False      False              False          None   \n",
       "1019       False      False              False          None   \n",
       "1020       False      False              False          None   \n",
       "1021       False      False              False          None   \n",
       "1022       False      False              False          None   \n",
       "1023       False      False              False          None   \n",
       "1024        True      False              False          None   \n",
       "1025        True      False              False          None   \n",
       "1026       False      False              False          None   \n",
       "1027       False      False              False          None   \n",
       "1028       False      False              False          None   \n",
       "1029       False      False              False          None   \n",
       "1030       False      False              False          None   \n",
       "1031       False      False              False          None   \n",
       "1032       False      False              False          None   \n",
       "1033       False      False               True            L4   \n",
       "1034       False      False              False          None   \n",
       "1035       False      False              False          None   \n",
       "1036       False      False              False          None   \n",
       "1037       False      False              False          None   \n",
       "1038       False      False              False          None   \n",
       "1039       False      False              False          None   \n",
       "1040       False      False              False          None   \n",
       "1041       False      False              False          None   \n",
       "1042       False      False              False          None   \n",
       "1043       False      False               True            L4   \n",
       "1044       False      False              False          None   \n",
       "1045       False      False              False          None   \n",
       "1046       False      False              False          None   \n",
       "1047       False      False              False          None   \n",
       "1048       False      False              False          None   \n",
       "1049       False      False              False          None   \n",
       "1050       False      False              False          None   \n",
       "1051       False      False              False          None   \n",
       "1052       False      False              False          None   \n",
       "1053       False      False               True            L4   \n",
       "1054       False      False              False          None   \n",
       "1055       False      False              False          None   \n",
       "1056       False      False              False          None   \n",
       "1057       False      False              False          None   \n",
       "1058       False      False              False          None   \n",
       "1059       False      False              False          None   \n",
       "1060       False      False              False          None   \n",
       "1061       False      False              False          None   \n",
       "1062       False      False              False          None   \n",
       "1063       False      False              False          None   \n",
       "1064        True      False              False          None   \n",
       "1065        True      False              False          None   \n",
       "1066       False      False              False          None   \n",
       "1067       False      False              False          None   \n",
       "1068       False      False              False          None   \n",
       "1069       False      False              False          None   \n",
       "1070       False      False               True            L3   \n",
       "1071       False      False              False          None   \n",
       "1072       False      False              False          None   \n",
       "1073       False      False              False          None   \n",
       "1074       False      False               True            L2   \n",
       "1075       False      False              False          None   \n",
       "1076       False      False              False          None   \n",
       "1077       False      False              False          None   \n",
       "1078       False      False              False          None   \n",
       "1079       False      False              False          None   \n",
       "1080       False      False               True            L4   \n",
       "1081       False      False              False          None   \n",
       "1082       False      False              False          None   \n",
       "1083       False      False              False          None   \n",
       "1084       False      False              False          None   \n",
       "1085       False      False              False          None   \n",
       "1086       False      False               True            L3   \n",
       "1087       False      False              False          None   \n",
       "1088       False      False              False          None   \n",
       "1089       False      False              False          None   \n",
       "1090       False      False               True            L3   \n",
       "1091       False      False              False          None   \n",
       "1092       False      False              False          None   \n",
       "1093       False      False              False          None   \n",
       "1094       False      False              False          None   \n",
       "1095       False      False              False          None   \n",
       "1096       False      False               True            L3   \n",
       "1097       False      False              False          None   \n",
       "1098       False      False              False          None   \n",
       "1099       False      False              False          None   \n",
       "1100       False      False               True            L3   \n",
       "1101       False      False              False          None   \n",
       "1102       False      False              False          None   \n",
       "1103       False      False              False          None   \n",
       "1104       False      False               True            L4   \n",
       "1105       False      False              False          None   \n",
       "1106       False      False               True            L4   \n",
       "1107       False      False              False          None   \n",
       "1108       False      False              False          None   \n",
       "1109       False      False              False          None   \n",
       "1110       False      False              False          None   \n",
       "1111       False      False              False          None   \n",
       "1112       False      False              False          None   \n",
       "1113       False      False              False          None   \n",
       "1114       False      False               True            L4   \n",
       "1115       False      False              False          None   \n",
       "1116       False      False              False          None   \n",
       "1117       False      False              False          None   \n",
       "1118       False      False              False          None   \n",
       "1119       False      False              False          None   \n",
       "1120       False      False               True            L4   \n",
       "1121       False      False              False          None   \n",
       "1122       False      False              False          None   \n",
       "1123       False      False              False          None   \n",
       "1124       False      False               True            L4   \n",
       "1125       False      False              False          None   \n",
       "1126       False      False              False          None   \n",
       "1127       False      False              False          None   \n",
       "1128       False      False               True            L4   \n",
       "1129       False      False              False          None   \n",
       "1130       False      False              False          None   \n",
       "1131       False      False              False          None   \n",
       "1132       False      False               True            L4   \n",
       "1133       False      False              False          None   \n",
       "1134       False      False              False          None   \n",
       "1135       False      False              False          None   \n",
       "1136       False      False              False          None   \n",
       "1137       False      False              False          None   \n",
       "1138        True      False              False          None   \n",
       "1139        True      False              False          None   \n",
       "1140       False      False              False          None   \n",
       "1141       False      False               True            L2   \n",
       "1142       False      False              False          None   \n",
       "1143       False      False              False          None   \n",
       "1144       False      False              False          None   \n",
       "1145       False      False               True            L3   \n",
       "1146       False      False              False          None   \n",
       "1147       False      False              False          None   \n",
       "1148       False      False              False          None   \n",
       "1149       False      False               True            L3   \n",
       "1150       False      False              False          None   \n",
       "1151       False      False              False          None   \n",
       "1152       False      False              False          None   \n",
       "1153       False      False               True            L3   \n",
       "1154       False      False              False          None   \n",
       "1155       False      False              False          None   \n",
       "1156       False      False              False          None   \n",
       "1157       False      False              False          None   \n",
       "1158       False      False               True            L1   \n",
       "1159       False      False              False          None   \n",
       "1160       False      False               True            L2   \n",
       "1161       False      False              False          None   \n",
       "1162       False      False              False          None   \n",
       "1163       False      False              False          None   \n",
       "1164       False      False              False          None   \n",
       "1165       False      False              False          None   \n",
       "1166       False      False              False          None   \n",
       "1167       False      False              False          None   \n",
       "1168       False      False              False          None   \n",
       "1169       False      False              False          None   \n",
       "1170       False      False              False          None   \n",
       "1171       False      False               True            L2   \n",
       "1172       False      False              False          None   \n",
       "1173       False      False              False          None   \n",
       "1174       False      False              False          None   \n",
       "1175       False      False               True            L2   \n",
       "1176       False      False              False          None   \n",
       "1177        True      False              False          None   \n",
       "1178       False      False              False          None   \n",
       "1179       False      False              False          None   \n",
       "1180       False      False              False          None   \n",
       "1181       False      False               True            L2   \n",
       "1182       False      False              False          None   \n",
       "1183       False      False              False          None   \n",
       "1184       False      False              False          None   \n",
       "1185       False      False               True            L2   \n",
       "1186       False      False              False          None   \n",
       "1187       False      False              False          None   \n",
       "1188       False      False              False          None   \n",
       "1189       False      False              False          None   \n",
       "1190       False      False              False          None   \n",
       "1191       False      False               True            L2   \n",
       "1192       False      False              False          None   \n",
       "1193       False      False              False          None   \n",
       "1194       False      False              False          None   \n",
       "1195       False      False              False          None   \n",
       "1196       False      False               True            L1   \n",
       "1197       False      False              False          None   \n",
       "1198       False      False              False          None   \n",
       "1199       False      False              False          None   \n",
       "1200       False      False              False          None   \n",
       "1201       False      False              False          None   \n",
       "1202       False      False              False          None   \n",
       "1203       False      False              False          None   \n",
       "1204       False      False               True            L1   \n",
       "1205       False      False              False          None   \n",
       "1206       False      False              False          None   \n",
       "1207       False      False              False          None   \n",
       "1208       False      False              False          None   \n",
       "1209       False      False              False          None   \n",
       "1210       False      False              False          None   \n",
       "1211       False      False               True            L1   \n",
       "1212       False      False              False          None   \n",
       "1213       False      False              False          None   \n",
       "1214       False      False              False          None   \n",
       "1215       False      False              False          None   \n",
       "1216       False      False              False          None   \n",
       "1217       False      False               True            L1   \n",
       "1218       False      False              False          None   \n",
       "1219       False      False              False          None   \n",
       "1220       False      False              False          None   \n",
       "1221       False      False              False          None   \n",
       "\n",
       "                                                                                                                                                                                                         Text  \\\n",
       "0                                                                                                                                                                                                         ...   \n",
       "1                                                                                                                                                                                                               \n",
       "2                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                               \n",
       "4                                                                                                                                                                                                               \n",
       "5                                                                                                                                                                                                               \n",
       "6                                                                                                                                                                                                               \n",
       "7                                                                                                                                                                                                               \n",
       "8                                                                                                                                                                                                               \n",
       "9                                                                                                                                                                                                               \n",
       "10                                                                                                                                                                                                              \n",
       "11                                                                                                                                                                                                              \n",
       "12                                                                                                                                                                                                              \n",
       "13                                                                                                                                                                                                              \n",
       "14                                                                                                                                                                                                              \n",
       "15                                                                                                                                                                                                              \n",
       "16                                                                                                                                                                                                              \n",
       "17                                                                                                                                                                                                              \n",
       "18                                                                                                                                                                                                              \n",
       "19                                                                                                                                                                                                              \n",
       "20                                                                                                                                                                                                              \n",
       "21                                                                                                                                                                                                              \n",
       "22                                                                                                                                                                                                              \n",
       "23                                                                                                                                                                                                              \n",
       "24                                                                                                                                                                                                    ANEXO I   \n",
       "25                                                                                                                                                                                                              \n",
       "26                                                                                                                                                FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO   \n",
       "27                                                                                                                                                                                                              \n",
       "28                                                                                                                                                                                                              \n",
       "29                                                                                                                                                                                                              \n",
       "30                                                                                                                                                                                                              \n",
       "31                                                                                                                                                                                                              \n",
       "32                                                                                                                                                                                                              \n",
       "33                                                                                                                                                                                                              \n",
       "34                                                                                                                                                                            1.       NOMBRE DEL MEDICAMENTO   \n",
       "35                                                                                                                                                                                                              \n",
       "36                                                                                                                                                        Kalydeco 75 mg comprimidos recubiertos con película   \n",
       "37                                                                                                                                                       Kalydeco 150 mg comprimidos recubiertos con película   \n",
       "38                                                                                                                                                                                                              \n",
       "39                                                                                                                                                                                                              \n",
       "40                                                                                                                                                                                                              \n",
       "41                                                                                                                                                            2.       COMPOSICIÓN CUALITATIVA Y CUANTITATIVA   \n",
       "42                                                                                                                                                                                                              \n",
       "43                                                                                                                                                        Kalydeco 75 mg comprimidos recubiertos con película   \n",
       "44                                                                                                                                                                                                              \n",
       "45                                                                                                                                       Cada comprimido recubierto con película contiene 75 mg de ivacaftor.   \n",
       "46                                                                                                                                                                                                              \n",
       "47                                                                                                                                                                             Excipiente con efecto conocido   \n",
       "48                                                                                                                                                                                                              \n",
       "49                                                                                                                           Cada comprimido recubierto con película contiene 83,6 mg de lactosa monohidrato.   \n",
       "50                                                                                                                                                                                                              \n",
       "51                                                                                                                                                       Kalydeco 150 mg comprimidos recubiertos con película   \n",
       "52                                                                                                                                                                                                              \n",
       "53                                                                                                                                      Cada comprimido recubierto con película contiene 150 mg de ivacaftor.   \n",
       "54                                                                                                                                                                                                              \n",
       "55                                                                                                                                                                             Excipiente con efecto conocido   \n",
       "56                                                                                                                                                                                                              \n",
       "57                                                                                                                          Cada comprimido recubierto con película contiene 167,2 mg de lactosa monohidrato.   \n",
       "58                                                                                                                                                                                                              \n",
       "59                                                                                                                                          Para consultar la lista completa de excipientes, ver sección 6.1.   \n",
       "60                                                                                                                                                                                                              \n",
       "61                                                                                                                                                                                                              \n",
       "62                                                                                                                                                                                3.       FORMA FARMACÉUTICA   \n",
       "63                                                                                                                                                                                                              \n",
       "64                                                                                                                                                            Comprimido recubierto con película (comprimido)   \n",
       "65                                                                                                                                                                                                              \n",
       "66                                                                                                                                                        Kalydeco 75 mg comprimidos recubiertos con película   \n",
       "67                                                                                                                                                                                                              \n",
       "68    Comprimidos recubiertos con película con forma de cápsula de color azul claro, con la impresión “V 75” en tinta negra en una cara y nada en la otra (12,7 mm x 6,8 mm en la forma de comprimido modi...   \n",
       "69                                                                                                                                                                                                              \n",
       "70                                                                                                                                                       Kalydeco 150 mg comprimidos recubiertos con película   \n",
       "71                                                                                                                                                                                                              \n",
       "72    Comprimidos recubiertos con película con forma de cápsula de color azul claro, con la impresión “V 150” en tinta negra en una cara y nada en la otra (16,5 mm x 8,4 mm en la forma de comprimido mod...   \n",
       "73                                                                                                                                                                                                              \n",
       "74                                                                                                                                                                                                              \n",
       "75                                                                                                                                                                                    4.       Datos clínicos   \n",
       "76                                                                                                                                                                                                              \n",
       "77                                                                                                                                                                          4.1     Indicaciones terapéuticas   \n",
       "78                                                                                                                                                                                                              \n",
       "79                                                                                                                                                                        Kalydeco comprimidos está indicado:   \n",
       "80    ·         En monoterapia para el tratamiento de adultos, adolescentes y niños de 6 años o mayores con un peso de 25 kg o más con fibrosis quística (FQ) y una mutación R117H en el gen CFTR o una de...   \n",
       "81                                                                                                                                                                                                              \n",
       "82    ·         En un esquema combinado con comprimidos de tezacaftor/vacaftor para el tratamiento de adultos, adolescentes y niños de 6 años de edad o mayores con fibrosis quística (FQ) homocigóticos p...   \n",
       "83                                                                                                                                                                                                              \n",
       "84    ·         En un esquema combinado con comprimidos ivacaftor/tezacaftor/elexacaftor para el tratamiento de adultos y adolescentes de 12 años de edad o mayores con fibrosis quística (FQ) homocigótic...   \n",
       "85                                                                                                                                                                                                              \n",
       "86                                                                                                                                                                4.2     Posología y forma de administración   \n",
       "87                                                                                                                                                                                                              \n",
       "88    Únicamente los médicos con experiencia en el tratamiento de la fibrosis quística deben prescribir Kalydeco. Si se desconoce el genotipo del paciente, se debe utilizar un método de genotipificación...   \n",
       "89                                                                                                                                                                                                              \n",
       "90                                                                                                                                                                                                  Posología   \n",
       "91                                                                                                                                                                                                              \n",
       "92                                                                                                         Los adultos, adolescentes y niños de 6 años de edad o mayores deben ser tratados según la Tabla 1.   \n",
       "93                                                                                                                                                                                                              \n",
       "94                                                                                                                                                                       Tabla 1: Recomendaciones posológicas   \n",
       "95            Mañana   Noche      Ivacaftor en monoterapia     6 años o mayores,   ≥25 kg   Un   comprimido de 150 mg de ivacaftor   Un   comprimido de 150 mg de ivacaftor     Ivacaftor   en combinación...   \n",
       "96                                                                                                                                                                                                              \n",
       "97                               La dosis de la mañana y la dosis de la noche se deben tomar con un intervalo de 12 horas aproximadamente y con alimentos que contengan grasas (ver Forma de administración).   \n",
       "98                                                                                                                                                                                                              \n",
       "99                                                                                                                                                                                            Dosis olvidadas   \n",
       "100                                                                                                                                                                                                             \n",
       "101   Si han transcurrido 6 horas o menos desde la dosis olvidada de la mañana o de la noche, se debe indicar al paciente que la tome lo antes posible y luego tomar la siguiente dosis a la hora habitual...   \n",
       "102                                                                                                                                                                                                             \n",
       "103                                            Se debe indicar a los pacientes tratados con Kalydeco en un esquema combinado que no tomen más de una dosis de cualquiera de los medicamentos al mismo tiempo.   \n",
       "104                                                                                                                                                                                                             \n",
       "105                                                                                                                                                                  Uso concomitante de inhibidores de CYP3A   \n",
       "106                                                                                                                                                                                                             \n",
       "107   En administración concomitante con inhibidores moderados o potentes de CYP3A, ya sea en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor, se debe r...   \n",
       "108                                                                                                                                                                                                             \n",
       "109                                                                                               Tabla 2: Recomendaciones posológicas para el uso concomitante con inhibidores moderados o potentes de CYP3A   \n",
       "110           Inhibidores moderados de    CYP3A   Inhibidores potentes de    CYP3A      Ivacaftor en monoterapia     6 años o   mayores, ≥25 kg   Un comprimido por la mañana de 150 mg de ivacaftor una  ...   \n",
       "111                                                                                                                                                                                                             \n",
       "112                                                                                                                                                                                    Poblaciones especiales   \n",
       "113                                                                                                                                                                                                             \n",
       "114                                                                                                                                                                                Pacientes de edad avanzada   \n",
       "115                                                                                                                                                                                                             \n",
       "116   Se dispone de datos muy limitados para pacientes de edad avanzada tratados con ivacaftor (administrado en monoterapia o en un esquema combinado. No es necesario realizar un ajuste de la dosis espe...   \n",
       "117                                                                                                                                                                                                             \n",
       "118                                                                                                                                                                                       Insuficiencia renal   \n",
       "119                                                                                                                                                                                                             \n",
       "120   No es necesario ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Se recomienda precaución en pacientes con insuficiencia renal grave (aclaramiento de la creatinina menor o ig...   \n",
       "121                                                                                                                                                                                                             \n",
       "122                                                                                                                                                                                    Insuficiencia hepática   \n",
       "123                                                                                                                                                                                                             \n",
       "124                                                 No es necesario ajustar la dosis de ivacaftor en monoterapia o en un esquema combinado en pacientes con insuficiencia hepática leve (Child-Pugh Clase A).   \n",
       "125                                                                                                                                                                                                             \n",
       "126                                                Para los pacientes con insuficiencia hepática moderada (Child-Pugh Clase B), se debe reducir la dosis de ivacaftor en monoterapia a 150 mg una vez al día.   \n",
       "127                                                                                                                                                                                                             \n",
       "128                           Para los pacientes con insuficiencia hepática grave (Child-Pugh Clase C), se debe reducir la dosis de ivacaftor en monoterapia a 150 mg cada dos días o a una frecuencia menor.   \n",
       "129                                                                                                                                                                                                             \n",
       "130                              Para el uso como dosis de la noche en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor, ver la Tabla 3 para las recomendaciones posológicas.   \n",
       "131                                                                                                                                                                                                             \n",
       "132                                                                                                             Tabla 3: Recomendaciones posológicas en pacientes con insuficiencia hepática moderada o grave   \n",
       "133           Moderada    (Child-Pugh Clase B)   Grave    (Child-Pugh Clase C)      Ivacaftor en monoterapia     6 años o   mayores, ≥25 kg   Un comprimido por la mañana de 150 mg de ivacaftor una   vez...   \n",
       "134                                                                                                                                                                                                             \n",
       "135                                                                                                                                                                                      Población pediátrica   \n",
       "136                                                                                                                                                                                                             \n",
       "137   No se ha establecido la seguridad y eficacia de ivacaftor en monoterapia en niños menores de 4 meses, ni en combinación con tezacaftor/ivacaftor en niños menores de 6 años ni en combinación con te...   \n",
       "138                                                                                                                                                                                                             \n",
       "139   Los datos disponibles en pacientes menores de 6 años con una mutación R117H en el gen CFTR son limitados. Los datos disponibles en pacientes de 6 años o mayores están descritos en las secciones 4....   \n",
       "140                                                                                                                                                                                                             \n",
       "141                                                                                                                                                                                   Forma de administración   \n",
       "142                                                                                                                                                                                                             \n",
       "143                                                                                                                                                                                                 Vía oral.   \n",
       "144                                                                                                                                                                                                             \n",
       "145   Se debe indicar a los pacientes que ingieran los comprimidos enteros. Los comprimidos no se deben masticar, triturar ni partir antes de tomarlos ya que actualmente no hay datos clínicos que respal...   \n",
       "146                                                                                                                                                                                                             \n",
       "147                                                                                                                           Los comprimidos de ivacaftor se deben tomar con alimentos que contengan grasas.   \n",
       "148                                                                                                                                                                                                             \n",
       "149                                                                                                    Se deben evitar los alimentos o bebidas que contienen pomelo durante el tratamiento (ver sección 4.5).   \n",
       "150                                                                                                                                                                                                             \n",
       "151                                                                                                                                                                                4.3     Contraindicaciones   \n",
       "152                                                                                                                                                                                                             \n",
       "153                                                                                                          Hipersensibilidad al principio activo o a alguno de los excipientes incluidos en la sección 6.1.   \n",
       "154                                                                                                                                                                                                             \n",
       "155                                                                                                                                                  4.4     Advertencias y precauciones especiales de empleo   \n",
       "156                                                                                                                                                                                                             \n",
       "157   Únicamente los pacientes con FQ con una mutación de apertura del canal (clase III): G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N o S549R o una mutación G970R o R117H en al menos un a...   \n",
       "158                                                                                                                                                                                                             \n",
       "159   En el estudio 5 fueron incluidos cuatro pacientes con la mutación G970R. En tres de los cuatro pacientes el cambio en la prueba de cloruro en el sudor fue <5 mmol/l y este grupo no demostró una me...   \n",
       "160                                                                                                                                                                                                             \n",
       "161   Los resultados de eficacia de un estudio de fase 2 en pacientes con FQ homocigóticos para la mutación F508del en el gen CFTR no mostraron una diferencia estadísticamente significativa en el VEF1 a...   \n",
       "162                                                                                                                                                                                                             \n",
       "163             En el estudio 6, se ha demostrado menos evidencia de un efecto positivo de ivacaftor en pacientes con una mutación R117H-7T asociada a una menor gravedad de la enfermedad (ver sección 5.1).   \n",
       "164                                                                                                                                                                                                             \n",
       "165   No se debe prescribir ivacaftor en un esquema combinado con tezacaftor/ivacaftor a pacientes con FQ heterocigóticos para la mutación F508del con una segunda mutación en el gen CFTR que no se menci...   \n",
       "166                                                                                                                                                                                                             \n",
       "167                                                                                                                                                              Efecto en las pruebas de la función hepática   \n",
       "168                                                                                                                                                                                                             \n",
       "169   Es frecuente el aumento moderado de las aminotransferasas (alanina-aminotransferasa [ALAT] o aspartato‑aminotransferasa [ASAT]) en los sujetos con FQ. Se han observado aumentos de las aminotransfe...   \n",
       "170                                                                                                                                                                                                             \n",
       "171                                                                                                                                                                                    Insuficiencia hepática   \n",
       "172                                                                                                                                                                                                             \n",
       "173   No se recomienda utilizar ivacaftor, en monoterapia o en un esquema combinado con tezacaftor/ivacaftor, en pacientes con insuficiencia hepática grave a menos que los beneficios esperados superen l...   \n",
       "174                                                                                                                                                                                                             \n",
       "175   En los pacientes con insuficiencia hepática moderada, no se recomienda el uso de ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor. Únicamente se debe considerar el tratamient...   \n",
       "176                                                                                                                                                                                                             \n",
       "177                                                                                                                                                                                       Insuficiencia renal   \n",
       "178                                                                                                                                                                                                             \n",
       "179   Se recomienda precaución mientras se utiliza ivacaftor, en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor, en pacientes con insuficiencia renal g...   \n",
       "180                                                                                                                                                                                                             \n",
       "181                                                                                                                                                             Pacientes después de un trasplante de órganos   \n",
       "182                                                                                                                                                                                                             \n",
       "183   Ivacaftor, en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor, no se ha estudiado en pacientes con FQ que se han sometido a un trasplante de órgan...   \n",
       "184                                                                                                                                                                                                             \n",
       "185                                                                                                                                                                               Acontecimientos de exantema   \n",
       "186                                                                                                                                                                                                             \n",
       "187   La incidencia de los acontecimientos de exantema con ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor fue mayor en las mujeres que en los hombres, particularmente en las muje...   \n",
       "188                                                                                                                                                                                                             \n",
       "189                                                                                                                                                                      Interacciones con otros medicamentos   \n",
       "190                                                                                                                                                                                                             \n",
       "191                                                                                                                                                                                       Inductores de CYP3A   \n",
       "192                                                                                                                                                                                                             \n",
       "193   La exposición a ivacaftor disminuye significativamente y se espera que las exposiciones a elexacaftor y tezacaftor aumenten con el uso concomitante de inductores de CYP3A, pudiendo dar lugar a una...   \n",
       "194                                                                                                                                                                                                             \n",
       "195                                                                                                                                                                                      Inhibidores de CYP3A   \n",
       "196                                                                                                                                                                                                             \n",
       "197   La exposición a ivacaftor, tezacaftor y elexacaftor aumenta cuando se administra con inhibidores potentes o moderados de CYP3A. Se debe ajustar la dosis de ivacaftor (en monoterapia o en un esquem...   \n",
       "198                                                                                                                                                                                                             \n",
       "199                                                                                                                                                                                      Población pediátrica   \n",
       "200                                                                                                                                                                                                             \n",
       "201   Se han notificado casos de opacidad del cristalino/cataratas no congénitas sin afectar a la visión en pacientes pediátricos tratados con ivacaftor y con esquemas que contienen ivacaftor. Aunque en...   \n",
       "202                                                                                                                                                                                                             \n",
       "203                                                                                                                                                                                      Contenido de lactosa   \n",
       "204                                                                                                                                                                                                             \n",
       "205          Kalydeco contiene lactosa. Los pacientes con intolerancia hereditaria a galactosa, deficiencia total de lactasa o problemas de absorción de glucosa o galactosa no deben tomar este medicamento.   \n",
       "206                                                                                                                                                                                                             \n",
       "207                                                                                                                                                                                        Contenido de sodio   \n",
       "208                                                                                                                                                                                                             \n",
       "209                                                                                 Este medicamento contiene menos de 23 mg de sodio (1 mmol) por unidad de dosis; esto es, esencialmente “exento de sodio”.   \n",
       "210                                                                                                                                                                                                             \n",
       "211                                                                                                                                  4.5     Interacción con otros medicamentos y otras formas de interacción   \n",
       "212                                                                                                                                                                                                             \n",
       "213           Ivacaftor es un sustrato de CYP3A4 y CYP3A5. Es un inhibidor débil de CYP3A y P‑gp y un posible inhibidor de CYP2C9. Los estudios in vitro demostraron que ivacaftor no es un sustrato de P‑gp.   \n",
       "214                                                                                                                                                                                                             \n",
       "215                                                                                                                                                Medicamentos que afectan a la farmacocinética de ivacaftor   \n",
       "216                                                                                                                                                                                                             \n",
       "217                                                                                                                                                                                       Inductores de CYP3A   \n",
       "218                                                                                                                                                                                                             \n",
       "219   La administración conjunta de ivacaftor con rifampicina, un inductor potente de CYP3A, disminuyó la exposición a ivacaftor (AUC) en un 89 % y a hidroximetil-ivacaftor (M1), aunque en menor grado q...   \n",
       "220                                                                                                                                                                                                             \n",
       "221   No se recomienda un ajuste de la dosis cuando se utilice ivacaftor (en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor) junto con inductores débil...   \n",
       "222                                                                                                                                                                                                             \n",
       "223                                                                                                                                                                                      Inhibidores de CYP3A   \n",
       "224                                                                                                                                                                                                             \n",
       "225   Ivacaftor es un sustrato sensible de CYP3A. La administración conjunta con ketoconazol, un inhibidor potente de CYP3A, aumentó la exposición a ivacaftor (determinada como área bajo la curva [AUC])...   \n",
       "226                                                                                                                                                                                                             \n",
       "227   La administración conjunta con fluconazol, un inhibidor moderado de CYP3A, aumentó la exposición a ivacaftor en 3 veces y a su metabolito M1, aunque en menor grado que a ivacaftor. Se recomienda d...   \n",
       "228                                                                                                                                                                                                             \n",
       "229   La administración conjunta de ivacaftor con zumo de pomelo, que contiene uno o más componentes que inhiben de forma moderada CYP3A, puede aumentar la exposición a ivacaftor. Se deben evitar los al...   \n",
       "230                                                                                                                                                                                                             \n",
       "231                                                                                                                                               Capacidad de ivacaftor para interactuar con transportadores   \n",
       "232                                                                                                                                                                                                             \n",
       "233   Los estudios in vitro demostraron que ivacaftor no es un sustrato de OATP1B1 ni de OATP1B3. Ivacaftor y sus metabolitos son sustratos de BCRP in vitro. Debido a su alta permeabilidad intrínseca y ...   \n",
       "234                                                                                                                                                                                                             \n",
       "235                                                                                                                                                                                            Ciprofloxacino   \n",
       "236                                                                                                                                                                                                             \n",
       "237   La administración conjunta de ciprofloxacino con ivacaftor no afectó a la exposición a ivacaftor. No es necesario ajustar la dosis cuando ivacaftor (en monoterapia o en un esquema combinado con te...   \n",
       "238                                                                                                                                                                                                             \n",
       "239                                                                                                                                                                   Medicamentos a los que afecta ivacaftor   \n",
       "240                                                                                                                                                                                                             \n",
       "241   La administración de ivacaftor puede aumentar la exposición sistémica de los medicamentos que son sustratos sensibles de CYP2C9, y/o P‑gp y/o CYP3A, lo que puede aumentar o prolongar su efecto ter...   \n",
       "242                                                                                                                                                                                                             \n",
       "243                                                                                                                                                                                       Sustratos de CYP2C9   \n",
       "244                                                                                                                                                                                                             \n",
       "245   Ivacaftor puede inhibir CYP2C9. Por lo tanto, se recomienda controlar la razón internacional normalizada (INR) durante la administración conjunta de warfarina con ivacaftor (en monoterapia o en un...   \n",
       "246                                                                                                                                                                                                             \n",
       "247                                                                                                                                                                        Digoxina y otros sustratos de P‑gp   \n",
       "248                                                                                                                                                                                                             \n",
       "249   La administración conjunta con digoxina, un sustrato sensible de la P‑gp, aumentó la exposición a digoxina en 1,3 veces, lo que es coherente con la inhibición débil de la P‑gp por ivacaftor. La ad...   \n",
       "250                                                                                                                                                                                                             \n",
       "251                                                                                                                                                                                        Sustratos de CYP3A   \n",
       "252                                                                                                                                                                                                             \n",
       "253   La administración conjunta con midazolam (oral), un sustrato de CYP3A sensible, aumentó la exposición a midazolam en 1,5 veces, lo que es coherente con la inhibición débil de CYP3A por ivacaftor. ...   \n",
       "254                                                                                                                                                                                                             \n",
       "255                                                                                                                                                                                Anticonceptivos hormonales   \n",
       "256                                                                                                                                                                                                             \n",
       "257   Se ha estudiado ivacaftor (en monoterapia o en un esquema combinado con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor) con un anticonceptivo oral de estrógeno/progesterona y se observó q...   \n",
       "258                                                                                                                                                                                                             \n",
       "259                                                                                                                                                                                      Población pediátrica   \n",
       "260                                                                                                                                                                                                             \n",
       "261                                                                                                                                           Los estudios de interacciones se han realizado solo en adultos.   \n",
       "262                                                                                                                                                                                                             \n",
       "263                                                                                                                                                                  4.6     Fertilidad, embarazo y lactancia   \n",
       "264                                                                                                                                                                                                             \n",
       "265                                                                                                                                                                                                  Embarazo   \n",
       "266                                                                                                                                                                                                             \n",
       "267   No hay datos o estos son limitados (datos en menos de 300 embarazos) relativos al uso de ivacaftor en mujeres embarazadas. Los estudios en animales no sugieren efectos perjudiciales directos ni in...   \n",
       "268                                                                                                                                                                                                             \n",
       "269                                                                                                                                                                                                 Lactancia   \n",
       "270                                                                                                                                                                                                             \n",
       "271   Se desconoce si ivacaftor y/o sus metabolitos se excretan en la leche materna. Los datos farmacocinéticos disponibles en animales muestran que ivacaftor se excreta en la leche de ratas hembra en p...   \n",
       "272                                                                                                                                                                                                             \n",
       "273                                                                                                                                                                                                Fertilidad   \n",
       "274                                                                                                                                                                                                             \n",
       "275                                                    No se dispone de datos sobre el efecto de ivacaftor en la fertilidad en humanos. Ivacaftor tuvo un efecto en la fertilidad en ratas (ver sección 5.3).   \n",
       "276                                                                                                                                                                                                             \n",
       "277                                                                                                                                      4.7     Efectos sobre la capacidad para conducir y utilizar máquinas   \n",
       "278                                                                                                                                                                                                             \n",
       "279   La influencia de ivacaftor sobre la capacidad para conducir y utilizar máquinas es pequeña. Ivacaftor puede producir mareos (ver sección 4.8) y, por lo tanto, se debe aconsejar a los pacientes que...   \n",
       "280                                                                                                                                                                                                             \n",
       "281                                                                                                                                                                               4.8     Reacciones adversas   \n",
       "282                                                                                                                                                                                                             \n",
       "283                                                                                                                                                                           Resumen del perfil de seguridad   \n",
       "284                                                                                                                                                                                                             \n",
       "285   Las reacciones adversas más frecuentes experimentadas por los pacientes de 6 años o mayores que recibieron ivacaftor son cefalea (23,9 %), dolor bucofaríngeo (22,0 %), infección en las vías respir...   \n",
       "286                                                                                                                                                                                                             \n",
       "287   En pacientes de 2 a menos de 6 años las reacciones adversas más frecuentes fueron congestión nasal (26,5 %), infección en las vías respiratorias altas (23,5 %), aumento de las aminotransferasas (1...   \n",
       "288                                                                                                                                                                                                             \n",
       "289                                      Las reacciones adversas graves observadas en los pacientes que recibieron ivacaftor incluyeron dolor abdominal y aumento de las aminotransferasas (ver sección 4.4).   \n",
       "290                                                                                                                                                                                                             \n",
       "291                                                                                                                                                                              Tabla de reacciones adversas   \n",
       "292                                                                                                                                                                                                             \n",
       "293   La Tabla 4 muestra las reacciones adversas observadas con ivacaftor en monoterapia en los ensayos clínicos (estudios controlados con placebo y estudios no controlados) en los que la duración de la...   \n",
       "294                                                                                                                                                                                                             \n",
       "295                                                                                                                                                                              Tabla 4: Reacciones adversas   \n",
       "296       Sistema    de clasificación de órganos   Reacciones adversas   Frecuencia      Infecciones e   infestaciones   Infección en   las vías respiratorias altas   Muy   frecuentes     Nasofaringitis...   \n",
       "297                                                                                * Reacción adversa y frecuencia notificadas en los estudios clínicos de ivacaftor en combinación con tezacaftor/ivacaftor.   \n",
       "298                                                                    † Reacción adversa y frecuencia notificadas en los estudios clínicos de ivacaftor en combinación con ivacaftor/tezacaftor/elexacaftor.   \n",
       "299                                                                                                                                                                                                             \n",
       "300                                                                                                                                                          Descripción de reacciones adversas seleccionadas   \n",
       "301                                                                                                                                                                                                             \n",
       "302                                                                                                                                                                          Aumento de las aminotransferasas   \n",
       "303                                                                                                                                                                                                             \n",
       "304   Durante los estudios clínicos 1 y 2 controlados con placebo, de 48 semanas de duración, de ivacaftor en monoterapia en pacientes de 6 años o mayores, la incidencia de niveles máximos de las aminot...   \n",
       "305                                                                                                                                                                                                             \n",
       "306   Durante los estudios de fase 3, controlados con placebo (hasta 24 semanas) de tezacaftor/ivacaftor, la incidencia de niveles máximos de las aminotransferasas (ALAT o ASAT) >8, >5 o >3 veces el LSN...   \n",
       "307                                                                                                                                                                                                             \n",
       "308   Durante el estudio de fase 3, controlados con placebo de 24 semanas de duración de ivacaftor/tezacaftor/elexacaftor, estas cifras fueron del 1,5 %, 2,5 % y 7,9 % en los pacientes tratados con ivac...   \n",
       "309                                                                                                                                                                                                             \n",
       "310                                                                                                                                                                               Acontecimientos de exantema   \n",
       "311                                                                                                                                                                                                             \n",
       "312   Se han observado acontecimientos de exantema, por lo general de intensidad leve a moderada, con el uso de ivacaftor en un esquema combinado, y ocurrieron con más frecuencia en las mujeres tratadas...   \n",
       "313                                                                                                                                                                                                             \n",
       "314                                                                                                                                                                       Aumento de la creatina fosfoquinasa   \n",
       "315                                                                                                                                                                                                             \n",
       "316   Se observaron aumentos, por lo genral transitorios y asintomáticos, de la creatina fosfoquinasa en los pacientes tratados con ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor...   \n",
       "317                                                                                                                                                                                                             \n",
       "318                                                                                                                                                                                  Presión arterial elevada   \n",
       "319                                                                                                                                                                                                             \n",
       "320   Se observó un aumento de presión arterial sistólica y diastólica media desde el valor basal fue de 3,5 mmHg y 1,9 mmHg, respectivamente, en los pacientes tratados con ivacaftor en un esquema combi...   \n",
       "321                                                                                                                                                                                                             \n",
       "322                                                                                                                                                                                      Población pediátrica   \n",
       "323                                                                                                                                                                                                             \n",
       "324   Los datos de seguridad de ivacaftor en monoterapia se evaluaron en 6 pacientes de entre 4 meses y menos de 6 meses de edad, 11 pacientes de entre 6 meses y menos de 12 meses de edad, en 19 pacient...   \n",
       "325                                                                                                                                                                                                             \n",
       "326        El perfil de seguridad de ivacaftor (en monoterapia o en un esquema combinado) es por lo general coherente entre los pacientes pediátricos y también es coherente con el de los pacientes adultos.   \n",
       "327                                                                                                                                                                                                             \n",
       "328   La incidencia de aumento de las aminotransferasas (ALAT o ASAT) observada en los estudios 2, 5 y 6 (pacientes de 6 a menos de 12 años), el estudio 7 (pacientes de 2 a menos de 6 años) y el estudio...   \n",
       "329                                                                                                                                                                                                             \n",
       "330                                                                                       Tabla 5: Aumentos de las aminotransferasas en pacientes de 4 meses a <12 años tratados con ivacaftor en monoterapia   \n",
       "331          n   % de pacientes >3 veces el LSN   % de pacientes >5 veces el LSN   % de pacientes >8 veces el LSN     6 a   <12 años   40   15,0 % (6)   2,5 % (1)   2,5 % (1)     2 a   <6 años   34   14...   \n",
       "332                                                                                                                                                                                                             \n",
       "333                                                                                                                                                          Notificación de sospechas de reacciones adversas   \n",
       "334                                                                                                                                                                                                             \n",
       "335   Es importante notificar sospechas de reacciones adversas al medicamento tras su autorización. Ello permite una supervisión continuada de la relación beneficio/riesgo del medicamento. Se invita a l...   \n",
       "336                                                                                                                                                                                                             \n",
       "337                                                                                                                                                                                        4.9     Sobredosis   \n",
       "338                                                                                                                                                                                                             \n",
       "339   No existe un antídoto específico para la sobredosis de ivacaftor. El tratamiento de la sobredosis consiste en las medidas de soporte generales que incluyen control de las constantes vitales, prueb...   \n",
       "340                                                                                                                                                                                                             \n",
       "341                                                                                                                                                                                                             \n",
       "342                                                                                                                                                                       5.       PROPIEDADES FARMACOLÓGICAS   \n",
       "343                                                                                                                                                                                                             \n",
       "344                                                                                                                                                                      5.1     Propiedades farmacodinámicas   \n",
       "345                                                                                                                                                                                                             \n",
       "346                                                                                                                   Grupo farmacoterapéutico: Otros productos del sistema respiratorio, código ATC: R07AX02   \n",
       "347                                                                                                                                                                                                             \n",
       "348                                                                                                                                                                                       Mecanismo de acción   \n",
       "349                                                                                                                                                                                                             \n",
       "350   Ivacaftor es un potenciador de la proteína CFTR, es decir, ivacaftor in vitro aumenta la apertura del canal de CFTR para intensificar el transporte de cloruro en las mutaciones de apertura del can...   \n",
       "351                                                                                                                                                                                                             \n",
       "352   Las respuestas in vitro observadas en los experimentos de fijación de membranas de un solo canal utilizando membranas de células de roedores que expresaban las formas de CFTR mutantes no correspon...   \n",
       "353                                                                                                                                                                                                             \n",
       "354                                                                                                                                                                                  Efectos farmacodinámicos   \n",
       "355                                                                                                                                                                                                             \n",
       "356                                                                                                                                                                                  Ivacaftor en monoterapia   \n",
       "357                                                                                                                                                                                                             \n",
       "358   En los estudios 1 y 2 en pacientes con la mutación G551D en un alelo del gen CFTR, ivacaftor dio lugar a disminuciones rápidas (15 días), sustanciales (el cambio medio del cloruro en el sudor desd...   \n",
       "359                                                                                                                                                                                                             \n",
       "360   En la parte 1 del estudio 5 en pacientes con una mutación de apertura del canal no G551D en el gen CFTR, el tratamiento con ivacaftor dio lugar a un cambio medio rápido (15 días) e importante desd...   \n",
       "361                                                                                                                                                                                                             \n",
       "362   En el estudio 6, en pacientes de 6 años o mayores con FQ con una mutación R117H en el gen CFTR, la diferencia entre tratamientos en el cambio medio del cloruro en el sudor desde el valor basal has...   \n",
       "363                                                                                                                                                                                                             \n",
       "364                                                                                                                                                Ivacaftor en un esquema combinado con tezacaftor/ivacaftor   \n",
       "365                                                                                                                                                                                                             \n",
       "366   En pacientes homocigóticos para la mutación F508del, la diferencia del tratamiento entre ivacaftor en combinación con tezacaftor/ivacaftor y placebo en el cambio absoluto medio desde el valor basa...   \n",
       "367                                                                                                                                                                                                             \n",
       "368   En pacientes heterocigóticos para la mutación F508del y una segunda mutación asociada a la actividad residual de CFTR, la diferencia del tratamiento en el cambio absoluto medio desde el valor basa...   \n",
       "369                                                                                                                                                                                                             \n",
       "370   En pacientes de 6 a menos de 12 años homocigóticos o heterocigóticos para la mutación F508del y una segunda mutación asociada a la actividad residual de CFTR, el cambio absoluto medio dentro del g...   \n",
       "371                                                                                                                                                                                                             \n",
       "372                                                                                                                                    Ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor   \n",
       "373                                                                                                                                                                                                             \n",
       "374   En pacientes con una mutación F508del en un alelo y una mutación en el segundo alelo que da lugar a una falta de producción de proteína CFTR o una proteína CFTR que no responde a ivacaftor ni a te...   \n",
       "375                                                                                                                                                                                                             \n",
       "376   En pacientes homocigóticos para la mutación F508del, la diferencia del tratamiento entre ivacaftor/tezacaftor/elexacaftor y tezacaftor/ivacaftor en el cambio absoluto medio del cloruro en el sudor...   \n",
       "377                                                                                                                                                                                                             \n",
       "378                                                                                                                                                                              Eficacia clínica y seguridad   \n",
       "379                                                                                                                                                                                                             \n",
       "380                                                                                                                                                                                  Ivacaftor en monoterapia   \n",
       "381                                                                                                                                                                                                             \n",
       "382                                                                                                                   Estudios 1 y 2: estudios en pacientes con FQ con mutaciones de apertura del canal G551D   \n",
       "383                                                                                                                                                                                                             \n",
       "384   Se ha evaluado la eficacia de ivacaftor en dos estudios de fase 3, aleatorizados, doble ciego, controlados con placebo, multicéntricos, de pacientes clínicamente estables con FQ que presentaban la...   \n",
       "385                                                                                                                                                                                                             \n",
       "386   Los pacientes de ambos estudios fueron aleatorizados 1:1 a recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos grasos durante 48 semanas, además de los tratamientos prescritos para l...   \n",
       "387                                                                                                                                                                                                             \n",
       "388   El estudio 1 evaluó a 161 pacientes de 12 años o mayores; 122 (75,8 %) pacientes presentaban la mutación F508del en el segundo alelo. Al inicio del estudio, los pacientes del grupo de placebo util...   \n",
       "389                                                                                                                                                                                                             \n",
       "390   El estudio 2 evaluó a 52 pacientes de 6 a 11 años en el momento de la selección; el peso corporal medio (DE) era de 30,9 (8,63) kg; 42 (80,8 %) pacientes presentaban la mutación F508del en el segu...   \n",
       "391                                                                                                                                                                                                             \n",
       "392                                La variable principal de eficacia en ambos estudios fue el cambio absoluto medio desde el valor basal en el porcentaje predicho de VEF1 hasta la semana 24 de tratamiento.   \n",
       "393                                                                                                                                                                                                             \n",
       "394   La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF1 desde el valor basal hasta la semana 24 fue de 10,6 puntos por...   \n",
       "395                                                                                                                                                                                                             \n",
       "396   La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF1 desde el valor basal hasta la semana 24 en pacientes de 12 a 1...   \n",
       "397                                                                                                                                                                                                             \n",
       "398                                                                              Los resultados correspondientes a las variables de valoración secundarias clínicamente relevantes se muestran en la Tabla 6.   \n",
       "399                                                                                                                                                                                                             \n",
       "400                                                                                                                         Tabla 6: Efecto de ivacaftor en otras variables de eficacia en los estudios 1 y 2   \n",
       "401           Estudio 1   Estudio 2     Variable   Diferencia del tratamientoa (IC del 95 %)   Valor p   Diferencia del tratamientoa (IC del 95 %)   Valor p      Cambio absoluto medio desde el   valor b...   \n",
       "402                                                                                                              IC: Intervalo de confianza; NA: no analizado debido a la baja incidencia de acontecimientos.   \n",
       "403                                                                                                                             a        Diferencia del tratamiento = efecto de ivacaftor –efecto de placebo.   \n",
       "404           b     CFQ-R: El cuestionario revisado de la calidad de vida para fibrosis quística es una determinación de la calidad de vida relacionada con la salud, específica a la enfermedad, para la FQ.   \n",
       "405   c     Los datos del estudio 1 fueron agrupados a partir del CFQ-R para adultos/adolescentes y del CFQ‑R para niños de 12 a 13 años; los datos del estudio 2 se obtuvieron a partir del CFQ-R para ni...   \n",
       "406                                                                                                                          d        Proporción de riesgo del tiempo hasta la primera exacerbación pulmonar.   \n",
       "407                                                                                                                                 e        En sujetos menores de 20 años (gráficos de crecimiento del CDC).   \n",
       "408                                                                                                                                                                                                             \n",
       "409                                                                                                                      Estudio 5: estudio en pacientes con FQ con mutaciones de apertura del canal no G551D   \n",
       "410                                                                                                                                                                                                             \n",
       "411   El estudio 5 fue un estudio de fase 3, de dos partes, aleatorizado, doble ciego, controlado con placebo y cruzado (parte 1) seguido de un periodo de extensión abierta de 16 semanas de duración (pa...   \n",
       "412                                                                                                                                                                                                             \n",
       "413   En la parte 1, los pacientes fueron aleatorizados 1:1 para recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos que contenían grasas durante 8 semanas además de los tratamientos presc...   \n",
       "414                                                                                                                                                                                                             \n",
       "415   Se incluyó en el estudio a 39 pacientes (edad media: 23 años) con un porcentaje predicho de VEF1 basal ≥40 % (porcentaje predicho medio de VEF1 del 78 % [intervalo: 43 % a 119 %]). Un 62 % (24/39)...   \n",
       "416                                                                                                                                                                                                             \n",
       "417   En la parte 1 del estudio 5, el porcentaje predicho medio de VEF1 basal en los pacientes tratados con placebo fue del 79,3 % mientras que en los pacientes tratados con ivacaftor este valor fue del...   \n",
       "418                                                                                                                                                                                                             \n",
       "419   El efecto de ivacaftor en la población global del estudio 5 (incluidas las variables secundarias del cambio absoluto en el IMC a las 8 semanas de tratamiento y el cambio absoluto en la puntuación ...   \n",
       "420                                                                                                                                                                                                             \n",
       "421                                                                       Tabla 7: Efecto de ivacaftor para las variables de eficacia en la población global y para las mutaciones específicas en el gen CFTR   \n",
       "422      Cambio absoluto en el porcentaje predicho de VEF1   IMC (kg/m2)   Puntuación (puntos) en el CFQ-R   dominio respiratorio       hasta la semana 8   a la semana 8   hasta la semana 8       Todos ...   \n",
       "423                                                                                                            *     No se realizaron análisis estadísticos debido al pequeño número de mutaciones concretas.   \n",
       "424                                                                                        †     Refleja los resultados de un paciente con la mutación G551S con datos en el punto temporal de las 8 semanas.   \n",
       "425                                                                                                                                ††   n = 3 para el análisis del cambio absoluto en el cloruro en el sudor.   \n",
       "426                                                                                          #     Causa un defecto de empalme que da lugar a un nivel bajo o nulo de proteína CFTR en la superficie celular.   \n",
       "427                                                                                                                                                                                                             \n",
       "428   En la parte 2 del estudio 5, el cambio absoluto medio (DE) en el porcentaje predicho de VEF1 tras 16 semanas (pacientes aleatorizados a la secuencia de tratamiento ivacaftor/placebo en la parte 1)...   \n",
       "429                                                                                                                                                                                                             \n",
       "430                                                                                                                             Estudio 3: estudio en pacientes con FQ con la mutación F508del en el gen CFTR   \n",
       "431                                                                                                                                                                                                             \n",
       "432   El estudio 3 (parte A) fue un estudio de fase 2, de grupos paralelos, controlado con placebo, doble ciego, aleatorizado 4:1, de 16 semanas de duración, en el que se administró ivacaftor (150 mg ca...   \n",
       "433                                                                                                                                                                                                             \n",
       "434   El cambio absoluto medio desde el valor basal hasta la semana 16 en el porcentaje predicho de VEF1 (variable principal de eficacia) fue de 1,5 puntos porcentuales en el grupo de ivacaftor y de −0,...   \n",
       "435                                                                                                                                                                                                             \n",
       "436                                                                                                                                                                   Estudio 4: estudio de extensión abierta   \n",
       "437                                                                                                                                                                                                             \n",
       "438   En el estudio 4 los pacientes que completaron el tratamiento en los estudios 1 y 2 con placebo pasaron al tratamiento con ivacaftor mientras que los pacientes tratados con ivacaftor continuaron re...   \n",
       "439                                                                                                                                                                                                             \n",
       "440   Ciento cuarenta y cuatro (144) pacientes del estudio 1 pasaron al estudio 4, 67 del grupo de placebo/ivacaftor y 77 del grupo de ivacaftor/ivacaftor. Cuarenta y ocho (48) pacientes del estudio 2 p...   \n",
       "441                                                                                                                                                                                                             \n",
       "442   La Tabla 8 muestra los resultados del cambio absoluto medio (DE) en el porcentaje predicho de VEF1 para ambos grupos de pacientes. Para los pacientes del grupo de placebo/ivacaftor el porcentaje p...   \n",
       "443                                                                                                                                                                                                             \n",
       "444                                                                                                                            Tabla 8: Efecto de ivacaftor en el porcentaje predicho de VEF1 en el estudio 4   \n",
       "445      Estudio   original y grupo de tratamiento   Duración del tratamiento con ivacaftor (semanas)   Cambio absoluto en el porcentaje predicho de VEF1 desde el valor basal (puntos porcentuales)      ...   \n",
       "446                                                                                     *     El tratamiento se administró durante el estudio de fase 3, doble ciego, controlado y de 48 semanas de duración.   \n",
       "447                                                                                                    †     Cambio desde el valor basal del estudio previo después de 48 semanas de tratamiento con placebo.   \n",
       "448                                                                                                                                                                                                             \n",
       "449   Cuando se compara el cambio absoluto medio (DE) en el porcentaje predicho de VEF1 desde el valor basal del estudio 4 para los pacientes del grupo de ivacaftor/ivacaftor (n = 72) que pasaron del es...   \n",
       "450                                                                                                                                                                                                             \n",
       "451   Para los pacientes del grupo de placebo/ivacaftor del estudio 1, la tasa anualizada de exacerbaciones pulmonares fue más alta en el estudio inicial cuando los pacientes recibían placebo (1,34 acon...   \n",
       "452                                                                                                                                                                                                             \n",
       "453                                                                                                         Para los pacientes que pasaron del estudio 2, el número de acontecimientos fue, en general, bajo.   \n",
       "454                                                                                                                                                                                                             \n",
       "455                                                                                                                              Estudio 6: estudio en pacientes con FQ con una mutación R117H en el gen CFTR   \n",
       "456                                                                                                                                                                                                             \n",
       "457   En el estudio 6 se evaluaron 69 pacientes de 6 años o mayores; 53 (76,8 %) pacientes tenían la mutación F508del en el segundo alelo. La variante poli-T de R117H confirmada fue 5T en 38 pacientes y...   \n",
       "458                                                                                                                                                                                                             \n",
       "459   Se realizó un análisis de subgrupos previamente planificado en pacientes de 18 años o mayores (26 pacientes con placebo y 24 con ivacaftor). El tratamiento con ivacaftor produjo un cambio absoluto...   \n",
       "460                                                                                                                                                                                                             \n",
       "461   En un análisis de subgrupos en pacientes con una variante genética R117H-5T confirmada, la diferencia en el cambio absoluto medio desde el valor basal hasta la semana 24 en el porcentaje predicho ...   \n",
       "462                                                                                                                                                                                                             \n",
       "463   Para las variables secundarias de eficacia, no se observaron diferencias del tratamiento para ivacaftor frente a placebo en el cambio absoluto desde el valor basal en el IMC en la semana 24 ni en ...   \n",
       "464                                                                                                                                                                                                             \n",
       "465                                                                                                         Ivacaftor en un esquema combinado con tezacaftor/ivacaftor o con ivacaftor/tezacaftor/elexacaftor   \n",
       "466                                                                                                                                                                                                             \n",
       "467   Se evaluaron la eficacia y la seguridad de ivacaftor en un esquema combinado con tezacaftor/ivacaftor en pacientes con FQ de 12 años o mayores en dos estudios clínicos: un estudio aleatorizado, do...   \n",
       "468                                                                                                                                                                                                             \n",
       "469   Se demostraron la eficacia y la seguridad de ivacaftor en un esquema combinado con ivacaftor/tezacaftor/elexacaftor en pacientes de 12 años o mayores en dos estudios de fase 3, aleatorizados, dobl...   \n",
       "470                                                                                                                                                                                                             \n",
       "471                                                                                                                                                                                      Población pediátrica   \n",
       "472                                                                                                                                                                                                             \n",
       "473                                                                                                                                                Ivacaftor en un esquema combinado con tezacaftor/ivacaftor   \n",
       "474                                                                                                                                                                                                             \n",
       "475   Se evaluó la eficacia y la seguridad en pacientes de 6 a menos de 12 años (edad media de 8,6 años) en un estudio de fase 3, doble ciego, de 8 semanas de duración con 67 pacientes que fueron aleato...   \n",
       "476                                                                                                                                                                                                             \n",
       "477   La Agencia Europea de Medicamentos ha concedido al titular un aplazamiento para presentar los resultados de los ensayos realizados con Kalydeco ivacaftor en uno o más grupos de la población pediát...   \n",
       "478                                                                                                                                                                                                             \n",
       "479                                                                                                                                                                      5.2     Propiedades farmacocinéticas   \n",
       "480                                                                                                                                                                                                             \n",
       "481                                                                                                    La farmacocinética de ivacaftor es similar entre los voluntarios adultos sanos y los pacientes con FQ.   \n",
       "482                                                                                                                                                                                                             \n",
       "483   Después de la administración oral de una dosis única de 150 mg a voluntarios sanos con el estómago lleno, la media (± DE) para el AUC y la Cmáx fue de 10 600 (5260) ng*h/ml y de 768 (233) ng/ml, r...   \n",
       "484                                                                                                                                                                                                             \n",
       "485                                                                                                                                                                                                 Absorción   \n",
       "486                                                                                                                                                                                                             \n",
       "487   Después de la administración oral de dosis múltiples de ivacaftor, la exposición a ivacaftor aumentó por lo general con la dosis, de 25 mg cada 12 horas a 450 mg cada 12 horas. Cuando se administr...   \n",
       "488                                                                                                                                                                                                             \n",
       "489   El granulado de ivacaftor (2 sobres de 75 mg) presentó una biodisponibilidad similar a la de los comprimidos de 150 mg cuando se administraron con alimentos que contenían grasas a sujetos adultos ...   \n",
       "490                                                                                                                                                                                                             \n",
       "491                                                                                                                                                                                              Distribución   \n",
       "492                                                                                                                                                                                                             \n",
       "493   Aproximadamente el 99 % de ivacaftor se fija a las proteínas plasmáticas, principalmente a la alfa-1 glicoproteína ácida y a la albúmina. Ivacaftor no se fija a los eritrocitos humanos. Después de...   \n",
       "494                                                                                                                                                                                                             \n",
       "495                                                                                                                                                                                         Biotransformación   \n",
       "496                                                                                                                                                                                                             \n",
       "497   Ivacaftor se metaboliza extensamente en humanos. Los datos in vitro e in vivo indican que ivacaftor se metaboliza principalmente por CYP3A. El M1 y el M6 son los dos metabolitos principales de iva...   \n",
       "498                                                                                                                                                                                                             \n",
       "499   El efecto del genotipo heterocigótico de CYP3A4*22 en la exposición a ivacaftor, tezacaftor y elexacaftor es coherente con el efecto de la administración junto con un inhibidor débil de CYP3A4, lo...   \n",
       "500                                                                                                                                                                                                             \n",
       "501                                                                                                                                                                                               Eliminación   \n",
       "502                                                                                                                                                                                                             \n",
       "503   Tras la administración oral en voluntarios sanos, la mayor parte de ivacaftor (87,8 %) fue eliminada en las heces después de la conversión metabólica. Los metabolitos principales M1 y M6 represent...   \n",
       "504                                                                                                                                                                                                             \n",
       "505                                                                                                                                                                                  Linealidad/No linealidad   \n",
       "506                                                                                                                                                                                                             \n",
       "507                                                                                    La farmacocinética de ivacaftor es en general lineal con respecto al tiempo o al intervalo de dosis de 25 mg a 250 mg.   \n",
       "508                                                                                                                                                                                                             \n",
       "509                                                                                                                                                                                    Poblaciones especiales   \n",
       "510                                                                                                                                                                                                             \n",
       "511                                                                                                                                                                                    Insuficiencia hepática   \n",
       "512                                                                                                                                                                                                             \n",
       "513   Tras una sola dosis de 150 mg de ivacaftor, los sujetos adultos con insuficiencia hepática moderada (Child‑Pugh Clase B, puntuación 7 a 9) presentaron una Cmáx de ivacaftor similar (media [± DE] d...   \n",
       "514                                                                                                                                                                                                             \n",
       "515   En los sujetos con insuficiencia hepática moderada (Child‑Pugh Clase B, puntuación 7 a 9), el AUC de ivacaftor aumentó aproximadamente el 50 % tras la administración de múltiples dosis durante 10 ...   \n",
       "516                                                                                                                                                                                                             \n",
       "517   No se ha estudiado el impacto de la insuficiencia hepática grave (Child-Pugh Clase C, puntuación 10 a 15) en la farmacocinética de ivacaftor en monoterapia o en un esquema combinado con tezacaftor...   \n",
       "518                                                                                                                                                                                                             \n",
       "519                                                                                              Para obtener orientación sobre el uso adecuado y la modificación de la dosis, ver Tabla 3 en la sección 4.2.   \n",
       "520                                                                                                                                                                                                             \n",
       "521                                                                                                                                                                                       Insuficiencia renal   \n",
       "522                                                                                                                                                                                                             \n",
       "523   No se han realizado estudios farmacocinéticos con ivacaftor en pacientes con insuficiencia renal, ni en monoterapia ni en un esquema combinado con tezacaftor/ivacaftor o con ivacaftor/tezacaftor/e...   \n",
       "524                                                                                                                                                                                                             \n",
       "525   No se recomienda ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Se recomienda precaución cuando se administre ivacaftor, en monoterapia o en un esquema combinado con tezaca...   \n",
       "526                                                                                                                                                                                                             \n",
       "527                                                                                                                                                                                                      Raza   \n",
       "528                                                                                                                                                                                                             \n",
       "529                           En función del análisis de FC poblacional, la raza no tuvo ningún efecto clínicamente significativo en la FC de ivacaftor en pacientes blancos (n = 379) y no blancos (n = 29).   \n",
       "530                                                                                                                                                                                                             \n",
       "531                                                                                                                                                                                                      Sexo   \n",
       "532                                                                                                                                                                                                             \n",
       "533                            Los parámetros farmacocinéticos de ivacaftor, en monoterapia o en combinación con tezacaftor/ivacaftor o ivacaftor/tezacaftor/elexacaftor, son similares en hombres y mujeres.   \n",
       "534                                                                                                                                                                                                             \n",
       "535                                                                                                                                                                                Pacientes de edad avanzada   \n",
       "536                                                                                                                                                                                                             \n",
       "537   Los estudios clínicos con ivacaftor en monoterapia no incluyeron un número suficiente de pacientes de 65 años o mayores para determinar si los parámetros farmacocinéticos son similares o no a los ...   \n",
       "538                                                                                                                                                                                                             \n",
       "539   Los parámetros farmacocinéticos de ivacaftor en combinación con tezacaftor en pacientes de edad avanzada (65‑72 años) son comparables a los de los adultos más jóvenes. No se incluyó a ningún pacie...   \n",
       "540                                                                                                                                                                                                             \n",
       "541                                                                                                                                                                                      Población pediátrica   \n",
       "542                                                                                                                                                                                                             \n",
       "543   En la Tabla 9 se presenta por grupo de edad la exposición a ivacaftor predicha según las concentraciones de ivacaftor observadas en los estudios de fase 2 y 3, determinada mediante un análisis de ...   \n",
       "544                                                                                                                                                                                                             \n",
       "545                                                                                                                                              Tabla 9: Exposición media (DE) a ivacaftor por grupo de edad   \n",
       "546       Grupo de edad   Dosis   Cmín, ee (ng/ml)   AUCτ, ee (ng*h/ml)      6 meses   a menos de 12 meses (5 kg a <7 kg)*   25 mg   cada 12 h   336   5410     6 meses   a menos de 12 meses (7 kg a <14 ...   \n",
       "547                                                                                                            *     Valores basados en los datos de un solo paciente; no se comunicó la desviación estándar.   \n",
       "548                  †     Las exposiciones en los pacientes de 6 a 11 años son predicciones basadas en las simulaciones del modelo de FC poblacional utilizando los datos obtenidos para este grupo de edad.   \n",
       "549                                                                                                                                                                                                             \n",
       "550                                                                                        La exposición  de ivacaftor en combinación con tezacaftor y con tezacaftor/elexacaftor se presenta en la Tabla 10.   \n",
       "551                                                                                                                                                                                                             \n",
       "552                                                                                                                   Tabla 10: Exposición media (DE) a ivacaftor utilizado en combinación, por grupo de edad   \n",
       "553      Grupo de edad   Dosis   AUC0-12h,ee (ng*h/ml) media (DE) de ivacaftor     Niños (6 a menos de 12 años; <30 kg)   n = 71   50 mg de tezacaftor cada día/75 mg de   ivacaftor cada 12 h   7100 (195...   \n",
       "554                                                                                     *Las exposiciones en el intervalo de peso de ≥30 kg a <40 kg son predicciones derivadas del modelo de FC poblacional.   \n",
       "555                                                                                                                                                                                                             \n",
       "556                                                                                                                                                                 5.3     Datos preclínicos sobre seguridad   \n",
       "557                                                                                                                                                                                                             \n",
       "558   Los datos de los estudios preclínicos no muestran riesgos especiales para los seres humanos según los estudios convencionales de farmacología de seguridad, toxicidad a dosis repetidas, genotoxicid...   \n",
       "559                                                                                                                                                                                                             \n",
       "560                                                                                                                                                                                     Embarazo y fertilidad   \n",
       "561                                                                                                                                                                                                             \n",
       "562   Ivacaftor se asoció a una disminución ligera del peso de las vesículas seminales, a una disminución del índice de fertilidad global y del número de gestaciones en las hembras apareadas con machos ...   \n",
       "563                                                                                                                                                                                                             \n",
       "564                                                                                                                                                                           Desarrollo perinatal y posnatal   \n",
       "565                                                                                                                                                                                                             \n",
       "566   Ivacaftor redujo los índices de supervivencia y lactancia y produjo una disminución en los pesos corporales de las crías. La dosis sin efecto adverso observado para viabilidad y crecimiento de las...   \n",
       "567                                                                                                                                                                                                             \n",
       "568                                                                                                                                                                              Estudios en animales jóvenes   \n",
       "569                                                                                                                                                                                                             \n",
       "570   Se observaron cataratas en las ratas jóvenes tratadas desde el día 7 después de nacer hasta el día 35 a niveles de exposición de ivacaftor de 0,22 veces la dosis máxima recomendada en humanos segú...   \n",
       "571                                                                                                                                                                                                             \n",
       "572                                                                                                                                                                                                             \n",
       "573                                                                                                                                                                              6.       DATOS FARMACÉUTICOS   \n",
       "574                                                                                                                                                                                                             \n",
       "575                                                                                                                                                                              6.1     Lista de excipientes   \n",
       "576                                                                                                                                                                                                             \n",
       "577                                                                                                                                                                                     Núcleo del comprimido   \n",
       "578                                                                                                                                                                                                             \n",
       "579                                                                                                                                                                                  Celulosa microcristalina   \n",
       "580                                                                                                                                                                                       Lactosa monohidrato   \n",
       "581                                                                                                                                                                          Succinato acetato de hipromelosa   \n",
       "582                                                                                                                                                                                      Croscarmelosa sódica   \n",
       "583                                                                                                                                                                               Laurilsulfato sódico (E487)   \n",
       "584                                                                                                                                                                                   Sílice coloidal anhidra   \n",
       "585                                                                                                                                                                                     Estearato de magnesio   \n",
       "586                                                                                                                                                                                                             \n",
       "587                                                                                                                                                                                   Película del comprimido   \n",
       "588                                                                                                                                                                                                             \n",
       "589                                                                                                                                                                                     Alcohol de polivinilo   \n",
       "590                                                                                                                                                                                 Dióxido de titanio (E171)   \n",
       "591                                                                                                                                                                                       Macrogol (PEG 3350)   \n",
       "592                                                                                                                                                                                                     Talco   \n",
       "593                                                                                                                                                                     Laca de aluminio índigo carmín (E132)   \n",
       "594                                                                                                                                                                                          Cera de carnauba   \n",
       "595                                                                                                                                                                                                             \n",
       "596                                                                                                                                                                                        Tinta de impresión   \n",
       "597                                                                                                                                                                                                             \n",
       "598                                                                                                                                                                                                   Shellac   \n",
       "599                                                                                                                                                                              Óxido de hierro negro (E172)   \n",
       "600                                                                                                                                                                                    Propilenglicol (E1520)   \n",
       "601                                                                                                                                                                          Solución concentrada de amoníaco   \n",
       "602                                                                                                                                                                                                             \n",
       "603                                                                                                                                                                                6.2     Incompatibilidades   \n",
       "604                                                                                                                                                                                                             \n",
       "605                                                                                                                                                                                               No procede.   \n",
       "606                                                                                                                                                                                                             \n",
       "607                                                                                                                                                                                6.3     Periodo de validez   \n",
       "608                                                                                                                                                                                                             \n",
       "609                                                                                                                                                                                                   4 años.   \n",
       "610                                                                                                                                                                                                             \n",
       "611                                                                                                                                                           6.4     Precauciones especiales de conservación   \n",
       "612                                                                                                                                                                                                             \n",
       "613                                                                                                                                                       No requiere condiciones especiales de conservación.   \n",
       "614                                                                                                                                                                                                             \n",
       "615                                                                                                                                                                 6.5     Naturaleza y contenido del envase   \n",
       "616                                                                                                                                                                                                             \n",
       "617   Los comprimidos recubiertos con película están envasados en blísteres termoformados (policlorotrifluoroetileno [PCTFE]/papel de aluminio) o en un frasco de polietileno de alta densidad (HDPE) con ...   \n",
       "618                                                                                                                                                                                                             \n",
       "619                                                                                                                                                       Kalydeco 75 mg comprimidos recubiertos con película   \n",
       "620                                                                                                                                                                                                             \n",
       "621                                                                                                                                                       Están disponibles los siguientes tamaños de envase:   \n",
       "622                                                                                                                -      Caja con estuches de blísteres que contiene 28 comprimidos recubiertos con película   \n",
       "623                                                                                                                                                                                                             \n",
       "624                                                                                                                                                      Kalydeco 150 mg comprimidos recubiertos con película   \n",
       "625                                                                                                                                                                                                             \n",
       "626                                                                                                                                                       Están disponibles los siguientes tamaños de envase:   \n",
       "627                                                                                                                -      Caja con estuches de blísteres que contiene 28 comprimidos recubiertos con película   \n",
       "628                                                                                                                             -      Caja de blísteres que contiene 56 comprimidos recubiertos con película   \n",
       "629                                                                                                                                        -      Frasco que contiene 56 comprimidos recubiertos con película   \n",
       "630                                                                                                                                                                                                             \n",
       "631                                                                                                                                     Puede que solamente estén comercializados algunos tamaños de envases.   \n",
       "632                                                                                                                                                                                                             \n",
       "633                                                                                                                                     6.6     Precauciones especiales de eliminación y otras manipulaciones   \n",
       "634                                                                                                                                                                                                             \n",
       "635                                                 La eliminación del medicamento no utilizado y de todos los materiales que hayan estado en contacto con él se realizará de acuerdo con la normativa local.   \n",
       "636                                                                                                                                                                                                             \n",
       "637                                                                                                                                                                                                             \n",
       "638                                                                                                                                                   7.       TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN   \n",
       "639                                                                                                                                                                                                             \n",
       "640                                                                                                                                                                  Vertex Pharmaceuticals (Ireland) Limited   \n",
       "641                                                                                                                                                                               28-32 Pembroke Street Upper   \n",
       "642                                                                                                                                                                                        Dublin 2, D02 EK84   \n",
       "643                                                                                                                                                                                                   Irlanda   \n",
       "644                                                                                                                                                                                                             \n",
       "645                                                                                                                                                                                                             \n",
       "646                                                                                                                                                    8.       NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓN   \n",
       "647                                                                                                                                                                                                             \n",
       "648                                                                                                                                                                                           EU/1/12/782/001   \n",
       "649                                                                                                                                                                                           EU/1/12/782/002   \n",
       "650                                                                                                                                                                                           EU/1/12/782/005   \n",
       "651                                                                                                                                                                                           EU/1/12/782/007   \n",
       "652                                                                                                                                                                                                             \n",
       "653                                                                                                                                                                                                             \n",
       "654                                                                                                                                   9.       FECHA DE LA PRIMERA AUTORIZACIÓN/RENOVACIÓN DE LA AUTORIZACIÓN   \n",
       "655                                                                                                                                                                                                             \n",
       "656                                                                                                                                                           Fecha de la primera autorización: 23/julio/2012   \n",
       "657                                                                                                                                                              Fecha de la última renovación: 28/abril/2017   \n",
       "658                                                                                                                                                                                                             \n",
       "659                                                                                                                                                                                                             \n",
       "660                                                                                                                                                                     10.    FECHA DE LA REVISIÓN DEL TEXTO   \n",
       "661                                                                                                                                                                                                             \n",
       "662                                                             La información detallada de este medicamento está disponible en la página web de la Agencia Europea de Medicamentos http://www.ema.europa.eu.   \n",
       "663                                                                                                                                                                                                             \n",
       "664                                                                                                                                                                                                             \n",
       "665                                                                                                                                                                           1.       NOMBRE DEL MEDICAMENTO   \n",
       "666                                                                                                                                                                                                             \n",
       "667                                                                                                                                                                         Kalydeco 25 mg granulado en sobre   \n",
       "668                                                                                                                                                                         Kalydeco 50 mg granulado en sobre   \n",
       "669                                                                                                                                                                         Kalydeco 75 mg granulado en sobre   \n",
       "670                                                                                                                                                                                                             \n",
       "671                                                                                                                                                                                                             \n",
       "672                                                                                                                                                           2.       COMPOSICIÓN CUALITATIVA Y CUANTITATIVA   \n",
       "673                                                                                                                                                                                                             \n",
       "674                                                                                                                                                                         Kalydeco 25 mg granulado en sobre   \n",
       "675                                                                                                                                                                                                             \n",
       "676                                                                                                                                                                   Cada sobre contiene 25 mg de ivacaftor.   \n",
       "677                                                                                                                                                                                                             \n",
       "678                                                                                                                                                                            Excipiente con efecto conocido   \n",
       "679                                                                                                                                                                                                             \n",
       "680                                                                                                                                                       Cada sobre contiene 36,6 mg de lactosa monohidrato.   \n",
       "681                                                                                                                                                                                                             \n",
       "682                                                                                                                                                                         Kalydeco 50 mg granulado en sobre   \n",
       "683                                                                                                                                                                                                             \n",
       "684                                                                                                                                                                   Cada sobre contiene 50 mg de ivacaftor.   \n",
       "685                                                                                                                                                                                                             \n",
       "686                                                                                                                                                                            Excipiente con efecto conocido   \n",
       "687                                                                                                                                                                                                             \n",
       "688                                                                                                                                                       Cada sobre contiene 73,2 mg de lactosa monohidrato.   \n",
       "689                                                                                                                                                                                                             \n",
       "690                                                                                                                                                                         Kalydeco 75 mg granulado en sobre   \n",
       "691                                                                                                                                                                                                             \n",
       "692                                                                                                                                                                   Cada sobre contiene 75 mg de ivacaftor.   \n",
       "693                                                                                                                                                                                                             \n",
       "694                                                                                                                                                                            Excipiente con efecto conocido   \n",
       "695                                                                                                                                                                                                             \n",
       "696                                                                                                                                                      Cada sobre contiene 109,8 mg de lactosa monohidrato.   \n",
       "697                                                                                                                                                                                                             \n",
       "698                                                                                                                                         Para consultar la lista completa de excipientes, ver sección 6.1.   \n",
       "699                                                                                                                                                                                                             \n",
       "700                                                                                                                                                                                                             \n",
       "701                                                                                                                                                                               3.       FORMA FARMACÉUTICA   \n",
       "702                                                                                                                                                                                                             \n",
       "703                                                                                                                                                                                       Granulado en sobre.   \n",
       "704                                                                                                                                                                                                             \n",
       "705                                                                                                                              Granulado de color blanco a blanquecino de 2 mm aproximadamente de diámetro.   \n",
       "706                                                                                                                                                                                                             \n",
       "707                                                                                                                                                                                                             \n",
       "708                                                                                                                                                                                   4.       Datos clínicos   \n",
       "709                                                                                                                                                                                                             \n",
       "710                                                                                                                                                                         4.1     Indicaciones terapéuticas   \n",
       "711                                                                                                                                                                                                             \n",
       "712   Kalydeco granulado está indicado para el tratamiento de lactantes de al menos 4 meses y niños con un peso de 5 kg a menos de 25 kg con fibrosis quística (FQ) y una mutación R117H en el gen CFTR o ...   \n",
       "713                                                                                                                                                                                                             \n",
       "714                                                                                                                                                               4.2     Posología y forma de administración   \n",
       "715                                                                                                                                                                                                             \n",
       "716   Únicamente los médicos con experiencia en el tratamiento de la fibrosis quística deben prescribir Kalydeco. Si se desconoce el genotipo del paciente, se debe utilizar un método de genotipificación...   \n",
       "717                                                                                                                                                                                                             \n",
       "718                                                                                                                                                                                                 Posología   \n",
       "719                                                                                                                                                                                                             \n",
       "720                                                                                                  La dosis en lactantes de al menos 4 meses, niños, adolescentes y adultos debe ser conforme a la Tabla 1.   \n",
       "721                                                                                                                                                                                                             \n",
       "722                                                                                                                              Tabla 1: Recomendaciones posológicas para los pacientes de 4 meses o mayores   \n",
       "723       Edad   Peso   Dosis   Dosis    total diaria     4 meses    a menos de 6 meses   ≥5 kg   25 mg de granulado por vía oral cada 12 horas con alimentos que    contengan grasas   50 mg     6 meses ...   \n",
       "724                                                                                                                                                                                                             \n",
       "725                                                                                                                                                                                           Dosis olvidadas   \n",
       "726                                                                                                                                                                                                             \n",
       "727   Si han transcurrido 6 horas o menos desde la dosis olvidada de la mañana o de la noche, se debe indicar al paciente que la tome lo antes posible y luego tomar la siguiente dosis a la hora habitual...   \n",
       "728                                                                                                                                                                                                             \n",
       "729                                                                                                                                                                  Uso concomitante de inhibidores de CYP3A   \n",
       "730                                                                                                                                                                                                             \n",
       "731   En administración concomitante con inhibidores potentes de CYP3A en pacientes de 6 meses o mayores, la dosis de ivacaftor se debe reducir a un sobre (25 mg de ivacaftor en pacientes con un peso de...   \n",
       "732                                                                                                                                                                                                             \n",
       "733   En administración concomitante con inhibidores moderados de CYP3A en pacientes de 6 meses o mayores, la dosis de ivacaftor es la recomendada anteriormente, pero administrada una vez al día (ver la...   \n",
       "734                                                                                                                                                                                                             \n",
       "735   Debido a la variabilidad en la maduración de las enzimas del citocromo (CYP) que intervienen en el metabolismo de ivacaftor, no se recomienda el tratamiento con ivacaftor en administración concomi...   \n",
       "736                                                                                                                                                                                                             \n",
       "737                                                                                                                                                                                    Poblaciones especiales   \n",
       "738                                                                                                                                                                                                             \n",
       "739                                                                                                                                                                                       Insuficiencia renal   \n",
       "740                                                                                                                                                                                                             \n",
       "741   No es necesario ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Se recomienda precaución en pacientes con insuficiencia renal grave (aclaramiento de la creatinina menor o ig...   \n",
       "742                                                                                                                                                                                                             \n",
       "743                                                                                                                                                                                    Insuficiencia hepática   \n",
       "744                                                                                                                                                                                                             \n",
       "745   No es necesario ajustar la dosis en pacientes de 6 meses o mayores con insuficiencia hepática leve (Child-Pugh Clase A). Para los pacientes de 6 meses o mayores con insuficiencia hepática moderada...   \n",
       "746                                                                                                                                                                                                             \n",
       "747   Debido a la variabilidad en la maduración de las enzimas del citocromo (CYP) que intervienen en el metabolismo de ivacaftor, no se recomienda el tratamiento con ivacaftor en pacientes de 4 meses a...   \n",
       "748                                                                                                                                                                                                             \n",
       "749                                                                                                                                                                                      Población pediátrica   \n",
       "750                                                                                                                                                                                                             \n",
       "751                                                                                            No se ha establecido la seguridad y eficacia de ivacaftor en niños menores de 4 meses. No se dispone de datos.   \n",
       "752                                                                                                                                                                                                             \n",
       "753   Los datos disponibles en pacientes menores de 6 años con una mutación R117H en el gen CFTR son limitados. Los datos disponibles en pacientes de 6 años o mayores están descritos en las secciones 4....   \n",
       "754                                                                                                                                                                                                             \n",
       "755                                                                                                                                                                                   Forma de administración   \n",
       "756                                                                                                                                                                                                             \n",
       "757                                                                                                                                                                                                 Vía oral.   \n",
       "758                                                                                                                                                                                                             \n",
       "759                                                                                                                                                                  Cada sobre es únicamente de un solo uso.   \n",
       "760                                                                                                                                                                                                             \n",
       "761   Cada sobre de granulado se debe mezclar con 5 ml de un alimento blando o líquido adecuado para la edad y consumir todo inmediatamente. El alimento o el líquido deben estar a temperatura ambiente o...   \n",
       "762                                                                                                                                                                                                             \n",
       "763                                                                                                    Se deben evitar los alimentos o bebidas que contienen pomelo durante el tratamiento (ver sección 4.5).   \n",
       "764                                                                                                                                                                                                             \n",
       "765                                                                                                                                                                                4.3     Contraindicaciones   \n",
       "766                                                                                                                                                                                                             \n",
       "767                                                                                                          Hipersensibilidad al principio activo o a alguno de los excipientes incluidos en la sección 6.1.   \n",
       "768                                                                                                                                                                                                             \n",
       "769                                                                                                                                                  4.4     Advertencias y precauciones especiales de empleo   \n",
       "770                                                                                                                                                                                                             \n",
       "771   Únicamente los pacientes con FQ con una mutación de apertura del canal (clase III): G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N o S549R o una mutación G970R en al menos un alelo del...   \n",
       "772                                                                                                                                                                                                             \n",
       "773             En el estudio 6, se ha demostrado menos evidencia de un efecto positivo de ivacaftor en pacientes con una mutación R117H-7T asociada a una menor gravedad de la enfermedad (ver sección 5.1).   \n",
       "774                                                                                                                                                                                                             \n",
       "775   En el estudio 5 fueron incluidos cuatro pacientes con la mutación G970R. En tres de los cuatro pacientes el cambio en la prueba de cloruro en el sudor fue <5 mmol/l y este grupo no demostró una me...   \n",
       "776                                                                                                                                                                                                             \n",
       "777   Los resultados de eficacia de un estudio de fase 2 en pacientes con FQ homocigóticos para la mutación F508del en el gen CFTR no mostraron una diferencia estadísticamente significativa en el VEF1 a...   \n",
       "778                                                                                                                                                                                                             \n",
       "779                                                                                                                                                              Efecto en las pruebas de la función hepática   \n",
       "780                                                                                                                                                                                                             \n",
       "781   Es frecuente el aumento moderado de las aminotransferasas (alanina-aminotransferasa [ALAT] o aspartato‑aminotransferasa [ASAT]) en los sujetos con FQ. Se han observado aumentos de las aminotransfe...   \n",
       "782                                                                                                                                                                                                             \n",
       "783                                                                                                                                                                                    Insuficiencia hepática   \n",
       "784                                                                                                                                                                                                             \n",
       "785   No se recomienda utilizar ivacaftor en pacientes con insuficiencia hepática grave a menos que los beneficios esperados superen los riesgos (ver las secciones 4.2 y 5.2). No se dispone de datos de ...   \n",
       "786                                                                                                                                                                                                             \n",
       "787                                                                                                                                                                                       Insuficiencia renal   \n",
       "788                                                                                                                                                                                                             \n",
       "789                                              Se recomienda precaución mientras se utiliza ivacaftor en pacientes con insuficiencia renal grave o enfermedad renal terminal (ver las secciones 4.2 y 5.2).   \n",
       "790                                                                                                                                                                                                             \n",
       "791                                                                                                                                                             Pacientes después de un trasplante de órganos   \n",
       "792                                                                                                                                                                                                             \n",
       "793   Ivacaftor no se ha estudiado en pacientes con FQ que se han sometido a un trasplante de órganos. Por lo tanto, no se recomienda utilizar en pacientes trasplantados. Ver sección 4.5 para las intera...   \n",
       "794                                                                                                                                                                                                             \n",
       "795                                                                                                                                                                      Interacciones con otros medicamentos   \n",
       "796                                                                                                                                                                                                             \n",
       "797                                                                                                                                                                                       Inductores de CYP3A   \n",
       "798                                                                                                                                                                                                             \n",
       "799   La exposición a ivacaftor disminuye significativamente con el uso concomitante de inductores de CYP3A, pudiendo dar lugar a una posible pérdida de la eficacia de ivacaftor; por lo tanto, no se rec...   \n",
       "800                                                                                                                                                                                                             \n",
       "801                                                                                                                                                                                      Inhibidores de CYP3A   \n",
       "802                                                                                                                                                                                                             \n",
       "803   La exposición a ivacaftor aumenta cuando se administra con inhibidores potentes o moderados de CYP3A. Se debe ajustar la dosis de ivacaftor cuando se utilice de forma concomitante con inhibidores ...   \n",
       "804                                                                                                                                                                                                             \n",
       "805                                                                                                                                                                                      Población pediátrica   \n",
       "806                                                                                                                                                                                                             \n",
       "807   Se han notificado casos de opacidad del cristalino/cataratas no congénitas sin afectar a la visión en pacientes pediátricos tratados con ivacaftor. Aunque en algunos casos había otros factores de ...   \n",
       "808                                                                                                                                                                                                             \n",
       "809                                                                                                                                                                                      Contenido de lactosa   \n",
       "810                                                                                                                                                                                                             \n",
       "811          Kalydeco contiene lactosa. Los pacientes con intolerancia hereditaria a galactosa, deficiencia total de lactasa o problemas de absorción de glucosa o galactosa no deben tomar este medicamento.   \n",
       "812                                                                                                                                                                                                             \n",
       "813                                                                                                                                                                                        Contenido de sodio   \n",
       "814                                                                                                                                                                                                             \n",
       "815                                                                                 Este medicamento contiene menos de 23 mg de sodio (1 mmol) por unidad de dosis; esto es, esencialmente “exento de sodio”.   \n",
       "816                                                                                                                                                                                                             \n",
       "817                                                                                                                                  4.5     Interacción con otros medicamentos y otras formas de interacción   \n",
       "818                                                                                                                                                                                                             \n",
       "819           Ivacaftor es un sustrato de CYP3A4 y CYP3A5. Es un inhibidor débil de CYP3A y P‑gp y un posible inhibidor de CYP2C9. Los estudios in vitro demostraron que ivacaftor no es un sustrato de P‑gp.   \n",
       "820                                                                                                                                                                                                             \n",
       "821                                                                                                                                                Medicamentos que afectan a la farmacocinética de ivacaftor   \n",
       "822                                                                                                                                                                                                             \n",
       "823                                                                                                                                                                                       Inductores de CYP3A   \n",
       "824                                                                                                                                                                                                             \n",
       "825   La administración conjunta de ivacaftor con rifampicina, un inductor potente de CYP3A, disminuyó la exposición a ivacaftor (AUC) en un 89 % y a hidroximetil-ivacaftor (M1), aunque en menor grado q...   \n",
       "826                                                                                                                                                                                                             \n",
       "827                                                                                     No se recomienda un ajuste de la dosis cuando se utilice ivacaftor junto con inductores débiles o moderados de CYP3A.   \n",
       "828                                                                                                                                                                                                             \n",
       "829                                                                                                                                                                                      Inhibidores de CYP3A   \n",
       "830                                                                                                                                                                                                             \n",
       "831   Ivacaftor es un sustrato sensible de CYP3A. La administración conjunta con ketoconazol, un inhibidor potente de CYP3A, aumentó la exposición a ivacaftor (determinada como área bajo la curva [AUC])...   \n",
       "832                                                                                                                                                                                                             \n",
       "833   La administración conjunta con fluconazol, un inhibidor moderado de CYP3A, aumentó la exposición a ivacaftor en 3 veces y a su metabolito M1, aunque en menor grado que a ivacaftor. Se recomienda d...   \n",
       "834                                                                                                                                                                                                             \n",
       "835   La administración conjunta de ivacaftor con zumo de pomelo, que contiene uno o más componentes que inhiben de forma moderada CYP3A, puede aumentar la exposición a ivacaftor. Se deben evitar los al...   \n",
       "836                                                                                                                                                                                                             \n",
       "837                                                                                                                                               Capacidad de ivacaftor para interactuar con transportadores   \n",
       "838                                                                                                                                                                                                             \n",
       "839   Los estudios in vitro demostraron que ivacaftor no es un sustrato de OATP1B1 ni de OATP1B3. Ivacaftor y sus metabolitos son sustratos de BCRP in vitro. Debido a su alta permeabilidad intrínseca y ...   \n",
       "840                                                                                                                                                                                                             \n",
       "841                                                                                                                                                                                            Ciprofloxacino   \n",
       "842                                                                                                                                                                                                             \n",
       "843       La administración conjunta de ciprofloxacino con ivacaftor no afectó a la exposición a ivacaftor. No es necesario ajustar la dosis cuando ivacaftor se administra conjuntamente con ciprofloxacino.   \n",
       "844                                                                                                                                                                                                             \n",
       "845                                                                                                                                                                   Medicamentos a los que afecta ivacaftor   \n",
       "846                                                                                                                                                                                                             \n",
       "847   La administración de ivacaftor puede aumentar la exposición sistémica de los medicamentos que son sustratos sensibles de CYP2C9, y/o P‑gp y/o CYP3A, lo que puede aumentar o prolongar su efecto ter...   \n",
       "848                                                                                                                                                                                                             \n",
       "849                                                                                                                                                                                       Sustratos de CYP2C9   \n",
       "850                                                                                                                                                                                                             \n",
       "851   Ivacaftor puede inhibir CYP2C9. Por lo tanto, se recomienda controlar la razón internacional normalizada (INR) durante la administración conjunta de warfarina con ivacaftor. Los otros medicamentos...   \n",
       "852                                                                                                                                                                                                             \n",
       "853                                                                                                                                                                        Digoxina y otros sustratos de P‑gp   \n",
       "854                                                                                                                                                                                                             \n",
       "855   La administración conjunta con digoxina, un sustrato sensible de la P‑gp, aumentó la exposición a digoxina en 1,3 veces, lo que es coherente con la inhibición débil de la P‑gp por ivacaftor. La ad...   \n",
       "856                                                                                                                                                                                                             \n",
       "857                                                                                                                                                                                        Sustratos de CYP3A   \n",
       "858                                                                                                                                                                                                             \n",
       "859   La administración conjunta con midazolam (oral), un sustrato de CYP3A sensible, aumentó la exposición a midazolam en 1,5 veces, lo que es coherente con la inhibición débil de CYP3A por ivacaftor. ...   \n",
       "860                                                                                                                                                                                                             \n",
       "861                                                                                                                                                                                Anticonceptivos hormonales   \n",
       "862                                                                                                                                                                                                             \n",
       "863   Se ha estudiado ivacaftor con un anticonceptivo oral de estrógeno/progesterona y se observó que no afectaba significativamente a la exposición al anticonceptivo oral. Por lo tanto, no es necesario...   \n",
       "864                                                                                                                                                                                                             \n",
       "865                                                                                                                                                                                      Población pediátrica   \n",
       "866                                                                                                                                                                                                             \n",
       "867                                                                                                                                           Los estudios de interacciones se han realizado solo en adultos.   \n",
       "868                                                                                                                                                                                                             \n",
       "869                                                                                                                                                                  4.6     Fertilidad, embarazo y lactancia   \n",
       "870                                                                                                                                                                                                             \n",
       "871                                                                                                                                                                                                  Embarazo   \n",
       "872                                                                                                                                                                                                             \n",
       "873   No hay datos o estos son limitados (datos en menos de 300 embarazos) relativos al uso de ivacaftor en mujeres embarazadas. Los estudios en animales no sugieren efectos perjudiciales directos ni in...   \n",
       "874                                                                                                                                                                                                             \n",
       "875                                                                                                                                                                                                 Lactancia   \n",
       "876                                                                                                                                                                                                             \n",
       "877   Se desconoce si ivacaftor y/o sus metabolitos se excretan en la leche materna. Los datos farmacocinéticos disponibles en animales muestran que ivacaftor se excreta en la leche de ratas hembra en p...   \n",
       "878                                                                                                                                                                                                             \n",
       "879                                                                                                                                                                                                Fertilidad   \n",
       "880                                                                                                                                                                                                             \n",
       "881                                                    No se dispone de datos sobre el efecto de ivacaftor en la fertilidad en humanos. Ivacaftor tuvo un efecto en la fertilidad en ratas (ver sección 5.3).   \n",
       "882                                                                                                                                                                                                             \n",
       "883                                                                                                                                      4.7     Efectos sobre la capacidad para conducir y utilizar máquinas   \n",
       "884                                                                                                                                                                                                             \n",
       "885   La influencia de ivacaftor sobre la capacidad para conducir y utilizar máquinas es pequeña. Ivacaftor puede producir mareos (ver sección 4.8) y, por lo tanto, se debe aconsejar a los pacientes que...   \n",
       "886                                                                                                                                                                                                             \n",
       "887                                                                                                                                                                               4.8     Reacciones adversas   \n",
       "888                                                                                                                                                                                                             \n",
       "889                                                                                                                                                                           Resumen del perfil de seguridad   \n",
       "890                                                                                                                                                                                                             \n",
       "891   Las reacciones adversas más frecuentes experimentadas por los pacientes de 6 años o mayores son cefalea (23,9 %), dolor bucofaríngeo (22,0 %), infección en las vías respiratorias altas (22,0 %), c...   \n",
       "892                                                                                                                                                                                                             \n",
       "893   En pacientes de 2 a menos de 6 años las reacciones adversas más frecuentes fueron congestión nasal (26,5 %), infección en las vías respiratorias altas (23,5 %), aumento de las aminotransferasas (1...   \n",
       "894                                                                                                                                                                                                             \n",
       "895                                      Las reacciones adversas graves observadas en los pacientes que recibieron ivacaftor incluyeron dolor abdominal y aumento de las aminotransferasas (ver sección 4.4).   \n",
       "896                                                                                                                                                                                                             \n",
       "897                                                                                                                                                                              Tabla de reacciones adversas   \n",
       "898                                                                                                                                                                                                             \n",
       "899   La Tabla 2 muestra las reacciones adversas observadas con ivacaftor en los ensayos clínicos (estudios controlados con placebo y estudios no controlados) en los que la duración de la exposición a i...   \n",
       "900                                                                                                                                                                                                             \n",
       "901                                                                                                                                                                              Tabla 2: Reacciones adversas   \n",
       "902       Sistema    de clasificación de órganos    Reacciones adversas   Frecuencia      Infecciones e   infestaciones   Infección en   las vías respiratorias altas   Muy   frecuentes     Nasofaringiti...   \n",
       "903                                                                                                                                                                                                             \n",
       "904                                                                                                                                                          Descripción de reacciones adversas seleccionadas   \n",
       "905                                                                                                                                                                                                             \n",
       "906                                                                                                                                                                          Aumento de las aminotransferasas   \n",
       "907                                                                                                                                                                                                             \n",
       "908   Durante los estudios clínicos 1 y 2 controlados con placebo, de 48 semanas de duración en pacientes de 6 años o mayores, la incidencia de niveles máximos de las aminotransferasas (ALAT o ASAT) >8,...   \n",
       "909                                                                                                                                                                                                             \n",
       "910   Durante los estudios de fase 3, controlados con placebo (hasta 24 semanas) de tezacaftor/ivacaftor, la incidencia de niveles máximos de las aminotransferasas (ALAT o ASAT) >8, >5 o >3 veces el LSN...   \n",
       "911                                                                                                                                                                                                             \n",
       "912   Durante el estudio de fase 3, controlados con placebo de 24 semanas de duración de ivacaftor/tezacaftor/elexacaftor, estas cifras fueron del 1,5 %, 2,5 % y 7,9 % en los pacientes tratados con ivac...   \n",
       "913                                                                                                                                                                                                             \n",
       "914                                                                                                                                                                                      Población pediátrica   \n",
       "915                                                                                                                                                                                                             \n",
       "916   Los datos de seguridad de ivacaftor se evaluaron en 6 pacientes de entre 4 meses y menos de 6 meses de edad, 11 pacientes de entre 6 meses y menos de 12 meses de edad, en 19 pacientes de entre 12 ...   \n",
       "917                                                                                                                                                                                                             \n",
       "918                                           El perfil de seguridad es por lo general coherente entre los pacientes pediátricos de 4 meses o mayores y también es coherente con el de los pacientes adultos.   \n",
       "919                                                                                                                                                                                                             \n",
       "920   La incidencia de aumento de las aminotransferasas (ALAT o ASAT) observada en los estudios 2, 5 y 6 (pacientes de 6 a menos de 12 años), el estudio 7 (pacientes de 2 a menos de 6 años) y el estudio...   \n",
       "921                                                                                                                                                                                                             \n",
       "922                                                                                       Tabla 3: Aumentos de las aminotransferasas en pacientes de 4 meses a <12 años tratados con ivacaftor en monoterapia   \n",
       "923          n   % de pacientes >3 veces el LSN   % de pacientes >5 veces el LSN   % de pacientes >8 veces el LSN     6 a   <12 años   40   15,0 % (6)   2,5 % (1)   2,5 % (1)     2 a   <6 años   34   14...   \n",
       "924                                                                                                                                                                                                             \n",
       "925                                                                                                                                                          Notificación de sospechas de reacciones adversas   \n",
       "926                                                                                                                                                                                                             \n",
       "927   Es importante notificar sospechas de reacciones adversas al medicamento tras su autorización. Ello permite una supervisión continuada de la relación beneficio/riesgo del medicamento. Se invita a l...   \n",
       "928                                                                                                                                                                                                             \n",
       "929                                                                                                                                                                                        4.9     Sobredosis   \n",
       "930                                                                                                                                                                                                             \n",
       "931   No existe un antídoto específico para la sobredosis de ivacaftor. El tratamiento de la sobredosis consiste en las medidas de soporte generales que incluyen control de las constantes vitales, prueb...   \n",
       "932                                                                                                                                                                                                             \n",
       "933                                                                                                                                                                                                             \n",
       "934                                                                                                                                                                       5.       PROPIEDADES FARMACOLÓGICAS   \n",
       "935                                                                                                                                                                                                             \n",
       "936                                                                                                                                                                      5.1     Propiedades farmacodinámicas   \n",
       "937                                                                                                                                                                                                             \n",
       "938                                                                                                                   Grupo farmacoterapéutico: Otros productos del sistema respiratorio, código ATC: R07AX02   \n",
       "939                                                                                                                                                                                                             \n",
       "940                                                                                                                                                                                       Mecanismo de acción   \n",
       "941                                                                                                                                                                                                             \n",
       "942   Ivacaftor es un potenciador de la proteína CFTR, es decir, ivacaftor in vitro aumenta la apertura del canal de CFTR para intensificar el transporte de cloruro en las mutaciones de apertura del can...   \n",
       "943                                                                                                                                                                                                             \n",
       "944   Las respuestas in vitro observadas en los experimentos de fijación de membranas de un solo canal utilizando membranas de células de roedores que expresaban las formas de CFTR mutantes no correspon...   \n",
       "945                                                                                                                                                                                                             \n",
       "946                                                                                                                                                                                  Efectos farmacodinámicos   \n",
       "947                                                                                                                                                                                                             \n",
       "948   En los estudios 1 y 2 en pacientes con la mutación G551D en un alelo del gen CFTR, ivacaftor dio lugar a disminuciones rápidas (15 días), sustanciales (el cambio medio del cloruro en el sudor desd...   \n",
       "949                                                                                                                                                                                                             \n",
       "950   En la parte 1 del estudio 5 en pacientes con una mutación de apertura del canal no G551D en el gen CFTR, el tratamiento con ivacaftor dio lugar a un cambio medio rápido (15 días) e importante desd...   \n",
       "951                                                                                                                                                                                                             \n",
       "952   En el estudio 6, en pacientes de 6 años o mayores con FQ con una mutación R117H en el gen CFTR, la diferencia entre tratamientos en el cambio medio del cloruro en el sudor desde el valor basal has...   \n",
       "953                                                                                                                                                                                                             \n",
       "954   En el estudio 7 en pacientes de 2 a menos de 6 años con una mutación de apertura del canal en al menos un alelo del gen CFTR que recibieron 50 mg o 75 mg de ivacaftor dos veces al día, el cambio a...   \n",
       "955                                                                                                                                                                                                             \n",
       "956   En el estudio 8 en pacientes con FQ menores de 24 meses, el cambio absoluto medio del cloruro en el sudor desde el valor basal fue de –65,1 mmol/l (IC del 95 %: –74,1; –56,0) en la semana 24. Los ...   \n",
       "957                                                                                                                                                                                                             \n",
       "958                                                                                                                                                                              Eficacia clínica y seguridad   \n",
       "959                                                                                                                                                                                                             \n",
       "960                                                                                                                   Estudios 1 y 2: estudios en pacientes con FQ con mutaciones de apertura del canal G551D   \n",
       "961                                                                                                                                                                                                             \n",
       "962   Se ha evaluado la eficacia de ivacaftor en dos estudios de fase 3, aleatorizados, doble ciego, controlados con placebo, multicéntricos, de pacientes clínicamente estables con FQ que presentaban la...   \n",
       "963                                                                                                                                                                                                             \n",
       "964   Los pacientes de ambos estudios fueron aleatorizados 1:1 a recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos grasos durante 48 semanas, además de los tratamientos prescritos para l...   \n",
       "965                                                                                                                                                                                                             \n",
       "966   El estudio 1 evaluó a 161 pacientes de 12 años o mayores; 122 (75,8 %) pacientes presentaban la mutación F508del en el segundo alelo. Al inicio del estudio, los pacientes del grupo de placebo util...   \n",
       "967                                                                                                                                                                                                             \n",
       "968   El estudio 2 evaluó a 52 pacientes de 6 a 11 años en el momento de la selección; el peso corporal medio (DE) era de 30,9 (8,63) kg; 42 (80,8 %) pacientes presentaban la mutación F508del en el segu...   \n",
       "969                                                                                                                                                                                                             \n",
       "970                                La variable principal de eficacia en ambos estudios fue el cambio absoluto medio desde el valor basal en el porcentaje predicho de VEF1 hasta la semana 24 de tratamiento.   \n",
       "971                                                                                                                                                                                                             \n",
       "972   La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF1 desde el valor basal hasta la semana 24 fue de 10,6 puntos por...   \n",
       "973                                                                                                                                                                                                             \n",
       "974   La diferencia del tratamiento entre ivacaftor y placebo para el cambio absoluto medio (IC del 95 %) en el porcentaje predicho de VEF1 desde el valor basal hasta la semana 24 en pacientes de 12 a 1...   \n",
       "975                                                                                                                                                                                                             \n",
       "976                                                                                             Los resultados correspondientes a las variables secundarias clínicamente relevantes se muestran en la Tabla 4   \n",
       "977                                                                                                                                                                                                             \n",
       "978                                                                                                                         Tabla 4: Efecto de ivacaftor en otras variables de eficacia en los estudios 1 y 2   \n",
       "979           Estudio 1   Estudio 2     Variable   Diferencia del tratamientoa (IC del 95 %)   Valor p   Diferencia del tratamientoa (IC del 95 %)   Valor p      Cambio absoluto medio desde el   valor b...   \n",
       "980                                                                                                              IC: Intervalo de confianza; NA: no analizado debido a la baja incidencia de acontecimientos.   \n",
       "981                                                                                                                                 a     Diferencia del tratamiento = efecto de ivacaftor–efecto de placebo.   \n",
       "982           b     CFQ-R: El cuestionario revisado de la calidad de vida para fibrosis quística es una determinación de la calidad de vida relacionada con la salud, específica a la enfermedad, para la FQ.   \n",
       "983   c     Los datos del estudio 1 fueron agrupados a partir del CFQ-R para adultos/adolescentes y del CFQ‑R para niños de 12 a 13 años; los datos del estudio 2 se obtuvieron a partir del CFQ-R para ni...   \n",
       "984                                                                                                                          d        Proporción de riesgo del tiempo hasta la primera exacerbación pulmonar.   \n",
       "985                                                                                                                                    e     En sujetos menores de 20 años (gráficos de crecimiento del CDC).   \n",
       "986                                                                                                                                                                                                             \n",
       "987                                                                                                                      Estudio 5: estudio en pacientes con FQ con mutaciones de apertura del canal no G551D   \n",
       "988                                                                                                                                                                                                             \n",
       "989   El estudio 5 fue un estudio de fase 3, de dos partes, aleatorizado, doble ciego, controlado con placebo y cruzado (parte 1) seguido de un periodo de extensión abierta de 16 semanas de duración (pa...   \n",
       "990                                                                                                                                                                                                             \n",
       "991   En la parte 1, los pacientes fueron aleatorizados 1:1 para recibir 150 mg de ivacaftor o placebo cada 12 horas con alimentos que contenían grasas durante 8 semanas además de los tratamientos presc...   \n",
       "992                                                                                                                                                                                                             \n",
       "993   Se incluyó en el estudio a 39 pacientes (edad media: 23 años) con un porcentaje predicho de VEF1 basal ≥40 % (porcentaje predicho medio de VEF1 del 78 % [intervalo: 43 % a 119 %]). Un 62 % (24/39)...   \n",
       "994                                                                                                                                                                                                             \n",
       "995   En la parte 1 del estudio 5, el porcentaje predicho medio de VEF1 basal en los pacientes tratados con placebo fue del 79,3 % mientras que en los pacientes tratados con ivacaftor este valor fue del...   \n",
       "996                                                                                                                                                                                                             \n",
       "997   El efecto de ivacaftor en la población global del estudio 5 (incluidas las variables secundarias del cambio absoluto en el IMC a las 8 semanas de tratamiento y el cambio absoluto en la puntuación ...   \n",
       "998                                                                                                                                                                                                             \n",
       "999                                                                       Tabla 5: Efecto de ivacaftor para las variables de eficacia en la población global y para las mutaciones específicas en el gen CFTR   \n",
       "1000     Cambio absoluto en el porcentaje predicho de VEF1   IMC (kg/m2)   Puntuación (puntos) en el CFQ-R   dominio respiratorio     hasta la semana 8   a la semana 8   hasta la semana 8     Todos los ...   \n",
       "1001                                                                                                           *     No se realizaron análisis estadísticos debido al pequeño número de mutaciones concretas.   \n",
       "1002                                                                                       †     Refleja los resultados de un paciente con la mutación G551S con datos en el punto temporal de las 8 semanas.   \n",
       "1003                                                                                                                               ††   n = 3 para el análisis del cambio absoluto en el cloruro en el sudor.   \n",
       "1004                                                                                         #     Causa un defecto de empalme que da lugar a un nivel bajo o nulo de proteína CFTR en la superficie celular.   \n",
       "1005                                                                                                                                                                                                            \n",
       "1006  En la parte 2 del estudio 5, el cambio absoluto medio (DE) en el porcentaje predicho de VEF1 tras 16 semanas (pacientes aleatorizados a la secuencia de tratamiento ivacaftor/placebo en la parte 1)...   \n",
       "1007                                                                                                                                                                                                            \n",
       "1008                                                                                                                            Estudio 3: estudio en pacientes con FQ con la mutación F508del en el gen CFTR   \n",
       "1009                                                                                                                                                                                                            \n",
       "1010  El estudio 3 (parte A) fue un estudio de fase 2, de grupos paralelos, controlado con placebo, doble ciego, aleatorizado 4:1, de 16 semanas de duración, en el que se administró ivacaftor (150 mg ca...   \n",
       "1011                                                                                                                                                                                                            \n",
       "1012  El cambio absoluto medio desde el valor basal hasta la semana 16 en el porcentaje predicho de VEF1 (variable principal de eficacia) fue de 1,5 puntos porcentuales en el grupo de ivacaftor y de −0,...   \n",
       "1013                                                                                                                                                                                                            \n",
       "1014                                                                                                                                                                  Estudio 4: estudio de extensión abierta   \n",
       "1015                                                                                                                                                                                                            \n",
       "1016  En el estudio 4, los pacientes que completaron el tratamiento en los estudios 1 y 2 con placebo pasaron al tratamiento con ivacaftor mientras que los pacientes tratados con ivacaftor continuaron r...   \n",
       "1017                                                                                                                                                                                                            \n",
       "1018  Ciento cuarenta y cuatro (144) pacientes del estudio 1 pasaron al estudio 4, 67 del grupo de placebo/ivacaftor y 77 del grupo de ivacaftor/ivacaftor. Cuarenta y ocho (48) pacientes del estudio 2 p...   \n",
       "1019                                                                                                                                                                                                            \n",
       "1020  La Tabla 6 muestra los resultados del cambio absoluto medio (DE) en el porcentaje predicho de VEF1 para ambos grupos de pacientes. Para los pacientes del grupo de placebo/ivacaftor el porcentaje p...   \n",
       "1021                                                                                                                                                                                                            \n",
       "1022                                                                                                                           Tabla 6: Efecto de ivacaftor en el porcentaje predicho de VEF1 en el estudio 4   \n",
       "1023     Estudio   original y grupo de tratamiento   Duración   del tratamiento con ivacaftor (semanas)   Cambio absoluto en el porcentaje predicho de VEF1 desde el valor basal (puntos porcentuales)    ...   \n",
       "1024                                                                                     *    El tratamiento se administró durante el estudio de fase 3, doble ciego, controlado y de 48 semanas de duración.   \n",
       "1025                                                                                                    †    Cambio desde el valor basal del estudio previo después de 48 semanas de tratamiento con placebo.   \n",
       "1026                                                                                                                                                                                                            \n",
       "1027  Cuando se compara el cambio absoluto medio (DE) en el porcentaje predicho de VEF1 desde el valor basal del estudio 4 para los pacientes del grupo de ivacaftor/ivacaftor (n = 72) que pasaron del es...   \n",
       "1028                                                                                                                                                                                                            \n",
       "1029  Para los pacientes del grupo de placebo/ivacaftor del estudio 1, la tasa anualizada de exacerbaciones pulmonares fue más alta en el estudio inicial cuando los pacientes recibían placebo (1,34 acon...   \n",
       "1030                                                                                                                                                                                                            \n",
       "1031                                                                                                        Para los pacientes que pasaron del estudio 2, el número de acontecimientos fue, en general, bajo.   \n",
       "1032                                                                                                                                                                                                            \n",
       "1033                                                                                                                             Estudio 6: estudio en pacientes con FQ con una mutación R117H en el gen CFTR   \n",
       "1034                                                                                                                                                                                                            \n",
       "1035  En el estudio 6 se evaluaron 69 pacientes de 6 años o mayores; 53 (76,8 %) pacientes tenían la mutación F508del en el segundo alelo. La variante poli-T de R117H confirmada fue 5T en 38 pacientes y...   \n",
       "1036                                                                                                                                                                                                            \n",
       "1037  Se realizó un análisis de subgrupos previamente planificado en pacientes de 18 años o mayores (26 pacientes con placebo y 24 con ivacaftor). El tratamiento con ivacaftor produjo un cambio absoluto...   \n",
       "1038                                                                                                                                                                                                            \n",
       "1039  En un análisis de subgrupos en pacientes con una variante genética R117H-5T confirmada, la diferencia en el cambio absoluto medio desde el valor basal hasta la semana 24 en el porcentaje predicho ...   \n",
       "1040                                                                                                                                                                                                            \n",
       "1041  Para las variables secundarias de eficacia, no se observaron diferencias del tratamiento para ivacaftor frente a placebo en el cambio absoluto desde el valor basal en el IMC en la semana 24 ni en ...   \n",
       "1042                                                                                                                                                                                                            \n",
       "1043                                                                    Estudio 7: estudio en pacientes pediátricos con FQ de 2 a menos de 6 años con la mutación G551D u otra mutación de apertura del canal   \n",
       "1044                                                                                                                                                                                                            \n",
       "1045  En un estudio no controlado de 24 semanas de duración con ivacaftor (los pacientes con un peso inferior a 14 kg recibieron 50 mg de ivacaftor y los pacientes con un peso de 14 kg o más recibieron ...   \n",
       "1046                                                                                                                                                                                                            \n",
       "1047  Los pacientes del estudio 7 tenían de 2 a menos de 6 años (edad media: 3 años). De los 34 pacientes incluidos, 26 pacientes (76,5 %) tenían un genotipo G551D/F508del del gen CFTR y solo 2 paciente...   \n",
       "1048                                                                                                                                                                                                            \n",
       "1049  Se evaluó la variable principal de seguridad hasta la semana 24 (ver sección 4.8). Las variables secundarias y exploratorias de eficacia evaluadas fueron el cambio absoluto desde el valor basal en...   \n",
       "1050                                                                                                                                                                                                            \n",
       "1051  El cambio absoluto medio (DE) global (los dos grupos de ivacaftor combinados) desde el valor basal en el IMC en la semana 24 fue de 0,32 kg/m2 (0,54) y el cambio medio (DE) global en la puntuación...   \n",
       "1052                                                                                                                                                                                                            \n",
       "1053                                                                                                                                   Estudio 8: estudio en pacientes pediátricos con FQ menores de 24 meses   \n",
       "1054                                                                                                                                                                                                            \n",
       "1055  Se evaluaron el perfil farmacocinético, la seguridad y la eficacia de ivacaftor en pacientes con FQ de 6 meses a menos de 24 meses en una cohorte completa de pacientes en un estudio clínico de fas...   \n",
       "1056                                                                                                                                                                                                            \n",
       "1057  En la parte B del estudio 8 fueron incluidos 19 pacientes de 12 meses a menos de 24 meses (edad media de 15,2 meses al inicio), de los cuales 18 pacientes completaron el periodo de tratamiento de ...   \n",
       "1058                                                                                                                                                                                                            \n",
       "1059  En la parte B del estudio 8 se evaluó la variable principal de seguridad durante las 24 semanas (ver sección 4.8). Las variables secundarias fueron la evaluación de la farmacocinética y el cambio ...   \n",
       "1060                                                                                                                                                                                                            \n",
       "1061  Para los pacientes de 4 meses a menos de 24 meses, con valores iniciales y de la semana 24 disponibles, se proporcionan en la Tabla 7 las puntuaciones z medias (DE) del peso ajustado a la edad, de...   \n",
       "1062                                                                                                                                                                                                            \n",
       "1063                                                        Tabla 7: Efecto de ivacaftor en los parámetros de crecimiento en pacientes de 4 meses a menos de 24 meses con valores iniciales y de la semana 24   \n",
       "1064                                          Parámetro   Número de pacientes   Inicio     Cambio absoluto   en la semana 24     Media (DE)   Mediana (mín, máx)   Media (DE)   Mediana (mín, máx)              \n",
       "1065                                                                                 Puntuación z   del peso ajustado a la edad   35   0,17 (0,85)   0,20 [−1,92; 1,79]   0,33 (0,53)   0,26 [−0,54; 1,63]      \n",
       "1066     Puntuación z de la estatura ajustada a la   edad   34   0,06 (1,03)    0,12 [−1,99; 2,79]   0,32 (0,92)   0,47 [−1,81; 3,38]     Puntuación   z del peso ajustado a la estatura   34   0,24 (1,01...   \n",
       "1067                                                                                                                                                                                                            \n",
       "1068  En los pacientes de 4 meses a menos de 24 meses, con valores iniciales y de la semana 24 disponibles, había 18 pacientes con insuficiencia pancreática al inicio (definida como valores de elastasa‑...   \n",
       "1069                                                                                                                                                                                                            \n",
       "1070                                                                                                                                                                                     Población pediátrica   \n",
       "1071                                                                                                                                                                                                            \n",
       "1072  La Agencia Europea de Medicamentos ha concedido al titular un aplazamiento para presentar los resultados de los ensayos realizados con Kalydeco en uno o más grupos de la población pediátrica en la...   \n",
       "1073                                                                                                                                                                                                            \n",
       "1074                                                                                                                                                                     5.2     Propiedades farmacocinéticas   \n",
       "1075                                                                                                                                                                                                            \n",
       "1076                                                                                                   La farmacocinética de ivacaftor es similar entre los voluntarios adultos sanos y los pacientes con FQ.   \n",
       "1077                                                                                                                                                                                                            \n",
       "1078  Después de la administración oral de una dosis única de 150 mg a voluntarios sanos con el estómago lleno, la media (± DE) para el AUC y la Cmáx fue de 10 600 (5260) ng*h/ml y de 768 (233) ng/ml, r...   \n",
       "1079                                                                                                                                                                                                            \n",
       "1080                                                                                                                                                                                                Absorción   \n",
       "1081                                                                                                                                                                                                            \n",
       "1082  Después de la administración oral de dosis múltiples de ivacaftor, la exposición a ivacaftor aumentó por lo general con la dosis, de 25 mg cada 12 horas a 450 mg cada 12 horas. Cuando se administr...   \n",
       "1083                                                                                                                                                                                                            \n",
       "1084  El granulado de ivacaftor (2 sobres de 75 mg) presentó una biodisponibilidad similar a la de los comprimidos de 150 mg cuando se administraron con alimentos que contenían grasas a sujetos adultos ...   \n",
       "1085                                                                                                                                                                                                            \n",
       "1086                                                                                                                                                                                             Distribución   \n",
       "1087                                                                                                                                                                                                            \n",
       "1088  Aproximadamente el 99 % de ivacaftor se fija a las proteínas plasmáticas, principalmente a la alfa-1 glicoproteína ácida y a la albúmina. Ivacaftor no se fija a los eritrocitos humanos. Después de...   \n",
       "1089                                                                                                                                                                                                            \n",
       "1090                                                                                                                                                                                        Biotransformación   \n",
       "1091                                                                                                                                                                                                            \n",
       "1092  Ivacaftor se metaboliza extensamente en humanos. Los datos in vitro e in vivo indican que ivacaftor se metaboliza principalmente por CYP3A. El M1 y el M6 son los dos metabolitos principales de iva...   \n",
       "1093                                                                                                                                                                                                            \n",
       "1094  El efecto del genotipo heterocigótico de CYP3A4*22 en la exposición a ivacaftor es coherente con el efecto de la administración junto con un inhibidor débil de CYP3A4, lo que no tiene relevancia c...   \n",
       "1095                                                                                                                                                                                                            \n",
       "1096                                                                                                                                                                                              Eliminación   \n",
       "1097                                                                                                                                                                                                            \n",
       "1098  Tras la administración oral en voluntarios sanos, la mayor parte de ivacaftor (87,8 %) fue eliminada en las heces después de la conversión metabólica. Los metabolitos principales M1 y M6 represent...   \n",
       "1099                                                                                                                                                                                                            \n",
       "1100                                                                                                                                                                                 Linealidad/No linealidad   \n",
       "1101                                                                                                                                                                                                            \n",
       "1102                                                                                   La farmacocinética de ivacaftor es en general lineal con respecto al tiempo o al intervalo de dosis de 25 mg a 250 mg.   \n",
       "1103                                                                                                                                                                                                            \n",
       "1104                                                                                                                                                                                   Poblaciones especiales   \n",
       "1105                                                                                                                                                                                                            \n",
       "1106                                                                                                                                                                                   Insuficiencia hepática   \n",
       "1107                                                                                                                                                                                                            \n",
       "1108  Tras una sola dosis de 150 mg de ivacaftor, los sujetos adultos con insuficiencia hepática moderada (Child‑Pugh Clase B, puntuación 7 a 9) presentaron una Cmáx de ivacaftor similar (media [± DE] d...   \n",
       "1109                                                                                                                                                                                                            \n",
       "1110  No se ha estudiado el impacto de la insuficiencia hepática grave (Child-Pugh Clase C, puntuación 10 a 15) en la farmacocinética de ivacaftor. Se desconoce la magnitud del aumento de la exposición ...   \n",
       "1111                                                                                                                                                                                                            \n",
       "1112                                                                                                                 No se considera necesario ajustar la dosis en pacientes con insuficiencia hepática leve.   \n",
       "1113                                                                                                                                                                                                            \n",
       "1114                                                                                                                                                                                      Insuficiencia renal   \n",
       "1115                                                                                                                                                                                                            \n",
       "1116  No se han realizado estudios farmacocinéticos con ivacaftor en pacientes con insuficiencia renal. En un estudio farmacocinético realizado en humanos, se observó una eliminación mínima de ivacaftor...   \n",
       "1117                                                                                                                                                                                                            \n",
       "1118  No se recomienda ajustar la dosis en pacientes con insuficiencia renal leve o moderada. Sin embargo, se recomienda precaución cuando se administre ivacaftor a pacientes con insuficiencia renal gra...   \n",
       "1119                                                                                                                                                                                                            \n",
       "1120                                                                                                                                                                                                     Raza   \n",
       "1121                                                                                                                                                                                                            \n",
       "1122                          En función del análisis de FC poblacional, la raza no tuvo ningún efecto clínicamente significativo en la FC de ivacaftor en pacientes blancos (n = 379) y no blancos (n = 29).   \n",
       "1123                                                                                                                                                                                                            \n",
       "1124                                                                                                                                                                                                     Sexo   \n",
       "1125                                                                                                                                                                                                            \n",
       "1126                                                                                                                         Los parámetros farmacocinéticos de ivacaftor son similares en hombres y mujeres.   \n",
       "1127                                                                                                                                                                                                            \n",
       "1128                                                                                                                                                                               Pacientes de edad avanzada   \n",
       "1129                                                                                                                                                                                                            \n",
       "1130  Los estudios clínicos con ivacaftor en monoterapia no incluyeron un número suficiente de pacientes de 65 años o mayores para determinar si los parámetros farmacocinéticos son similares o no a los ...   \n",
       "1131                                                                                                                                                                                                            \n",
       "1132                                                                                                                                                                                     Población pediátrica   \n",
       "1133                                                                                                                                                                                                            \n",
       "1134  En la Tabla 8 se presenta por grupo de edad la exposición a ivacaftor predicha según las concentraciones de ivacaftor observadas en los estudios de fase 2 y 3, determinada mediante un análisis de ...   \n",
       "1135                                                                                                                                                                                                            \n",
       "1136                                                                                                                                              Tabla 8 Exposición media (DE) a ivacaftor por grupo de edad   \n",
       "1137      Grupo de edad   Dosis   Cmín, ee (ng/ml)   AUCτ,ee (ng*h/ml)      4 meses   a menos de 6 meses (≥5 kg)   25 mg   cada 12 h   371 (183)   6480 (2520)     6 meses   a menos de 12 meses (5 kg a <...   \n",
       "1138                                                                                                           *     Valores basados en los datos de un solo paciente; no se comunicó la desviación estándar.   \n",
       "1139                 †     Las exposiciones en los pacientes de 6 a 11 años son predicciones basadas en las simulaciones del modelo de FC poblacional utilizando los datos obtenidos para este grupo de edad.   \n",
       "1140                                                                                                                                                                                                            \n",
       "1141                                                                                                                                                                5.3     Datos preclínicos sobre seguridad   \n",
       "1142                                                                                                                                                                                                            \n",
       "1143  Los datos de los estudios preclínicos no muestran riesgos especiales para los seres humanos según los estudios convencionales de farmacología de seguridad, toxicidad a dosis repetidas, genotoxicid...   \n",
       "1144                                                                                                                                                                                                            \n",
       "1145                                                                                                                                                                                    Embarazo y fertilidad   \n",
       "1146                                                                                                                                                                                                            \n",
       "1147  Ivacaftor se asoció a una disminución ligera del peso de las vesículas seminales, a una disminución del índice de fertilidad global y del número de gestaciones en las hembras apareadas con machos ...   \n",
       "1148                                                                                                                                                                                                            \n",
       "1149                                                                                                                                                                          Desarrollo perinatal y posnatal   \n",
       "1150                                                                                                                                                                                                            \n",
       "1151  Ivacaftor redujo los índices de supervivencia y lactancia y produjo una disminución en los pesos corporales de las crías. La dosis sin efecto adverso observado para viabilidad y crecimiento de las...   \n",
       "1152                                                                                                                                                                                                            \n",
       "1153                                                                                                                                                                             Estudios en animales jóvenes   \n",
       "1154                                                                                                                                                                                                            \n",
       "1155  Se observaron cataratas en las ratas jóvenes tratadas desde el día 7 después de nacer hasta el día 35 a niveles de exposición de ivacaftor de 0,22 veces la dosis máxima recomendada en humanos segú...   \n",
       "1156                                                                                                                                                                                                            \n",
       "1157                                                                                                                                                                                                            \n",
       "1158                                                                                                                                                                             6.       DATOS FARMACÉUTICOS   \n",
       "1159                                                                                                                                                                                                            \n",
       "1160                                                                                                                                                                             6.1     Lista de excipientes   \n",
       "1161                                                                                                                                                                                                            \n",
       "1162                                                                                                                                                                                  Sílice coloidal anhidra   \n",
       "1163                                                                                                                                                                                     Croscarmelosa sódica   \n",
       "1164                                                                                                                                                                         Succinato acetato de hipromelosa   \n",
       "1165                                                                                                                                                                                      Lactosa monohidrato   \n",
       "1166                                                                                                                                                                                    Estearato de magnesio   \n",
       "1167                                                                                                                                                                                                  Manitol   \n",
       "1168                                                                                                                                                                                                Sucralosa   \n",
       "1169                                                                                                                                                                              Laurilsulfato sódico (E487)   \n",
       "1170                                                                                                                                                                                                            \n",
       "1171                                                                                                                                                                               6.2     Incompatibilidades   \n",
       "1172                                                                                                                                                                                                            \n",
       "1173                                                                                                                                                                                              No procede.   \n",
       "1174                                                                                                                                                                                                            \n",
       "1175                                                                                                                                                                               6.3     Periodo de validez   \n",
       "1176                                                                                                                                                                                                            \n",
       "1177                                                                                                                                                                                                  3 años.   \n",
       "1178                                                                                                                                                                                                            \n",
       "1179                                                                                                                                  Una vez mezclado, la mezcla ha demostrado ser estable durante una hora.   \n",
       "1180                                                                                                                                                                                                            \n",
       "1181                                                                                                                                                          6.4     Precauciones especiales de conservación   \n",
       "1182                                                                                                                                                                                                            \n",
       "1183                                                                                                                                                      No requiere condiciones especiales de conservación.   \n",
       "1184                                                                                                                                                                                                            \n",
       "1185                                                                                                                                                                6.5     Naturaleza y contenido del envase   \n",
       "1186                                                                                                                                                                                                            \n",
       "1187                                   El granulado está envasado en un sobre de tereftalato de polietileno de orientación biaxial/polietileno/papel de aluminio/polietileno (BOPET/PE/papel de aluminio/PE).   \n",
       "1188                                                                                                                                                                                                            \n",
       "1189                                                                                                                  Tamaño de envase de 56 sobres (contiene 4 estuches individuales con 14 sobres cada uno)   \n",
       "1190                                                                                                                                                                                                            \n",
       "1191                                                                                                                                    6.6     Precauciones especiales de eliminación y otras manipulaciones   \n",
       "1192                                                                                                                                                                                                            \n",
       "1193                                                La eliminación del medicamento no utilizado y de todos los materiales que hayan estado en contacto con él se realizará de acuerdo con la normativa local.   \n",
       "1194                                                                                                                                                                                                            \n",
       "1195                                                                                                                                                                                                            \n",
       "1196                                                                                                                                                  7.       TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN   \n",
       "1197                                                                                                                                                                                                            \n",
       "1198                                                                                                                                                                 Vertex Pharmaceuticals (Ireland) Limited   \n",
       "1199                                                                                                                                                                              28-32 Pembroke Street Upper   \n",
       "1200                                                                                                                                                                                       Dublin 2, D02 EK84   \n",
       "1201                                                                                                                                                                                                  Irlanda   \n",
       "1202                                                                                                                                                                                                            \n",
       "1203                                                                                                                                                                                                            \n",
       "1204                                                                                                                                                   8.       NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓN   \n",
       "1205                                                                                                                                                                                                            \n",
       "1206                                                                                                                                                                                          EU/1/12/782/003   \n",
       "1207                                                                                                                                                                                          EU/1/12/782/004   \n",
       "1208                                                                                                                                                                                          EU/1/12/782/006   \n",
       "1209                                                                                                                                                                                                            \n",
       "1210                                                                                                                                                                                                            \n",
       "1211                                                                                                                                  9.       FECHA DE LA PRIMERA AUTORIZACIÓN/RENOVACIÓN DE LA AUTORIZACIÓN   \n",
       "1212                                                                                                                                                                                                            \n",
       "1213                                                                                                                                                          Fecha de la primera autorización: 23/julio/2012   \n",
       "1214                                                                                                                                                             Fecha de la última renovación: 28/abril/2017   \n",
       "1215                                                                                                                                                                                                            \n",
       "1216                                                                                                                                                                                                            \n",
       "1217                                                                                                                                                                    10.    FECHA DE LA REVISIÓN DEL TEXTO   \n",
       "1218                                                                                                                                                                                                            \n",
       "1219                                                                                                                                                                                                            \n",
       "1220                                                            La información detallada de este medicamento está disponible en la página web de la Agencia Europea de Medicamentos http://www.ema.europa.eu.   \n",
       "1221                                                                                                                                                                                                            \n",
       "\n",
       "                                  ParentId  StringLength  \n",
       "0     f8cea01e-5a38-4761-a231-51d257e0ad34             0  \n",
       "1     af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "2     af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "3     af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "4     af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "5     af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "6     af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "7     af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "8     af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "9     af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "10    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "11    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "12    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "13    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "14    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "15    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "16    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "17    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "18    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "19    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "20    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "21    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "22    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "23    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "24    af72c67e-e145-4951-a2ae-9d6e209e11df             7  \n",
       "25    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "26    af72c67e-e145-4951-a2ae-9d6e209e11df            59  \n",
       "27    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "28    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "29    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "30    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "31    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "32    7ecdb210-02c7-4ff0-b4ac-f566e0547c51             0  \n",
       "33    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "34    af72c67e-e145-4951-a2ae-9d6e209e11df            25  \n",
       "35    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "36    af72c67e-e145-4951-a2ae-9d6e209e11df            51  \n",
       "37    af72c67e-e145-4951-a2ae-9d6e209e11df            52  \n",
       "38    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "39    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "40    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "41    af72c67e-e145-4951-a2ae-9d6e209e11df            41  \n",
       "42    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "43    af72c67e-e145-4951-a2ae-9d6e209e11df            51  \n",
       "44    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "45    af72c67e-e145-4951-a2ae-9d6e209e11df            68  \n",
       "46    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "47    af72c67e-e145-4951-a2ae-9d6e209e11df            30  \n",
       "48    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "49    af72c67e-e145-4951-a2ae-9d6e209e11df            80  \n",
       "50    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "51    af72c67e-e145-4951-a2ae-9d6e209e11df            52  \n",
       "52    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "53    af72c67e-e145-4951-a2ae-9d6e209e11df            69  \n",
       "54    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "55    af72c67e-e145-4951-a2ae-9d6e209e11df            30  \n",
       "56    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "57    af72c67e-e145-4951-a2ae-9d6e209e11df            81  \n",
       "58    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "59    af72c67e-e145-4951-a2ae-9d6e209e11df            65  \n",
       "60    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "61    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "62    af72c67e-e145-4951-a2ae-9d6e209e11df            21  \n",
       "63    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "64    af72c67e-e145-4951-a2ae-9d6e209e11df            47  \n",
       "65    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "66    af72c67e-e145-4951-a2ae-9d6e209e11df            51  \n",
       "67    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "68    af72c67e-e145-4951-a2ae-9d6e209e11df           204  \n",
       "69    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "70    af72c67e-e145-4951-a2ae-9d6e209e11df            52  \n",
       "71    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "72    af72c67e-e145-4951-a2ae-9d6e209e11df           205  \n",
       "73    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "74    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "75    af72c67e-e145-4951-a2ae-9d6e209e11df            17  \n",
       "76    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "77    af72c67e-e145-4951-a2ae-9d6e209e11df            29  \n",
       "78    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "79    af72c67e-e145-4951-a2ae-9d6e209e11df            35  \n",
       "80    af72c67e-e145-4951-a2ae-9d6e209e11df           431  \n",
       "81    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "82    af72c67e-e145-4951-a2ae-9d6e209e11df           495  \n",
       "83    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "84    af72c67e-e145-4951-a2ae-9d6e209e11df           337  \n",
       "85    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "86    af72c67e-e145-4951-a2ae-9d6e209e11df            39  \n",
       "87    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "88    af72c67e-e145-4951-a2ae-9d6e209e11df           470  \n",
       "89    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "90    af72c67e-e145-4951-a2ae-9d6e209e11df             9  \n",
       "91    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "92    af72c67e-e145-4951-a2ae-9d6e209e11df            98  \n",
       "93    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "94    af72c67e-e145-4951-a2ae-9d6e209e11df            36  \n",
       "95    af72c67e-e145-4951-a2ae-9d6e209e11df           736  \n",
       "96    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "97    af72c67e-e145-4951-a2ae-9d6e209e11df           172  \n",
       "98    af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "99    af72c67e-e145-4951-a2ae-9d6e209e11df            15  \n",
       "100   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "101   af72c67e-e145-4951-a2ae-9d6e209e11df           372  \n",
       "102   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "103   af72c67e-e145-4951-a2ae-9d6e209e11df           158  \n",
       "104   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "105   af72c67e-e145-4951-a2ae-9d6e209e11df            40  \n",
       "106   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "107   af72c67e-e145-4951-a2ae-9d6e209e11df           390  \n",
       "108   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "109   af72c67e-e145-4951-a2ae-9d6e209e11df           107  \n",
       "110   af72c67e-e145-4951-a2ae-9d6e209e11df          2220  \n",
       "111   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "112   af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "113   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "114   af72c67e-e145-4951-a2ae-9d6e209e11df            26  \n",
       "115   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "116   af72c67e-e145-4951-a2ae-9d6e209e11df           251  \n",
       "117   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "118   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "119   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "120   af72c67e-e145-4951-a2ae-9d6e209e11df           271  \n",
       "121   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "122   af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "123   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "124   af72c67e-e145-4951-a2ae-9d6e209e11df           153  \n",
       "125   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "126   af72c67e-e145-4951-a2ae-9d6e209e11df           154  \n",
       "127   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "128   af72c67e-e145-4951-a2ae-9d6e209e11df           175  \n",
       "129   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "130   af72c67e-e145-4951-a2ae-9d6e209e11df           172  \n",
       "131   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "132   af72c67e-e145-4951-a2ae-9d6e209e11df            93  \n",
       "133   af72c67e-e145-4951-a2ae-9d6e209e11df          2489  \n",
       "134   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "135   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "136   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "137   af72c67e-e145-4951-a2ae-9d6e209e11df           279  \n",
       "138   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "139   af72c67e-e145-4951-a2ae-9d6e209e11df           209  \n",
       "140   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "141   af72c67e-e145-4951-a2ae-9d6e209e11df            23  \n",
       "142   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "143   af72c67e-e145-4951-a2ae-9d6e209e11df             9  \n",
       "144   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "145   af72c67e-e145-4951-a2ae-9d6e209e11df           231  \n",
       "146   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "147   af72c67e-e145-4951-a2ae-9d6e209e11df            79  \n",
       "148   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "149   af72c67e-e145-4951-a2ae-9d6e209e11df           102  \n",
       "150   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "151   af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "152   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "153   af72c67e-e145-4951-a2ae-9d6e209e11df            96  \n",
       "154   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "155   af72c67e-e145-4951-a2ae-9d6e209e11df            52  \n",
       "156   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "157   af72c67e-e145-4951-a2ae-9d6e209e11df           277  \n",
       "158   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "159   af72c67e-e145-4951-a2ae-9d6e209e11df           384  \n",
       "160   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "161   af72c67e-e145-4951-a2ae-9d6e209e11df           380  \n",
       "162   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "163   af72c67e-e145-4951-a2ae-9d6e209e11df           189  \n",
       "164   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "165   af72c67e-e145-4951-a2ae-9d6e209e11df           218  \n",
       "166   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "167   af72c67e-e145-4951-a2ae-9d6e209e11df            44  \n",
       "168   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "169   af72c67e-e145-4951-a2ae-9d6e209e11df          1223  \n",
       "170   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "171   af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "172   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "173   af72c67e-e145-4951-a2ae-9d6e209e11df           393  \n",
       "174   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "175   af72c67e-e145-4951-a2ae-9d6e209e11df           395  \n",
       "176   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "177   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "178   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "179   af72c67e-e145-4951-a2ae-9d6e209e11df           259  \n",
       "180   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "181   af72c67e-e145-4951-a2ae-9d6e209e11df            45  \n",
       "182   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "183   af72c67e-e145-4951-a2ae-9d6e209e11df           337  \n",
       "184   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "185   af72c67e-e145-4951-a2ae-9d6e209e11df            27  \n",
       "186   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "187   af72c67e-e145-4951-a2ae-9d6e209e11df           892  \n",
       "188   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "189   af72c67e-e145-4951-a2ae-9d6e209e11df            36  \n",
       "190   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "191   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "192   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "193   af72c67e-e145-4951-a2ae-9d6e209e11df           464  \n",
       "194   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "195   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "196   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "197   af72c67e-e145-4951-a2ae-9d6e209e11df           398  \n",
       "198   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "199   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "200   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "201   af72c67e-e145-4951-a2ae-9d6e209e11df           661  \n",
       "202   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "203   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "204   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "205   af72c67e-e145-4951-a2ae-9d6e209e11df           192  \n",
       "206   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "207   af72c67e-e145-4951-a2ae-9d6e209e11df            18  \n",
       "208   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "209   af72c67e-e145-4951-a2ae-9d6e209e11df           121  \n",
       "210   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "211   af72c67e-e145-4951-a2ae-9d6e209e11df            68  \n",
       "212   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "213   af72c67e-e145-4951-a2ae-9d6e209e11df           191  \n",
       "214   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "215   af72c67e-e145-4951-a2ae-9d6e209e11df            58  \n",
       "216   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "217   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "218   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "219   af72c67e-e145-4951-a2ae-9d6e209e11df           543  \n",
       "220   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "221   af72c67e-e145-4951-a2ae-9d6e209e11df           220  \n",
       "222   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "223   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "224   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "225   af72c67e-e145-4951-a2ae-9d6e209e11df           610  \n",
       "226   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "227   af72c67e-e145-4951-a2ae-9d6e209e11df           500  \n",
       "228   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "229   af72c67e-e145-4951-a2ae-9d6e209e11df           392  \n",
       "230   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "231   af72c67e-e145-4951-a2ae-9d6e209e11df            59  \n",
       "232   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "233   af72c67e-e145-4951-a2ae-9d6e209e11df           482  \n",
       "234   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "235   af72c67e-e145-4951-a2ae-9d6e209e11df            14  \n",
       "236   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "237   af72c67e-e145-4951-a2ae-9d6e209e11df           298  \n",
       "238   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "239   af72c67e-e145-4951-a2ae-9d6e209e11df            39  \n",
       "240   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "241   af72c67e-e145-4951-a2ae-9d6e209e11df           231  \n",
       "242   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "243   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "244   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "245   af72c67e-e145-4951-a2ae-9d6e209e11df           424  \n",
       "246   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "247   af72c67e-e145-4951-a2ae-9d6e209e11df            34  \n",
       "248   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "249   af72c67e-e145-4951-a2ae-9d6e209e11df           719  \n",
       "250   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "251   af72c67e-e145-4951-a2ae-9d6e209e11df            18  \n",
       "252   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "253   af72c67e-e145-4951-a2ae-9d6e209e11df           451  \n",
       "254   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "255   af72c67e-e145-4951-a2ae-9d6e209e11df            26  \n",
       "256   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "257   af72c67e-e145-4951-a2ae-9d6e209e11df           347  \n",
       "258   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "259   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "260   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "261   af72c67e-e145-4951-a2ae-9d6e209e11df            63  \n",
       "262   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "263   af72c67e-e145-4951-a2ae-9d6e209e11df            36  \n",
       "264   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "265   af72c67e-e145-4951-a2ae-9d6e209e11df             8  \n",
       "266   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "267   af72c67e-e145-4951-a2ae-9d6e209e11df           358  \n",
       "268   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "269   af72c67e-e145-4951-a2ae-9d6e209e11df             9  \n",
       "270   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "271   af72c67e-e145-4951-a2ae-9d6e209e11df           489  \n",
       "272   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "273   af72c67e-e145-4951-a2ae-9d6e209e11df            10  \n",
       "274   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "275   af72c67e-e145-4951-a2ae-9d6e209e11df           150  \n",
       "276   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "277   af72c67e-e145-4951-a2ae-9d6e209e11df            64  \n",
       "278   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "279   af72c67e-e145-4951-a2ae-9d6e209e11df           286  \n",
       "280   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "281   af72c67e-e145-4951-a2ae-9d6e209e11df            23  \n",
       "282   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "283   af72c67e-e145-4951-a2ae-9d6e209e11df            31  \n",
       "284   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "285   af72c67e-e145-4951-a2ae-9d6e209e11df           537  \n",
       "286   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "287   af72c67e-e145-4951-a2ae-9d6e209e11df           256  \n",
       "288   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "289   af72c67e-e145-4951-a2ae-9d6e209e11df           164  \n",
       "290   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "291   af72c67e-e145-4951-a2ae-9d6e209e11df            28  \n",
       "292   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "293   af72c67e-e145-4951-a2ae-9d6e209e11df           868  \n",
       "294   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "295   af72c67e-e145-4951-a2ae-9d6e209e11df            28  \n",
       "296   af72c67e-e145-4951-a2ae-9d6e209e11df          1680  \n",
       "297   af72c67e-e145-4951-a2ae-9d6e209e11df           122  \n",
       "298   af72c67e-e145-4951-a2ae-9d6e209e11df           134  \n",
       "299   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "300   af72c67e-e145-4951-a2ae-9d6e209e11df            48  \n",
       "301   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "302   af72c67e-e145-4951-a2ae-9d6e209e11df            32  \n",
       "303   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "304   af72c67e-e145-4951-a2ae-9d6e209e11df          1288  \n",
       "305   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "306   af72c67e-e145-4951-a2ae-9d6e209e11df           693  \n",
       "307   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "308   af72c67e-e145-4951-a2ae-9d6e209e11df           531  \n",
       "309   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "310   af72c67e-e145-4951-a2ae-9d6e209e11df            27  \n",
       "311   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "312   af72c67e-e145-4951-a2ae-9d6e209e11df           285  \n",
       "313   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "314   af72c67e-e145-4951-a2ae-9d6e209e11df            35  \n",
       "315   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "316   af72c67e-e145-4951-a2ae-9d6e209e11df           252  \n",
       "317   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "318   af72c67e-e145-4951-a2ae-9d6e209e11df            24  \n",
       "319   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "320   af72c67e-e145-4951-a2ae-9d6e209e11df           238  \n",
       "321   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "322   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "323   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "324   af72c67e-e145-4951-a2ae-9d6e209e11df           411  \n",
       "325   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "326   af72c67e-e145-4951-a2ae-9d6e209e11df           194  \n",
       "327   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "328   af72c67e-e145-4951-a2ae-9d6e209e11df          1408  \n",
       "329   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "330   af72c67e-e145-4951-a2ae-9d6e209e11df           115  \n",
       "331   af72c67e-e145-4951-a2ae-9d6e209e11df           333  \n",
       "332   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "333   af72c67e-e145-4951-a2ae-9d6e209e11df            48  \n",
       "334   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "335   af72c67e-e145-4951-a2ae-9d6e209e11df           345  \n",
       "336   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "337   af72c67e-e145-4951-a2ae-9d6e209e11df            14  \n",
       "338   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "339   af72c67e-e145-4951-a2ae-9d6e209e11df           268  \n",
       "340   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "341   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "342   af72c67e-e145-4951-a2ae-9d6e209e11df            29  \n",
       "343   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "344   af72c67e-e145-4951-a2ae-9d6e209e11df            32  \n",
       "345   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "346   af72c67e-e145-4951-a2ae-9d6e209e11df            87  \n",
       "347   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "348   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "349   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "350   af72c67e-e145-4951-a2ae-9d6e209e11df           842  \n",
       "351   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "352   af72c67e-e145-4951-a2ae-9d6e209e11df           501  \n",
       "353   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "354   af72c67e-e145-4951-a2ae-9d6e209e11df            24  \n",
       "355   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "356   af72c67e-e145-4951-a2ae-9d6e209e11df            24  \n",
       "357   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "358   af72c67e-e145-4951-a2ae-9d6e209e11df           404  \n",
       "359   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "360   af72c67e-e145-4951-a2ae-9d6e209e11df           787  \n",
       "361   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "362   af72c67e-e145-4951-a2ae-9d6e209e11df           579  \n",
       "363   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "364   af72c67e-e145-4951-a2ae-9d6e209e11df            58  \n",
       "365   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "366   af72c67e-e145-4951-a2ae-9d6e209e11df           288  \n",
       "367   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "368   af72c67e-e145-4951-a2ae-9d6e209e11df           390  \n",
       "369   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "370   af72c67e-e145-4951-a2ae-9d6e209e11df           344  \n",
       "371   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "372   af72c67e-e145-4951-a2ae-9d6e209e11df            70  \n",
       "373   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "374   af72c67e-e145-4951-a2ae-9d6e209e11df           438  \n",
       "375   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "376   af72c67e-e145-4951-a2ae-9d6e209e11df           281  \n",
       "377   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "378   af72c67e-e145-4951-a2ae-9d6e209e11df            28  \n",
       "379   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "380   af72c67e-e145-4951-a2ae-9d6e209e11df            24  \n",
       "381   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "382   af72c67e-e145-4951-a2ae-9d6e209e11df            87  \n",
       "383   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "384   af72c67e-e145-4951-a2ae-9d6e209e11df           284  \n",
       "385   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "386   af72c67e-e145-4951-a2ae-9d6e209e11df           306  \n",
       "387   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "388   af72c67e-e145-4951-a2ae-9d6e209e11df           624  \n",
       "389   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "390   af72c67e-e145-4951-a2ae-9d6e209e11df           508  \n",
       "391   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "392   af72c67e-e145-4951-a2ae-9d6e209e11df           170  \n",
       "393   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "394   af72c67e-e145-4951-a2ae-9d6e209e11df           905  \n",
       "395   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "396   af72c67e-e145-4951-a2ae-9d6e209e11df           564  \n",
       "397   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "398   af72c67e-e145-4951-a2ae-9d6e209e11df           124  \n",
       "399   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "400   af72c67e-e145-4951-a2ae-9d6e209e11df            81  \n",
       "401   af72c67e-e145-4951-a2ae-9d6e209e11df          1127  \n",
       "402   af72c67e-e145-4951-a2ae-9d6e209e11df            92  \n",
       "403   af72c67e-e145-4951-a2ae-9d6e209e11df            70  \n",
       "404   af72c67e-e145-4951-a2ae-9d6e209e11df           187  \n",
       "405   af72c67e-e145-4951-a2ae-9d6e209e11df           211  \n",
       "406   af72c67e-e145-4951-a2ae-9d6e209e11df            73  \n",
       "407   af72c67e-e145-4951-a2ae-9d6e209e11df            66  \n",
       "408   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "409   af72c67e-e145-4951-a2ae-9d6e209e11df            84  \n",
       "410   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "411   af72c67e-e145-4951-a2ae-9d6e209e11df           439  \n",
       "412   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "413   af72c67e-e145-4951-a2ae-9d6e209e11df           810  \n",
       "414   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "415   af72c67e-e145-4951-a2ae-9d6e209e11df           367  \n",
       "416   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "417   af72c67e-e145-4951-a2ae-9d6e209e11df           610  \n",
       "418   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "419   af72c67e-e145-4951-a2ae-9d6e209e11df           641  \n",
       "420   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "421   af72c67e-e145-4951-a2ae-9d6e209e11df           131  \n",
       "422   af72c67e-e145-4951-a2ae-9d6e209e11df          1058  \n",
       "423   af72c67e-e145-4951-a2ae-9d6e209e11df            90  \n",
       "424   af72c67e-e145-4951-a2ae-9d6e209e11df           110  \n",
       "425   af72c67e-e145-4951-a2ae-9d6e209e11df            72  \n",
       "426   af72c67e-e145-4951-a2ae-9d6e209e11df           108  \n",
       "427   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "428   af72c67e-e145-4951-a2ae-9d6e209e11df           936  \n",
       "429   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "430   af72c67e-e145-4951-a2ae-9d6e209e11df            77  \n",
       "431   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "432   af72c67e-e145-4951-a2ae-9d6e209e11df           347  \n",
       "433   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "434   af72c67e-e145-4951-a2ae-9d6e209e11df           435  \n",
       "435   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "436   af72c67e-e145-4951-a2ae-9d6e209e11df            39  \n",
       "437   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "438   af72c67e-e145-4951-a2ae-9d6e209e11df           461  \n",
       "439   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "440   af72c67e-e145-4951-a2ae-9d6e209e11df           289  \n",
       "441   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "442   af72c67e-e145-4951-a2ae-9d6e209e11df           347  \n",
       "443   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "444   af72c67e-e145-4951-a2ae-9d6e209e11df            78  \n",
       "445   af72c67e-e145-4951-a2ae-9d6e209e11df           396  \n",
       "446   af72c67e-e145-4951-a2ae-9d6e209e11df           113  \n",
       "447   af72c67e-e145-4951-a2ae-9d6e209e11df            98  \n",
       "448   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "449   af72c67e-e145-4951-a2ae-9d6e209e11df           718  \n",
       "450   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "451   af72c67e-e145-4951-a2ae-9d6e209e11df           858  \n",
       "452   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "453   af72c67e-e145-4951-a2ae-9d6e209e11df            97  \n",
       "454   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "455   af72c67e-e145-4951-a2ae-9d6e209e11df            76  \n",
       "456   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "457   af72c67e-e145-4951-a2ae-9d6e209e11df           737  \n",
       "458   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "459   af72c67e-e145-4951-a2ae-9d6e209e11df           493  \n",
       "460   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "461   af72c67e-e145-4951-a2ae-9d6e209e11df           452  \n",
       "462   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "463   af72c67e-e145-4951-a2ae-9d6e209e11df           598  \n",
       "464   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "465   af72c67e-e145-4951-a2ae-9d6e209e11df            97  \n",
       "466   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "467   af72c67e-e145-4951-a2ae-9d6e209e11df           888  \n",
       "468   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "469   af72c67e-e145-4951-a2ae-9d6e209e11df          1352  \n",
       "470   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "471   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "472   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "473   af72c67e-e145-4951-a2ae-9d6e209e11df            58  \n",
       "474   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "475   af72c67e-e145-4951-a2ae-9d6e209e11df           612  \n",
       "476   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "477   af72c67e-e145-4951-a2ae-9d6e209e11df           313  \n",
       "478   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "479   af72c67e-e145-4951-a2ae-9d6e209e11df            32  \n",
       "480   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "481   af72c67e-e145-4951-a2ae-9d6e209e11df           102  \n",
       "482   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "483   af72c67e-e145-4951-a2ae-9d6e209e11df           411  \n",
       "484   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "485   af72c67e-e145-4951-a2ae-9d6e209e11df             9  \n",
       "486   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "487   af72c67e-e145-4951-a2ae-9d6e209e11df           740  \n",
       "488   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "489   af72c67e-e145-4951-a2ae-9d6e209e11df           530  \n",
       "490   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "491   af72c67e-e145-4951-a2ae-9d6e209e11df            12  \n",
       "492   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "493   af72c67e-e145-4951-a2ae-9d6e209e11df           383  \n",
       "494   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "495   af72c67e-e145-4951-a2ae-9d6e209e11df            17  \n",
       "496   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "497   af72c67e-e145-4951-a2ae-9d6e209e11df           437  \n",
       "498   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "499   af72c67e-e145-4951-a2ae-9d6e209e11df           468  \n",
       "500   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "501   af72c67e-e145-4951-a2ae-9d6e209e11df            11  \n",
       "502   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "503   af72c67e-e145-4951-a2ae-9d6e209e11df           702  \n",
       "504   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "505   af72c67e-e145-4951-a2ae-9d6e209e11df            24  \n",
       "506   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "507   af72c67e-e145-4951-a2ae-9d6e209e11df           118  \n",
       "508   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "509   af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "510   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "511   af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "512   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "513   af72c67e-e145-4951-a2ae-9d6e209e11df           771  \n",
       "514   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "515   af72c67e-e145-4951-a2ae-9d6e209e11df           266  \n",
       "516   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "517   af72c67e-e145-4951-a2ae-9d6e209e11df           430  \n",
       "518   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "519   af72c67e-e145-4951-a2ae-9d6e209e11df           108  \n",
       "520   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "521   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "522   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "523   af72c67e-e145-4951-a2ae-9d6e209e11df           602  \n",
       "524   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "525   af72c67e-e145-4951-a2ae-9d6e209e11df           413  \n",
       "526   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "527   af72c67e-e145-4951-a2ae-9d6e209e11df             4  \n",
       "528   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "529   af72c67e-e145-4951-a2ae-9d6e209e11df           175  \n",
       "530   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "531   af72c67e-e145-4951-a2ae-9d6e209e11df             4  \n",
       "532   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "533   af72c67e-e145-4951-a2ae-9d6e209e11df           174  \n",
       "534   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "535   af72c67e-e145-4951-a2ae-9d6e209e11df            26  \n",
       "536   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "537   af72c67e-e145-4951-a2ae-9d6e209e11df           223  \n",
       "538   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "539   af72c67e-e145-4951-a2ae-9d6e209e11df           407  \n",
       "540   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "541   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "542   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "543   af72c67e-e145-4951-a2ae-9d6e209e11df           211  \n",
       "544   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "545   af72c67e-e145-4951-a2ae-9d6e209e11df            60  \n",
       "546   af72c67e-e145-4951-a2ae-9d6e209e11df           750  \n",
       "547   af72c67e-e145-4951-a2ae-9d6e209e11df            90  \n",
       "548   af72c67e-e145-4951-a2ae-9d6e209e11df           180  \n",
       "549   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "550   af72c67e-e145-4951-a2ae-9d6e209e11df           113  \n",
       "551   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "552   af72c67e-e145-4951-a2ae-9d6e209e11df            87  \n",
       "553   af72c67e-e145-4951-a2ae-9d6e209e11df           706  \n",
       "554   af72c67e-e145-4951-a2ae-9d6e209e11df           117  \n",
       "555   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "556   af72c67e-e145-4951-a2ae-9d6e209e11df            37  \n",
       "557   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "558   af72c67e-e145-4951-a2ae-9d6e209e11df           225  \n",
       "559   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "560   af72c67e-e145-4951-a2ae-9d6e209e11df            21  \n",
       "561   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "562   af72c67e-e145-4951-a2ae-9d6e209e11df           824  \n",
       "563   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "564   af72c67e-e145-4951-a2ae-9d6e209e11df            31  \n",
       "565   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "566   af72c67e-e145-4951-a2ae-9d6e209e11df           434  \n",
       "567   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "568   af72c67e-e145-4951-a2ae-9d6e209e11df            28  \n",
       "569   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "570   af72c67e-e145-4951-a2ae-9d6e209e11df           708  \n",
       "571   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "572   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "573   af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "574   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "575   af72c67e-e145-4951-a2ae-9d6e209e11df            24  \n",
       "576   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "577   af72c67e-e145-4951-a2ae-9d6e209e11df            21  \n",
       "578   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "579   af72c67e-e145-4951-a2ae-9d6e209e11df            24  \n",
       "580   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "581   af72c67e-e145-4951-a2ae-9d6e209e11df            32  \n",
       "582   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "583   af72c67e-e145-4951-a2ae-9d6e209e11df            27  \n",
       "584   af72c67e-e145-4951-a2ae-9d6e209e11df            23  \n",
       "585   af72c67e-e145-4951-a2ae-9d6e209e11df            21  \n",
       "586   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "587   af72c67e-e145-4951-a2ae-9d6e209e11df            23  \n",
       "588   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "589   af72c67e-e145-4951-a2ae-9d6e209e11df            21  \n",
       "590   af72c67e-e145-4951-a2ae-9d6e209e11df            25  \n",
       "591   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "592   af72c67e-e145-4951-a2ae-9d6e209e11df             5  \n",
       "593   af72c67e-e145-4951-a2ae-9d6e209e11df            37  \n",
       "594   af72c67e-e145-4951-a2ae-9d6e209e11df            16  \n",
       "595   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "596   af72c67e-e145-4951-a2ae-9d6e209e11df            18  \n",
       "597   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "598   af72c67e-e145-4951-a2ae-9d6e209e11df             7  \n",
       "599   af72c67e-e145-4951-a2ae-9d6e209e11df            28  \n",
       "600   af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "601   af72c67e-e145-4951-a2ae-9d6e209e11df            32  \n",
       "602   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "603   af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "604   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "605   af72c67e-e145-4951-a2ae-9d6e209e11df            11  \n",
       "606   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "607   af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "608   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "609   af72c67e-e145-4951-a2ae-9d6e209e11df             7  \n",
       "610   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "611   af72c67e-e145-4951-a2ae-9d6e209e11df            43  \n",
       "612   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "613   af72c67e-e145-4951-a2ae-9d6e209e11df            51  \n",
       "614   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "615   af72c67e-e145-4951-a2ae-9d6e209e11df            37  \n",
       "616   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "617   af72c67e-e145-4951-a2ae-9d6e209e11df           333  \n",
       "618   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "619   af72c67e-e145-4951-a2ae-9d6e209e11df            51  \n",
       "620   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "621   af72c67e-e145-4951-a2ae-9d6e209e11df            51  \n",
       "622   af72c67e-e145-4951-a2ae-9d6e209e11df            85  \n",
       "623   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "624   af72c67e-e145-4951-a2ae-9d6e209e11df            52  \n",
       "625   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "626   af72c67e-e145-4951-a2ae-9d6e209e11df            51  \n",
       "627   af72c67e-e145-4951-a2ae-9d6e209e11df            85  \n",
       "628   af72c67e-e145-4951-a2ae-9d6e209e11df            72  \n",
       "629   af72c67e-e145-4951-a2ae-9d6e209e11df            61  \n",
       "630   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "631   af72c67e-e145-4951-a2ae-9d6e209e11df            69  \n",
       "632   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "633   af72c67e-e145-4951-a2ae-9d6e209e11df            65  \n",
       "634   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "635   af72c67e-e145-4951-a2ae-9d6e209e11df           153  \n",
       "636   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "637   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "638   af72c67e-e145-4951-a2ae-9d6e209e11df            49  \n",
       "639   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "640   af72c67e-e145-4951-a2ae-9d6e209e11df            40  \n",
       "641   af72c67e-e145-4951-a2ae-9d6e209e11df            27  \n",
       "642   af72c67e-e145-4951-a2ae-9d6e209e11df            18  \n",
       "643   af72c67e-e145-4951-a2ae-9d6e209e11df             7  \n",
       "644   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "645   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "646   af72c67e-e145-4951-a2ae-9d6e209e11df            48  \n",
       "647   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "648   af72c67e-e145-4951-a2ae-9d6e209e11df            15  \n",
       "649   af72c67e-e145-4951-a2ae-9d6e209e11df            15  \n",
       "650   af72c67e-e145-4951-a2ae-9d6e209e11df            15  \n",
       "651   af72c67e-e145-4951-a2ae-9d6e209e11df            15  \n",
       "652   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "653   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "654   af72c67e-e145-4951-a2ae-9d6e209e11df            65  \n",
       "655   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "656   af72c67e-e145-4951-a2ae-9d6e209e11df            47  \n",
       "657   af72c67e-e145-4951-a2ae-9d6e209e11df            44  \n",
       "658   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "659   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "660   af72c67e-e145-4951-a2ae-9d6e209e11df            34  \n",
       "661   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "662   af72c67e-e145-4951-a2ae-9d6e209e11df           141  \n",
       "663   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "664   3f7e1571-fc75-4ebf-bdd5-e9f623ee11d9             0  \n",
       "665   af72c67e-e145-4951-a2ae-9d6e209e11df            25  \n",
       "666   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "667   af72c67e-e145-4951-a2ae-9d6e209e11df            33  \n",
       "668   af72c67e-e145-4951-a2ae-9d6e209e11df            33  \n",
       "669   af72c67e-e145-4951-a2ae-9d6e209e11df            33  \n",
       "670   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "671   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "672   af72c67e-e145-4951-a2ae-9d6e209e11df            41  \n",
       "673   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "674   af72c67e-e145-4951-a2ae-9d6e209e11df            33  \n",
       "675   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "676   af72c67e-e145-4951-a2ae-9d6e209e11df            39  \n",
       "677   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "678   af72c67e-e145-4951-a2ae-9d6e209e11df            30  \n",
       "679   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "680   af72c67e-e145-4951-a2ae-9d6e209e11df            51  \n",
       "681   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "682   af72c67e-e145-4951-a2ae-9d6e209e11df            33  \n",
       "683   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "684   af72c67e-e145-4951-a2ae-9d6e209e11df            39  \n",
       "685   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "686   af72c67e-e145-4951-a2ae-9d6e209e11df            30  \n",
       "687   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "688   af72c67e-e145-4951-a2ae-9d6e209e11df            51  \n",
       "689   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "690   af72c67e-e145-4951-a2ae-9d6e209e11df            33  \n",
       "691   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "692   af72c67e-e145-4951-a2ae-9d6e209e11df            39  \n",
       "693   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "694   af72c67e-e145-4951-a2ae-9d6e209e11df            30  \n",
       "695   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "696   af72c67e-e145-4951-a2ae-9d6e209e11df            52  \n",
       "697   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "698   af72c67e-e145-4951-a2ae-9d6e209e11df            65  \n",
       "699   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "700   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "701   af72c67e-e145-4951-a2ae-9d6e209e11df            21  \n",
       "702   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "703   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "704   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "705   af72c67e-e145-4951-a2ae-9d6e209e11df            76  \n",
       "706   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "707   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "708   af72c67e-e145-4951-a2ae-9d6e209e11df            17  \n",
       "709   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "710   af72c67e-e145-4951-a2ae-9d6e209e11df            29  \n",
       "711   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "712   af72c67e-e145-4951-a2ae-9d6e209e11df           376  \n",
       "713   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "714   af72c67e-e145-4951-a2ae-9d6e209e11df            39  \n",
       "715   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "716   af72c67e-e145-4951-a2ae-9d6e209e11df           489  \n",
       "717   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "718   af72c67e-e145-4951-a2ae-9d6e209e11df             9  \n",
       "719   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "720   af72c67e-e145-4951-a2ae-9d6e209e11df           104  \n",
       "721   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "722   af72c67e-e145-4951-a2ae-9d6e209e11df            76  \n",
       "723   af72c67e-e145-4951-a2ae-9d6e209e11df           600  \n",
       "724   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "725   af72c67e-e145-4951-a2ae-9d6e209e11df            15  \n",
       "726   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "727   af72c67e-e145-4951-a2ae-9d6e209e11df           372  \n",
       "728   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "729   af72c67e-e145-4951-a2ae-9d6e209e11df            40  \n",
       "730   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "731   af72c67e-e145-4951-a2ae-9d6e209e11df           388  \n",
       "732   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "733   af72c67e-e145-4951-a2ae-9d6e209e11df           219  \n",
       "734   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "735   af72c67e-e145-4951-a2ae-9d6e209e11df           630  \n",
       "736   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "737   af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "738   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "739   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "740   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "741   af72c67e-e145-4951-a2ae-9d6e209e11df           271  \n",
       "742   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "743   af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "744   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "745   af72c67e-e145-4951-a2ae-9d6e209e11df           920  \n",
       "746   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "747   af72c67e-e145-4951-a2ae-9d6e209e11df           540  \n",
       "748   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "749   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "750   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "751   af72c67e-e145-4951-a2ae-9d6e209e11df           110  \n",
       "752   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "753   af72c67e-e145-4951-a2ae-9d6e209e11df           209  \n",
       "754   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "755   af72c67e-e145-4951-a2ae-9d6e209e11df            23  \n",
       "756   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "757   af72c67e-e145-4951-a2ae-9d6e209e11df             9  \n",
       "758   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "759   af72c67e-e145-4951-a2ae-9d6e209e11df            40  \n",
       "760   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "761   af72c67e-e145-4951-a2ae-9d6e209e11df           469  \n",
       "762   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "763   af72c67e-e145-4951-a2ae-9d6e209e11df           102  \n",
       "764   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "765   af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "766   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "767   af72c67e-e145-4951-a2ae-9d6e209e11df            96  \n",
       "768   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "769   af72c67e-e145-4951-a2ae-9d6e209e11df            52  \n",
       "770   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "771   af72c67e-e145-4951-a2ae-9d6e209e11df           269  \n",
       "772   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "773   af72c67e-e145-4951-a2ae-9d6e209e11df           189  \n",
       "774   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "775   af72c67e-e145-4951-a2ae-9d6e209e11df           384  \n",
       "776   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "777   af72c67e-e145-4951-a2ae-9d6e209e11df           380  \n",
       "778   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "779   af72c67e-e145-4951-a2ae-9d6e209e11df            44  \n",
       "780   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "781   af72c67e-e145-4951-a2ae-9d6e209e11df          1138  \n",
       "782   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "783   af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "784   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "785   af72c67e-e145-4951-a2ae-9d6e209e11df           325  \n",
       "786   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "787   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "788   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "789   af72c67e-e145-4951-a2ae-9d6e209e11df           156  \n",
       "790   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "791   af72c67e-e145-4951-a2ae-9d6e209e11df            45  \n",
       "792   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "793   af72c67e-e145-4951-a2ae-9d6e209e11df           234  \n",
       "794   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "795   af72c67e-e145-4951-a2ae-9d6e209e11df            36  \n",
       "796   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "797   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "798   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "799   af72c67e-e145-4951-a2ae-9d6e209e11df           292  \n",
       "800   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "801   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "802   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "803   af72c67e-e145-4951-a2ae-9d6e209e11df           457  \n",
       "804   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "805   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "806   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "807   af72c67e-e145-4951-a2ae-9d6e209e11df           502  \n",
       "808   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "809   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "810   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "811   af72c67e-e145-4951-a2ae-9d6e209e11df           192  \n",
       "812   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "813   af72c67e-e145-4951-a2ae-9d6e209e11df            18  \n",
       "814   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "815   af72c67e-e145-4951-a2ae-9d6e209e11df           121  \n",
       "816   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "817   af72c67e-e145-4951-a2ae-9d6e209e11df            68  \n",
       "818   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "819   af72c67e-e145-4951-a2ae-9d6e209e11df           191  \n",
       "820   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "821   af72c67e-e145-4951-a2ae-9d6e209e11df            58  \n",
       "822   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "823   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "824   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "825   af72c67e-e145-4951-a2ae-9d6e209e11df           440  \n",
       "826   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "827   af72c67e-e145-4951-a2ae-9d6e209e11df           117  \n",
       "828   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "829   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "830   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "831   af72c67e-e145-4951-a2ae-9d6e209e11df           495  \n",
       "832   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "833   af72c67e-e145-4951-a2ae-9d6e209e11df           387  \n",
       "834   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "835   af72c67e-e145-4951-a2ae-9d6e209e11df           290  \n",
       "836   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "837   af72c67e-e145-4951-a2ae-9d6e209e11df            59  \n",
       "838   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "839   af72c67e-e145-4951-a2ae-9d6e209e11df           482  \n",
       "840   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "841   af72c67e-e145-4951-a2ae-9d6e209e11df            14  \n",
       "842   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "843   af72c67e-e145-4951-a2ae-9d6e209e11df           195  \n",
       "844   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "845   af72c67e-e145-4951-a2ae-9d6e209e11df            39  \n",
       "846   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "847   af72c67e-e145-4951-a2ae-9d6e209e11df           231  \n",
       "848   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "849   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "850   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "851   af72c67e-e145-4951-a2ae-9d6e209e11df           321  \n",
       "852   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "853   af72c67e-e145-4951-a2ae-9d6e209e11df            34  \n",
       "854   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "855   af72c67e-e145-4951-a2ae-9d6e209e11df           616  \n",
       "856   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "857   af72c67e-e145-4951-a2ae-9d6e209e11df            18  \n",
       "858   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "859   af72c67e-e145-4951-a2ae-9d6e209e11df           348  \n",
       "860   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "861   af72c67e-e145-4951-a2ae-9d6e209e11df            26  \n",
       "862   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "863   af72c67e-e145-4951-a2ae-9d6e209e11df           244  \n",
       "864   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "865   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "866   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "867   af72c67e-e145-4951-a2ae-9d6e209e11df            63  \n",
       "868   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "869   af72c67e-e145-4951-a2ae-9d6e209e11df            36  \n",
       "870   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "871   af72c67e-e145-4951-a2ae-9d6e209e11df             8  \n",
       "872   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "873   af72c67e-e145-4951-a2ae-9d6e209e11df           358  \n",
       "874   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "875   af72c67e-e145-4951-a2ae-9d6e209e11df             9  \n",
       "876   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "877   af72c67e-e145-4951-a2ae-9d6e209e11df           489  \n",
       "878   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "879   af72c67e-e145-4951-a2ae-9d6e209e11df            10  \n",
       "880   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "881   af72c67e-e145-4951-a2ae-9d6e209e11df           150  \n",
       "882   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "883   af72c67e-e145-4951-a2ae-9d6e209e11df            64  \n",
       "884   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "885   af72c67e-e145-4951-a2ae-9d6e209e11df           286  \n",
       "886   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "887   af72c67e-e145-4951-a2ae-9d6e209e11df            23  \n",
       "888   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "889   af72c67e-e145-4951-a2ae-9d6e209e11df            31  \n",
       "890   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "891   af72c67e-e145-4951-a2ae-9d6e209e11df           512  \n",
       "892   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "893   af72c67e-e145-4951-a2ae-9d6e209e11df           256  \n",
       "894   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "895   af72c67e-e145-4951-a2ae-9d6e209e11df           164  \n",
       "896   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "897   af72c67e-e145-4951-a2ae-9d6e209e11df            28  \n",
       "898   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "899   af72c67e-e145-4951-a2ae-9d6e209e11df           639  \n",
       "900   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "901   af72c67e-e145-4951-a2ae-9d6e209e11df            28  \n",
       "902   af72c67e-e145-4951-a2ae-9d6e209e11df          1206  \n",
       "903   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "904   af72c67e-e145-4951-a2ae-9d6e209e11df            48  \n",
       "905   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "906   af72c67e-e145-4951-a2ae-9d6e209e11df            32  \n",
       "907   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "908   af72c67e-e145-4951-a2ae-9d6e209e11df          1260  \n",
       "909   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "910   af72c67e-e145-4951-a2ae-9d6e209e11df           693  \n",
       "911   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "912   af72c67e-e145-4951-a2ae-9d6e209e11df           531  \n",
       "913   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "914   af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "915   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "916   af72c67e-e145-4951-a2ae-9d6e209e11df           396  \n",
       "917   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "918   af72c67e-e145-4951-a2ae-9d6e209e11df           159  \n",
       "919   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "920   af72c67e-e145-4951-a2ae-9d6e209e11df          1408  \n",
       "921   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "922   af72c67e-e145-4951-a2ae-9d6e209e11df           115  \n",
       "923   af72c67e-e145-4951-a2ae-9d6e209e11df           333  \n",
       "924   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "925   af72c67e-e145-4951-a2ae-9d6e209e11df            48  \n",
       "926   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "927   af72c67e-e145-4951-a2ae-9d6e209e11df           345  \n",
       "928   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "929   af72c67e-e145-4951-a2ae-9d6e209e11df            14  \n",
       "930   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "931   af72c67e-e145-4951-a2ae-9d6e209e11df           268  \n",
       "932   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "933   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "934   af72c67e-e145-4951-a2ae-9d6e209e11df            29  \n",
       "935   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "936   af72c67e-e145-4951-a2ae-9d6e209e11df            32  \n",
       "937   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "938   af72c67e-e145-4951-a2ae-9d6e209e11df            87  \n",
       "939   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "940   af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "941   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "942   af72c67e-e145-4951-a2ae-9d6e209e11df           842  \n",
       "943   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "944   af72c67e-e145-4951-a2ae-9d6e209e11df           501  \n",
       "945   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "946   af72c67e-e145-4951-a2ae-9d6e209e11df            24  \n",
       "947   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "948   af72c67e-e145-4951-a2ae-9d6e209e11df           404  \n",
       "949   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "950   af72c67e-e145-4951-a2ae-9d6e209e11df           787  \n",
       "951   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "952   af72c67e-e145-4951-a2ae-9d6e209e11df           579  \n",
       "953   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "954   af72c67e-e145-4951-a2ae-9d6e209e11df           313  \n",
       "955   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "956   af72c67e-e145-4951-a2ae-9d6e209e11df           337  \n",
       "957   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "958   af72c67e-e145-4951-a2ae-9d6e209e11df            28  \n",
       "959   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "960   af72c67e-e145-4951-a2ae-9d6e209e11df            87  \n",
       "961   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "962   af72c67e-e145-4951-a2ae-9d6e209e11df           284  \n",
       "963   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "964   af72c67e-e145-4951-a2ae-9d6e209e11df           306  \n",
       "965   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "966   af72c67e-e145-4951-a2ae-9d6e209e11df           624  \n",
       "967   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "968   af72c67e-e145-4951-a2ae-9d6e209e11df           508  \n",
       "969   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "970   af72c67e-e145-4951-a2ae-9d6e209e11df           170  \n",
       "971   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "972   af72c67e-e145-4951-a2ae-9d6e209e11df           905  \n",
       "973   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "974   af72c67e-e145-4951-a2ae-9d6e209e11df           564  \n",
       "975   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "976   af72c67e-e145-4951-a2ae-9d6e209e11df           109  \n",
       "977   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "978   af72c67e-e145-4951-a2ae-9d6e209e11df            81  \n",
       "979   af72c67e-e145-4951-a2ae-9d6e209e11df          1127  \n",
       "980   af72c67e-e145-4951-a2ae-9d6e209e11df            92  \n",
       "981   af72c67e-e145-4951-a2ae-9d6e209e11df            69  \n",
       "982   af72c67e-e145-4951-a2ae-9d6e209e11df           187  \n",
       "983   af72c67e-e145-4951-a2ae-9d6e209e11df           211  \n",
       "984   af72c67e-e145-4951-a2ae-9d6e209e11df            73  \n",
       "985   af72c67e-e145-4951-a2ae-9d6e209e11df            66  \n",
       "986   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "987   af72c67e-e145-4951-a2ae-9d6e209e11df            84  \n",
       "988   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "989   af72c67e-e145-4951-a2ae-9d6e209e11df           439  \n",
       "990   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "991   af72c67e-e145-4951-a2ae-9d6e209e11df           810  \n",
       "992   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "993   af72c67e-e145-4951-a2ae-9d6e209e11df           367  \n",
       "994   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "995   af72c67e-e145-4951-a2ae-9d6e209e11df           610  \n",
       "996   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "997   af72c67e-e145-4951-a2ae-9d6e209e11df           641  \n",
       "998   af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "999   af72c67e-e145-4951-a2ae-9d6e209e11df           131  \n",
       "1000  af72c67e-e145-4951-a2ae-9d6e209e11df          1058  \n",
       "1001  af72c67e-e145-4951-a2ae-9d6e209e11df            90  \n",
       "1002  af72c67e-e145-4951-a2ae-9d6e209e11df           110  \n",
       "1003  af72c67e-e145-4951-a2ae-9d6e209e11df            72  \n",
       "1004  af72c67e-e145-4951-a2ae-9d6e209e11df           108  \n",
       "1005  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1006  af72c67e-e145-4951-a2ae-9d6e209e11df           936  \n",
       "1007  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1008  af72c67e-e145-4951-a2ae-9d6e209e11df            77  \n",
       "1009  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1010  af72c67e-e145-4951-a2ae-9d6e209e11df           347  \n",
       "1011  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1012  af72c67e-e145-4951-a2ae-9d6e209e11df           435  \n",
       "1013  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1014  af72c67e-e145-4951-a2ae-9d6e209e11df            39  \n",
       "1015  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1016  af72c67e-e145-4951-a2ae-9d6e209e11df           462  \n",
       "1017  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1018  af72c67e-e145-4951-a2ae-9d6e209e11df           289  \n",
       "1019  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1020  af72c67e-e145-4951-a2ae-9d6e209e11df           347  \n",
       "1021  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1022  af72c67e-e145-4951-a2ae-9d6e209e11df            78  \n",
       "1023  af72c67e-e145-4951-a2ae-9d6e209e11df           396  \n",
       "1024  af72c67e-e145-4951-a2ae-9d6e209e11df           113  \n",
       "1025  af72c67e-e145-4951-a2ae-9d6e209e11df            98  \n",
       "1026  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1027  af72c67e-e145-4951-a2ae-9d6e209e11df           718  \n",
       "1028  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1029  af72c67e-e145-4951-a2ae-9d6e209e11df           858  \n",
       "1030  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1031  af72c67e-e145-4951-a2ae-9d6e209e11df            97  \n",
       "1032  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1033  af72c67e-e145-4951-a2ae-9d6e209e11df            76  \n",
       "1034  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1035  af72c67e-e145-4951-a2ae-9d6e209e11df           737  \n",
       "1036  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1037  af72c67e-e145-4951-a2ae-9d6e209e11df           493  \n",
       "1038  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1039  af72c67e-e145-4951-a2ae-9d6e209e11df           452  \n",
       "1040  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1041  af72c67e-e145-4951-a2ae-9d6e209e11df           598  \n",
       "1042  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1043  af72c67e-e145-4951-a2ae-9d6e209e11df           133  \n",
       "1044  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1045  af72c67e-e145-4951-a2ae-9d6e209e11df           578  \n",
       "1046  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1047  af72c67e-e145-4951-a2ae-9d6e209e11df           402  \n",
       "1048  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1049  af72c67e-e145-4951-a2ae-9d6e209e11df           677  \n",
       "1050  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1051  af72c67e-e145-4951-a2ae-9d6e209e11df           688  \n",
       "1052  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1053  af72c67e-e145-4951-a2ae-9d6e209e11df            70  \n",
       "1054  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1055  af72c67e-e145-4951-a2ae-9d6e209e11df           292  \n",
       "1056  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1057  af72c67e-e145-4951-a2ae-9d6e209e11df           833  \n",
       "1058  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1059  af72c67e-e145-4951-a2ae-9d6e209e11df           435  \n",
       "1060  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1061  af72c67e-e145-4951-a2ae-9d6e209e11df           262  \n",
       "1062  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1063  af72c67e-e145-4951-a2ae-9d6e209e11df           145  \n",
       "1064  af72c67e-e145-4951-a2ae-9d6e209e11df           129  \n",
       "1065  af72c67e-e145-4951-a2ae-9d6e209e11df           106  \n",
       "1066  af72c67e-e145-4951-a2ae-9d6e209e11df           222  \n",
       "1067  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1068  af72c67e-e145-4951-a2ae-9d6e209e11df           543  \n",
       "1069  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1070  af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "1071  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1072  af72c67e-e145-4951-a2ae-9d6e209e11df           303  \n",
       "1073  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1074  af72c67e-e145-4951-a2ae-9d6e209e11df            32  \n",
       "1075  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1076  af72c67e-e145-4951-a2ae-9d6e209e11df           102  \n",
       "1077  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1078  af72c67e-e145-4951-a2ae-9d6e209e11df           411  \n",
       "1079  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1080  af72c67e-e145-4951-a2ae-9d6e209e11df             9  \n",
       "1081  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1082  af72c67e-e145-4951-a2ae-9d6e209e11df           474  \n",
       "1083  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1084  af72c67e-e145-4951-a2ae-9d6e209e11df           530  \n",
       "1085  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1086  af72c67e-e145-4951-a2ae-9d6e209e11df            12  \n",
       "1087  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1088  af72c67e-e145-4951-a2ae-9d6e209e11df           383  \n",
       "1089  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1090  af72c67e-e145-4951-a2ae-9d6e209e11df            17  \n",
       "1091  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1092  af72c67e-e145-4951-a2ae-9d6e209e11df           437  \n",
       "1093  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1094  af72c67e-e145-4951-a2ae-9d6e209e11df           416  \n",
       "1095  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1096  af72c67e-e145-4951-a2ae-9d6e209e11df            11  \n",
       "1097  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1098  af72c67e-e145-4951-a2ae-9d6e209e11df           702  \n",
       "1099  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1100  af72c67e-e145-4951-a2ae-9d6e209e11df            24  \n",
       "1101  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1102  af72c67e-e145-4951-a2ae-9d6e209e11df           118  \n",
       "1103  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1104  af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "1105  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1106  af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "1107  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1108  af72c67e-e145-4951-a2ae-9d6e209e11df           934  \n",
       "1109  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1110  af72c67e-e145-4951-a2ae-9d6e209e11df           502  \n",
       "1111  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1112  af72c67e-e145-4951-a2ae-9d6e209e11df            88  \n",
       "1113  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1114  af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "1115  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1116  af72c67e-e145-4951-a2ae-9d6e209e11df           463  \n",
       "1117  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1118  af72c67e-e145-4951-a2ae-9d6e209e11df           319  \n",
       "1119  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1120  af72c67e-e145-4951-a2ae-9d6e209e11df             4  \n",
       "1121  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1122  af72c67e-e145-4951-a2ae-9d6e209e11df           175  \n",
       "1123  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1124  af72c67e-e145-4951-a2ae-9d6e209e11df             4  \n",
       "1125  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1126  af72c67e-e145-4951-a2ae-9d6e209e11df            80  \n",
       "1127  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1128  af72c67e-e145-4951-a2ae-9d6e209e11df            26  \n",
       "1129  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1130  af72c67e-e145-4951-a2ae-9d6e209e11df           223  \n",
       "1131  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1132  af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "1133  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1134  af72c67e-e145-4951-a2ae-9d6e209e11df           211  \n",
       "1135  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1136  af72c67e-e145-4951-a2ae-9d6e209e11df            59  \n",
       "1137  af72c67e-e145-4951-a2ae-9d6e209e11df           823  \n",
       "1138  af72c67e-e145-4951-a2ae-9d6e209e11df            90  \n",
       "1139  af72c67e-e145-4951-a2ae-9d6e209e11df           180  \n",
       "1140  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1141  af72c67e-e145-4951-a2ae-9d6e209e11df            37  \n",
       "1142  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1143  af72c67e-e145-4951-a2ae-9d6e209e11df           225  \n",
       "1144  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1145  af72c67e-e145-4951-a2ae-9d6e209e11df            21  \n",
       "1146  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1147  af72c67e-e145-4951-a2ae-9d6e209e11df           824  \n",
       "1148  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1149  af72c67e-e145-4951-a2ae-9d6e209e11df            31  \n",
       "1150  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1151  af72c67e-e145-4951-a2ae-9d6e209e11df           434  \n",
       "1152  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1153  af72c67e-e145-4951-a2ae-9d6e209e11df            28  \n",
       "1154  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1155  af72c67e-e145-4951-a2ae-9d6e209e11df           708  \n",
       "1156  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1157  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1158  af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "1159  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1160  af72c67e-e145-4951-a2ae-9d6e209e11df            24  \n",
       "1161  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1162  af72c67e-e145-4951-a2ae-9d6e209e11df            23  \n",
       "1163  af72c67e-e145-4951-a2ae-9d6e209e11df            20  \n",
       "1164  af72c67e-e145-4951-a2ae-9d6e209e11df            32  \n",
       "1165  af72c67e-e145-4951-a2ae-9d6e209e11df            19  \n",
       "1166  af72c67e-e145-4951-a2ae-9d6e209e11df            21  \n",
       "1167  af72c67e-e145-4951-a2ae-9d6e209e11df             7  \n",
       "1168  af72c67e-e145-4951-a2ae-9d6e209e11df             9  \n",
       "1169  af72c67e-e145-4951-a2ae-9d6e209e11df            27  \n",
       "1170  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1171  af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "1172  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1173  af72c67e-e145-4951-a2ae-9d6e209e11df            11  \n",
       "1174  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1175  af72c67e-e145-4951-a2ae-9d6e209e11df            22  \n",
       "1176  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1177  af72c67e-e145-4951-a2ae-9d6e209e11df             7  \n",
       "1178  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1179  af72c67e-e145-4951-a2ae-9d6e209e11df            71  \n",
       "1180  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1181  af72c67e-e145-4951-a2ae-9d6e209e11df            43  \n",
       "1182  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1183  af72c67e-e145-4951-a2ae-9d6e209e11df            51  \n",
       "1184  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1185  af72c67e-e145-4951-a2ae-9d6e209e11df            37  \n",
       "1186  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1187  af72c67e-e145-4951-a2ae-9d6e209e11df           166  \n",
       "1188  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1189  af72c67e-e145-4951-a2ae-9d6e209e11df            87  \n",
       "1190  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1191  af72c67e-e145-4951-a2ae-9d6e209e11df            65  \n",
       "1192  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1193  af72c67e-e145-4951-a2ae-9d6e209e11df           153  \n",
       "1194  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1195  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1196  af72c67e-e145-4951-a2ae-9d6e209e11df            49  \n",
       "1197  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1198  af72c67e-e145-4951-a2ae-9d6e209e11df            40  \n",
       "1199  af72c67e-e145-4951-a2ae-9d6e209e11df            27  \n",
       "1200  af72c67e-e145-4951-a2ae-9d6e209e11df            18  \n",
       "1201  af72c67e-e145-4951-a2ae-9d6e209e11df             7  \n",
       "1202  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1203  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1204  af72c67e-e145-4951-a2ae-9d6e209e11df            48  \n",
       "1205  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1206  af72c67e-e145-4951-a2ae-9d6e209e11df            15  \n",
       "1207  af72c67e-e145-4951-a2ae-9d6e209e11df            15  \n",
       "1208  af72c67e-e145-4951-a2ae-9d6e209e11df            15  \n",
       "1209  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1210  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1211  af72c67e-e145-4951-a2ae-9d6e209e11df            65  \n",
       "1212  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1213  af72c67e-e145-4951-a2ae-9d6e209e11df            47  \n",
       "1214  af72c67e-e145-4951-a2ae-9d6e209e11df            44  \n",
       "1215  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1216  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1217  af72c67e-e145-4951-a2ae-9d6e209e11df            34  \n",
       "1218  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1219  af72c67e-e145-4951-a2ae-9d6e209e11df             0  \n",
       "1220  af72c67e-e145-4951-a2ae-9d6e209e11df           141  \n",
       "1221  af72c67e-e145-4951-a2ae-9d6e209e11df             0  "
      ]
     },
     "execution_count": 65,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Content Extraction Stage"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-04-22 11:47:46,065 : ExtractContentBetween_y : Cleaning Match Results\n",
      "2021-04-22 11:47:46,070 : ExtractContentBetween_y : Finished Cleaning Match Results\n",
      "2021-04-22 11:47:46,098 : ExtractContentBetween_y : Extracting Content Between Headings\n",
      "2021-04-22 11:47:46,121 : ExtractContentBetween_y : Finished Extracting Content Between Headings\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "File being processed: C:\\Users\\psaga\\source\\repos\\EMA\\EMA%20EPI%20PoC\\function_code\\data\\partitionedJSONs\\Abilify-h-471-e_ PACKAGE LEAFLET.json\n",
      "--------------------------------------------\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>index</th>\n",
       "      <th>id</th>\n",
       "      <th>Procedure type</th>\n",
       "      <th>Display code</th>\n",
       "      <th>Name</th>\n",
       "      <th>parent_id</th>\n",
       "      <th>htmlText</th>\n",
       "      <th>htmlIndex</th>\n",
       "      <th>htmlId</th>\n",
       "      <th>SubSectionIndex</th>\n",
       "      <th>doc_parent_id</th>\n",
       "      <th>Text</th>\n",
       "      <th>Html_betw</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>786</td>\n",
       "      <td>23001</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PACKAGE LEAFLET</td>\n",
       "      <td>NaN</td>\n",
       "      <td>B. PACKAGE LEAFLET</td>\n",
       "      <td>24</td>\n",
       "      <td>ba7f0011-777c-4c87-ab14-945b7f219145</td>\n",
       "      <td>0</td>\n",
       "      <td></td>\n",
       "      <td>\\nB. PACKAGE LEAFLET\\n\\n \\n\\nPackage leaflet: Information for the user\\n \\nABILIFY 5 mg tablets\\nABILIFY 10 mg tablets\\nABILIFY 15 mg tablets\\nABILIFY 30 mg tablets\\n \\naripiprazole\\n \\nRead all o...</td>\n",
       "      <td>&lt;p class=\"TitleA\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;B. PACKAGE LEAFLET&lt;/span&gt;&lt;/p&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif; color:black'&gt;&lt;br clear=\"all...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>788</td>\n",
       "      <td>23003</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>23001</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>43</td>\n",
       "      <td>6399df46-b26b-41ef-8faa-1e468be43bd7</td>\n",
       "      <td>0</td>\n",
       "      <td>23001</td>\n",
       "      <td>\\nWhat is in this leaflet\\n1.       What ABILIFY is and what it is used for\\n2.       What you need to know before you take ABILIFY\\n3.      How to take ABILIFY\\n4.      Possible side effects\\n5  ...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;What is in this leaflet&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"EN-GB\" sty...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>789</td>\n",
       "      <td>23004</td>\n",
       "      <td>CAP</td>\n",
       "      <td>1</td>\n",
       "      <td>What X is and what it is used for</td>\n",
       "      <td>23001</td>\n",
       "      <td>1.       What ABILIFY is and what it is used for</td>\n",
       "      <td>52</td>\n",
       "      <td>10306e47-6cf5-4529-b240-c8c69af4c4c7</td>\n",
       "      <td>0</td>\n",
       "      <td>23001</td>\n",
       "      <td>\\n1.       What ABILIFY is and what it is used for\\n \\nABILIFY contains the active substance aripiprazole and belong to a group of medicines called antipsychotics. It is used to treat adults and a...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;1.       What ABILIFY is and what it is used for&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyTex...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>790</td>\n",
       "      <td>23005</td>\n",
       "      <td>CAP</td>\n",
       "      <td>2</td>\n",
       "      <td>What you need to know before you &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23001</td>\n",
       "      <td>2.       What you need to know before you take ABILIFY</td>\n",
       "      <td>59</td>\n",
       "      <td>1fe30967-1779-470d-95e2-9c90a04c60c4</td>\n",
       "      <td>0</td>\n",
       "      <td>23001</td>\n",
       "      <td>\\n2.       What you need to know before you take ABILIFY\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;2.       What you need to know before you take ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEAB...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>791</td>\n",
       "      <td>23006</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Do not &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Do not take ABILIFY</td>\n",
       "      <td>61</td>\n",
       "      <td>b62e92fa-848f-4e9e-b9cb-b3b7fb89afdf</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nDo not take ABILIFY\\n•        if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6).\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Do not take ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyTextIndent\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;•        if you are allergic t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>792</td>\n",
       "      <td>23007</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>23005</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>64</td>\n",
       "      <td>20686598-1bda-4358-a32d-52fc5ce73748</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nWarnings and precautions\\nTalk to your doctor before taking ABILIFY.\\n \\nSuicidal thoughts and behaviours have been reported during aripiprazole treatment. Tell your doctor immediately if you ar...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Warnings and precautions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Talk to your doctor before taki...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>793</td>\n",
       "      <td>23008</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children &lt;and adolescents&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Children and adolescents</td>\n",
       "      <td>90</td>\n",
       "      <td>2ef4ce01-dcb9-4ef2-bf32-9ce8368cfae7</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nChildren and adolescents\\nDo not use this medicine in children and adolescents under 13 years of age. It is not known if it is safe and effective in these patients.\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Children and adolescents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Do not use this medicine in childr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>794</td>\n",
       "      <td>23009</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other medicines and X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Other medicines and ABILIFY</td>\n",
       "      <td>93</td>\n",
       "      <td>64c7ac18-2ac4-43bf-bd98-1338a58e3276</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nOther medicines and ABILIFY\\nTell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.\\n \\nBlo...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Other medicines and ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Tell your doctor or pharmacist ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>795</td>\n",
       "      <td>23010</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X with &lt;food&gt; &lt;and&gt; &lt;,&gt; &lt;drink&gt; &lt;and&gt; &lt;alcohol&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY with food, drink and alcohol</td>\n",
       "      <td>121</td>\n",
       "      <td>bf52352e-edd8-4b45-ba51-e791cc8fdcd4</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nABILIFY with food, drink and alcohol\\nThis medicine can be taken regardless of meals.\\nAlcohol should be avoided.\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY with food, drink and alcohol&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;This medicine can b...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>796</td>\n",
       "      <td>23011</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pregnancy &lt;and&gt; &lt;,&gt; breast-feeding &lt;and fertility&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Pregnancy, breast-feeding and fertility</td>\n",
       "      <td>125</td>\n",
       "      <td>7294f0d4-67e1-40ff-bfc6-4effd7beb960</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nPregnancy, breast-feeding and fertility\\nIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.\\...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Pregnancy, breast-feeding and fertility&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you are pregn...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>797</td>\n",
       "      <td>23012</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>23005</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>132</td>\n",
       "      <td>ec700889-50b2-46ed-85eb-8c8b518cb788</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nDriving and using machines\\nDizziness and vision problems may occur during treatment with this medicine (see section 4).\\nThis should be considered in cases where full alertness is required, e.g...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Driving and using machines&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\"&gt;Dizziness and vision problems may occur during treat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains lactose</td>\n",
       "      <td>136</td>\n",
       "      <td>3d5f5b60-1614-4102-a47b-65bbedc6655a</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nABILIFY contains lactose\\nIf you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.\\n \\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY contains lactose&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you have been told by your d...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>799</td>\n",
       "      <td>23014</td>\n",
       "      <td>CAP</td>\n",
       "      <td>3</td>\n",
       "      <td>How to &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23001</td>\n",
       "      <td>3.       How to take ABILIFY</td>\n",
       "      <td>140</td>\n",
       "      <td>215cb022-ee9e-4187-8d7a-1682d49cb7ef</td>\n",
       "      <td>0</td>\n",
       "      <td>23001</td>\n",
       "      <td>\\n3.       How to take ABILIFY\\n \\nAlways take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.\\n \\nThe recommended dose f...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;3.       How to take ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>800</td>\n",
       "      <td>23015</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Use in children &lt;and adolescents&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>Use in children and adolescents</td>\n",
       "      <td>146</td>\n",
       "      <td>69f5c85f-35d3-45cf-9a4b-7d70bfd55abd</td>\n",
       "      <td>0</td>\n",
       "      <td>23014</td>\n",
       "      <td>\\nUse in children and adolescents\\nThis medicinal product may be started at a low dose with the oral solution (liquid) form.\\nThe dose may be gradually increased to the recommended dose for adoles...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Use in children and adolescents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;This medicinal product m...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>801</td>\n",
       "      <td>23016</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you &lt;take&gt; &lt;use&gt; more X than you should</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you take more ABILIFY than you should</td>\n",
       "      <td>156</td>\n",
       "      <td>68739525-e8d0-40a3-b375-5e6ad85b44c5</td>\n",
       "      <td>0</td>\n",
       "      <td>23014</td>\n",
       "      <td>\\nIf you take more ABILIFY than you should\\nIf you realise you have taken more ABILIFY than your doctor has recommended (or if someone else has taken some of your ABILIFY), contact your doctor rig...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you take more ABILIFY than you should&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you realise ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>802</td>\n",
       "      <td>23017</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you forget to &lt;take&gt; &lt;use&gt; X&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you forget to take ABILIFY</td>\n",
       "      <td>169</td>\n",
       "      <td>664b61ff-ced3-47e7-85f2-5a87f8b512a6</td>\n",
       "      <td>0</td>\n",
       "      <td>23014</td>\n",
       "      <td>\\nIf you forget to take ABILIFY\\nIf you miss a dose, take the missed dose as soon as you remember but do not take two doses in one day.\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you forget to take ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you miss a dose, take t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>803</td>\n",
       "      <td>23018</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you stop &lt;taking&gt; &lt;using&gt; X&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you stop taking ABILIFY</td>\n",
       "      <td>172</td>\n",
       "      <td>618e0d93-0148-4265-ab5d-bcb393e51f03</td>\n",
       "      <td>0</td>\n",
       "      <td>23014</td>\n",
       "      <td>\\nIf you stop taking ABILIFY\\nDo not stop your treatment just because you feel better. It is important that you carry on taking ABILIFY for as long as your doctor has told you to.\\n \\nIf you have ...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;em&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black;font-style:normal\"&gt;If you stop taking &lt;/span&gt;&lt;/b&gt;&lt;/em&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"Ms...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>804</td>\n",
       "      <td>23019</td>\n",
       "      <td>CAP</td>\n",
       "      <td>4</td>\n",
       "      <td>Possible side effects</td>\n",
       "      <td>23001</td>\n",
       "      <td>4.       Possible side effects</td>\n",
       "      <td>178</td>\n",
       "      <td>caae52f5-9b8e-4a85-bd49-36977f0c50f8</td>\n",
       "      <td>0</td>\n",
       "      <td>23001</td>\n",
       "      <td>\\n4.       Possible side effects\\n \\nLike all medicines, this medicine can cause side effects, although not everybody gets them.\\n \\nCommon side effects (may affect up to 1 in 10 people):\\n \\n•   ...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;4.       Possible side effects&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEAHeading1\" style=\"margin-l...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>805</td>\n",
       "      <td>23020</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Additional side effects in children &lt;and adolescents&gt;</td>\n",
       "      <td>23019</td>\n",
       "      <td>Additional side effects in children and adolescents</td>\n",
       "      <td>282</td>\n",
       "      <td>ca628b27-4900-4f04-aec4-cd4f5821d201</td>\n",
       "      <td>0</td>\n",
       "      <td>23019</td>\n",
       "      <td>\\nAdditional side effects in children and adolescents\\nAdolescents aged 13 years and older experienced side effects that were similar in frequency and type to those in adults except that sleepines...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Additional side effects in children and adolescents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Adol...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>806</td>\n",
       "      <td>23021</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>23019</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>285</td>\n",
       "      <td>4e5c19cb-c772-4d68-8211-6ce6f84a1641</td>\n",
       "      <td>0</td>\n",
       "      <td>23019</td>\n",
       "      <td>\\nReporting of side effects\\nIf you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects di...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Reporting of side effects&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you get any side effects, t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>807</td>\n",
       "      <td>23022</td>\n",
       "      <td>CAP</td>\n",
       "      <td>5</td>\n",
       "      <td>How to store X</td>\n",
       "      <td>23001</td>\n",
       "      <td>5.       How to store ABILIFY</td>\n",
       "      <td>289</td>\n",
       "      <td>1d1d8138-cf62-4d68-a7fa-411c64250ac0</td>\n",
       "      <td>0</td>\n",
       "      <td>23001</td>\n",
       "      <td>\\n5.       How to store ABILIFY\\n \\nKeep this medicine out of the sight and reach of children.\\n \\nDo not use this medicine after the expiry date which is stated on the blister and on the carton a...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;5.       How to store ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>808</td>\n",
       "      <td>23023</td>\n",
       "      <td>CAP</td>\n",
       "      <td>6</td>\n",
       "      <td>Contents of the pack and other information</td>\n",
       "      <td>23001</td>\n",
       "      <td>6.       Contents of the pack and other information</td>\n",
       "      <td>300</td>\n",
       "      <td>3cf52e31-0edf-47fd-8525-8934112ce5a7</td>\n",
       "      <td>0</td>\n",
       "      <td>23001</td>\n",
       "      <td>\\n6.       Contents of the pack and other information\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;6.       Contents of the pack and other information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABody...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>809</td>\n",
       "      <td>23024</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X contains</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY contains</td>\n",
       "      <td>302</td>\n",
       "      <td>8719defc-d27a-493c-9d20-4d14b9c50496</td>\n",
       "      <td>0</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nWhat ABILIFY contains\\n•        The active substance is aripiprazole.\\n          Each tablet contains 5 mg of aripiprazole.\\n          Each tablet contains 10 mg of aripiprazole.\\n          Each...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;What ABILIFY contains&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyTextIndent\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;•        The active substanc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>810</td>\n",
       "      <td>23025</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X looks like and contents of the pack</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY looks like and contents of the pack</td>\n",
       "      <td>316</td>\n",
       "      <td>57f5bc1e-7d49-4a3c-8221-e1d9a266ffa9</td>\n",
       "      <td>0</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nWhat ABILIFY looks like and contents of the pack\\nABILIFY 5 mg tablets are rectangular and blue, marked with ‘A-007’ and ‘5’ on one side.\\nABILIFY 10 mg tablets are rectangular and pink, marked ...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;What ABILIFY looks like and contents of the pack&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>811</td>\n",
       "      <td>23026</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Marketing Authorisation Holder &lt;and Manufacturer&gt;</td>\n",
       "      <td>23023</td>\n",
       "      <td>Marketing Authorisation Holder</td>\n",
       "      <td>326</td>\n",
       "      <td>42fe4795-5be4-455e-8ab6-9b5ba8e9f2bd</td>\n",
       "      <td>0</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nMarketing Authorisation Holder\\nOtsuka Pharmaceutical Netherlands B.V.\\nHerikerbergweg 292\\n1101 CT, Amsterdam\\nNetherlands\\n \\nManufacturer\\nElaiapharm\\n2881 Route des Crêtes, Z.I. Les Bouilid...</td>\n",
       "      <td>&lt;p class=\"EMEAHeading2\" style=\"page-break-after:auto\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Marketing Authorisation Holder&lt;/span&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Ot...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>813</td>\n",
       "      <td>23028</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This leaflet was last revised in &lt;{MM/YYYY}&gt;&lt;{month YYYY}&gt;.</td>\n",
       "      <td>23023</td>\n",
       "      <td>This leaflet was last revised in {MM/YYYY}</td>\n",
       "      <td>342</td>\n",
       "      <td>8b3e2d1c-5b91-4ad4-b710-f7402708acc4</td>\n",
       "      <td>0</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nThis leaflet was last revised in {MM/YYYY}\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;This leaflet was last revised in {MM/YYYY}&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>814</td>\n",
       "      <td>23029</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>23023</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>344</td>\n",
       "      <td>01ae6f19-7b5e-42cc-8563-16acd8743705</td>\n",
       "      <td>0</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nOther sources of information\\n \\nDetailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.\\n \\n\\nPackage leaflet: Information for th...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Other sources of information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;b&gt;&lt;spa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>788</td>\n",
       "      <td>23003</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>23001</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>363</td>\n",
       "      <td>4f65c4f1-e91e-4d03-97bd-0e5d8ed8b7a6</td>\n",
       "      <td>1</td>\n",
       "      <td></td>\n",
       "      <td>\\nWhat is in this leaflet\\n1.       What ABILIFY is and what it is used for\\n2.       What you need to know before you take ABILIFY\\n3.       How to take ABILIFY\\n4.       Possible side effects\\n5...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;What is in this leaflet&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"EN-GB\" sty...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>789</td>\n",
       "      <td>23004</td>\n",
       "      <td>CAP</td>\n",
       "      <td>1</td>\n",
       "      <td>What X is and what it is used for</td>\n",
       "      <td>23001</td>\n",
       "      <td>1.       What ABILIFY is and what it is used for</td>\n",
       "      <td>372</td>\n",
       "      <td>0ca4f398-e781-4971-a846-f159db4c9932</td>\n",
       "      <td>1</td>\n",
       "      <td>23003</td>\n",
       "      <td>\\n1.       What ABILIFY is and what it is used for\\n \\nABILIFY contains the active substance aripiprazole and belong to a group of medicines called antipsychotics. It is used to treat adults and a...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;1.       What ABILIFY is and what it is used for&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyTex...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>790</td>\n",
       "      <td>23005</td>\n",
       "      <td>CAP</td>\n",
       "      <td>2</td>\n",
       "      <td>What you need to know before you &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23001</td>\n",
       "      <td>2.       What you need to know before you take ABILIFY</td>\n",
       "      <td>379</td>\n",
       "      <td>fc10acb3-0df9-413c-9231-a6995ad6177d</td>\n",
       "      <td>1</td>\n",
       "      <td>23004</td>\n",
       "      <td>\\n2.       What you need to know before you take ABILIFY\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;2.       What you need to know before you take ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEAB...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>791</td>\n",
       "      <td>23006</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Do not &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Do not take ABILIFY</td>\n",
       "      <td>381</td>\n",
       "      <td>dbe8ffd9-d1ea-4cff-aa5d-2eeb2d6cb423</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nDo not take ABILIFY\\n•        if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6).\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Do not take ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"EN-GB\" style=\"...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>792</td>\n",
       "      <td>23007</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>23005</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>384</td>\n",
       "      <td>22f3170c-fc1d-41bd-9c26-861759ee1620</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nWarnings and precautions\\nTalk to your doctor before taking ABILIFY.\\n \\nSuicidal thoughts and behaviours have been reported during aripiprazole treatment. Tell your doctor immediately if you ar...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Warnings and precautions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Talk to your doctor before taki...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>793</td>\n",
       "      <td>23008</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children &lt;and adolescents&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Children and adolescents</td>\n",
       "      <td>410</td>\n",
       "      <td>05ee6c1f-cc2b-4707-a7a3-48bd0623e7b7</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nChildren and adolescents\\nDo not use this medicine in children and adolescents under 13 years of age. It is not known if it is safe and effective in these patients.\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Children and adolescents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Do not use this medicine in chi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>794</td>\n",
       "      <td>23009</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other medicines and X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Other medicines and ABILIFY</td>\n",
       "      <td>413</td>\n",
       "      <td>edd492ec-09fd-4262-8dd8-7fa0b7507f97</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nOther medicines and ABILIFY\\nTell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.\\n \\nBlo...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Other medicines and ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Tell your doctor or pharmacist ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>795</td>\n",
       "      <td>23010</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X with &lt;food&gt; &lt;and&gt; &lt;,&gt; &lt;drink&gt; &lt;and&gt; &lt;alcohol&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY with food, drink and alcohol</td>\n",
       "      <td>441</td>\n",
       "      <td>3eb499d1-1a3b-43ab-b921-96ee688a828e</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nABILIFY with food, drink and alcohol\\nThis medicine can be taken regardless of meals.\\nAlcohol should be avoided.\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY with food, drink and alcohol&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;This medicine can b...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>796</td>\n",
       "      <td>23011</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pregnancy &lt;and&gt; &lt;,&gt; breast-feeding &lt;and fertility&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Pregnancy, breast-feeding and fertility</td>\n",
       "      <td>445</td>\n",
       "      <td>a7374bc4-89fd-444a-b181-cddc65f5f91c</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nPregnancy, breast-feeding and fertility\\nIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.\\...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Pregnancy, breast-feeding and fertility&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you are pregn...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>797</td>\n",
       "      <td>23012</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>23005</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>452</td>\n",
       "      <td>f4bf2238-189d-46e4-820c-1d3385b789db</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nDriving and using machines\\nDizziness and vision problems may occur during treatment with this medicine (see section 4).\\nThis should be considered in cases where full alertness is required, e.g...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Driving and using machines&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\"&gt;Dizziness and vision problems may occur during treat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains aspartame</td>\n",
       "      <td>456</td>\n",
       "      <td>4f3e2097-ac09-444c-a74b-d3ac2b6897fa</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nABILIFY contains aspartame\\nABILIFY 10 mg orodispersible tablets: This medicine contains 2 mg aspartame in each tablet.\\nABILIFY 15 mg orodispersible tablets: This medicine contains 3 mg asparta...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY contains aspartame&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY 10 mg orodispersible ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains lactose</td>\n",
       "      <td>462</td>\n",
       "      <td>7ab98a29-42ec-464e-9fc6-5d9fcf6bdce6</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nABILIFY contains lactose\\nIf you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY contains lactose&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you have been told by your d...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains sodium</td>\n",
       "      <td>465</td>\n",
       "      <td>39b82250-a98a-495c-b5ed-2a288bd4089e</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nABILIFY contains sodium\\nThis medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.\\n \\n</td>\n",
       "      <td>&lt;p class=\"EMEABodyText\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY contains sodium&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;This medicine contains less t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>799</td>\n",
       "      <td>23014</td>\n",
       "      <td>CAP</td>\n",
       "      <td>3</td>\n",
       "      <td>How to &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23001</td>\n",
       "      <td>3.       How to take ABILIFY</td>\n",
       "      <td>469</td>\n",
       "      <td>655f11eb-a52d-4a39-9d66-1d3f08518998</td>\n",
       "      <td>1</td>\n",
       "      <td>23013</td>\n",
       "      <td>\\n3.       How to take ABILIFY\\n \\nAlways take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.\\n \\nThe recommended dose f...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;3.       How to take ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>800</td>\n",
       "      <td>23015</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Use in children &lt;and adolescents&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>Use in children and adolescents</td>\n",
       "      <td>475</td>\n",
       "      <td>4fd11b3b-5a3a-4944-ac2e-c01472245a5d</td>\n",
       "      <td>1</td>\n",
       "      <td>23014</td>\n",
       "      <td>\\nUse in children and adolescents\\nThis medicinal product may be started at a low dose with the oral solution (liquid) form.\\nThe dose may be gradually increased to the recommended dose for adoles...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Use in children and adolescents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;This medicinal product m...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>801</td>\n",
       "      <td>23016</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you &lt;take&gt; &lt;use&gt; more X than you should</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you take more ABILIFY than you should</td>\n",
       "      <td>488</td>\n",
       "      <td>a7cb028f-75f2-4703-b497-565fad4edd38</td>\n",
       "      <td>1</td>\n",
       "      <td>23014</td>\n",
       "      <td>\\nIf you take more ABILIFY than you should\\nIf you realise you have taken more ABILIFY than your doctor has recommended (or if someone else has taken some of your ABILIFY), contact your doctor rig...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you take more ABILIFY than you should&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you realise ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>802</td>\n",
       "      <td>23017</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you forget to &lt;take&gt; &lt;use&gt; X&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you forget to take ABILIFY</td>\n",
       "      <td>501</td>\n",
       "      <td>e404e630-4ca8-4737-85b0-0243dc4e1af3</td>\n",
       "      <td>1</td>\n",
       "      <td>23014</td>\n",
       "      <td>\\nIf you forget to take ABILIFY\\nIf you miss a dose, take the missed dose as soon as you remember but do not take two doses in one day.\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you forget to take ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you miss a dose, take t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>803</td>\n",
       "      <td>23018</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you stop &lt;taking&gt; &lt;using&gt; X&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you stop taking ABILIFY</td>\n",
       "      <td>504</td>\n",
       "      <td>38c55c46-64c1-470f-b143-347406edb287</td>\n",
       "      <td>1</td>\n",
       "      <td>23014</td>\n",
       "      <td>\\nIf you stop taking ABILIFY\\nDo not stop your treatment just because you feel better. It is important that you carry on taking ABILIFY for as long as your doctor has told you to.\\n \\nIf you have ...</td>\n",
       "      <td>&lt;p class=\"EMEABodyText\"&gt;&lt;em&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black;font-style: normal\"&gt;If you stop taking &lt;/span&gt;&lt;/b&gt;&lt;/em&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>804</td>\n",
       "      <td>23019</td>\n",
       "      <td>CAP</td>\n",
       "      <td>4</td>\n",
       "      <td>Possible side effects</td>\n",
       "      <td>23001</td>\n",
       "      <td>4.       Possible side effects</td>\n",
       "      <td>510</td>\n",
       "      <td>6c040fc4-4a56-431a-83ec-709b77667e95</td>\n",
       "      <td>1</td>\n",
       "      <td>23018</td>\n",
       "      <td>\\n4.       Possible side effects\\n \\nLike all medicines, this medicine can cause side effects, although not everybody gets them.\\n \\nCommon side effects (may affect up to 1 in 10 people):\\n \\n•   ...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;4.       Possible side effects&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\"...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>805</td>\n",
       "      <td>23020</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Additional side effects in children &lt;and adolescents&gt;</td>\n",
       "      <td>23019</td>\n",
       "      <td>Additional side effects in children and adolescents</td>\n",
       "      <td>614</td>\n",
       "      <td>641467ee-1641-456e-b013-a56b36f2ff77</td>\n",
       "      <td>1</td>\n",
       "      <td>23019</td>\n",
       "      <td>\\nAdditional side effects in children and adolescents\\nAdolescents aged 13 years and older experienced side effects that were similar in frequency and type to those in adults except that sleepines...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Additional side effects in children and adolescents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Adol...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>806</td>\n",
       "      <td>23021</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>23019</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>617</td>\n",
       "      <td>08202e3a-d475-4d47-a211-f7e07278999b</td>\n",
       "      <td>1</td>\n",
       "      <td>23019</td>\n",
       "      <td>\\nReporting of side effects\\nIf you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects di...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Reporting of side effects&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you get any side effects, t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>807</td>\n",
       "      <td>23022</td>\n",
       "      <td>CAP</td>\n",
       "      <td>5</td>\n",
       "      <td>How to store X</td>\n",
       "      <td>23001</td>\n",
       "      <td>5.       How to store ABILIFY</td>\n",
       "      <td>621</td>\n",
       "      <td>456d341f-e4a8-4e8d-85d7-9c661dd6264c</td>\n",
       "      <td>1</td>\n",
       "      <td>23021</td>\n",
       "      <td>\\n5.       How to store ABILIFY\\n \\nKeep this medicine out of the sight and reach of children.\\n \\nDo not use this medicine after the expiry date which is stated on the blister and on the carton a...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;5.       How to store ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>808</td>\n",
       "      <td>23023</td>\n",
       "      <td>CAP</td>\n",
       "      <td>6</td>\n",
       "      <td>Contents of the pack and other information</td>\n",
       "      <td>23001</td>\n",
       "      <td>6.       Contents of the pack and other information</td>\n",
       "      <td>632</td>\n",
       "      <td>f1875f64-4532-4bfd-928a-ce18a1558129</td>\n",
       "      <td>1</td>\n",
       "      <td>23022</td>\n",
       "      <td>\\n6.       Contents of the pack and other information\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;6.       Contents of the pack and other information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABody...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>809</td>\n",
       "      <td>23024</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X contains</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY contains</td>\n",
       "      <td>634</td>\n",
       "      <td>09ef7199-8840-48d3-97b9-2cd4ea1558c9</td>\n",
       "      <td>1</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nWhat ABILIFY contains\\n•        The active substance is aripiprazole.\\n          Each orodispersible tablet contains 10 mg of aripiprazole.\\n          Each orodispersible tablet contains 15 mg o...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;What ABILIFY contains&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyTextIndent\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;•        The active substanc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>810</td>\n",
       "      <td>23025</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X looks like and contents of the pack</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY looks like and contents of the pack</td>\n",
       "      <td>646</td>\n",
       "      <td>0f852c02-e2e0-415b-9c57-9f2fbef7961e</td>\n",
       "      <td>1</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nWhat ABILIFY looks like and contents of the pack\\nABILIFY 10 mg orodispersible tablets are round and pink, marked with ‘\"A\" over \"640\"’ on one side and ‘10’ on the other.\\nABILIFY 15 mg orodispe...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;What ABILIFY looks like and contents of the pack&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>811</td>\n",
       "      <td>23026</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Marketing Authorisation Holder &lt;and Manufacturer&gt;</td>\n",
       "      <td>23023</td>\n",
       "      <td>Marketing Authorisation Holder</td>\n",
       "      <td>655</td>\n",
       "      <td>219bb058-4c68-4861-afe4-80177a844121</td>\n",
       "      <td>1</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nMarketing Authorisation Holder\\nOtsuka Pharmaceutical Netherlands B.V.\\nHerikerbergweg 292\\n1101 CT, Amsterdam\\nNetherlands\\n \\nManufacturer\\nElaiapharm\\n2881 Route des Crêtes, Z.I. Les Bouilid...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Marketing Authorisation Holder&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Otsuka Pharmaceutical Nether...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>813</td>\n",
       "      <td>23028</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This leaflet was last revised in &lt;{MM/YYYY}&gt;&lt;{month YYYY}&gt;.</td>\n",
       "      <td>23023</td>\n",
       "      <td>This leaflet was last revised in {MM/YYYY}</td>\n",
       "      <td>671</td>\n",
       "      <td>abea3cf8-3c1c-47a0-a464-766bcecc0c52</td>\n",
       "      <td>1</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nThis leaflet was last revised in {MM/YYYY}\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;This leaflet was last revised in {MM/YYYY}&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>814</td>\n",
       "      <td>23029</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>23023</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>673</td>\n",
       "      <td>4ee904cf-deb9-46e8-9502-2d4a821584e9</td>\n",
       "      <td>1</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nOther sources of information\\n \\nDetailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.\\n \\n\\nPackage leaflet: Information for th...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Other sources of information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;b&gt;&lt;spa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>788</td>\n",
       "      <td>23003</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>23001</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>689</td>\n",
       "      <td>a5ee6aa4-171a-406d-af8a-c6be76c37038</td>\n",
       "      <td>2</td>\n",
       "      <td></td>\n",
       "      <td>\\nWhat is in this leaflet\\n1.       What ABILIFY is and what it is used for\\n2.       What you need to know before you take ABILIFY\\n3.       How to take ABILIFY\\n4.       Possible side effects\\n5...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;What is in this leaflet&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"EN-GB\" sty...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>789</td>\n",
       "      <td>23004</td>\n",
       "      <td>CAP</td>\n",
       "      <td>1</td>\n",
       "      <td>What X is and what it is used for</td>\n",
       "      <td>23001</td>\n",
       "      <td>1.       What ABILIFY is and what it is used for</td>\n",
       "      <td>698</td>\n",
       "      <td>fb7a5f49-ed2f-4ee8-9a96-d787f2c34985</td>\n",
       "      <td>2</td>\n",
       "      <td>23003</td>\n",
       "      <td>\\n1.       What ABILIFY is and what it is used for\\n \\nABILIFY contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics. It is used to treat adults and ...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;1.       What ABILIFY is and what it is used for&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyTex...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>790</td>\n",
       "      <td>23005</td>\n",
       "      <td>CAP</td>\n",
       "      <td>2</td>\n",
       "      <td>What you need to know before you &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23001</td>\n",
       "      <td>2.       What you need to know before you take ABILIFY</td>\n",
       "      <td>705</td>\n",
       "      <td>861bd2b5-04e7-4eaa-abe7-4ac7e127381a</td>\n",
       "      <td>2</td>\n",
       "      <td>23004</td>\n",
       "      <td>\\n2.       What you need to know before you take ABILIFY\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;2.       What you need to know before you take ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt; ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>791</td>\n",
       "      <td>23006</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Do not &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Do not take ABILIFY</td>\n",
       "      <td>707</td>\n",
       "      <td>2d8c3f8a-f7be-4f54-be2e-6d7410ebee0c</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nDo not take ABILIFY\\n•        if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6).\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Do not take ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyTextIndent\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;•        if you are allergic t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>792</td>\n",
       "      <td>23007</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>23005</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>710</td>\n",
       "      <td>b519a8f4-dbb9-4a45-821a-15111499aa33</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nWarnings and precautions\\nTalk to your doctor before taking ABILIFY.\\n \\nSuicidal thoughts and behaviours have been reported during aripiprazole treatment. Tell your doctor immediately if you ar...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Warnings and precautions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Talk to your doctor before taki...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>793</td>\n",
       "      <td>23008</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children &lt;and adolescents&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Children and adolescents</td>\n",
       "      <td>736</td>\n",
       "      <td>55a4498a-f045-450d-a5ea-ce5e8ab669d8</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nChildren and adolescents\\nDo not use this medicine in children and adolescents under 13 years of age. It is not known if it is safe and effective in these patients.\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Children and adolescents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Do not use this medicine in childr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>794</td>\n",
       "      <td>23009</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other medicines and X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Other medicines and ABILIFY</td>\n",
       "      <td>739</td>\n",
       "      <td>678c2221-b859-4819-b110-efa46498d8e0</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nOther medicines and ABILIFY\\nTell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.\\n \\nBlo...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Other medicines and ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Tell your doctor or pharmacist ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>795</td>\n",
       "      <td>23010</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X with &lt;food&gt; &lt;and&gt; &lt;,&gt; &lt;drink&gt; &lt;and&gt; &lt;alcohol&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY with food, drink and alcohol</td>\n",
       "      <td>767</td>\n",
       "      <td>2ba81bba-a5c9-4817-bc17-84d1e0a16acb</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nABILIFY with food, drink and alcohol\\nThis medicine can be taken regardless of meals. However, the oral solution should not be diluted with other liquids or mixed with any food prior to administ...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY with food, drink and alcohol&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;This medicine can b...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>796</td>\n",
       "      <td>23011</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pregnancy &lt;and&gt; &lt;,&gt; breast-feeding &lt;and fertility&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Pregnancy, breast-feeding and fertility</td>\n",
       "      <td>771</td>\n",
       "      <td>3a2f8c7f-df89-421e-ac07-7822b458efaf</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nPregnancy, breast-feeding and fertility\\nIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.\\...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Pregnancy, breast-feeding and fertility&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you are pregn...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>797</td>\n",
       "      <td>23012</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>23005</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>778</td>\n",
       "      <td>67e7bf58-0e7f-455f-ada6-018ef79f6f23</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nDriving and using machines\\nDizziness and vision problems may occur during treatment with this medicine (see section 4).\\nThis should be considered in cases where full alertness is required, e.g...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Driving and using machines&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\"&gt;Dizziness and vision problems may occur during treat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains fructose and sucrose</td>\n",
       "      <td>782</td>\n",
       "      <td>ec3e924b-e3db-4190-bf5e-d14a11c8d9e7</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nABILIFY contains fructose and sucrose\\nThis medicine contains 200 mg of fructose and 400 mg of sucrose in each mL. If you have been told by your doctor that you have an intolerance to some sugar...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY contains fructose and sucrose&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;This medicine cont...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains parahydroxybenzoates</td>\n",
       "      <td>785</td>\n",
       "      <td>6d3225d2-b6c6-4321-9890-5fe73b306d8b</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nABILIFY contains parahydroxybenzoates\\nMay cause allergic reactions (possibly delayed).\\n</td>\n",
       "      <td>&lt;p class=\"EMEABodyText\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY contains parahydroxybenzoates&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;May cause aller...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains sodium</td>\n",
       "      <td>788</td>\n",
       "      <td>431a94d1-f0ac-4c69-8b91-281f6f529a74</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nABILIFY contains sodium\\nThis medicine contains less than 1 mmol sodium (23 mg) per dosage unit, that is to say essentially ‘sodium-free’.\\n \\n</td>\n",
       "      <td>&lt;p class=\"EMEABodyText\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY contains sodium&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;This medicine contains less t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>799</td>\n",
       "      <td>23014</td>\n",
       "      <td>CAP</td>\n",
       "      <td>3</td>\n",
       "      <td>How to &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23001</td>\n",
       "      <td>3.       How to take ABILIFY</td>\n",
       "      <td>792</td>\n",
       "      <td>8e8abaa9-c68c-4643-95e3-0d81e9d6b93c</td>\n",
       "      <td>2</td>\n",
       "      <td>23013</td>\n",
       "      <td>\\n3.       How to take ABILIFY\\n \\nAlways take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.\\n \\nThe recommended dose f...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;3.       How to take ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>800</td>\n",
       "      <td>23015</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Use in children &lt;and adolescents&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>Use in children and adolescents</td>\n",
       "      <td>798</td>\n",
       "      <td>cd5cf1fc-d291-4a06-89df-7158594e670e</td>\n",
       "      <td>2</td>\n",
       "      <td>23014</td>\n",
       "      <td>\\nUse in children and adolescents\\nThe recommended dose for adolescents is 10 mL solution (corresponding to 10 mg aripiprazole) once a day. However your doctor may prescribe a lower or higher dose...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Use in children and adolescents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black;layout-grid-mode: line...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>801</td>\n",
       "      <td>23016</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you &lt;take&gt; &lt;use&gt; more X than you should</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you take more ABILIFY than you should</td>\n",
       "      <td>809</td>\n",
       "      <td>3b8bf1cc-469a-4b2c-8c4d-aee39532152c</td>\n",
       "      <td>2</td>\n",
       "      <td>23014</td>\n",
       "      <td>\\nIf you take more ABILIFY than you should\\nIf you realise you have taken more ABILIFY than your doctor has recommended (or if someone else has taken some of your ABILIFY), contact your doctor rig...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you take more ABILIFY than you should&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you realise ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>802</td>\n",
       "      <td>23017</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you forget to &lt;take&gt; &lt;use&gt; X&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you forget to take ABILIFY</td>\n",
       "      <td>822</td>\n",
       "      <td>9472c6d1-ddbd-475f-a427-10e14c0daab9</td>\n",
       "      <td>2</td>\n",
       "      <td>23014</td>\n",
       "      <td>\\nIf you forget to take ABILIFY\\nIf you miss a dose, take the missed dose as soon as you remember but do not take two doses in one day.\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you forget to take ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you miss a dose, take t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>803</td>\n",
       "      <td>23018</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you stop &lt;taking&gt; &lt;using&gt; X&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you stop taking ABILIFY</td>\n",
       "      <td>825</td>\n",
       "      <td>9ee68d9c-284b-49ff-95e4-6e470191d07c</td>\n",
       "      <td>2</td>\n",
       "      <td>23014</td>\n",
       "      <td>\\nIf you stop taking ABILIFY\\nDo not stop your treatment just because you feel better. It is important that you carry on taking ABILIFY for as long as your doctor has told you to.\\n \\nIf you have ...</td>\n",
       "      <td>&lt;p class=\"EMEABodyText\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you stop taking &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;em&gt;&lt;span lang=...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>804</td>\n",
       "      <td>23019</td>\n",
       "      <td>CAP</td>\n",
       "      <td>4</td>\n",
       "      <td>Possible side effects</td>\n",
       "      <td>23001</td>\n",
       "      <td>4.       Possible side effects</td>\n",
       "      <td>831</td>\n",
       "      <td>40612ebd-9a22-4948-bfec-a3267c5a66f2</td>\n",
       "      <td>2</td>\n",
       "      <td>23018</td>\n",
       "      <td>\\n4.       Possible side effects\\n \\nLike all medicines, this medicine can cause side effects, although not everybody gets them.\\n \\nCommon side effects (may affect up to 1 in 10 people):\\n \\n•   ...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;4.       Possible side effects&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\"...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>805</td>\n",
       "      <td>23020</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Additional side effects in children &lt;and adolescents&gt;</td>\n",
       "      <td>23019</td>\n",
       "      <td>Additional side effects in children and adolescents</td>\n",
       "      <td>935</td>\n",
       "      <td>406f7cbd-6225-4372-8d43-e26dde9e5604</td>\n",
       "      <td>2</td>\n",
       "      <td>23019</td>\n",
       "      <td>\\nAdditional side effects in children and adolescents\\nAdolescents aged 13 years and older experienced side effects that were similar in frequency and type to those in adults except that sleepines...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Additional side effects in children and adolescents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Adol...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>806</td>\n",
       "      <td>23021</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>23019</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>938</td>\n",
       "      <td>97317f00-2cc7-47fc-8f37-af43bc71b01f</td>\n",
       "      <td>2</td>\n",
       "      <td>23019</td>\n",
       "      <td>\\nReporting of side effects\\nIf you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects di...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Reporting of side effects&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you get any side effects, t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>807</td>\n",
       "      <td>23022</td>\n",
       "      <td>CAP</td>\n",
       "      <td>5</td>\n",
       "      <td>How to store X</td>\n",
       "      <td>23001</td>\n",
       "      <td>5.       How to store ABILIFY</td>\n",
       "      <td>942</td>\n",
       "      <td>ad3dbf0e-929e-4e06-b834-b9b4fa8cec24</td>\n",
       "      <td>2</td>\n",
       "      <td>23021</td>\n",
       "      <td>\\n5.       How to store ABILIFY\\n \\nKeep this medicine out of the sight and reach of children.\\n \\nDo not use this medicine after the expiry date which is stated on the bottle and on the carton af...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;5.       How to store ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>808</td>\n",
       "      <td>23023</td>\n",
       "      <td>CAP</td>\n",
       "      <td>6</td>\n",
       "      <td>Contents of the pack and other information</td>\n",
       "      <td>23001</td>\n",
       "      <td>6.       Contents of the pack and other information</td>\n",
       "      <td>954</td>\n",
       "      <td>e39ee105-8558-4dba-8a87-1c63bce86b99</td>\n",
       "      <td>2</td>\n",
       "      <td>23022</td>\n",
       "      <td>\\n6.       Contents of the pack and other information\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;6.       Contents of the pack and other information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABody...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>809</td>\n",
       "      <td>23024</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X contains</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY contains</td>\n",
       "      <td>956</td>\n",
       "      <td>2c693717-5391-4fc6-b0db-3a1f5dc89e13</td>\n",
       "      <td>2</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nWhat ABILIFY contains\\n•        The active substance is aripiprazole.\\nEach mL contains 1 mg of aripiprazole.\\n \\n•        The other ingredients are disodium edetate, fructose, glycerin, lactic ...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;What ABILIFY contains&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyTextIndent\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;•        The active substanc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>810</td>\n",
       "      <td>23025</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X looks like and contents of the pack</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY looks like and contents of the pack</td>\n",
       "      <td>962</td>\n",
       "      <td>05ff25e5-d7b7-45e4-8639-d72341c96835</td>\n",
       "      <td>2</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nWhat ABILIFY looks like and contents of the pack\\nABILIFY 1 mg/mL oral solution is a clear, colourless to light yellow liquid supplied in bottles with polypropylene child-resistant closure conta...</td>\n",
       "      <td>&lt;p class=\"EMEABodyText\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;What ABILIFY looks like and contents of the pack&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABIL...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>811</td>\n",
       "      <td>23026</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Marketing Authorisation Holder &lt;and Manufacturer&gt;</td>\n",
       "      <td>23023</td>\n",
       "      <td>Marketing Authorisation Holder</td>\n",
       "      <td>969</td>\n",
       "      <td>ed06fd6a-a0eb-4404-a500-bd9bcd768661</td>\n",
       "      <td>2</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nMarketing Authorisation Holder\\nOtsuka Pharmaceutical Netherlands B.V.\\nHerikerbergweg 292\\n1101 CT, Amsterdam\\nNetherlands\\n \\nManufacturer\\nElaiapharm\\n2881 Route des Crêtes, Z.I. Les Bouilid...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Marketing Authorisation Holder&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Otsuka Pharmaceutical Nether...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>813</td>\n",
       "      <td>23028</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This leaflet was last revised in &lt;{MM/YYYY}&gt;&lt;{month YYYY}&gt;.</td>\n",
       "      <td>23023</td>\n",
       "      <td>This leaflet was last revised in {MM/YYYY}</td>\n",
       "      <td>985</td>\n",
       "      <td>29ad8fbb-62c3-4152-bac7-99584007cc6f</td>\n",
       "      <td>2</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nThis leaflet was last revised in {MM/YYYY}\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;This leaflet was last revised in {MM/YYYY}&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>814</td>\n",
       "      <td>23029</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>23023</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>987</td>\n",
       "      <td>dfe4af4e-fe3c-40e7-a9c1-8f80c7e7a848</td>\n",
       "      <td>2</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nOther sources of information\\n \\nDetailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.\\n\\n \\n\\nPackage leaflet: Information for ...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Other sources of information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\" style=\"page-break-after:avoid\"&gt;&lt;spa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>788</td>\n",
       "      <td>23003</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>23001</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>1004</td>\n",
       "      <td>4f84a70c-ed8d-44f7-88ad-ebe47669ce22</td>\n",
       "      <td>3</td>\n",
       "      <td></td>\n",
       "      <td>\\nWhat is in this leaflet\\n1.       What ABILIFY is and what it is used for\\n2.       What you need to know before you are given ABILIFY\\n3.       How ABILIFY is given\\n4.       Possible side effe...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;What is in this leaflet&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"EN-GB\" sty...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>789</td>\n",
       "      <td>23004</td>\n",
       "      <td>CAP</td>\n",
       "      <td>1</td>\n",
       "      <td>What X is and what it is used for</td>\n",
       "      <td>23001</td>\n",
       "      <td>1.       What ABILIFY is and what it is used for</td>\n",
       "      <td>1013</td>\n",
       "      <td>d5e5ec94-6988-44d4-9687-33a1568bb872</td>\n",
       "      <td>3</td>\n",
       "      <td>23003</td>\n",
       "      <td>\\n1.       What ABILIFY is and what it is used for\\n \\nABILIFY contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics. ABILIFY is used to treat quickl...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;1.       What ABILIFY is and what it is used for&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyTex...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>790</td>\n",
       "      <td>23005</td>\n",
       "      <td>CAP</td>\n",
       "      <td>2</td>\n",
       "      <td>What you need to know before you &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23001</td>\n",
       "      <td>2.       What you need to know before you are given ABILIFY</td>\n",
       "      <td>1022</td>\n",
       "      <td>cdae7f3e-2226-4d75-8ce3-ffa23abaae33</td>\n",
       "      <td>3</td>\n",
       "      <td>23004</td>\n",
       "      <td>\\n2.       What you need to know before you are given ABILIFY\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;2.       What you need to know before you are given ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>791</td>\n",
       "      <td>23006</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Do not &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Do not use ABILIFY</td>\n",
       "      <td>1024</td>\n",
       "      <td>2dc51d0e-51c0-48e4-9e86-97bcb2db44e1</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nDo not use ABILIFY\\n•        if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6).\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Do not use ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyTextIndent\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;•        if you are allergic to...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>792</td>\n",
       "      <td>23007</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>23005</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>1027</td>\n",
       "      <td>e333b5a8-d41b-4e46-9f34-8390a98e7848</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nWarnings and precautions\\nTalk to your doctor before you are given ABILIFY.\\n \\nSuicidal thoughts and behaviours have been reported during aripiprazole treatment. Tell your doctor immediately if...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Warnings and precautions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Talk to your doctor before you ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>793</td>\n",
       "      <td>23008</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children &lt;and adolescents&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Children and adolescents</td>\n",
       "      <td>1055</td>\n",
       "      <td>1ff2cf98-a8f1-4709-ba5e-ccb9942a1387</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nChildren and adolescents\\nDo not use this medicine in children and adolescents under 18 years of age. It is not known if it is safe and effective in these patients.\\n</td>\n",
       "      <td>&lt;p class=\"EMEAHeading2\" style=\"page-break-after:auto\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Children and adolescents&lt;/span&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Do not u...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>794</td>\n",
       "      <td>23009</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other medicines and X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Other medicines and ABILIFY</td>\n",
       "      <td>1058</td>\n",
       "      <td>5dc255bb-5d80-4e38-b795-2fa28eae6bf8</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nOther medicines and ABILIFY\\nTell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.\\n \\nBlood pressure-lowering medicines: ABILIFY may increase ...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Other medicines and ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black;background:white\"&gt;Tell your d...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>795</td>\n",
       "      <td>23010</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X with &lt;food&gt; &lt;and&gt; &lt;,&gt; &lt;drink&gt; &lt;and&gt; &lt;alcohol&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY with food, drink and alcohol</td>\n",
       "      <td>1088</td>\n",
       "      <td>c51d7b8a-0e21-4b90-a652-51c149a1656b</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nABILIFY with food, drink and alcohol\\nThis medicine can be given regardless of meals.\\nAlcohol should be avoided.\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY with food, drink and alcohol&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;This medicine can b...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>796</td>\n",
       "      <td>23011</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pregnancy &lt;and&gt; &lt;,&gt; breast-feeding &lt;and fertility&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Pregnancy, breast-feeding and fertility</td>\n",
       "      <td>1092</td>\n",
       "      <td>d93d00af-207e-49aa-b97d-53f21f527dc1</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nPregnancy, breast-feeding and fertility\\nIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.\\...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Pregnancy, breast-feeding and fertility&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you are pregn...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>797</td>\n",
       "      <td>23012</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>23005</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>1099</td>\n",
       "      <td>5bd0acb8-0851-4a8a-bccc-4a98acc9ad24</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nDriving and using machines\\nDizziness and vision problems may occur during treatment with this medicine (see section 4).\\nThis should be considered in cases where full alertness is required, e.g...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Driving and using machines&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\"&gt;Dizziness and vision problems may occur during treat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains sodium</td>\n",
       "      <td>1103</td>\n",
       "      <td>c7d04569-9aa1-4cf4-81e9-6b1d5681d142</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "      <td>\\nABILIFY contains sodium\\nThis medicine contains less than 1 mmol sodium (23 mg) per dosage unit, that is to say essentially ‘sodium-free’.\\n \\n \\n3.       How ABILIFY is given\\n \\nYour doctor wi...</td>\n",
       "      <td>&lt;p class=\"EMEABodyText\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY contains sodium&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;This medicine contains less t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>801</td>\n",
       "      <td>23016</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you &lt;take&gt; &lt;use&gt; more X than you should</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you are given more ABILIFY than you need</td>\n",
       "      <td>1113</td>\n",
       "      <td>b60f6dab-165d-460b-a106-63ebc30124f9</td>\n",
       "      <td>3</td>\n",
       "      <td>23013</td>\n",
       "      <td>\\nIf you are given more ABILIFY than you need\\nThis medicine will be given to you under medical supervision; it is therefore unlikely that you will be given too much. If you see more than one doct...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you are given more &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;ABILIFY than you need&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>804</td>\n",
       "      <td>23019</td>\n",
       "      <td>CAP</td>\n",
       "      <td>4</td>\n",
       "      <td>Possible side effects</td>\n",
       "      <td>23001</td>\n",
       "      <td>4.       Possible side effects</td>\n",
       "      <td>1135</td>\n",
       "      <td>f877ea6a-66bd-4160-b82d-503e1a9de5a4</td>\n",
       "      <td>3</td>\n",
       "      <td>23016</td>\n",
       "      <td>\\n4.       Possible side effects\\n \\nLike all medicines, this medicine can cause side effects, although not everybody gets them.\\n \\nCommon side effects (may affect up to 1 in 10 people):\\n \\n•   ...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;4.       Possible side effects&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\"...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>806</td>\n",
       "      <td>23021</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>23019</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>1242</td>\n",
       "      <td>f1e76341-ce50-441d-b7bd-5950aa7dd4a7</td>\n",
       "      <td>3</td>\n",
       "      <td>23019</td>\n",
       "      <td>\\nReporting of side effects\\nIf you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects di...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Reporting of side effects&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;If you get any side effects, t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>807</td>\n",
       "      <td>23022</td>\n",
       "      <td>CAP</td>\n",
       "      <td>5</td>\n",
       "      <td>How to store X</td>\n",
       "      <td>23001</td>\n",
       "      <td>5.       How to store ABILIFY</td>\n",
       "      <td>1246</td>\n",
       "      <td>0da73d74-78e0-4995-bc18-538ee7f8cf16</td>\n",
       "      <td>3</td>\n",
       "      <td>23021</td>\n",
       "      <td>\\n5.       How to store ABILIFY\\n \\nKeep this medicine out of the sight and reach of children.\\n \\nDo not use this medicine after the expiry date which is stated on the carton and on the vial afte...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;5.       How to store ABILIFY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>808</td>\n",
       "      <td>23023</td>\n",
       "      <td>CAP</td>\n",
       "      <td>6</td>\n",
       "      <td>Contents of the pack and other information</td>\n",
       "      <td>23001</td>\n",
       "      <td>6.       Contents of the pack and other information</td>\n",
       "      <td>1257</td>\n",
       "      <td>2f93a169-7d74-41d1-bafd-371685034cda</td>\n",
       "      <td>3</td>\n",
       "      <td>23022</td>\n",
       "      <td>\\n6.       Contents of the pack and other information\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;6.       Contents of the pack and other information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABody...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>809</td>\n",
       "      <td>23024</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X contains</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY contains</td>\n",
       "      <td>1259</td>\n",
       "      <td>24f9947c-a466-4034-87c7-5fa2bf52f0d5</td>\n",
       "      <td>3</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nWhat ABILIFY contains\\n•        The active substance is aripiprazole.\\nEach mL contains 7.5 mg aripiprazole.\\nA vial contains 9.75 mg (1.3 mL) aripiprazole.\\n \\n•        The other ingredients ar...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;What ABILIFY contains&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyTextIndent\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;•        The active substanc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>810</td>\n",
       "      <td>23025</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X looks like and contents of the pack</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY looks like and contents of the pack</td>\n",
       "      <td>1266</td>\n",
       "      <td>a9d32233-9afc-4f94-9d4a-4cf5c0619ecc</td>\n",
       "      <td>3</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nWhat ABILIFY looks like and contents of the pack\\nThe ABILIFY solution for injection is a clear, colourless, aqueous solution.\\n \\nEach carton contains one single-use type I glass vial with a ru...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;What ABILIFY looks like and contents of the pack&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;The ABI...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>811</td>\n",
       "      <td>23026</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Marketing Authorisation Holder &lt;and Manufacturer&gt;</td>\n",
       "      <td>23023</td>\n",
       "      <td>Marketing Authorisation Holder</td>\n",
       "      <td>1271</td>\n",
       "      <td>af37d74f-9d34-4653-add2-b5cfd350e96c</td>\n",
       "      <td>3</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nMarketing Authorisation Holder\\nOtsuka Pharmaceutical Netherlands B.V.\\nHerikerbergweg 292\\n1101 CT, Amsterdam\\nNetherlands\\n \\nManufacturer\\nZambon S.p.A.\\nVia della Chimica, 9\\nI-36100 Vicenza...</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Marketing Authorisation Holder&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Otsuka Pharmaceutical Nether...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>813</td>\n",
       "      <td>23028</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This leaflet was last revised in &lt;{MM/YYYY}&gt;&lt;{month YYYY}&gt;.</td>\n",
       "      <td>23023</td>\n",
       "      <td>This leaflet was last revised in {MM/YYYY}</td>\n",
       "      <td>1287</td>\n",
       "      <td>98e335a7-7d17-41c3-aba0-8cfcb8398d43</td>\n",
       "      <td>3</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nThis leaflet was last revised in {MM/YYYY}\\n</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;This leaflet was last revised in {MM/YYYY}&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"EMEABodyText\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;&lt;span styl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>814</td>\n",
       "      <td>23029</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>23023</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>1289</td>\n",
       "      <td>404831f9-d222-4ab5-aff0-3808b9cd1672</td>\n",
       "      <td>3</td>\n",
       "      <td>23023</td>\n",
       "      <td>\\nOther sources of information\\n \\nDetailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.</td>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Other sources of information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"MsoNormal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p class=\"E...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     index     id Procedure type Display code  \\\n",
       "0      786  23001            CAP          NaN   \n",
       "1      788  23003            CAP          NaN   \n",
       "2      789  23004            CAP            1   \n",
       "3      790  23005            CAP            2   \n",
       "4      791  23006            CAP          NaN   \n",
       "5      792  23007            CAP          NaN   \n",
       "6      793  23008            CAP          NaN   \n",
       "7      794  23009            CAP          NaN   \n",
       "8      795  23010            CAP          NaN   \n",
       "9      796  23011            CAP          NaN   \n",
       "10     797  23012            CAP          NaN   \n",
       "11     798  23013            CAP          NaN   \n",
       "12     799  23014            CAP            3   \n",
       "13     800  23015            CAP          NaN   \n",
       "14     801  23016            CAP          NaN   \n",
       "15     802  23017            CAP          NaN   \n",
       "16     803  23018            CAP          NaN   \n",
       "17     804  23019            CAP            4   \n",
       "18     805  23020            CAP          NaN   \n",
       "19     806  23021            CAP          NaN   \n",
       "20     807  23022            CAP            5   \n",
       "21     808  23023            CAP            6   \n",
       "22     809  23024            CAP          NaN   \n",
       "23     810  23025            CAP          NaN   \n",
       "24     811  23026            CAP          NaN   \n",
       "25     813  23028            CAP          NaN   \n",
       "26     814  23029            CAP          NaN   \n",
       "27     788  23003            CAP          NaN   \n",
       "28     789  23004            CAP            1   \n",
       "29     790  23005            CAP            2   \n",
       "30     791  23006            CAP          NaN   \n",
       "31     792  23007            CAP          NaN   \n",
       "32     793  23008            CAP          NaN   \n",
       "33     794  23009            CAP          NaN   \n",
       "34     795  23010            CAP          NaN   \n",
       "35     796  23011            CAP          NaN   \n",
       "36     797  23012            CAP          NaN   \n",
       "37     798  23013            CAP          NaN   \n",
       "38     798  23013            CAP          NaN   \n",
       "39     798  23013            CAP          NaN   \n",
       "40     799  23014            CAP            3   \n",
       "41     800  23015            CAP          NaN   \n",
       "42     801  23016            CAP          NaN   \n",
       "43     802  23017            CAP          NaN   \n",
       "44     803  23018            CAP          NaN   \n",
       "45     804  23019            CAP            4   \n",
       "46     805  23020            CAP          NaN   \n",
       "47     806  23021            CAP          NaN   \n",
       "48     807  23022            CAP            5   \n",
       "49     808  23023            CAP            6   \n",
       "50     809  23024            CAP          NaN   \n",
       "51     810  23025            CAP          NaN   \n",
       "52     811  23026            CAP          NaN   \n",
       "53     813  23028            CAP          NaN   \n",
       "54     814  23029            CAP          NaN   \n",
       "55     788  23003            CAP          NaN   \n",
       "56     789  23004            CAP            1   \n",
       "57     790  23005            CAP            2   \n",
       "58     791  23006            CAP          NaN   \n",
       "59     792  23007            CAP          NaN   \n",
       "60     793  23008            CAP          NaN   \n",
       "61     794  23009            CAP          NaN   \n",
       "62     795  23010            CAP          NaN   \n",
       "63     796  23011            CAP          NaN   \n",
       "64     797  23012            CAP          NaN   \n",
       "65     798  23013            CAP          NaN   \n",
       "66     798  23013            CAP          NaN   \n",
       "67     798  23013            CAP          NaN   \n",
       "68     799  23014            CAP            3   \n",
       "69     800  23015            CAP          NaN   \n",
       "70     801  23016            CAP          NaN   \n",
       "71     802  23017            CAP          NaN   \n",
       "72     803  23018            CAP          NaN   \n",
       "73     804  23019            CAP            4   \n",
       "74     805  23020            CAP          NaN   \n",
       "75     806  23021            CAP          NaN   \n",
       "76     807  23022            CAP            5   \n",
       "77     808  23023            CAP            6   \n",
       "78     809  23024            CAP          NaN   \n",
       "79     810  23025            CAP          NaN   \n",
       "80     811  23026            CAP          NaN   \n",
       "81     813  23028            CAP          NaN   \n",
       "82     814  23029            CAP          NaN   \n",
       "83     788  23003            CAP          NaN   \n",
       "84     789  23004            CAP            1   \n",
       "85     790  23005            CAP            2   \n",
       "86     791  23006            CAP          NaN   \n",
       "87     792  23007            CAP          NaN   \n",
       "88     793  23008            CAP          NaN   \n",
       "89     794  23009            CAP          NaN   \n",
       "90     795  23010            CAP          NaN   \n",
       "91     796  23011            CAP          NaN   \n",
       "92     797  23012            CAP          NaN   \n",
       "93     798  23013            CAP          NaN   \n",
       "94     801  23016            CAP          NaN   \n",
       "95     804  23019            CAP            4   \n",
       "96     806  23021            CAP          NaN   \n",
       "97     807  23022            CAP            5   \n",
       "98     808  23023            CAP            6   \n",
       "99     809  23024            CAP          NaN   \n",
       "100    810  23025            CAP          NaN   \n",
       "101    811  23026            CAP          NaN   \n",
       "102    813  23028            CAP          NaN   \n",
       "103    814  23029            CAP          NaN   \n",
       "\n",
       "                                                            Name parent_id  \\\n",
       "0                                                PACKAGE LEAFLET       NaN   \n",
       "1                                        What is in this leaflet     23001   \n",
       "2                              What X is and what it is used for     23001   \n",
       "3               What you need to know before you <take> <use> X      23001   \n",
       "4                                          Do not <take> <use> X     23005   \n",
       "5                                      Warnings and precautions      23005   \n",
       "6                                     Children <and adolescents>     23005   \n",
       "7                                          Other medicines and X     23005   \n",
       "8                X with <food> <and> <,> <drink> <and> <alcohol>     23005   \n",
       "9             Pregnancy <and> <,> breast-feeding <and fertility>     23005   \n",
       "10                                    Driving and using machines     23005   \n",
       "11                            X contains {name the excipient(s)}     23005   \n",
       "12                                        How to <take> <use> X      23001   \n",
       "13                             Use in children <and adolescents>     23014   \n",
       "14                    If you <take> <use> more X than you should     23014   \n",
       "15                              If you forget to <take> <use> X>     23014   \n",
       "16                               If you stop <taking> <using> X>     23014   \n",
       "17                                         Possible side effects     23001   \n",
       "18         Additional side effects in children <and adolescents>     23019   \n",
       "19                                     Reporting of side effects     23019   \n",
       "20                                                How to store X     23001   \n",
       "21                    Contents of the pack and other information     23001   \n",
       "22                                              What X contains      23023   \n",
       "23                    What X looks like and contents of the pack     23023   \n",
       "24             Marketing Authorisation Holder <and Manufacturer>     23023   \n",
       "25   This leaflet was last revised in <{MM/YYYY}><{month YYYY}>.     23023   \n",
       "26                                  Other sources of information     23023   \n",
       "27                                       What is in this leaflet     23001   \n",
       "28                             What X is and what it is used for     23001   \n",
       "29              What you need to know before you <take> <use> X      23001   \n",
       "30                                         Do not <take> <use> X     23005   \n",
       "31                                     Warnings and precautions      23005   \n",
       "32                                    Children <and adolescents>     23005   \n",
       "33                                         Other medicines and X     23005   \n",
       "34               X with <food> <and> <,> <drink> <and> <alcohol>     23005   \n",
       "35            Pregnancy <and> <,> breast-feeding <and fertility>     23005   \n",
       "36                                    Driving and using machines     23005   \n",
       "37                            X contains {name the excipient(s)}     23005   \n",
       "38                            X contains {name the excipient(s)}     23005   \n",
       "39                            X contains {name the excipient(s)}     23005   \n",
       "40                                        How to <take> <use> X      23001   \n",
       "41                             Use in children <and adolescents>     23014   \n",
       "42                    If you <take> <use> more X than you should     23014   \n",
       "43                              If you forget to <take> <use> X>     23014   \n",
       "44                               If you stop <taking> <using> X>     23014   \n",
       "45                                         Possible side effects     23001   \n",
       "46         Additional side effects in children <and adolescents>     23019   \n",
       "47                                     Reporting of side effects     23019   \n",
       "48                                                How to store X     23001   \n",
       "49                    Contents of the pack and other information     23001   \n",
       "50                                              What X contains      23023   \n",
       "51                    What X looks like and contents of the pack     23023   \n",
       "52             Marketing Authorisation Holder <and Manufacturer>     23023   \n",
       "53   This leaflet was last revised in <{MM/YYYY}><{month YYYY}>.     23023   \n",
       "54                                  Other sources of information     23023   \n",
       "55                                       What is in this leaflet     23001   \n",
       "56                             What X is and what it is used for     23001   \n",
       "57              What you need to know before you <take> <use> X      23001   \n",
       "58                                         Do not <take> <use> X     23005   \n",
       "59                                     Warnings and precautions      23005   \n",
       "60                                    Children <and adolescents>     23005   \n",
       "61                                         Other medicines and X     23005   \n",
       "62               X with <food> <and> <,> <drink> <and> <alcohol>     23005   \n",
       "63            Pregnancy <and> <,> breast-feeding <and fertility>     23005   \n",
       "64                                    Driving and using machines     23005   \n",
       "65                            X contains {name the excipient(s)}     23005   \n",
       "66                            X contains {name the excipient(s)}     23005   \n",
       "67                            X contains {name the excipient(s)}     23005   \n",
       "68                                        How to <take> <use> X      23001   \n",
       "69                             Use in children <and adolescents>     23014   \n",
       "70                    If you <take> <use> more X than you should     23014   \n",
       "71                              If you forget to <take> <use> X>     23014   \n",
       "72                               If you stop <taking> <using> X>     23014   \n",
       "73                                         Possible side effects     23001   \n",
       "74         Additional side effects in children <and adolescents>     23019   \n",
       "75                                     Reporting of side effects     23019   \n",
       "76                                                How to store X     23001   \n",
       "77                    Contents of the pack and other information     23001   \n",
       "78                                              What X contains      23023   \n",
       "79                    What X looks like and contents of the pack     23023   \n",
       "80             Marketing Authorisation Holder <and Manufacturer>     23023   \n",
       "81   This leaflet was last revised in <{MM/YYYY}><{month YYYY}>.     23023   \n",
       "82                                  Other sources of information     23023   \n",
       "83                                       What is in this leaflet     23001   \n",
       "84                             What X is and what it is used for     23001   \n",
       "85              What you need to know before you <take> <use> X      23001   \n",
       "86                                         Do not <take> <use> X     23005   \n",
       "87                                     Warnings and precautions      23005   \n",
       "88                                    Children <and adolescents>     23005   \n",
       "89                                         Other medicines and X     23005   \n",
       "90               X with <food> <and> <,> <drink> <and> <alcohol>     23005   \n",
       "91            Pregnancy <and> <,> breast-feeding <and fertility>     23005   \n",
       "92                                    Driving and using machines     23005   \n",
       "93                            X contains {name the excipient(s)}     23005   \n",
       "94                    If you <take> <use> more X than you should     23014   \n",
       "95                                         Possible side effects     23001   \n",
       "96                                     Reporting of side effects     23019   \n",
       "97                                                How to store X     23001   \n",
       "98                    Contents of the pack and other information     23001   \n",
       "99                                              What X contains      23023   \n",
       "100                   What X looks like and contents of the pack     23023   \n",
       "101            Marketing Authorisation Holder <and Manufacturer>     23023   \n",
       "102  This leaflet was last revised in <{MM/YYYY}><{month YYYY}>.     23023   \n",
       "103                                 Other sources of information     23023   \n",
       "\n",
       "                                                        htmlText  htmlIndex  \\\n",
       "0                                             B. PACKAGE LEAFLET         24   \n",
       "1                                        What is in this leaflet         43   \n",
       "2               1.       What ABILIFY is and what it is used for         52   \n",
       "3         2.       What you need to know before you take ABILIFY         59   \n",
       "4                                            Do not take ABILIFY         61   \n",
       "5                                       Warnings and precautions         64   \n",
       "6                                       Children and adolescents         90   \n",
       "7                                    Other medicines and ABILIFY         93   \n",
       "8                           ABILIFY with food, drink and alcohol        121   \n",
       "9                        Pregnancy, breast-feeding and fertility        125   \n",
       "10                                    Driving and using machines        132   \n",
       "11                                      ABILIFY contains lactose        136   \n",
       "12                                  3.       How to take ABILIFY        140   \n",
       "13                               Use in children and adolescents        146   \n",
       "14                      If you take more ABILIFY than you should        156   \n",
       "15                                 If you forget to take ABILIFY        169   \n",
       "16                                    If you stop taking ABILIFY        172   \n",
       "17                                4.       Possible side effects        178   \n",
       "18           Additional side effects in children and adolescents        282   \n",
       "19                                     Reporting of side effects        285   \n",
       "20                                 5.       How to store ABILIFY        289   \n",
       "21           6.       Contents of the pack and other information        300   \n",
       "22                                         What ABILIFY contains        302   \n",
       "23              What ABILIFY looks like and contents of the pack        316   \n",
       "24                                Marketing Authorisation Holder        326   \n",
       "25                    This leaflet was last revised in {MM/YYYY}        342   \n",
       "26                                  Other sources of information        344   \n",
       "27                                       What is in this leaflet        363   \n",
       "28              1.       What ABILIFY is and what it is used for        372   \n",
       "29        2.       What you need to know before you take ABILIFY        379   \n",
       "30                                           Do not take ABILIFY        381   \n",
       "31                                      Warnings and precautions        384   \n",
       "32                                      Children and adolescents        410   \n",
       "33                                   Other medicines and ABILIFY        413   \n",
       "34                          ABILIFY with food, drink and alcohol        441   \n",
       "35                       Pregnancy, breast-feeding and fertility        445   \n",
       "36                                    Driving and using machines        452   \n",
       "37                                    ABILIFY contains aspartame        456   \n",
       "38                                      ABILIFY contains lactose        462   \n",
       "39                                       ABILIFY contains sodium        465   \n",
       "40                                  3.       How to take ABILIFY        469   \n",
       "41                               Use in children and adolescents        475   \n",
       "42                      If you take more ABILIFY than you should        488   \n",
       "43                                 If you forget to take ABILIFY        501   \n",
       "44                                    If you stop taking ABILIFY        504   \n",
       "45                                4.       Possible side effects        510   \n",
       "46           Additional side effects in children and adolescents        614   \n",
       "47                                     Reporting of side effects        617   \n",
       "48                                 5.       How to store ABILIFY        621   \n",
       "49           6.       Contents of the pack and other information        632   \n",
       "50                                         What ABILIFY contains        634   \n",
       "51              What ABILIFY looks like and contents of the pack        646   \n",
       "52                                Marketing Authorisation Holder        655   \n",
       "53                    This leaflet was last revised in {MM/YYYY}        671   \n",
       "54                                  Other sources of information        673   \n",
       "55                                       What is in this leaflet        689   \n",
       "56              1.       What ABILIFY is and what it is used for        698   \n",
       "57        2.       What you need to know before you take ABILIFY        705   \n",
       "58                                           Do not take ABILIFY        707   \n",
       "59                                      Warnings and precautions        710   \n",
       "60                                      Children and adolescents        736   \n",
       "61                                   Other medicines and ABILIFY        739   \n",
       "62                          ABILIFY with food, drink and alcohol        767   \n",
       "63                       Pregnancy, breast-feeding and fertility        771   \n",
       "64                                    Driving and using machines        778   \n",
       "65                         ABILIFY contains fructose and sucrose        782   \n",
       "66                         ABILIFY contains parahydroxybenzoates        785   \n",
       "67                                       ABILIFY contains sodium        788   \n",
       "68                                  3.       How to take ABILIFY        792   \n",
       "69                               Use in children and adolescents        798   \n",
       "70                      If you take more ABILIFY than you should        809   \n",
       "71                                 If you forget to take ABILIFY        822   \n",
       "72                                    If you stop taking ABILIFY        825   \n",
       "73                                4.       Possible side effects        831   \n",
       "74           Additional side effects in children and adolescents        935   \n",
       "75                                     Reporting of side effects        938   \n",
       "76                                 5.       How to store ABILIFY        942   \n",
       "77           6.       Contents of the pack and other information        954   \n",
       "78                                         What ABILIFY contains        956   \n",
       "79              What ABILIFY looks like and contents of the pack        962   \n",
       "80                                Marketing Authorisation Holder        969   \n",
       "81                    This leaflet was last revised in {MM/YYYY}        985   \n",
       "82                                  Other sources of information        987   \n",
       "83                                       What is in this leaflet       1004   \n",
       "84              1.       What ABILIFY is and what it is used for       1013   \n",
       "85   2.       What you need to know before you are given ABILIFY       1022   \n",
       "86                                            Do not use ABILIFY       1024   \n",
       "87                                      Warnings and precautions       1027   \n",
       "88                                      Children and adolescents       1055   \n",
       "89                                   Other medicines and ABILIFY       1058   \n",
       "90                          ABILIFY with food, drink and alcohol       1088   \n",
       "91                       Pregnancy, breast-feeding and fertility       1092   \n",
       "92                                    Driving and using machines       1099   \n",
       "93                                       ABILIFY contains sodium       1103   \n",
       "94                   If you are given more ABILIFY than you need       1113   \n",
       "95                                4.       Possible side effects       1135   \n",
       "96                                     Reporting of side effects       1242   \n",
       "97                                 5.       How to store ABILIFY       1246   \n",
       "98           6.       Contents of the pack and other information       1257   \n",
       "99                                         What ABILIFY contains       1259   \n",
       "100             What ABILIFY looks like and contents of the pack       1266   \n",
       "101                               Marketing Authorisation Holder       1271   \n",
       "102                   This leaflet was last revised in {MM/YYYY}       1287   \n",
       "103                                 Other sources of information       1289   \n",
       "\n",
       "                                   htmlId  SubSectionIndex doc_parent_id  \\\n",
       "0    ba7f0011-777c-4c87-ab14-945b7f219145                0                 \n",
       "1    6399df46-b26b-41ef-8faa-1e468be43bd7                0         23001   \n",
       "2    10306e47-6cf5-4529-b240-c8c69af4c4c7                0         23001   \n",
       "3    1fe30967-1779-470d-95e2-9c90a04c60c4                0         23001   \n",
       "4    b62e92fa-848f-4e9e-b9cb-b3b7fb89afdf                0         23005   \n",
       "5    20686598-1bda-4358-a32d-52fc5ce73748                0         23005   \n",
       "6    2ef4ce01-dcb9-4ef2-bf32-9ce8368cfae7                0         23005   \n",
       "7    64c7ac18-2ac4-43bf-bd98-1338a58e3276                0         23005   \n",
       "8    bf52352e-edd8-4b45-ba51-e791cc8fdcd4                0         23005   \n",
       "9    7294f0d4-67e1-40ff-bfc6-4effd7beb960                0         23005   \n",
       "10   ec700889-50b2-46ed-85eb-8c8b518cb788                0         23005   \n",
       "11   3d5f5b60-1614-4102-a47b-65bbedc6655a                0         23005   \n",
       "12   215cb022-ee9e-4187-8d7a-1682d49cb7ef                0         23001   \n",
       "13   69f5c85f-35d3-45cf-9a4b-7d70bfd55abd                0         23014   \n",
       "14   68739525-e8d0-40a3-b375-5e6ad85b44c5                0         23014   \n",
       "15   664b61ff-ced3-47e7-85f2-5a87f8b512a6                0         23014   \n",
       "16   618e0d93-0148-4265-ab5d-bcb393e51f03                0         23014   \n",
       "17   caae52f5-9b8e-4a85-bd49-36977f0c50f8                0         23001   \n",
       "18   ca628b27-4900-4f04-aec4-cd4f5821d201                0         23019   \n",
       "19   4e5c19cb-c772-4d68-8211-6ce6f84a1641                0         23019   \n",
       "20   1d1d8138-cf62-4d68-a7fa-411c64250ac0                0         23001   \n",
       "21   3cf52e31-0edf-47fd-8525-8934112ce5a7                0         23001   \n",
       "22   8719defc-d27a-493c-9d20-4d14b9c50496                0         23023   \n",
       "23   57f5bc1e-7d49-4a3c-8221-e1d9a266ffa9                0         23023   \n",
       "24   42fe4795-5be4-455e-8ab6-9b5ba8e9f2bd                0         23023   \n",
       "25   8b3e2d1c-5b91-4ad4-b710-f7402708acc4                0         23023   \n",
       "26   01ae6f19-7b5e-42cc-8563-16acd8743705                0         23023   \n",
       "27   4f65c4f1-e91e-4d03-97bd-0e5d8ed8b7a6                1                 \n",
       "28   0ca4f398-e781-4971-a846-f159db4c9932                1         23003   \n",
       "29   fc10acb3-0df9-413c-9231-a6995ad6177d                1         23004   \n",
       "30   dbe8ffd9-d1ea-4cff-aa5d-2eeb2d6cb423                1         23005   \n",
       "31   22f3170c-fc1d-41bd-9c26-861759ee1620                1         23005   \n",
       "32   05ee6c1f-cc2b-4707-a7a3-48bd0623e7b7                1         23005   \n",
       "33   edd492ec-09fd-4262-8dd8-7fa0b7507f97                1         23005   \n",
       "34   3eb499d1-1a3b-43ab-b921-96ee688a828e                1         23005   \n",
       "35   a7374bc4-89fd-444a-b181-cddc65f5f91c                1         23005   \n",
       "36   f4bf2238-189d-46e4-820c-1d3385b789db                1         23005   \n",
       "37   4f3e2097-ac09-444c-a74b-d3ac2b6897fa                1         23005   \n",
       "38   7ab98a29-42ec-464e-9fc6-5d9fcf6bdce6                1         23005   \n",
       "39   39b82250-a98a-495c-b5ed-2a288bd4089e                1         23005   \n",
       "40   655f11eb-a52d-4a39-9d66-1d3f08518998                1         23013   \n",
       "41   4fd11b3b-5a3a-4944-ac2e-c01472245a5d                1         23014   \n",
       "42   a7cb028f-75f2-4703-b497-565fad4edd38                1         23014   \n",
       "43   e404e630-4ca8-4737-85b0-0243dc4e1af3                1         23014   \n",
       "44   38c55c46-64c1-470f-b143-347406edb287                1         23014   \n",
       "45   6c040fc4-4a56-431a-83ec-709b77667e95                1         23018   \n",
       "46   641467ee-1641-456e-b013-a56b36f2ff77                1         23019   \n",
       "47   08202e3a-d475-4d47-a211-f7e07278999b                1         23019   \n",
       "48   456d341f-e4a8-4e8d-85d7-9c661dd6264c                1         23021   \n",
       "49   f1875f64-4532-4bfd-928a-ce18a1558129                1         23022   \n",
       "50   09ef7199-8840-48d3-97b9-2cd4ea1558c9                1         23023   \n",
       "51   0f852c02-e2e0-415b-9c57-9f2fbef7961e                1         23023   \n",
       "52   219bb058-4c68-4861-afe4-80177a844121                1         23023   \n",
       "53   abea3cf8-3c1c-47a0-a464-766bcecc0c52                1         23023   \n",
       "54   4ee904cf-deb9-46e8-9502-2d4a821584e9                1         23023   \n",
       "55   a5ee6aa4-171a-406d-af8a-c6be76c37038                2                 \n",
       "56   fb7a5f49-ed2f-4ee8-9a96-d787f2c34985                2         23003   \n",
       "57   861bd2b5-04e7-4eaa-abe7-4ac7e127381a                2         23004   \n",
       "58   2d8c3f8a-f7be-4f54-be2e-6d7410ebee0c                2         23005   \n",
       "59   b519a8f4-dbb9-4a45-821a-15111499aa33                2         23005   \n",
       "60   55a4498a-f045-450d-a5ea-ce5e8ab669d8                2         23005   \n",
       "61   678c2221-b859-4819-b110-efa46498d8e0                2         23005   \n",
       "62   2ba81bba-a5c9-4817-bc17-84d1e0a16acb                2         23005   \n",
       "63   3a2f8c7f-df89-421e-ac07-7822b458efaf                2         23005   \n",
       "64   67e7bf58-0e7f-455f-ada6-018ef79f6f23                2         23005   \n",
       "65   ec3e924b-e3db-4190-bf5e-d14a11c8d9e7                2         23005   \n",
       "66   6d3225d2-b6c6-4321-9890-5fe73b306d8b                2         23005   \n",
       "67   431a94d1-f0ac-4c69-8b91-281f6f529a74                2         23005   \n",
       "68   8e8abaa9-c68c-4643-95e3-0d81e9d6b93c                2         23013   \n",
       "69   cd5cf1fc-d291-4a06-89df-7158594e670e                2         23014   \n",
       "70   3b8bf1cc-469a-4b2c-8c4d-aee39532152c                2         23014   \n",
       "71   9472c6d1-ddbd-475f-a427-10e14c0daab9                2         23014   \n",
       "72   9ee68d9c-284b-49ff-95e4-6e470191d07c                2         23014   \n",
       "73   40612ebd-9a22-4948-bfec-a3267c5a66f2                2         23018   \n",
       "74   406f7cbd-6225-4372-8d43-e26dde9e5604                2         23019   \n",
       "75   97317f00-2cc7-47fc-8f37-af43bc71b01f                2         23019   \n",
       "76   ad3dbf0e-929e-4e06-b834-b9b4fa8cec24                2         23021   \n",
       "77   e39ee105-8558-4dba-8a87-1c63bce86b99                2         23022   \n",
       "78   2c693717-5391-4fc6-b0db-3a1f5dc89e13                2         23023   \n",
       "79   05ff25e5-d7b7-45e4-8639-d72341c96835                2         23023   \n",
       "80   ed06fd6a-a0eb-4404-a500-bd9bcd768661                2         23023   \n",
       "81   29ad8fbb-62c3-4152-bac7-99584007cc6f                2         23023   \n",
       "82   dfe4af4e-fe3c-40e7-a9c1-8f80c7e7a848                2         23023   \n",
       "83   4f84a70c-ed8d-44f7-88ad-ebe47669ce22                3                 \n",
       "84   d5e5ec94-6988-44d4-9687-33a1568bb872                3         23003   \n",
       "85   cdae7f3e-2226-4d75-8ce3-ffa23abaae33                3         23004   \n",
       "86   2dc51d0e-51c0-48e4-9e86-97bcb2db44e1                3         23005   \n",
       "87   e333b5a8-d41b-4e46-9f34-8390a98e7848                3         23005   \n",
       "88   1ff2cf98-a8f1-4709-ba5e-ccb9942a1387                3         23005   \n",
       "89   5dc255bb-5d80-4e38-b795-2fa28eae6bf8                3         23005   \n",
       "90   c51d7b8a-0e21-4b90-a652-51c149a1656b                3         23005   \n",
       "91   d93d00af-207e-49aa-b97d-53f21f527dc1                3         23005   \n",
       "92   5bd0acb8-0851-4a8a-bccc-4a98acc9ad24                3         23005   \n",
       "93   c7d04569-9aa1-4cf4-81e9-6b1d5681d142                3         23005   \n",
       "94   b60f6dab-165d-460b-a106-63ebc30124f9                3         23013   \n",
       "95   f877ea6a-66bd-4160-b82d-503e1a9de5a4                3         23016   \n",
       "96   f1e76341-ce50-441d-b7bd-5950aa7dd4a7                3         23019   \n",
       "97   0da73d74-78e0-4995-bc18-538ee7f8cf16                3         23021   \n",
       "98   2f93a169-7d74-41d1-bafd-371685034cda                3         23022   \n",
       "99   24f9947c-a466-4034-87c7-5fa2bf52f0d5                3         23023   \n",
       "100  a9d32233-9afc-4f94-9d4a-4cf5c0619ecc                3         23023   \n",
       "101  af37d74f-9d34-4653-add2-b5cfd350e96c                3         23023   \n",
       "102  98e335a7-7d17-41c3-aba0-8cfcb8398d43                3         23023   \n",
       "103  404831f9-d222-4ab5-aff0-3808b9cd1672                3         23023   \n",
       "\n",
       "                                                                                                                                                                                                        Text  \\\n",
       "0    \\nB. PACKAGE LEAFLET\\n\\n \\n\\nPackage leaflet: Information for the user\\n \\nABILIFY 5 mg tablets\\nABILIFY 10 mg tablets\\nABILIFY 15 mg tablets\\nABILIFY 30 mg tablets\\n \\naripiprazole\\n \\nRead all o...   \n",
       "1    \\nWhat is in this leaflet\\n1.       What ABILIFY is and what it is used for\\n2.       What you need to know before you take ABILIFY\\n3.      How to take ABILIFY\\n4.      Possible side effects\\n5  ...   \n",
       "2    \\n1.       What ABILIFY is and what it is used for\\n \\nABILIFY contains the active substance aripiprazole and belong to a group of medicines called antipsychotics. It is used to treat adults and a...   \n",
       "3                                                                                                                                                \\n2.       What you need to know before you take ABILIFY\\n    \n",
       "4                                                             \\nDo not take ABILIFY\\n•        if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6).\\n    \n",
       "5    \\nWarnings and precautions\\nTalk to your doctor before taking ABILIFY.\\n \\nSuicidal thoughts and behaviours have been reported during aripiprazole treatment. Tell your doctor immediately if you ar...   \n",
       "6                                  \\nChildren and adolescents\\nDo not use this medicine in children and adolescents under 13 years of age. It is not known if it is safe and effective in these patients.\\n    \n",
       "7    \\nOther medicines and ABILIFY\\nTell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.\\n \\nBlo...   \n",
       "8                                                                                     \\nABILIFY with food, drink and alcohol\\nThis medicine can be taken regardless of meals.\\nAlcohol should be avoided.\\n    \n",
       "9    \\nPregnancy, breast-feeding and fertility\\nIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.\\...   \n",
       "10   \\nDriving and using machines\\nDizziness and vision problems may occur during treatment with this medicine (see section 4).\\nThis should be considered in cases where full alertness is required, e.g...   \n",
       "11                                      \\nABILIFY contains lactose\\nIf you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.\\n \\n    \n",
       "12   \\n3.       How to take ABILIFY\\n \\nAlways take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.\\n \\nThe recommended dose f...   \n",
       "13   \\nUse in children and adolescents\\nThis medicinal product may be started at a low dose with the oral solution (liquid) form.\\nThe dose may be gradually increased to the recommended dose for adoles...   \n",
       "14   \\nIf you take more ABILIFY than you should\\nIf you realise you have taken more ABILIFY than your doctor has recommended (or if someone else has taken some of your ABILIFY), contact your doctor rig...   \n",
       "15                                                                \\nIf you forget to take ABILIFY\\nIf you miss a dose, take the missed dose as soon as you remember but do not take two doses in one day.\\n    \n",
       "16   \\nIf you stop taking ABILIFY\\nDo not stop your treatment just because you feel better. It is important that you carry on taking ABILIFY for as long as your doctor has told you to.\\n \\nIf you have ...   \n",
       "17   \\n4.       Possible side effects\\n \\nLike all medicines, this medicine can cause side effects, although not everybody gets them.\\n \\nCommon side effects (may affect up to 1 in 10 people):\\n \\n•   ...   \n",
       "18   \\nAdditional side effects in children and adolescents\\nAdolescents aged 13 years and older experienced side effects that were similar in frequency and type to those in adults except that sleepines...   \n",
       "19   \\nReporting of side effects\\nIf you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects di...   \n",
       "20   \\n5.       How to store ABILIFY\\n \\nKeep this medicine out of the sight and reach of children.\\n \\nDo not use this medicine after the expiry date which is stated on the blister and on the carton a...   \n",
       "21                                                                                                                                                  \\n6.       Contents of the pack and other information\\n    \n",
       "22   \\nWhat ABILIFY contains\\n•        The active substance is aripiprazole.\\n          Each tablet contains 5 mg of aripiprazole.\\n          Each tablet contains 10 mg of aripiprazole.\\n          Each...   \n",
       "23   \\nWhat ABILIFY looks like and contents of the pack\\nABILIFY 5 mg tablets are rectangular and blue, marked with ‘A-007’ and ‘5’ on one side.\\nABILIFY 10 mg tablets are rectangular and pink, marked ...   \n",
       "24   \\nMarketing Authorisation Holder\\nOtsuka Pharmaceutical Netherlands B.V.\\nHerikerbergweg 292\\n1101 CT, Amsterdam\\nNetherlands\\n \\nManufacturer\\nElaiapharm\\n2881 Route des Crêtes, Z.I. Les Bouilid...   \n",
       "25                                                                                                                                                           \\nThis leaflet was last revised in {MM/YYYY}\\n    \n",
       "26   \\nOther sources of information\\n \\nDetailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.\\n \\n\\nPackage leaflet: Information for th...   \n",
       "27   \\nWhat is in this leaflet\\n1.       What ABILIFY is and what it is used for\\n2.       What you need to know before you take ABILIFY\\n3.       How to take ABILIFY\\n4.       Possible side effects\\n5...   \n",
       "28   \\n1.       What ABILIFY is and what it is used for\\n \\nABILIFY contains the active substance aripiprazole and belong to a group of medicines called antipsychotics. It is used to treat adults and a...   \n",
       "29                                                                                                                                               \\n2.       What you need to know before you take ABILIFY\\n    \n",
       "30                                                            \\nDo not take ABILIFY\\n•        if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6).\\n    \n",
       "31   \\nWarnings and precautions\\nTalk to your doctor before taking ABILIFY.\\n \\nSuicidal thoughts and behaviours have been reported during aripiprazole treatment. Tell your doctor immediately if you ar...   \n",
       "32                                 \\nChildren and adolescents\\nDo not use this medicine in children and adolescents under 13 years of age. It is not known if it is safe and effective in these patients.\\n    \n",
       "33   \\nOther medicines and ABILIFY\\nTell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.\\n \\nBlo...   \n",
       "34                                                                                    \\nABILIFY with food, drink and alcohol\\nThis medicine can be taken regardless of meals.\\nAlcohol should be avoided.\\n    \n",
       "35   \\nPregnancy, breast-feeding and fertility\\nIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.\\...   \n",
       "36   \\nDriving and using machines\\nDizziness and vision problems may occur during treatment with this medicine (see section 4).\\nThis should be considered in cases where full alertness is required, e.g...   \n",
       "37   \\nABILIFY contains aspartame\\nABILIFY 10 mg orodispersible tablets: This medicine contains 2 mg aspartame in each tablet.\\nABILIFY 15 mg orodispersible tablets: This medicine contains 3 mg asparta...   \n",
       "38                                         \\nABILIFY contains lactose\\nIf you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.\\n    \n",
       "39                                                             \\nABILIFY contains sodium\\nThis medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.\\n \\n    \n",
       "40   \\n3.       How to take ABILIFY\\n \\nAlways take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.\\n \\nThe recommended dose f...   \n",
       "41   \\nUse in children and adolescents\\nThis medicinal product may be started at a low dose with the oral solution (liquid) form.\\nThe dose may be gradually increased to the recommended dose for adoles...   \n",
       "42   \\nIf you take more ABILIFY than you should\\nIf you realise you have taken more ABILIFY than your doctor has recommended (or if someone else has taken some of your ABILIFY), contact your doctor rig...   \n",
       "43                                                                \\nIf you forget to take ABILIFY\\nIf you miss a dose, take the missed dose as soon as you remember but do not take two doses in one day.\\n    \n",
       "44   \\nIf you stop taking ABILIFY\\nDo not stop your treatment just because you feel better. It is important that you carry on taking ABILIFY for as long as your doctor has told you to.\\n \\nIf you have ...   \n",
       "45   \\n4.       Possible side effects\\n \\nLike all medicines, this medicine can cause side effects, although not everybody gets them.\\n \\nCommon side effects (may affect up to 1 in 10 people):\\n \\n•   ...   \n",
       "46   \\nAdditional side effects in children and adolescents\\nAdolescents aged 13 years and older experienced side effects that were similar in frequency and type to those in adults except that sleepines...   \n",
       "47   \\nReporting of side effects\\nIf you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects di...   \n",
       "48   \\n5.       How to store ABILIFY\\n \\nKeep this medicine out of the sight and reach of children.\\n \\nDo not use this medicine after the expiry date which is stated on the blister and on the carton a...   \n",
       "49                                                                                                                                                  \\n6.       Contents of the pack and other information\\n    \n",
       "50   \\nWhat ABILIFY contains\\n•        The active substance is aripiprazole.\\n          Each orodispersible tablet contains 10 mg of aripiprazole.\\n          Each orodispersible tablet contains 15 mg o...   \n",
       "51   \\nWhat ABILIFY looks like and contents of the pack\\nABILIFY 10 mg orodispersible tablets are round and pink, marked with ‘\"A\" over \"640\"’ on one side and ‘10’ on the other.\\nABILIFY 15 mg orodispe...   \n",
       "52   \\nMarketing Authorisation Holder\\nOtsuka Pharmaceutical Netherlands B.V.\\nHerikerbergweg 292\\n1101 CT, Amsterdam\\nNetherlands\\n \\nManufacturer\\nElaiapharm\\n2881 Route des Crêtes, Z.I. Les Bouilid...   \n",
       "53                                                                                                                                                           \\nThis leaflet was last revised in {MM/YYYY}\\n    \n",
       "54   \\nOther sources of information\\n \\nDetailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.\\n \\n\\nPackage leaflet: Information for th...   \n",
       "55   \\nWhat is in this leaflet\\n1.       What ABILIFY is and what it is used for\\n2.       What you need to know before you take ABILIFY\\n3.       How to take ABILIFY\\n4.       Possible side effects\\n5...   \n",
       "56   \\n1.       What ABILIFY is and what it is used for\\n \\nABILIFY contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics. It is used to treat adults and ...   \n",
       "57                                                                                                                                               \\n2.       What you need to know before you take ABILIFY\\n    \n",
       "58                                                            \\nDo not take ABILIFY\\n•        if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6).\\n    \n",
       "59   \\nWarnings and precautions\\nTalk to your doctor before taking ABILIFY.\\n \\nSuicidal thoughts and behaviours have been reported during aripiprazole treatment. Tell your doctor immediately if you ar...   \n",
       "60                                 \\nChildren and adolescents\\nDo not use this medicine in children and adolescents under 13 years of age. It is not known if it is safe and effective in these patients.\\n    \n",
       "61   \\nOther medicines and ABILIFY\\nTell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.\\n \\nBlo...   \n",
       "62   \\nABILIFY with food, drink and alcohol\\nThis medicine can be taken regardless of meals. However, the oral solution should not be diluted with other liquids or mixed with any food prior to administ...   \n",
       "63   \\nPregnancy, breast-feeding and fertility\\nIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.\\...   \n",
       "64   \\nDriving and using machines\\nDizziness and vision problems may occur during treatment with this medicine (see section 4).\\nThis should be considered in cases where full alertness is required, e.g...   \n",
       "65   \\nABILIFY contains fructose and sucrose\\nThis medicine contains 200 mg of fructose and 400 mg of sucrose in each mL. If you have been told by your doctor that you have an intolerance to some sugar...   \n",
       "66                                                                                                              \\nABILIFY contains parahydroxybenzoates\\nMay cause allergic reactions (possibly delayed).\\n    \n",
       "67                                                        \\nABILIFY contains sodium\\nThis medicine contains less than 1 mmol sodium (23 mg) per dosage unit, that is to say essentially ‘sodium-free’.\\n \\n    \n",
       "68   \\n3.       How to take ABILIFY\\n \\nAlways take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.\\n \\nThe recommended dose f...   \n",
       "69   \\nUse in children and adolescents\\nThe recommended dose for adolescents is 10 mL solution (corresponding to 10 mg aripiprazole) once a day. However your doctor may prescribe a lower or higher dose...   \n",
       "70   \\nIf you take more ABILIFY than you should\\nIf you realise you have taken more ABILIFY than your doctor has recommended (or if someone else has taken some of your ABILIFY), contact your doctor rig...   \n",
       "71                                                                \\nIf you forget to take ABILIFY\\nIf you miss a dose, take the missed dose as soon as you remember but do not take two doses in one day.\\n    \n",
       "72   \\nIf you stop taking ABILIFY\\nDo not stop your treatment just because you feel better. It is important that you carry on taking ABILIFY for as long as your doctor has told you to.\\n \\nIf you have ...   \n",
       "73   \\n4.       Possible side effects\\n \\nLike all medicines, this medicine can cause side effects, although not everybody gets them.\\n \\nCommon side effects (may affect up to 1 in 10 people):\\n \\n•   ...   \n",
       "74   \\nAdditional side effects in children and adolescents\\nAdolescents aged 13 years and older experienced side effects that were similar in frequency and type to those in adults except that sleepines...   \n",
       "75   \\nReporting of side effects\\nIf you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects di...   \n",
       "76   \\n5.       How to store ABILIFY\\n \\nKeep this medicine out of the sight and reach of children.\\n \\nDo not use this medicine after the expiry date which is stated on the bottle and on the carton af...   \n",
       "77                                                                                                                                                  \\n6.       Contents of the pack and other information\\n    \n",
       "78   \\nWhat ABILIFY contains\\n•        The active substance is aripiprazole.\\nEach mL contains 1 mg of aripiprazole.\\n \\n•        The other ingredients are disodium edetate, fructose, glycerin, lactic ...   \n",
       "79   \\nWhat ABILIFY looks like and contents of the pack\\nABILIFY 1 mg/mL oral solution is a clear, colourless to light yellow liquid supplied in bottles with polypropylene child-resistant closure conta...   \n",
       "80   \\nMarketing Authorisation Holder\\nOtsuka Pharmaceutical Netherlands B.V.\\nHerikerbergweg 292\\n1101 CT, Amsterdam\\nNetherlands\\n \\nManufacturer\\nElaiapharm\\n2881 Route des Crêtes, Z.I. Les Bouilid...   \n",
       "81                                                                                                                                                           \\nThis leaflet was last revised in {MM/YYYY}\\n    \n",
       "82   \\nOther sources of information\\n \\nDetailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.\\n\\n \\n\\nPackage leaflet: Information for ...   \n",
       "83   \\nWhat is in this leaflet\\n1.       What ABILIFY is and what it is used for\\n2.       What you need to know before you are given ABILIFY\\n3.       How ABILIFY is given\\n4.       Possible side effe...   \n",
       "84   \\n1.       What ABILIFY is and what it is used for\\n \\nABILIFY contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics. ABILIFY is used to treat quickl...   \n",
       "85                                                                                                                                          \\n2.       What you need to know before you are given ABILIFY\\n    \n",
       "86                                                             \\nDo not use ABILIFY\\n•        if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6).\\n    \n",
       "87   \\nWarnings and precautions\\nTalk to your doctor before you are given ABILIFY.\\n \\nSuicidal thoughts and behaviours have been reported during aripiprazole treatment. Tell your doctor immediately if...   \n",
       "88                                 \\nChildren and adolescents\\nDo not use this medicine in children and adolescents under 18 years of age. It is not known if it is safe and effective in these patients.\\n    \n",
       "89   \\nOther medicines and ABILIFY\\nTell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.\\n \\nBlood pressure-lowering medicines: ABILIFY may increase ...   \n",
       "90                                                                                    \\nABILIFY with food, drink and alcohol\\nThis medicine can be given regardless of meals.\\nAlcohol should be avoided.\\n    \n",
       "91   \\nPregnancy, breast-feeding and fertility\\nIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.\\...   \n",
       "92   \\nDriving and using machines\\nDizziness and vision problems may occur during treatment with this medicine (see section 4).\\nThis should be considered in cases where full alertness is required, e.g...   \n",
       "93   \\nABILIFY contains sodium\\nThis medicine contains less than 1 mmol sodium (23 mg) per dosage unit, that is to say essentially ‘sodium-free’.\\n \\n \\n3.       How ABILIFY is given\\n \\nYour doctor wi...   \n",
       "94   \\nIf you are given more ABILIFY than you need\\nThis medicine will be given to you under medical supervision; it is therefore unlikely that you will be given too much. If you see more than one doct...   \n",
       "95   \\n4.       Possible side effects\\n \\nLike all medicines, this medicine can cause side effects, although not everybody gets them.\\n \\nCommon side effects (may affect up to 1 in 10 people):\\n \\n•   ...   \n",
       "96   \\nReporting of side effects\\nIf you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects di...   \n",
       "97   \\n5.       How to store ABILIFY\\n \\nKeep this medicine out of the sight and reach of children.\\n \\nDo not use this medicine after the expiry date which is stated on the carton and on the vial afte...   \n",
       "98                                                                                                                                                  \\n6.       Contents of the pack and other information\\n    \n",
       "99   \\nWhat ABILIFY contains\\n•        The active substance is aripiprazole.\\nEach mL contains 7.5 mg aripiprazole.\\nA vial contains 9.75 mg (1.3 mL) aripiprazole.\\n \\n•        The other ingredients ar...   \n",
       "100  \\nWhat ABILIFY looks like and contents of the pack\\nThe ABILIFY solution for injection is a clear, colourless, aqueous solution.\\n \\nEach carton contains one single-use type I glass vial with a ru...   \n",
       "101  \\nMarketing Authorisation Holder\\nOtsuka Pharmaceutical Netherlands B.V.\\nHerikerbergweg 292\\n1101 CT, Amsterdam\\nNetherlands\\n \\nManufacturer\\nZambon S.p.A.\\nVia della Chimica, 9\\nI-36100 Vicenza...   \n",
       "102                                                                                                                                                          \\nThis leaflet was last revised in {MM/YYYY}\\n    \n",
       "103                                               \\nOther sources of information\\n \\nDetailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.   \n",
       "\n",
       "                                                                                                                                                                                                   Html_betw  \n",
       "0    <p class=\"TitleA\"><span lang=\"EN-GB\" style=\"color:black\">B. PACKAGE LEAFLET</span></p><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif; color:black'><br clear=\"all...  \n",
       "1    <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">What is in this leaflet</span></b></p><p class=\"EMEABodyText\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" sty...  \n",
       "2    <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">1.       What ABILIFY is and what it is used for</span></b></p><p class=\"EMEABodyTex...  \n",
       "3    <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">2.       What you need to know before you take ABILIFY</span></b></p><p class=\"EMEAB...  \n",
       "4    <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Do not take ABILIFY</span></b></p><p class=\"EMEABodyTextIndent\"><span lang=\"EN-GB\" style=\"color:black\">•        if you are allergic t...  \n",
       "5    <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Warnings and precautions</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">Talk to your doctor before taki...  \n",
       "6    <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Children and adolescents</span></b></p><p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Do not use this medicine in childr...  \n",
       "7    <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Other medicines and ABILIFY</span></b></p><p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Tell your doctor or pharmacist ...  \n",
       "8    <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY with food, drink and alcohol</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">This medicine can b...  \n",
       "9    <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Pregnancy, breast-feeding and fertility</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you are pregn...  \n",
       "10   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Driving and using machines</span></b></p><p class=\"MsoNormal\"><span lang=\"EN-GB\">Dizziness and vision problems may occur during treat...  \n",
       "11   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY contains lactose</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you have been told by your d...  \n",
       "12   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">3.       How to take ABILIFY</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB...  \n",
       "13   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Use in children and adolescents</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">This medicinal product m...  \n",
       "14   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">If you take more ABILIFY than you should</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you realise ...  \n",
       "15   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">If you forget to take ABILIFY</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you miss a dose, take t...  \n",
       "16   <p class=\"MsoNormal\"><em><b><span lang=\"EN-GB\" style=\"color:black;font-style:normal\">If you stop taking </span></b></em><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY</span></b></p><p class=\"Ms...  \n",
       "17   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">4.       Possible side effects</span></b></p><p class=\"EMEAHeading1\" style=\"margin-l...  \n",
       "18   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Additional side effects in children and adolescents</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">Adol...  \n",
       "19   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Reporting of side effects</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you get any side effects, t...  \n",
       "20   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">5.       How to store ABILIFY</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-G...  \n",
       "21   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">6.       Contents of the pack and other information</span></b></p><p class=\"EMEABody...  \n",
       "22   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">What ABILIFY contains</span></b></p><p class=\"EMEABodyTextIndent\"><span lang=\"EN-GB\" style=\"color:black\">•        The active substanc...  \n",
       "23   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">What ABILIFY looks like and contents of the pack</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">ABILIFY...  \n",
       "24   <p class=\"EMEAHeading2\" style=\"page-break-after:auto\"><span lang=\"EN-GB\" style=\"color:black\">Marketing Authorisation Holder</span></p><p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Ot...  \n",
       "25       <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">This leaflet was last revised in {MM/YYYY}</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\"> </span></p>  \n",
       "26   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"color:black\">Other sources of information</span></b></p><p class=\"MsoNormal\" style=\"page-break-after:avoid\"><b><spa...  \n",
       "27   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">What is in this leaflet</span></b></p><p class=\"EMEABodyText\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" sty...  \n",
       "28   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">1.       What ABILIFY is and what it is used for</span></b></p><p class=\"EMEABodyTex...  \n",
       "29   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">2.       What you need to know before you take ABILIFY</span></b></p><p class=\"EMEAB...  \n",
       "30   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Do not take ABILIFY</span></b></p><p class=\"EMEABodyText\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"...  \n",
       "31   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Warnings and precautions</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">Talk to your doctor before taki...  \n",
       "32   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Children and adolescents</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">Do not use this medicine in chi...  \n",
       "33   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Other medicines and ABILIFY</span></b></p><p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Tell your doctor or pharmacist ...  \n",
       "34   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY with food, drink and alcohol</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">This medicine can b...  \n",
       "35   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Pregnancy, breast-feeding and fertility</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you are pregn...  \n",
       "36   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Driving and using machines</span></b></p><p class=\"MsoNormal\"><span lang=\"EN-GB\">Dizziness and vision problems may occur during treat...  \n",
       "37   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY contains aspartame</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">ABILIFY 10 mg orodispersible ...  \n",
       "38   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY contains lactose</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you have been told by your d...  \n",
       "39   <p class=\"EMEABodyText\"><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY contains sodium</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">This medicine contains less t...  \n",
       "40   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">3.       How to take ABILIFY</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB...  \n",
       "41   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Use in children and adolescents</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">This medicinal product m...  \n",
       "42   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">If you take more ABILIFY than you should</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you realise ...  \n",
       "43   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">If you forget to take ABILIFY</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you miss a dose, take t...  \n",
       "44   <p class=\"EMEABodyText\"><em><b><span lang=\"EN-GB\" style=\"color:black;font-style: normal\">If you stop taking </span></b></em><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY</span></b></p><p class...  \n",
       "45   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">4.       Possible side effects</span></b></p><p class=\"MsoNormal\"><span lang=\"EN-GB\"...  \n",
       "46   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Additional side effects in children and adolescents</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">Adol...  \n",
       "47   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Reporting of side effects</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you get any side effects, t...  \n",
       "48   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">5.       How to store ABILIFY</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-G...  \n",
       "49   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">6.       Contents of the pack and other information</span></b></p><p class=\"EMEABody...  \n",
       "50   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">What ABILIFY contains</span></b></p><p class=\"EMEABodyTextIndent\"><span lang=\"EN-GB\" style=\"color:black\">•        The active substanc...  \n",
       "51   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">What ABILIFY looks like and contents of the pack</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">ABILIFY...  \n",
       "52   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Marketing Authorisation Holder</span></b></p><p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Otsuka Pharmaceutical Nether...  \n",
       "53       <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">This leaflet was last revised in {MM/YYYY}</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\"> </span></p>  \n",
       "54   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"color:black\">Other sources of information</span></b></p><p class=\"MsoNormal\" style=\"page-break-after:avoid\"><b><spa...  \n",
       "55   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">What is in this leaflet</span></b></p><p class=\"EMEABodyText\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" sty...  \n",
       "56   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">1.       What ABILIFY is and what it is used for</span></b></p><p class=\"EMEABodyTex...  \n",
       "57   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">2.       What you need to know before you take ABILIFY</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\"> ...  \n",
       "58   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Do not take ABILIFY</span></b></p><p class=\"EMEABodyTextIndent\"><span lang=\"EN-GB\" style=\"color:black\">•        if you are allergic t...  \n",
       "59   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Warnings and precautions</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">Talk to your doctor before taki...  \n",
       "60   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Children and adolescents</span></b></p><p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Do not use this medicine in childr...  \n",
       "61   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Other medicines and ABILIFY</span></b></p><p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Tell your doctor or pharmacist ...  \n",
       "62   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY with food, drink and alcohol</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">This medicine can b...  \n",
       "63   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Pregnancy, breast-feeding and fertility</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you are pregn...  \n",
       "64   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Driving and using machines</span></b></p><p class=\"MsoNormal\"><span lang=\"EN-GB\">Dizziness and vision problems may occur during treat...  \n",
       "65   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY contains fructose and sucrose</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">This medicine cont...  \n",
       "66   <p class=\"EMEABodyText\"><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY contains parahydroxybenzoates</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">May cause aller...  \n",
       "67   <p class=\"EMEABodyText\"><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY contains sodium</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">This medicine contains less t...  \n",
       "68   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">3.       How to take ABILIFY</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB...  \n",
       "69   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Use in children and adolescents</span></b></p><p class=\"EMEABodyText\"><b><span lang=\"EN-GB\" style=\"color:black;layout-grid-mode: line...  \n",
       "70   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">If you take more ABILIFY than you should</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you realise ...  \n",
       "71   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">If you forget to take ABILIFY</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you miss a dose, take t...  \n",
       "72   <p class=\"EMEABodyText\"><b><span lang=\"EN-GB\" style=\"color:black\">If you stop taking </span></b><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY</span></b></p><p class=\"MsoNormal\"><em><span lang=...  \n",
       "73   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">4.       Possible side effects</span></b></p><p class=\"MsoNormal\"><span lang=\"EN-GB\"...  \n",
       "74   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Additional side effects in children and adolescents</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">Adol...  \n",
       "75   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Reporting of side effects</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you get any side effects, t...  \n",
       "76   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">5.       How to store ABILIFY</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-G...  \n",
       "77   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">6.       Contents of the pack and other information</span></b></p><p class=\"EMEABody...  \n",
       "78   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">What ABILIFY contains</span></b></p><p class=\"EMEABodyTextIndent\"><span lang=\"EN-GB\" style=\"color:black\">•        The active substanc...  \n",
       "79   <p class=\"EMEABodyText\"><b><span lang=\"EN-GB\" style=\"color:black\">What ABILIFY looks like and contents of the pack</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">ABIL...  \n",
       "80   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Marketing Authorisation Holder</span></b></p><p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Otsuka Pharmaceutical Nether...  \n",
       "81       <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">This leaflet was last revised in {MM/YYYY}</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\"> </span></p>  \n",
       "82   <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"color:black\">Other sources of information</span></b></p><p class=\"EMEABodyText\" style=\"page-break-after:avoid\"><spa...  \n",
       "83   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">What is in this leaflet</span></b></p><p class=\"EMEABodyText\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" sty...  \n",
       "84   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">1.       What ABILIFY is and what it is used for</span></b></p><p class=\"EMEABodyTex...  \n",
       "85   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">2.       What you need to know before you are given ABILIFY</span></b></p><p class=\"...  \n",
       "86   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Do not use ABILIFY</span></b></p><p class=\"EMEABodyTextIndent\"><span lang=\"EN-GB\" style=\"color:black\">•        if you are allergic to...  \n",
       "87   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Warnings and precautions</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">Talk to your doctor before you ...  \n",
       "88   <p class=\"EMEAHeading2\" style=\"page-break-after:auto\"><span lang=\"EN-GB\" style=\"color:black\">Children and adolescents</span></p><p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Do not u...  \n",
       "89   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Other medicines and ABILIFY</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black;background:white\">Tell your d...  \n",
       "90   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY with food, drink and alcohol</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">This medicine can b...  \n",
       "91   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Pregnancy, breast-feeding and fertility</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you are pregn...  \n",
       "92   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Driving and using machines</span></b></p><p class=\"MsoNormal\"><span lang=\"EN-GB\">Dizziness and vision problems may occur during treat...  \n",
       "93   <p class=\"EMEABodyText\"><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY contains sodium</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">This medicine contains less t...  \n",
       "94   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">If you are given more </span></b><b><span lang=\"EN-GB\" style=\"color:black\">ABILIFY than you need</span></b></p><p class=\"MsoNormal\"><...  \n",
       "95   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">4.       Possible side effects</span></b></p><p class=\"MsoNormal\"><span lang=\"EN-GB\"...  \n",
       "96   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Reporting of side effects</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">If you get any side effects, t...  \n",
       "97   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">5.       How to store ABILIFY</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-G...  \n",
       "98   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><b><span lang=\"EN-GB\" style=\"color:black\">6.       Contents of the pack and other information</span></b></p><p class=\"EMEABody...  \n",
       "99   <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">What ABILIFY contains</span></b></p><p class=\"EMEABodyTextIndent\"><span lang=\"EN-GB\" style=\"color:black\">•        The active substanc...  \n",
       "100  <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">What ABILIFY looks like and contents of the pack</span></b></p><p class=\"EMEABodyText\"><span lang=\"EN-GB\" style=\"color:black\">The ABI...  \n",
       "101  <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Marketing Authorisation Holder</span></b></p><p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Otsuka Pharmaceutical Nether...  \n",
       "102  <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">This leaflet was last revised in {MM/YYYY}</span></b></p><p class=\"EMEABodyText\"><u><span lang=\"EN-GB\" style=\"color:black\"><span styl...  \n",
       "103  <p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Other sources of information</span></b></p><p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\"> </span></b></p><p class=\"E...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "extractContentlogger = loggerCreator('ExtractContentBetween_'+ getRandomString(1))\n",
    "extractorObj = DataBetweenHeadingsExtractor(extractContentlogger, coll)\n",
    "dfExtractedHierRR = extractorObj.extractContentBetweenHeadings('Abilify-h-471-e_ PACKAGE LEAFLET.json')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# XML Generation Stage"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-04-22 11:47:56,146 : XmlGeneration_4 : Initiating XML Generation\n",
      "2021-04-22 11:47:56,415 : XmlGeneration_4 : Writing to File:Abilify-h-471-e_ PACKAGE LEAFLET.xml\n"
     ]
    }
   ],
   "source": [
    "xmlLogger = loggerCreator('XmlGeneration_'+ getRandomString(1))\n",
    "fhirXmlGeneratorObj = FhirXmlGenerator(xmlLogger)\n",
    "fhirXmlGeneratorObj.generateXml(dfExtractedHierRR,  'Abilify-h-471-e_ PACKAGE LEAFLET.xml')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>index</th>\n",
       "      <th>id</th>\n",
       "      <th>Procedure type</th>\n",
       "      <th>Display code</th>\n",
       "      <th>Name</th>\n",
       "      <th>parent_id</th>\n",
       "      <th>htmlText</th>\n",
       "      <th>htmlIndex</th>\n",
       "      <th>htmlId</th>\n",
       "      <th>SubSectionIndex</th>\n",
       "      <th>doc_parent_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>786</td>\n",
       "      <td>23001</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PACKAGE LEAFLET</td>\n",
       "      <td>NaN</td>\n",
       "      <td>B. PACKAGE LEAFLET</td>\n",
       "      <td>24</td>\n",
       "      <td>ba7f0011-777c-4c87-ab14-945b7f219145</td>\n",
       "      <td>0</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>788</td>\n",
       "      <td>23003</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>23001</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>43</td>\n",
       "      <td>6399df46-b26b-41ef-8faa-1e468be43bd7</td>\n",
       "      <td>0</td>\n",
       "      <td>23001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>789</td>\n",
       "      <td>23004</td>\n",
       "      <td>CAP</td>\n",
       "      <td>1</td>\n",
       "      <td>What X is and what it is used for</td>\n",
       "      <td>23001</td>\n",
       "      <td>1.       What ABILIFY is and what it is used for</td>\n",
       "      <td>52</td>\n",
       "      <td>10306e47-6cf5-4529-b240-c8c69af4c4c7</td>\n",
       "      <td>0</td>\n",
       "      <td>23001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>790</td>\n",
       "      <td>23005</td>\n",
       "      <td>CAP</td>\n",
       "      <td>2</td>\n",
       "      <td>What you need to know before you &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23001</td>\n",
       "      <td>2.       What you need to know before you take ABILIFY</td>\n",
       "      <td>59</td>\n",
       "      <td>1fe30967-1779-470d-95e2-9c90a04c60c4</td>\n",
       "      <td>0</td>\n",
       "      <td>23001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>791</td>\n",
       "      <td>23006</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Do not &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Do not take ABILIFY</td>\n",
       "      <td>61</td>\n",
       "      <td>b62e92fa-848f-4e9e-b9cb-b3b7fb89afdf</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>792</td>\n",
       "      <td>23007</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>23005</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>64</td>\n",
       "      <td>20686598-1bda-4358-a32d-52fc5ce73748</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>793</td>\n",
       "      <td>23008</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children &lt;and adolescents&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Children and adolescents</td>\n",
       "      <td>90</td>\n",
       "      <td>2ef4ce01-dcb9-4ef2-bf32-9ce8368cfae7</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>794</td>\n",
       "      <td>23009</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other medicines and X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Other medicines and ABILIFY</td>\n",
       "      <td>93</td>\n",
       "      <td>64c7ac18-2ac4-43bf-bd98-1338a58e3276</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>795</td>\n",
       "      <td>23010</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X with &lt;food&gt; &lt;and&gt; &lt;,&gt; &lt;drink&gt; &lt;and&gt; &lt;alcohol&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY with food, drink and alcohol</td>\n",
       "      <td>121</td>\n",
       "      <td>bf52352e-edd8-4b45-ba51-e791cc8fdcd4</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>796</td>\n",
       "      <td>23011</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pregnancy &lt;and&gt; &lt;,&gt; breast-feeding &lt;and fertility&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Pregnancy, breast-feeding and fertility</td>\n",
       "      <td>125</td>\n",
       "      <td>7294f0d4-67e1-40ff-bfc6-4effd7beb960</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>797</td>\n",
       "      <td>23012</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>23005</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>132</td>\n",
       "      <td>ec700889-50b2-46ed-85eb-8c8b518cb788</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains lactose</td>\n",
       "      <td>136</td>\n",
       "      <td>3d5f5b60-1614-4102-a47b-65bbedc6655a</td>\n",
       "      <td>0</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>799</td>\n",
       "      <td>23014</td>\n",
       "      <td>CAP</td>\n",
       "      <td>3</td>\n",
       "      <td>How to &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23001</td>\n",
       "      <td>3.       How to take ABILIFY</td>\n",
       "      <td>140</td>\n",
       "      <td>215cb022-ee9e-4187-8d7a-1682d49cb7ef</td>\n",
       "      <td>0</td>\n",
       "      <td>23001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>800</td>\n",
       "      <td>23015</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Use in children &lt;and adolescents&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>Use in children and adolescents</td>\n",
       "      <td>146</td>\n",
       "      <td>69f5c85f-35d3-45cf-9a4b-7d70bfd55abd</td>\n",
       "      <td>0</td>\n",
       "      <td>23014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>801</td>\n",
       "      <td>23016</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you &lt;take&gt; &lt;use&gt; more X than you should</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you take more ABILIFY than you should</td>\n",
       "      <td>156</td>\n",
       "      <td>68739525-e8d0-40a3-b375-5e6ad85b44c5</td>\n",
       "      <td>0</td>\n",
       "      <td>23014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>802</td>\n",
       "      <td>23017</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you forget to &lt;take&gt; &lt;use&gt; X&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you forget to take ABILIFY</td>\n",
       "      <td>169</td>\n",
       "      <td>664b61ff-ced3-47e7-85f2-5a87f8b512a6</td>\n",
       "      <td>0</td>\n",
       "      <td>23014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>803</td>\n",
       "      <td>23018</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you stop &lt;taking&gt; &lt;using&gt; X&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you stop taking ABILIFY</td>\n",
       "      <td>172</td>\n",
       "      <td>618e0d93-0148-4265-ab5d-bcb393e51f03</td>\n",
       "      <td>0</td>\n",
       "      <td>23014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>804</td>\n",
       "      <td>23019</td>\n",
       "      <td>CAP</td>\n",
       "      <td>4</td>\n",
       "      <td>Possible side effects</td>\n",
       "      <td>23001</td>\n",
       "      <td>4.       Possible side effects</td>\n",
       "      <td>178</td>\n",
       "      <td>caae52f5-9b8e-4a85-bd49-36977f0c50f8</td>\n",
       "      <td>0</td>\n",
       "      <td>23001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>805</td>\n",
       "      <td>23020</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Additional side effects in children &lt;and adolescents&gt;</td>\n",
       "      <td>23019</td>\n",
       "      <td>Additional side effects in children and adolescents</td>\n",
       "      <td>282</td>\n",
       "      <td>ca628b27-4900-4f04-aec4-cd4f5821d201</td>\n",
       "      <td>0</td>\n",
       "      <td>23019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>806</td>\n",
       "      <td>23021</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>23019</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>285</td>\n",
       "      <td>4e5c19cb-c772-4d68-8211-6ce6f84a1641</td>\n",
       "      <td>0</td>\n",
       "      <td>23019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>807</td>\n",
       "      <td>23022</td>\n",
       "      <td>CAP</td>\n",
       "      <td>5</td>\n",
       "      <td>How to store X</td>\n",
       "      <td>23001</td>\n",
       "      <td>5.       How to store ABILIFY</td>\n",
       "      <td>289</td>\n",
       "      <td>1d1d8138-cf62-4d68-a7fa-411c64250ac0</td>\n",
       "      <td>0</td>\n",
       "      <td>23001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>808</td>\n",
       "      <td>23023</td>\n",
       "      <td>CAP</td>\n",
       "      <td>6</td>\n",
       "      <td>Contents of the pack and other information</td>\n",
       "      <td>23001</td>\n",
       "      <td>6.       Contents of the pack and other information</td>\n",
       "      <td>300</td>\n",
       "      <td>3cf52e31-0edf-47fd-8525-8934112ce5a7</td>\n",
       "      <td>0</td>\n",
       "      <td>23001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>809</td>\n",
       "      <td>23024</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X contains</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY contains</td>\n",
       "      <td>302</td>\n",
       "      <td>8719defc-d27a-493c-9d20-4d14b9c50496</td>\n",
       "      <td>0</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>810</td>\n",
       "      <td>23025</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X looks like and contents of the pack</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY looks like and contents of the pack</td>\n",
       "      <td>316</td>\n",
       "      <td>57f5bc1e-7d49-4a3c-8221-e1d9a266ffa9</td>\n",
       "      <td>0</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>811</td>\n",
       "      <td>23026</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Marketing Authorisation Holder &lt;and Manufacturer&gt;</td>\n",
       "      <td>23023</td>\n",
       "      <td>Marketing Authorisation Holder</td>\n",
       "      <td>326</td>\n",
       "      <td>42fe4795-5be4-455e-8ab6-9b5ba8e9f2bd</td>\n",
       "      <td>0</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>813</td>\n",
       "      <td>23028</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This leaflet was last revised in &lt;{MM/YYYY}&gt;&lt;{month YYYY}&gt;.</td>\n",
       "      <td>23023</td>\n",
       "      <td>This leaflet was last revised in {MM/YYYY}</td>\n",
       "      <td>342</td>\n",
       "      <td>8b3e2d1c-5b91-4ad4-b710-f7402708acc4</td>\n",
       "      <td>0</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>814</td>\n",
       "      <td>23029</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>23023</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>344</td>\n",
       "      <td>01ae6f19-7b5e-42cc-8563-16acd8743705</td>\n",
       "      <td>0</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>788</td>\n",
       "      <td>23003</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>23001</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>363</td>\n",
       "      <td>4f65c4f1-e91e-4d03-97bd-0e5d8ed8b7a6</td>\n",
       "      <td>1</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>789</td>\n",
       "      <td>23004</td>\n",
       "      <td>CAP</td>\n",
       "      <td>1</td>\n",
       "      <td>What X is and what it is used for</td>\n",
       "      <td>23001</td>\n",
       "      <td>1.       What ABILIFY is and what it is used for</td>\n",
       "      <td>372</td>\n",
       "      <td>0ca4f398-e781-4971-a846-f159db4c9932</td>\n",
       "      <td>1</td>\n",
       "      <td>23003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>790</td>\n",
       "      <td>23005</td>\n",
       "      <td>CAP</td>\n",
       "      <td>2</td>\n",
       "      <td>What you need to know before you &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23001</td>\n",
       "      <td>2.       What you need to know before you take ABILIFY</td>\n",
       "      <td>379</td>\n",
       "      <td>fc10acb3-0df9-413c-9231-a6995ad6177d</td>\n",
       "      <td>1</td>\n",
       "      <td>23004</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>791</td>\n",
       "      <td>23006</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Do not &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Do not take ABILIFY</td>\n",
       "      <td>381</td>\n",
       "      <td>dbe8ffd9-d1ea-4cff-aa5d-2eeb2d6cb423</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>792</td>\n",
       "      <td>23007</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>23005</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>384</td>\n",
       "      <td>22f3170c-fc1d-41bd-9c26-861759ee1620</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>793</td>\n",
       "      <td>23008</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children &lt;and adolescents&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Children and adolescents</td>\n",
       "      <td>410</td>\n",
       "      <td>05ee6c1f-cc2b-4707-a7a3-48bd0623e7b7</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>794</td>\n",
       "      <td>23009</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other medicines and X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Other medicines and ABILIFY</td>\n",
       "      <td>413</td>\n",
       "      <td>edd492ec-09fd-4262-8dd8-7fa0b7507f97</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>795</td>\n",
       "      <td>23010</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X with &lt;food&gt; &lt;and&gt; &lt;,&gt; &lt;drink&gt; &lt;and&gt; &lt;alcohol&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY with food, drink and alcohol</td>\n",
       "      <td>441</td>\n",
       "      <td>3eb499d1-1a3b-43ab-b921-96ee688a828e</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>796</td>\n",
       "      <td>23011</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pregnancy &lt;and&gt; &lt;,&gt; breast-feeding &lt;and fertility&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Pregnancy, breast-feeding and fertility</td>\n",
       "      <td>445</td>\n",
       "      <td>a7374bc4-89fd-444a-b181-cddc65f5f91c</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>797</td>\n",
       "      <td>23012</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>23005</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>452</td>\n",
       "      <td>f4bf2238-189d-46e4-820c-1d3385b789db</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains aspartame</td>\n",
       "      <td>456</td>\n",
       "      <td>4f3e2097-ac09-444c-a74b-d3ac2b6897fa</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains lactose</td>\n",
       "      <td>462</td>\n",
       "      <td>7ab98a29-42ec-464e-9fc6-5d9fcf6bdce6</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains sodium</td>\n",
       "      <td>465</td>\n",
       "      <td>39b82250-a98a-495c-b5ed-2a288bd4089e</td>\n",
       "      <td>1</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>799</td>\n",
       "      <td>23014</td>\n",
       "      <td>CAP</td>\n",
       "      <td>3</td>\n",
       "      <td>How to &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23001</td>\n",
       "      <td>3.       How to take ABILIFY</td>\n",
       "      <td>469</td>\n",
       "      <td>655f11eb-a52d-4a39-9d66-1d3f08518998</td>\n",
       "      <td>1</td>\n",
       "      <td>23013</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>800</td>\n",
       "      <td>23015</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Use in children &lt;and adolescents&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>Use in children and adolescents</td>\n",
       "      <td>475</td>\n",
       "      <td>4fd11b3b-5a3a-4944-ac2e-c01472245a5d</td>\n",
       "      <td>1</td>\n",
       "      <td>23014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>801</td>\n",
       "      <td>23016</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you &lt;take&gt; &lt;use&gt; more X than you should</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you take more ABILIFY than you should</td>\n",
       "      <td>488</td>\n",
       "      <td>a7cb028f-75f2-4703-b497-565fad4edd38</td>\n",
       "      <td>1</td>\n",
       "      <td>23014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>802</td>\n",
       "      <td>23017</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you forget to &lt;take&gt; &lt;use&gt; X&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you forget to take ABILIFY</td>\n",
       "      <td>501</td>\n",
       "      <td>e404e630-4ca8-4737-85b0-0243dc4e1af3</td>\n",
       "      <td>1</td>\n",
       "      <td>23014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>803</td>\n",
       "      <td>23018</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you stop &lt;taking&gt; &lt;using&gt; X&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you stop taking ABILIFY</td>\n",
       "      <td>504</td>\n",
       "      <td>38c55c46-64c1-470f-b143-347406edb287</td>\n",
       "      <td>1</td>\n",
       "      <td>23014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>804</td>\n",
       "      <td>23019</td>\n",
       "      <td>CAP</td>\n",
       "      <td>4</td>\n",
       "      <td>Possible side effects</td>\n",
       "      <td>23001</td>\n",
       "      <td>4.       Possible side effects</td>\n",
       "      <td>510</td>\n",
       "      <td>6c040fc4-4a56-431a-83ec-709b77667e95</td>\n",
       "      <td>1</td>\n",
       "      <td>23018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>805</td>\n",
       "      <td>23020</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Additional side effects in children &lt;and adolescents&gt;</td>\n",
       "      <td>23019</td>\n",
       "      <td>Additional side effects in children and adolescents</td>\n",
       "      <td>614</td>\n",
       "      <td>641467ee-1641-456e-b013-a56b36f2ff77</td>\n",
       "      <td>1</td>\n",
       "      <td>23019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>806</td>\n",
       "      <td>23021</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>23019</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>617</td>\n",
       "      <td>08202e3a-d475-4d47-a211-f7e07278999b</td>\n",
       "      <td>1</td>\n",
       "      <td>23019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>807</td>\n",
       "      <td>23022</td>\n",
       "      <td>CAP</td>\n",
       "      <td>5</td>\n",
       "      <td>How to store X</td>\n",
       "      <td>23001</td>\n",
       "      <td>5.       How to store ABILIFY</td>\n",
       "      <td>621</td>\n",
       "      <td>456d341f-e4a8-4e8d-85d7-9c661dd6264c</td>\n",
       "      <td>1</td>\n",
       "      <td>23021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>808</td>\n",
       "      <td>23023</td>\n",
       "      <td>CAP</td>\n",
       "      <td>6</td>\n",
       "      <td>Contents of the pack and other information</td>\n",
       "      <td>23001</td>\n",
       "      <td>6.       Contents of the pack and other information</td>\n",
       "      <td>632</td>\n",
       "      <td>f1875f64-4532-4bfd-928a-ce18a1558129</td>\n",
       "      <td>1</td>\n",
       "      <td>23022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>809</td>\n",
       "      <td>23024</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X contains</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY contains</td>\n",
       "      <td>634</td>\n",
       "      <td>09ef7199-8840-48d3-97b9-2cd4ea1558c9</td>\n",
       "      <td>1</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>810</td>\n",
       "      <td>23025</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X looks like and contents of the pack</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY looks like and contents of the pack</td>\n",
       "      <td>646</td>\n",
       "      <td>0f852c02-e2e0-415b-9c57-9f2fbef7961e</td>\n",
       "      <td>1</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>811</td>\n",
       "      <td>23026</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Marketing Authorisation Holder &lt;and Manufacturer&gt;</td>\n",
       "      <td>23023</td>\n",
       "      <td>Marketing Authorisation Holder</td>\n",
       "      <td>655</td>\n",
       "      <td>219bb058-4c68-4861-afe4-80177a844121</td>\n",
       "      <td>1</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>813</td>\n",
       "      <td>23028</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This leaflet was last revised in &lt;{MM/YYYY}&gt;&lt;{month YYYY}&gt;.</td>\n",
       "      <td>23023</td>\n",
       "      <td>This leaflet was last revised in {MM/YYYY}</td>\n",
       "      <td>671</td>\n",
       "      <td>abea3cf8-3c1c-47a0-a464-766bcecc0c52</td>\n",
       "      <td>1</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>814</td>\n",
       "      <td>23029</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>23023</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>673</td>\n",
       "      <td>4ee904cf-deb9-46e8-9502-2d4a821584e9</td>\n",
       "      <td>1</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>788</td>\n",
       "      <td>23003</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>23001</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>689</td>\n",
       "      <td>a5ee6aa4-171a-406d-af8a-c6be76c37038</td>\n",
       "      <td>2</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>789</td>\n",
       "      <td>23004</td>\n",
       "      <td>CAP</td>\n",
       "      <td>1</td>\n",
       "      <td>What X is and what it is used for</td>\n",
       "      <td>23001</td>\n",
       "      <td>1.       What ABILIFY is and what it is used for</td>\n",
       "      <td>698</td>\n",
       "      <td>fb7a5f49-ed2f-4ee8-9a96-d787f2c34985</td>\n",
       "      <td>2</td>\n",
       "      <td>23003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>790</td>\n",
       "      <td>23005</td>\n",
       "      <td>CAP</td>\n",
       "      <td>2</td>\n",
       "      <td>What you need to know before you &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23001</td>\n",
       "      <td>2.       What you need to know before you take ABILIFY</td>\n",
       "      <td>705</td>\n",
       "      <td>861bd2b5-04e7-4eaa-abe7-4ac7e127381a</td>\n",
       "      <td>2</td>\n",
       "      <td>23004</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>791</td>\n",
       "      <td>23006</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Do not &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Do not take ABILIFY</td>\n",
       "      <td>707</td>\n",
       "      <td>2d8c3f8a-f7be-4f54-be2e-6d7410ebee0c</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>792</td>\n",
       "      <td>23007</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>23005</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>710</td>\n",
       "      <td>b519a8f4-dbb9-4a45-821a-15111499aa33</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>793</td>\n",
       "      <td>23008</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children &lt;and adolescents&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Children and adolescents</td>\n",
       "      <td>736</td>\n",
       "      <td>55a4498a-f045-450d-a5ea-ce5e8ab669d8</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>794</td>\n",
       "      <td>23009</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other medicines and X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Other medicines and ABILIFY</td>\n",
       "      <td>739</td>\n",
       "      <td>678c2221-b859-4819-b110-efa46498d8e0</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>795</td>\n",
       "      <td>23010</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X with &lt;food&gt; &lt;and&gt; &lt;,&gt; &lt;drink&gt; &lt;and&gt; &lt;alcohol&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY with food, drink and alcohol</td>\n",
       "      <td>767</td>\n",
       "      <td>2ba81bba-a5c9-4817-bc17-84d1e0a16acb</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>796</td>\n",
       "      <td>23011</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pregnancy &lt;and&gt; &lt;,&gt; breast-feeding &lt;and fertility&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Pregnancy, breast-feeding and fertility</td>\n",
       "      <td>771</td>\n",
       "      <td>3a2f8c7f-df89-421e-ac07-7822b458efaf</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>797</td>\n",
       "      <td>23012</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>23005</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>778</td>\n",
       "      <td>67e7bf58-0e7f-455f-ada6-018ef79f6f23</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains fructose and sucrose</td>\n",
       "      <td>782</td>\n",
       "      <td>ec3e924b-e3db-4190-bf5e-d14a11c8d9e7</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains parahydroxybenzoates</td>\n",
       "      <td>785</td>\n",
       "      <td>6d3225d2-b6c6-4321-9890-5fe73b306d8b</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains sodium</td>\n",
       "      <td>788</td>\n",
       "      <td>431a94d1-f0ac-4c69-8b91-281f6f529a74</td>\n",
       "      <td>2</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>799</td>\n",
       "      <td>23014</td>\n",
       "      <td>CAP</td>\n",
       "      <td>3</td>\n",
       "      <td>How to &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23001</td>\n",
       "      <td>3.       How to take ABILIFY</td>\n",
       "      <td>792</td>\n",
       "      <td>8e8abaa9-c68c-4643-95e3-0d81e9d6b93c</td>\n",
       "      <td>2</td>\n",
       "      <td>23013</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>800</td>\n",
       "      <td>23015</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Use in children &lt;and adolescents&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>Use in children and adolescents</td>\n",
       "      <td>798</td>\n",
       "      <td>cd5cf1fc-d291-4a06-89df-7158594e670e</td>\n",
       "      <td>2</td>\n",
       "      <td>23014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>801</td>\n",
       "      <td>23016</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you &lt;take&gt; &lt;use&gt; more X than you should</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you take more ABILIFY than you should</td>\n",
       "      <td>809</td>\n",
       "      <td>3b8bf1cc-469a-4b2c-8c4d-aee39532152c</td>\n",
       "      <td>2</td>\n",
       "      <td>23014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>802</td>\n",
       "      <td>23017</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you forget to &lt;take&gt; &lt;use&gt; X&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you forget to take ABILIFY</td>\n",
       "      <td>822</td>\n",
       "      <td>9472c6d1-ddbd-475f-a427-10e14c0daab9</td>\n",
       "      <td>2</td>\n",
       "      <td>23014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>803</td>\n",
       "      <td>23018</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you stop &lt;taking&gt; &lt;using&gt; X&gt;</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you stop taking ABILIFY</td>\n",
       "      <td>825</td>\n",
       "      <td>9ee68d9c-284b-49ff-95e4-6e470191d07c</td>\n",
       "      <td>2</td>\n",
       "      <td>23014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>804</td>\n",
       "      <td>23019</td>\n",
       "      <td>CAP</td>\n",
       "      <td>4</td>\n",
       "      <td>Possible side effects</td>\n",
       "      <td>23001</td>\n",
       "      <td>4.       Possible side effects</td>\n",
       "      <td>831</td>\n",
       "      <td>40612ebd-9a22-4948-bfec-a3267c5a66f2</td>\n",
       "      <td>2</td>\n",
       "      <td>23018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>805</td>\n",
       "      <td>23020</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Additional side effects in children &lt;and adolescents&gt;</td>\n",
       "      <td>23019</td>\n",
       "      <td>Additional side effects in children and adolescents</td>\n",
       "      <td>935</td>\n",
       "      <td>406f7cbd-6225-4372-8d43-e26dde9e5604</td>\n",
       "      <td>2</td>\n",
       "      <td>23019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>806</td>\n",
       "      <td>23021</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>23019</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>938</td>\n",
       "      <td>97317f00-2cc7-47fc-8f37-af43bc71b01f</td>\n",
       "      <td>2</td>\n",
       "      <td>23019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>807</td>\n",
       "      <td>23022</td>\n",
       "      <td>CAP</td>\n",
       "      <td>5</td>\n",
       "      <td>How to store X</td>\n",
       "      <td>23001</td>\n",
       "      <td>5.       How to store ABILIFY</td>\n",
       "      <td>942</td>\n",
       "      <td>ad3dbf0e-929e-4e06-b834-b9b4fa8cec24</td>\n",
       "      <td>2</td>\n",
       "      <td>23021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>808</td>\n",
       "      <td>23023</td>\n",
       "      <td>CAP</td>\n",
       "      <td>6</td>\n",
       "      <td>Contents of the pack and other information</td>\n",
       "      <td>23001</td>\n",
       "      <td>6.       Contents of the pack and other information</td>\n",
       "      <td>954</td>\n",
       "      <td>e39ee105-8558-4dba-8a87-1c63bce86b99</td>\n",
       "      <td>2</td>\n",
       "      <td>23022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>809</td>\n",
       "      <td>23024</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X contains</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY contains</td>\n",
       "      <td>956</td>\n",
       "      <td>2c693717-5391-4fc6-b0db-3a1f5dc89e13</td>\n",
       "      <td>2</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>810</td>\n",
       "      <td>23025</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X looks like and contents of the pack</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY looks like and contents of the pack</td>\n",
       "      <td>962</td>\n",
       "      <td>05ff25e5-d7b7-45e4-8639-d72341c96835</td>\n",
       "      <td>2</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>811</td>\n",
       "      <td>23026</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Marketing Authorisation Holder &lt;and Manufacturer&gt;</td>\n",
       "      <td>23023</td>\n",
       "      <td>Marketing Authorisation Holder</td>\n",
       "      <td>969</td>\n",
       "      <td>ed06fd6a-a0eb-4404-a500-bd9bcd768661</td>\n",
       "      <td>2</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>813</td>\n",
       "      <td>23028</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This leaflet was last revised in &lt;{MM/YYYY}&gt;&lt;{month YYYY}&gt;.</td>\n",
       "      <td>23023</td>\n",
       "      <td>This leaflet was last revised in {MM/YYYY}</td>\n",
       "      <td>985</td>\n",
       "      <td>29ad8fbb-62c3-4152-bac7-99584007cc6f</td>\n",
       "      <td>2</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>814</td>\n",
       "      <td>23029</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>23023</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>987</td>\n",
       "      <td>dfe4af4e-fe3c-40e7-a9c1-8f80c7e7a848</td>\n",
       "      <td>2</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>788</td>\n",
       "      <td>23003</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>23001</td>\n",
       "      <td>What is in this leaflet</td>\n",
       "      <td>1004</td>\n",
       "      <td>4f84a70c-ed8d-44f7-88ad-ebe47669ce22</td>\n",
       "      <td>3</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>789</td>\n",
       "      <td>23004</td>\n",
       "      <td>CAP</td>\n",
       "      <td>1</td>\n",
       "      <td>What X is and what it is used for</td>\n",
       "      <td>23001</td>\n",
       "      <td>1.       What ABILIFY is and what it is used for</td>\n",
       "      <td>1013</td>\n",
       "      <td>d5e5ec94-6988-44d4-9687-33a1568bb872</td>\n",
       "      <td>3</td>\n",
       "      <td>23003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>790</td>\n",
       "      <td>23005</td>\n",
       "      <td>CAP</td>\n",
       "      <td>2</td>\n",
       "      <td>What you need to know before you &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23001</td>\n",
       "      <td>2.       What you need to know before you are given ABILIFY</td>\n",
       "      <td>1022</td>\n",
       "      <td>cdae7f3e-2226-4d75-8ce3-ffa23abaae33</td>\n",
       "      <td>3</td>\n",
       "      <td>23004</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>791</td>\n",
       "      <td>23006</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Do not &lt;take&gt; &lt;use&gt; X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Do not use ABILIFY</td>\n",
       "      <td>1024</td>\n",
       "      <td>2dc51d0e-51c0-48e4-9e86-97bcb2db44e1</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>792</td>\n",
       "      <td>23007</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>23005</td>\n",
       "      <td>Warnings and precautions</td>\n",
       "      <td>1027</td>\n",
       "      <td>e333b5a8-d41b-4e46-9f34-8390a98e7848</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>793</td>\n",
       "      <td>23008</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children &lt;and adolescents&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Children and adolescents</td>\n",
       "      <td>1055</td>\n",
       "      <td>1ff2cf98-a8f1-4709-ba5e-ccb9942a1387</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>794</td>\n",
       "      <td>23009</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other medicines and X</td>\n",
       "      <td>23005</td>\n",
       "      <td>Other medicines and ABILIFY</td>\n",
       "      <td>1058</td>\n",
       "      <td>5dc255bb-5d80-4e38-b795-2fa28eae6bf8</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>795</td>\n",
       "      <td>23010</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X with &lt;food&gt; &lt;and&gt; &lt;,&gt; &lt;drink&gt; &lt;and&gt; &lt;alcohol&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY with food, drink and alcohol</td>\n",
       "      <td>1088</td>\n",
       "      <td>c51d7b8a-0e21-4b90-a652-51c149a1656b</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>796</td>\n",
       "      <td>23011</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pregnancy &lt;and&gt; &lt;,&gt; breast-feeding &lt;and fertility&gt;</td>\n",
       "      <td>23005</td>\n",
       "      <td>Pregnancy, breast-feeding and fertility</td>\n",
       "      <td>1092</td>\n",
       "      <td>d93d00af-207e-49aa-b97d-53f21f527dc1</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>797</td>\n",
       "      <td>23012</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>23005</td>\n",
       "      <td>Driving and using machines</td>\n",
       "      <td>1099</td>\n",
       "      <td>5bd0acb8-0851-4a8a-bccc-4a98acc9ad24</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>798</td>\n",
       "      <td>23013</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>X contains {name the excipient(s)}</td>\n",
       "      <td>23005</td>\n",
       "      <td>ABILIFY contains sodium</td>\n",
       "      <td>1103</td>\n",
       "      <td>c7d04569-9aa1-4cf4-81e9-6b1d5681d142</td>\n",
       "      <td>3</td>\n",
       "      <td>23005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>801</td>\n",
       "      <td>23016</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>If you &lt;take&gt; &lt;use&gt; more X than you should</td>\n",
       "      <td>23014</td>\n",
       "      <td>If you are given more ABILIFY than you need</td>\n",
       "      <td>1113</td>\n",
       "      <td>b60f6dab-165d-460b-a106-63ebc30124f9</td>\n",
       "      <td>3</td>\n",
       "      <td>23013</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>804</td>\n",
       "      <td>23019</td>\n",
       "      <td>CAP</td>\n",
       "      <td>4</td>\n",
       "      <td>Possible side effects</td>\n",
       "      <td>23001</td>\n",
       "      <td>4.       Possible side effects</td>\n",
       "      <td>1135</td>\n",
       "      <td>f877ea6a-66bd-4160-b82d-503e1a9de5a4</td>\n",
       "      <td>3</td>\n",
       "      <td>23016</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>806</td>\n",
       "      <td>23021</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>23019</td>\n",
       "      <td>Reporting of side effects</td>\n",
       "      <td>1242</td>\n",
       "      <td>f1e76341-ce50-441d-b7bd-5950aa7dd4a7</td>\n",
       "      <td>3</td>\n",
       "      <td>23019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>807</td>\n",
       "      <td>23022</td>\n",
       "      <td>CAP</td>\n",
       "      <td>5</td>\n",
       "      <td>How to store X</td>\n",
       "      <td>23001</td>\n",
       "      <td>5.       How to store ABILIFY</td>\n",
       "      <td>1246</td>\n",
       "      <td>0da73d74-78e0-4995-bc18-538ee7f8cf16</td>\n",
       "      <td>3</td>\n",
       "      <td>23021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>808</td>\n",
       "      <td>23023</td>\n",
       "      <td>CAP</td>\n",
       "      <td>6</td>\n",
       "      <td>Contents of the pack and other information</td>\n",
       "      <td>23001</td>\n",
       "      <td>6.       Contents of the pack and other information</td>\n",
       "      <td>1257</td>\n",
       "      <td>2f93a169-7d74-41d1-bafd-371685034cda</td>\n",
       "      <td>3</td>\n",
       "      <td>23022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>809</td>\n",
       "      <td>23024</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X contains</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY contains</td>\n",
       "      <td>1259</td>\n",
       "      <td>24f9947c-a466-4034-87c7-5fa2bf52f0d5</td>\n",
       "      <td>3</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>810</td>\n",
       "      <td>23025</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>What X looks like and contents of the pack</td>\n",
       "      <td>23023</td>\n",
       "      <td>What ABILIFY looks like and contents of the pack</td>\n",
       "      <td>1266</td>\n",
       "      <td>a9d32233-9afc-4f94-9d4a-4cf5c0619ecc</td>\n",
       "      <td>3</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>811</td>\n",
       "      <td>23026</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Marketing Authorisation Holder &lt;and Manufacturer&gt;</td>\n",
       "      <td>23023</td>\n",
       "      <td>Marketing Authorisation Holder</td>\n",
       "      <td>1271</td>\n",
       "      <td>af37d74f-9d34-4653-add2-b5cfd350e96c</td>\n",
       "      <td>3</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>813</td>\n",
       "      <td>23028</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This leaflet was last revised in &lt;{MM/YYYY}&gt;&lt;{month YYYY}&gt;.</td>\n",
       "      <td>23023</td>\n",
       "      <td>This leaflet was last revised in {MM/YYYY}</td>\n",
       "      <td>1287</td>\n",
       "      <td>98e335a7-7d17-41c3-aba0-8cfcb8398d43</td>\n",
       "      <td>3</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>814</td>\n",
       "      <td>23029</td>\n",
       "      <td>CAP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>23023</td>\n",
       "      <td>Other sources of information</td>\n",
       "      <td>1289</td>\n",
       "      <td>404831f9-d222-4ab5-aff0-3808b9cd1672</td>\n",
       "      <td>3</td>\n",
       "      <td>23023</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     index     id Procedure type Display code  \\\n",
       "0      786  23001            CAP          NaN   \n",
       "1      788  23003            CAP          NaN   \n",
       "2      789  23004            CAP            1   \n",
       "3      790  23005            CAP            2   \n",
       "4      791  23006            CAP          NaN   \n",
       "5      792  23007            CAP          NaN   \n",
       "6      793  23008            CAP          NaN   \n",
       "7      794  23009            CAP          NaN   \n",
       "8      795  23010            CAP          NaN   \n",
       "9      796  23011            CAP          NaN   \n",
       "10     797  23012            CAP          NaN   \n",
       "11     798  23013            CAP          NaN   \n",
       "12     799  23014            CAP            3   \n",
       "13     800  23015            CAP          NaN   \n",
       "14     801  23016            CAP          NaN   \n",
       "15     802  23017            CAP          NaN   \n",
       "16     803  23018            CAP          NaN   \n",
       "17     804  23019            CAP            4   \n",
       "18     805  23020            CAP          NaN   \n",
       "19     806  23021            CAP          NaN   \n",
       "20     807  23022            CAP            5   \n",
       "21     808  23023            CAP            6   \n",
       "22     809  23024            CAP          NaN   \n",
       "23     810  23025            CAP          NaN   \n",
       "24     811  23026            CAP          NaN   \n",
       "25     813  23028            CAP          NaN   \n",
       "26     814  23029            CAP          NaN   \n",
       "27     788  23003            CAP          NaN   \n",
       "28     789  23004            CAP            1   \n",
       "29     790  23005            CAP            2   \n",
       "30     791  23006            CAP          NaN   \n",
       "31     792  23007            CAP          NaN   \n",
       "32     793  23008            CAP          NaN   \n",
       "33     794  23009            CAP          NaN   \n",
       "34     795  23010            CAP          NaN   \n",
       "35     796  23011            CAP          NaN   \n",
       "36     797  23012            CAP          NaN   \n",
       "37     798  23013            CAP          NaN   \n",
       "38     798  23013            CAP          NaN   \n",
       "39     798  23013            CAP          NaN   \n",
       "40     799  23014            CAP            3   \n",
       "41     800  23015            CAP          NaN   \n",
       "42     801  23016            CAP          NaN   \n",
       "43     802  23017            CAP          NaN   \n",
       "44     803  23018            CAP          NaN   \n",
       "45     804  23019            CAP            4   \n",
       "46     805  23020            CAP          NaN   \n",
       "47     806  23021            CAP          NaN   \n",
       "48     807  23022            CAP            5   \n",
       "49     808  23023            CAP            6   \n",
       "50     809  23024            CAP          NaN   \n",
       "51     810  23025            CAP          NaN   \n",
       "52     811  23026            CAP          NaN   \n",
       "53     813  23028            CAP          NaN   \n",
       "54     814  23029            CAP          NaN   \n",
       "55     788  23003            CAP          NaN   \n",
       "56     789  23004            CAP            1   \n",
       "57     790  23005            CAP            2   \n",
       "58     791  23006            CAP          NaN   \n",
       "59     792  23007            CAP          NaN   \n",
       "60     793  23008            CAP          NaN   \n",
       "61     794  23009            CAP          NaN   \n",
       "62     795  23010            CAP          NaN   \n",
       "63     796  23011            CAP          NaN   \n",
       "64     797  23012            CAP          NaN   \n",
       "65     798  23013            CAP          NaN   \n",
       "66     798  23013            CAP          NaN   \n",
       "67     798  23013            CAP          NaN   \n",
       "68     799  23014            CAP            3   \n",
       "69     800  23015            CAP          NaN   \n",
       "70     801  23016            CAP          NaN   \n",
       "71     802  23017            CAP          NaN   \n",
       "72     803  23018            CAP          NaN   \n",
       "73     804  23019            CAP            4   \n",
       "74     805  23020            CAP          NaN   \n",
       "75     806  23021            CAP          NaN   \n",
       "76     807  23022            CAP            5   \n",
       "77     808  23023            CAP            6   \n",
       "78     809  23024            CAP          NaN   \n",
       "79     810  23025            CAP          NaN   \n",
       "80     811  23026            CAP          NaN   \n",
       "81     813  23028            CAP          NaN   \n",
       "82     814  23029            CAP          NaN   \n",
       "83     788  23003            CAP          NaN   \n",
       "84     789  23004            CAP            1   \n",
       "85     790  23005            CAP            2   \n",
       "86     791  23006            CAP          NaN   \n",
       "87     792  23007            CAP          NaN   \n",
       "88     793  23008            CAP          NaN   \n",
       "89     794  23009            CAP          NaN   \n",
       "90     795  23010            CAP          NaN   \n",
       "91     796  23011            CAP          NaN   \n",
       "92     797  23012            CAP          NaN   \n",
       "93     798  23013            CAP          NaN   \n",
       "94     801  23016            CAP          NaN   \n",
       "95     804  23019            CAP            4   \n",
       "96     806  23021            CAP          NaN   \n",
       "97     807  23022            CAP            5   \n",
       "98     808  23023            CAP            6   \n",
       "99     809  23024            CAP          NaN   \n",
       "100    810  23025            CAP          NaN   \n",
       "101    811  23026            CAP          NaN   \n",
       "102    813  23028            CAP          NaN   \n",
       "103    814  23029            CAP          NaN   \n",
       "\n",
       "                                                            Name parent_id  \\\n",
       "0                                                PACKAGE LEAFLET       NaN   \n",
       "1                                        What is in this leaflet     23001   \n",
       "2                              What X is and what it is used for     23001   \n",
       "3               What you need to know before you <take> <use> X      23001   \n",
       "4                                          Do not <take> <use> X     23005   \n",
       "5                                      Warnings and precautions      23005   \n",
       "6                                     Children <and adolescents>     23005   \n",
       "7                                          Other medicines and X     23005   \n",
       "8                X with <food> <and> <,> <drink> <and> <alcohol>     23005   \n",
       "9             Pregnancy <and> <,> breast-feeding <and fertility>     23005   \n",
       "10                                    Driving and using machines     23005   \n",
       "11                            X contains {name the excipient(s)}     23005   \n",
       "12                                        How to <take> <use> X      23001   \n",
       "13                             Use in children <and adolescents>     23014   \n",
       "14                    If you <take> <use> more X than you should     23014   \n",
       "15                              If you forget to <take> <use> X>     23014   \n",
       "16                               If you stop <taking> <using> X>     23014   \n",
       "17                                         Possible side effects     23001   \n",
       "18         Additional side effects in children <and adolescents>     23019   \n",
       "19                                     Reporting of side effects     23019   \n",
       "20                                                How to store X     23001   \n",
       "21                    Contents of the pack and other information     23001   \n",
       "22                                              What X contains      23023   \n",
       "23                    What X looks like and contents of the pack     23023   \n",
       "24             Marketing Authorisation Holder <and Manufacturer>     23023   \n",
       "25   This leaflet was last revised in <{MM/YYYY}><{month YYYY}>.     23023   \n",
       "26                                  Other sources of information     23023   \n",
       "27                                       What is in this leaflet     23001   \n",
       "28                             What X is and what it is used for     23001   \n",
       "29              What you need to know before you <take> <use> X      23001   \n",
       "30                                         Do not <take> <use> X     23005   \n",
       "31                                     Warnings and precautions      23005   \n",
       "32                                    Children <and adolescents>     23005   \n",
       "33                                         Other medicines and X     23005   \n",
       "34               X with <food> <and> <,> <drink> <and> <alcohol>     23005   \n",
       "35            Pregnancy <and> <,> breast-feeding <and fertility>     23005   \n",
       "36                                    Driving and using machines     23005   \n",
       "37                            X contains {name the excipient(s)}     23005   \n",
       "38                            X contains {name the excipient(s)}     23005   \n",
       "39                            X contains {name the excipient(s)}     23005   \n",
       "40                                        How to <take> <use> X      23001   \n",
       "41                             Use in children <and adolescents>     23014   \n",
       "42                    If you <take> <use> more X than you should     23014   \n",
       "43                              If you forget to <take> <use> X>     23014   \n",
       "44                               If you stop <taking> <using> X>     23014   \n",
       "45                                         Possible side effects     23001   \n",
       "46         Additional side effects in children <and adolescents>     23019   \n",
       "47                                     Reporting of side effects     23019   \n",
       "48                                                How to store X     23001   \n",
       "49                    Contents of the pack and other information     23001   \n",
       "50                                              What X contains      23023   \n",
       "51                    What X looks like and contents of the pack     23023   \n",
       "52             Marketing Authorisation Holder <and Manufacturer>     23023   \n",
       "53   This leaflet was last revised in <{MM/YYYY}><{month YYYY}>.     23023   \n",
       "54                                  Other sources of information     23023   \n",
       "55                                       What is in this leaflet     23001   \n",
       "56                             What X is and what it is used for     23001   \n",
       "57              What you need to know before you <take> <use> X      23001   \n",
       "58                                         Do not <take> <use> X     23005   \n",
       "59                                     Warnings and precautions      23005   \n",
       "60                                    Children <and adolescents>     23005   \n",
       "61                                         Other medicines and X     23005   \n",
       "62               X with <food> <and> <,> <drink> <and> <alcohol>     23005   \n",
       "63            Pregnancy <and> <,> breast-feeding <and fertility>     23005   \n",
       "64                                    Driving and using machines     23005   \n",
       "65                            X contains {name the excipient(s)}     23005   \n",
       "66                            X contains {name the excipient(s)}     23005   \n",
       "67                            X contains {name the excipient(s)}     23005   \n",
       "68                                        How to <take> <use> X      23001   \n",
       "69                             Use in children <and adolescents>     23014   \n",
       "70                    If you <take> <use> more X than you should     23014   \n",
       "71                              If you forget to <take> <use> X>     23014   \n",
       "72                               If you stop <taking> <using> X>     23014   \n",
       "73                                         Possible side effects     23001   \n",
       "74         Additional side effects in children <and adolescents>     23019   \n",
       "75                                     Reporting of side effects     23019   \n",
       "76                                                How to store X     23001   \n",
       "77                    Contents of the pack and other information     23001   \n",
       "78                                              What X contains      23023   \n",
       "79                    What X looks like and contents of the pack     23023   \n",
       "80             Marketing Authorisation Holder <and Manufacturer>     23023   \n",
       "81   This leaflet was last revised in <{MM/YYYY}><{month YYYY}>.     23023   \n",
       "82                                  Other sources of information     23023   \n",
       "83                                       What is in this leaflet     23001   \n",
       "84                             What X is and what it is used for     23001   \n",
       "85              What you need to know before you <take> <use> X      23001   \n",
       "86                                         Do not <take> <use> X     23005   \n",
       "87                                     Warnings and precautions      23005   \n",
       "88                                    Children <and adolescents>     23005   \n",
       "89                                         Other medicines and X     23005   \n",
       "90               X with <food> <and> <,> <drink> <and> <alcohol>     23005   \n",
       "91            Pregnancy <and> <,> breast-feeding <and fertility>     23005   \n",
       "92                                    Driving and using machines     23005   \n",
       "93                            X contains {name the excipient(s)}     23005   \n",
       "94                    If you <take> <use> more X than you should     23014   \n",
       "95                                         Possible side effects     23001   \n",
       "96                                     Reporting of side effects     23019   \n",
       "97                                                How to store X     23001   \n",
       "98                    Contents of the pack and other information     23001   \n",
       "99                                              What X contains      23023   \n",
       "100                   What X looks like and contents of the pack     23023   \n",
       "101            Marketing Authorisation Holder <and Manufacturer>     23023   \n",
       "102  This leaflet was last revised in <{MM/YYYY}><{month YYYY}>.     23023   \n",
       "103                                 Other sources of information     23023   \n",
       "\n",
       "                                                        htmlText  htmlIndex  \\\n",
       "0                                             B. PACKAGE LEAFLET         24   \n",
       "1                                        What is in this leaflet         43   \n",
       "2               1.       What ABILIFY is and what it is used for         52   \n",
       "3         2.       What you need to know before you take ABILIFY         59   \n",
       "4                                            Do not take ABILIFY         61   \n",
       "5                                       Warnings and precautions         64   \n",
       "6                                       Children and adolescents         90   \n",
       "7                                    Other medicines and ABILIFY         93   \n",
       "8                           ABILIFY with food, drink and alcohol        121   \n",
       "9                        Pregnancy, breast-feeding and fertility        125   \n",
       "10                                    Driving and using machines        132   \n",
       "11                                      ABILIFY contains lactose        136   \n",
       "12                                  3.       How to take ABILIFY        140   \n",
       "13                               Use in children and adolescents        146   \n",
       "14                      If you take more ABILIFY than you should        156   \n",
       "15                                 If you forget to take ABILIFY        169   \n",
       "16                                    If you stop taking ABILIFY        172   \n",
       "17                                4.       Possible side effects        178   \n",
       "18           Additional side effects in children and adolescents        282   \n",
       "19                                     Reporting of side effects        285   \n",
       "20                                 5.       How to store ABILIFY        289   \n",
       "21           6.       Contents of the pack and other information        300   \n",
       "22                                         What ABILIFY contains        302   \n",
       "23              What ABILIFY looks like and contents of the pack        316   \n",
       "24                                Marketing Authorisation Holder        326   \n",
       "25                    This leaflet was last revised in {MM/YYYY}        342   \n",
       "26                                  Other sources of information        344   \n",
       "27                                       What is in this leaflet        363   \n",
       "28              1.       What ABILIFY is and what it is used for        372   \n",
       "29        2.       What you need to know before you take ABILIFY        379   \n",
       "30                                           Do not take ABILIFY        381   \n",
       "31                                      Warnings and precautions        384   \n",
       "32                                      Children and adolescents        410   \n",
       "33                                   Other medicines and ABILIFY        413   \n",
       "34                          ABILIFY with food, drink and alcohol        441   \n",
       "35                       Pregnancy, breast-feeding and fertility        445   \n",
       "36                                    Driving and using machines        452   \n",
       "37                                    ABILIFY contains aspartame        456   \n",
       "38                                      ABILIFY contains lactose        462   \n",
       "39                                       ABILIFY contains sodium        465   \n",
       "40                                  3.       How to take ABILIFY        469   \n",
       "41                               Use in children and adolescents        475   \n",
       "42                      If you take more ABILIFY than you should        488   \n",
       "43                                 If you forget to take ABILIFY        501   \n",
       "44                                    If you stop taking ABILIFY        504   \n",
       "45                                4.       Possible side effects        510   \n",
       "46           Additional side effects in children and adolescents        614   \n",
       "47                                     Reporting of side effects        617   \n",
       "48                                 5.       How to store ABILIFY        621   \n",
       "49           6.       Contents of the pack and other information        632   \n",
       "50                                         What ABILIFY contains        634   \n",
       "51              What ABILIFY looks like and contents of the pack        646   \n",
       "52                                Marketing Authorisation Holder        655   \n",
       "53                    This leaflet was last revised in {MM/YYYY}        671   \n",
       "54                                  Other sources of information        673   \n",
       "55                                       What is in this leaflet        689   \n",
       "56              1.       What ABILIFY is and what it is used for        698   \n",
       "57        2.       What you need to know before you take ABILIFY        705   \n",
       "58                                           Do not take ABILIFY        707   \n",
       "59                                      Warnings and precautions        710   \n",
       "60                                      Children and adolescents        736   \n",
       "61                                   Other medicines and ABILIFY        739   \n",
       "62                          ABILIFY with food, drink and alcohol        767   \n",
       "63                       Pregnancy, breast-feeding and fertility        771   \n",
       "64                                    Driving and using machines        778   \n",
       "65                         ABILIFY contains fructose and sucrose        782   \n",
       "66                         ABILIFY contains parahydroxybenzoates        785   \n",
       "67                                       ABILIFY contains sodium        788   \n",
       "68                                  3.       How to take ABILIFY        792   \n",
       "69                               Use in children and adolescents        798   \n",
       "70                      If you take more ABILIFY than you should        809   \n",
       "71                                 If you forget to take ABILIFY        822   \n",
       "72                                    If you stop taking ABILIFY        825   \n",
       "73                                4.       Possible side effects        831   \n",
       "74           Additional side effects in children and adolescents        935   \n",
       "75                                     Reporting of side effects        938   \n",
       "76                                 5.       How to store ABILIFY        942   \n",
       "77           6.       Contents of the pack and other information        954   \n",
       "78                                         What ABILIFY contains        956   \n",
       "79              What ABILIFY looks like and contents of the pack        962   \n",
       "80                                Marketing Authorisation Holder        969   \n",
       "81                    This leaflet was last revised in {MM/YYYY}        985   \n",
       "82                                  Other sources of information        987   \n",
       "83                                       What is in this leaflet       1004   \n",
       "84              1.       What ABILIFY is and what it is used for       1013   \n",
       "85   2.       What you need to know before you are given ABILIFY       1022   \n",
       "86                                            Do not use ABILIFY       1024   \n",
       "87                                      Warnings and precautions       1027   \n",
       "88                                      Children and adolescents       1055   \n",
       "89                                   Other medicines and ABILIFY       1058   \n",
       "90                          ABILIFY with food, drink and alcohol       1088   \n",
       "91                       Pregnancy, breast-feeding and fertility       1092   \n",
       "92                                    Driving and using machines       1099   \n",
       "93                                       ABILIFY contains sodium       1103   \n",
       "94                   If you are given more ABILIFY than you need       1113   \n",
       "95                                4.       Possible side effects       1135   \n",
       "96                                     Reporting of side effects       1242   \n",
       "97                                 5.       How to store ABILIFY       1246   \n",
       "98           6.       Contents of the pack and other information       1257   \n",
       "99                                         What ABILIFY contains       1259   \n",
       "100             What ABILIFY looks like and contents of the pack       1266   \n",
       "101                               Marketing Authorisation Holder       1271   \n",
       "102                   This leaflet was last revised in {MM/YYYY}       1287   \n",
       "103                                 Other sources of information       1289   \n",
       "\n",
       "                                   htmlId  SubSectionIndex doc_parent_id  \n",
       "0    ba7f0011-777c-4c87-ab14-945b7f219145                0                \n",
       "1    6399df46-b26b-41ef-8faa-1e468be43bd7                0         23001  \n",
       "2    10306e47-6cf5-4529-b240-c8c69af4c4c7                0         23001  \n",
       "3    1fe30967-1779-470d-95e2-9c90a04c60c4                0         23001  \n",
       "4    b62e92fa-848f-4e9e-b9cb-b3b7fb89afdf                0         23005  \n",
       "5    20686598-1bda-4358-a32d-52fc5ce73748                0         23005  \n",
       "6    2ef4ce01-dcb9-4ef2-bf32-9ce8368cfae7                0         23005  \n",
       "7    64c7ac18-2ac4-43bf-bd98-1338a58e3276                0         23005  \n",
       "8    bf52352e-edd8-4b45-ba51-e791cc8fdcd4                0         23005  \n",
       "9    7294f0d4-67e1-40ff-bfc6-4effd7beb960                0         23005  \n",
       "10   ec700889-50b2-46ed-85eb-8c8b518cb788                0         23005  \n",
       "11   3d5f5b60-1614-4102-a47b-65bbedc6655a                0         23005  \n",
       "12   215cb022-ee9e-4187-8d7a-1682d49cb7ef                0         23001  \n",
       "13   69f5c85f-35d3-45cf-9a4b-7d70bfd55abd                0         23014  \n",
       "14   68739525-e8d0-40a3-b375-5e6ad85b44c5                0         23014  \n",
       "15   664b61ff-ced3-47e7-85f2-5a87f8b512a6                0         23014  \n",
       "16   618e0d93-0148-4265-ab5d-bcb393e51f03                0         23014  \n",
       "17   caae52f5-9b8e-4a85-bd49-36977f0c50f8                0         23001  \n",
       "18   ca628b27-4900-4f04-aec4-cd4f5821d201                0         23019  \n",
       "19   4e5c19cb-c772-4d68-8211-6ce6f84a1641                0         23019  \n",
       "20   1d1d8138-cf62-4d68-a7fa-411c64250ac0                0         23001  \n",
       "21   3cf52e31-0edf-47fd-8525-8934112ce5a7                0         23001  \n",
       "22   8719defc-d27a-493c-9d20-4d14b9c50496                0         23023  \n",
       "23   57f5bc1e-7d49-4a3c-8221-e1d9a266ffa9                0         23023  \n",
       "24   42fe4795-5be4-455e-8ab6-9b5ba8e9f2bd                0         23023  \n",
       "25   8b3e2d1c-5b91-4ad4-b710-f7402708acc4                0         23023  \n",
       "26   01ae6f19-7b5e-42cc-8563-16acd8743705                0         23023  \n",
       "27   4f65c4f1-e91e-4d03-97bd-0e5d8ed8b7a6                1                \n",
       "28   0ca4f398-e781-4971-a846-f159db4c9932                1         23003  \n",
       "29   fc10acb3-0df9-413c-9231-a6995ad6177d                1         23004  \n",
       "30   dbe8ffd9-d1ea-4cff-aa5d-2eeb2d6cb423                1         23005  \n",
       "31   22f3170c-fc1d-41bd-9c26-861759ee1620                1         23005  \n",
       "32   05ee6c1f-cc2b-4707-a7a3-48bd0623e7b7                1         23005  \n",
       "33   edd492ec-09fd-4262-8dd8-7fa0b7507f97                1         23005  \n",
       "34   3eb499d1-1a3b-43ab-b921-96ee688a828e                1         23005  \n",
       "35   a7374bc4-89fd-444a-b181-cddc65f5f91c                1         23005  \n",
       "36   f4bf2238-189d-46e4-820c-1d3385b789db                1         23005  \n",
       "37   4f3e2097-ac09-444c-a74b-d3ac2b6897fa                1         23005  \n",
       "38   7ab98a29-42ec-464e-9fc6-5d9fcf6bdce6                1         23005  \n",
       "39   39b82250-a98a-495c-b5ed-2a288bd4089e                1         23005  \n",
       "40   655f11eb-a52d-4a39-9d66-1d3f08518998                1         23013  \n",
       "41   4fd11b3b-5a3a-4944-ac2e-c01472245a5d                1         23014  \n",
       "42   a7cb028f-75f2-4703-b497-565fad4edd38                1         23014  \n",
       "43   e404e630-4ca8-4737-85b0-0243dc4e1af3                1         23014  \n",
       "44   38c55c46-64c1-470f-b143-347406edb287                1         23014  \n",
       "45   6c040fc4-4a56-431a-83ec-709b77667e95                1         23018  \n",
       "46   641467ee-1641-456e-b013-a56b36f2ff77                1         23019  \n",
       "47   08202e3a-d475-4d47-a211-f7e07278999b                1         23019  \n",
       "48   456d341f-e4a8-4e8d-85d7-9c661dd6264c                1         23021  \n",
       "49   f1875f64-4532-4bfd-928a-ce18a1558129                1         23022  \n",
       "50   09ef7199-8840-48d3-97b9-2cd4ea1558c9                1         23023  \n",
       "51   0f852c02-e2e0-415b-9c57-9f2fbef7961e                1         23023  \n",
       "52   219bb058-4c68-4861-afe4-80177a844121                1         23023  \n",
       "53   abea3cf8-3c1c-47a0-a464-766bcecc0c52                1         23023  \n",
       "54   4ee904cf-deb9-46e8-9502-2d4a821584e9                1         23023  \n",
       "55   a5ee6aa4-171a-406d-af8a-c6be76c37038                2                \n",
       "56   fb7a5f49-ed2f-4ee8-9a96-d787f2c34985                2         23003  \n",
       "57   861bd2b5-04e7-4eaa-abe7-4ac7e127381a                2         23004  \n",
       "58   2d8c3f8a-f7be-4f54-be2e-6d7410ebee0c                2         23005  \n",
       "59   b519a8f4-dbb9-4a45-821a-15111499aa33                2         23005  \n",
       "60   55a4498a-f045-450d-a5ea-ce5e8ab669d8                2         23005  \n",
       "61   678c2221-b859-4819-b110-efa46498d8e0                2         23005  \n",
       "62   2ba81bba-a5c9-4817-bc17-84d1e0a16acb                2         23005  \n",
       "63   3a2f8c7f-df89-421e-ac07-7822b458efaf                2         23005  \n",
       "64   67e7bf58-0e7f-455f-ada6-018ef79f6f23                2         23005  \n",
       "65   ec3e924b-e3db-4190-bf5e-d14a11c8d9e7                2         23005  \n",
       "66   6d3225d2-b6c6-4321-9890-5fe73b306d8b                2         23005  \n",
       "67   431a94d1-f0ac-4c69-8b91-281f6f529a74                2         23005  \n",
       "68   8e8abaa9-c68c-4643-95e3-0d81e9d6b93c                2         23013  \n",
       "69   cd5cf1fc-d291-4a06-89df-7158594e670e                2         23014  \n",
       "70   3b8bf1cc-469a-4b2c-8c4d-aee39532152c                2         23014  \n",
       "71   9472c6d1-ddbd-475f-a427-10e14c0daab9                2         23014  \n",
       "72   9ee68d9c-284b-49ff-95e4-6e470191d07c                2         23014  \n",
       "73   40612ebd-9a22-4948-bfec-a3267c5a66f2                2         23018  \n",
       "74   406f7cbd-6225-4372-8d43-e26dde9e5604                2         23019  \n",
       "75   97317f00-2cc7-47fc-8f37-af43bc71b01f                2         23019  \n",
       "76   ad3dbf0e-929e-4e06-b834-b9b4fa8cec24                2         23021  \n",
       "77   e39ee105-8558-4dba-8a87-1c63bce86b99                2         23022  \n",
       "78   2c693717-5391-4fc6-b0db-3a1f5dc89e13                2         23023  \n",
       "79   05ff25e5-d7b7-45e4-8639-d72341c96835                2         23023  \n",
       "80   ed06fd6a-a0eb-4404-a500-bd9bcd768661                2         23023  \n",
       "81   29ad8fbb-62c3-4152-bac7-99584007cc6f                2         23023  \n",
       "82   dfe4af4e-fe3c-40e7-a9c1-8f80c7e7a848                2         23023  \n",
       "83   4f84a70c-ed8d-44f7-88ad-ebe47669ce22                3                \n",
       "84   d5e5ec94-6988-44d4-9687-33a1568bb872                3         23003  \n",
       "85   cdae7f3e-2226-4d75-8ce3-ffa23abaae33                3         23004  \n",
       "86   2dc51d0e-51c0-48e4-9e86-97bcb2db44e1                3         23005  \n",
       "87   e333b5a8-d41b-4e46-9f34-8390a98e7848                3         23005  \n",
       "88   1ff2cf98-a8f1-4709-ba5e-ccb9942a1387                3         23005  \n",
       "89   5dc255bb-5d80-4e38-b795-2fa28eae6bf8                3         23005  \n",
       "90   c51d7b8a-0e21-4b90-a652-51c149a1656b                3         23005  \n",
       "91   d93d00af-207e-49aa-b97d-53f21f527dc1                3         23005  \n",
       "92   5bd0acb8-0851-4a8a-bccc-4a98acc9ad24                3         23005  \n",
       "93   c7d04569-9aa1-4cf4-81e9-6b1d5681d142                3         23005  \n",
       "94   b60f6dab-165d-460b-a106-63ebc30124f9                3         23013  \n",
       "95   f877ea6a-66bd-4160-b82d-503e1a9de5a4                3         23016  \n",
       "96   f1e76341-ce50-441d-b7bd-5950aa7dd4a7                3         23019  \n",
       "97   0da73d74-78e0-4995-bc18-538ee7f8cf16                3         23021  \n",
       "98   2f93a169-7d74-41d1-bafd-371685034cda                3         23022  \n",
       "99   24f9947c-a466-4034-87c7-5fa2bf52f0d5                3         23023  \n",
       "100  a9d32233-9afc-4f94-9d4a-4cf5c0619ecc                3         23023  \n",
       "101  af37d74f-9d34-4653-add2-b5cfd350e96c                3         23023  \n",
       "102  98e335a7-7d17-41c3-aba0-8cfcb8398d43                3         23023  \n",
       "103  404831f9-d222-4ab5-aff0-3808b9cd1672                3         23023  "
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "convertCollectionToDataFrame(coll)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 326,
   "metadata": {},
   "outputs": [],
   "source": [
    "documentAnnotationObj = DocumentAnnotation('Kalydeco II-86-PI-clean_SmPC.json','c270d6ccaf9e47e9b20b322e2383c4ba','https://spor-uat.azure-api.net/pms/api/v2/',df,coll)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 327,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Warning: Multiple Authorization Token Found In The Document Kalydeco II-86-PI-clean_SmPC.json :- \n",
      " ['EU/1/12/782/001', 'EU/1/12/782/002', 'EU/1/12/782/005', 'EU/1/12/782/003', 'EU/1/12/782/004', 'EU/1/12/782/006']\n",
      "EU/1/12/782/001\n"
     ]
    },
    {
     "ename": "MissingKeyValuePair",
     "evalue": "Missing Key 'entry' in the regulated authorization API output",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mMissingKeyValuePair\u001b[0m                       Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-327-16160de9b858>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[1;32m----> 1\u001b[1;33m \u001b[0mdocumentAnnotationObj\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mprocessRegulatedAuthorizationForDoc\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[1;32mF:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\code\\documentAnnotation\\documentAnnotation.py\u001b[0m in \u001b[0;36mprocessRegulatedAuthorizationForDoc\u001b[1;34m(self, listRegulatedAuthorizationIdentifiers)\u001b[0m\n\u001b[0;32m    326\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    327\u001b[0m             processedOutputRA = self.processRegulatedAuthorization(\n\u001b[1;32m--> 328\u001b[1;33m                 authorizationIdentifier=authIdentifier)\n\u001b[0m\u001b[0;32m    329\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    330\u001b[0m             \u001b[1;32mfor\u001b[0m \u001b[0mproduct\u001b[0m \u001b[1;32min\u001b[0m \u001b[0mprocessedOutputRA\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mF:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\code\\documentAnnotation\\documentAnnotation.py\u001b[0m in \u001b[0;36mprocessRegulatedAuthorization\u001b[1;34m(self, authorizationIdentifier)\u001b[0m\n\u001b[0;32m    220\u001b[0m         \u001b[1;32melse\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    221\u001b[0m             raise MissingKeyValuePair(\n\u001b[1;32m--> 222\u001b[1;33m                 \"Missing Key 'entry' in the regulated authorization API output\")\n\u001b[0m\u001b[0;32m    223\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    224\u001b[0m         \u001b[1;32mif\u001b[0m \u001b[0mdirectFlag\u001b[0m \u001b[1;32mis\u001b[0m \u001b[1;32mTrue\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;31mMissingKeyValuePair\u001b[0m: Missing Key 'entry' in the regulated authorization API output"
     ]
    }
   ],
   "source": [
    "documentAnnotationObj.processRegulatedAuthorizationForDoc()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 328,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "EU/3/00/001\n",
      "Skipping entry due to incorrect code 220000000062\n",
      "No Regulated Authorization find with code 220000000061\n",
      "Skipping entry due to incorrect code 220000000062\n",
      "No Regulated Authorization find with code 220000000061\n",
      "Skipping entry due to incorrect code 220000000062\n",
      "No Regulated Authorization find with code 220000000061\n",
      "EU/1/97/039/003\n",
      "Found entry with code 220000000061\n",
      "['0', '600000034241']\n",
      "Cystagon 150 mg - Capsule, hard\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[('0', '600000034241', 'Cystagon 150 mg - Capsule, hard')]"
      ]
     },
     "execution_count": 328,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "documentAnnotationObj.processRegulatedAuthorizationForDoc(['EU/3/00/001','EU/1/97/039/003'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 329,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
